data_2dnr_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2dnr _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 99.1 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.865 0.364 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 895' ' ' VAL . . . . . . . . . . . . . 17.7 m -116.26 142.24 30.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.076 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . 0.462 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 6.5 mp -90.52 139.15 30.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.926 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 70.5 t -139.01 125.29 23.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.139 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 11.1 t -126.6 155.02 43.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.862 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . 0.553 HG12 ' CE2' ' A' ' 909' ' ' PHE . 2.6 pt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.123 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 909' ' ' PHE . . . . . 0.553 ' CE2' HG12 ' A' ' 899' ' ' ILE . 79.7 m-85 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.84 0.352 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -97.56 -177.25 3.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.835 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -61.92 -36.07 80.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -67.72 -57.36 6.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.112 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 22.6 mt -49.79 -47.0 51.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.923 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 914' ' ' ILE . . . . . 0.426 HD13 ' CZ ' ' A' ' 932' ' ' PHE . 47.5 mt -69.99 -65.93 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.125 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -38.81 -53.47 1.68 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.843 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -58.24 -51.15 70.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.893 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 917' ' ' LEU . . . . . 0.497 ' HB3' ' CE2' ' A' ' 921' ' ' PHE . 23.9 mt -48.93 -54.79 14.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.883 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 918' ' ' LEU . . . . . 0.434 ' C ' ' O ' ' A' ' 917' ' ' LEU . 52.4 mt -35.04 -58.81 0.52 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.939 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -54.76 -51.17 66.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.934 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 920' ' ' GLN . . . . . 0.42 ' NE2' ' CD2' ' A' ' 958' ' ' LEU . 14.4 mt-30 -51.27 -41.43 60.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.926 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 921' ' ' PHE . . . . . 0.497 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 23.6 m-85 -70.93 -32.1 68.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -58.3 -39.22 78.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.097 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -45.03 -25.58 0.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.918 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 924' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 1.0 OUTLIER -120.96 -64.1 1.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.878 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -121.33 145.08 16.96 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.467 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -85.82 97.23 10.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.88 0.372 . . . . 0.0 110.902 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 29.1 t -46.31 145.64 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.107 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 928' ' ' ILE . . . . . 0.444 HG13 ' N ' ' A' ' 929' ' ' LEU . 25.1 pt -126.63 -42.89 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.167 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 929' ' ' LEU . . . . . 0.444 ' N ' HG13 ' A' ' 928' ' ' ILE . 10.2 tp -133.7 145.84 50.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.946 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 81.7 mt -133.69 124.58 47.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.099 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 41.1 ttt180 -115.21 124.35 51.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.91 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 932' ' ' PHE . . . . . 0.426 ' CZ ' HD13 ' A' ' 914' ' ' ILE . 62.9 m-85 -90.76 122.42 33.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.912 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 933' ' ' VAL . . . . . 0.527 ' CG2' ' CD1' ' A' ' 938' ' ' TRP . 2.7 t -90.51 156.94 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.151 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 934' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 933' ' ' VAL . 14.7 mt-10 -34.49 -52.12 0.49 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.9 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.93 -25.52 3.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.896 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -96.63 172.92 7.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.864 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 937' ' ' MET . . . . . 0.544 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 15.9 ttt -133.54 110.73 10.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.903 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 938' ' ' TRP . . . . . 0.527 ' CD1' ' CG2' ' A' ' 933' ' ' VAL . 37.8 m0 -90.85 148.98 22.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.924 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 47.6 t -137.88 124.83 28.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.106 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 21.3 m -93.0 150.48 20.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.147 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 941' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -128.49 158.56 38.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.839 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 23.2 tp -40.72 -53.54 2.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.939 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -134.48 167.82 20.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.866 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -64.74 -47.4 83.68 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.523 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 70.5 m -50.06 -43.86 51.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.923 0.392 . . . . 0.0 110.831 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 1.9 t -56.64 -36.72 69.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.91 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -69.82 -13.64 62.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.103 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 23.8 mt -87.15 -25.23 24.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -82.78 -38.08 23.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 9.0 p -61.28 -18.47 18.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.139 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 58.7 mt -53.27 -17.84 2.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.941 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 46.3 m -61.77 -12.98 19.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.888 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 953' ' ' LEU . . . . . 0.464 ' HB2' ' CD1' ' A' ' 965' ' ' ILE . 75.3 mt -96.86 12.84 30.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.956 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -66.03 107.24 1.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.934 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 100.02 -26.85 22.9 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.487 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 8.4 tmtm? -40.17 128.86 2.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.772 0.32 . . . . 0.0 110.909 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -93.01 130.38 38.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.848 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 958' ' ' LEU . . . . . 0.42 ' CD2' ' NE2' ' A' ' 920' ' ' GLN . 16.2 tp -136.3 145.99 46.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.931 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 26.0 mt 44.94 52.24 8.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.953 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 49.26 31.85 3.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 961' ' ' ARG . . . . . . . . . . . . . 56.0 mtt-85 -138.89 111.76 7.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 18.7 m -66.25 116.57 7.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.164 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 963' ' ' ILE . . . . . . . . . . . . . 92.9 mt -97.82 137.21 26.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.114 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 9.6 m -122.41 110.42 15.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.134 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 965' ' ' ILE . . . . . 0.464 ' CD1' ' HB2' ' A' ' 953' ' ' LEU . 38.3 mt -94.61 143.23 12.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.139 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 966' ' ' ALA . . . . . 0.459 ' N ' HG22 ' A' ' 965' ' ' ILE . . . -157.3 133.26 9.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.149 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 967' ' ' LEU . . . . . . . . . . . . . 31.8 mt -67.12 157.73 32.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.905 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 19.3 tptp . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.897 179.842 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 53.6 m . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.822 0.344 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 895' ' ' VAL . . . . . . . . . . . . . 16.8 m -112.23 141.6 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.122 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . 0.53 ' HG ' ' CD1' ' A' ' 938' ' ' TRP . 3.6 mp -91.84 148.07 22.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.93 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 58.1 t -145.3 127.37 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.165 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 6.4 t -127.82 153.95 46.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.891 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 2.1 pt . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.109 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 909' ' ' PHE . . . . . 0.569 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 87.5 m-85 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.866 0.365 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -87.51 166.42 14.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.876 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -49.32 -44.83 44.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.855 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -62.96 -52.29 63.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.105 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 50.3 mt -53.69 -49.31 68.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.921 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 47.3 mt -65.85 -61.62 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.14 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -42.77 -60.72 1.47 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.869 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -48.92 -52.62 23.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.909 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 917' ' ' LEU . . . . . 0.519 ' HB3' ' CE2' ' A' ' 921' ' ' PHE . 29.6 mt -47.81 -54.71 11.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 918' ' ' LEU . . . . . 0.448 ' CD2' HD13 ' A' ' 930' ' ' ILE . 87.4 mt -35.22 -59.12 0.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.905 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -54.79 -44.66 73.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.89 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 62.5 mm-40 -57.46 -41.08 79.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 921' ' ' PHE . . . . . 0.519 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 23.5 m-85 -70.05 -34.22 72.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -60.67 -34.39 74.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.089 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -47.12 -24.15 0.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 924' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 1.2 m-85 -125.7 -55.23 1.52 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.878 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -129.16 135.07 8.25 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.453 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -79.08 98.37 6.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.918 0.39 . . . . 0.0 110.914 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 42.2 t -51.63 151.46 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.132 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 928' ' ' ILE . . . . . 0.458 HG13 ' N ' ' A' ' 929' ' ' LEU . 20.1 pt -125.81 -45.43 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.1 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 929' ' ' LEU . . . . . 0.458 ' N ' HG13 ' A' ' 928' ' ' ILE . 11.2 tp -132.87 148.08 52.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 930' ' ' ILE . . . . . 0.448 HD13 ' CD2' ' A' ' 918' ' ' LEU . 74.5 mt -133.12 132.86 58.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.128 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -120.87 123.92 43.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.847 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -90.69 120.18 31.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.877 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 933' ' ' VAL . . . . . 0.468 HG23 ' NE1' ' A' ' 938' ' ' TRP . 2.6 t -90.48 157.13 2.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.086 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 934' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 933' ' ' VAL . 58.3 mt-10 -33.94 -51.6 0.41 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.908 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -125.19 -25.49 3.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.878 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 936' ' ' LYS . . . . . 0.416 ' O ' ' N ' ' A' ' 933' ' ' VAL . 12.0 tttt -98.27 172.98 7.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.881 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 937' ' ' MET . . . . . 0.569 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 13.5 ttt -135.33 110.65 9.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 938' ' ' TRP . . . . . 0.53 ' CD1' ' HG ' ' A' ' 896' ' ' LEU . 40.2 m0 -88.69 149.11 23.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.944 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 12.1 t -139.12 129.36 32.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.128 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 17.3 m -93.73 151.15 19.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.151 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 941' ' ' PHE . . . . . 0.422 ' O ' ' C ' ' A' ' 942' ' ' LEU . 9.5 m-85 -130.56 139.82 50.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.917 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 942' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 941' ' ' PHE . 24.5 tp -35.14 -62.5 0.38 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.909 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -116.38 154.47 30.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.87 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -58.54 -50.01 71.23 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.442 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 12.6 t -48.21 -43.48 32.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.848 0.356 . . . . 0.0 110.857 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 14.6 m -55.77 -29.02 58.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.853 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -81.44 -23.0 37.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.073 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 38.3 mt -79.68 -25.71 41.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -84.6 -51.44 6.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.873 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 9.8 p -47.55 -21.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.163 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 951' ' ' LEU . . . . . 0.463 HD13 ' CD1' ' A' ' 967' ' ' LEU . 35.3 mt -49.52 -27.25 4.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.959 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 74.8 m -53.72 -15.29 1.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.903 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 953' ' ' LEU . . . . . 0.408 ' C ' HD11 ' A' ' 965' ' ' ILE . 57.7 mt -90.36 16.51 8.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.926 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.95 120.01 14.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 955' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 956' ' ' LYS . . . 86.21 -25.94 6.62 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.493 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 956' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 955' ' ' GLY . 8.9 tmtm? -36.21 126.84 0.77 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.747 0.308 . . . . 0.0 110.857 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -94.72 125.59 39.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 14.2 tp -138.35 153.69 48.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 959' ' ' LEU . . . . . 0.415 ' C ' ' CG ' ' A' ' 960' ' ' ASN . 45.3 mt 41.79 48.39 3.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 960' ' ' ASN . . . . . 0.415 ' CG ' ' C ' ' A' ' 959' ' ' LEU . 0.7 OUTLIER 46.5 42.94 11.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 961' ' ' ARG . . . . . . . . . . . . . 45.8 mtt85 -149.69 105.27 3.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 7.4 m -59.49 122.16 13.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.111 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 963' ' ' ILE . . . . . . . . . . . . . 88.3 mt -106.69 142.35 19.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.152 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 6.5 m -126.48 116.41 21.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.135 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 965' ' ' ILE . . . . . 0.438 HG21 ' N ' ' A' ' 966' ' ' ALA . 67.6 mt -98.03 139.28 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.179 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 966' ' ' ALA . . . . . 0.438 ' N ' HG21 ' A' ' 965' ' ' ILE . . . -148.7 128.09 13.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.07 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 967' ' ' LEU . . . . . 0.463 ' CD1' HD13 ' A' ' 951' ' ' LEU . 30.4 mt -66.51 157.46 32.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 30.5 tptt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 179.849 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 86.8 m . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.817 0.341 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 895' ' ' VAL . . . . . . . . . . . . . 27.5 m -120.19 139.28 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.143 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . 0.467 ' N ' HD12 ' A' ' 896' ' ' LEU . 6.4 mp -89.18 138.97 30.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . 0.424 HG21 ' C ' ' A' ' 896' ' ' LEU . 63.8 t -139.71 122.61 17.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.138 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 16.5 t -125.66 155.5 40.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.902 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . 0.523 HG12 ' CE2' ' A' ' 909' ' ' PHE . 2.3 pt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.128 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 909' ' ' PHE . . . . . 0.523 ' CE2' HG12 ' A' ' 899' ' ' ILE . 27.1 m-85 . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.841 0.353 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -86.18 177.31 7.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.871 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -55.17 -42.96 73.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.859 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -63.96 -47.24 81.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.076 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 52.1 mt -61.01 -48.95 79.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.926 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 914' ' ' ILE . . . . . 0.491 HD11 ' CZ ' ' A' ' 932' ' ' PHE . 49.6 mt -65.81 -59.95 3.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.14 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -45.28 -58.01 3.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.902 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -50.84 -52.53 40.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.891 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 917' ' ' LEU . . . . . 0.568 ' HB3' ' CE2' ' A' ' 921' ' ' PHE . 29.6 mt -46.4 -54.01 9.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.909 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 918' ' ' LEU . . . . . 0.414 ' C ' ' O ' ' A' ' 917' ' ' LEU . 20.6 mt -36.63 -64.42 0.34 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.939 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -50.14 -51.92 39.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.912 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -50.47 -40.97 52.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 921' ' ' PHE . . . . . 0.568 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 24.1 m-85 -69.74 -48.18 60.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.855 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -48.19 -28.31 2.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.108 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 923' ' ' SER . . . . . 0.563 ' HB3' ' CD1' ' A' ' 924' ' ' PHE . 16.7 t -47.49 -29.66 2.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.897 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 924' ' ' PHE . . . . . 0.563 ' CD1' ' HB3' ' A' ' 923' ' ' SER . 1.0 OUTLIER -123.02 -64.43 1.18 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.856 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -115.74 155.29 16.37 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.51 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -91.96 138.44 31.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.885 0.374 . . . . 0.0 110.909 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 55.9 t -93.07 146.16 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.114 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 928' ' ' ILE . . . . . 0.469 HG13 ' N ' ' A' ' 929' ' ' LEU . 30.2 pt -123.32 -42.86 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.107 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 929' ' ' LEU . . . . . 0.469 ' N ' HG13 ' A' ' 928' ' ' ILE . 15.0 tp -138.76 141.81 38.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 94.3 mt -127.36 125.47 65.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.154 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -113.44 122.82 48.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 932' ' ' PHE . . . . . 0.491 ' CZ ' HD11 ' A' ' 914' ' ' ILE . 61.6 m-85 -90.6 122.14 33.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.928 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 933' ' ' VAL . . . . . 0.569 HG22 ' CD1' ' A' ' 938' ' ' TRP . 2.9 t -89.9 157.09 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.158 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 934' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 933' ' ' VAL . 61.8 mt-10 -34.11 -50.53 0.4 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.891 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -126.05 -26.73 3.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.823 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 936' ' ' LYS . . . . . 0.414 ' NZ ' ' HB2' ' A' ' 936' ' ' LYS . 0.7 OUTLIER -96.53 172.73 7.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.933 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 937' ' ' MET . . . . . 0.485 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 14.5 ttt -135.26 111.78 9.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.863 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 938' ' ' TRP . . . . . 0.569 ' CD1' HG22 ' A' ' 933' ' ' VAL . 37.0 m0 -92.47 146.33 23.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 65.0 t -132.62 121.27 44.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.132 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 18.9 m -85.18 152.59 23.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.156 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 941' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -133.74 141.84 47.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 19.7 tp -42.55 -47.97 5.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.899 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -120.63 176.13 5.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -89.74 -39.2 6.28 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.519 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 36.0 p -59.54 -41.23 89.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.921 0.391 . . . . 0.0 110.861 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 80.0 p -56.38 -34.45 66.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.881 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -70.81 -15.18 62.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.103 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 25.5 mt -84.01 -31.53 25.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -75.67 -49.31 18.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.842 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 8.5 p -53.35 -17.31 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.143 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 52.3 mt -52.98 -24.96 10.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 35.9 p -55.88 -22.92 28.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 76.7 mt -83.25 17.9 1.92 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -72.63 110.35 6.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 96.02 -26.42 20.89 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.481 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -38.33 127.46 1.39 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.732 0.301 . . . . 0.0 110.897 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -94.9 128.42 41.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.901 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 958' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 961' ' ' ARG . 13.7 tp -136.97 160.04 40.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.926 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 959' ' ' LEU . . . . . 0.406 ' C ' ' O ' ' A' ' 958' ' ' LEU . 43.5 mt 37.7 43.07 0.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.967 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 55.44 43.31 28.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.871 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 961' ' ' ARG . . . . . 0.45 ' N ' ' O ' ' A' ' 958' ' ' LEU . 69.2 mtt-85 -149.71 122.89 8.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.844 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 6.0 m -75.05 112.72 11.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.119 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 963' ' ' ILE . . . . . . . . . . . . . 82.8 mt -98.02 138.17 23.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.088 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 9.3 m -122.13 113.25 19.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.109 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 965' ' ' ILE . . . . . . . . . . . . . 55.3 mt -98.75 135.07 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.113 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -149.27 136.63 20.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.095 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 967' ' ' LEU . . . . . . . . . . . . . 30.7 mt -65.44 156.58 31.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.895 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 968' ' ' LYS . . . . . 0.429 ' HE3' ' CH2' ' A' ' 938' ' ' TRP . 21.5 tttt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 84.8 m . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.823 0.344 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 895' ' ' VAL . . . . . . . . . . . . . 11.3 m -114.25 147.19 17.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.117 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . 0.459 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 3.5 mp -96.17 144.26 26.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.937 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 59.2 t -143.72 131.88 18.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.137 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 14.2 t -134.14 160.23 38.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.82 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 4.1 pt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.162 179.945 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 909' ' ' PHE . . . . . 0.547 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 90.0 m-85 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.899 0.381 . . . . 0.0 110.841 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -72.44 163.61 27.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.842 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -51.47 -35.95 42.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.831 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -70.49 -50.95 32.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.091 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 913' ' ' LEU . . . . . 0.416 HD21 ' CD ' ' A' ' 961' ' ' ARG . 87.4 mt -54.8 -35.43 63.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 91.2 mt -79.28 -65.0 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.14 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -39.69 -55.97 1.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.919 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -51.95 -48.46 64.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 917' ' ' LEU . . . . . 0.546 ' HB3' ' CE2' ' A' ' 921' ' ' PHE . 28.8 mt -55.06 -47.49 74.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 918' ' ' LEU . . . . . . . . . . . . . 44.6 mt -43.29 -55.58 3.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -58.63 -38.65 78.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 39.4 mm-40 -64.31 -35.83 82.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.888 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 921' ' ' PHE . . . . . 0.546 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 19.4 m-85 -76.03 -33.01 59.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -58.24 -31.92 67.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.104 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 923' ' ' SER . . . . . 0.478 ' OG ' ' CE2' ' A' ' 924' ' ' PHE . 31.9 p -56.93 -13.51 2.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.855 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 924' ' ' PHE . . . . . 0.478 ' CE2' ' OG ' ' A' ' 923' ' ' SER . 74.5 m-85 -125.97 -57.33 1.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.86 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -137.17 140.14 11.14 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.462 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -74.96 98.85 3.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.896 0.379 . . . . 0.0 110.871 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 58.0 t -50.29 145.16 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.146 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 928' ' ' ILE . . . . . 0.457 HG13 ' N ' ' A' ' 929' ' ' LEU . 20.0 pt -120.28 -45.38 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.138 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 929' ' ' LEU . . . . . 0.457 ' N ' HG13 ' A' ' 928' ' ' ILE . 11.2 tp -137.78 151.85 48.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.914 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 40.7 mt -135.97 129.85 48.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.113 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 21.4 ttt-85 -116.56 123.8 48.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -91.58 123.85 35.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.885 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 933' ' ' VAL . . . . . 0.558 HG23 ' CD1' ' A' ' 938' ' ' TRP . 3.6 t -90.78 156.97 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.17 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 934' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 933' ' ' VAL . 61.2 mm-40 -34.37 -51.32 0.45 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.1 -25.46 3.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.803 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.03 173.02 7.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 937' ' ' MET . . . . . 0.547 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 15.1 ttt -134.19 113.51 12.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.877 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 938' ' ' TRP . . . . . 0.558 ' CD1' HG23 ' A' ' 933' ' ' VAL . 37.1 m0 -93.89 151.89 19.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.889 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 39.8 t -134.86 139.19 47.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.161 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 29.2 m -110.66 146.8 35.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.15 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 941' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -130.21 149.84 51.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.884 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 21.2 tp -40.25 -63.63 0.6 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.902 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -107.43 168.48 9.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.91 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -76.42 -49.8 7.91 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.482 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 6.6 p -49.41 -27.25 3.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.921 0.391 . . . . 0.0 110.883 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 70.5 m -63.22 -47.59 81.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.864 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -60.28 -27.88 67.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.107 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 18.3 mt -73.66 -25.12 60.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.933 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -81.8 -45.05 16.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.919 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 3.2 p -57.83 -18.8 10.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.13 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 23.0 mt -51.77 -31.42 26.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.962 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 6.4 t -51.52 -17.19 0.74 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.837 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 953' ' ' LEU . . . . . 0.444 ' CB ' HD11 ' A' ' 965' ' ' ILE . 39.8 mt -87.85 13.76 10.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.888 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -66.28 117.22 8.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 90.88 -26.7 10.29 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.5 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -41.43 128.54 3.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.794 0.331 . . . . 0.0 110.881 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -97.78 130.43 44.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.857 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 15.3 tp -134.74 156.21 49.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.935 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 47.0 mt 38.83 46.02 1.01 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.922 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 51.88 45.32 28.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.847 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 961' ' ' ARG . . . . . 0.416 ' CD ' HD21 ' A' ' 913' ' ' LEU . 52.0 mtt85 -151.65 105.42 3.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.925 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 18.7 m -57.75 117.49 4.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.152 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 963' ' ' ILE . . . . . . . . . . . . . 97.4 mt -101.14 139.03 23.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 4.2 m -123.66 116.06 22.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.177 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 965' ' ' ILE . . . . . 0.444 HD11 ' CB ' ' A' ' 953' ' ' LEU . 55.2 mt -101.1 139.94 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.159 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -152.03 131.25 12.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.142 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 967' ' ' LEU . . . . . . . . . . . . . 33.7 mt -64.55 157.87 25.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.939 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 22.8 tptm . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 179.849 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 33.9 m . . . . . 0 N--CA 1.457 -0.107 0 CA-C-O 120.798 0.332 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 895' ' ' VAL . . . . . . . . . . . . . 13.9 m -116.31 139.76 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.152 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . 0.47 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 3.2 mp -89.53 150.82 22.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.891 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 64.3 t -144.95 131.66 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.178 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 5.2 t -133.53 154.71 50.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 4.1 pt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.111 179.994 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 909' ' ' PHE . . . . . 0.544 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 50.6 m-85 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.854 0.359 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -96.91 169.1 10.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -48.12 -38.55 18.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.878 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -67.59 -54.24 21.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.064 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 913' ' ' LEU . . . . . 0.424 HD21 ' CD ' ' A' ' 961' ' ' ARG . 36.7 mt -52.92 -42.01 64.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.908 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 60.7 mt -74.08 -64.91 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.11 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -40.02 -61.55 0.85 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -48.89 -55.52 11.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.904 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 917' ' ' LEU . . . . . 0.552 ' HB3' ' CZ ' ' A' ' 921' ' ' PHE . 24.9 mt -46.5 -54.15 9.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 918' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 917' ' ' LEU . 89.4 mt -36.81 -59.39 0.69 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -55.35 -48.69 73.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -53.16 -41.3 65.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.938 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 921' ' ' PHE . . . . . 0.552 ' CZ ' ' HB3' ' A' ' 917' ' ' LEU . 19.8 m-85 -64.72 -45.0 88.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.925 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -54.03 -30.99 49.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.102 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 29.7 t -45.54 -30.98 1.62 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 924' ' ' PHE . . . . . 0.532 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 1.0 OUTLIER -120.73 -57.63 1.88 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -127.03 152.22 18.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.512 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -87.62 135.51 33.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.855 0.36 . . . . 0.0 110.889 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 46.7 t -87.7 145.93 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.113 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 928' ' ' ILE . . . . . 0.429 HG13 ' N ' ' A' ' 929' ' ' LEU . 26.6 pt -120.65 -41.56 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.093 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 929' ' ' LEU . . . . . 0.429 ' N ' HG13 ' A' ' 928' ' ' ILE . 21.9 tp -141.06 149.05 41.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.95 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 58.4 mt -133.24 132.54 58.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.144 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -118.39 130.58 56.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -97.59 120.78 38.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.851 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 933' ' ' VAL . . . . . 0.566 HG22 ' CD1' ' A' ' 938' ' ' TRP . 2.8 t -91.58 157.12 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.109 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 934' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 933' ' ' VAL . 44.3 mt-10 -33.56 -54.01 0.43 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.905 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -124.5 -22.42 4.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.817 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 6.3 ttmt -99.59 173.14 6.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.868 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 937' ' ' MET . . . . . 0.544 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 17.3 ttt -136.14 114.31 11.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 938' ' ' TRP . . . . . 0.566 ' CD1' HG22 ' A' ' 933' ' ' VAL . 37.8 m0 -94.72 143.9 26.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.96 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 47.9 t -130.78 137.82 55.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.16 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 19.4 m -106.85 144.36 33.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.18 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 941' ' ' PHE . . . . . 0.444 ' O ' ' C ' ' A' ' 942' ' ' LEU . 6.0 m-85 -125.38 144.22 50.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.909 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 942' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 941' ' ' PHE . 43.1 tp -34.33 -67.84 0.13 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.925 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -104.44 171.81 7.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.903 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -76.02 -49.6 8.48 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.499 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 95.6 p -50.44 -25.93 4.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.865 0.364 . . . . 0.0 110.869 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 60.7 m -65.63 -42.59 91.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.793 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -68.62 -16.29 63.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.091 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 13.6 mt -87.86 -24.18 23.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.948 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -81.71 -51.05 8.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.944 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 9.8 p -52.02 -20.11 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.135 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 73.0 mt -50.72 -20.73 1.33 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 26.1 m -61.88 -9.43 6.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.822 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 58.8 mt -95.76 11.55 33.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.926 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -67.16 117.43 9.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 90.28 -23.06 23.47 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.517 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.05 127.14 8.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.731 0.3 . . . . 0.0 110.915 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -93.06 123.06 36.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 14.9 tp -129.35 154.94 46.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.948 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 39.0 mt 39.23 46.29 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.906 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 50.95 46.06 26.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.86 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 961' ' ' ARG . . . . . 0.424 ' CD ' HD21 ' A' ' 913' ' ' LEU . 41.4 mtt85 -152.02 106.47 3.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.929 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 7.7 m -60.16 111.18 1.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.141 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 963' ' ' ILE . . . . . . . . . . . . . 79.7 mt -95.78 146.32 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.152 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 5.4 m -129.43 118.23 21.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.131 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 965' ' ' ILE . . . . . 0.462 HG22 ' N ' ' A' ' 966' ' ' ALA . 60.8 mt -105.11 141.28 20.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.086 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 966' ' ' ALA . . . . . 0.462 ' N ' HG22 ' A' ' 965' ' ' ILE . . . -151.59 135.69 16.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.064 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 967' ' ' LEU . . . . . . . . . . . . . 31.5 mt -68.22 158.13 33.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.917 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 11.3 tptt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 179.857 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 90.3 m . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.794 0.33 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 895' ' ' VAL . . . . . . . . . . . . . 23.7 m -121.0 138.86 50.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.138 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . 0.457 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 4.1 mp -89.71 146.4 24.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 70.2 t -144.83 125.32 7.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.098 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 10.6 t -128.07 154.13 46.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.848 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . 0.564 HG21 ' CE2' ' A' ' 909' ' ' PHE . 3.6 pt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 909' ' ' PHE . . . . . 0.564 ' CE2' HG21 ' A' ' 899' ' ' ILE . 91.6 m-85 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.839 0.352 . . . . 0.0 110.914 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.29 179.41 5.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -57.3 -45.43 84.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -57.66 -57.69 11.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.108 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 87.4 mt -49.48 -55.24 13.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.965 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 49.6 mt -60.64 -63.49 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.096 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -41.12 -59.45 1.49 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -53.84 -48.94 69.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.866 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 917' ' ' LEU . . . . . 0.542 ' HB3' ' CE2' ' A' ' 921' ' ' PHE . 27.5 mt -50.97 -58.67 5.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.887 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 918' ' ' LEU . . . . . 0.45 ' CD2' HD11 ' A' ' 930' ' ' ILE . 73.0 mt -34.44 -48.16 0.34 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.915 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -63.77 -45.98 87.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.891 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 920' ' ' GLN . . . . . 0.454 ' N ' ' O ' ' A' ' 917' ' ' LEU . 15.2 mm-40 -58.1 -35.04 70.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.914 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 921' ' ' PHE . . . . . 0.542 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 17.6 m-85 -75.2 -37.7 61.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -57.76 -32.62 67.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.114 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -50.82 -23.3 2.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 924' ' ' PHE . . . . . 0.58 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 0.4 OUTLIER -125.13 -58.29 1.46 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.909 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -129.33 150.53 18.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.432 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -88.99 132.37 34.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.885 0.374 . . . . 0.0 110.86 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 927' ' ' VAL . . . . . 0.44 HG13 ' N ' ' A' ' 928' ' ' ILE . 22.9 t -84.58 147.33 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.19 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 928' ' ' ILE . . . . . 0.442 HG13 ' N ' ' A' ' 929' ' ' LEU . 41.6 pt -123.38 -38.19 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.158 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 929' ' ' LEU . . . . . 0.442 ' N ' HG13 ' A' ' 928' ' ' ILE . 12.0 tp -141.78 147.86 37.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 930' ' ' ILE . . . . . 0.45 HD11 ' CD2' ' A' ' 918' ' ' LEU . 79.4 mt -133.42 124.55 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.119 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -111.68 125.8 54.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -91.98 123.89 35.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.846 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 933' ' ' VAL . . . . . 0.564 HG23 ' CD1' ' A' ' 938' ' ' TRP . 3.1 t -92.07 157.02 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.078 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 934' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 933' ' ' VAL . 15.8 mt-10 -34.35 -52.37 0.48 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -125.08 -25.47 3.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.825 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.02 173.04 7.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.914 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 937' ' ' MET . . . . . 0.528 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 15.1 ttt -132.51 108.35 9.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 938' ' ' TRP . . . . . 0.564 ' CD1' HG23 ' A' ' 933' ' ' VAL . 38.1 m0 -90.26 144.89 25.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.961 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 61.1 t -131.76 133.56 61.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.131 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 940' ' ' THR . . . . . 0.413 ' CG2' ' N ' ' A' ' 941' ' ' PHE . 51.6 m -96.81 156.31 16.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.138 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 941' ' ' PHE . . . . . 0.413 ' N ' ' CG2' ' A' ' 940' ' ' THR . 15.1 m-85 -137.93 144.39 41.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.879 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 29.9 tp -47.04 -44.57 20.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.949 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -123.44 170.39 10.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.921 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -86.34 -41.15 7.08 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.465 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 38.6 p -54.66 -35.21 63.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.839 0.352 . . . . 0.0 110.86 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.76 -40.95 98.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.841 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -64.44 -19.09 65.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.097 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 23.9 mt -83.45 -27.41 29.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -81.82 -51.26 8.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.921 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 7.0 p -48.02 -21.5 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.096 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 951' ' ' LEU . . . . . 0.422 HD13 ' CD1' ' A' ' 967' ' ' LEU . 34.1 mt -49.11 -28.44 4.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.918 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 1.1 t -50.9 -17.54 0.59 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 953' ' ' LEU . . . . . 0.401 ' C ' HD11 ' A' ' 965' ' ' ILE . 46.6 mt -90.39 17.32 7.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.895 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -70.87 110.79 5.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.884 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 93.66 -25.14 22.64 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.493 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -39.38 127.23 1.82 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.705 0.288 . . . . 0.0 110.865 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -94.24 125.08 38.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.87 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 958' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 959' ' ' LEU . 14.9 tp -135.41 158.65 43.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.882 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 959' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 958' ' ' LEU . 51.8 mt 38.23 44.24 0.67 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.927 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 51.56 44.39 29.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 961' ' ' ARG . . . . . . . . . . . . . 34.1 mtt85 -151.45 108.69 3.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 8.6 m -62.14 118.24 7.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.132 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 963' ' ' ILE . . . . . . . . . . . . . 92.0 mt -103.7 137.63 31.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.136 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 7.0 m -121.47 112.78 18.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.184 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 965' ' ' ILE . . . . . 0.457 HG23 ' N ' ' A' ' 966' ' ' ALA . 61.8 mt -97.42 139.98 18.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.105 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 966' ' ' ALA . . . . . 0.457 ' N ' HG23 ' A' ' 965' ' ' ILE . . . -149.01 138.36 21.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.098 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 967' ' ' LEU . . . . . 0.422 ' CD1' HD13 ' A' ' 951' ' ' LEU . 39.0 mt -75.84 156.07 34.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.897 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 22.0 tptm . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.912 179.822 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 54.1 m . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.786 0.327 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 895' ' ' VAL . . . . . . . . . . . . . 21.4 m -119.09 141.33 39.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.13 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . 0.458 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 4.5 mp -90.23 142.25 27.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . 0.417 HG22 ' C ' ' A' ' 896' ' ' LEU . 96.6 t -141.83 129.54 21.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.114 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 4.4 t -131.49 160.11 36.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.842 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . 0.43 HG12 ' CE1' ' A' ' 909' ' ' PHE . 2.0 pt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.149 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 909' ' ' PHE . . . . . 0.546 ' CE2' ' HB2' ' A' ' 937' ' ' MET . 47.2 m-85 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.888 0.375 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -73.89 161.85 29.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.857 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -49.35 -50.97 37.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.865 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -54.78 -50.58 68.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.13 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 913' ' ' LEU . . . . . 0.422 HD12 ' CD ' ' A' ' 961' ' ' ARG . 20.1 mt -51.72 -52.3 49.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 54.2 mt -60.73 -57.99 9.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.147 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -49.49 -64.0 0.94 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.893 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -44.9 -50.45 10.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.892 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 917' ' ' LEU . . . . . 0.502 ' HB3' ' CE2' ' A' ' 921' ' ' PHE . 28.4 mt -48.37 -55.1 11.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 918' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 917' ' ' LEU . 58.4 mt -36.47 -62.98 0.43 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.941 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -54.0 -44.8 71.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -56.5 -37.39 70.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.883 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 921' ' ' PHE . . . . . 0.502 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 24.2 m-85 -73.74 -39.22 64.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.857 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -53.79 -28.07 32.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 923' ' ' SER . . . . . 0.512 ' HB3' ' CE1' ' A' ' 924' ' ' PHE . 40.9 t -46.14 -30.84 2.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.834 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 924' ' ' PHE . . . . . 0.56 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 0.3 OUTLIER -122.66 -65.09 1.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.873 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -111.67 144.96 17.7 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.462 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -87.47 96.52 10.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.874 0.369 . . . . 0.0 110.89 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 927' ' ' VAL . . . . . 0.431 HG13 ' N ' ' A' ' 928' ' ' ILE . 44.4 t -53.02 144.08 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.131 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 928' ' ' ILE . . . . . 0.448 HG13 ' N ' ' A' ' 929' ' ' LEU . 15.2 pt -121.92 -46.79 2.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.102 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 929' ' ' LEU . . . . . 0.448 ' N ' HG13 ' A' ' 928' ' ' ILE . 17.3 tp -131.08 149.73 52.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 930' ' ' ILE . . . . . 0.414 HG21 ' N ' ' A' ' 931' ' ' ARG . 45.2 mt -135.13 136.1 51.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.176 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 931' ' ' ARG . . . . . 0.414 ' N ' HG21 ' A' ' 930' ' ' ILE . 7.7 tpt180 -119.8 121.43 39.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.882 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -87.43 116.85 25.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 933' ' ' VAL . . . . . 0.562 ' CG2' ' CD1' ' A' ' 938' ' ' TRP . 2.9 t -85.54 156.01 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.126 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 934' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 933' ' ' VAL . 31.1 mt-10 -34.21 -51.36 0.44 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -124.15 -27.14 3.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.877 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -96.01 173.06 7.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 937' ' ' MET . . . . . 0.546 ' HB2' ' CE2' ' A' ' 909' ' ' PHE . 17.7 ttt -135.01 106.69 6.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 938' ' ' TRP . . . . . 0.562 ' CD1' ' CG2' ' A' ' 933' ' ' VAL . 33.3 m0 -85.92 153.6 22.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.924 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 87.4 t -139.74 128.25 26.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.139 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 27.0 m -90.95 151.51 21.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.128 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 941' ' ' PHE . . . . . 0.438 ' O ' ' C ' ' A' ' 942' ' ' LEU . 11.6 m-85 -132.68 141.84 48.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.857 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 942' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 941' ' ' PHE . 19.6 tp -34.41 -64.59 0.24 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.89 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -117.82 150.96 38.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.874 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -53.43 -45.95 65.4 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.458 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 14.6 t -50.77 -41.05 56.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.845 0.355 . . . . 0.0 110.832 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 9.2 m -58.77 -26.29 63.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.836 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -81.58 -13.11 58.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.127 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 33.6 mt -88.06 -28.08 21.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.953 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 33.0 m-20 -82.88 -45.37 14.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 8.7 p -53.47 -22.79 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.174 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 63.1 mt -50.95 -25.54 4.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.886 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 15.3 m -54.4 -16.65 2.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.849 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 953' ' ' LEU . . . . . 0.434 ' CB ' HD13 ' A' ' 965' ' ' ILE . 23.4 mt -89.61 16.02 8.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.912 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -68.44 119.96 13.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.937 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 955' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 956' ' ' LYS . . . 88.11 -30.79 4.98 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.524 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 956' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 955' ' ' GLY . 8.6 tmtm? -35.38 127.87 0.58 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.693 0.282 . . . . 0.0 110.911 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -96.41 131.8 42.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.835 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 13.5 tp -138.1 154.56 49.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 87.6 mt 39.53 45.39 1.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.938 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 55.96 46.36 22.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 961' ' ' ARG . . . . . 0.422 ' CD ' HD12 ' A' ' 913' ' ' LEU . 46.3 mtt85 -154.64 121.86 5.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.884 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 8.3 m -74.08 108.39 6.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.124 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 963' ' ' ILE . . . . . 0.435 ' CD1' HD22 ' A' ' 917' ' ' LEU . 90.1 mt -88.95 130.94 37.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.177 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 9.2 m -116.45 119.38 35.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.1 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 965' ' ' ILE . . . . . 0.456 HG22 ' N ' ' A' ' 966' ' ' ALA . 59.3 mt -103.36 140.31 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.124 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 966' ' ' ALA . . . . . 0.456 ' N ' HG22 ' A' ' 965' ' ' ILE . . . -149.47 136.06 19.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.082 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 967' ' ' LEU . . . . . . . . . . . . . 27.0 mt -70.57 154.62 41.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.921 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 16.2 tptm . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.871 179.856 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 97.3 m . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.792 0.33 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 895' ' ' VAL . . . . . . . . . . . . . 20.3 m -112.72 140.06 34.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.091 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . 0.465 ' HG ' ' CD1' ' A' ' 938' ' ' TRP . 3.9 mp -91.46 142.68 27.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . 0.462 HG11 ' CG2' ' A' ' 963' ' ' ILE . 93.7 t -140.46 124.92 18.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.135 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 18.0 t -127.54 154.88 44.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 5.2 pt . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.107 -179.999 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 909' ' ' PHE . . . . . 0.497 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 91.5 m-85 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.861 0.363 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -93.1 -178.59 4.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -55.72 -42.53 75.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.854 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -65.5 -57.89 7.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.102 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 913' ' ' LEU . . . . . 0.42 ' CD2' ' HD2' ' A' ' 961' ' ' ARG . 19.4 mt -49.96 -45.84 51.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.938 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 914' ' ' ILE . . . . . 0.533 HD13 ' CE1' ' A' ' 932' ' ' PHE . 44.2 mt -71.47 -64.76 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.102 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -38.03 -59.58 0.83 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -52.25 -52.33 53.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.863 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 917' ' ' LEU . . . . . 0.552 ' HB3' ' CE2' ' A' ' 921' ' ' PHE . 31.6 mt -49.58 -55.93 11.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.918 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 918' ' ' LEU . . . . . 0.439 ' C ' ' O ' ' A' ' 917' ' ' LEU . 77.8 mt -35.06 -57.86 0.55 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -58.15 -40.79 82.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.92 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 920' ' ' GLN . . . . . 0.545 ' NE2' ' HZ1' ' A' ' 956' ' ' LYS . 35.6 mm-40 -61.56 -38.08 86.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 921' ' ' PHE . . . . . 0.552 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 20.1 m-85 -70.88 -36.06 72.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -58.86 -34.65 71.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.133 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.7 m -47.18 -26.54 1.18 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 924' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 0.7 OUTLIER -121.01 -65.37 1.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.894 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -122.22 150.76 16.95 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.507 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -85.71 140.16 30.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.881 0.372 . . . . 0.0 110.879 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 62.1 t -94.74 142.63 13.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.076 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 928' ' ' ILE . . . . . 0.467 HG13 ' N ' ' A' ' 929' ' ' LEU . 41.4 pt -121.64 -39.92 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.13 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 929' ' ' LEU . . . . . 0.467 ' N ' HG13 ' A' ' 928' ' ' ILE . 17.7 tp -139.97 139.21 36.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.926 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 74.0 mt -127.52 129.47 70.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.123 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 5.0 tpm_? -116.23 125.25 51.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.888 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 932' ' ' PHE . . . . . 0.533 ' CE1' HD13 ' A' ' 914' ' ' ILE . 60.4 m-85 -94.84 114.9 26.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 933' ' ' VAL . . . . . 0.472 HG22 ' NE1' ' A' ' 938' ' ' TRP . 2.6 t -83.41 157.11 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.167 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 934' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 933' ' ' VAL . 53.2 mt-10 -34.04 -50.85 0.4 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.909 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -125.31 -25.93 3.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.855 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 936' ' ' LYS . . . . . 0.447 ' O ' ' N ' ' A' ' 933' ' ' VAL . 1.0 OUTLIER -97.3 169.83 9.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 937' ' ' MET . . . . . 0.497 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 16.4 ttt -132.03 111.52 11.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.844 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 938' ' ' TRP . . . . . 0.472 ' NE1' HG22 ' A' ' 933' ' ' VAL . 39.2 m0 -91.96 144.13 25.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.932 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 47.0 t -131.46 135.82 58.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 23.1 m -108.88 148.17 31.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.133 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 941' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -128.32 152.14 48.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.826 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 45.1 tp -41.92 -62.73 0.85 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.944 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -105.63 172.3 6.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -77.49 -44.83 12.04 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.517 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 45.6 t -56.67 -30.5 63.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.872 0.368 . . . . 0.0 110.858 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 72.7 m -58.94 -33.94 71.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.819 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -74.19 -20.19 60.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.057 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 30.0 mt -83.48 -26.06 30.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.871 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -80.14 -41.24 25.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.87 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 8.2 p -61.75 -21.98 27.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.159 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 50.7 mt -50.38 -25.41 3.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 952' ' ' SER . . . . . 0.408 ' HB2' ' CE2' ' A' ' 924' ' ' PHE . 67.9 m -56.1 -13.72 2.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.832 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 953' ' ' LEU . . . . . 0.46 ' CB ' HD13 ' A' ' 965' ' ' ILE . 24.4 mt -93.3 17.24 11.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.908 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -70.77 119.24 14.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 88.09 -25.26 9.12 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.489 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 956' ' ' LYS . . . . . 0.545 ' HZ1' ' NE2' ' A' ' 920' ' ' GLN . 0.3 OUTLIER -41.63 127.43 3.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.759 0.314 . . . . 0.0 110.896 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -95.65 124.28 39.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.86 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 14.9 tp -131.93 151.64 51.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.931 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 44.0 mt 41.14 49.63 3.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.916 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 50.47 37.27 15.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 961' ' ' ARG . . . . . 0.42 ' HD2' ' CD2' ' A' ' 913' ' ' LEU . 56.9 mtt85 -143.63 106.06 4.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.851 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 60.5 m -65.31 112.78 3.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.14 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 963' ' ' ILE . . . . . 0.462 ' CG2' HG11 ' A' ' 897' ' ' VAL . 71.2 mt -93.17 149.26 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.128 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 1.7 m -131.94 109.02 9.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.136 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 965' ' ' ILE . . . . . 0.46 HD13 ' CB ' ' A' ' 953' ' ' LEU . 70.3 mt -92.5 139.24 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.102 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 966' ' ' ALA . . . . . 0.427 ' N ' HG21 ' A' ' 965' ' ' ILE . . . -150.6 135.17 17.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.103 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 967' ' ' LEU . . . . . . . . . . . . . 26.6 mt -67.94 154.39 41.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.895 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 16.7 tptp . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.925 179.806 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 89.4 m . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.887 0.375 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 895' ' ' VAL . . . . . . . . . . . . . 10.8 m -113.63 138.61 42.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.088 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . 0.462 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 4.2 mp -90.47 143.57 26.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.968 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . 0.418 HG23 ' C ' ' A' ' 896' ' ' LEU . 95.6 t -141.78 130.36 22.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.107 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 10.8 t -129.53 152.37 49.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . 0.482 HG21 ' CE2' ' A' ' 909' ' ' PHE . 2.8 pt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.111 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 909' ' ' PHE . . . . . 0.563 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 97.1 m-85 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.855 0.36 . . . . 0.0 110.878 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -84.71 179.02 7.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.87 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -58.61 -45.26 89.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -60.15 -60.85 3.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.068 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 913' ' ' LEU . . . . . 0.465 ' CD1' ' NH1' ' A' ' 961' ' ' ARG . 35.4 mt -45.31 -49.49 12.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.961 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 52.0 mt -63.6 -53.19 48.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.157 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -46.4 -56.63 5.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.846 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -56.65 -51.49 68.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 917' ' ' LEU . . . . . 0.535 ' HB3' ' CE2' ' A' ' 921' ' ' PHE . 51.0 mt -46.13 -57.85 4.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 918' ' ' LEU . . . . . . . . . . . . . 99.3 mt -36.95 -62.99 0.45 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.953 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -54.02 -44.22 70.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.919 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 920' ' ' GLN . . . . . 0.417 ' NE2' ' HZ3' ' A' ' 956' ' ' LYS . 44.5 mm-40 -57.67 -38.91 75.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 921' ' ' PHE . . . . . 0.535 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 23.3 m-85 -72.68 -36.88 68.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.903 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -56.73 -32.69 65.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.102 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -52.04 -17.89 1.21 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.854 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 924' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 1.8 m-85 -126.06 -58.17 1.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.88 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -134.68 151.12 20.28 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.505 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -83.1 134.95 34.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.887 0.375 . . . . 0.0 110.872 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 41.2 t -89.01 143.47 11.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.177 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 928' ' ' ILE . . . . . 0.466 HG13 ' N ' ' A' ' 929' ' ' LEU . 20.4 pt -121.82 -45.83 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 929' ' ' LEU . . . . . 0.466 ' N ' HG13 ' A' ' 928' ' ' ILE . 25.5 tp -131.66 146.16 52.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 93.5 mt -136.71 122.86 28.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.113 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -111.26 123.35 50.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -87.64 118.58 27.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 933' ' ' VAL . . . . . 0.523 HG23 ' CD1' ' A' ' 938' ' ' TRP . 3.5 t -86.17 157.14 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.119 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 934' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 933' ' ' VAL . 32.3 mt-10 -33.82 -53.82 0.45 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -124.18 -20.73 5.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.89 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 19.3 tttt -101.31 173.04 6.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.897 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 937' ' ' MET . . . . . 0.563 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 12.7 ttt -133.58 114.03 13.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.897 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 938' ' ' TRP . . . . . 0.523 ' CD1' HG23 ' A' ' 933' ' ' VAL . 43.3 m0 -91.25 146.2 24.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 61.0 t -136.15 122.27 30.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.117 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 6.8 m -91.07 150.49 21.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.151 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 941' ' ' PHE . . . . . 0.444 ' O ' ' C ' ' A' ' 942' ' ' LEU . 9.1 m-85 -130.28 144.26 51.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.912 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 942' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 941' ' ' PHE . 61.1 tp -34.55 -59.76 0.45 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -117.9 169.65 9.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.892 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -71.68 -49.13 25.36 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.514 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 74.1 p -50.56 -28.61 8.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.859 0.362 . . . . 0.0 110.857 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 6.0 m -67.05 -32.32 73.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.881 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -82.36 -13.82 56.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.086 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 42.8 mt -87.36 -29.53 21.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.924 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -82.49 -37.66 24.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.903 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 9.2 p -61.94 -15.61 14.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.098 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 40.0 mt -53.93 -26.32 24.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.94 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 33.3 t -53.46 -15.78 1.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.861 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 953' ' ' LEU . . . . . 0.413 ' C ' HD11 ' A' ' 965' ' ' ILE . 36.9 mt -89.89 14.15 12.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.929 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -68.76 116.97 9.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.864 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 90.58 -25.82 12.22 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.473 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 956' ' ' LYS . . . . . 0.417 ' HZ3' ' NE2' ' A' ' 920' ' ' GLN . 3.5 tmtt? -39.71 127.76 2.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.744 0.307 . . . . 0.0 110.883 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -94.48 131.37 40.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.901 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 958' ' ' LEU . . . . . 0.407 HD12 ' NZ ' ' A' ' 956' ' ' LYS . 15.8 tp -141.35 153.18 44.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.881 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 959' ' ' LEU . . . . . 0.444 ' O ' ' CG ' ' A' ' 960' ' ' ASN . 38.2 mt 41.42 48.2 3.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.952 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 960' ' ' ASN . . . . . 0.444 ' CG ' ' O ' ' A' ' 959' ' ' LEU . 14.1 p30 48.18 42.41 17.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 961' ' ' ARG . . . . . 0.465 ' NH1' ' CD1' ' A' ' 913' ' ' LEU . 73.9 mtt180 -149.72 108.49 3.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 6.8 m -60.26 119.11 7.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.156 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 963' ' ' ILE . . . . . . . . . . . . . 91.4 mt -102.6 134.0 44.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.148 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 3.8 m -119.76 119.17 32.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.108 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 965' ' ' ILE . . . . . 0.439 HG22 ' N ' ' A' ' 966' ' ' ALA . 51.2 mt -101.26 142.12 16.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.128 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 966' ' ' ALA . . . . . 0.439 ' N ' HG22 ' A' ' 965' ' ' ILE . . . -151.21 131.5 13.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.082 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 967' ' ' LEU . . . . . . . . . . . . . 30.9 mt -69.85 158.34 35.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 18.5 tptt . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.935 179.85 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 75.8 m . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.839 0.352 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 895' ' ' VAL . . . . . . . . . . . . . 18.8 m -112.29 142.92 23.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.125 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . 0.466 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 4.2 mp -91.08 146.84 23.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 92.9 t -146.9 125.56 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.118 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 6.4 t -125.71 155.59 40.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 2.2 pt . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.093 179.974 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 909' ' ' PHE . . . . . 0.448 ' CE1' ' CB ' ' A' ' 937' ' ' MET . 76.2 m-85 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.849 0.356 . . . . 0.0 110.883 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -92.99 159.03 15.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.879 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -45.08 -49.71 11.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -53.92 -51.92 62.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.087 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 41.3 mt -53.36 -53.45 50.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.909 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 54.2 mt -60.14 -62.9 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.125 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -42.38 -51.03 5.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -61.49 -44.11 97.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.864 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 917' ' ' LEU . . . . . 0.56 ' HB3' ' CE2' ' A' ' 921' ' ' PHE . 26.1 mt -56.84 -57.9 10.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 918' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 917' ' ' LEU . 66.5 mt -34.82 -48.83 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -64.94 -47.56 77.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 60.2 mm-40 -55.75 -37.43 68.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 921' ' ' PHE . . . . . 0.56 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 22.4 m-85 -67.32 -50.8 58.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -46.27 -24.23 0.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.07 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 923' ' ' SER . . . . . 0.459 ' HB3' ' CE1' ' A' ' 924' ' ' PHE . 31.2 t -48.76 -32.06 7.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 924' ' ' PHE . . . . . 0.57 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 0.3 OUTLIER -123.18 -52.94 1.84 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -131.84 147.92 18.85 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.524 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -84.87 135.43 34.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.854 0.359 . . . . 0.0 110.926 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 11.9 t -81.86 145.37 8.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.143 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 928' ' ' ILE . . . . . 0.461 HG13 ' N ' ' A' ' 929' ' ' LEU . 42.8 pt -122.17 -36.39 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.161 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 929' ' ' LEU . . . . . 0.461 ' N ' HG13 ' A' ' 928' ' ' ILE . 10.2 tp -144.09 146.48 32.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.889 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 50.0 mt -135.9 128.8 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.135 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 16.0 ttt-85 -118.75 123.93 46.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.907 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -91.22 122.06 33.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 933' ' ' VAL . . . . . 0.47 HG22 ' NE1' ' A' ' 938' ' ' TRP . 2.8 t -90.22 157.09 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.114 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 934' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 933' ' ' VAL . 81.2 mm-40 -33.71 -51.77 0.39 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.886 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -124.96 -26.18 3.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 936' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' A' ' 933' ' ' VAL . 7.9 ttmm -96.45 170.87 8.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 937' ' ' MET . . . . . 0.448 ' CB ' ' CE1' ' A' ' 909' ' ' PHE . 16.2 ttt -134.46 112.17 10.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.863 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 938' ' ' TRP . . . . . 0.47 ' NE1' HG22 ' A' ' 933' ' ' VAL . 36.0 m0 -93.35 142.13 27.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 53.9 t -130.48 127.43 62.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.171 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 8.9 m -98.57 152.63 19.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 941' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -127.92 145.89 50.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 942' ' ' LEU . . . . . 0.423 ' CA ' HG23 ' A' ' 928' ' ' ILE . 22.7 tp -41.22 -40.84 1.69 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.949 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -130.39 176.69 7.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.919 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -86.32 -53.76 2.87 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.526 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 59.0 p -46.69 -22.34 0.28 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.882 0.372 . . . . 0.0 110.884 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 2.1 p -75.22 -37.12 61.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.841 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -70.7 -16.35 62.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 29.1 mt -84.05 -28.87 27.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.943 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -80.95 -46.48 15.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.859 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 7.6 p -53.83 -17.38 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.127 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 60.8 mt -53.15 -23.27 7.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.872 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 1.8 t -59.05 -11.15 3.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.838 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 51.1 mt -94.03 16.26 14.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 954' ' ' ASN . . . . . 0.402 ' O ' ' CG ' ' A' ' 954' ' ' ASN . 1.9 p30 -70.64 119.37 14.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 955' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 956' ' ' LYS . . . 86.15 -28.48 5.11 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.531 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 956' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 955' ' ' GLY . 0.1 OUTLIER -36.13 127.23 0.75 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.756 0.313 . . . . 0.0 110.873 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -92.94 128.02 38.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 14.2 tp -138.41 148.41 44.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.95 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 49.4 mt 43.13 52.53 5.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.944 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 44.83 44.7 7.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.904 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 961' ' ' ARG . . . . . . . . . . . . . 41.6 mtt85 -151.33 106.07 3.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.844 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 6.3 m -61.44 119.02 7.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.088 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 963' ' ' ILE . . . . . . . . . . . . . 92.7 mt -102.47 139.88 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.147 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 6.1 m -124.73 112.25 16.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.119 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 965' ' ' ILE . . . . . 0.437 HG23 ' N ' ' A' ' 966' ' ' ALA . 61.4 mt -98.42 139.04 21.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.077 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 966' ' ' ALA . . . . . 0.437 ' N ' HG23 ' A' ' 965' ' ' ILE . . . -153.84 137.88 16.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.129 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 967' ' ' LEU . . . . . . . . . . . . . 26.2 mt -68.63 156.37 38.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.922 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 11.6 tptm . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 179.837 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 87.5 m . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.786 0.327 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 895' ' ' VAL . . . . . . . . . . . . . 6.3 m -120.09 137.0 55.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.115 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . 0.467 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 4.7 mp -89.2 142.94 27.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.906 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 99.4 t -140.22 127.69 23.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.166 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 13.5 t -130.18 156.68 44.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.83 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . 0.417 HG22 ' CE2' ' A' ' 909' ' ' PHE . 4.1 pt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.122 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 909' ' ' PHE . . . . . 0.559 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 49.8 m-85 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.826 0.346 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -98.75 178.79 4.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.89 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -58.56 -26.04 63.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.863 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -78.52 -57.39 3.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.11 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 82.0 mt -52.87 -39.95 63.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.97 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 28.9 mt -72.57 -64.09 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.164 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -43.21 -54.07 4.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.84 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -55.43 -51.03 68.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 917' ' ' LEU . . . . . 0.542 ' HB3' ' CE2' ' A' ' 921' ' ' PHE . 20.6 mt -48.94 -54.14 16.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.905 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 918' ' ' LEU . . . . . 0.426 ' C ' ' O ' ' A' ' 917' ' ' LEU . 41.9 mt -34.75 -65.79 0.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.905 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -51.11 -52.26 45.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -48.85 -40.2 28.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.873 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 921' ' ' PHE . . . . . 0.542 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 23.1 m-85 -71.21 -42.79 68.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 922' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 924' ' ' PHE . . . -49.62 -39.48 35.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.095 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.7 m -43.02 -24.25 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.837 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 924' ' ' PHE . . . . . 0.554 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 0.6 OUTLIER -123.67 -63.02 1.26 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -123.13 147.24 16.67 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.469 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -84.39 128.01 34.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.931 0.396 . . . . 0.0 110.88 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 34.4 t -81.71 144.24 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.144 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 928' ' ' ILE . . . . . 0.467 HG13 ' N ' ' A' ' 929' ' ' LEU . 23.9 pt -123.18 -44.72 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.1 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 929' ' ' LEU . . . . . 0.467 ' N ' HG13 ' A' ' 928' ' ' ILE . 21.0 tp -134.48 144.05 47.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.964 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 43.5 mt -135.71 134.55 51.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.118 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.26 124.52 32.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -86.95 118.66 26.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 933' ' ' VAL . . . . . 0.487 ' CG2' ' CD1' ' A' ' 938' ' ' TRP . 2.6 t -82.95 157.37 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 934' ' ' GLU . . . . . 0.472 ' C ' ' O ' ' A' ' 933' ' ' VAL . 29.4 mm-40 -32.24 -53.41 0.3 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.905 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -125.31 -25.89 3.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -97.23 173.14 7.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.9 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 937' ' ' MET . . . . . 0.559 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 15.3 ttt -135.71 110.29 8.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.907 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 938' ' ' TRP . . . . . 0.487 ' CD1' ' CG2' ' A' ' 933' ' ' VAL . 20.3 m0 -95.95 138.58 33.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.874 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 94.4 t -122.35 134.97 63.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.117 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 52.3 m -98.62 148.96 23.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.145 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 941' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -130.69 152.06 50.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.862 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 55.5 tp -48.79 -53.53 18.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.891 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -115.91 177.81 4.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -87.34 -46.92 4.82 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.494 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 91.8 p -50.89 -39.47 54.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.924 0.392 . . . . 0.0 110.857 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.11 -27.63 67.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.858 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -80.22 -15.38 57.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.135 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 21.6 mt -87.34 -29.35 21.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.907 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -79.9 -41.35 26.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.903 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 4.3 p -56.06 -16.92 3.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.166 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 31.1 mt -52.65 -29.74 27.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 3.1 m -53.03 -25.56 12.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.861 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 32.1 mt -78.95 9.04 4.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.948 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.43 118.49 13.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.841 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 92.33 -26.38 13.85 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.442 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 3.7 tmtt? -42.08 128.35 3.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.751 0.31 . . . . 0.0 110.893 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -93.87 127.17 39.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 13.6 tp -140.45 157.07 46.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.955 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 37.4 mt 39.1 44.84 0.98 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.954 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 49.79 44.36 24.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.906 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 961' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 -152.07 108.06 3.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 2.9 m -61.81 118.67 7.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.102 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 963' ' ' ILE . . . . . . . . . . . . . 86.3 mt -103.24 137.94 29.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.12 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 9.7 m -123.87 117.43 24.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.183 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 965' ' ' ILE . . . . . 0.46 HG21 ' N ' ' A' ' 966' ' ' ALA . 19.1 mt -97.77 146.93 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.186 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 966' ' ' ALA . . . . . 0.46 ' N ' HG21 ' A' ' 965' ' ' ILE . . . -155.18 128.86 8.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.098 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 967' ' ' LEU . . . . . . . . . . . . . 33.5 mt -66.05 157.98 29.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.88 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 15.8 tptp . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.899 179.85 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 87.2 m . . . . . 0 N--CA 1.457 -0.11 0 CA-C-O 120.762 0.315 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 895' ' ' VAL . . . . . . . . . . . . . 17.6 m -118.18 138.81 47.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.165 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . 0.469 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 6.3 mp -90.34 138.63 31.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.936 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 86.6 t -139.54 124.3 20.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.1 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 12.3 t -127.96 155.68 43.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.848 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . 0.412 HG12 ' CE2' ' A' ' 909' ' ' PHE . 2.7 pt . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.144 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 909' ' ' PHE . . . . . 0.567 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 48.3 m-85 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.885 0.374 . . . . 0.0 110.86 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.99 177.56 5.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.898 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.66 -45.31 77.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -59.65 -54.99 40.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.093 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 22.2 mt -53.47 -54.81 31.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.931 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 46.3 mt -58.86 -57.85 9.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.164 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -50.26 -63.98 0.95 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -45.71 -50.16 13.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.847 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 917' ' ' LEU . . . . . 0.568 ' HB3' ' CE2' ' A' ' 921' ' ' PHE . 28.2 mt -50.3 -53.24 30.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.937 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 918' ' ' LEU . . . . . 0.458 ' CD2' HD12 ' A' ' 930' ' ' ILE . 88.4 mt -38.59 -62.44 0.6 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.955 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -53.16 -53.68 46.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.925 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 -47.65 -45.34 27.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.857 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 921' ' ' PHE . . . . . 0.568 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 23.7 m-85 -60.26 -49.04 79.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.839 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -45.29 -33.5 2.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.073 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 923' ' ' SER . . . . . 0.523 ' HB3' ' CD1' ' A' ' 924' ' ' PHE . 8.6 t -41.18 -29.84 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 924' ' ' PHE . . . . . 0.523 ' CD1' ' HB3' ' A' ' 923' ' ' SER . 1.6 m-85 -120.02 -58.92 1.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.893 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -130.76 154.65 20.82 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.536 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -87.05 139.45 30.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 0.0 110.938 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 44.1 t -87.25 146.15 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 928' ' ' ILE . . . . . 0.471 HG13 ' N ' ' A' ' 929' ' ' LEU . 46.1 pt -122.7 -38.46 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.124 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 929' ' ' LEU . . . . . 0.471 ' N ' HG13 ' A' ' 928' ' ' ILE . 11.4 tp -142.41 146.24 34.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 930' ' ' ILE . . . . . 0.458 HD12 ' CD2' ' A' ' 918' ' ' LEU . 79.1 mt -132.09 131.51 61.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.153 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 15.8 ttp180 -121.3 124.3 44.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.879 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -91.38 121.8 33.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 933' ' ' VAL . . . . . 0.468 HG22 ' NE1' ' A' ' 938' ' ' TRP . 4.7 t -89.38 157.27 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.123 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 934' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 933' ' ' VAL . 15.2 mm-40 -33.28 -54.5 0.41 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.942 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.03 -21.61 5.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.859 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -98.98 171.68 7.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.869 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 937' ' ' MET . . . . . 0.567 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 17.2 ttt -131.81 108.66 9.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 938' ' ' TRP . . . . . 0.469 ' NE1' ' HG ' ' A' ' 896' ' ' LEU . 41.5 m0 -90.82 144.77 25.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.905 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 87.0 t -133.56 131.24 57.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.143 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 17.8 m -97.19 150.45 20.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.129 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 941' ' ' PHE . . . . . 0.425 ' O ' ' C ' ' A' ' 942' ' ' LEU . 9.9 m-85 -129.83 144.99 51.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.893 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 942' ' ' LEU . . . . . 0.425 ' C ' ' O ' ' A' ' 941' ' ' PHE . 30.3 tp -35.94 -56.88 0.7 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.924 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -122.09 164.91 16.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.871 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -66.95 -44.9 87.66 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.478 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 95.2 p -52.22 -37.45 55.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.868 0.366 . . . . 0.0 110.889 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 49.4 m -57.72 -37.51 73.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.857 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -73.05 -25.24 60.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.058 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 28.8 mt -76.63 -23.83 53.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.923 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 37.3 m-20 -88.26 -50.25 6.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.85 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 9.6 p -49.66 -18.65 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.166 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 24.4 mt -52.38 -28.51 19.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.907 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 952' ' ' SER . . . . . 0.505 ' HB2' ' CZ ' ' A' ' 924' ' ' PHE . 20.6 m -50.95 -17.54 0.6 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 953' ' ' LEU . . . . . 0.416 ' CB ' HD11 ' A' ' 965' ' ' ILE . 37.7 mt -88.45 17.48 5.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.946 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -71.43 120.79 17.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 86.51 -24.48 8.45 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.495 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -40.49 128.92 2.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.732 0.301 . . . . 0.0 110.938 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -94.59 134.01 37.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.905 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 14.6 tp -144.52 146.77 32.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 56.0 mt 44.82 52.06 8.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.958 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 45.13 44.02 8.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.89 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 961' ' ' ARG . . . . . . . . . . . . . 71.0 mtt-85 -150.54 110.49 4.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.917 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 6.4 m -64.41 120.13 11.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.13 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 963' ' ' ILE . . . . . 0.41 ' CD1' HD21 ' A' ' 917' ' ' LEU . 82.7 mt -103.93 139.53 24.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.156 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 6.7 m -123.8 116.87 23.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.122 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 965' ' ' ILE . . . . . 0.456 HG22 ' N ' ' A' ' 966' ' ' ALA . 61.0 mt -102.07 140.57 20.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.142 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 966' ' ' ALA . . . . . 0.456 ' N ' HG22 ' A' ' 965' ' ' ILE . . . -152.68 128.8 10.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.117 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 967' ' ' LEU . . . . . . . . . . . . . 30.7 mt -67.98 158.37 32.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 179.82 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 99.5 m . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.797 0.332 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 895' ' ' VAL . . . . . . . . . . . . . 16.9 m -115.06 139.51 40.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.156 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . 0.463 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 4.7 mp -88.98 143.22 27.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 89.1 t -141.08 127.01 19.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.113 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 11.4 t -129.08 155.78 44.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.864 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 3.8 pt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.175 179.928 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 909' ' ' PHE . . . . . 0.565 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 89.1 m-85 . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.835 0.35 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -90.07 169.83 10.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.884 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.09 -42.45 65.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -63.22 -50.29 70.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.113 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 20.8 mt -56.89 -50.54 72.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.951 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 66.1 mt -63.51 -59.47 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -50.42 -52.03 41.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -57.04 -43.59 82.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 917' ' ' LEU . . . . . 0.529 ' HB3' ' CE2' ' A' ' 921' ' ' PHE . 19.9 mt -54.54 -55.65 27.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.887 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 918' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 917' ' ' LEU . 24.8 mt -34.52 -62.48 0.34 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.951 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -52.68 -52.08 57.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -49.93 -39.07 39.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.908 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 921' ' ' PHE . . . . . 0.529 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 23.8 m-85 -73.36 -41.51 63.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.882 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -52.84 -27.26 17.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.107 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 923' ' ' SER . . . . . 0.551 ' HB3' ' CE1' ' A' ' 924' ' ' PHE . 19.6 t -48.7 -30.27 5.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 924' ' ' PHE . . . . . 0.551 ' CE1' ' HB3' ' A' ' 923' ' ' SER . 0.8 OUTLIER -121.27 -50.58 2.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.913 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -134.54 147.19 19.03 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.475 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -85.46 132.05 34.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.865 0.364 . . . . 0.0 110.889 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 927' ' ' VAL . . . . . 0.417 HG11 ' N ' ' A' ' 928' ' ' ILE . 16.8 t -83.2 146.93 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.131 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 928' ' ' ILE . . . . . 0.443 HG13 ' N ' ' A' ' 929' ' ' LEU . 41.8 pt -124.56 -33.36 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.143 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 929' ' ' LEU . . . . . 0.443 ' N ' HG13 ' A' ' 928' ' ' ILE . 8.5 tp -146.59 145.25 30.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.86 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 48.0 mt -135.01 128.9 50.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.122 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 -110.59 123.09 49.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.862 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -89.67 112.74 24.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.902 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 933' ' ' VAL . . . . . 0.543 ' CG2' ' CD1' ' A' ' 938' ' ' TRP . 2.6 t -83.15 149.05 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.153 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 934' ' ' GLU . . . . . 0.489 ' C ' ' O ' ' A' ' 933' ' ' VAL . 84.5 mt-10 -31.34 -50.03 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -124.65 -23.53 4.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.854 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.46 173.23 6.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 937' ' ' MET . . . . . 0.565 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 16.6 ttt -136.06 106.67 6.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 938' ' ' TRP . . . . . 0.543 ' CD1' ' CG2' ' A' ' 933' ' ' VAL . 34.3 m0 -88.1 142.24 27.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 89.7 t -129.18 120.31 51.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.174 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 940' ' ' THR . . . . . 0.416 ' CG2' ' N ' ' A' ' 941' ' ' PHE . 8.5 m -91.19 153.17 20.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.107 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 941' ' ' PHE . . . . . 0.416 ' N ' ' CG2' ' A' ' 940' ' ' THR . 9.3 m-85 -129.57 154.28 47.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 43.6 tp -52.25 -50.68 61.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.933 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -116.29 171.7 7.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.902 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -84.94 -37.66 9.97 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.467 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 75.4 p -60.73 -29.08 69.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.912 0.387 . . . . 0.0 110.907 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 1.9 p -68.11 -35.06 77.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.818 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -72.55 -12.85 61.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.098 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 27.7 mt -89.48 -26.7 20.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -84.81 -40.88 16.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.9 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 9.1 p -57.24 -17.85 7.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.1 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 43.1 mt -52.19 -27.14 13.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.903 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 19.9 m -53.2 -16.27 1.18 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.834 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 953' ' ' LEU . . . . . 0.456 ' HB2' ' CD1' ' A' ' 965' ' ' ILE . 56.8 mt -92.38 19.01 7.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -74.9 105.11 5.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 101.45 -25.24 28.83 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.47 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -43.07 128.88 4.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.763 0.316 . . . . 0.0 110.921 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -95.98 135.09 38.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.855 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 958' ' ' LEU . . . . . 0.41 ' O ' ' N ' ' A' ' 961' ' ' ARG . 14.3 tp -141.37 157.45 45.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.913 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 96.2 mt 38.38 45.1 0.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.9 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 52.88 44.09 30.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.848 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 961' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' A' ' 958' ' ' LEU . 61.2 mtt85 -151.4 105.84 3.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 63.2 m -60.88 115.79 3.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.118 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 963' ' ' ILE . . . . . 0.424 ' CD1' HD21 ' A' ' 917' ' ' LEU . 75.2 mt -98.56 139.7 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.107 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 13.5 m -122.75 115.75 22.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.125 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 965' ' ' ILE . . . . . 0.456 ' CD1' ' HB2' ' A' ' 953' ' ' LEU . 61.5 mt -102.22 138.2 27.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.142 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 966' ' ' ALA . . . . . 0.42 ' N ' HG21 ' A' ' 965' ' ' ILE . . . -150.6 129.83 12.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.124 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 967' ' ' LEU . . . . . . . . . . . . . 32.3 mt -65.49 157.87 28.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.893 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 14.7 tptp . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.939 179.831 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 93.3 m . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.789 0.328 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 895' ' ' VAL . . . . . . . . . . . . . 26.7 m -122.76 140.03 47.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.149 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . 0.468 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 6.4 mp -88.8 142.67 27.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.908 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . 0.421 HG23 ' C ' ' A' ' 896' ' ' LEU . 97.9 t -142.66 124.07 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.135 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 7.8 t -127.57 156.32 42.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.829 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . 0.447 ' CG2' HG12 ' A' ' 963' ' ' ILE . 2.5 pt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.116 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 909' ' ' PHE . . . . . 0.545 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 58.3 m-85 . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.881 0.372 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -89.74 -179.07 5.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.884 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -58.46 -41.92 86.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.878 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -64.38 -51.64 62.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.082 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 72.2 mt -55.2 -53.31 57.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.917 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 44.9 mt -62.69 -61.92 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.133 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -44.55 -58.27 3.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -52.03 -45.68 64.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 917' ' ' LEU . . . . . 0.447 ' O ' ' C ' ' A' ' 918' ' ' LEU . 23.0 mt -56.58 -53.79 53.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.923 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 918' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 917' ' ' LEU . 80.4 mt -34.45 -54.1 0.52 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.949 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -58.71 -49.83 76.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.902 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -51.89 -36.98 50.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 921' ' ' PHE . . . . . 0.42 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 21.9 m-85 -73.11 -39.89 65.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.845 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -55.9 -33.0 64.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.119 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 53.4 p -54.22 -17.79 3.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.874 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 924' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -121.54 -52.4 2.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.872 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -147.12 154.95 26.29 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.458 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -86.18 126.34 34.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.896 0.379 . . . . 0.0 110.896 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 6.4 t -78.09 150.76 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.175 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 928' ' ' ILE . . . . . 0.447 HG13 ' N ' ' A' ' 929' ' ' LEU . 40.3 pt -120.67 -38.71 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.153 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 929' ' ' LEU . . . . . 0.447 ' N ' HG13 ' A' ' 928' ' ' ILE . 13.3 tp -142.73 151.8 41.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.95 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 76.0 mt -134.87 125.87 46.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.126 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -115.46 125.02 52.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.861 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -94.09 123.55 37.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.862 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 933' ' ' VAL . . . . . 0.518 HG23 ' CE2' ' A' ' 938' ' ' TRP . 5.1 t -91.21 157.31 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.111 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 934' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 933' ' ' VAL . 10.2 mm-40 -33.54 -52.61 0.4 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.911 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -124.72 -24.81 4.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -96.58 171.68 8.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.891 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 937' ' ' MET . . . . . 0.545 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 0.3 OUTLIER -132.7 115.08 14.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.892 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 938' ' ' TRP . . . . . 0.518 ' CE2' HG23 ' A' ' 933' ' ' VAL . 31.0 m0 -100.34 146.37 27.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.942 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 939' ' ' VAL . . . . . 0.431 ' CG2' ' SD ' ' A' ' 937' ' ' MET . 60.4 t -137.07 129.12 43.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.121 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 940' ' ' THR . . . . . 0.426 HG23 ' N ' ' A' ' 941' ' ' PHE . 18.8 m -93.12 153.24 18.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.13 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 941' ' ' PHE . . . . . 0.426 ' N ' HG23 ' A' ' 940' ' ' THR . 9.5 m-85 -128.05 150.74 49.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 25.0 tp -51.75 -46.37 64.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -118.4 171.06 8.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.855 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -84.44 -42.27 7.48 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.481 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 39.3 p -56.85 -40.57 76.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.881 0.372 . . . . 0.0 110.897 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 1.2 p -54.16 -35.99 62.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.848 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -72.42 -14.44 61.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.15 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 21.9 mt -86.66 -26.4 24.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.928 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -82.76 -50.83 8.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 6.0 p -49.84 -19.45 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.125 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 39.5 mt -55.14 -24.79 28.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.917 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 44.8 t -58.28 -11.75 3.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.867 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 36.6 mt -92.09 13.18 19.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.914 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 954' ' ' ASN . . . . . 0.412 ' O ' ' CG ' ' A' ' 954' ' ' ASN . 3.7 p30 -66.03 117.96 9.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 89.47 -26.09 9.79 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.525 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -40.65 129.28 2.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.751 0.31 . . . . 0.0 110.907 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -97.87 135.22 39.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.854 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 958' ' ' LEU . . . . . 0.486 ' O ' ' N ' ' A' ' 961' ' ' ARG . 18.0 tp -139.16 160.44 39.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.951 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 959' ' ' LEU . . . . . 0.449 ' C ' ' O ' ' A' ' 958' ' ' LEU . 97.1 mt 34.29 37.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 960' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 958' ' ' LEU . 6.7 m-80 60.91 48.4 6.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 961' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 958' ' ' LEU . 68.8 mtt85 -153.05 106.08 2.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.869 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 5.3 m -61.34 115.41 3.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.132 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 963' ' ' ILE . . . . . 0.447 HG12 ' CG2' ' A' ' 899' ' ' ILE . 57.8 mt -100.69 144.81 12.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.148 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 3.6 m -127.79 113.03 15.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.109 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 965' ' ' ILE . . . . . 0.45 HG21 ' N ' ' A' ' 966' ' ' ALA . 61.9 mt -95.17 147.14 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.127 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 966' ' ' ALA . . . . . 0.45 ' N ' HG21 ' A' ' 965' ' ' ILE . . . -154.03 126.95 8.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.061 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 967' ' ' LEU . . . . . . . . . . . . . 32.9 mt -65.25 157.98 27.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 968' ' ' LYS . . . . . 0.427 ' HE2' ' CH2' ' A' ' 938' ' ' TRP . 16.0 tttp . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 97.7 m . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.789 0.328 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 895' ' ' VAL . . . . . . . . . . . . . 22.4 m -121.34 138.51 51.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.148 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . 0.464 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 5.5 mp -88.99 145.74 25.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . 0.459 HG12 ' CG2' ' A' ' 963' ' ' ILE . 79.1 t -147.01 126.34 4.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 11.1 t -127.1 152.28 47.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.824 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 3.5 pt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.122 179.928 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 909' ' ' PHE . . . . . 0.56 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 69.0 m-85 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.865 0.364 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -97.95 169.11 9.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.876 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -48.16 -49.06 33.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.888 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -57.17 -56.04 26.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.089 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 31.3 mt -49.23 -54.18 17.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 56.0 mt -60.68 -64.48 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.137 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -42.94 -56.78 3.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.83 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -52.57 -50.98 61.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.849 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 917' ' ' LEU . . . . . 0.514 ' HB3' ' CE2' ' A' ' 921' ' ' PHE . 25.9 mt -48.15 -57.45 5.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 918' ' ' LEU . . . . . 0.445 ' C ' ' O ' ' A' ' 917' ' ' LEU . 40.5 mt -34.37 -55.37 0.52 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.887 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -56.77 -45.54 82.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.9 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 920' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 917' ' ' LEU . 88.5 mm-40 -58.76 -36.54 74.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 921' ' ' PHE . . . . . 0.514 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 22.1 m-85 -72.64 -47.46 47.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.852 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -48.77 -34.65 12.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.078 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -46.38 -32.87 3.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 924' ' ' PHE . . . . . 0.553 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 0.5 OUTLIER -121.63 -58.5 1.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.915 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -121.02 148.47 17.49 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.525 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -90.1 128.7 36.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.868 0.366 . . . . 0.0 110.874 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 41.1 t -84.14 139.95 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 928' ' ' ILE . . . . . 0.457 HG13 ' N ' ' A' ' 929' ' ' LEU . 35.4 pt -122.43 -40.54 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.12 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 929' ' ' LEU . . . . . 0.457 ' N ' HG13 ' A' ' 928' ' ' ILE . 15.6 tp -136.83 136.05 38.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.907 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 81.7 mt -122.76 126.56 74.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.089 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 11.8 tpt85 -112.18 124.68 52.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.868 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -93.57 117.01 29.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 933' ' ' VAL . . . . . 0.493 HG23 ' CE2' ' A' ' 938' ' ' TRP . 2.9 t -85.78 156.99 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.104 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 934' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 933' ' ' VAL . 33.1 mt-10 -34.43 -51.33 0.46 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.857 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -125.49 -26.25 3.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -96.16 173.04 7.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.917 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 937' ' ' MET . . . . . 0.56 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 15.3 ttt -134.11 111.73 10.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.905 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 938' ' ' TRP . . . . . 0.493 ' CE2' HG23 ' A' ' 933' ' ' VAL . 38.8 m0 -92.11 148.13 22.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.957 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 43.0 t -134.14 125.8 48.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.083 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 14.0 m -92.46 151.75 20.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.152 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 941' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -132.24 143.87 50.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.862 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 54.2 tp -41.27 -52.87 3.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.878 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -118.17 177.99 4.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -86.67 -48.08 4.6 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.525 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 46.6 t -50.8 -39.07 51.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.863 0.363 . . . . 0.0 110.841 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 56.8 p -57.51 -32.36 66.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.87 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -76.4 -20.91 56.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.086 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 36.5 mt -77.97 -27.93 49.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.926 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -81.93 -51.56 7.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.883 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 9.5 p -48.21 -21.56 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.12 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 34.2 mt -49.37 -29.43 6.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.937 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 35.7 p -50.28 -19.77 0.89 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.839 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 953' ' ' LEU . . . . . 0.427 ' CB ' HD13 ' A' ' 965' ' ' ILE . 76.7 mt -88.84 20.15 3.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.885 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -74.41 106.34 5.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.928 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 98.85 -26.76 22.84 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.461 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -37.97 128.19 1.25 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.71 0.291 . . . . 0.0 110.887 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -93.38 125.15 37.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 15.2 tp -133.01 154.58 50.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 43.2 mt 41.01 47.78 2.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.913 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 51.64 40.5 27.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 961' ' ' ARG . . . . . . . . . . . . . 65.2 mtt85 -147.63 122.69 10.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.858 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 6.1 m -74.17 115.08 13.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.154 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 963' ' ' ILE . . . . . 0.459 ' CG2' HG12 ' A' ' 897' ' ' VAL . 84.6 mt -99.81 135.51 35.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.124 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 14.9 m -119.74 112.5 19.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.173 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 965' ' ' ILE . . . . . 0.433 HG22 ' N ' ' A' ' 966' ' ' ALA . 67.3 mt -98.99 137.48 26.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.122 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 966' ' ' ALA . . . . . 0.433 ' N ' HG22 ' A' ' 965' ' ' ILE . . . -151.37 135.33 16.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.087 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 967' ' ' LEU . . . . . . . . . . . . . 28.9 mt -66.26 157.98 30.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.907 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.918 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 39.3 m . . . . . 0 N--CA 1.457 -0.125 0 CA-C-O 120.865 0.364 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 895' ' ' VAL . . . . . . . . . . . . . 17.8 m -117.49 144.09 26.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.169 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . 0.472 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 6.8 mp -92.89 137.92 31.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 60.1 t -140.13 131.24 31.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.161 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 3.1 t -130.62 156.32 45.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.881 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 3.3 pt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.183 179.918 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 909' ' ' PHE . . . . . 0.518 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 87.4 m-85 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.857 0.36 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -97.89 165.65 11.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.871 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -48.51 -50.06 33.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -56.84 -48.92 76.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.117 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 72.4 mt -56.72 -50.45 72.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.895 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 50.6 mt -64.0 -63.79 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.108 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -42.07 -56.47 2.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.819 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -54.34 -46.81 72.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.876 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 917' ' ' LEU . . . . . 0.549 ' HB3' ' CE2' ' A' ' 921' ' ' PHE . 24.9 mt -54.15 -56.08 21.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.933 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 918' ' ' LEU . . . . . 0.461 ' CD2' HD13 ' A' ' 930' ' ' ILE . 68.3 mt -34.41 -60.6 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.883 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -52.31 -51.07 60.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -52.48 -40.05 61.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 921' ' ' PHE . . . . . 0.549 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 22.9 m-85 -66.82 -44.59 80.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.865 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -50.57 -33.63 22.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.123 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 923' ' ' SER . . . . . 0.54 ' HB3' ' CE1' ' A' ' 924' ' ' PHE . 10.4 t -41.86 -34.64 0.69 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.87 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 924' ' ' PHE . . . . . 0.54 ' CE1' ' HB3' ' A' ' 923' ' ' SER . 0.9 OUTLIER -120.17 -51.68 2.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.844 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -128.27 141.56 12.71 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.442 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -85.58 99.47 11.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.896 0.379 . . . . 0.0 110.894 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 927' ' ' VAL . . . . . 0.446 HG12 ' N ' ' A' ' 928' ' ' ILE . 40.2 t -51.23 143.91 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.122 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 928' ' ' ILE . . . . . 0.452 HG13 ' N ' ' A' ' 929' ' ' LEU . 21.0 pt -120.04 -44.8 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.093 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 929' ' ' LEU . . . . . 0.452 ' N ' HG13 ' A' ' 928' ' ' ILE . 11.1 tp -135.56 146.51 48.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.949 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 930' ' ' ILE . . . . . 0.461 HD13 ' CD2' ' A' ' 918' ' ' LEU . 57.0 mt -130.05 137.57 56.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.13 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -125.88 122.29 35.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -88.48 124.07 33.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.845 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 933' ' ' VAL . . . . . 0.482 ' O ' ' C ' ' A' ' 934' ' ' GLU . 13.5 t -92.63 157.52 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.089 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 934' ' ' GLU . . . . . 0.482 ' C ' ' O ' ' A' ' 933' ' ' VAL . 15.2 mm-40 -31.24 -56.03 0.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -121.88 -26.01 4.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.859 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 4.7 tttm -96.12 173.25 7.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.839 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 937' ' ' MET . . . . . 0.518 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 10.8 ttt -132.39 105.93 7.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 938' ' ' TRP . . . . . 0.481 ' NE1' HG21 ' A' ' 933' ' ' VAL . 44.1 m0 -85.25 142.49 29.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.928 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 939' ' ' VAL . . . . . 0.44 ' CG1' HG13 ' A' ' 927' ' ' VAL . 43.8 t -132.56 129.62 59.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.133 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 32.9 m -92.53 154.23 18.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.162 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 941' ' ' PHE . . . . . 0.413 ' O ' ' C ' ' A' ' 942' ' ' LEU . 11.2 m-85 -134.17 146.97 50.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.865 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 942' ' ' LEU . . . . . 0.413 ' C ' ' O ' ' A' ' 941' ' ' PHE . 23.6 tp -36.91 -61.49 0.55 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -125.62 153.53 43.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -50.5 -51.01 33.96 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.509 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 945' ' ' SER . . . . . 0.408 ' HA ' ' CD1' ' A' ' 948' ' ' LEU . 82.6 p -46.7 -42.86 17.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.9 0.381 . . . . 0.0 110.843 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 14.5 m -56.32 -30.86 63.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -82.47 -16.73 47.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.118 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 948' ' ' LEU . . . . . 0.408 ' CD1' ' HA ' ' A' ' 945' ' ' SER . 23.4 mt -83.23 -23.6 32.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.927 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -88.34 -46.47 9.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.92 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 7.2 p -51.33 -22.25 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.148 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 39.5 mt -50.41 -24.84 3.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.918 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 32.5 m -55.26 -15.51 2.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 953' ' ' LEU . . . . . 0.407 ' C ' HD13 ' A' ' 965' ' ' ILE . 36.5 mt -91.53 17.01 9.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.905 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -69.06 120.85 15.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.929 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 85.63 -27.31 5.35 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.458 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -38.21 127.36 1.35 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.74 0.305 . . . . 0.0 110.893 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -95.4 125.49 40.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.862 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 14.5 tp -134.46 153.44 51.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.969 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 959' ' ' LEU . . . . . 0.441 ' O ' ' CG ' ' A' ' 960' ' ' ASN . 35.0 mt 41.56 49.17 3.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 960' ' ' ASN . . . . . 0.441 ' CG ' ' O ' ' A' ' 959' ' ' LEU . 13.0 p30 47.75 40.29 11.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 961' ' ' ARG . . . . . . . . . . . . . 47.1 mtt85 -147.56 104.99 3.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 27.1 m -58.94 120.88 9.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.133 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 963' ' ' ILE . . . . . 0.418 ' CD1' HD21 ' A' ' 917' ' ' LEU . 87.2 mt -103.98 143.4 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 8.7 m -127.22 119.93 27.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.134 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 965' ' ' ILE . . . . . 0.439 HG22 ' N ' ' A' ' 966' ' ' ALA . 63.4 mt -103.77 140.27 22.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.131 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 966' ' ' ALA . . . . . 0.439 ' N ' HG22 ' A' ' 965' ' ' ILE . . . -149.85 137.12 19.75 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.077 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 967' ' ' LEU . . . . . . . . . . . . . 25.1 mt -73.75 153.48 40.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.95 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 19.2 tptp . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.89 179.842 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 71.9 m . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.805 0.336 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 895' ' ' VAL . . . . . . . . . . . . . 13.7 m -117.17 142.86 29.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.157 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . 0.467 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 5.0 mp -91.74 143.15 26.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 79.8 t -142.44 127.5 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 9.7 t -129.61 158.05 40.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.841 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 2.7 pt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.12 179.948 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 909' ' ' PHE . . . . . 0.557 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 94.1 m-85 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.888 0.375 . . . . 0.0 110.87 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -85.04 160.11 20.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.884 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -45.64 -40.43 9.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.852 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -65.33 -49.99 67.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.104 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 913' ' ' LEU . . . . . 0.4 HD13 ' CD ' ' A' ' 961' ' ' ARG . 29.4 mt -56.76 -45.85 81.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 914' ' ' ILE . . . . . 0.516 HD12 ' CZ ' ' A' ' 932' ' ' PHE . 36.5 mt -69.52 -59.75 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.155 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -48.89 -50.99 32.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.86 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -56.89 -40.8 76.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.86 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 917' ' ' LEU . . . . . 0.543 ' HB3' ' CE2' ' A' ' 921' ' ' PHE . 22.0 mt -59.88 -51.64 68.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 918' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 917' ' ' LEU . 30.8 mt -34.89 -64.19 0.28 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.906 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -50.2 -51.98 39.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.904 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -49.63 -40.5 39.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.922 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 921' ' ' PHE . . . . . 0.543 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 22.7 m-85 -72.37 -42.78 64.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.899 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -50.99 -38.03 48.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.114 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -46.81 -21.13 0.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 924' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 1.4 m-85 -124.0 -58.88 1.54 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.914 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -130.1 151.0 19.26 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.512 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -88.86 125.35 34.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.887 0.375 . . . . 0.0 110.863 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 6.1 t -78.93 150.29 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.141 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 928' ' ' ILE . . . . . 0.451 HG13 ' N ' ' A' ' 929' ' ' LEU . 35.1 pt -125.63 -40.46 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.101 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 929' ' ' LEU . . . . . 0.451 ' N ' HG13 ' A' ' 928' ' ' ILE . 12.0 tp -141.12 146.34 36.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.941 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 930' ' ' ILE . . . . . 0.423 HG21 ' N ' ' A' ' 931' ' ' ARG . 51.3 mt -134.62 143.04 38.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.119 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 931' ' ' ARG . . . . . 0.423 ' N ' HG21 ' A' ' 930' ' ' ILE . 0.0 OUTLIER -135.62 128.69 31.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.849 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 932' ' ' PHE . . . . . 0.516 ' CZ ' HD12 ' A' ' 914' ' ' ILE . 32.0 m-85 -91.99 123.55 35.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.87 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 933' ' ' VAL . . . . . 0.559 ' CG2' ' CD1' ' A' ' 938' ' ' TRP . 2.6 t -87.89 157.18 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.13 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 934' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 933' ' ' VAL . 45.8 mt-10 -33.49 -49.7 0.3 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.838 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -127.12 -28.22 2.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.867 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 936' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 933' ' ' VAL . 6.8 ttmm -96.02 173.12 7.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 937' ' ' MET . . . . . 0.557 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 12.5 ttt -135.18 108.06 7.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 938' ' ' TRP . . . . . 0.559 ' CD1' ' CG2' ' A' ' 933' ' ' VAL . 13.4 m0 -94.88 143.62 26.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.929 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 43.6 t -128.65 139.99 50.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.131 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 940' ' ' THR . . . . . 0.412 ' CG2' ' N ' ' A' ' 941' ' ' PHE . 53.0 m -98.51 156.26 16.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.099 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 941' ' ' PHE . . . . . 0.412 ' N ' ' CG2' ' A' ' 940' ' ' THR . 13.2 m-85 -136.23 149.86 48.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.916 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 32.5 tp -51.04 -52.13 46.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.953 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -114.69 173.91 6.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.904 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -86.89 -47.18 4.87 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.472 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 13.0 m -56.06 -27.2 52.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.917 0.389 . . . . 0.0 110.882 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 50.6 p -67.91 -28.14 67.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.862 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -79.32 -13.26 59.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.083 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 32.3 mt -85.4 -31.97 22.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.912 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 41.8 m-20 -75.62 -42.33 52.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 5.7 p -56.77 -15.76 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.149 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 31.6 mt -55.62 -29.1 58.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.904 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 70.7 m -55.99 -23.16 30.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.845 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 39.2 mt -82.03 9.08 9.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.887 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.04 119.09 13.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 91.95 -25.41 16.93 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.487 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -44.07 128.65 5.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.748 0.309 . . . . 0.0 110.941 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -93.08 133.27 36.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.922 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 13.8 tp -147.87 158.32 43.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.949 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 33.1 mt 40.06 46.71 1.86 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.948 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 48.1 42.13 16.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 961' ' ' ARG . . . . . 0.4 ' CD ' HD13 ' A' ' 913' ' ' LEU . 64.1 mtt85 -152.14 115.22 4.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 12.5 m -68.31 123.97 22.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.115 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 963' ' ' ILE . . . . . . . . . . . . . 85.8 mt -107.17 143.86 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.083 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 10.1 m -129.1 117.57 21.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.177 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 965' ' ' ILE . . . . . 0.445 HG21 ' N ' ' A' ' 966' ' ' ALA . 23.2 mt -98.64 145.15 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.152 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 966' ' ' ALA . . . . . 0.445 ' N ' HG21 ' A' ' 965' ' ' ILE . . . -155.93 129.6 8.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 967' ' ' LEU . . . . . . . . . . . . . 38.3 mt -65.22 157.7 28.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 34.4 tptt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 179.81 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 59.1 m . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.816 0.341 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 895' ' ' VAL . . . . . . . . . . . . . 12.8 m -118.56 143.42 29.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.118 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . 0.462 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 3.5 mp -93.22 145.75 24.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.927 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 98.0 t -146.2 128.57 8.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.131 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 30.9 t -133.21 159.53 39.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.893 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.132 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 909' ' ' PHE . . . . . 0.569 ' CE2' ' HB2' ' A' ' 937' ' ' MET . 45.9 m-85 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.867 0.365 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -83.71 157.71 22.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.904 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -43.75 -58.4 2.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.904 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -45.26 -58.0 3.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.12 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 24.7 mt -44.26 -56.23 4.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.925 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 71.4 mt -58.86 -62.21 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -43.46 -67.52 0.27 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -43.78 -55.22 4.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.854 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 917' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 920' ' ' GLN . 30.3 mt -44.97 -58.89 2.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.903 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 918' ' ' LEU . . . . . 0.439 ' C ' ' O ' ' A' ' 917' ' ' LEU . 90.1 mt -35.25 -58.16 0.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.983 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -56.68 -38.52 72.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.924 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 920' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 917' ' ' LEU . 72.7 mm-40 -63.74 -36.67 84.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 921' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -72.02 -37.38 69.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -57.89 -34.04 69.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.131 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -47.91 -25.21 1.25 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 924' ' ' PHE . . . . . 0.477 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 2.4 m-85 -121.64 -64.35 1.23 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.884 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -123.26 154.38 17.24 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.504 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -88.57 135.11 33.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.919 0.39 . . . . 0.0 110.895 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 19.9 t -86.29 149.06 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.115 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 928' ' ' ILE . . . . . 0.458 HG13 ' N ' ' A' ' 929' ' ' LEU . 27.7 pt -129.12 -42.85 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.14 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 929' ' ' LEU . . . . . 0.458 ' N ' HG13 ' A' ' 928' ' ' ILE . 15.8 tp -136.27 145.71 45.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.919 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 64.9 mt -133.72 128.92 54.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.136 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -120.11 126.73 51.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.862 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -92.17 120.59 32.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.841 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 933' ' ' VAL . . . . . 0.593 ' CG2' ' CD1' ' A' ' 938' ' ' TRP . 3.0 t -86.96 157.09 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.179 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 934' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 933' ' ' VAL . 34.4 mm-40 -33.98 -52.51 0.44 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -124.95 -24.74 4.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.853 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 936' ' ' LYS . . . . . 0.417 ' NZ ' ' HB3' ' A' ' 896' ' ' LEU . 14.7 tttm -97.57 173.07 7.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 937' ' ' MET . . . . . 0.569 ' HB2' ' CE2' ' A' ' 909' ' ' PHE . 16.5 ttt -132.04 115.09 15.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.915 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 938' ' ' TRP . . . . . 0.593 ' CD1' ' CG2' ' A' ' 933' ' ' VAL . 39.5 m0 -94.63 150.37 20.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.955 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 70.0 t -142.36 128.24 17.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.104 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 5.6 m -95.54 150.88 19.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.115 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 941' ' ' PHE . . . . . 0.446 ' O ' ' C ' ' A' ' 942' ' ' LEU . 9.6 m-85 -129.37 145.59 51.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 942' ' ' LEU . . . . . 0.446 ' C ' ' O ' ' A' ' 941' ' ' PHE . 16.0 tp -34.4 -64.82 0.23 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -114.81 165.57 12.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -65.92 -54.09 26.86 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.52 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 84.3 p -48.15 -27.14 2.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.912 0.387 . . . . 0.0 110.869 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 69.1 m -67.23 -34.78 78.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -80.04 -13.79 59.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.111 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 20.0 mt -87.44 -22.97 24.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.933 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 -85.54 -38.48 18.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.88 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 8.4 p -60.09 -21.96 23.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.163 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 43.5 mt -50.14 -23.06 1.93 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.924 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 18.6 m -56.9 -15.0 3.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.826 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 953' ' ' LEU . . . . . 0.434 ' HB2' ' CD1' ' A' ' 965' ' ' ILE . 56.9 mt -92.99 11.48 27.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.938 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -63.4 116.51 5.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.888 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 90.67 -25.67 12.77 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.544 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -42.37 128.21 3.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.785 0.326 . . . . 0.0 110.922 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -95.68 128.39 42.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.92 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 14.9 tp -135.58 153.41 51.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.891 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 36.0 mt 42.73 49.6 4.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 47.6 44.07 16.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.89 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 961' ' ' ARG . . . . . . . . . . . . . 57.8 mtt-85 -152.29 109.72 3.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 31.1 m -62.56 122.3 15.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.17 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 963' ' ' ILE . . . . . . . . . . . . . 93.3 mt -105.11 148.8 9.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.173 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 5.7 m -132.67 113.78 13.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.124 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 965' ' ' ILE . . . . . 0.439 HG21 ' N ' ' A' ' 966' ' ' ALA . 56.5 mt -96.58 140.28 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.157 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 966' ' ' ALA . . . . . 0.439 ' N ' HG21 ' A' ' 965' ' ' ILE . . . -149.29 135.46 19.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.119 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 967' ' ' LEU . . . . . . . . . . . . . 26.8 mt -71.89 154.95 40.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.894 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 13.6 tptm . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 179.886 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 69.4 m . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.816 0.341 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 895' ' ' VAL . . . . . . . . . . . . . 17.1 m -115.45 143.68 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.15 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . 0.469 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 5.0 mp -91.65 141.94 28.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 80.6 t -137.03 129.72 44.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.132 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 12.4 t -133.46 158.48 42.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.83 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 2.5 pt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.117 179.934 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 909' ' ' PHE . . . . . 0.552 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 92.9 m-85 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.829 0.347 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -96.71 173.05 7.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.845 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -53.75 -36.71 62.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.854 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -69.0 -49.54 56.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.071 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 22.2 mt -59.06 -44.83 91.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 54.3 mt -69.74 -59.88 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.151 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -41.58 -64.92 0.5 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.843 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -47.27 -56.05 7.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 917' ' ' LEU . . . . . 0.553 ' HB3' ' CE2' ' A' ' 921' ' ' PHE . 26.9 mt -42.16 -54.22 3.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 918' ' ' LEU . . . . . . . . . . . . . 62.8 mt -40.46 -57.69 1.74 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.954 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -58.71 -42.93 89.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -58.71 -38.8 79.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 921' ' ' PHE . . . . . 0.553 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 24.5 m-85 -69.92 -37.39 75.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -56.27 -35.45 67.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.071 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.7 m -44.53 -29.16 0.67 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 924' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 1.8 m-85 -121.3 -59.6 1.7 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.849 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -124.26 140.21 12.48 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.514 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -82.52 99.41 9.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.814 0.34 . . . . 0.0 110.88 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 34.7 t -50.27 143.71 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.163 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 928' ' ' ILE . . . . . . . . . . . . . 15.3 pt -120.02 -39.97 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.15 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 929' ' ' LEU . . . . . . . . . . . . . 8.6 tp -140.44 149.36 42.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.913 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 930' ' ' ILE . . . . . 0.434 HG22 ' N ' ' A' ' 931' ' ' ARG . 41.9 mt -137.05 145.58 29.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.104 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 931' ' ' ARG . . . . . 0.434 ' N ' HG22 ' A' ' 930' ' ' ILE . 8.1 ttp180 -135.78 124.19 23.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.917 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -87.75 120.38 29.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.909 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 933' ' ' VAL . . . . . 0.553 HG23 ' CD1' ' A' ' 938' ' ' TRP . 3.6 t -87.15 157.15 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.106 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 934' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 933' ' ' VAL . 22.8 mm-40 -34.04 -53.72 0.47 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -124.17 -21.57 4.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.834 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 16.9 ttmt -99.93 172.94 6.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 937' ' ' MET . . . . . 0.552 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 15.2 ttt -131.85 109.03 9.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.841 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 938' ' ' TRP . . . . . 0.553 ' CD1' HG23 ' A' ' 933' ' ' VAL . 43.4 m0 -89.41 143.13 27.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.913 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 46.6 t -135.8 122.73 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.095 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 18.4 m -91.04 152.94 20.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.154 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 941' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -129.21 155.53 45.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.869 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 16.1 tp -38.47 -56.72 1.23 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.959 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -136.11 165.67 25.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.862 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -52.97 -53.44 33.72 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.461 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 77.3 p -46.38 -44.6 17.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.835 0.35 . . . . 0.0 110.847 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 72.2 m -55.17 -32.85 62.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -82.51 -13.43 56.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.102 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 60.2 mt -85.65 -28.35 24.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.909 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -85.37 -34.09 21.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.13 -20.26 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.16 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 41.2 mt -52.85 -26.56 15.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.93 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 9.7 m -56.36 -21.49 24.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.841 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 953' ' ' LEU . . . . . 0.423 ' C ' HD11 ' A' ' 965' ' ' ILE . 26.6 mt -82.04 4.96 20.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.89 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.16 122.71 17.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 88.7 -26.56 8.12 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.485 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -42.32 127.15 3.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.752 0.31 . . . . 0.0 110.913 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -93.63 130.82 39.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 14.8 tp -141.36 152.46 44.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.913 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 81.4 mt 42.03 48.42 4.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.964 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 48.57 40.74 16.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.839 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 961' ' ' ARG . . . . . . . . . . . . . 51.5 mtt85 -148.94 105.0 3.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.871 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 56.3 m -62.67 121.35 13.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.12 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 963' ' ' ILE . . . . . 0.406 ' CD1' HD23 ' A' ' 917' ' ' LEU . 64.7 mt -102.32 152.87 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.14 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 11.6 m -136.45 117.51 14.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.1 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 965' ' ' ILE . . . . . 0.433 HG22 ' N ' ' A' ' 966' ' ' ALA . 33.7 mt -100.37 143.62 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.104 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 966' ' ' ALA . . . . . 0.433 ' N ' HG22 ' A' ' 965' ' ' ILE . . . -154.28 129.38 9.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.128 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 967' ' ' LEU . . . . . . . . . . . . . 36.5 mt -63.15 158.0 20.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.926 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 12.7 tptp . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 179.854 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 97.5 m . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.825 0.345 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 895' ' ' VAL . . . . . . . . . . . . . 17.2 m -115.0 142.48 27.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.113 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . 0.471 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 3.9 mp -91.58 142.64 27.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 897' ' ' VAL . . . . . 0.406 HG21 ' C ' ' A' ' 896' ' ' LEU . 94.5 t -139.86 131.43 32.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.131 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 11.8 t -132.6 151.73 51.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.827 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 899' ' ' ILE . . . . . 0.514 HG22 ' CE2' ' A' ' 909' ' ' PHE . 3.8 pt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.159 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 909' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 24.6 m-85 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.895 0.378 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 910' ' ' ASP . . . . . 0.409 ' CG ' ' N ' ' A' ' 911' ' ' ASP . 23.6 t70 -89.89 168.3 12.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.85 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 911' ' ' ASP . . . . . 0.409 ' N ' ' CG ' ' A' ' 910' ' ' ASP . 0.7 OUTLIER -49.04 -45.89 43.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -61.46 -58.27 8.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.095 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 913' ' ' LEU . . . . . 0.446 ' CD2' ' HD2' ' A' ' 961' ' ' ARG . 84.3 mt -47.84 -47.18 31.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.88 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 57.3 mt -66.47 -64.28 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.118 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -39.34 -61.93 0.73 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -47.83 -57.25 5.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.934 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 917' ' ' LEU . . . . . 0.528 ' HB3' ' CE2' ' A' ' 921' ' ' PHE . 33.8 mt -41.73 -56.91 2.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 918' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 917' ' ' LEU . 37.5 mt -36.11 -57.54 0.7 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -54.83 -42.78 72.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 920' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 917' ' ' LEU . 60.5 mm-40 -61.17 -39.14 89.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.913 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 921' ' ' PHE . . . . . 0.528 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 22.0 m-85 -71.34 -34.56 70.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -60.62 -34.52 74.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.086 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -47.24 -23.72 0.59 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.851 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 924' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 0.6 OUTLIER -125.42 -55.97 1.53 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.896 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -127.56 141.23 12.45 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.469 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -83.55 100.26 10.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.88 0.372 . . . . 0.0 110.884 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 927' ' ' VAL . . . . . 0.408 HG12 ' N ' ' A' ' 928' ' ' ILE . 60.9 t -53.14 146.32 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.134 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 928' ' ' ILE . . . . . 0.408 ' N ' HG12 ' A' ' 927' ' ' VAL . 29.1 pt -124.85 -37.38 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.159 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 929' ' ' LEU . . . . . . . . . . . . . 22.2 tp -139.7 146.88 40.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.964 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 64.1 mt -136.23 129.26 46.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.119 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -118.81 124.7 47.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -90.96 119.53 31.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.862 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 933' ' ' VAL . . . . . 0.571 HG21 ' CD1' ' A' ' 938' ' ' TRP . 9.0 t -85.64 157.27 3.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.148 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 934' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 933' ' ' VAL . 65.7 mt-10 -33.77 -50.34 0.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.871 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.76 -26.2 3.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.841 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 936' ' ' LYS . . . . . 0.414 ' O ' ' N ' ' A' ' 933' ' ' VAL . 1.0 OUTLIER -96.48 173.2 7.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 -179.984 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 937' ' ' MET . . . . . 0.57 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 18.8 ttt -134.8 110.39 9.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.848 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 938' ' ' TRP . . . . . 0.571 ' CD1' HG21 ' A' ' 933' ' ' VAL . 43.8 m0 -89.51 152.31 21.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.939 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 939' ' ' VAL . . . . . 0.409 HG22 ' C ' ' A' ' 938' ' ' TRP . 93.0 t -140.99 123.57 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.127 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 18.8 m -90.4 150.04 22.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.137 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 941' ' ' PHE . . . . . 0.401 ' O ' ' C ' ' A' ' 942' ' ' LEU . 10.8 m-85 -129.41 150.49 50.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.891 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 942' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 941' ' ' PHE . 21.7 tp -37.09 -59.62 0.71 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.909 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -130.41 163.26 27.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 944' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 947' ' ' ALA . . . -55.49 -56.84 21.55 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.5 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 68.6 p -39.57 -48.71 2.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.889 0.376 . . . . 0.0 110.836 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 18.3 m -54.14 -37.93 64.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 947' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 944' ' ' GLY . . . -74.57 -13.81 60.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.098 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 26.7 mt -89.29 -21.85 22.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -88.77 -44.85 10.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.91 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 7.3 p -52.45 -22.76 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.109 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 31.1 mt -48.68 -26.65 2.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.904 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 26.3 m -52.78 -16.14 0.91 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.889 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 953' ' ' LEU . . . . . 0.415 ' CB ' HD11 ' A' ' 965' ' ' ILE . 36.5 mt -92.13 16.48 11.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.865 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.41 119.0 13.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 87.8 -27.92 6.28 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.499 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -38.61 127.52 1.49 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.73 0.3 . . . . 0.0 110.896 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -97.17 122.87 40.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.904 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 14.2 tp -132.91 156.75 46.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 959' ' ' LEU . . . . . 0.453 ' O ' ' CG ' ' A' ' 960' ' ' ASN . 24.9 mt 42.19 49.23 4.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.931 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 960' ' ' ASN . . . . . 0.453 ' CG ' ' O ' ' A' ' 959' ' ' LEU . 17.0 p30 47.53 38.94 8.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 961' ' ' ARG . . . . . 0.446 ' HD2' ' CD2' ' A' ' 913' ' ' LEU . 49.7 mtt85 -146.88 112.0 5.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.871 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 55.8 m -64.9 119.52 10.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.127 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 963' ' ' ILE . . . . . . . . . . . . . 89.1 mt -102.12 145.65 11.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.115 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 7.6 m -130.43 110.26 11.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.126 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 965' ' ' ILE . . . . . 0.415 HD11 ' CB ' ' A' ' 953' ' ' LEU . 62.5 mt -96.64 136.61 26.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.146 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -147.72 134.47 20.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.136 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 967' ' ' LEU . . . . . . . . . . . . . 26.9 mt -64.54 155.75 32.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.927 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 11.9 tptp . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.883 179.853 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 N-CA-C 112.527 -0.229 . . . . 0.0 112.527 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 4.8 t -147.28 119.85 8.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.858 0.361 . . . . 0.0 110.879 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 30.0 t -112.57 137.31 50.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.784 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . 97.76 113.03 3.12 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.534 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 1.2 t -174.34 113.38 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.893 0.378 . . . . 0.0 110.841 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 20.9 m -82.62 86.98 6.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.835 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 164.48 -126.64 1.53 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.519 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . 159.89 43.08 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.482 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 99.1 m -97.01 120.01 36.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 0.0 111.125 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 895' ' ' VAL . . . . . . . . . . . . . 17.7 m -116.26 142.24 30.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.076 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . 0.462 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 6.5 mp -90.52 139.15 30.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.926 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 70.5 t -139.01 125.29 23.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.139 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 11.1 t -126.6 155.02 43.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.862 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . 0.553 HG12 ' CE2' ' A' ' 909' ' ' PHE . 2.6 pt -120.26 131.71 71.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.123 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.66 119.09 22.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 901' ' ' SER . . . . . . . . . . . . . 1.4 t -133.31 178.87 6.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.832 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 3.2 m -101.28 -48.39 4.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.87 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 14.7 mt -86.2 151.45 54.1 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.615 0.721 . . . . 0.0 110.895 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -76.86 -15.89 16.52 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.686 2.257 . . . . 0.0 112.358 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -97.66 11.16 37.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 906' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -109.45 -22.11 12.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.87 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 38.9 m-20 -48.62 -22.7 0.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.894 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -67.64 137.66 55.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.88 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 909' ' ' PHE . . . . . 0.553 ' CE2' HG12 ' A' ' 899' ' ' ILE . 79.7 m-85 -84.34 132.51 34.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.904 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -97.56 -177.25 3.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.835 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -61.92 -36.07 80.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -67.72 -57.36 6.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.112 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 22.6 mt -49.79 -47.0 51.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.923 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 914' ' ' ILE . . . . . 0.426 HD13 ' CZ ' ' A' ' 932' ' ' PHE . 47.5 mt -69.99 -65.93 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.125 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -38.81 -53.47 1.68 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.843 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -58.24 -51.15 70.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.893 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 917' ' ' LEU . . . . . 0.497 ' HB3' ' CE2' ' A' ' 921' ' ' PHE . 23.9 mt -48.93 -54.79 14.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.883 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 918' ' ' LEU . . . . . 0.434 ' C ' ' O ' ' A' ' 917' ' ' LEU . 52.4 mt -35.04 -58.81 0.52 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.939 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -54.76 -51.17 66.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.934 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 920' ' ' GLN . . . . . 0.42 ' NE2' ' CD2' ' A' ' 958' ' ' LEU . 14.4 mt-30 -51.27 -41.43 60.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.926 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 921' ' ' PHE . . . . . 0.497 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 23.6 m-85 -70.93 -32.1 68.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -58.3 -39.22 78.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.097 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -45.03 -25.58 0.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.918 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 924' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 1.0 OUTLIER -120.96 -64.1 1.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.878 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -121.33 145.08 16.96 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.467 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -85.82 97.23 10.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.88 0.372 . . . . 0.0 110.902 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 29.1 t -46.31 145.64 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.107 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 928' ' ' ILE . . . . . 0.444 HG13 ' N ' ' A' ' 929' ' ' LEU . 25.1 pt -126.63 -42.89 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.167 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 929' ' ' LEU . . . . . 0.444 ' N ' HG13 ' A' ' 928' ' ' ILE . 10.2 tp -133.7 145.84 50.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.946 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 81.7 mt -133.69 124.58 47.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.099 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 41.1 ttt180 -115.21 124.35 51.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.91 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 932' ' ' PHE . . . . . 0.426 ' CZ ' HD13 ' A' ' 914' ' ' ILE . 62.9 m-85 -90.76 122.42 33.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.912 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 933' ' ' VAL . . . . . 0.527 ' CG2' ' CD1' ' A' ' 938' ' ' TRP . 2.7 t -90.51 156.94 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.151 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 934' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 933' ' ' VAL . 14.7 mt-10 -34.49 -52.12 0.49 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.9 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.93 -25.52 3.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.896 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -96.63 172.92 7.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.864 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 937' ' ' MET . . . . . 0.544 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 15.9 ttt -133.54 110.73 10.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.903 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 938' ' ' TRP . . . . . 0.527 ' CD1' ' CG2' ' A' ' 933' ' ' VAL . 37.8 m0 -90.85 148.98 22.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.924 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 47.6 t -137.88 124.83 28.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.106 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 21.3 m -93.0 150.48 20.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.147 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 941' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -128.49 158.56 38.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.839 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 23.2 tp -40.72 -53.54 2.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.939 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -134.48 167.82 20.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.866 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -64.74 -47.4 83.68 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.523 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 70.5 m -50.06 -43.86 51.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.923 0.392 . . . . 0.0 110.831 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 1.9 t -56.64 -36.72 69.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.91 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -69.82 -13.64 62.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.103 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 23.8 mt -87.15 -25.23 24.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -82.78 -38.08 23.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 9.0 p -61.28 -18.47 18.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.139 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 58.7 mt -53.27 -17.84 2.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.941 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 46.3 m -61.77 -12.98 19.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.888 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 953' ' ' LEU . . . . . 0.464 ' HB2' ' CD1' ' A' ' 965' ' ' ILE . 75.3 mt -96.86 12.84 30.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.956 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -66.03 107.24 1.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.934 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 100.02 -26.85 22.9 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.487 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 8.4 tmtm? -40.17 128.86 2.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.772 0.32 . . . . 0.0 110.909 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -93.01 130.38 38.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.848 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 958' ' ' LEU . . . . . 0.42 ' CD2' ' NE2' ' A' ' 920' ' ' GLN . 16.2 tp -136.3 145.99 46.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.931 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 26.0 mt 44.94 52.24 8.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.953 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 49.26 31.85 3.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 961' ' ' ARG . . . . . . . . . . . . . 56.0 mtt-85 -138.89 111.76 7.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 18.7 m -66.25 116.57 7.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.164 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 963' ' ' ILE . . . . . . . . . . . . . 92.9 mt -97.82 137.21 26.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.114 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 9.6 m -122.41 110.42 15.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.134 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 965' ' ' ILE . . . . . 0.464 ' CD1' ' HB2' ' A' ' 953' ' ' LEU . 38.3 mt -94.61 143.23 12.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.139 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 966' ' ' ALA . . . . . 0.459 ' N ' HG22 ' A' ' 965' ' ' ILE . . . -157.3 133.26 9.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.149 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 967' ' ' LEU . . . . . . . . . . . . . 31.8 mt -67.12 157.73 32.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.905 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 19.3 tptp -87.93 91.14 8.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.897 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 87.6 p -60.31 143.51 89.12 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.647 0.737 . . . . 0.0 110.852 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -78.06 115.07 3.7 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.665 2.243 . . . . 0.0 112.39 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 34.1 p -58.71 -42.91 89.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -101.39 146.72 17.39 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.505 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.75 155.23 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.727 2.285 . . . . 0.0 112.32 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 98.2 p -77.6 -44.57 27.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.88 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 1.8 t -63.81 165.56 8.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.869 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.509 -179.994 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 47.9 t -126.81 83.67 2.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.905 0.383 . . . . 0.0 110.836 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 29.8 t -73.05 105.31 4.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.877 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . -155.93 -131.61 1.43 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.482 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 47.8 m 54.14 38.36 28.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.873 0.368 . . . . 0.0 110.855 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 41.4 t -48.96 -54.96 13.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.819 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -111.13 -135.07 6.71 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.455 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . -158.64 42.89 0.49 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.47 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 53.6 m -90.11 121.75 32.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.822 0.344 . . . . 0.0 111.143 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 895' ' ' VAL . . . . . . . . . . . . . 16.8 m -112.23 141.6 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.122 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . 0.53 ' HG ' ' CD1' ' A' ' 938' ' ' TRP . 3.6 mp -91.84 148.07 22.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.93 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 58.1 t -145.3 127.37 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.165 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 6.4 t -127.82 153.95 46.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.891 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 2.1 pt -122.84 130.52 74.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.109 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -89.76 120.02 30.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.918 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 901' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 902' ' ' SER . 16.6 t -134.95 139.08 44.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 902' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 901' ' ' SER . 66.2 p -38.01 -54.56 1.31 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 61.8 mt -94.53 147.47 33.29 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.647 0.737 . . . . 0.0 110.907 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -77.17 -32.08 3.32 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.691 2.261 . . . . 0.0 112.352 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -67.58 -9.58 44.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.886 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 906' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -101.56 11.78 38.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -72.95 -2.02 19.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.894 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -80.98 128.68 33.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.899 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 909' ' ' PHE . . . . . 0.569 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 87.5 m-85 -72.64 121.41 19.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.872 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -87.51 166.42 14.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.876 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -49.32 -44.83 44.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.855 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -62.96 -52.29 63.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.105 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 50.3 mt -53.69 -49.31 68.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.921 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 47.3 mt -65.85 -61.62 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.14 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -42.77 -60.72 1.47 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.869 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -48.92 -52.62 23.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.909 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 917' ' ' LEU . . . . . 0.519 ' HB3' ' CE2' ' A' ' 921' ' ' PHE . 29.6 mt -47.81 -54.71 11.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 918' ' ' LEU . . . . . 0.448 ' CD2' HD13 ' A' ' 930' ' ' ILE . 87.4 mt -35.22 -59.12 0.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.905 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -54.79 -44.66 73.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.89 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 62.5 mm-40 -57.46 -41.08 79.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 921' ' ' PHE . . . . . 0.519 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 23.5 m-85 -70.05 -34.22 72.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -60.67 -34.39 74.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.089 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -47.12 -24.15 0.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 924' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 1.2 m-85 -125.7 -55.23 1.52 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.878 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -129.16 135.07 8.25 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.453 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -79.08 98.37 6.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.918 0.39 . . . . 0.0 110.914 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 42.2 t -51.63 151.46 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.132 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 928' ' ' ILE . . . . . 0.458 HG13 ' N ' ' A' ' 929' ' ' LEU . 20.1 pt -125.81 -45.43 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.1 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 929' ' ' LEU . . . . . 0.458 ' N ' HG13 ' A' ' 928' ' ' ILE . 11.2 tp -132.87 148.08 52.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 930' ' ' ILE . . . . . 0.448 HD13 ' CD2' ' A' ' 918' ' ' LEU . 74.5 mt -133.12 132.86 58.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.128 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -120.87 123.92 43.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.847 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -90.69 120.18 31.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.877 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 933' ' ' VAL . . . . . 0.468 HG23 ' NE1' ' A' ' 938' ' ' TRP . 2.6 t -90.48 157.13 2.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.086 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 934' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 933' ' ' VAL . 58.3 mt-10 -33.94 -51.6 0.41 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.908 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -125.19 -25.49 3.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.878 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 936' ' ' LYS . . . . . 0.416 ' O ' ' N ' ' A' ' 933' ' ' VAL . 12.0 tttt -98.27 172.98 7.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.881 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 937' ' ' MET . . . . . 0.569 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 13.5 ttt -135.33 110.65 9.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 938' ' ' TRP . . . . . 0.53 ' CD1' ' HG ' ' A' ' 896' ' ' LEU . 40.2 m0 -88.69 149.11 23.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.944 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 12.1 t -139.12 129.36 32.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.128 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 17.3 m -93.73 151.15 19.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.151 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 941' ' ' PHE . . . . . 0.422 ' O ' ' C ' ' A' ' 942' ' ' LEU . 9.5 m-85 -130.56 139.82 50.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.917 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 942' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 941' ' ' PHE . 24.5 tp -35.14 -62.5 0.38 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.909 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -116.38 154.47 30.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.87 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -58.54 -50.01 71.23 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.442 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 12.6 t -48.21 -43.48 32.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.848 0.356 . . . . 0.0 110.857 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 14.6 m -55.77 -29.02 58.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.853 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -81.44 -23.0 37.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.073 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 38.3 mt -79.68 -25.71 41.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -84.6 -51.44 6.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.873 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 9.8 p -47.55 -21.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.163 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 951' ' ' LEU . . . . . 0.463 HD13 ' CD1' ' A' ' 967' ' ' LEU . 35.3 mt -49.52 -27.25 4.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.959 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 74.8 m -53.72 -15.29 1.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.903 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 953' ' ' LEU . . . . . 0.408 ' C ' HD11 ' A' ' 965' ' ' ILE . 57.7 mt -90.36 16.51 8.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.926 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.95 120.01 14.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 955' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 956' ' ' LYS . . . 86.21 -25.94 6.62 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.493 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 956' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 955' ' ' GLY . 8.9 tmtm? -36.21 126.84 0.77 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.747 0.308 . . . . 0.0 110.857 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -94.72 125.59 39.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 14.2 tp -138.35 153.69 48.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . 0.415 ' C ' ' CG ' ' A' ' 960' ' ' ASN . 45.3 mt 41.79 48.39 3.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 960' ' ' ASN . . . . . 0.415 ' CG ' ' C ' ' A' ' 959' ' ' LEU . 0.7 OUTLIER 46.5 42.94 11.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 961' ' ' ARG . . . . . . . . . . . . . 45.8 mtt85 -149.69 105.27 3.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 7.4 m -59.49 122.16 13.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.111 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 963' ' ' ILE . . . . . . . . . . . . . 88.3 mt -106.69 142.35 19.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.152 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 6.5 m -126.48 116.41 21.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.135 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 965' ' ' ILE . . . . . 0.438 HG21 ' N ' ' A' ' 966' ' ' ALA . 67.6 mt -98.03 139.28 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.179 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 966' ' ' ALA . . . . . 0.438 ' N ' HG21 ' A' ' 965' ' ' ILE . . . -148.7 128.09 13.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.07 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 967' ' ' LEU . . . . . 0.463 ' CD1' HD13 ' A' ' 951' ' ' LEU . 30.4 mt -66.51 157.46 32.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 30.5 tptt -97.81 102.55 14.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 67.8 p -127.1 93.12 42.39 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.663 0.744 . . . . 0.0 110.842 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -44.12 -50.41 7.66 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.672 2.248 . . . . 0.0 112.344 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 3.3 t -71.29 124.28 24.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -124.9 95.31 0.48 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.478 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.31 137.07 18.52 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.668 2.245 . . . . 0.0 112.332 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 45.4 m -96.57 99.74 11.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 12.6 t -69.53 83.64 0.42 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.862 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.534 -179.992 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 73.7 m -100.31 -55.74 2.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.912 0.387 . . . . 0.0 110.872 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 25.9 p -86.55 124.07 32.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.813 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . 162.24 87.27 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.474 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 20.2 m -46.43 169.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.888 0.375 . . . . 0.0 110.802 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 17.0 t -70.55 121.93 18.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.822 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 137.84 131.19 2.89 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.488 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . -105.26 57.52 0.49 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.481 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 86.8 m -86.67 120.18 27.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.817 0.341 . . . . 0.0 111.174 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 895' ' ' VAL . . . . . . . . . . . . . 27.5 m -120.19 139.28 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.143 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . 0.467 ' N ' HD12 ' A' ' 896' ' ' LEU . 6.4 mp -89.18 138.97 30.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . 0.424 HG21 ' C ' ' A' ' 896' ' ' LEU . 63.8 t -139.71 122.61 17.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.138 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 16.5 t -125.66 155.5 40.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.902 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . 0.523 HG12 ' CE2' ' A' ' 909' ' ' PHE . 2.3 pt -121.1 129.31 75.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.128 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 48.9 mttp -69.71 110.72 5.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 901' ' ' SER . . . . . . . . . . . . . 11.7 p -131.98 151.53 51.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.838 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 31.3 t -92.94 -43.93 8.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.839 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 9.8 mt -84.4 150.88 58.25 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.588 0.709 . . . . 0.0 110.944 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.78 -16.99 18.24 Favored 'Trans proline' 0 N--CA 1.466 -0.133 0 C-N-CA 122.714 2.276 . . . . 0.0 112.359 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -97.23 25.13 5.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.927 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 906' ' ' ASN . . . . . 0.402 ' C ' ' N ' ' A' ' 908' ' ' PHE . 95.2 m-20 -129.99 -32.63 1.83 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.885 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -42.63 -25.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.862 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 908' ' ' PHE . . . . . 0.402 ' N ' ' C ' ' A' ' 906' ' ' ASN . 24.1 m-85 -76.04 145.62 40.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 909' ' ' PHE . . . . . 0.523 ' CE2' HG12 ' A' ' 899' ' ' ILE . 27.1 m-85 -89.73 121.91 32.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.893 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -86.18 177.31 7.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.871 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -55.17 -42.96 73.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.859 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -63.96 -47.24 81.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.076 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 52.1 mt -61.01 -48.95 79.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.926 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 914' ' ' ILE . . . . . 0.491 HD11 ' CZ ' ' A' ' 932' ' ' PHE . 49.6 mt -65.81 -59.95 3.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.14 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -45.28 -58.01 3.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.902 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -50.84 -52.53 40.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.891 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 917' ' ' LEU . . . . . 0.568 ' HB3' ' CE2' ' A' ' 921' ' ' PHE . 29.6 mt -46.4 -54.01 9.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.909 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 918' ' ' LEU . . . . . 0.414 ' C ' ' O ' ' A' ' 917' ' ' LEU . 20.6 mt -36.63 -64.42 0.34 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.939 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -50.14 -51.92 39.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.912 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -50.47 -40.97 52.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 921' ' ' PHE . . . . . 0.568 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 24.1 m-85 -69.74 -48.18 60.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.855 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -48.19 -28.31 2.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.108 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 923' ' ' SER . . . . . 0.563 ' HB3' ' CD1' ' A' ' 924' ' ' PHE . 16.7 t -47.49 -29.66 2.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.897 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 924' ' ' PHE . . . . . 0.563 ' CD1' ' HB3' ' A' ' 923' ' ' SER . 1.0 OUTLIER -123.02 -64.43 1.18 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.856 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -115.74 155.29 16.37 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.51 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -91.96 138.44 31.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.885 0.374 . . . . 0.0 110.909 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 55.9 t -93.07 146.16 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.114 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 928' ' ' ILE . . . . . 0.469 HG13 ' N ' ' A' ' 929' ' ' LEU . 30.2 pt -123.32 -42.86 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.107 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 929' ' ' LEU . . . . . 0.469 ' N ' HG13 ' A' ' 928' ' ' ILE . 15.0 tp -138.76 141.81 38.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 94.3 mt -127.36 125.47 65.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.154 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -113.44 122.82 48.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 932' ' ' PHE . . . . . 0.491 ' CZ ' HD11 ' A' ' 914' ' ' ILE . 61.6 m-85 -90.6 122.14 33.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.928 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 933' ' ' VAL . . . . . 0.569 HG22 ' CD1' ' A' ' 938' ' ' TRP . 2.9 t -89.9 157.09 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.158 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 934' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 933' ' ' VAL . 61.8 mt-10 -34.11 -50.53 0.4 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.891 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -126.05 -26.73 3.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.823 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 936' ' ' LYS . . . . . 0.414 ' NZ ' ' HB2' ' A' ' 936' ' ' LYS . 0.7 OUTLIER -96.53 172.73 7.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.933 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 937' ' ' MET . . . . . 0.485 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 14.5 ttt -135.26 111.78 9.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.863 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 938' ' ' TRP . . . . . 0.569 ' CD1' HG22 ' A' ' 933' ' ' VAL . 37.0 m0 -92.47 146.33 23.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 65.0 t -132.62 121.27 44.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.132 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 18.9 m -85.18 152.59 23.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.156 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 941' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -133.74 141.84 47.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 19.7 tp -42.55 -47.97 5.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.899 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -120.63 176.13 5.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -89.74 -39.2 6.28 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.519 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 36.0 p -59.54 -41.23 89.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.921 0.391 . . . . 0.0 110.861 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 80.0 p -56.38 -34.45 66.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.881 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -70.81 -15.18 62.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.103 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 25.5 mt -84.01 -31.53 25.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -75.67 -49.31 18.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.842 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 8.5 p -53.35 -17.31 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.143 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 52.3 mt -52.98 -24.96 10.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 35.9 p -55.88 -22.92 28.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 76.7 mt -83.25 17.9 1.92 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -72.63 110.35 6.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 96.02 -26.42 20.89 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.481 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -38.33 127.46 1.39 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.732 0.301 . . . . 0.0 110.897 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -94.9 128.42 41.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.901 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 958' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 961' ' ' ARG . 13.7 tp -136.97 160.04 40.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.926 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . 0.406 ' C ' ' O ' ' A' ' 958' ' ' LEU . 43.5 mt 37.7 43.07 0.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.967 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 55.44 43.31 28.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.871 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 961' ' ' ARG . . . . . 0.45 ' N ' ' O ' ' A' ' 958' ' ' LEU . 69.2 mtt-85 -149.71 122.89 8.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.844 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 6.0 m -75.05 112.72 11.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.119 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 963' ' ' ILE . . . . . . . . . . . . . 82.8 mt -98.02 138.17 23.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.088 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 9.3 m -122.13 113.25 19.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.109 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 965' ' ' ILE . . . . . . . . . . . . . 55.3 mt -98.75 135.07 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.113 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -149.27 136.63 20.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.095 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 967' ' ' LEU . . . . . . . . . . . . . 30.7 mt -65.44 156.58 31.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.895 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 968' ' ' LYS . . . . . 0.429 ' HE3' ' CH2' ' A' ' 938' ' ' TRP . 21.5 tttt -96.2 144.04 26.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 94.1 p -69.61 144.42 93.97 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.666 0.746 . . . . 0.0 110.886 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -78.02 171.27 17.46 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.751 2.301 . . . . 0.0 112.327 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 32.8 p -121.62 -58.57 1.75 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.916 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . 128.81 167.72 12.23 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.481 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.45 161.53 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.739 2.293 . . . . 0.0 112.326 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 36.7 t -134.21 140.67 46.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.873 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 43.2 m -128.59 127.44 42.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.837 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.449 179.973 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.446 -0.262 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 2.2 m -103.78 88.33 3.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.844 0.354 . . . . 0.0 110.872 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 15.0 m -105.52 154.36 20.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.831 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . 70.76 158.86 2.8 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.507 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 4.8 m -74.12 148.94 41.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.926 0.394 . . . . 0.0 110.822 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 77.5 p -137.42 157.16 47.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.832 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -60.88 -167.59 0.39 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.503 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . -141.51 42.95 1.12 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.474 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 84.8 m -127.23 122.47 34.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.823 0.344 . . . . 0.0 111.136 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 895' ' ' VAL . . . . . . . . . . . . . 11.3 m -114.25 147.19 17.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.117 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . 0.459 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 3.5 mp -96.17 144.26 26.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.937 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 59.2 t -143.72 131.88 18.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.137 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 14.2 t -134.14 160.23 38.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.82 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 4.1 pt -121.62 162.19 21.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.162 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 900' ' ' LYS . . . . . 0.451 ' CD ' ' HB ' ' A' ' 962' ' ' THR . 31.6 mtpt -99.33 105.45 17.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 901' ' ' SER . . . . . . . . . . . . . 10.7 m -137.88 136.22 36.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.826 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 37.3 m -80.19 -61.05 2.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 17.1 mt -58.49 147.9 67.35 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.638 0.732 . . . . 0.0 110.915 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.59 -13.14 18.31 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.669 2.246 . . . . 0.0 112.346 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -99.97 20.37 14.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.885 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 906' ' ' ASN . . . . . 0.492 ' O ' ' N ' ' A' ' 908' ' ' PHE . 41.4 m-20 -123.6 -37.84 2.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.917 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -38.02 -27.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.857 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 908' ' ' PHE . . . . . 0.492 ' N ' ' O ' ' A' ' 906' ' ' ASN . 38.4 m-85 -65.35 153.35 41.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 909' ' ' PHE . . . . . 0.547 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 90.0 m-85 -95.55 107.67 19.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.841 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -72.44 163.61 27.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.842 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -51.47 -35.95 42.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.831 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -70.49 -50.95 32.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.091 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 913' ' ' LEU . . . . . 0.416 HD21 ' CD ' ' A' ' 961' ' ' ARG . 87.4 mt -54.8 -35.43 63.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 91.2 mt -79.28 -65.0 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.14 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -39.69 -55.97 1.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.919 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -51.95 -48.46 64.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 917' ' ' LEU . . . . . 0.546 ' HB3' ' CE2' ' A' ' 921' ' ' PHE . 28.8 mt -55.06 -47.49 74.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 918' ' ' LEU . . . . . . . . . . . . . 44.6 mt -43.29 -55.58 3.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -58.63 -38.65 78.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 39.4 mm-40 -64.31 -35.83 82.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.888 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 921' ' ' PHE . . . . . 0.546 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 19.4 m-85 -76.03 -33.01 59.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -58.24 -31.92 67.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.104 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 923' ' ' SER . . . . . 0.478 ' OG ' ' CE2' ' A' ' 924' ' ' PHE . 31.9 p -56.93 -13.51 2.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.855 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 924' ' ' PHE . . . . . 0.478 ' CE2' ' OG ' ' A' ' 923' ' ' SER . 74.5 m-85 -125.97 -57.33 1.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.86 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -137.17 140.14 11.14 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.462 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -74.96 98.85 3.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.896 0.379 . . . . 0.0 110.871 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 58.0 t -50.29 145.16 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.146 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 928' ' ' ILE . . . . . 0.457 HG13 ' N ' ' A' ' 929' ' ' LEU . 20.0 pt -120.28 -45.38 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.138 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 929' ' ' LEU . . . . . 0.457 ' N ' HG13 ' A' ' 928' ' ' ILE . 11.2 tp -137.78 151.85 48.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.914 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 40.7 mt -135.97 129.85 48.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.113 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 21.4 ttt-85 -116.56 123.8 48.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -91.58 123.85 35.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.885 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 933' ' ' VAL . . . . . 0.558 HG23 ' CD1' ' A' ' 938' ' ' TRP . 3.6 t -90.78 156.97 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.17 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 934' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 933' ' ' VAL . 61.2 mm-40 -34.37 -51.32 0.45 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.1 -25.46 3.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.803 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.03 173.02 7.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 937' ' ' MET . . . . . 0.547 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 15.1 ttt -134.19 113.51 12.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.877 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 938' ' ' TRP . . . . . 0.558 ' CD1' HG23 ' A' ' 933' ' ' VAL . 37.1 m0 -93.89 151.89 19.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.889 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 39.8 t -134.86 139.19 47.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.161 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 29.2 m -110.66 146.8 35.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.15 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 941' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -130.21 149.84 51.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.884 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 21.2 tp -40.25 -63.63 0.6 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.902 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -107.43 168.48 9.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.91 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -76.42 -49.8 7.91 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.482 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 6.6 p -49.41 -27.25 3.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.921 0.391 . . . . 0.0 110.883 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 70.5 m -63.22 -47.59 81.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.864 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -60.28 -27.88 67.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.107 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 18.3 mt -73.66 -25.12 60.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.933 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -81.8 -45.05 16.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.919 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 3.2 p -57.83 -18.8 10.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.13 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 23.0 mt -51.77 -31.42 26.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.962 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 6.4 t -51.52 -17.19 0.74 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.837 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 953' ' ' LEU . . . . . 0.444 ' CB ' HD11 ' A' ' 965' ' ' ILE . 39.8 mt -87.85 13.76 10.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.888 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -66.28 117.22 8.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 90.88 -26.7 10.29 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.5 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -41.43 128.54 3.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.794 0.331 . . . . 0.0 110.881 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -97.78 130.43 44.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.857 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 15.3 tp -134.74 156.21 49.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.935 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 47.0 mt 38.83 46.02 1.01 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.922 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 51.88 45.32 28.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.847 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 961' ' ' ARG . . . . . 0.416 ' CD ' HD21 ' A' ' 913' ' ' LEU . 52.0 mtt85 -151.65 105.42 3.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.925 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 962' ' ' THR . . . . . 0.451 ' HB ' ' CD ' ' A' ' 900' ' ' LYS . 18.7 m -57.75 117.49 4.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.152 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 963' ' ' ILE . . . . . . . . . . . . . 97.4 mt -101.14 139.03 23.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 4.2 m -123.66 116.06 22.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.177 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 965' ' ' ILE . . . . . 0.444 HD11 ' CB ' ' A' ' 953' ' ' LEU . 55.2 mt -101.1 139.94 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.159 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -152.03 131.25 12.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.142 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 967' ' ' LEU . . . . . . . . . . . . . 33.7 mt -64.55 157.87 25.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.939 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -83.75 -69.95 0.6 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 86.1 p -159.84 145.16 11.44 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.615 0.721 . . . . 0.0 110.879 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -77.64 13.13 1.72 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.682 2.254 . . . . 0.0 112.373 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 7.6 m -151.7 125.47 9.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.825 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . 147.16 73.72 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.459 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -46.38 -41.27 22.87 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.653 2.236 . . . . 0.0 112.358 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 2.0 m 53.68 32.56 14.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 16.3 p -83.59 170.72 14.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.852 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.531 -179.929 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 1.6 t -81.39 137.2 35.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.894 0.378 . . . . 0.0 110.822 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 79.7 p -64.02 -10.23 20.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.838 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . 109.77 102.82 2.75 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.53 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 13.5 t -75.76 131.29 39.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.826 0.346 . . . . 0.0 110.9 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 14.5 t -98.78 108.43 21.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.865 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -163.34 -91.82 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.483 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . 81.7 -38.06 2.49 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.485 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 33.9 m -84.75 119.73 25.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.798 0.332 . . . . 0.0 111.19 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 895' ' ' VAL . . . . . . . . . . . . . 13.9 m -116.31 139.76 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.152 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . 0.47 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 3.2 mp -89.53 150.82 22.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.891 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 64.3 t -144.95 131.66 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.178 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 5.2 t -133.53 154.71 50.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 4.1 pt -119.91 164.17 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.111 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 5.9 tptp -100.06 103.68 15.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 901' ' ' SER . . . . . . . . . . . . . 73.1 m -140.1 134.4 31.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.861 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 63.2 m -74.33 -66.04 0.78 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.87 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 28.0 mt -52.16 144.15 22.56 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.633 0.73 . . . . 0.0 110.921 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.29 -11.16 19.23 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.717 2.278 . . . . 0.0 112.33 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -98.87 0.94 45.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.89 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 906' ' ' ASN . . . . . 0.523 ' N ' HD21 ' A' ' 906' ' ' ASN . 1.2 m-80 -104.49 -32.59 8.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.899 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -38.97 -26.4 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 908' ' ' PHE . . . . . 0.485 ' N ' ' O ' ' A' ' 906' ' ' ASN . 51.2 m-85 -71.98 136.84 46.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 909' ' ' PHE . . . . . 0.544 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 50.6 m-85 -75.3 133.88 41.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.88 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -96.91 169.1 10.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -48.12 -38.55 18.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.878 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -67.59 -54.24 21.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.064 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 913' ' ' LEU . . . . . 0.424 HD21 ' CD ' ' A' ' 961' ' ' ARG . 36.7 mt -52.92 -42.01 64.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.908 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 60.7 mt -74.08 -64.91 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.11 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -40.02 -61.55 0.85 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -48.89 -55.52 11.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.904 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 917' ' ' LEU . . . . . 0.552 ' HB3' ' CZ ' ' A' ' 921' ' ' PHE . 24.9 mt -46.5 -54.15 9.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 918' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 917' ' ' LEU . 89.4 mt -36.81 -59.39 0.69 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -55.35 -48.69 73.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -53.16 -41.3 65.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.938 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 921' ' ' PHE . . . . . 0.552 ' CZ ' ' HB3' ' A' ' 917' ' ' LEU . 19.8 m-85 -64.72 -45.0 88.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.925 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -54.03 -30.99 49.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.102 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 29.7 t -45.54 -30.98 1.62 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 924' ' ' PHE . . . . . 0.532 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 1.0 OUTLIER -120.73 -57.63 1.88 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -127.03 152.22 18.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.512 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -87.62 135.51 33.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.855 0.36 . . . . 0.0 110.889 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 46.7 t -87.7 145.93 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.113 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 928' ' ' ILE . . . . . 0.429 HG13 ' N ' ' A' ' 929' ' ' LEU . 26.6 pt -120.65 -41.56 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.093 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 929' ' ' LEU . . . . . 0.429 ' N ' HG13 ' A' ' 928' ' ' ILE . 21.9 tp -141.06 149.05 41.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.95 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 58.4 mt -133.24 132.54 58.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.144 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -118.39 130.58 56.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -97.59 120.78 38.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.851 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 933' ' ' VAL . . . . . 0.566 HG22 ' CD1' ' A' ' 938' ' ' TRP . 2.8 t -91.58 157.12 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.109 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 934' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 933' ' ' VAL . 44.3 mt-10 -33.56 -54.01 0.43 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.905 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -124.5 -22.42 4.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.817 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 6.3 ttmt -99.59 173.14 6.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.868 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 937' ' ' MET . . . . . 0.544 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 17.3 ttt -136.14 114.31 11.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 938' ' ' TRP . . . . . 0.566 ' CD1' HG22 ' A' ' 933' ' ' VAL . 37.8 m0 -94.72 143.9 26.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.96 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 47.9 t -130.78 137.82 55.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.16 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 19.4 m -106.85 144.36 33.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.18 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 941' ' ' PHE . . . . . 0.444 ' O ' ' C ' ' A' ' 942' ' ' LEU . 6.0 m-85 -125.38 144.22 50.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.909 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 942' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 941' ' ' PHE . 43.1 tp -34.33 -67.84 0.13 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.925 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -104.44 171.81 7.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.903 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -76.02 -49.6 8.48 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.499 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 95.6 p -50.44 -25.93 4.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.865 0.364 . . . . 0.0 110.869 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 60.7 m -65.63 -42.59 91.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.793 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -68.62 -16.29 63.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.091 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 13.6 mt -87.86 -24.18 23.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.948 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -81.71 -51.05 8.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.944 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 9.8 p -52.02 -20.11 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.135 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 73.0 mt -50.72 -20.73 1.33 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 26.1 m -61.88 -9.43 6.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.822 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 58.8 mt -95.76 11.55 33.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.926 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -67.16 117.43 9.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 90.28 -23.06 23.47 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.517 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.05 127.14 8.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.731 0.3 . . . . 0.0 110.915 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -93.06 123.06 36.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 14.9 tp -129.35 154.94 46.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.948 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 39.0 mt 39.23 46.29 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.906 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 50.95 46.06 26.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.86 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 961' ' ' ARG . . . . . 0.424 ' CD ' HD21 ' A' ' 913' ' ' LEU . 41.4 mtt85 -152.02 106.47 3.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.929 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 7.7 m -60.16 111.18 1.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.141 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 963' ' ' ILE . . . . . . . . . . . . . 79.7 mt -95.78 146.32 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.152 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 5.4 m -129.43 118.23 21.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.131 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 965' ' ' ILE . . . . . 0.462 HG22 ' N ' ' A' ' 966' ' ' ALA . 60.8 mt -105.11 141.28 20.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.086 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 966' ' ' ALA . . . . . 0.462 ' N ' HG22 ' A' ' 965' ' ' ILE . . . -151.59 135.69 16.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.064 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 967' ' ' LEU . . . . . . . . . . . . . 31.5 mt -68.22 158.13 33.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.917 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 968' ' ' LYS . . . . . 0.443 ' HG3' ' N ' ' A' ' 969' ' ' SER . 11.3 tptt -96.56 153.5 17.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 969' ' ' SER . . . . . 0.443 ' N ' ' HG3' ' A' ' 968' ' ' LYS . 44.9 p -129.89 92.78 36.0 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.664 0.745 . . . . 0.0 110.908 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.17 92.36 1.0 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.687 2.258 . . . . 0.0 112.388 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 53.2 p -55.97 155.83 5.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.869 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . 119.91 -95.38 0.59 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.446 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -78.49 131.94 10.81 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.684 2.256 . . . . 0.0 112.358 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 46.0 p -70.79 -49.85 42.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.869 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 1.8 m -85.68 -61.0 1.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.836 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.515 -179.956 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 25.3 p -131.93 105.18 7.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.838 0.352 . . . . 0.0 110.871 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 93.8 p -79.48 102.91 9.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.891 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . -151.93 -162.57 10.9 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.49 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 32.2 p -101.53 -45.2 5.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.88 0.371 . . . . 0.0 110.828 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 3.3 m -74.15 140.84 45.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 80.37 85.16 0.65 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.468 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . -138.26 38.66 1.67 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.441 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 90.3 m -88.05 128.8 35.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.794 0.33 . . . . 0.0 111.131 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 895' ' ' VAL . . . . . . . . . . . . . 23.7 m -121.0 138.86 50.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.138 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . 0.457 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 4.1 mp -89.71 146.4 24.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 70.2 t -144.83 125.32 7.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.098 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 10.6 t -128.07 154.13 46.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.848 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . 0.564 HG21 ' CE2' ' A' ' 909' ' ' PHE . 3.6 pt -122.34 144.98 29.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -98.77 110.22 22.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 901' ' ' SER . . . . . . . . . . . . . 1.7 t -123.1 136.19 54.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.817 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 5.6 m -42.07 -47.85 4.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.829 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 14.8 mt -98.87 150.0 36.27 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.604 0.716 . . . . 0.0 110.96 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.72 -30.87 4.48 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.722 2.281 . . . . 0.0 112.343 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -70.45 -11.49 60.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 906' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -101.72 13.15 35.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.845 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -75.98 0.49 18.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.908 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -87.77 122.51 31.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.922 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 909' ' ' PHE . . . . . 0.564 ' CE2' HG21 ' A' ' 899' ' ' ILE . 91.6 m-85 -63.08 128.25 34.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.914 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.29 179.41 5.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -57.3 -45.43 84.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -57.66 -57.69 11.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.108 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 87.4 mt -49.48 -55.24 13.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.965 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 49.6 mt -60.64 -63.49 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.096 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -41.12 -59.45 1.49 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -53.84 -48.94 69.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.866 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 917' ' ' LEU . . . . . 0.542 ' HB3' ' CE2' ' A' ' 921' ' ' PHE . 27.5 mt -50.97 -58.67 5.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.887 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 918' ' ' LEU . . . . . 0.45 ' CD2' HD11 ' A' ' 930' ' ' ILE . 73.0 mt -34.44 -48.16 0.34 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.915 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -63.77 -45.98 87.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.891 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 920' ' ' GLN . . . . . 0.454 ' N ' ' O ' ' A' ' 917' ' ' LEU . 15.2 mm-40 -58.1 -35.04 70.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.914 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 921' ' ' PHE . . . . . 0.542 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 17.6 m-85 -75.2 -37.7 61.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -57.76 -32.62 67.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.114 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -50.82 -23.3 2.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 924' ' ' PHE . . . . . 0.58 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 0.4 OUTLIER -125.13 -58.29 1.46 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.909 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -129.33 150.53 18.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.432 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -88.99 132.37 34.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.885 0.374 . . . . 0.0 110.86 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 927' ' ' VAL . . . . . 0.44 HG13 ' N ' ' A' ' 928' ' ' ILE . 22.9 t -84.58 147.33 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.19 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 928' ' ' ILE . . . . . 0.442 HG13 ' N ' ' A' ' 929' ' ' LEU . 41.6 pt -123.38 -38.19 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.158 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 929' ' ' LEU . . . . . 0.442 ' N ' HG13 ' A' ' 928' ' ' ILE . 12.0 tp -141.78 147.86 37.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 930' ' ' ILE . . . . . 0.45 HD11 ' CD2' ' A' ' 918' ' ' LEU . 79.4 mt -133.42 124.55 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.119 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -111.68 125.8 54.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -91.98 123.89 35.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.846 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 933' ' ' VAL . . . . . 0.564 HG23 ' CD1' ' A' ' 938' ' ' TRP . 3.1 t -92.07 157.02 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.078 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 934' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 933' ' ' VAL . 15.8 mt-10 -34.35 -52.37 0.48 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -125.08 -25.47 3.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.825 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.02 173.04 7.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.914 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 937' ' ' MET . . . . . 0.528 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 15.1 ttt -132.51 108.35 9.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 938' ' ' TRP . . . . . 0.564 ' CD1' HG23 ' A' ' 933' ' ' VAL . 38.1 m0 -90.26 144.89 25.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.961 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 61.1 t -131.76 133.56 61.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.131 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 940' ' ' THR . . . . . 0.413 ' CG2' ' N ' ' A' ' 941' ' ' PHE . 51.6 m -96.81 156.31 16.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.138 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 941' ' ' PHE . . . . . 0.413 ' N ' ' CG2' ' A' ' 940' ' ' THR . 15.1 m-85 -137.93 144.39 41.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.879 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 29.9 tp -47.04 -44.57 20.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.949 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -123.44 170.39 10.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.921 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -86.34 -41.15 7.08 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.465 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 38.6 p -54.66 -35.21 63.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.839 0.352 . . . . 0.0 110.86 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.76 -40.95 98.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.841 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -64.44 -19.09 65.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.097 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 23.9 mt -83.45 -27.41 29.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -81.82 -51.26 8.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.921 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 7.0 p -48.02 -21.5 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.096 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 951' ' ' LEU . . . . . 0.422 HD13 ' CD1' ' A' ' 967' ' ' LEU . 34.1 mt -49.11 -28.44 4.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.918 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 1.1 t -50.9 -17.54 0.59 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 953' ' ' LEU . . . . . 0.401 ' C ' HD11 ' A' ' 965' ' ' ILE . 46.6 mt -90.39 17.32 7.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.895 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -70.87 110.79 5.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.884 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 93.66 -25.14 22.64 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.493 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -39.38 127.23 1.82 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.705 0.288 . . . . 0.0 110.865 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -94.24 125.08 38.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.87 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 958' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 959' ' ' LEU . 14.9 tp -135.41 158.65 43.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.882 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 958' ' ' LEU . 51.8 mt 38.23 44.24 0.67 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.927 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 51.56 44.39 29.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 961' ' ' ARG . . . . . . . . . . . . . 34.1 mtt85 -151.45 108.69 3.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 8.6 m -62.14 118.24 7.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.132 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 963' ' ' ILE . . . . . . . . . . . . . 92.0 mt -103.7 137.63 31.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.136 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 7.0 m -121.47 112.78 18.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.184 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 965' ' ' ILE . . . . . 0.457 HG23 ' N ' ' A' ' 966' ' ' ALA . 61.8 mt -97.42 139.98 18.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.105 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 966' ' ' ALA . . . . . 0.457 ' N ' HG23 ' A' ' 965' ' ' ILE . . . -149.01 138.36 21.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.098 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 967' ' ' LEU . . . . . 0.422 ' CD1' HD13 ' A' ' 951' ' ' LEU . 39.0 mt -75.84 156.07 34.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.897 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -90.24 155.77 18.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.912 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 18.2 t -116.74 92.86 39.44 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.675 0.75 . . . . 0.0 110.893 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -44.54 149.17 1.09 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.705 2.27 . . . . 0.0 112.316 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 14.6 t -124.99 154.5 41.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . 113.07 95.68 2.2 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.504 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.91 93.19 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.65 2.233 . . . . 0.0 112.379 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 29.1 t -168.88 149.21 4.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.846 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 8.1 t -122.23 -48.91 2.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.89 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.475 -179.985 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 112.418 -0.273 . . . . 0.0 112.418 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 89.0 p -102.0 -5.06 25.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.905 0.383 . . . . 0.0 110.852 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 36.8 p -95.02 174.03 7.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.882 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . -61.2 -171.91 0.91 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.492 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 29.6 t -136.1 154.24 51.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.84 0.352 . . . . 0.0 110.86 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 59.9 p -148.63 152.28 36.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.86 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 41.07 -157.72 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.486 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . -161.67 37.4 0.39 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.474 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 54.1 m -98.27 121.57 40.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.786 0.327 . . . . 0.0 111.149 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 895' ' ' VAL . . . . . . . . . . . . . 21.4 m -119.09 141.33 39.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.13 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . 0.458 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 4.5 mp -90.23 142.25 27.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . 0.417 HG22 ' C ' ' A' ' 896' ' ' LEU . 96.6 t -141.83 129.54 21.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.114 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 4.4 t -131.49 160.11 36.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.842 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . 0.43 HG12 ' CE1' ' A' ' 909' ' ' PHE . 2.0 pt -123.21 115.03 44.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.149 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 8.9 tttp -96.63 122.64 39.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 901' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 902' ' ' SER . 1.4 t -126.94 163.54 23.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.857 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 902' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 901' ' ' SER . 47.4 m -36.18 -63.61 0.37 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.863 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 42.6 mt -98.57 157.48 34.21 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.539 0.685 . . . . 0.0 110.928 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -77.13 -25.12 8.97 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.65 2.234 . . . . 0.0 112.332 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -75.49 5.07 6.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 906' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -116.75 14.8 15.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.897 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -83.92 37.5 0.6 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.902 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -99.75 144.76 28.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 909' ' ' PHE . . . . . 0.546 ' CE2' ' HB2' ' A' ' 937' ' ' MET . 47.2 m-85 -91.58 95.66 10.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.889 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -73.89 161.85 29.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.857 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -49.35 -50.97 37.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.865 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -54.78 -50.58 68.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.13 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 913' ' ' LEU . . . . . 0.422 HD12 ' CD ' ' A' ' 961' ' ' ARG . 20.1 mt -51.72 -52.3 49.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 54.2 mt -60.73 -57.99 9.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.147 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -49.49 -64.0 0.94 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.893 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -44.9 -50.45 10.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.892 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 917' ' ' LEU . . . . . 0.502 ' HB3' ' CE2' ' A' ' 921' ' ' PHE . 28.4 mt -48.37 -55.1 11.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 918' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 917' ' ' LEU . 58.4 mt -36.47 -62.98 0.43 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.941 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -54.0 -44.8 71.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -56.5 -37.39 70.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.883 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 921' ' ' PHE . . . . . 0.502 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 24.2 m-85 -73.74 -39.22 64.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.857 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -53.79 -28.07 32.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 923' ' ' SER . . . . . 0.512 ' HB3' ' CE1' ' A' ' 924' ' ' PHE . 40.9 t -46.14 -30.84 2.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.834 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 924' ' ' PHE . . . . . 0.56 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 0.3 OUTLIER -122.66 -65.09 1.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.873 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -111.67 144.96 17.7 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.462 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -87.47 96.52 10.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.874 0.369 . . . . 0.0 110.89 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 927' ' ' VAL . . . . . 0.431 HG13 ' N ' ' A' ' 928' ' ' ILE . 44.4 t -53.02 144.08 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.131 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 928' ' ' ILE . . . . . 0.448 HG13 ' N ' ' A' ' 929' ' ' LEU . 15.2 pt -121.92 -46.79 2.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.102 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 929' ' ' LEU . . . . . 0.448 ' N ' HG13 ' A' ' 928' ' ' ILE . 17.3 tp -131.08 149.73 52.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 930' ' ' ILE . . . . . 0.414 HG21 ' N ' ' A' ' 931' ' ' ARG . 45.2 mt -135.13 136.1 51.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.176 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 931' ' ' ARG . . . . . 0.414 ' N ' HG21 ' A' ' 930' ' ' ILE . 7.7 tpt180 -119.8 121.43 39.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.882 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -87.43 116.85 25.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 933' ' ' VAL . . . . . 0.562 ' CG2' ' CD1' ' A' ' 938' ' ' TRP . 2.9 t -85.54 156.01 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.126 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 934' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 933' ' ' VAL . 31.1 mt-10 -34.21 -51.36 0.44 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -124.15 -27.14 3.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.877 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -96.01 173.06 7.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 937' ' ' MET . . . . . 0.546 ' HB2' ' CE2' ' A' ' 909' ' ' PHE . 17.7 ttt -135.01 106.69 6.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 938' ' ' TRP . . . . . 0.562 ' CD1' ' CG2' ' A' ' 933' ' ' VAL . 33.3 m0 -85.92 153.6 22.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.924 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 87.4 t -139.74 128.25 26.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.139 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 27.0 m -90.95 151.51 21.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.128 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 941' ' ' PHE . . . . . 0.438 ' O ' ' C ' ' A' ' 942' ' ' LEU . 11.6 m-85 -132.68 141.84 48.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.857 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 942' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 941' ' ' PHE . 19.6 tp -34.41 -64.59 0.24 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.89 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -117.82 150.96 38.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.874 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -53.43 -45.95 65.4 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.458 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 14.6 t -50.77 -41.05 56.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.845 0.355 . . . . 0.0 110.832 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 9.2 m -58.77 -26.29 63.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.836 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -81.58 -13.11 58.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.127 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 33.6 mt -88.06 -28.08 21.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.953 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 33.0 m-20 -82.88 -45.37 14.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 8.7 p -53.47 -22.79 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.174 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 63.1 mt -50.95 -25.54 4.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.886 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 15.3 m -54.4 -16.65 2.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.849 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 953' ' ' LEU . . . . . 0.434 ' CB ' HD13 ' A' ' 965' ' ' ILE . 23.4 mt -89.61 16.02 8.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.912 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -68.44 119.96 13.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.937 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 955' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 956' ' ' LYS . . . 88.11 -30.79 4.98 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.524 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 956' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 955' ' ' GLY . 8.6 tmtm? -35.38 127.87 0.58 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.693 0.282 . . . . 0.0 110.911 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -96.41 131.8 42.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.835 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 13.5 tp -138.1 154.56 49.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 87.6 mt 39.53 45.39 1.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.938 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 55.96 46.36 22.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 961' ' ' ARG . . . . . 0.422 ' CD ' HD12 ' A' ' 913' ' ' LEU . 46.3 mtt85 -154.64 121.86 5.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.884 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 8.3 m -74.08 108.39 6.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.124 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 963' ' ' ILE . . . . . 0.435 ' CD1' HD22 ' A' ' 917' ' ' LEU . 90.1 mt -88.95 130.94 37.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.177 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 9.2 m -116.45 119.38 35.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.1 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 965' ' ' ILE . . . . . 0.456 HG22 ' N ' ' A' ' 966' ' ' ALA . 59.3 mt -103.36 140.31 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.124 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 966' ' ' ALA . . . . . 0.456 ' N ' HG22 ' A' ' 965' ' ' ILE . . . -149.47 136.06 19.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.082 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 967' ' ' LEU . . . . . . . . . . . . . 27.0 mt -70.57 154.62 41.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.921 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -87.17 148.59 25.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.871 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 89.7 p -121.36 79.0 36.22 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.676 0.751 . . . . 0.0 110.862 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 970' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 971' ' ' SER . 72.6 Cg_exo -44.76 147.43 1.83 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.669 2.246 . . . . 0.0 112.353 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 971' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 970' ' ' PRO . 3.3 t -37.84 -53.87 1.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.917 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . 157.37 95.3 0.11 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.467 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.84 130.51 12.51 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.67 2.247 . . . . 0.0 112.338 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 37.6 p -166.4 140.31 4.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.873 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 3.3 m -47.12 -59.61 3.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.855 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.466 -179.976 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 N-CA-C 112.531 -0.227 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 65.6 p -75.58 82.35 2.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.869 0.366 . . . . 0.0 110.858 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 19.6 m 44.75 41.99 5.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.827 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . -100.7 156.19 19.34 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.525 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 8.3 t -39.27 -50.49 1.99 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 110.842 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 59.8 p -63.28 144.43 56.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.865 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 94.72 87.79 1.7 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.486 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . -121.04 34.9 3.85 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.499 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 97.3 m -102.35 119.13 38.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.792 0.33 . . . . 0.0 111.157 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 895' ' ' VAL . . . . . . . . . . . . . 20.3 m -112.72 140.06 34.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.091 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . 0.465 ' HG ' ' CD1' ' A' ' 938' ' ' TRP . 3.9 mp -91.46 142.68 27.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . 0.462 HG11 ' CG2' ' A' ' 963' ' ' ILE . 93.7 t -140.46 124.92 18.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.135 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 18.0 t -127.54 154.88 44.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 5.2 pt -121.41 155.66 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.107 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -99.65 109.17 21.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 901' ' ' SER . . . . . . . . . . . . . 15.6 m -139.64 129.09 24.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 55.2 m -52.59 -74.39 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 21.4 mt -65.05 150.53 95.23 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.614 0.721 . . . . 0.0 110.862 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.68 -26.8 9.53 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.735 2.29 . . . . 0.0 112.359 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -69.56 -1.9 9.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.885 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 906' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -118.13 -14.33 9.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 -63.73 -8.15 9.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.869 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -93.83 128.97 40.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.855 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 909' ' ' PHE . . . . . 0.497 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 91.5 m-85 -62.61 119.98 10.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.873 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -93.1 -178.59 4.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -55.72 -42.53 75.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.854 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -65.5 -57.89 7.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.102 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 913' ' ' LEU . . . . . 0.42 ' CD2' ' HD2' ' A' ' 961' ' ' ARG . 19.4 mt -49.96 -45.84 51.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.938 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 914' ' ' ILE . . . . . 0.533 HD13 ' CE1' ' A' ' 932' ' ' PHE . 44.2 mt -71.47 -64.76 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.102 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -38.03 -59.58 0.83 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -52.25 -52.33 53.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.863 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 917' ' ' LEU . . . . . 0.552 ' HB3' ' CE2' ' A' ' 921' ' ' PHE . 31.6 mt -49.58 -55.93 11.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.918 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 918' ' ' LEU . . . . . 0.439 ' C ' ' O ' ' A' ' 917' ' ' LEU . 77.8 mt -35.06 -57.86 0.55 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -58.15 -40.79 82.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.92 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 920' ' ' GLN . . . . . 0.545 ' NE2' ' HZ1' ' A' ' 956' ' ' LYS . 35.6 mm-40 -61.56 -38.08 86.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 921' ' ' PHE . . . . . 0.552 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 20.1 m-85 -70.88 -36.06 72.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -58.86 -34.65 71.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.133 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.7 m -47.18 -26.54 1.18 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 924' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 0.7 OUTLIER -121.01 -65.37 1.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.894 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -122.22 150.76 16.95 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.507 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -85.71 140.16 30.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.881 0.372 . . . . 0.0 110.879 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 62.1 t -94.74 142.63 13.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.076 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 928' ' ' ILE . . . . . 0.467 HG13 ' N ' ' A' ' 929' ' ' LEU . 41.4 pt -121.64 -39.92 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.13 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 929' ' ' LEU . . . . . 0.467 ' N ' HG13 ' A' ' 928' ' ' ILE . 17.7 tp -139.97 139.21 36.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.926 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 74.0 mt -127.52 129.47 70.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.123 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 5.0 tpm_? -116.23 125.25 51.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.888 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 932' ' ' PHE . . . . . 0.533 ' CE1' HD13 ' A' ' 914' ' ' ILE . 60.4 m-85 -94.84 114.9 26.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 933' ' ' VAL . . . . . 0.472 HG22 ' NE1' ' A' ' 938' ' ' TRP . 2.6 t -83.41 157.11 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.167 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 934' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 933' ' ' VAL . 53.2 mt-10 -34.04 -50.85 0.4 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.909 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -125.31 -25.93 3.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.855 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 936' ' ' LYS . . . . . 0.447 ' O ' ' N ' ' A' ' 933' ' ' VAL . 1.0 OUTLIER -97.3 169.83 9.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 937' ' ' MET . . . . . 0.497 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 16.4 ttt -132.03 111.52 11.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.844 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 938' ' ' TRP . . . . . 0.472 ' NE1' HG22 ' A' ' 933' ' ' VAL . 39.2 m0 -91.96 144.13 25.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.932 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 47.0 t -131.46 135.82 58.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 23.1 m -108.88 148.17 31.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.133 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 941' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -128.32 152.14 48.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.826 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 45.1 tp -41.92 -62.73 0.85 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.944 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -105.63 172.3 6.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -77.49 -44.83 12.04 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.517 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 45.6 t -56.67 -30.5 63.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.872 0.368 . . . . 0.0 110.858 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 72.7 m -58.94 -33.94 71.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.819 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -74.19 -20.19 60.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.057 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 30.0 mt -83.48 -26.06 30.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.871 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -80.14 -41.24 25.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.87 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 8.2 p -61.75 -21.98 27.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.159 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 50.7 mt -50.38 -25.41 3.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 952' ' ' SER . . . . . 0.408 ' HB2' ' CE2' ' A' ' 924' ' ' PHE . 67.9 m -56.1 -13.72 2.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.832 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 953' ' ' LEU . . . . . 0.46 ' CB ' HD13 ' A' ' 965' ' ' ILE . 24.4 mt -93.3 17.24 11.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.908 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -70.77 119.24 14.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 88.09 -25.26 9.12 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.489 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 956' ' ' LYS . . . . . 0.545 ' HZ1' ' NE2' ' A' ' 920' ' ' GLN . 0.3 OUTLIER -41.63 127.43 3.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.759 0.314 . . . . 0.0 110.896 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -95.65 124.28 39.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.86 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 14.9 tp -131.93 151.64 51.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.931 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 44.0 mt 41.14 49.63 3.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.916 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 50.47 37.27 15.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 961' ' ' ARG . . . . . 0.42 ' HD2' ' CD2' ' A' ' 913' ' ' LEU . 56.9 mtt85 -143.63 106.06 4.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.851 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 60.5 m -65.31 112.78 3.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.14 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 963' ' ' ILE . . . . . 0.462 ' CG2' HG11 ' A' ' 897' ' ' VAL . 71.2 mt -93.17 149.26 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.128 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 1.7 m -131.94 109.02 9.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.136 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 965' ' ' ILE . . . . . 0.46 HD13 ' CB ' ' A' ' 953' ' ' LEU . 70.3 mt -92.5 139.24 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.102 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 966' ' ' ALA . . . . . 0.427 ' N ' HG21 ' A' ' 965' ' ' ILE . . . -150.6 135.17 17.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.103 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 967' ' ' LEU . . . . . . . . . . . . . 26.6 mt -67.94 154.39 41.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.895 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 16.7 tptp -86.63 113.2 22.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.925 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 95.0 p -145.48 144.18 22.14 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.617 0.722 . . . . 0.0 110.897 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.62 -48.44 13.83 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.709 2.273 . . . . 0.0 112.343 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 3.8 m -132.42 130.33 40.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.84 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -65.34 -71.18 0.92 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.489 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.68 101.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.688 2.258 . . . . 0.0 112.315 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 69.8 m -56.61 145.57 28.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.88 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 21.0 t -150.01 168.78 22.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.829 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.502 179.998 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 58.3 m -151.9 163.5 39.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.898 0.38 . . . . 0.0 110.865 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 5.9 t -155.09 164.21 39.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.853 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . -106.54 51.64 0.73 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.454 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 37.2 m -78.0 171.24 15.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.93 0.395 . . . . 0.0 110.859 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 32.7 t -167.57 134.11 2.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.825 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 125.94 98.37 1.11 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.482 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . -97.05 53.45 1.38 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.496 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 89.4 m -98.05 120.41 38.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.887 0.375 . . . . 0.0 111.129 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 895' ' ' VAL . . . . . . . . . . . . . 10.8 m -113.63 138.61 42.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.088 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . 0.462 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 4.2 mp -90.47 143.57 26.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.968 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . 0.418 HG23 ' C ' ' A' ' 896' ' ' LEU . 95.6 t -141.78 130.36 22.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.107 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 10.8 t -129.53 152.37 49.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . 0.482 HG21 ' CE2' ' A' ' 909' ' ' PHE . 2.8 pt -121.05 141.79 40.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.111 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 900' ' ' LYS . . . . . 0.418 ' HD2' ' N ' ' A' ' 900' ' ' LYS . 0.0 OUTLIER -85.89 109.62 18.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.936 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 901' ' ' SER . . . . . . . . . . . . . 95.1 p -124.97 161.55 26.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.826 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 23.5 m -96.48 -39.03 9.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.884 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 38.0 mt -98.63 151.0 37.25 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.572 0.701 . . . . 0.0 110.922 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.49 -13.62 20.36 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.702 2.268 . . . . 0.0 112.31 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -94.16 11.42 30.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.862 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 906' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -122.99 -26.16 4.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 36.2 p-10 -48.02 -28.02 2.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -74.76 115.96 14.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 909' ' ' PHE . . . . . 0.563 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 97.1 m-85 -51.07 119.92 4.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -84.71 179.02 7.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.87 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -58.61 -45.26 89.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -60.15 -60.85 3.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.068 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 913' ' ' LEU . . . . . 0.465 ' CD1' ' NH1' ' A' ' 961' ' ' ARG . 35.4 mt -45.31 -49.49 12.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.961 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 52.0 mt -63.6 -53.19 48.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.157 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -46.4 -56.63 5.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.846 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -56.65 -51.49 68.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 917' ' ' LEU . . . . . 0.535 ' HB3' ' CE2' ' A' ' 921' ' ' PHE . 51.0 mt -46.13 -57.85 4.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 918' ' ' LEU . . . . . . . . . . . . . 99.3 mt -36.95 -62.99 0.45 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.953 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -54.02 -44.22 70.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.919 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 920' ' ' GLN . . . . . 0.417 ' NE2' ' HZ3' ' A' ' 956' ' ' LYS . 44.5 mm-40 -57.67 -38.91 75.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 921' ' ' PHE . . . . . 0.535 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 23.3 m-85 -72.68 -36.88 68.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.903 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -56.73 -32.69 65.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.102 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -52.04 -17.89 1.21 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.854 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 924' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 1.8 m-85 -126.06 -58.17 1.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.88 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -134.68 151.12 20.28 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.505 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -83.1 134.95 34.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.887 0.375 . . . . 0.0 110.872 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 41.2 t -89.01 143.47 11.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.177 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 928' ' ' ILE . . . . . 0.466 HG13 ' N ' ' A' ' 929' ' ' LEU . 20.4 pt -121.82 -45.83 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 929' ' ' LEU . . . . . 0.466 ' N ' HG13 ' A' ' 928' ' ' ILE . 25.5 tp -131.66 146.16 52.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 93.5 mt -136.71 122.86 28.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.113 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -111.26 123.35 50.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -87.64 118.58 27.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 933' ' ' VAL . . . . . 0.523 HG23 ' CD1' ' A' ' 938' ' ' TRP . 3.5 t -86.17 157.14 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.119 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 934' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 933' ' ' VAL . 32.3 mt-10 -33.82 -53.82 0.45 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -124.18 -20.73 5.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.89 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 19.3 tttt -101.31 173.04 6.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.897 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 937' ' ' MET . . . . . 0.563 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 12.7 ttt -133.58 114.03 13.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.897 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 938' ' ' TRP . . . . . 0.523 ' CD1' HG23 ' A' ' 933' ' ' VAL . 43.3 m0 -91.25 146.2 24.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 61.0 t -136.15 122.27 30.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.117 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 6.8 m -91.07 150.49 21.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.151 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 941' ' ' PHE . . . . . 0.444 ' O ' ' C ' ' A' ' 942' ' ' LEU . 9.1 m-85 -130.28 144.26 51.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.912 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 942' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 941' ' ' PHE . 61.1 tp -34.55 -59.76 0.45 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -117.9 169.65 9.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.892 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -71.68 -49.13 25.36 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.514 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 74.1 p -50.56 -28.61 8.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.859 0.362 . . . . 0.0 110.857 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 6.0 m -67.05 -32.32 73.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.881 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -82.36 -13.82 56.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.086 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 42.8 mt -87.36 -29.53 21.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.924 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -82.49 -37.66 24.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.903 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 9.2 p -61.94 -15.61 14.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.098 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 40.0 mt -53.93 -26.32 24.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.94 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 33.3 t -53.46 -15.78 1.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.861 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 953' ' ' LEU . . . . . 0.413 ' C ' HD11 ' A' ' 965' ' ' ILE . 36.9 mt -89.89 14.15 12.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.929 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -68.76 116.97 9.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.864 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 90.58 -25.82 12.22 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.473 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 956' ' ' LYS . . . . . 0.417 ' HZ3' ' NE2' ' A' ' 920' ' ' GLN . 3.5 tmtt? -39.71 127.76 2.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.744 0.307 . . . . 0.0 110.883 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -94.48 131.37 40.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.901 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 958' ' ' LEU . . . . . 0.407 HD12 ' NZ ' ' A' ' 956' ' ' LYS . 15.8 tp -141.35 153.18 44.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.881 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . 0.444 ' O ' ' CG ' ' A' ' 960' ' ' ASN . 38.2 mt 41.42 48.2 3.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.952 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 960' ' ' ASN . . . . . 0.444 ' CG ' ' O ' ' A' ' 959' ' ' LEU . 14.1 p30 48.18 42.41 17.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 961' ' ' ARG . . . . . 0.465 ' NH1' ' CD1' ' A' ' 913' ' ' LEU . 73.9 mtt180 -149.72 108.49 3.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 6.8 m -60.26 119.11 7.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.156 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 963' ' ' ILE . . . . . . . . . . . . . 91.4 mt -102.6 134.0 44.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.148 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 3.8 m -119.76 119.17 32.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.108 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 965' ' ' ILE . . . . . 0.439 HG22 ' N ' ' A' ' 966' ' ' ALA . 51.2 mt -101.26 142.12 16.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.128 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 966' ' ' ALA . . . . . 0.439 ' N ' HG22 ' A' ' 965' ' ' ILE . . . -151.21 131.5 13.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.082 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 967' ' ' LEU . . . . . . . . . . . . . 30.9 mt -69.85 158.34 35.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 968' ' ' LYS . . . . . 0.458 ' O ' ' C ' ' A' ' 969' ' ' SER . 18.5 tptt -98.65 145.14 27.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.935 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 969' ' ' SER . . . . . 0.458 ' C ' ' O ' ' A' ' 968' ' ' LYS . 27.3 m -33.84 97.01 0.11 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.655 0.741 . . . . 0.0 110.851 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 970' ' ' PRO . . . . . 0.432 ' N ' ' O ' ' A' ' 968' ' ' LYS . 61.8 Cg_endo -76.93 41.75 0.98 Allowed 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.678 2.252 . . . . 0.0 112.323 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 68.7 m -51.09 -45.0 61.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.864 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . 86.96 94.07 0.9 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.499 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -76.64 133.53 14.29 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.659 2.239 . . . . 0.0 112.399 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 23.1 t -74.34 167.56 21.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.866 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 6.1 m -62.92 163.87 8.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.85 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.457 -179.981 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.42 -0.272 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 38.7 p -138.52 171.17 14.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.874 0.369 . . . . 0.0 110.843 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 20.2 t -65.44 110.93 2.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.884 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 889' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 890' ' ' SER . . . -134.26 -81.78 0.16 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.494 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 890' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 889' ' ' GLY . 60.5 p 34.57 38.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.914 0.387 . . . . 0.0 110.875 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 3.5 m -138.66 139.44 38.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.839 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 125.95 -170.01 17.85 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.476 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . 119.46 -84.59 0.37 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.495 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 75.8 m -93.53 116.94 29.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.839 0.352 . . . . 0.0 111.122 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 895' ' ' VAL . . . . . . . . . . . . . 18.8 m -112.29 142.92 23.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.125 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . 0.466 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 4.2 mp -91.08 146.84 23.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 92.9 t -146.9 125.56 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.118 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 6.4 t -125.71 155.59 40.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 2.2 pt -121.82 137.23 56.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.093 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 34.4 mtmt -88.93 113.81 24.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.899 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 901' ' ' SER . . . . . . . . . . . . . 78.5 p -125.5 139.56 53.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.861 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 38.9 m -42.05 -64.03 0.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.862 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 7.4 mt -96.34 140.98 22.48 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.571 0.701 . . . . 0.0 110.907 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -49.71 -43.59 39.46 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.657 2.238 . . . . 0.0 112.371 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -56.7 -15.42 4.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.865 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 906' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -98.07 14.92 25.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.887 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -83.0 -13.02 56.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.859 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -75.82 127.83 33.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 909' ' ' PHE . . . . . 0.448 ' CE1' ' CB ' ' A' ' 937' ' ' MET . 76.2 m-85 -64.43 127.36 31.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -92.99 159.03 15.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.879 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -45.08 -49.71 11.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -53.92 -51.92 62.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.087 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 41.3 mt -53.36 -53.45 50.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.909 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 54.2 mt -60.14 -62.9 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.125 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -42.38 -51.03 5.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -61.49 -44.11 97.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.864 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 917' ' ' LEU . . . . . 0.56 ' HB3' ' CE2' ' A' ' 921' ' ' PHE . 26.1 mt -56.84 -57.9 10.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 918' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 917' ' ' LEU . 66.5 mt -34.82 -48.83 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -64.94 -47.56 77.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 60.2 mm-40 -55.75 -37.43 68.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 921' ' ' PHE . . . . . 0.56 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 22.4 m-85 -67.32 -50.8 58.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -46.27 -24.23 0.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.07 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 923' ' ' SER . . . . . 0.459 ' HB3' ' CE1' ' A' ' 924' ' ' PHE . 31.2 t -48.76 -32.06 7.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 924' ' ' PHE . . . . . 0.57 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 0.3 OUTLIER -123.18 -52.94 1.84 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -131.84 147.92 18.85 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.524 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -84.87 135.43 34.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.854 0.359 . . . . 0.0 110.926 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 11.9 t -81.86 145.37 8.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.143 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 928' ' ' ILE . . . . . 0.461 HG13 ' N ' ' A' ' 929' ' ' LEU . 42.8 pt -122.17 -36.39 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.161 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 929' ' ' LEU . . . . . 0.461 ' N ' HG13 ' A' ' 928' ' ' ILE . 10.2 tp -144.09 146.48 32.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.889 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 50.0 mt -135.9 128.8 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.135 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 16.0 ttt-85 -118.75 123.93 46.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.907 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -91.22 122.06 33.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 933' ' ' VAL . . . . . 0.47 HG22 ' NE1' ' A' ' 938' ' ' TRP . 2.8 t -90.22 157.09 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.114 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 934' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 933' ' ' VAL . 81.2 mm-40 -33.71 -51.77 0.39 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.886 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -124.96 -26.18 3.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 936' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' A' ' 933' ' ' VAL . 7.9 ttmm -96.45 170.87 8.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 937' ' ' MET . . . . . 0.448 ' CB ' ' CE1' ' A' ' 909' ' ' PHE . 16.2 ttt -134.46 112.17 10.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.863 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 938' ' ' TRP . . . . . 0.47 ' NE1' HG22 ' A' ' 933' ' ' VAL . 36.0 m0 -93.35 142.13 27.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 53.9 t -130.48 127.43 62.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.171 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 8.9 m -98.57 152.63 19.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 941' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -127.92 145.89 50.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 942' ' ' LEU . . . . . 0.423 ' CA ' HG23 ' A' ' 928' ' ' ILE . 22.7 tp -41.22 -40.84 1.69 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.949 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -130.39 176.69 7.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.919 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -86.32 -53.76 2.87 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.526 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 59.0 p -46.69 -22.34 0.28 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.882 0.372 . . . . 0.0 110.884 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 2.1 p -75.22 -37.12 61.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.841 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -70.7 -16.35 62.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 29.1 mt -84.05 -28.87 27.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.943 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -80.95 -46.48 15.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.859 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 7.6 p -53.83 -17.38 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.127 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 60.8 mt -53.15 -23.27 7.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.872 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 1.8 t -59.05 -11.15 3.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.838 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 51.1 mt -94.03 16.26 14.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 954' ' ' ASN . . . . . 0.402 ' O ' ' CG ' ' A' ' 954' ' ' ASN . 1.9 p30 -70.64 119.37 14.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 955' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 956' ' ' LYS . . . 86.15 -28.48 5.11 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.531 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 956' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 955' ' ' GLY . 0.1 OUTLIER -36.13 127.23 0.75 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.756 0.313 . . . . 0.0 110.873 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -92.94 128.02 38.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 14.2 tp -138.41 148.41 44.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.95 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 49.4 mt 43.13 52.53 5.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.944 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 44.83 44.7 7.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.904 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 961' ' ' ARG . . . . . . . . . . . . . 41.6 mtt85 -151.33 106.07 3.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.844 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 6.3 m -61.44 119.02 7.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.088 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 963' ' ' ILE . . . . . . . . . . . . . 92.7 mt -102.47 139.88 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.147 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 6.1 m -124.73 112.25 16.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.119 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 965' ' ' ILE . . . . . 0.437 HG23 ' N ' ' A' ' 966' ' ' ALA . 61.4 mt -98.42 139.04 21.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.077 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 966' ' ' ALA . . . . . 0.437 ' N ' HG23 ' A' ' 965' ' ' ILE . . . -153.84 137.88 16.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.129 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 967' ' ' LEU . . . . . . . . . . . . . 26.2 mt -68.63 156.37 38.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.922 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 11.6 tptm -74.3 -59.07 2.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 3.8 m -158.92 154.36 22.38 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.717 0.77 . . . . 0.0 110.808 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.19 -26.24 7.8 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.649 2.233 . . . . 0.0 112.351 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 13.2 t -101.09 -54.04 2.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.87 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . 178.64 178.77 48.21 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.529 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -76.93 -22.58 11.44 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.669 2.246 . . . . 0.0 112.332 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 26.5 t -157.22 107.82 2.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 41.9 m -147.91 161.85 40.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.874 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.467 179.99 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.461 -0.256 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 31.9 t -88.3 84.62 6.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.858 0.361 . . . . 0.0 110.877 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 3.3 m -107.64 140.73 40.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.849 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . 136.67 146.92 5.26 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.473 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 8.5 t 56.66 40.15 29.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.862 0.363 . . . . 0.0 110.9 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 50.6 p -140.18 136.37 33.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 100.08 168.91 29.42 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.524 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . -151.35 45.22 0.64 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.513 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 87.5 m -108.31 126.74 53.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.786 0.327 . . . . 0.0 111.146 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 895' ' ' VAL . . . . . . . . . . . . . 6.3 m -120.09 137.0 55.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.115 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . 0.467 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 4.7 mp -89.2 142.94 27.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.906 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 99.4 t -140.22 127.69 23.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.166 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 13.5 t -130.18 156.68 44.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.83 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . 0.417 HG22 ' CE2' ' A' ' 909' ' ' PHE . 4.1 pt -121.17 150.36 24.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.122 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.73 107.72 19.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 901' ' ' SER . . . . . . . . . . . . . 60.4 p -127.97 162.2 27.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.869 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 73.1 m -99.58 -45.39 5.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.89 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 12.3 mt -89.14 156.04 49.1 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.635 0.731 . . . . 0.0 110.893 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.14 -19.69 15.34 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.647 2.231 . . . . 0.0 112.394 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -89.98 17.03 7.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 906' ' ' ASN . . . . . 0.428 ' O ' ' N ' ' A' ' 908' ' ' PHE . 3.3 m-80 -127.66 -34.07 2.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.912 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 36.4 p-10 -40.96 -26.41 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 908' ' ' PHE . . . . . 0.428 ' N ' ' O ' ' A' ' 906' ' ' ASN . 15.4 m-85 -76.17 159.99 30.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.914 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 909' ' ' PHE . . . . . 0.559 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 49.8 m-85 -96.63 134.19 40.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -98.75 178.79 4.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.89 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -58.56 -26.04 63.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.863 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -78.52 -57.39 3.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.11 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 82.0 mt -52.87 -39.95 63.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.97 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 28.9 mt -72.57 -64.09 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.164 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -43.21 -54.07 4.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.84 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -55.43 -51.03 68.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 917' ' ' LEU . . . . . 0.542 ' HB3' ' CE2' ' A' ' 921' ' ' PHE . 20.6 mt -48.94 -54.14 16.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.905 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 918' ' ' LEU . . . . . 0.426 ' C ' ' O ' ' A' ' 917' ' ' LEU . 41.9 mt -34.75 -65.79 0.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.905 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -51.11 -52.26 45.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -48.85 -40.2 28.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.873 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 921' ' ' PHE . . . . . 0.542 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 23.1 m-85 -71.21 -42.79 68.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 922' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 924' ' ' PHE . . . -49.62 -39.48 35.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.095 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.7 m -43.02 -24.25 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.837 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 924' ' ' PHE . . . . . 0.554 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 0.6 OUTLIER -123.67 -63.02 1.26 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -123.13 147.24 16.67 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.469 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -84.39 128.01 34.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.931 0.396 . . . . 0.0 110.88 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 34.4 t -81.71 144.24 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.144 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 928' ' ' ILE . . . . . 0.467 HG13 ' N ' ' A' ' 929' ' ' LEU . 23.9 pt -123.18 -44.72 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.1 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 929' ' ' LEU . . . . . 0.467 ' N ' HG13 ' A' ' 928' ' ' ILE . 21.0 tp -134.48 144.05 47.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.964 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 43.5 mt -135.71 134.55 51.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.118 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.26 124.52 32.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -86.95 118.66 26.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 933' ' ' VAL . . . . . 0.487 ' CG2' ' CD1' ' A' ' 938' ' ' TRP . 2.6 t -82.95 157.37 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 934' ' ' GLU . . . . . 0.472 ' C ' ' O ' ' A' ' 933' ' ' VAL . 29.4 mm-40 -32.24 -53.41 0.3 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.905 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -125.31 -25.89 3.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -97.23 173.14 7.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.9 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 937' ' ' MET . . . . . 0.559 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 15.3 ttt -135.71 110.29 8.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.907 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 938' ' ' TRP . . . . . 0.487 ' CD1' ' CG2' ' A' ' 933' ' ' VAL . 20.3 m0 -95.95 138.58 33.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.874 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 94.4 t -122.35 134.97 63.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.117 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 52.3 m -98.62 148.96 23.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.145 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 941' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -130.69 152.06 50.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.862 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 55.5 tp -48.79 -53.53 18.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.891 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -115.91 177.81 4.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -87.34 -46.92 4.82 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.494 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 91.8 p -50.89 -39.47 54.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.924 0.392 . . . . 0.0 110.857 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.11 -27.63 67.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.858 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -80.22 -15.38 57.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.135 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 21.6 mt -87.34 -29.35 21.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.907 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -79.9 -41.35 26.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.903 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 4.3 p -56.06 -16.92 3.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.166 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 31.1 mt -52.65 -29.74 27.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 3.1 m -53.03 -25.56 12.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.861 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 32.1 mt -78.95 9.04 4.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.948 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.43 118.49 13.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.841 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 92.33 -26.38 13.85 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.442 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 3.7 tmtt? -42.08 128.35 3.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.751 0.31 . . . . 0.0 110.893 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -93.87 127.17 39.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 13.6 tp -140.45 157.07 46.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.955 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 37.4 mt 39.1 44.84 0.98 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.954 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 49.79 44.36 24.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.906 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 961' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 -152.07 108.06 3.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 2.9 m -61.81 118.67 7.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.102 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 963' ' ' ILE . . . . . . . . . . . . . 86.3 mt -103.24 137.94 29.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.12 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 9.7 m -123.87 117.43 24.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.183 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 965' ' ' ILE . . . . . 0.46 HG21 ' N ' ' A' ' 966' ' ' ALA . 19.1 mt -97.77 146.93 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.186 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 966' ' ' ALA . . . . . 0.46 ' N ' HG21 ' A' ' 965' ' ' ILE . . . -155.18 128.86 8.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.098 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 967' ' ' LEU . . . . . . . . . . . . . 33.5 mt -66.05 157.98 29.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.88 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 968' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 969' ' ' SER . 15.8 tptp -105.12 -63.67 1.21 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.899 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 969' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 968' ' ' LYS . 18.3 p -34.74 143.93 0.21 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.674 0.749 . . . . 0.0 110.872 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -78.1 106.62 2.19 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.701 2.267 . . . . 0.0 112.362 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 24.1 m -76.93 -49.05 16.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.883 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -72.93 -175.7 29.16 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.486 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.6 141.53 7.95 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.701 2.268 . . . . 0.0 112.367 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 30.1 t -45.73 143.37 2.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.858 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 97.0 p -158.15 177.3 11.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.848 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.499 179.993 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 36.8 p -155.36 160.03 40.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.863 0.363 . . . . 0.0 110.864 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 18.3 m -107.42 159.21 16.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.858 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . -123.31 -43.95 0.34 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.504 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 97.3 p -71.74 -44.21 64.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.887 0.375 . . . . 0.0 110.889 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 3.5 t -57.52 163.21 2.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.844 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -87.84 -114.29 1.12 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.47 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . -151.36 45.71 0.62 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.467 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 87.2 m -90.79 126.95 36.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.762 0.315 . . . . 0.0 111.21 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 895' ' ' VAL . . . . . . . . . . . . . 17.6 m -118.18 138.81 47.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.165 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . 0.469 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 6.3 mp -90.34 138.63 31.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.936 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 86.6 t -139.54 124.3 20.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.1 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 12.3 t -127.96 155.68 43.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.848 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . 0.412 HG12 ' CE2' ' A' ' 909' ' ' PHE . 2.7 pt -120.37 135.22 61.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.144 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -96.16 115.92 28.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.9 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 901' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 902' ' ' SER . 5.6 t -132.28 145.02 51.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.824 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 902' ' ' SER . . . . . 0.438 ' C ' ' O ' ' A' ' 901' ' ' SER . 3.4 m -35.04 -58.12 0.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.887 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 9.1 mt -98.21 144.34 27.9 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.639 0.733 . . . . 0.0 110.889 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.88 -23.17 14.33 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.65 2.233 . . . . 0.0 112.346 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -64.41 -17.15 63.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.853 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 906' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -98.94 13.56 32.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -58.16 -29.55 65.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -61.26 154.75 22.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.883 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 909' ' ' PHE . . . . . 0.567 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 48.3 m-85 -100.01 140.54 34.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.86 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.99 177.56 5.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.898 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.66 -45.31 77.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -59.65 -54.99 40.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.093 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 22.2 mt -53.47 -54.81 31.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.931 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 46.3 mt -58.86 -57.85 9.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.164 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -50.26 -63.98 0.95 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -45.71 -50.16 13.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.847 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 917' ' ' LEU . . . . . 0.568 ' HB3' ' CE2' ' A' ' 921' ' ' PHE . 28.2 mt -50.3 -53.24 30.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.937 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 918' ' ' LEU . . . . . 0.458 ' CD2' HD12 ' A' ' 930' ' ' ILE . 88.4 mt -38.59 -62.44 0.6 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.955 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -53.16 -53.68 46.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.925 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 -47.65 -45.34 27.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.857 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 921' ' ' PHE . . . . . 0.568 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 23.7 m-85 -60.26 -49.04 79.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.839 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -45.29 -33.5 2.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.073 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 923' ' ' SER . . . . . 0.523 ' HB3' ' CD1' ' A' ' 924' ' ' PHE . 8.6 t -41.18 -29.84 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 924' ' ' PHE . . . . . 0.523 ' CD1' ' HB3' ' A' ' 923' ' ' SER . 1.6 m-85 -120.02 -58.92 1.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.893 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -130.76 154.65 20.82 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.536 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -87.05 139.45 30.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 0.0 110.938 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 44.1 t -87.25 146.15 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 928' ' ' ILE . . . . . 0.471 HG13 ' N ' ' A' ' 929' ' ' LEU . 46.1 pt -122.7 -38.46 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.124 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 929' ' ' LEU . . . . . 0.471 ' N ' HG13 ' A' ' 928' ' ' ILE . 11.4 tp -142.41 146.24 34.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 930' ' ' ILE . . . . . 0.458 HD12 ' CD2' ' A' ' 918' ' ' LEU . 79.1 mt -132.09 131.51 61.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.153 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 15.8 ttp180 -121.3 124.3 44.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.879 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -91.38 121.8 33.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 933' ' ' VAL . . . . . 0.468 HG22 ' NE1' ' A' ' 938' ' ' TRP . 4.7 t -89.38 157.27 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.123 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 934' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 933' ' ' VAL . 15.2 mm-40 -33.28 -54.5 0.41 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.942 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.03 -21.61 5.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.859 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -98.98 171.68 7.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.869 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 937' ' ' MET . . . . . 0.567 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 17.2 ttt -131.81 108.66 9.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 938' ' ' TRP . . . . . 0.469 ' NE1' ' HG ' ' A' ' 896' ' ' LEU . 41.5 m0 -90.82 144.77 25.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.905 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 87.0 t -133.56 131.24 57.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.143 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 17.8 m -97.19 150.45 20.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.129 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 941' ' ' PHE . . . . . 0.425 ' O ' ' C ' ' A' ' 942' ' ' LEU . 9.9 m-85 -129.83 144.99 51.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.893 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 942' ' ' LEU . . . . . 0.425 ' C ' ' O ' ' A' ' 941' ' ' PHE . 30.3 tp -35.94 -56.88 0.7 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.924 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -122.09 164.91 16.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.871 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -66.95 -44.9 87.66 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.478 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 95.2 p -52.22 -37.45 55.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.868 0.366 . . . . 0.0 110.889 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 49.4 m -57.72 -37.51 73.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.857 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -73.05 -25.24 60.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.058 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 28.8 mt -76.63 -23.83 53.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.923 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 37.3 m-20 -88.26 -50.25 6.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.85 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 9.6 p -49.66 -18.65 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.166 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 24.4 mt -52.38 -28.51 19.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.907 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 952' ' ' SER . . . . . 0.505 ' HB2' ' CZ ' ' A' ' 924' ' ' PHE . 20.6 m -50.95 -17.54 0.6 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 953' ' ' LEU . . . . . 0.416 ' CB ' HD11 ' A' ' 965' ' ' ILE . 37.7 mt -88.45 17.48 5.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.946 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -71.43 120.79 17.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 86.51 -24.48 8.45 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.495 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -40.49 128.92 2.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.732 0.301 . . . . 0.0 110.938 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -94.59 134.01 37.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.905 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 14.6 tp -144.52 146.77 32.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 56.0 mt 44.82 52.06 8.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.958 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 45.13 44.02 8.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.89 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 961' ' ' ARG . . . . . . . . . . . . . 71.0 mtt-85 -150.54 110.49 4.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.917 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 6.4 m -64.41 120.13 11.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.13 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 963' ' ' ILE . . . . . 0.41 ' CD1' HD21 ' A' ' 917' ' ' LEU . 82.7 mt -103.93 139.53 24.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.156 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 6.7 m -123.8 116.87 23.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.122 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 965' ' ' ILE . . . . . 0.456 HG22 ' N ' ' A' ' 966' ' ' ALA . 61.0 mt -102.07 140.57 20.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.142 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 966' ' ' ALA . . . . . 0.456 ' N ' HG22 ' A' ' 965' ' ' ILE . . . -152.68 128.8 10.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.117 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 967' ' ' LEU . . . . . . . . . . . . . 30.7 mt -67.98 158.37 32.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -82.11 96.91 7.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 48.4 t -109.91 91.34 10.73 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.638 0.732 . . . . 0.0 110.868 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.44 90.51 1.19 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.638 2.225 . . . . 0.0 112.392 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 22.1 m -87.1 135.83 33.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.834 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . 158.22 174.82 28.42 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.465 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.54 147.6 2.71 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.699 2.266 . . . . 0.0 112.336 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 2.7 m -50.61 104.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.844 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 26.0 m -108.87 42.31 1.44 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.883 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.488 -179.967 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 27.3 p -84.62 148.71 26.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.888 0.375 . . . . 0.0 110.816 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 31.1 t -166.03 141.86 4.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.856 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . -123.51 100.57 0.66 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.455 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 94.5 p -124.06 123.3 40.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.888 0.375 . . . . 0.0 110.853 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 14.2 m -92.42 133.21 36.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.91 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 892' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 894' ' ' THR . . . -138.78 89.75 0.2 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.448 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . -38.21 -29.57 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.482 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 894' ' ' THR . . . . . 0.437 ' N ' ' O ' ' A' ' 892' ' ' GLY . 99.5 m -87.89 115.7 25.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.797 0.332 . . . . 0.0 111.144 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 895' ' ' VAL . . . . . . . . . . . . . 16.9 m -115.06 139.51 40.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.156 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . 0.463 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 4.7 mp -88.98 143.22 27.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 89.1 t -141.08 127.01 19.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.113 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 11.4 t -129.08 155.78 44.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.864 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 3.8 pt -120.03 138.07 51.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.175 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.27 106.58 13.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.888 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 901' ' ' SER . . . . . . . . . . . . . 2.6 m -139.63 126.39 20.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.89 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 18.9 m -58.6 -70.66 0.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.846 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 35.1 mt -65.38 151.71 93.59 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.616 0.722 . . . . 0.0 110.956 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . 0.532 ' O ' ' CE2' ' A' ' 908' ' ' PHE . 61.5 Cg_endo -76.43 -26.97 8.19 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.681 2.254 . . . . 0.0 112.332 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -70.0 -0.83 8.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.937 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 906' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -118.14 -17.73 9.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.928 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -58.28 -28.93 65.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.908 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 908' ' ' PHE . . . . . 0.532 ' CE2' ' O ' ' A' ' 904' ' ' PRO . 8.0 m-85 -74.47 124.06 25.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 909' ' ' PHE . . . . . 0.565 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 89.1 m-85 -58.93 125.03 21.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.896 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -90.07 169.83 10.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.884 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.09 -42.45 65.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -63.22 -50.29 70.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.113 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 20.8 mt -56.89 -50.54 72.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.951 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 66.1 mt -63.51 -59.47 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -50.42 -52.03 41.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -57.04 -43.59 82.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 917' ' ' LEU . . . . . 0.529 ' HB3' ' CE2' ' A' ' 921' ' ' PHE . 19.9 mt -54.54 -55.65 27.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.887 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 918' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 917' ' ' LEU . 24.8 mt -34.52 -62.48 0.34 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.951 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -52.68 -52.08 57.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -49.93 -39.07 39.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.908 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 921' ' ' PHE . . . . . 0.529 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 23.8 m-85 -73.36 -41.51 63.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.882 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -52.84 -27.26 17.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.107 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 923' ' ' SER . . . . . 0.551 ' HB3' ' CE1' ' A' ' 924' ' ' PHE . 19.6 t -48.7 -30.27 5.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 924' ' ' PHE . . . . . 0.551 ' CE1' ' HB3' ' A' ' 923' ' ' SER . 0.8 OUTLIER -121.27 -50.58 2.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.913 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -134.54 147.19 19.03 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.475 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -85.46 132.05 34.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.865 0.364 . . . . 0.0 110.889 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 927' ' ' VAL . . . . . 0.417 HG11 ' N ' ' A' ' 928' ' ' ILE . 16.8 t -83.2 146.93 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.131 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 928' ' ' ILE . . . . . 0.443 HG13 ' N ' ' A' ' 929' ' ' LEU . 41.8 pt -124.56 -33.36 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.143 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 929' ' ' LEU . . . . . 0.443 ' N ' HG13 ' A' ' 928' ' ' ILE . 8.5 tp -146.59 145.25 30.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.86 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 48.0 mt -135.01 128.9 50.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.122 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 -110.59 123.09 49.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.862 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -89.67 112.74 24.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.902 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 933' ' ' VAL . . . . . 0.543 ' CG2' ' CD1' ' A' ' 938' ' ' TRP . 2.6 t -83.15 149.05 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.153 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 934' ' ' GLU . . . . . 0.489 ' C ' ' O ' ' A' ' 933' ' ' VAL . 84.5 mt-10 -31.34 -50.03 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -124.65 -23.53 4.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.854 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.46 173.23 6.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 937' ' ' MET . . . . . 0.565 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 16.6 ttt -136.06 106.67 6.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 938' ' ' TRP . . . . . 0.543 ' CD1' ' CG2' ' A' ' 933' ' ' VAL . 34.3 m0 -88.1 142.24 27.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 89.7 t -129.18 120.31 51.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.174 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 940' ' ' THR . . . . . 0.416 ' CG2' ' N ' ' A' ' 941' ' ' PHE . 8.5 m -91.19 153.17 20.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.107 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 941' ' ' PHE . . . . . 0.416 ' N ' ' CG2' ' A' ' 940' ' ' THR . 9.3 m-85 -129.57 154.28 47.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 43.6 tp -52.25 -50.68 61.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.933 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -116.29 171.7 7.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.902 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -84.94 -37.66 9.97 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.467 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 75.4 p -60.73 -29.08 69.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.912 0.387 . . . . 0.0 110.907 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 1.9 p -68.11 -35.06 77.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.818 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -72.55 -12.85 61.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.098 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 27.7 mt -89.48 -26.7 20.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -84.81 -40.88 16.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.9 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 9.1 p -57.24 -17.85 7.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.1 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 43.1 mt -52.19 -27.14 13.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.903 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 19.9 m -53.2 -16.27 1.18 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.834 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 953' ' ' LEU . . . . . 0.456 ' HB2' ' CD1' ' A' ' 965' ' ' ILE . 56.8 mt -92.38 19.01 7.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -74.9 105.11 5.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 101.45 -25.24 28.83 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.47 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -43.07 128.88 4.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.763 0.316 . . . . 0.0 110.921 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -95.98 135.09 38.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.855 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 958' ' ' LEU . . . . . 0.41 ' O ' ' N ' ' A' ' 961' ' ' ARG . 14.3 tp -141.37 157.45 45.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.913 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 96.2 mt 38.38 45.1 0.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.9 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 52.88 44.09 30.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.848 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 961' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' A' ' 958' ' ' LEU . 61.2 mtt85 -151.4 105.84 3.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 63.2 m -60.88 115.79 3.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.118 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 963' ' ' ILE . . . . . 0.424 ' CD1' HD21 ' A' ' 917' ' ' LEU . 75.2 mt -98.56 139.7 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.107 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 13.5 m -122.75 115.75 22.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.125 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 965' ' ' ILE . . . . . 0.456 ' CD1' ' HB2' ' A' ' 953' ' ' LEU . 61.5 mt -102.22 138.2 27.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.142 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 966' ' ' ALA . . . . . 0.42 ' N ' HG21 ' A' ' 965' ' ' ILE . . . -150.6 129.83 12.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.124 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 967' ' ' LEU . . . . . . . . . . . . . 32.3 mt -65.49 157.87 28.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.893 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 14.7 tptp -95.78 153.14 17.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.939 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 87.2 p -116.55 145.1 34.5 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.65 0.738 . . . . 0.0 110.851 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -78.38 90.31 1.28 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.654 2.236 . . . . 0.0 112.361 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 34.8 m -78.09 151.38 33.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.828 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . 92.67 157.21 33.41 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.432 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.61 154.87 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.671 2.247 . . . . 0.0 112.334 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 30.4 t -41.77 154.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.834 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 1.3 t -90.06 53.44 2.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.8 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.477 -179.974 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 83.2 p -97.92 137.04 37.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.892 0.377 . . . . 0.0 110.839 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 15.2 m -90.21 -49.73 6.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.845 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . 158.45 118.32 0.53 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.45 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 1.5 t -114.59 104.85 12.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.898 0.38 . . . . 0.0 110.786 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 49.1 m -93.67 106.08 18.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.857 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 48.67 -160.3 0.68 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.478 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . -140.4 44.14 1.07 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.497 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 93.3 m -95.88 126.95 41.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.789 0.328 . . . . 0.0 111.149 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 895' ' ' VAL . . . . . . . . . . . . . 26.7 m -122.76 140.03 47.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.149 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . 0.468 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 6.4 mp -88.8 142.67 27.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.908 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . 0.421 HG23 ' C ' ' A' ' 896' ' ' LEU . 97.9 t -142.66 124.07 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.135 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 7.8 t -127.57 156.32 42.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.829 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . 0.447 ' CG2' HG12 ' A' ' 963' ' ' ILE . 2.5 pt -125.86 130.61 72.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.116 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -77.71 114.05 16.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 901' ' ' SER . . . . . . . . . . . . . 2.6 t -139.99 122.82 16.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.842 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 3.2 m -50.79 -55.59 16.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.832 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 24.9 mt -80.97 148.25 63.9 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.613 0.721 . . . . 0.0 110.947 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -77.58 -21.9 11.06 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.69 2.26 . . . . 0.0 112.38 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -74.55 -0.62 18.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.921 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 906' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 -114.54 -13.22 12.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.845 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 -61.44 -10.26 7.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -92.81 121.09 33.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.878 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 909' ' ' PHE . . . . . 0.545 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 58.3 m-85 -63.07 121.93 14.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.832 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -89.74 -179.07 5.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.884 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -58.46 -41.92 86.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.878 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -64.38 -51.64 62.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.082 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 72.2 mt -55.2 -53.31 57.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.917 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 44.9 mt -62.69 -61.92 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.133 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -44.55 -58.27 3.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -52.03 -45.68 64.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 917' ' ' LEU . . . . . 0.447 ' O ' ' C ' ' A' ' 918' ' ' LEU . 23.0 mt -56.58 -53.79 53.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.923 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 918' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 917' ' ' LEU . 80.4 mt -34.45 -54.1 0.52 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.949 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -58.71 -49.83 76.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.902 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -51.89 -36.98 50.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 921' ' ' PHE . . . . . 0.42 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 21.9 m-85 -73.11 -39.89 65.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.845 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -55.9 -33.0 64.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.119 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 53.4 p -54.22 -17.79 3.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.874 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 924' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -121.54 -52.4 2.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.872 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -147.12 154.95 26.29 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.458 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -86.18 126.34 34.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.896 0.379 . . . . 0.0 110.896 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 6.4 t -78.09 150.76 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.175 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 928' ' ' ILE . . . . . 0.447 HG13 ' N ' ' A' ' 929' ' ' LEU . 40.3 pt -120.67 -38.71 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.153 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 929' ' ' LEU . . . . . 0.447 ' N ' HG13 ' A' ' 928' ' ' ILE . 13.3 tp -142.73 151.8 41.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.95 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 76.0 mt -134.87 125.87 46.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.126 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -115.46 125.02 52.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.861 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -94.09 123.55 37.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.862 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 933' ' ' VAL . . . . . 0.518 HG23 ' CE2' ' A' ' 938' ' ' TRP . 5.1 t -91.21 157.31 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.111 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 934' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 933' ' ' VAL . 10.2 mm-40 -33.54 -52.61 0.4 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.911 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -124.72 -24.81 4.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -96.58 171.68 8.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.891 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 937' ' ' MET . . . . . 0.545 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 0.3 OUTLIER -132.7 115.08 14.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.892 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 938' ' ' TRP . . . . . 0.518 ' CE2' HG23 ' A' ' 933' ' ' VAL . 31.0 m0 -100.34 146.37 27.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.942 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 939' ' ' VAL . . . . . 0.431 ' CG2' ' SD ' ' A' ' 937' ' ' MET . 60.4 t -137.07 129.12 43.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.121 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 940' ' ' THR . . . . . 0.426 HG23 ' N ' ' A' ' 941' ' ' PHE . 18.8 m -93.12 153.24 18.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.13 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 941' ' ' PHE . . . . . 0.426 ' N ' HG23 ' A' ' 940' ' ' THR . 9.5 m-85 -128.05 150.74 49.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 25.0 tp -51.75 -46.37 64.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -118.4 171.06 8.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.855 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -84.44 -42.27 7.48 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.481 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 39.3 p -56.85 -40.57 76.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.881 0.372 . . . . 0.0 110.897 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 1.2 p -54.16 -35.99 62.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.848 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -72.42 -14.44 61.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.15 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 21.9 mt -86.66 -26.4 24.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.928 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -82.76 -50.83 8.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 6.0 p -49.84 -19.45 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.125 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 39.5 mt -55.14 -24.79 28.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.917 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 44.8 t -58.28 -11.75 3.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.867 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 36.6 mt -92.09 13.18 19.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.914 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 954' ' ' ASN . . . . . 0.412 ' O ' ' CG ' ' A' ' 954' ' ' ASN . 3.7 p30 -66.03 117.96 9.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 89.47 -26.09 9.79 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.525 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -40.65 129.28 2.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.751 0.31 . . . . 0.0 110.907 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -97.87 135.22 39.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.854 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 958' ' ' LEU . . . . . 0.486 ' O ' ' N ' ' A' ' 961' ' ' ARG . 18.0 tp -139.16 160.44 39.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.951 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . 0.449 ' C ' ' O ' ' A' ' 958' ' ' LEU . 97.1 mt 34.29 37.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 960' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 958' ' ' LEU . 6.7 m-80 60.91 48.4 6.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 961' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 958' ' ' LEU . 68.8 mtt85 -153.05 106.08 2.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.869 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 5.3 m -61.34 115.41 3.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.132 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 963' ' ' ILE . . . . . 0.447 HG12 ' CG2' ' A' ' 899' ' ' ILE . 57.8 mt -100.69 144.81 12.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.148 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 3.6 m -127.79 113.03 15.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.109 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 965' ' ' ILE . . . . . 0.45 HG21 ' N ' ' A' ' 966' ' ' ALA . 61.9 mt -95.17 147.14 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.127 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 966' ' ' ALA . . . . . 0.45 ' N ' HG21 ' A' ' 965' ' ' ILE . . . -154.03 126.95 8.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.061 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 967' ' ' LEU . . . . . . . . . . . . . 32.9 mt -65.25 157.98 27.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 968' ' ' LYS . . . . . 0.427 ' HE2' ' CH2' ' A' ' 938' ' ' TRP . 16.0 tttp -123.26 97.09 5.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 61.5 p -158.2 143.64 12.23 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.618 0.723 . . . . 0.0 110.861 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -78.57 104.05 1.76 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.708 2.272 . . . . 0.0 112.33 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 2.8 m -50.91 122.08 6.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.849 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . 156.59 95.3 0.11 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.48 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 973' ' ' PRO . . . . . 0.411 ' O ' ' C ' ' A' ' 974' ' ' SER . 72.5 Cg_exo -44.78 147.28 1.91 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.633 2.222 . . . . 0.0 112.38 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 974' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 973' ' ' PRO . 10.5 t -37.22 131.18 0.84 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.817 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 34.6 m -152.18 127.43 9.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.833 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.498 -179.993 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 58.0 m -100.89 139.08 37.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.839 0.352 . . . . 0.0 110.886 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 3.4 m -63.1 130.04 42.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.851 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . 165.8 91.08 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.522 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 12.9 m -104.33 108.77 20.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.826 0.346 . . . . 0.0 110.826 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 3.5 m -68.85 168.59 13.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.893 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 43.53 -112.38 0.54 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.454 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . 172.12 47.3 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.474 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 97.7 m -88.44 119.51 28.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.789 0.328 . . . . 0.0 111.123 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 895' ' ' VAL . . . . . . . . . . . . . 22.4 m -121.34 138.51 51.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.148 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . 0.464 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 5.5 mp -88.99 145.74 25.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . 0.459 HG12 ' CG2' ' A' ' 963' ' ' ILE . 79.1 t -147.01 126.34 4.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 11.1 t -127.1 152.28 47.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.824 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 3.5 pt -120.49 133.59 66.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.122 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -90.71 123.85 34.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.896 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 901' ' ' SER . . . . . . . . . . . . . 1.2 t -137.75 177.8 7.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.846 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 31.9 t -97.67 -56.61 2.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.823 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 13.5 mt -74.92 152.01 86.57 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.645 0.736 . . . . 0.0 110.918 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -77.21 -13.18 17.15 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.684 2.256 . . . . 0.0 112.334 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -95.0 10.12 36.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.874 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 906' ' ' ASN . . . . . 0.432 ' O ' ' N ' ' A' ' 908' ' ' PHE . 46.2 m-20 -107.47 -35.85 6.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 907' ' ' ASN . . . . . 0.414 ' C ' ' O ' ' A' ' 906' ' ' ASN . 30.8 m-20 -37.33 -31.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.883 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 908' ' ' PHE . . . . . 0.432 ' N ' ' O ' ' A' ' 906' ' ' ASN . 10.9 m-85 -74.37 119.14 18.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.897 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 909' ' ' PHE . . . . . 0.56 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 69.0 m-85 -56.84 132.62 52.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -97.95 169.11 9.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.876 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -48.16 -49.06 33.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.888 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -57.17 -56.04 26.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.089 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 31.3 mt -49.23 -54.18 17.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 56.0 mt -60.68 -64.48 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.137 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -42.94 -56.78 3.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.83 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -52.57 -50.98 61.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.849 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 917' ' ' LEU . . . . . 0.514 ' HB3' ' CE2' ' A' ' 921' ' ' PHE . 25.9 mt -48.15 -57.45 5.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 918' ' ' LEU . . . . . 0.445 ' C ' ' O ' ' A' ' 917' ' ' LEU . 40.5 mt -34.37 -55.37 0.52 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.887 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -56.77 -45.54 82.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.9 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 920' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 917' ' ' LEU . 88.5 mm-40 -58.76 -36.54 74.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 921' ' ' PHE . . . . . 0.514 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 22.1 m-85 -72.64 -47.46 47.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.852 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -48.77 -34.65 12.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.078 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -46.38 -32.87 3.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 924' ' ' PHE . . . . . 0.553 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 0.5 OUTLIER -121.63 -58.5 1.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.915 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -121.02 148.47 17.49 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.525 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -90.1 128.7 36.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.868 0.366 . . . . 0.0 110.874 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 41.1 t -84.14 139.95 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 928' ' ' ILE . . . . . 0.457 HG13 ' N ' ' A' ' 929' ' ' LEU . 35.4 pt -122.43 -40.54 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.12 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 929' ' ' LEU . . . . . 0.457 ' N ' HG13 ' A' ' 928' ' ' ILE . 15.6 tp -136.83 136.05 38.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.907 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 81.7 mt -122.76 126.56 74.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.089 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 11.8 tpt85 -112.18 124.68 52.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.868 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -93.57 117.01 29.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 933' ' ' VAL . . . . . 0.493 HG23 ' CE2' ' A' ' 938' ' ' TRP . 2.9 t -85.78 156.99 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.104 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 934' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 933' ' ' VAL . 33.1 mt-10 -34.43 -51.33 0.46 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.857 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -125.49 -26.25 3.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -96.16 173.04 7.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.917 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 937' ' ' MET . . . . . 0.56 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 15.3 ttt -134.11 111.73 10.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.905 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 938' ' ' TRP . . . . . 0.493 ' CE2' HG23 ' A' ' 933' ' ' VAL . 38.8 m0 -92.11 148.13 22.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.957 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 43.0 t -134.14 125.8 48.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.083 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 14.0 m -92.46 151.75 20.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.152 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 941' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -132.24 143.87 50.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.862 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 54.2 tp -41.27 -52.87 3.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.878 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -118.17 177.99 4.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -86.67 -48.08 4.6 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.525 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 46.6 t -50.8 -39.07 51.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.863 0.363 . . . . 0.0 110.841 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 56.8 p -57.51 -32.36 66.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.87 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -76.4 -20.91 56.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.086 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 36.5 mt -77.97 -27.93 49.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.926 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -81.93 -51.56 7.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.883 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 9.5 p -48.21 -21.56 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.12 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 34.2 mt -49.37 -29.43 6.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.937 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 35.7 p -50.28 -19.77 0.89 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.839 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 953' ' ' LEU . . . . . 0.427 ' CB ' HD13 ' A' ' 965' ' ' ILE . 76.7 mt -88.84 20.15 3.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.885 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -74.41 106.34 5.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.928 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 98.85 -26.76 22.84 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.461 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -37.97 128.19 1.25 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.71 0.291 . . . . 0.0 110.887 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -93.38 125.15 37.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 15.2 tp -133.01 154.58 50.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 43.2 mt 41.01 47.78 2.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.913 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 51.64 40.5 27.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 961' ' ' ARG . . . . . . . . . . . . . 65.2 mtt85 -147.63 122.69 10.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.858 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 6.1 m -74.17 115.08 13.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.154 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 963' ' ' ILE . . . . . 0.459 ' CG2' HG12 ' A' ' 897' ' ' VAL . 84.6 mt -99.81 135.51 35.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.124 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 14.9 m -119.74 112.5 19.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.173 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 965' ' ' ILE . . . . . 0.433 HG22 ' N ' ' A' ' 966' ' ' ALA . 67.3 mt -98.99 137.48 26.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.122 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 966' ' ' ALA . . . . . 0.433 ' N ' HG22 ' A' ' 965' ' ' ILE . . . -151.37 135.33 16.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.087 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 967' ' ' LEU . . . . . . . . . . . . . 28.9 mt -66.26 157.98 30.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.907 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.57 121.55 25.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.918 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 88.0 p -66.11 144.2 98.68 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.619 0.723 . . . . 0.0 110.876 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.61 101.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.663 2.242 . . . . 0.0 112.315 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 6.1 t -142.24 114.74 8.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.85 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . 170.25 -99.45 0.15 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.455 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -78.56 17.46 1.1 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.7 2.267 . . . . 0.0 112.368 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 13.4 t -143.31 106.69 4.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.823 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 3.1 t 50.68 42.79 27.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.878 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.476 179.962 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 59.3 p -72.77 -44.31 61.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.845 0.355 . . . . 0.0 110.828 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 2.0 m -103.74 102.77 12.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . -50.37 117.22 4.81 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.519 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 61.9 p -53.63 115.59 2.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.888 0.375 . . . . 0.0 110.874 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 6.6 m -165.48 174.18 10.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.855 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -56.76 -103.89 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.485 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . -170.97 40.07 0.18 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.502 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 39.3 m -82.04 122.84 28.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.865 0.364 . . . . 0.0 111.171 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 895' ' ' VAL . . . . . . . . . . . . . 17.8 m -117.49 144.09 26.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.169 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . 0.472 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 6.8 mp -92.89 137.92 31.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 60.1 t -140.13 131.24 31.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.161 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 3.1 t -130.62 156.32 45.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.881 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 3.3 pt -122.28 135.77 61.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.183 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.73 119.97 23.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 901' ' ' SER . . . . . . . . . . . . . 19.4 p -135.85 174.96 10.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.826 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 1.1 t -110.63 -43.19 3.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.841 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 12.8 mt -87.05 152.75 53.73 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.611 0.72 . . . . 0.0 110.929 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.76 -16.39 16.46 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.689 2.26 . . . . 0.0 112.355 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -99.37 17.67 19.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 906' ' ' ASN . . . . . 0.457 ' O ' ' N ' ' A' ' 908' ' ' PHE . 1.8 m-80 -118.23 -35.11 3.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.931 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -40.15 -26.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.926 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 908' ' ' PHE . . . . . 0.457 ' N ' ' O ' ' A' ' 906' ' ' ASN . 56.1 m-85 -70.81 124.61 24.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.878 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 909' ' ' PHE . . . . . 0.518 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 87.4 m-85 -61.28 132.13 52.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.897 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -97.89 165.65 11.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.871 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -48.51 -50.06 33.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -56.84 -48.92 76.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.117 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 72.4 mt -56.72 -50.45 72.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.895 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 50.6 mt -64.0 -63.79 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.108 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -42.07 -56.47 2.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.819 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -54.34 -46.81 72.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.876 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 917' ' ' LEU . . . . . 0.549 ' HB3' ' CE2' ' A' ' 921' ' ' PHE . 24.9 mt -54.15 -56.08 21.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.933 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 918' ' ' LEU . . . . . 0.461 ' CD2' HD13 ' A' ' 930' ' ' ILE . 68.3 mt -34.41 -60.6 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.883 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -52.31 -51.07 60.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -52.48 -40.05 61.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 921' ' ' PHE . . . . . 0.549 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 22.9 m-85 -66.82 -44.59 80.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.865 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -50.57 -33.63 22.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.123 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 923' ' ' SER . . . . . 0.54 ' HB3' ' CE1' ' A' ' 924' ' ' PHE . 10.4 t -41.86 -34.64 0.69 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.87 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 924' ' ' PHE . . . . . 0.54 ' CE1' ' HB3' ' A' ' 923' ' ' SER . 0.9 OUTLIER -120.17 -51.68 2.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.844 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -128.27 141.56 12.71 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.442 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -85.58 99.47 11.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.896 0.379 . . . . 0.0 110.894 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 927' ' ' VAL . . . . . 0.446 HG12 ' N ' ' A' ' 928' ' ' ILE . 40.2 t -51.23 143.91 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.122 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 928' ' ' ILE . . . . . 0.452 HG13 ' N ' ' A' ' 929' ' ' LEU . 21.0 pt -120.04 -44.8 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.093 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 929' ' ' LEU . . . . . 0.452 ' N ' HG13 ' A' ' 928' ' ' ILE . 11.1 tp -135.56 146.51 48.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.949 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 930' ' ' ILE . . . . . 0.461 HD13 ' CD2' ' A' ' 918' ' ' LEU . 57.0 mt -130.05 137.57 56.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.13 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -125.88 122.29 35.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -88.48 124.07 33.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.845 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 933' ' ' VAL . . . . . 0.482 ' O ' ' C ' ' A' ' 934' ' ' GLU . 13.5 t -92.63 157.52 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.089 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 934' ' ' GLU . . . . . 0.482 ' C ' ' O ' ' A' ' 933' ' ' VAL . 15.2 mm-40 -31.24 -56.03 0.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -121.88 -26.01 4.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.859 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 4.7 tttm -96.12 173.25 7.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.839 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 937' ' ' MET . . . . . 0.518 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 10.8 ttt -132.39 105.93 7.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 938' ' ' TRP . . . . . 0.481 ' NE1' HG21 ' A' ' 933' ' ' VAL . 44.1 m0 -85.25 142.49 29.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.928 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 939' ' ' VAL . . . . . 0.44 ' CG1' HG13 ' A' ' 927' ' ' VAL . 43.8 t -132.56 129.62 59.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.133 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 32.9 m -92.53 154.23 18.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.162 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 941' ' ' PHE . . . . . 0.413 ' O ' ' C ' ' A' ' 942' ' ' LEU . 11.2 m-85 -134.17 146.97 50.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.865 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 942' ' ' LEU . . . . . 0.413 ' C ' ' O ' ' A' ' 941' ' ' PHE . 23.6 tp -36.91 -61.49 0.55 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -125.62 153.53 43.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -50.5 -51.01 33.96 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.509 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 945' ' ' SER . . . . . 0.408 ' HA ' ' CD1' ' A' ' 948' ' ' LEU . 82.6 p -46.7 -42.86 17.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.9 0.381 . . . . 0.0 110.843 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 14.5 m -56.32 -30.86 63.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -82.47 -16.73 47.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.118 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 948' ' ' LEU . . . . . 0.408 ' CD1' ' HA ' ' A' ' 945' ' ' SER . 23.4 mt -83.23 -23.6 32.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.927 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -88.34 -46.47 9.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.92 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 7.2 p -51.33 -22.25 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.148 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 39.5 mt -50.41 -24.84 3.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.918 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 32.5 m -55.26 -15.51 2.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 953' ' ' LEU . . . . . 0.407 ' C ' HD13 ' A' ' 965' ' ' ILE . 36.5 mt -91.53 17.01 9.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.905 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -69.06 120.85 15.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.929 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 85.63 -27.31 5.35 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.458 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -38.21 127.36 1.35 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.74 0.305 . . . . 0.0 110.893 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -95.4 125.49 40.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.862 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 14.5 tp -134.46 153.44 51.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.969 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . 0.441 ' O ' ' CG ' ' A' ' 960' ' ' ASN . 35.0 mt 41.56 49.17 3.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 960' ' ' ASN . . . . . 0.441 ' CG ' ' O ' ' A' ' 959' ' ' LEU . 13.0 p30 47.75 40.29 11.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 961' ' ' ARG . . . . . . . . . . . . . 47.1 mtt85 -147.56 104.99 3.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 27.1 m -58.94 120.88 9.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.133 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 963' ' ' ILE . . . . . 0.418 ' CD1' HD21 ' A' ' 917' ' ' LEU . 87.2 mt -103.98 143.4 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 8.7 m -127.22 119.93 27.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.134 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 965' ' ' ILE . . . . . 0.439 HG22 ' N ' ' A' ' 966' ' ' ALA . 63.4 mt -103.77 140.27 22.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.131 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 966' ' ' ALA . . . . . 0.439 ' N ' HG22 ' A' ' 965' ' ' ILE . . . -149.85 137.12 19.75 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.077 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 967' ' ' LEU . . . . . . . . . . . . . 25.1 mt -73.75 153.48 40.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.95 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 19.2 tptp -86.71 149.24 25.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.89 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 66.3 p -58.61 143.48 81.54 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.661 0.743 . . . . 0.0 110.869 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.01 -50.36 11.08 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.681 2.254 . . . . 0.0 112.399 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 14.7 t -55.67 152.73 8.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.854 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -162.44 72.32 0.2 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.474 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.69 163.09 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.698 2.265 . . . . 0.0 112.359 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 38.3 m -81.58 -55.07 4.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.868 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 85.5 p -39.41 116.2 0.58 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.825 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.443 179.955 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 86.3 p -57.08 98.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.847 0.356 . . . . 0.0 110.882 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 87.6 p -92.53 113.84 26.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.825 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . 172.59 165.29 29.42 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.464 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 4.3 t -158.12 145.93 18.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.842 0.353 . . . . 0.0 110.87 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 891' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 892' ' ' GLY . 61.1 p -173.46 178.79 2.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.83 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 892' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 891' ' ' SER . . . -36.89 -81.23 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.445 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . 156.32 46.14 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.48 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 71.9 m -112.03 119.45 38.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.805 0.336 . . . . 0.0 111.159 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 895' ' ' VAL . . . . . . . . . . . . . 13.7 m -117.17 142.86 29.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.157 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . 0.467 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 5.0 mp -91.74 143.15 26.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 79.8 t -142.44 127.5 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 9.7 t -129.61 158.05 40.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.841 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 2.7 pt -121.54 163.84 19.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.12 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 21.9 mttp -98.85 109.07 21.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 901' ' ' SER . . . . . . . . . . . . . 5.2 m -139.2 128.79 24.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.827 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 2.6 t -76.01 -47.66 24.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.859 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 14.4 mt -73.62 147.63 87.08 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.574 0.702 . . . . 0.0 110.945 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.98 -13.51 19.41 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.675 2.25 . . . . 0.0 112.352 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -99.66 15.18 27.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 906' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 908' ' ' PHE . 2.4 m-80 -118.17 -37.09 3.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.935 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -39.34 -26.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 908' ' ' PHE . . . . . 0.474 ' N ' ' O ' ' A' ' 906' ' ' ASN . 59.0 m-85 -69.1 135.61 51.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.863 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 909' ' ' PHE . . . . . 0.557 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 94.1 m-85 -77.65 119.97 21.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.87 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -85.04 160.11 20.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.884 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -45.64 -40.43 9.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.852 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -65.33 -49.99 67.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.104 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 913' ' ' LEU . . . . . 0.4 HD13 ' CD ' ' A' ' 961' ' ' ARG . 29.4 mt -56.76 -45.85 81.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 914' ' ' ILE . . . . . 0.516 HD12 ' CZ ' ' A' ' 932' ' ' PHE . 36.5 mt -69.52 -59.75 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.155 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -48.89 -50.99 32.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.86 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -56.89 -40.8 76.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.86 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 917' ' ' LEU . . . . . 0.543 ' HB3' ' CE2' ' A' ' 921' ' ' PHE . 22.0 mt -59.88 -51.64 68.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 918' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 917' ' ' LEU . 30.8 mt -34.89 -64.19 0.28 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.906 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -50.2 -51.98 39.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.904 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -49.63 -40.5 39.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.922 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 921' ' ' PHE . . . . . 0.543 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 22.7 m-85 -72.37 -42.78 64.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.899 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -50.99 -38.03 48.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.114 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -46.81 -21.13 0.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 924' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 1.4 m-85 -124.0 -58.88 1.54 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.914 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -130.1 151.0 19.26 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.512 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -88.86 125.35 34.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.887 0.375 . . . . 0.0 110.863 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 6.1 t -78.93 150.29 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.141 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 928' ' ' ILE . . . . . 0.451 HG13 ' N ' ' A' ' 929' ' ' LEU . 35.1 pt -125.63 -40.46 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.101 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 929' ' ' LEU . . . . . 0.451 ' N ' HG13 ' A' ' 928' ' ' ILE . 12.0 tp -141.12 146.34 36.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.941 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 930' ' ' ILE . . . . . 0.423 HG21 ' N ' ' A' ' 931' ' ' ARG . 51.3 mt -134.62 143.04 38.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.119 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 931' ' ' ARG . . . . . 0.423 ' N ' HG21 ' A' ' 930' ' ' ILE . 0.0 OUTLIER -135.62 128.69 31.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.849 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 932' ' ' PHE . . . . . 0.516 ' CZ ' HD12 ' A' ' 914' ' ' ILE . 32.0 m-85 -91.99 123.55 35.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.87 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 933' ' ' VAL . . . . . 0.559 ' CG2' ' CD1' ' A' ' 938' ' ' TRP . 2.6 t -87.89 157.18 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.13 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 934' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 933' ' ' VAL . 45.8 mt-10 -33.49 -49.7 0.3 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.838 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -127.12 -28.22 2.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.867 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 936' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 933' ' ' VAL . 6.8 ttmm -96.02 173.12 7.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 937' ' ' MET . . . . . 0.557 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 12.5 ttt -135.18 108.06 7.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 938' ' ' TRP . . . . . 0.559 ' CD1' ' CG2' ' A' ' 933' ' ' VAL . 13.4 m0 -94.88 143.62 26.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.929 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 43.6 t -128.65 139.99 50.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.131 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 940' ' ' THR . . . . . 0.412 ' CG2' ' N ' ' A' ' 941' ' ' PHE . 53.0 m -98.51 156.26 16.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.099 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 941' ' ' PHE . . . . . 0.412 ' N ' ' CG2' ' A' ' 940' ' ' THR . 13.2 m-85 -136.23 149.86 48.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.916 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 32.5 tp -51.04 -52.13 46.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.953 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -114.69 173.91 6.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.904 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -86.89 -47.18 4.87 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.472 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 13.0 m -56.06 -27.2 52.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.917 0.389 . . . . 0.0 110.882 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 50.6 p -67.91 -28.14 67.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.862 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -79.32 -13.26 59.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.083 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 32.3 mt -85.4 -31.97 22.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.912 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 41.8 m-20 -75.62 -42.33 52.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 5.7 p -56.77 -15.76 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.149 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 31.6 mt -55.62 -29.1 58.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.904 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 70.7 m -55.99 -23.16 30.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.845 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 39.2 mt -82.03 9.08 9.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.887 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.04 119.09 13.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 91.95 -25.41 16.93 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.487 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -44.07 128.65 5.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.748 0.309 . . . . 0.0 110.941 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -93.08 133.27 36.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.922 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 13.8 tp -147.87 158.32 43.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.949 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 33.1 mt 40.06 46.71 1.86 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.948 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 48.1 42.13 16.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 961' ' ' ARG . . . . . 0.4 ' CD ' HD13 ' A' ' 913' ' ' LEU . 64.1 mtt85 -152.14 115.22 4.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 12.5 m -68.31 123.97 22.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.115 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 963' ' ' ILE . . . . . . . . . . . . . 85.8 mt -107.17 143.86 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.083 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 10.1 m -129.1 117.57 21.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.177 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 965' ' ' ILE . . . . . 0.445 HG21 ' N ' ' A' ' 966' ' ' ALA . 23.2 mt -98.64 145.15 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.152 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 966' ' ' ALA . . . . . 0.445 ' N ' HG21 ' A' ' 965' ' ' ILE . . . -155.93 129.6 8.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 967' ' ' LEU . . . . . . . . . . . . . 38.3 mt -65.22 157.7 28.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 34.4 tptt -92.69 150.03 20.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 57.1 p -47.88 142.62 6.95 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.66 0.743 . . . . 0.0 110.856 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.94 165.33 0.09 OUTLIER 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.712 2.274 . . . . 0.0 112.307 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 6.5 t 55.5 43.55 28.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.861 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -78.93 -147.88 3.96 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.485 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.25 117.43 4.85 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.641 2.227 . . . . 0.0 112.376 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 74.8 m -96.7 125.81 41.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 51.5 p 38.99 42.37 0.66 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.852 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.51 179.993 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 12.8 t -110.11 87.96 2.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.865 0.364 . . . . 0.0 110.852 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 47.4 t -111.0 142.5 43.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.875 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . 85.25 84.91 1.0 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.453 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 59.5 p -121.37 123.73 42.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.851 0.358 . . . . 0.0 110.865 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 6.5 t -98.84 140.66 32.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.882 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 64.88 143.13 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.443 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . -107.56 40.65 2.44 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.479 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 59.1 m -92.76 122.18 34.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.816 0.341 . . . . 0.0 111.136 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 895' ' ' VAL . . . . . . . . . . . . . 12.8 m -118.56 143.42 29.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.118 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . 0.462 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 3.5 mp -93.22 145.75 24.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.927 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 98.0 t -146.2 128.57 8.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.131 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 30.9 t -133.21 159.53 39.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.893 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.87 121.42 65.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.132 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 14.1 ttpp -83.62 121.2 26.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 901' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 902' ' ' SER . 1.8 t -132.56 140.07 48.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 902' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 901' ' ' SER . 3.2 m -36.73 -57.12 0.81 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.852 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 61.9 mt -95.08 146.31 31.09 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.589 0.709 . . . . 0.0 110.941 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.27 -27.12 13.89 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.698 2.266 . . . . 0.0 112.355 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -79.75 9.21 5.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.847 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 906' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -119.82 16.59 12.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -87.33 25.56 1.38 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.909 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -84.73 144.38 28.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.856 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 909' ' ' PHE . . . . . 0.569 ' CE2' ' HB2' ' A' ' 937' ' ' MET . 45.9 m-85 -91.59 107.54 19.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.843 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -83.71 157.71 22.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.904 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -43.75 -58.4 2.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.904 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -45.26 -58.0 3.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.12 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 24.7 mt -44.26 -56.23 4.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.925 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 71.4 mt -58.86 -62.21 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -43.46 -67.52 0.27 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -43.78 -55.22 4.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.854 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 917' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 920' ' ' GLN . 30.3 mt -44.97 -58.89 2.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.903 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 918' ' ' LEU . . . . . 0.439 ' C ' ' O ' ' A' ' 917' ' ' LEU . 90.1 mt -35.25 -58.16 0.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.983 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -56.68 -38.52 72.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.924 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 920' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 917' ' ' LEU . 72.7 mm-40 -63.74 -36.67 84.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 921' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -72.02 -37.38 69.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -57.89 -34.04 69.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.131 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -47.91 -25.21 1.25 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 924' ' ' PHE . . . . . 0.477 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 2.4 m-85 -121.64 -64.35 1.23 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.884 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -123.26 154.38 17.24 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.504 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -88.57 135.11 33.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.919 0.39 . . . . 0.0 110.895 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 19.9 t -86.29 149.06 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.115 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 928' ' ' ILE . . . . . 0.458 HG13 ' N ' ' A' ' 929' ' ' LEU . 27.7 pt -129.12 -42.85 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.14 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 929' ' ' LEU . . . . . 0.458 ' N ' HG13 ' A' ' 928' ' ' ILE . 15.8 tp -136.27 145.71 45.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.919 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 64.9 mt -133.72 128.92 54.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.136 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -120.11 126.73 51.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.862 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -92.17 120.59 32.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.841 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 933' ' ' VAL . . . . . 0.593 ' CG2' ' CD1' ' A' ' 938' ' ' TRP . 3.0 t -86.96 157.09 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.179 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 934' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 933' ' ' VAL . 34.4 mm-40 -33.98 -52.51 0.44 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -124.95 -24.74 4.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.853 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 936' ' ' LYS . . . . . 0.417 ' NZ ' ' HB3' ' A' ' 896' ' ' LEU . 14.7 tttm -97.57 173.07 7.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 937' ' ' MET . . . . . 0.569 ' HB2' ' CE2' ' A' ' 909' ' ' PHE . 16.5 ttt -132.04 115.09 15.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.915 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 938' ' ' TRP . . . . . 0.593 ' CD1' ' CG2' ' A' ' 933' ' ' VAL . 39.5 m0 -94.63 150.37 20.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.955 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 70.0 t -142.36 128.24 17.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.104 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 5.6 m -95.54 150.88 19.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.115 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 941' ' ' PHE . . . . . 0.446 ' O ' ' C ' ' A' ' 942' ' ' LEU . 9.6 m-85 -129.37 145.59 51.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 942' ' ' LEU . . . . . 0.446 ' C ' ' O ' ' A' ' 941' ' ' PHE . 16.0 tp -34.4 -64.82 0.23 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -114.81 165.57 12.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -65.92 -54.09 26.86 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.52 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 84.3 p -48.15 -27.14 2.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.912 0.387 . . . . 0.0 110.869 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 69.1 m -67.23 -34.78 78.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -80.04 -13.79 59.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.111 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 20.0 mt -87.44 -22.97 24.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.933 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 -85.54 -38.48 18.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.88 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 8.4 p -60.09 -21.96 23.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.163 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 43.5 mt -50.14 -23.06 1.93 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.924 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 18.6 m -56.9 -15.0 3.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.826 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 953' ' ' LEU . . . . . 0.434 ' HB2' ' CD1' ' A' ' 965' ' ' ILE . 56.9 mt -92.99 11.48 27.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.938 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -63.4 116.51 5.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.888 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 90.67 -25.67 12.77 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.544 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -42.37 128.21 3.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.785 0.326 . . . . 0.0 110.922 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -95.68 128.39 42.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.92 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 14.9 tp -135.58 153.41 51.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.891 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 36.0 mt 42.73 49.6 4.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 47.6 44.07 16.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.89 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 961' ' ' ARG . . . . . . . . . . . . . 57.8 mtt-85 -152.29 109.72 3.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 31.1 m -62.56 122.3 15.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.17 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 963' ' ' ILE . . . . . . . . . . . . . 93.3 mt -105.11 148.8 9.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.173 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 5.7 m -132.67 113.78 13.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.124 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 965' ' ' ILE . . . . . 0.439 HG21 ' N ' ' A' ' 966' ' ' ALA . 56.5 mt -96.58 140.28 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.157 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 966' ' ' ALA . . . . . 0.439 ' N ' HG21 ' A' ' 965' ' ' ILE . . . -149.29 135.46 19.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.119 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 967' ' ' LEU . . . . . . . . . . . . . 26.8 mt -71.89 154.95 40.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.894 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -86.74 115.96 24.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 95.7 p -43.42 155.71 0.29 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.659 0.743 . . . . 0.0 110.872 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.56 111.17 0.3 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.672 2.248 . . . . 0.0 112.357 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 43.1 t -90.92 -52.28 4.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.866 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . 175.29 95.26 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.491 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -76.82 41.96 1.0 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.661 2.241 . . . . 0.0 112.307 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 17.6 m -108.39 -60.02 1.79 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.897 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 52.5 p -113.75 126.09 54.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.49 179.982 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 28.1 m -73.06 115.24 12.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.835 0.35 . . . . 0.0 110.913 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 11.9 p -130.57 -44.49 1.1 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.821 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . 157.47 -110.89 0.46 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.507 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 890' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 891' ' ' SER . 60.9 m -127.48 115.69 19.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.885 0.374 . . . . 0.0 110.841 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 891' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 890' ' ' SER . 3.9 t 35.45 39.46 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.89 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 80.44 50.29 5.44 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.44 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . 53.19 37.56 54.88 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.511 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 69.4 m -96.61 120.44 36.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.816 0.341 . . . . 0.0 111.146 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 895' ' ' VAL . . . . . . . . . . . . . 17.1 m -115.45 143.68 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.15 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . 0.469 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 5.0 mp -91.65 141.94 28.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 80.6 t -137.03 129.72 44.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.132 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 12.4 t -133.46 158.48 42.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.83 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 2.5 pt -119.94 150.56 22.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.117 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -86.47 104.75 16.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 901' ' ' SER . . . . . . . . . . . . . 52.4 p -140.09 136.9 34.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.914 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 17.6 m -72.87 -57.91 3.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.892 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 35.2 mt -76.18 150.3 82.91 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.586 0.708 . . . . 0.0 110.921 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.16 -31.11 8.02 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.698 2.265 . . . . 0.0 112.316 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -65.94 -6.62 13.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.901 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 906' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -107.96 -23.41 12.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 32.1 m-20 -52.8 -19.31 2.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -80.09 136.91 36.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.899 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 909' ' ' PHE . . . . . 0.552 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 92.9 m-85 -79.22 129.93 34.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -96.71 173.05 7.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.845 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -53.75 -36.71 62.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.854 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -69.0 -49.54 56.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.071 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 913' ' ' LEU . . . . . . . . . . . . . 22.2 mt -59.06 -44.83 91.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 54.3 mt -69.74 -59.88 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.151 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -41.58 -64.92 0.5 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.843 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -47.27 -56.05 7.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 917' ' ' LEU . . . . . 0.553 ' HB3' ' CE2' ' A' ' 921' ' ' PHE . 26.9 mt -42.16 -54.22 3.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 918' ' ' LEU . . . . . . . . . . . . . 62.8 mt -40.46 -57.69 1.74 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.954 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -58.71 -42.93 89.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -58.71 -38.8 79.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 921' ' ' PHE . . . . . 0.553 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 24.5 m-85 -69.92 -37.39 75.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -56.27 -35.45 67.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.071 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.7 m -44.53 -29.16 0.67 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 924' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 1.8 m-85 -121.3 -59.6 1.7 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.849 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -124.26 140.21 12.48 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.514 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -82.52 99.41 9.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.814 0.34 . . . . 0.0 110.88 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 34.7 t -50.27 143.71 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.163 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 928' ' ' ILE . . . . . . . . . . . . . 15.3 pt -120.02 -39.97 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.15 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 929' ' ' LEU . . . . . . . . . . . . . 8.6 tp -140.44 149.36 42.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.913 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 930' ' ' ILE . . . . . 0.434 HG22 ' N ' ' A' ' 931' ' ' ARG . 41.9 mt -137.05 145.58 29.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.104 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 931' ' ' ARG . . . . . 0.434 ' N ' HG22 ' A' ' 930' ' ' ILE . 8.1 ttp180 -135.78 124.19 23.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.917 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -87.75 120.38 29.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.909 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 933' ' ' VAL . . . . . 0.553 HG23 ' CD1' ' A' ' 938' ' ' TRP . 3.6 t -87.15 157.15 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.106 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 934' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 933' ' ' VAL . 22.8 mm-40 -34.04 -53.72 0.47 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -124.17 -21.57 4.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.834 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 16.9 ttmt -99.93 172.94 6.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 937' ' ' MET . . . . . 0.552 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 15.2 ttt -131.85 109.03 9.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.841 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 938' ' ' TRP . . . . . 0.553 ' CD1' HG23 ' A' ' 933' ' ' VAL . 43.4 m0 -89.41 143.13 27.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.913 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 46.6 t -135.8 122.73 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.095 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 18.4 m -91.04 152.94 20.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.154 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 941' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -129.21 155.53 45.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.869 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 16.1 tp -38.47 -56.72 1.23 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.959 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -136.11 165.67 25.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.862 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -52.97 -53.44 33.72 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.461 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 77.3 p -46.38 -44.6 17.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.835 0.35 . . . . 0.0 110.847 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 72.2 m -55.17 -32.85 62.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -82.51 -13.43 56.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.102 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 60.2 mt -85.65 -28.35 24.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.909 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -85.37 -34.09 21.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.13 -20.26 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.16 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 41.2 mt -52.85 -26.56 15.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.93 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 9.7 m -56.36 -21.49 24.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.841 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 953' ' ' LEU . . . . . 0.423 ' C ' HD11 ' A' ' 965' ' ' ILE . 26.6 mt -82.04 4.96 20.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.89 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.16 122.71 17.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 88.7 -26.56 8.12 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.485 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -42.32 127.15 3.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.752 0.31 . . . . 0.0 110.913 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -93.63 130.82 39.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 14.8 tp -141.36 152.46 44.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.913 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 81.4 mt 42.03 48.42 4.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.964 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 48.57 40.74 16.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.839 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 961' ' ' ARG . . . . . . . . . . . . . 51.5 mtt85 -148.94 105.0 3.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.871 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 56.3 m -62.67 121.35 13.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.12 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 963' ' ' ILE . . . . . 0.406 ' CD1' HD23 ' A' ' 917' ' ' LEU . 64.7 mt -102.32 152.87 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.14 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 11.6 m -136.45 117.51 14.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.1 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 965' ' ' ILE . . . . . 0.433 HG22 ' N ' ' A' ' 966' ' ' ALA . 33.7 mt -100.37 143.62 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.104 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 966' ' ' ALA . . . . . 0.433 ' N ' HG22 ' A' ' 965' ' ' ILE . . . -154.28 129.38 9.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.128 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 967' ' ' LEU . . . . . . . . . . . . . 36.5 mt -63.15 158.0 20.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.926 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 12.7 tptp -89.14 140.51 29.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 68.3 m -104.84 97.5 12.92 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.673 0.749 . . . . 0.0 110.874 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.93 -5.86 17.36 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.719 2.279 . . . . 0.0 112.376 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 51.8 p -40.17 127.41 2.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.878 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -171.31 -165.83 29.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.481 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -79.38 20.89 0.8 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.656 2.237 . . . . 0.0 112.357 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 34.9 p -57.09 -48.31 78.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 13.1 t -45.86 -46.65 15.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.86 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.529 -179.989 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 46.6 p -94.21 97.42 10.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.88 0.372 . . . . 0.0 110.929 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 19.3 m -102.15 118.1 36.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.871 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . -79.1 112.7 3.51 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.499 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 41.6 m -108.44 159.57 16.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.855 0.36 . . . . 0.0 110.87 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 60.3 m -122.82 146.08 47.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.844 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 135.4 -68.71 0.53 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.477 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . 99.94 47.25 1.78 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.52 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 97.5 m -83.65 121.91 27.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.825 0.345 . . . . 0.0 111.092 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 895' ' ' VAL . . . . . . . . . . . . . 17.2 m -115.0 142.48 27.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.113 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . 0.471 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 3.9 mp -91.58 142.64 27.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 897' ' ' VAL . . . . . 0.406 HG21 ' C ' ' A' ' 896' ' ' LEU . 94.5 t -139.86 131.43 32.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.131 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 11.8 t -132.6 151.73 51.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.827 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 899' ' ' ILE . . . . . 0.514 HG22 ' CE2' ' A' ' 909' ' ' PHE . 3.8 pt -119.95 121.05 64.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.159 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 6.0 tppt? -77.43 117.49 18.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 901' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 902' ' ' SER . 3.8 t -133.45 138.97 46.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.837 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 902' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 901' ' ' SER . 4.0 t -36.85 -55.89 0.88 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.839 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 16.9 mt -98.53 154.11 37.67 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.612 0.72 . . . . 0.0 110.913 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -77.47 -33.86 2.25 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.727 2.285 . . . . 0.0 112.363 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -60.45 -10.31 4.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.9 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 906' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -104.82 15.26 28.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -68.37 -23.43 64.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -66.54 150.82 48.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 909' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 24.6 m-85 -96.25 131.05 43.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 910' ' ' ASP . . . . . 0.409 ' CG ' ' N ' ' A' ' 911' ' ' ASP . 23.6 t70 -89.89 168.3 12.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.85 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 911' ' ' ASP . . . . . 0.409 ' N ' ' CG ' ' A' ' 910' ' ' ASP . 0.7 OUTLIER -49.04 -45.89 43.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -61.46 -58.27 8.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.095 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 913' ' ' LEU . . . . . 0.446 ' CD2' ' HD2' ' A' ' 961' ' ' ARG . 84.3 mt -47.84 -47.18 31.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.88 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 57.3 mt -66.47 -64.28 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.118 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -39.34 -61.93 0.73 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -47.83 -57.25 5.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.934 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 917' ' ' LEU . . . . . 0.528 ' HB3' ' CE2' ' A' ' 921' ' ' PHE . 33.8 mt -41.73 -56.91 2.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 918' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 917' ' ' LEU . 37.5 mt -36.11 -57.54 0.7 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -54.83 -42.78 72.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 920' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 917' ' ' LEU . 60.5 mm-40 -61.17 -39.14 89.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.913 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 921' ' ' PHE . . . . . 0.528 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 22.0 m-85 -71.34 -34.56 70.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -60.62 -34.52 74.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.086 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -47.24 -23.72 0.59 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.851 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 924' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 0.6 OUTLIER -125.42 -55.97 1.53 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.896 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -127.56 141.23 12.45 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.469 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -83.55 100.26 10.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.88 0.372 . . . . 0.0 110.884 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 927' ' ' VAL . . . . . 0.408 HG12 ' N ' ' A' ' 928' ' ' ILE . 60.9 t -53.14 146.32 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.134 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 928' ' ' ILE . . . . . 0.408 ' N ' HG12 ' A' ' 927' ' ' VAL . 29.1 pt -124.85 -37.38 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.159 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 929' ' ' LEU . . . . . . . . . . . . . 22.2 tp -139.7 146.88 40.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.964 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 64.1 mt -136.23 129.26 46.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.119 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -118.81 124.7 47.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -90.96 119.53 31.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.862 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 933' ' ' VAL . . . . . 0.571 HG21 ' CD1' ' A' ' 938' ' ' TRP . 9.0 t -85.64 157.27 3.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.148 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 934' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 933' ' ' VAL . 65.7 mt-10 -33.77 -50.34 0.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.871 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.76 -26.2 3.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.841 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 936' ' ' LYS . . . . . 0.414 ' O ' ' N ' ' A' ' 933' ' ' VAL . 1.0 OUTLIER -96.48 173.2 7.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 -179.984 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 937' ' ' MET . . . . . 0.57 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 18.8 ttt -134.8 110.39 9.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.848 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 938' ' ' TRP . . . . . 0.571 ' CD1' HG21 ' A' ' 933' ' ' VAL . 43.8 m0 -89.51 152.31 21.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.939 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 939' ' ' VAL . . . . . 0.409 HG22 ' C ' ' A' ' 938' ' ' TRP . 93.0 t -140.99 123.57 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.127 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 18.8 m -90.4 150.04 22.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.137 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 941' ' ' PHE . . . . . 0.401 ' O ' ' C ' ' A' ' 942' ' ' LEU . 10.8 m-85 -129.41 150.49 50.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.891 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 942' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 941' ' ' PHE . 21.7 tp -37.09 -59.62 0.71 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.909 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -130.41 163.26 27.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 944' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 947' ' ' ALA . . . -55.49 -56.84 21.55 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.5 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 68.6 p -39.57 -48.71 2.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.889 0.376 . . . . 0.0 110.836 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 18.3 m -54.14 -37.93 64.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 947' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 944' ' ' GLY . . . -74.57 -13.81 60.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.098 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 26.7 mt -89.29 -21.85 22.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -88.77 -44.85 10.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.91 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 7.3 p -52.45 -22.76 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.109 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 31.1 mt -48.68 -26.65 2.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.904 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 26.3 m -52.78 -16.14 0.91 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.889 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 953' ' ' LEU . . . . . 0.415 ' CB ' HD11 ' A' ' 965' ' ' ILE . 36.5 mt -92.13 16.48 11.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.865 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.41 119.0 13.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 87.8 -27.92 6.28 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.499 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -38.61 127.52 1.49 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.73 0.3 . . . . 0.0 110.896 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -97.17 122.87 40.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.904 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 14.2 tp -132.91 156.75 46.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 959' ' ' LEU . . . . . 0.453 ' O ' ' CG ' ' A' ' 960' ' ' ASN . 24.9 mt 42.19 49.23 4.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.931 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 960' ' ' ASN . . . . . 0.453 ' CG ' ' O ' ' A' ' 959' ' ' LEU . 17.0 p30 47.53 38.94 8.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 961' ' ' ARG . . . . . 0.446 ' HD2' ' CD2' ' A' ' 913' ' ' LEU . 49.7 mtt85 -146.88 112.0 5.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.871 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 55.8 m -64.9 119.52 10.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.127 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 963' ' ' ILE . . . . . . . . . . . . . 89.1 mt -102.12 145.65 11.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.115 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 7.6 m -130.43 110.26 11.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.126 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 965' ' ' ILE . . . . . 0.415 HD11 ' CB ' ' A' ' 953' ' ' LEU . 62.5 mt -96.64 136.61 26.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.146 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -147.72 134.47 20.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.136 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 967' ' ' LEU . . . . . . . . . . . . . 26.9 mt -64.54 155.75 32.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.927 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 11.9 tptp -94.35 -70.52 0.7 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.883 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 99.6 p -42.35 146.5 0.68 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.657 0.741 . . . . 0.0 110.849 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.69 -49.53 10.67 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.711 2.274 . . . . 0.0 112.354 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 28.5 t -161.39 122.37 2.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -46.53 146.25 3.4 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.498 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -77.42 100.48 1.4 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.711 2.274 . . . . 0.0 112.344 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 48.6 m -128.28 144.88 51.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.862 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 48.5 p -85.7 -46.86 10.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.857 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.372 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.487 179.988 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 99.1 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.865 0.364 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 895' ' ' VAL . . . . . 0.575 HG12 HD23 ' A' ' 967' ' ' LEU . 17.7 m -116.26 142.24 30.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.076 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 896' ' ' LEU . . . . . 0.465 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 6.5 mp -90.52 139.15 30.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.926 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.403 HG13 ' CG2' ' A' ' 963' ' ' ILE . 70.5 t -139.01 125.29 23.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.139 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 11.1 t -126.6 155.02 43.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.862 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.551 HG12 ' CE2' ' A' ' 909' ' ' PHE . 2.6 pt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.123 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 909' ' ' PHE . . . . . 0.757 ' HA ' HD12 ' A' ' 913' ' ' LEU . 79.7 m-85 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.84 0.352 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -97.56 -177.25 3.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.835 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -61.92 -36.07 80.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -67.72 -57.36 6.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.112 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 913' ' ' LEU . . . . . 0.757 HD12 ' HA ' ' A' ' 909' ' ' PHE . 22.6 mt -49.79 -47.0 51.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.923 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 47.5 mt -69.99 -65.93 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.125 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -38.81 -53.47 1.68 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.843 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 916' ' ' GLU . . . . . 0.468 ' HB3' HD21 ' A' ' 958' ' ' LEU . 60.8 mm-40 -58.24 -51.15 70.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.893 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 917' ' ' LEU . . . . . 0.974 HD21 HD13 ' A' ' 963' ' ' ILE . 23.9 mt -48.93 -54.79 14.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.883 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 918' ' ' LEU . . . . . 0.434 ' C ' ' O ' ' A' ' 917' ' ' LEU . 52.4 mt -35.04 -58.81 0.52 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.939 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -54.76 -51.17 66.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.934 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 920' ' ' GLN . . . . . 0.972 ' NE2' HD22 ' A' ' 958' ' ' LEU . 14.4 mt-30 -51.27 -41.43 60.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.926 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 921' ' ' PHE . . . . . 0.505 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 23.6 m-85 -70.93 -32.1 68.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -58.3 -39.22 78.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.097 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -45.03 -25.58 0.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.918 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 924' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 1.0 OUTLIER -120.96 -64.1 1.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.878 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -121.33 145.08 16.96 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.467 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -85.82 97.23 10.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.88 0.372 . . . . 0.0 110.902 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 29.1 t -46.31 145.64 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.107 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 928' ' ' ILE . . . . . 0.468 HG13 ' N ' ' A' ' 929' ' ' LEU . 25.1 pt -126.63 -42.89 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.167 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 929' ' ' LEU . . . . . 0.468 ' N ' HG13 ' A' ' 928' ' ' ILE . 10.2 tp -133.7 145.84 50.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.946 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 930' ' ' ILE . . . . . 0.41 HD11 ' CD2' ' A' ' 918' ' ' LEU . 81.7 mt -133.69 124.58 47.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.099 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 41.1 ttt180 -115.21 124.35 51.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.91 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -90.76 122.42 33.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.912 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 933' ' ' VAL . . . . . 0.723 HG21 ' NE1' ' A' ' 938' ' ' TRP . 2.7 t -90.51 156.94 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.151 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 934' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 933' ' ' VAL . 14.7 mt-10 -34.49 -52.12 0.49 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.9 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.93 -25.52 3.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.896 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -96.63 172.92 7.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.864 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 937' ' ' MET . . . . . 0.565 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 15.9 ttt -133.54 110.73 10.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.903 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 938' ' ' TRP . . . . . 0.723 ' NE1' HG21 ' A' ' 933' ' ' VAL . 37.8 m0 -90.85 148.98 22.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.924 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 939' ' ' VAL . . . . . 0.44 ' O ' HG22 ' A' ' 895' ' ' VAL . 47.6 t -137.88 124.83 28.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.106 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 21.3 m -93.0 150.48 20.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.147 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 941' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -128.49 158.56 38.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.839 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 23.2 tp -40.72 -53.54 2.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.939 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -134.48 167.82 20.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.866 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -64.74 -47.4 83.68 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.523 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 70.5 m -50.06 -43.86 51.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.923 0.392 . . . . 0.0 110.831 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 1.9 t -56.64 -36.72 69.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.91 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 947' ' ' ALA . . . . . 0.468 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -69.82 -13.64 62.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.103 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 948' ' ' LEU . . . . . 0.404 ' O ' HD12 ' A' ' 951' ' ' LEU . 23.8 mt -87.15 -25.23 24.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -82.78 -38.08 23.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 9.0 p -61.28 -18.47 18.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.139 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 951' ' ' LEU . . . . . 0.524 HD21 ' HG ' ' A' ' 967' ' ' LEU . 58.7 mt -53.27 -17.84 2.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.941 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 46.3 m -61.77 -12.98 19.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.888 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 953' ' ' LEU . . . . . 0.486 ' HB2' ' CD1' ' A' ' 965' ' ' ILE . 75.3 mt -96.86 12.84 30.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.956 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -66.03 107.24 1.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.934 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 100.02 -26.85 22.9 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.487 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 8.4 tmtm? -40.17 128.86 2.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.772 0.32 . . . . 0.0 110.909 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -93.01 130.38 38.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.848 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 958' ' ' LEU . . . . . 0.972 HD22 ' NE2' ' A' ' 920' ' ' GLN . 16.2 tp -136.3 145.99 46.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.931 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 959' ' ' LEU . . . . . 0.587 HD13 HD23 ' A' ' 913' ' ' LEU . 26.0 mt 44.94 52.24 8.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.953 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 49.26 31.85 3.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 961' ' ' ARG . . . . . . . . . . . . . 56.0 mtt-85 -138.89 111.76 7.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 18.7 m -66.25 116.57 7.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.164 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 963' ' ' ILE . . . . . 0.974 HD13 HD21 ' A' ' 917' ' ' LEU . 92.9 mt -97.82 137.21 26.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.114 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 9.6 m -122.41 110.42 15.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.134 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 965' ' ' ILE . . . . . 0.486 ' CD1' ' HB2' ' A' ' 953' ' ' LEU . 38.3 mt -94.61 143.23 12.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.139 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -157.3 133.26 9.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.149 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 967' ' ' LEU . . . . . 0.575 HD23 HG12 ' A' ' 895' ' ' VAL . 31.8 mt -67.12 157.73 32.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.905 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 19.3 tptp . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.897 179.842 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 53.6 m . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.822 0.344 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 895' ' ' VAL . . . . . 0.599 HG12 HD23 ' A' ' 967' ' ' LEU . 16.8 m -112.23 141.6 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.122 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 896' ' ' LEU . . . . . 0.534 ' HG ' ' CD1' ' A' ' 938' ' ' TRP . 3.6 mp -91.84 148.07 22.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.93 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.401 HG13 ' CG2' ' A' ' 963' ' ' ILE . 58.1 t -145.3 127.37 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.165 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 6.4 t -127.82 153.95 46.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.891 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.562 HG22 HG12 ' A' ' 963' ' ' ILE . 2.1 pt . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.109 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 909' ' ' PHE . . . . . 0.59 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 87.5 m-85 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.866 0.365 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 910' ' ' ASP . . . . . 0.447 ' H ' HD12 ' A' ' 913' ' ' LEU . 32.3 t70 -87.51 166.42 14.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.876 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -49.32 -44.83 44.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.855 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -62.96 -52.29 63.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.105 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 913' ' ' LEU . . . . . 0.754 HD21 ' HD2' ' A' ' 961' ' ' ARG . 50.3 mt -53.69 -49.31 68.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.921 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 47.3 mt -65.85 -61.62 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.14 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -42.77 -60.72 1.47 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.869 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -48.92 -52.62 23.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.909 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 917' ' ' LEU . . . . . 0.979 HD21 HD13 ' A' ' 963' ' ' ILE . 29.6 mt -47.81 -54.71 11.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 918' ' ' LEU . . . . . 0.472 ' CD2' HD11 ' A' ' 930' ' ' ILE . 87.4 mt -35.22 -59.12 0.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.905 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -54.79 -44.66 73.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.89 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 62.5 mm-40 -57.46 -41.08 79.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 921' ' ' PHE . . . . . 0.53 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 23.5 m-85 -70.05 -34.22 72.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -60.67 -34.39 74.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.089 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -47.12 -24.15 0.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 924' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 1.2 m-85 -125.7 -55.23 1.52 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.878 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -129.16 135.07 8.25 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.453 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -79.08 98.37 6.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.918 0.39 . . . . 0.0 110.914 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 42.2 t -51.63 151.46 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.132 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 928' ' ' ILE . . . . . 0.479 HG13 ' N ' ' A' ' 929' ' ' LEU . 20.1 pt -125.81 -45.43 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.1 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 929' ' ' LEU . . . . . 0.479 ' N ' HG13 ' A' ' 928' ' ' ILE . 11.2 tp -132.87 148.08 52.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 930' ' ' ILE . . . . . 0.618 HG12 HG13 ' A' ' 939' ' ' VAL . 74.5 mt -133.12 132.86 58.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.128 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -120.87 123.92 43.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.847 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -90.69 120.18 31.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.877 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 933' ' ' VAL . . . . . 0.624 HG21 ' NE1' ' A' ' 938' ' ' TRP . 2.6 t -90.48 157.13 2.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.086 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 934' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 933' ' ' VAL . 58.3 mt-10 -33.94 -51.6 0.41 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.908 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -125.19 -25.49 3.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.878 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 936' ' ' LYS . . . . . 0.4 ' O ' ' N ' ' A' ' 933' ' ' VAL . 12.0 tttt -98.27 172.98 7.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.881 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 937' ' ' MET . . . . . 0.59 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 13.5 ttt -135.33 110.65 9.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 938' ' ' TRP . . . . . 0.624 ' NE1' HG21 ' A' ' 933' ' ' VAL . 40.2 m0 -88.69 149.11 23.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.944 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 939' ' ' VAL . . . . . 0.618 HG13 HG12 ' A' ' 930' ' ' ILE . 12.1 t -139.12 129.36 32.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.128 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 17.3 m -93.73 151.15 19.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.151 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 941' ' ' PHE . . . . . 0.422 ' O ' ' C ' ' A' ' 942' ' ' LEU . 9.5 m-85 -130.56 139.82 50.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.917 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 942' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 941' ' ' PHE . 24.5 tp -35.14 -62.5 0.38 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.909 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -116.38 154.47 30.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.87 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -58.54 -50.01 71.23 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.442 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 12.6 t -48.21 -43.48 32.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.848 0.356 . . . . 0.0 110.857 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 14.6 m -55.77 -29.02 58.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.853 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 947' ' ' ALA . . . . . 0.492 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -81.44 -23.0 37.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.073 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 38.3 mt -79.68 -25.71 41.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -84.6 -51.44 6.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.873 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 950' ' ' VAL . . . . . 0.425 ' CG2' HD12 ' A' ' 953' ' ' LEU . 9.8 p -47.55 -21.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.163 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 951' ' ' LEU . . . . . 0.64 HD21 ' HG ' ' A' ' 967' ' ' LEU . 35.3 mt -49.52 -27.25 4.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.959 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 74.8 m -53.72 -15.29 1.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.903 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 953' ' ' LEU . . . . . 0.425 HD12 ' CG2' ' A' ' 950' ' ' VAL . 57.7 mt -90.36 16.51 8.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.926 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.95 120.01 14.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 955' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 956' ' ' LYS . . . 86.21 -25.94 6.62 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.493 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 956' ' ' LYS . . . . . 0.423 ' HE3' HD13 ' A' ' 958' ' ' LEU . 8.9 tmtm? -36.21 126.84 0.77 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.747 0.308 . . . . 0.0 110.857 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -94.72 125.59 39.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 958' ' ' LEU . . . . . 0.423 HD13 ' HE3' ' A' ' 956' ' ' LYS . 14.2 tp -138.35 153.69 48.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 959' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 913' ' ' LEU . 45.3 mt 41.79 48.39 3.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 960' ' ' ASN . . . . . 0.415 ' CG ' ' C ' ' A' ' 959' ' ' LEU . 0.7 OUTLIER 46.5 42.94 11.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 961' ' ' ARG . . . . . 0.754 ' HD2' HD21 ' A' ' 913' ' ' LEU . 45.8 mtt85 -149.69 105.27 3.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 7.4 m -59.49 122.16 13.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.111 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 963' ' ' ILE . . . . . 0.979 HD13 HD21 ' A' ' 917' ' ' LEU . 88.3 mt -106.69 142.35 19.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.152 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 6.5 m -126.48 116.41 21.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.135 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 965' ' ' ILE . . . . . . . . . . . . . 67.6 mt -98.03 139.28 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.179 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -148.7 128.09 13.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.07 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 967' ' ' LEU . . . . . 0.64 ' HG ' HD21 ' A' ' 951' ' ' LEU . 30.4 mt -66.51 157.46 32.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 968' ' ' LYS . . . . . 0.421 ' HD3' HD11 ' A' ' 896' ' ' LEU . 30.5 tptt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 86.8 m . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.817 0.341 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 895' ' ' VAL . . . . . 0.451 HG12 HD23 ' A' ' 967' ' ' LEU . 27.5 m -120.19 139.28 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.143 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 896' ' ' LEU . . . . . 0.463 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 6.4 mp -89.18 138.97 30.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.415 HG13 ' CG2' ' A' ' 963' ' ' ILE . 63.8 t -139.71 122.61 17.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.138 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 16.5 t -125.66 155.5 40.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.902 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.565 HG22 HG12 ' A' ' 963' ' ' ILE . 2.3 pt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.128 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 909' ' ' PHE . . . . . 0.527 ' CE2' HG12 ' A' ' 899' ' ' ILE . 27.1 m-85 . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.841 0.353 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 910' ' ' ASP . . . . . 0.46 ' H ' HD12 ' A' ' 913' ' ' LEU . 3.0 m-20 -86.18 177.31 7.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.871 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -55.17 -42.96 73.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.859 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -63.96 -47.24 81.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.076 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 913' ' ' LEU . . . . . 0.926 HD21 ' HD2' ' A' ' 961' ' ' ARG . 52.1 mt -61.01 -48.95 79.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.926 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 49.6 mt -65.81 -59.95 3.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.14 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -45.28 -58.01 3.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.902 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -50.84 -52.53 40.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.891 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 917' ' ' LEU . . . . . 0.909 HD21 HD13 ' A' ' 963' ' ' ILE . 29.6 mt -46.4 -54.01 9.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.909 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 918' ' ' LEU . . . . . 0.414 ' C ' ' O ' ' A' ' 917' ' ' LEU . 20.6 mt -36.63 -64.42 0.34 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.939 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -50.14 -51.92 39.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.912 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -50.47 -40.97 52.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 921' ' ' PHE . . . . . 0.579 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 24.1 m-85 -69.74 -48.18 60.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.855 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -48.19 -28.31 2.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.108 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 923' ' ' SER . . . . . 0.554 ' HB3' ' CD1' ' A' ' 924' ' ' PHE . 16.7 t -47.49 -29.66 2.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.897 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 924' ' ' PHE . . . . . 0.554 ' CD1' ' HB3' ' A' ' 923' ' ' SER . 1.0 OUTLIER -123.02 -64.43 1.18 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.856 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -115.74 155.29 16.37 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.51 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -91.96 138.44 31.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.885 0.374 . . . . 0.0 110.909 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 55.9 t -93.07 146.16 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.114 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 928' ' ' ILE . . . . . 0.491 HG13 ' N ' ' A' ' 929' ' ' LEU . 30.2 pt -123.32 -42.86 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.107 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 929' ' ' LEU . . . . . 0.491 ' N ' HG13 ' A' ' 928' ' ' ILE . 15.0 tp -138.76 141.81 38.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 94.3 mt -127.36 125.47 65.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.154 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -113.44 122.82 48.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -90.6 122.14 33.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.928 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 933' ' ' VAL . . . . . 0.569 HG21 ' NE1' ' A' ' 938' ' ' TRP . 2.9 t -89.9 157.09 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.158 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 934' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 933' ' ' VAL . 61.8 mt-10 -34.11 -50.53 0.4 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.891 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -126.05 -26.73 3.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.823 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 936' ' ' LYS . . . . . 0.417 ' NZ ' ' HB2' ' A' ' 936' ' ' LYS . 0.7 OUTLIER -96.53 172.73 7.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.933 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 937' ' ' MET . . . . . 0.507 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 14.5 ttt -135.26 111.78 9.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.863 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 938' ' ' TRP . . . . . 0.569 ' NE1' HG21 ' A' ' 933' ' ' VAL . 37.0 m0 -92.47 146.33 23.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 939' ' ' VAL . . . . . 0.41 HG12 ' CE1' ' A' ' 941' ' ' PHE . 65.0 t -132.62 121.27 44.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.132 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 18.9 m -85.18 152.59 23.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.156 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 941' ' ' PHE . . . . . 0.41 ' CE1' HG12 ' A' ' 939' ' ' VAL . 12.0 m-85 -133.74 141.84 47.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 19.7 tp -42.55 -47.97 5.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.899 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -120.63 176.13 5.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -89.74 -39.2 6.28 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.519 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 36.0 p -59.54 -41.23 89.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.921 0.391 . . . . 0.0 110.861 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 80.0 p -56.38 -34.45 66.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.881 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -70.81 -15.18 62.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.103 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 25.5 mt -84.01 -31.53 25.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -75.67 -49.31 18.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.842 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 8.5 p -53.35 -17.31 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.143 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 951' ' ' LEU . . . . . 0.472 HD21 ' HG ' ' A' ' 967' ' ' LEU . 52.3 mt -52.98 -24.96 10.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 35.9 p -55.88 -22.92 28.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 76.7 mt -83.25 17.9 1.92 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -72.63 110.35 6.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 96.02 -26.42 20.89 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.481 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -38.33 127.46 1.39 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.732 0.301 . . . . 0.0 110.897 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -94.9 128.42 41.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.901 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 958' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 961' ' ' ARG . 13.7 tp -136.97 160.04 40.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.926 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 959' ' ' LEU . . . . . 0.406 ' C ' ' O ' ' A' ' 958' ' ' LEU . 43.5 mt 37.7 43.07 0.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.967 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 8.9 m120 55.44 43.31 28.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.871 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 961' ' ' ARG . . . . . 0.926 ' HD2' HD21 ' A' ' 913' ' ' LEU . 69.2 mtt-85 -149.71 122.89 8.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.844 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 6.0 m -75.05 112.72 11.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.119 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 963' ' ' ILE . . . . . 0.909 HD13 HD21 ' A' ' 917' ' ' LEU . 82.8 mt -98.02 138.17 23.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.088 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 9.3 m -122.13 113.25 19.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.109 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 965' ' ' ILE . . . . . 0.409 HG12 HG22 ' A' ' 897' ' ' VAL . 55.3 mt -98.75 135.07 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.113 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -149.27 136.63 20.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.095 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 967' ' ' LEU . . . . . 0.472 ' HG ' HD21 ' A' ' 951' ' ' LEU . 30.7 mt -65.44 156.58 31.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.895 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 968' ' ' LYS . . . . . 0.418 ' HE3' ' CH2' ' A' ' 938' ' ' TRP . 21.5 tttt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 84.8 m . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.823 0.344 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 895' ' ' VAL . . . . . 0.712 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 11.3 m -114.25 147.19 17.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.117 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 896' ' ' LEU . . . . . 0.46 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 3.5 mp -96.17 144.26 26.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.937 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.418 HG22 HG12 ' A' ' 965' ' ' ILE . 59.2 t -143.72 131.88 18.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.137 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 14.2 t -134.14 160.23 38.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.82 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.42 HG22 HG12 ' A' ' 963' ' ' ILE . 4.1 pt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.162 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 909' ' ' PHE . . . . . 0.567 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 90.0 m-85 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.899 0.381 . . . . 0.0 110.841 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 910' ' ' ASP . . . . . 0.663 ' H ' HD12 ' A' ' 913' ' ' LEU . 7.4 t70 -72.44 163.61 27.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.842 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -51.47 -35.95 42.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.831 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -70.49 -50.95 32.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.091 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 913' ' ' LEU . . . . . 0.849 HD21 ' HD2' ' A' ' 961' ' ' ARG . 87.4 mt -54.8 -35.43 63.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 91.2 mt -79.28 -65.0 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.14 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -39.69 -55.97 1.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.919 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 916' ' ' GLU . . . . . 0.535 ' HB3' HD21 ' A' ' 958' ' ' LEU . 69.0 mm-40 -51.95 -48.46 64.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 917' ' ' LEU . . . . . 1.008 HD21 HD13 ' A' ' 963' ' ' ILE . 28.8 mt -55.06 -47.49 74.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 918' ' ' LEU . . . . . . . . . . . . . 44.6 mt -43.29 -55.58 3.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -58.63 -38.65 78.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 39.4 mm-40 -64.31 -35.83 82.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.888 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 921' ' ' PHE . . . . . 0.557 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 19.4 m-85 -76.03 -33.01 59.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -58.24 -31.92 67.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.104 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 923' ' ' SER . . . . . 0.478 ' OG ' ' CE2' ' A' ' 924' ' ' PHE . 31.9 p -56.93 -13.51 2.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.855 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 924' ' ' PHE . . . . . 0.478 ' CE2' ' OG ' ' A' ' 923' ' ' SER . 74.5 m-85 -125.97 -57.33 1.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.86 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -137.17 140.14 11.14 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.462 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -74.96 98.85 3.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.896 0.379 . . . . 0.0 110.871 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 58.0 t -50.29 145.16 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.146 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 928' ' ' ILE . . . . . 0.571 HD13 ' HA ' ' A' ' 942' ' ' LEU . 20.0 pt -120.28 -45.38 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.138 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 929' ' ' LEU . . . . . 0.479 ' N ' HG13 ' A' ' 928' ' ' ILE . 11.2 tp -137.78 151.85 48.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.914 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 40.7 mt -135.97 129.85 48.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.113 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 21.4 ttt-85 -116.56 123.8 48.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -91.58 123.85 35.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.885 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 933' ' ' VAL . . . . . 0.759 HG21 ' NE1' ' A' ' 938' ' ' TRP . 3.6 t -90.78 156.97 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.17 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 934' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 933' ' ' VAL . 61.2 mm-40 -34.37 -51.32 0.45 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.1 -25.46 3.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.803 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.03 173.02 7.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 937' ' ' MET . . . . . 0.567 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 15.1 ttt -134.19 113.51 12.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.877 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 938' ' ' TRP . . . . . 0.759 ' NE1' HG21 ' A' ' 933' ' ' VAL . 37.1 m0 -93.89 151.89 19.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.889 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 939' ' ' VAL . . . . . 0.437 HG12 ' CE1' ' A' ' 941' ' ' PHE . 39.8 t -134.86 139.19 47.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.161 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 940' ' ' THR . . . . . 0.421 HG22 HD11 ' A' ' 928' ' ' ILE . 29.2 m -110.66 146.8 35.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.15 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 941' ' ' PHE . . . . . 0.437 ' CE1' HG12 ' A' ' 939' ' ' VAL . 9.7 m-85 -130.21 149.84 51.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.884 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 942' ' ' LEU . . . . . 0.571 ' HA ' HD13 ' A' ' 928' ' ' ILE . 21.2 tp -40.25 -63.63 0.6 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.902 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -107.43 168.48 9.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.91 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -76.42 -49.8 7.91 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.482 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 6.6 p -49.41 -27.25 3.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.921 0.391 . . . . 0.0 110.883 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 70.5 m -63.22 -47.59 81.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.864 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 947' ' ' ALA . . . . . 0.712 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -60.28 -27.88 67.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.107 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 18.3 mt -73.66 -25.12 60.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.933 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -81.8 -45.05 16.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.919 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 950' ' ' VAL . . . . . 0.508 HG12 ' O ' ' A' ' 947' ' ' ALA . 3.2 p -57.83 -18.8 10.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.13 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 951' ' ' LEU . . . . . 0.483 HD21 ' HG ' ' A' ' 967' ' ' LEU . 23.0 mt -51.77 -31.42 26.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.962 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 6.4 t -51.52 -17.19 0.74 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.837 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 39.8 mt -87.85 13.76 10.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.888 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -66.28 117.22 8.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 90.88 -26.7 10.29 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.5 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -41.43 128.54 3.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.794 0.331 . . . . 0.0 110.881 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -97.78 130.43 44.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.857 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 958' ' ' LEU . . . . . 0.535 HD21 ' HB3' ' A' ' 916' ' ' GLU . 15.3 tp -134.74 156.21 49.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.935 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 959' ' ' LEU . . . . . 0.427 HD11 ' HG3' ' A' ' 916' ' ' GLU . 47.0 mt 38.83 46.02 1.01 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.922 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 51.88 45.32 28.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.847 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 961' ' ' ARG . . . . . 0.849 ' HD2' HD21 ' A' ' 913' ' ' LEU . 52.0 mtt85 -151.65 105.42 3.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.925 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 18.7 m -57.75 117.49 4.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.152 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 963' ' ' ILE . . . . . 1.008 HD13 HD21 ' A' ' 917' ' ' LEU . 97.4 mt -101.14 139.03 23.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 4.2 m -123.66 116.06 22.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.177 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 965' ' ' ILE . . . . . 0.418 HG12 HG22 ' A' ' 897' ' ' VAL . 55.2 mt -101.1 139.94 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.159 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -152.03 131.25 12.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.142 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 967' ' ' LEU . . . . . 0.54 HD23 HG12 ' A' ' 895' ' ' VAL . 33.7 mt -64.55 157.87 25.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.939 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 22.8 tptm . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 179.849 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 33.9 m . . . . . 0 N--CA 1.457 -0.107 0 CA-C-O 120.798 0.332 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 895' ' ' VAL . . . . . 0.766 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 13.9 m -116.31 139.76 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.152 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 896' ' ' LEU . . . . . 0.47 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 3.2 mp -89.53 150.82 22.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.891 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 64.3 t -144.95 131.66 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.178 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 5.2 t -133.53 154.71 50.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.53 HG23 ' CE2' ' A' ' 909' ' ' PHE . 4.1 pt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.111 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 909' ' ' PHE . . . . . 0.563 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 50.6 m-85 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.854 0.359 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -96.91 169.1 10.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -48.12 -38.55 18.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.878 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -67.59 -54.24 21.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.064 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 913' ' ' LEU . . . . . 0.571 ' O ' HD12 ' A' ' 917' ' ' LEU . 36.7 mt -52.92 -42.01 64.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.908 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 60.7 mt -74.08 -64.91 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.11 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -40.02 -61.55 0.85 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 916' ' ' GLU . . . . . 0.573 ' HG3' HD11 ' A' ' 959' ' ' LEU . 74.9 mm-40 -48.89 -55.52 11.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.904 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 917' ' ' LEU . . . . . 0.803 HD21 HD13 ' A' ' 963' ' ' ILE . 24.9 mt -46.5 -54.15 9.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 918' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 917' ' ' LEU . 89.4 mt -36.81 -59.39 0.69 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -55.35 -48.69 73.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -53.16 -41.3 65.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.938 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 921' ' ' PHE . . . . . 0.557 ' CZ ' ' HB3' ' A' ' 917' ' ' LEU . 19.8 m-85 -64.72 -45.0 88.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.925 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -54.03 -30.99 49.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.102 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 29.7 t -45.54 -30.98 1.62 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 924' ' ' PHE . . . . . 0.532 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 1.0 OUTLIER -120.73 -57.63 1.88 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -127.03 152.22 18.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.512 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -87.62 135.51 33.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.855 0.36 . . . . 0.0 110.889 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 46.7 t -87.7 145.93 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.113 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 928' ' ' ILE . . . . . 0.449 HG13 ' N ' ' A' ' 929' ' ' LEU . 26.6 pt -120.65 -41.56 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.093 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 929' ' ' LEU . . . . . 0.449 ' N ' HG13 ' A' ' 928' ' ' ILE . 21.9 tp -141.06 149.05 41.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.95 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 58.4 mt -133.24 132.54 58.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.144 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -118.39 130.58 56.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -97.59 120.78 38.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.851 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 933' ' ' VAL . . . . . 0.57 HG21 ' NE1' ' A' ' 938' ' ' TRP . 2.8 t -91.58 157.12 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.109 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 934' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 933' ' ' VAL . 44.3 mt-10 -33.56 -54.01 0.43 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.905 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -124.5 -22.42 4.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.817 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 6.3 ttmt -99.59 173.14 6.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.868 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 937' ' ' MET . . . . . 0.563 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 17.3 ttt -136.14 114.31 11.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 938' ' ' TRP . . . . . 0.57 ' NE1' HG21 ' A' ' 933' ' ' VAL . 37.8 m0 -94.72 143.9 26.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.96 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 47.9 t -130.78 137.82 55.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.16 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 19.4 m -106.85 144.36 33.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.18 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 941' ' ' PHE . . . . . 0.444 ' O ' ' C ' ' A' ' 942' ' ' LEU . 6.0 m-85 -125.38 144.22 50.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.909 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 942' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 941' ' ' PHE . 43.1 tp -34.33 -67.84 0.13 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.925 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -104.44 171.81 7.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.903 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -76.02 -49.6 8.48 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.499 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 945' ' ' SER . . . . . 0.428 ' HA ' HD12 ' A' ' 948' ' ' LEU . 95.6 p -50.44 -25.93 4.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.865 0.364 . . . . 0.0 110.869 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 60.7 m -65.63 -42.59 91.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.793 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 947' ' ' ALA . . . . . 0.766 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -68.62 -16.29 63.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.091 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 948' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 945' ' ' SER . 13.6 mt -87.86 -24.18 23.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.948 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -81.71 -51.05 8.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.944 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 950' ' ' VAL . . . . . 0.467 ' CG2' HD12 ' A' ' 953' ' ' LEU . 9.8 p -52.02 -20.11 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.135 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 951' ' ' LEU . . . . . 0.593 HD21 ' HG ' ' A' ' 967' ' ' LEU . 73.0 mt -50.72 -20.73 1.33 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 26.1 m -61.88 -9.43 6.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.822 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 953' ' ' LEU . . . . . 0.467 HD12 ' CG2' ' A' ' 950' ' ' VAL . 58.8 mt -95.76 11.55 33.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.926 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -67.16 117.43 9.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 90.28 -23.06 23.47 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.517 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.05 127.14 8.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.731 0.3 . . . . 0.0 110.915 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -93.06 123.06 36.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 14.9 tp -129.35 154.94 46.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.948 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 959' ' ' LEU . . . . . 0.573 HD11 ' HG3' ' A' ' 916' ' ' GLU . 39.0 mt 39.23 46.29 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.906 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 50.95 46.06 26.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.86 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 961' ' ' ARG . . . . . . . . . . . . . 41.4 mtt85 -152.02 106.47 3.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.929 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 7.7 m -60.16 111.18 1.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.141 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 963' ' ' ILE . . . . . 0.803 HD13 HD21 ' A' ' 917' ' ' LEU . 79.7 mt -95.78 146.32 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.152 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 5.4 m -129.43 118.23 21.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.131 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 965' ' ' ILE . . . . . . . . . . . . . 60.8 mt -105.11 141.28 20.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.086 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -151.59 135.69 16.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.064 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 967' ' ' LEU . . . . . 0.593 ' HG ' HD21 ' A' ' 951' ' ' LEU . 31.5 mt -68.22 158.13 33.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.917 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 11.3 tptt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 179.857 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 90.3 m . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.794 0.33 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 895' ' ' VAL . . . . . 0.539 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 23.7 m -121.0 138.86 50.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.138 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 896' ' ' LEU . . . . . 0.46 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 4.1 mp -89.71 146.4 24.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 70.2 t -144.83 125.32 7.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.098 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 10.6 t -128.07 154.13 46.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.848 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.663 HG22 HG12 ' A' ' 963' ' ' ILE . 3.6 pt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 909' ' ' PHE . . . . . 0.583 ' CE2' HG23 ' A' ' 899' ' ' ILE . 91.6 m-85 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.839 0.352 . . . . 0.0 110.914 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.29 179.41 5.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -57.3 -45.43 84.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -57.66 -57.69 11.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.108 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 913' ' ' LEU . . . . . 0.525 HD21 ' HD2' ' A' ' 961' ' ' ARG . 87.4 mt -49.48 -55.24 13.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.965 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 49.6 mt -60.64 -63.49 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.096 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -41.12 -59.45 1.49 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -53.84 -48.94 69.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.866 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 917' ' ' LEU . . . . . 0.809 HD21 HD13 ' A' ' 963' ' ' ILE . 27.5 mt -50.97 -58.67 5.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.887 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 918' ' ' LEU . . . . . 0.469 ' CD2' HD11 ' A' ' 930' ' ' ILE . 73.0 mt -34.44 -48.16 0.34 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.915 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -63.77 -45.98 87.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.891 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 920' ' ' GLN . . . . . 0.454 ' N ' ' O ' ' A' ' 917' ' ' LEU . 15.2 mm-40 -58.1 -35.04 70.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.914 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 921' ' ' PHE . . . . . 0.553 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 17.6 m-85 -75.2 -37.7 61.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -57.76 -32.62 67.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.114 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -50.82 -23.3 2.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 924' ' ' PHE . . . . . 0.58 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 0.4 OUTLIER -125.13 -58.29 1.46 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.909 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -129.33 150.53 18.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.432 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -88.99 132.37 34.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.885 0.374 . . . . 0.0 110.86 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 22.9 t -84.58 147.33 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.19 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 928' ' ' ILE . . . . . 0.463 HG13 ' N ' ' A' ' 929' ' ' LEU . 41.6 pt -123.38 -38.19 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.158 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 929' ' ' LEU . . . . . 0.463 ' N ' HG13 ' A' ' 928' ' ' ILE . 12.0 tp -141.78 147.86 37.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 930' ' ' ILE . . . . . 0.469 HD11 ' CD2' ' A' ' 918' ' ' LEU . 79.4 mt -133.42 124.55 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.119 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -111.68 125.8 54.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -91.98 123.89 35.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.846 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 933' ' ' VAL . . . . . 0.741 HG21 ' CD1' ' A' ' 938' ' ' TRP . 3.1 t -92.07 157.02 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.078 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 934' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 933' ' ' VAL . 15.8 mt-10 -34.35 -52.37 0.48 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -125.08 -25.47 3.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.825 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.02 173.04 7.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.914 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 937' ' ' MET . . . . . 0.548 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 15.1 ttt -132.51 108.35 9.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 938' ' ' TRP . . . . . 0.741 ' CD1' HG21 ' A' ' 933' ' ' VAL . 38.1 m0 -90.26 144.89 25.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.961 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 61.1 t -131.76 133.56 61.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.131 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 940' ' ' THR . . . . . 0.462 HG22 ' N ' ' A' ' 941' ' ' PHE . 51.6 m -96.81 156.31 16.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.138 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 941' ' ' PHE . . . . . 0.462 ' N ' HG22 ' A' ' 940' ' ' THR . 15.1 m-85 -137.93 144.39 41.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.879 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 29.9 tp -47.04 -44.57 20.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.949 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -123.44 170.39 10.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.921 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -86.34 -41.15 7.08 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.465 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 38.6 p -54.66 -35.21 63.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.839 0.352 . . . . 0.0 110.86 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.76 -40.95 98.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.841 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 947' ' ' ALA . . . . . 0.539 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -64.44 -19.09 65.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.097 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 23.9 mt -83.45 -27.41 29.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -81.82 -51.26 8.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.921 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 7.0 p -48.02 -21.5 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.096 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 951' ' ' LEU . . . . . 0.604 HD21 ' HG ' ' A' ' 967' ' ' LEU . 34.1 mt -49.11 -28.44 4.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.918 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 1.1 t -50.9 -17.54 0.59 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 46.6 mt -90.39 17.32 7.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.895 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -70.87 110.79 5.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.884 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 93.66 -25.14 22.64 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.493 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -39.38 127.23 1.82 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.705 0.288 . . . . 0.0 110.865 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -94.24 125.08 38.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.87 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 958' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 959' ' ' LEU . 14.9 tp -135.41 158.65 43.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.882 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 959' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 958' ' ' LEU . 51.8 mt 38.23 44.24 0.67 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.927 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 2.7 m120 51.56 44.39 29.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 961' ' ' ARG . . . . . 0.525 ' HD2' HD21 ' A' ' 913' ' ' LEU . 34.1 mtt85 -151.45 108.69 3.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 8.6 m -62.14 118.24 7.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.132 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 963' ' ' ILE . . . . . 0.809 HD13 HD21 ' A' ' 917' ' ' LEU . 92.0 mt -103.7 137.63 31.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.136 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 7.0 m -121.47 112.78 18.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.184 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 965' ' ' ILE . . . . . . . . . . . . . 61.8 mt -97.42 139.98 18.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.105 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -149.01 138.36 21.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.098 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 967' ' ' LEU . . . . . 0.604 ' HG ' HD21 ' A' ' 951' ' ' LEU . 39.0 mt -75.84 156.07 34.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.897 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 22.0 tptm . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.912 179.822 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 54.1 m . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.786 0.327 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 895' ' ' VAL . . . . . 0.562 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 21.4 m -119.09 141.33 39.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.13 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 896' ' ' LEU . . . . . 0.46 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 4.5 mp -90.23 142.25 27.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.419 HG22 HG12 ' A' ' 965' ' ' ILE . 96.6 t -141.83 129.54 21.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.114 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 4.4 t -131.49 160.11 36.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.842 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.434 HG12 ' CE1' ' A' ' 909' ' ' PHE . 2.0 pt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.149 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 909' ' ' PHE . . . . . 0.566 ' CE2' ' HB2' ' A' ' 937' ' ' MET . 47.2 m-85 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.888 0.375 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 910' ' ' ASP . . . . . 0.716 ' H ' HD12 ' A' ' 913' ' ' LEU . 24.2 m-20 -73.89 161.85 29.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.857 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -49.35 -50.97 37.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.865 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -54.78 -50.58 68.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.13 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 913' ' ' LEU . . . . . 0.716 HD12 ' H ' ' A' ' 910' ' ' ASP . 20.1 mt -51.72 -52.3 49.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 54.2 mt -60.73 -57.99 9.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.147 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -49.49 -64.0 0.94 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.893 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 916' ' ' GLU . . . . . 0.777 ' HG3' HD11 ' A' ' 959' ' ' LEU . 5.2 mm-40 -44.9 -50.45 10.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.892 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 917' ' ' LEU . . . . . 1.022 HD21 HD13 ' A' ' 963' ' ' ILE . 28.4 mt -48.37 -55.1 11.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 918' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 917' ' ' LEU . 58.4 mt -36.47 -62.98 0.43 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.941 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -54.0 -44.8 71.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -56.5 -37.39 70.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.883 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 921' ' ' PHE . . . . . 0.509 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 24.2 m-85 -73.74 -39.22 64.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.857 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -53.79 -28.07 32.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 923' ' ' SER . . . . . 0.502 ' HB3' ' CE1' ' A' ' 924' ' ' PHE . 40.9 t -46.14 -30.84 2.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.834 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 924' ' ' PHE . . . . . 0.56 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 0.3 OUTLIER -122.66 -65.09 1.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.873 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -111.67 144.96 17.7 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.462 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -87.47 96.52 10.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.874 0.369 . . . . 0.0 110.89 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 44.4 t -53.02 144.08 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.131 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 928' ' ' ILE . . . . . 0.47 HG13 ' N ' ' A' ' 929' ' ' LEU . 15.2 pt -121.92 -46.79 2.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.102 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 929' ' ' LEU . . . . . 0.47 ' N ' HG13 ' A' ' 928' ' ' ILE . 17.3 tp -131.08 149.73 52.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 45.2 mt -135.13 136.1 51.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.176 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -119.8 121.43 39.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.882 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -87.43 116.85 25.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 933' ' ' VAL . . . . . 0.775 HG21 ' NE1' ' A' ' 938' ' ' TRP . 2.9 t -85.54 156.01 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.126 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 934' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 933' ' ' VAL . 31.1 mt-10 -34.21 -51.36 0.44 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -124.15 -27.14 3.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.877 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -96.01 173.06 7.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 937' ' ' MET . . . . . 0.566 ' HB2' ' CE2' ' A' ' 909' ' ' PHE . 17.7 ttt -135.01 106.69 6.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 938' ' ' TRP . . . . . 0.775 ' NE1' HG21 ' A' ' 933' ' ' VAL . 33.3 m0 -85.92 153.6 22.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.924 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 939' ' ' VAL . . . . . 0.442 ' O ' HG22 ' A' ' 895' ' ' VAL . 87.4 t -139.74 128.25 26.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.139 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 27.0 m -90.95 151.51 21.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.128 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 941' ' ' PHE . . . . . 0.438 ' O ' ' C ' ' A' ' 942' ' ' LEU . 11.6 m-85 -132.68 141.84 48.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.857 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 942' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 941' ' ' PHE . 19.6 tp -34.41 -64.59 0.24 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.89 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -117.82 150.96 38.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.874 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -53.43 -45.95 65.4 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.458 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 14.6 t -50.77 -41.05 56.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.845 0.355 . . . . 0.0 110.832 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 9.2 m -58.77 -26.29 63.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.836 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 947' ' ' ALA . . . . . 0.562 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -81.58 -13.11 58.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.127 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 33.6 mt -88.06 -28.08 21.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.953 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 33.0 m-20 -82.88 -45.37 14.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 8.7 p -53.47 -22.79 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.174 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 951' ' ' LEU . . . . . 0.481 HD21 ' HG ' ' A' ' 967' ' ' LEU . 63.1 mt -50.95 -25.54 4.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.886 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 15.3 m -54.4 -16.65 2.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.849 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 23.4 mt -89.61 16.02 8.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.912 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -68.44 119.96 13.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.937 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 955' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 956' ' ' LYS . . . 88.11 -30.79 4.98 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.524 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 956' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 955' ' ' GLY . 8.6 tmtm? -35.38 127.87 0.58 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.693 0.282 . . . . 0.0 110.911 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -96.41 131.8 42.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.835 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 13.5 tp -138.1 154.56 49.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 959' ' ' LEU . . . . . 0.777 HD11 ' HG3' ' A' ' 916' ' ' GLU . 87.6 mt 39.53 45.39 1.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.938 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 55.96 46.36 22.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 961' ' ' ARG . . . . . . . . . . . . . 46.3 mtt85 -154.64 121.86 5.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.884 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 8.3 m -74.08 108.39 6.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.124 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 963' ' ' ILE . . . . . 1.022 HD13 HD21 ' A' ' 917' ' ' LEU . 90.1 mt -88.95 130.94 37.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.177 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 9.2 m -116.45 119.38 35.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.1 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 965' ' ' ILE . . . . . 0.419 HG12 HG22 ' A' ' 897' ' ' VAL . 59.3 mt -103.36 140.31 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.124 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -149.47 136.06 19.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.082 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 967' ' ' LEU . . . . . 0.481 ' HG ' HD21 ' A' ' 951' ' ' LEU . 27.0 mt -70.57 154.62 41.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.921 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 16.2 tptm . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.871 179.856 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 97.3 m . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.792 0.33 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 895' ' ' VAL . . . . . 0.658 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 20.3 m -112.72 140.06 34.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.091 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 896' ' ' LEU . . . . . 0.47 ' HG ' ' CD1' ' A' ' 938' ' ' TRP . 3.9 mp -91.46 142.68 27.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.566 HG22 HG12 ' A' ' 965' ' ' ILE . 93.7 t -140.46 124.92 18.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.135 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 18.0 t -127.54 154.88 44.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.456 HD13 HD13 ' A' ' 913' ' ' LEU . 5.2 pt . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.107 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 909' ' ' PHE . . . . . 0.673 ' HA ' HD12 ' A' ' 913' ' ' LEU . 91.5 m-85 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.861 0.363 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -93.1 -178.59 4.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -55.72 -42.53 75.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.854 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -65.5 -57.89 7.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.102 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 913' ' ' LEU . . . . . 0.673 HD12 ' HA ' ' A' ' 909' ' ' PHE . 19.4 mt -49.96 -45.84 51.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.938 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 44.2 mt -71.47 -64.76 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.102 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -38.03 -59.58 0.83 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 916' ' ' GLU . . . . . 0.509 ' HB3' HD21 ' A' ' 958' ' ' LEU . 33.8 mm-40 -52.25 -52.33 53.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.863 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 917' ' ' LEU . . . . . 1.032 HD21 HD13 ' A' ' 963' ' ' ILE . 31.6 mt -49.58 -55.93 11.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.918 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 918' ' ' LEU . . . . . 0.439 ' C ' ' O ' ' A' ' 917' ' ' LEU . 77.8 mt -35.06 -57.86 0.55 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -58.15 -40.79 82.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.92 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 920' ' ' GLN . . . . . 0.433 ' N ' ' O ' ' A' ' 917' ' ' LEU . 35.6 mm-40 -61.56 -38.08 86.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 921' ' ' PHE . . . . . 0.566 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 20.1 m-85 -70.88 -36.06 72.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -58.86 -34.65 71.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.133 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.7 m -47.18 -26.54 1.18 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 924' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 0.7 OUTLIER -121.01 -65.37 1.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.894 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -122.22 150.76 16.95 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.507 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -85.71 140.16 30.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.881 0.372 . . . . 0.0 110.879 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 62.1 t -94.74 142.63 13.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.076 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 928' ' ' ILE . . . . . 0.487 HG13 ' N ' ' A' ' 929' ' ' LEU . 41.4 pt -121.64 -39.92 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.13 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 929' ' ' LEU . . . . . 0.487 ' N ' HG13 ' A' ' 928' ' ' ILE . 17.7 tp -139.97 139.21 36.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.926 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 74.0 mt -127.52 129.47 70.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.123 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 5.0 tpm_? -116.23 125.25 51.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.888 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -94.84 114.9 26.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 933' ' ' VAL . . . . . 0.605 HG21 ' NE1' ' A' ' 938' ' ' TRP . 2.6 t -83.41 157.11 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.167 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 934' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 933' ' ' VAL . 53.2 mt-10 -34.04 -50.85 0.4 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.909 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -125.31 -25.93 3.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.855 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 936' ' ' LYS . . . . . 0.447 ' O ' ' N ' ' A' ' 933' ' ' VAL . 1.0 OUTLIER -97.3 169.83 9.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 937' ' ' MET . . . . . 0.518 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 16.4 ttt -132.03 111.52 11.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.844 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 938' ' ' TRP . . . . . 0.605 ' NE1' HG21 ' A' ' 933' ' ' VAL . 39.2 m0 -91.96 144.13 25.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.932 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 939' ' ' VAL . . . . . 0.436 HG12 ' CE1' ' A' ' 941' ' ' PHE . 47.0 t -131.46 135.82 58.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 23.1 m -108.88 148.17 31.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.133 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 941' ' ' PHE . . . . . 0.436 ' CE1' HG12 ' A' ' 939' ' ' VAL . 6.9 m-85 -128.32 152.14 48.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.826 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 45.1 tp -41.92 -62.73 0.85 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.944 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -105.63 172.3 6.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -77.49 -44.83 12.04 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.517 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 45.6 t -56.67 -30.5 63.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.872 0.368 . . . . 0.0 110.858 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 72.7 m -58.94 -33.94 71.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.819 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 947' ' ' ALA . . . . . 0.658 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -74.19 -20.19 60.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.057 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 30.0 mt -83.48 -26.06 30.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.871 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -80.14 -41.24 25.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.87 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 8.2 p -61.75 -21.98 27.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.159 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 50.7 mt -50.38 -25.41 3.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 952' ' ' SER . . . . . 0.423 ' HB2' ' CE2' ' A' ' 924' ' ' PHE . 67.9 m -56.1 -13.72 2.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.832 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 24.4 mt -93.3 17.24 11.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.908 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -70.77 119.24 14.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 88.09 -25.26 9.12 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.489 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -41.63 127.43 3.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.759 0.314 . . . . 0.0 110.896 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -95.65 124.28 39.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.86 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 958' ' ' LEU . . . . . 0.509 HD21 ' HB3' ' A' ' 916' ' ' GLU . 14.9 tp -131.93 151.64 51.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.931 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 44.0 mt 41.14 49.63 3.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.916 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 50.47 37.27 15.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 961' ' ' ARG . . . . . 0.441 ' HD2' ' CD2' ' A' ' 913' ' ' LEU . 56.9 mtt85 -143.63 106.06 4.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.851 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 60.5 m -65.31 112.78 3.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.14 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 963' ' ' ILE . . . . . 1.032 HD13 HD21 ' A' ' 917' ' ' LEU . 71.2 mt -93.17 149.26 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.128 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 1.7 m -131.94 109.02 9.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.136 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 965' ' ' ILE . . . . . 0.566 HG12 HG22 ' A' ' 897' ' ' VAL . 70.3 mt -92.5 139.24 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.102 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -150.6 135.17 17.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.103 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 967' ' ' LEU . . . . . . . . . . . . . 26.6 mt -67.94 154.39 41.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.895 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 16.7 tptp . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.925 179.806 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 89.4 m . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.887 0.375 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 895' ' ' VAL . . . . . 0.695 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 10.8 m -113.63 138.61 42.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.088 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 896' ' ' LEU . . . . . 0.463 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 4.2 mp -90.47 143.57 26.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.968 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.423 HG13 ' CG2' ' A' ' 963' ' ' ILE . 95.6 t -141.78 130.36 22.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.107 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 10.8 t -129.53 152.37 49.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.551 HG23 ' CE2' ' A' ' 909' ' ' PHE . 2.8 pt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.111 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 909' ' ' PHE . . . . . 0.585 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 97.1 m-85 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.855 0.36 . . . . 0.0 110.878 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 910' ' ' ASP . . . . . 0.711 ' H ' HD12 ' A' ' 913' ' ' LEU . 6.3 t70 -84.71 179.02 7.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.87 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -58.61 -45.26 89.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -60.15 -60.85 3.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.068 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 913' ' ' LEU . . . . . 0.862 HD11 ' NH1' ' A' ' 961' ' ' ARG . 35.4 mt -45.31 -49.49 12.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.961 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 52.0 mt -63.6 -53.19 48.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.157 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -46.4 -56.63 5.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.846 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 916' ' ' GLU . . . . . 0.64 ' OE2' HD21 ' A' ' 959' ' ' LEU . 13.6 mt-10 -56.65 -51.49 68.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 917' ' ' LEU . . . . . 0.902 HD21 HD13 ' A' ' 963' ' ' ILE . 51.0 mt -46.13 -57.85 4.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 918' ' ' LEU . . . . . . . . . . . . . 99.3 mt -36.95 -62.99 0.45 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.953 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -54.02 -44.22 70.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.919 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -57.67 -38.91 75.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 921' ' ' PHE . . . . . 0.543 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 23.3 m-85 -72.68 -36.88 68.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.903 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -56.73 -32.69 65.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.102 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -52.04 -17.89 1.21 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.854 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 924' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 1.8 m-85 -126.06 -58.17 1.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.88 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -134.68 151.12 20.28 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.505 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -83.1 134.95 34.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.887 0.375 . . . . 0.0 110.872 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 41.2 t -89.01 143.47 11.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.177 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 928' ' ' ILE . . . . . 0.487 HG13 ' N ' ' A' ' 929' ' ' LEU . 20.4 pt -121.82 -45.83 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 929' ' ' LEU . . . . . 0.487 ' N ' HG13 ' A' ' 928' ' ' ILE . 25.5 tp -131.66 146.16 52.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 93.5 mt -136.71 122.86 28.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.113 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -111.26 123.35 50.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -87.64 118.58 27.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 933' ' ' VAL . . . . . 0.737 HG21 ' NE1' ' A' ' 938' ' ' TRP . 3.5 t -86.17 157.14 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.119 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 934' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 933' ' ' VAL . 32.3 mt-10 -33.82 -53.82 0.45 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -124.18 -20.73 5.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.89 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 19.3 tttt -101.31 173.04 6.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.897 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 937' ' ' MET . . . . . 0.585 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 12.7 ttt -133.58 114.03 13.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.897 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 938' ' ' TRP . . . . . 0.737 ' NE1' HG21 ' A' ' 933' ' ' VAL . 43.3 m0 -91.25 146.2 24.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 939' ' ' VAL . . . . . 0.479 HG12 ' CE1' ' A' ' 941' ' ' PHE . 61.0 t -136.15 122.27 30.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.117 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 6.8 m -91.07 150.49 21.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.151 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 941' ' ' PHE . . . . . 0.479 ' CE1' HG12 ' A' ' 939' ' ' VAL . 9.1 m-85 -130.28 144.26 51.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.912 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 942' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 941' ' ' PHE . 61.1 tp -34.55 -59.76 0.45 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -117.9 169.65 9.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.892 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -71.68 -49.13 25.36 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.514 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 74.1 p -50.56 -28.61 8.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.859 0.362 . . . . 0.0 110.857 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 6.0 m -67.05 -32.32 73.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.881 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 947' ' ' ALA . . . . . 0.695 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -82.36 -13.82 56.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.086 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 42.8 mt -87.36 -29.53 21.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.924 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -82.49 -37.66 24.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.903 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 9.2 p -61.94 -15.61 14.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.098 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 951' ' ' LEU . . . . . 0.644 HD11 HD11 ' A' ' 967' ' ' LEU . 40.0 mt -53.93 -26.32 24.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.94 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 33.3 t -53.46 -15.78 1.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.861 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 36.9 mt -89.89 14.15 12.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.929 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -68.76 116.97 9.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.864 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 90.58 -25.82 12.22 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.473 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 956' ' ' LYS . . . . . 0.58 ' HZ3' HD13 ' A' ' 958' ' ' LEU . 3.5 tmtt? -39.71 127.76 2.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.744 0.307 . . . . 0.0 110.883 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -94.48 131.37 40.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.901 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 958' ' ' LEU . . . . . 0.58 HD13 ' HZ3' ' A' ' 956' ' ' LYS . 15.8 tp -141.35 153.18 44.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.881 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 959' ' ' LEU . . . . . 0.64 HD21 ' OE2' ' A' ' 916' ' ' GLU . 38.2 mt 41.42 48.2 3.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.952 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 960' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 960' ' ' ASN . 1.4 p-10 48.18 42.41 17.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 961' ' ' ARG . . . . . 0.862 ' NH1' HD11 ' A' ' 913' ' ' LEU . 73.9 mtt180 -149.72 108.49 3.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 6.8 m -60.26 119.11 7.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.156 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 963' ' ' ILE . . . . . 0.902 HD13 HD21 ' A' ' 917' ' ' LEU . 91.4 mt -102.6 134.0 44.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.148 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 3.8 m -119.76 119.17 32.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.108 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 965' ' ' ILE . . . . . . . . . . . . . 51.2 mt -101.26 142.12 16.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.128 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -151.21 131.5 13.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.082 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 967' ' ' LEU . . . . . 0.644 HD11 HD11 ' A' ' 951' ' ' LEU . 30.9 mt -69.85 158.34 35.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 18.5 tptt . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.935 179.85 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 75.8 m . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.839 0.352 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 895' ' ' VAL . . . . . 0.566 HG12 HD23 ' A' ' 967' ' ' LEU . 18.8 m -112.29 142.92 23.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.125 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 896' ' ' LEU . . . . . 0.468 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 4.2 mp -91.08 146.84 23.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.651 HG22 HG12 ' A' ' 965' ' ' ILE . 92.9 t -146.9 125.56 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.118 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 6.4 t -125.71 155.59 40.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.549 HG23 ' CE2' ' A' ' 909' ' ' PHE . 2.2 pt . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.093 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 909' ' ' PHE . . . . . 0.549 ' CE2' HG23 ' A' ' 899' ' ' ILE . 76.2 m-85 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.849 0.356 . . . . 0.0 110.883 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 910' ' ' ASP . . . . . 0.585 ' H ' HD12 ' A' ' 913' ' ' LEU . 35.0 m-20 -92.99 159.03 15.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.879 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -45.08 -49.71 11.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -53.92 -51.92 62.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.087 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 913' ' ' LEU . . . . . 0.649 HD11 ' CD ' ' A' ' 961' ' ' ARG . 41.3 mt -53.36 -53.45 50.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.909 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 54.2 mt -60.14 -62.9 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.125 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -42.38 -51.03 5.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -61.49 -44.11 97.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.864 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 917' ' ' LEU . . . . . 0.842 HD21 HD13 ' A' ' 963' ' ' ILE . 26.1 mt -56.84 -57.9 10.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 918' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 917' ' ' LEU . 66.5 mt -34.82 -48.83 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -64.94 -47.56 77.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 60.2 mm-40 -55.75 -37.43 68.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 921' ' ' PHE . . . . . 0.571 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 22.4 m-85 -67.32 -50.8 58.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -46.27 -24.23 0.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.07 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 923' ' ' SER . . . . . 0.449 ' HB3' ' CE1' ' A' ' 924' ' ' PHE . 31.2 t -48.76 -32.06 7.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 924' ' ' PHE . . . . . 0.57 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 0.3 OUTLIER -123.18 -52.94 1.84 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -131.84 147.92 18.85 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.524 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -84.87 135.43 34.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.854 0.359 . . . . 0.0 110.926 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 11.9 t -81.86 145.37 8.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.143 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 928' ' ' ILE . . . . . 0.62 HD13 ' HA ' ' A' ' 942' ' ' LEU . 42.8 pt -122.17 -36.39 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.161 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 929' ' ' LEU . . . . . 0.478 ' N ' HG13 ' A' ' 928' ' ' ILE . 10.2 tp -144.09 146.48 32.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.889 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 50.0 mt -135.9 128.8 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.135 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 16.0 ttt-85 -118.75 123.93 46.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.907 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -91.22 122.06 33.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 933' ' ' VAL . . . . . 0.574 HG21 ' NE1' ' A' ' 938' ' ' TRP . 2.8 t -90.22 157.09 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.114 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 934' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 933' ' ' VAL . 81.2 mm-40 -33.71 -51.77 0.39 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.886 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -124.96 -26.18 3.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 7.9 ttmm -96.45 170.87 8.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 937' ' ' MET . . . . . 0.466 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 16.2 ttt -134.46 112.17 10.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.863 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 938' ' ' TRP . . . . . 0.574 ' NE1' HG21 ' A' ' 933' ' ' VAL . 36.0 m0 -93.35 142.13 27.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 53.9 t -130.48 127.43 62.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.171 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 8.9 m -98.57 152.63 19.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 941' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -127.92 145.89 50.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 942' ' ' LEU . . . . . 0.62 ' HA ' HD13 ' A' ' 928' ' ' ILE . 22.7 tp -41.22 -40.84 1.69 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.949 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -130.39 176.69 7.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.919 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -86.32 -53.76 2.87 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.526 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 59.0 p -46.69 -22.34 0.28 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.882 0.372 . . . . 0.0 110.884 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 2.1 p -75.22 -37.12 61.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.841 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 947' ' ' ALA . . . . . 0.499 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -70.7 -16.35 62.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 29.1 mt -84.05 -28.87 27.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.943 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -80.95 -46.48 15.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.859 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 7.6 p -53.83 -17.38 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.127 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 60.8 mt -53.15 -23.27 7.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.872 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 1.8 t -59.05 -11.15 3.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.838 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 51.1 mt -94.03 16.26 14.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 954' ' ' ASN . . . . . 0.402 ' O ' ' CG ' ' A' ' 954' ' ' ASN . 1.9 p30 -70.64 119.37 14.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 955' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 956' ' ' LYS . . . 86.15 -28.48 5.11 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.531 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 956' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 955' ' ' GLY . 0.1 OUTLIER -36.13 127.23 0.75 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.756 0.313 . . . . 0.0 110.873 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -92.94 128.02 38.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 14.2 tp -138.41 148.41 44.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.95 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 49.4 mt 43.13 52.53 5.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.944 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 44.83 44.7 7.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.904 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 961' ' ' ARG . . . . . 0.649 ' CD ' HD11 ' A' ' 913' ' ' LEU . 41.6 mtt85 -151.33 106.07 3.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.844 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 6.3 m -61.44 119.02 7.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.088 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 963' ' ' ILE . . . . . 0.842 HD13 HD21 ' A' ' 917' ' ' LEU . 92.7 mt -102.47 139.88 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.147 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 6.1 m -124.73 112.25 16.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.119 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 965' ' ' ILE . . . . . 0.651 HG12 HG22 ' A' ' 897' ' ' VAL . 61.4 mt -98.42 139.04 21.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.077 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -153.84 137.88 16.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.129 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 967' ' ' LEU . . . . . 0.566 HD23 HG12 ' A' ' 895' ' ' VAL . 26.2 mt -68.63 156.37 38.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.922 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 11.6 tptm . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 179.837 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 87.5 m . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.786 0.327 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 895' ' ' VAL . . . . . 0.442 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 6.3 m -120.09 137.0 55.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.115 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 896' ' ' LEU . . . . . 0.471 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 4.7 mp -89.2 142.94 27.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.906 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.408 HG13 ' CG2' ' A' ' 963' ' ' ILE . 99.4 t -140.22 127.69 23.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.166 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 13.5 t -130.18 156.68 44.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.83 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.489 HG22 HG12 ' A' ' 963' ' ' ILE . 4.1 pt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.122 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 909' ' ' PHE . . . . . 0.581 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 49.8 m-85 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.826 0.346 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -98.75 178.79 4.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.89 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -58.56 -26.04 63.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.863 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -78.52 -57.39 3.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.11 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 913' ' ' LEU . . . . . 0.608 HD21 ' CD ' ' A' ' 961' ' ' ARG . 82.0 mt -52.87 -39.95 63.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.97 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 914' ' ' ILE . . . . . 0.435 HD13 ' CZ ' ' A' ' 932' ' ' PHE . 28.9 mt -72.57 -64.09 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.164 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -43.21 -54.07 4.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.84 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -55.43 -51.03 68.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 917' ' ' LEU . . . . . 0.93 HD21 HD13 ' A' ' 963' ' ' ILE . 20.6 mt -48.94 -54.14 16.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.905 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 918' ' ' LEU . . . . . 0.426 ' C ' ' O ' ' A' ' 917' ' ' LEU . 41.9 mt -34.75 -65.79 0.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.905 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -51.11 -52.26 45.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 920' ' ' GLN . . . . . 0.4 ' O ' HD11 ' A' ' 953' ' ' LEU . 89.3 mm-40 -48.85 -40.2 28.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.873 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 921' ' ' PHE . . . . . 0.549 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 23.1 m-85 -71.21 -42.79 68.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 922' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 924' ' ' PHE . . . -49.62 -39.48 35.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.095 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.7 m -43.02 -24.25 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.837 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 924' ' ' PHE . . . . . 0.554 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 0.6 OUTLIER -123.67 -63.02 1.26 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -123.13 147.24 16.67 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.469 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -84.39 128.01 34.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.931 0.396 . . . . 0.0 110.88 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 34.4 t -81.71 144.24 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.144 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 928' ' ' ILE . . . . . 0.486 HG13 ' N ' ' A' ' 929' ' ' LEU . 23.9 pt -123.18 -44.72 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.1 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 929' ' ' LEU . . . . . 0.486 ' N ' HG13 ' A' ' 928' ' ' ILE . 21.0 tp -134.48 144.05 47.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.964 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 930' ' ' ILE . . . . . 0.462 ' H ' HD12 ' A' ' 929' ' ' LEU . 43.5 mt -135.71 134.55 51.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.118 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.26 124.52 32.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 932' ' ' PHE . . . . . 0.435 ' CZ ' HD13 ' A' ' 914' ' ' ILE . 30.4 m-85 -86.95 118.66 26.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 933' ' ' VAL . . . . . 0.71 HG21 ' CD1' ' A' ' 938' ' ' TRP . 2.6 t -82.95 157.37 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 934' ' ' GLU . . . . . 0.472 ' C ' ' O ' ' A' ' 933' ' ' VAL . 29.4 mm-40 -32.24 -53.41 0.3 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.905 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -125.31 -25.89 3.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -97.23 173.14 7.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.9 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 937' ' ' MET . . . . . 0.581 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 15.3 ttt -135.71 110.29 8.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.907 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 938' ' ' TRP . . . . . 0.71 ' CD1' HG21 ' A' ' 933' ' ' VAL . 20.3 m0 -95.95 138.58 33.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.874 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 939' ' ' VAL . . . . . 0.426 HG12 ' CE1' ' A' ' 941' ' ' PHE . 94.4 t -122.35 134.97 63.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.117 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 52.3 m -98.62 148.96 23.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.145 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 941' ' ' PHE . . . . . 0.426 ' CE1' HG12 ' A' ' 939' ' ' VAL . 9.3 m-85 -130.69 152.06 50.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.862 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 942' ' ' LEU . . . . . 0.421 ' HA ' HD13 ' A' ' 928' ' ' ILE . 55.5 tp -48.79 -53.53 18.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.891 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -115.91 177.81 4.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -87.34 -46.92 4.82 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.494 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 91.8 p -50.89 -39.47 54.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.924 0.392 . . . . 0.0 110.857 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.11 -27.63 67.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.858 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 947' ' ' ALA . . . . . 0.442 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -80.22 -15.38 57.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.135 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 21.6 mt -87.34 -29.35 21.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.907 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -79.9 -41.35 26.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.903 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 4.3 p -56.06 -16.92 3.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.166 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 951' ' ' LEU . . . . . 0.651 HD21 ' HG ' ' A' ' 967' ' ' LEU . 31.1 mt -52.65 -29.74 27.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 3.1 m -53.03 -25.56 12.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.861 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 953' ' ' LEU . . . . . 0.555 ' C ' HD12 ' A' ' 965' ' ' ILE . 32.1 mt -78.95 9.04 4.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.948 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 954' ' ' ASN . . . . . 0.414 ' N ' HD12 ' A' ' 965' ' ' ILE . 0.4 OUTLIER -70.43 118.49 13.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.841 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 92.33 -26.38 13.85 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.442 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 956' ' ' LYS . . . . . 0.677 ' NZ ' HD13 ' A' ' 958' ' ' LEU . 3.7 tmtt? -42.08 128.35 3.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.751 0.31 . . . . 0.0 110.893 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -93.87 127.17 39.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 958' ' ' LEU . . . . . 0.677 HD13 ' NZ ' ' A' ' 956' ' ' LYS . 13.6 tp -140.45 157.07 46.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.955 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 37.4 mt 39.1 44.84 0.98 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.954 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 6.8 m120 49.79 44.36 24.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.906 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 961' ' ' ARG . . . . . 0.608 ' CD ' HD21 ' A' ' 913' ' ' LEU . 52.0 mtt180 -152.07 108.06 3.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 2.9 m -61.81 118.67 7.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.102 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 963' ' ' ILE . . . . . 0.93 HD13 HD21 ' A' ' 917' ' ' LEU . 86.3 mt -103.24 137.94 29.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.12 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 9.7 m -123.87 117.43 24.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.183 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 965' ' ' ILE . . . . . 0.555 HD12 ' C ' ' A' ' 953' ' ' LEU . 19.1 mt -97.77 146.93 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.186 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -155.18 128.86 8.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.098 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 967' ' ' LEU . . . . . 0.651 ' HG ' HD21 ' A' ' 951' ' ' LEU . 33.5 mt -66.05 157.98 29.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.88 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 15.8 tptp . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.899 179.85 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 87.2 m . . . . . 0 N--CA 1.457 -0.11 0 CA-C-O 120.762 0.315 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 895' ' ' VAL . . . . . 0.676 HG12 HD23 ' A' ' 967' ' ' LEU . 17.6 m -118.18 138.81 47.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.165 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 896' ' ' LEU . . . . . 0.47 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 6.3 mp -90.34 138.63 31.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.936 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.521 HG22 HG12 ' A' ' 965' ' ' ILE . 86.6 t -139.54 124.3 20.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.1 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 12.3 t -127.96 155.68 43.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.848 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.545 HG22 HG12 ' A' ' 963' ' ' ILE . 2.7 pt . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.144 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 909' ' ' PHE . . . . . 0.588 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 48.3 m-85 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.885 0.374 . . . . 0.0 110.86 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 910' ' ' ASP . . . . . 0.428 ' H ' HD12 ' A' ' 913' ' ' LEU . 0.3 OUTLIER -99.99 177.56 5.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.898 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.66 -45.31 77.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -59.65 -54.99 40.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.093 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 913' ' ' LEU . . . . . 0.428 HD12 ' H ' ' A' ' 910' ' ' ASP . 22.2 mt -53.47 -54.81 31.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.931 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 46.3 mt -58.86 -57.85 9.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.164 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -50.26 -63.98 0.95 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 916' ' ' GLU . . . . . 0.43 ' HB3' HD21 ' A' ' 958' ' ' LEU . 50.3 mm-40 -45.71 -50.16 13.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.847 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 917' ' ' LEU . . . . . 0.886 HD21 HD13 ' A' ' 963' ' ' ILE . 28.2 mt -50.3 -53.24 30.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.937 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 918' ' ' LEU . . . . . 0.524 HD21 ' CD1' ' A' ' 930' ' ' ILE . 88.4 mt -38.59 -62.44 0.6 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.955 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -53.16 -53.68 46.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.925 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 -47.65 -45.34 27.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.857 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 921' ' ' PHE . . . . . 0.578 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 23.7 m-85 -60.26 -49.04 79.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.839 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -45.29 -33.5 2.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.073 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 923' ' ' SER . . . . . 0.521 ' HB3' ' CD1' ' A' ' 924' ' ' PHE . 8.6 t -41.18 -29.84 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 924' ' ' PHE . . . . . 0.521 ' CD1' ' HB3' ' A' ' 923' ' ' SER . 1.6 m-85 -120.02 -58.92 1.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.893 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -130.76 154.65 20.82 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.536 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -87.05 139.45 30.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 0.0 110.938 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 44.1 t -87.25 146.15 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 928' ' ' ILE . . . . . 0.491 HG13 ' N ' ' A' ' 929' ' ' LEU . 46.1 pt -122.7 -38.46 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.124 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 929' ' ' LEU . . . . . 0.491 ' N ' HG13 ' A' ' 928' ' ' ILE . 11.4 tp -142.41 146.24 34.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 930' ' ' ILE . . . . . 0.524 ' CD1' HD21 ' A' ' 918' ' ' LEU . 79.1 mt -132.09 131.51 61.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.153 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 15.8 ttp180 -121.3 124.3 44.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.879 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -91.38 121.8 33.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 933' ' ' VAL . . . . . 0.634 HG21 ' CD1' ' A' ' 938' ' ' TRP . 4.7 t -89.38 157.27 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.123 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 934' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 933' ' ' VAL . 15.2 mm-40 -33.28 -54.5 0.41 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.942 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.03 -21.61 5.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.859 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -98.98 171.68 7.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.869 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 937' ' ' MET . . . . . 0.588 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 17.2 ttt -131.81 108.66 9.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 938' ' ' TRP . . . . . 0.634 ' CD1' HG21 ' A' ' 933' ' ' VAL . 41.5 m0 -90.82 144.77 25.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.905 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 87.0 t -133.56 131.24 57.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.143 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 17.8 m -97.19 150.45 20.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.129 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 941' ' ' PHE . . . . . 0.425 ' O ' ' C ' ' A' ' 942' ' ' LEU . 9.9 m-85 -129.83 144.99 51.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.893 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 942' ' ' LEU . . . . . 0.425 ' C ' ' O ' ' A' ' 941' ' ' PHE . 30.3 tp -35.94 -56.88 0.7 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.924 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -122.09 164.91 16.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.871 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -66.95 -44.9 87.66 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.478 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 95.2 p -52.22 -37.45 55.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.868 0.366 . . . . 0.0 110.889 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 49.4 m -57.72 -37.51 73.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.857 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 947' ' ' ALA . . . . . 0.532 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -73.05 -25.24 60.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.058 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 28.8 mt -76.63 -23.83 53.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.923 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 37.3 m-20 -88.26 -50.25 6.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.85 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 9.6 p -49.66 -18.65 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.166 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 951' ' ' LEU . . . . . 0.689 HD11 ' CD1' ' A' ' 967' ' ' LEU . 24.4 mt -52.38 -28.51 19.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.907 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 952' ' ' SER . . . . . 0.518 ' HB2' ' CZ ' ' A' ' 924' ' ' PHE . 20.6 m -50.95 -17.54 0.6 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 37.7 mt -88.45 17.48 5.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.946 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -71.43 120.79 17.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 86.51 -24.48 8.45 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.495 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -40.49 128.92 2.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.732 0.301 . . . . 0.0 110.938 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -94.59 134.01 37.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.905 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 958' ' ' LEU . . . . . 0.43 HD21 ' HB3' ' A' ' 916' ' ' GLU . 14.6 tp -144.52 146.77 32.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 56.0 mt 44.82 52.06 8.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.958 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 45.13 44.02 8.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.89 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 961' ' ' ARG . . . . . . . . . . . . . 71.0 mtt-85 -150.54 110.49 4.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.917 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 6.4 m -64.41 120.13 11.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.13 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 963' ' ' ILE . . . . . 0.886 HD13 HD21 ' A' ' 917' ' ' LEU . 82.7 mt -103.93 139.53 24.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.156 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 6.7 m -123.8 116.87 23.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.122 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 965' ' ' ILE . . . . . 0.521 HG12 HG22 ' A' ' 897' ' ' VAL . 61.0 mt -102.07 140.57 20.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.142 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -152.68 128.8 10.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.117 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 967' ' ' LEU . . . . . 0.689 ' CD1' HD11 ' A' ' 951' ' ' LEU . 30.7 mt -67.98 158.37 32.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 179.82 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 99.5 m . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.797 0.332 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 895' ' ' VAL . . . . . 0.777 HG12 HD23 ' A' ' 967' ' ' LEU . 16.9 m -115.06 139.51 40.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.156 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 896' ' ' LEU . . . . . 0.465 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 4.7 mp -88.98 143.22 27.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.468 HG22 HG12 ' A' ' 965' ' ' ILE . 89.1 t -141.08 127.01 19.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.113 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 11.4 t -129.08 155.78 44.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.864 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.614 HG23 ' CE2' ' A' ' 909' ' ' PHE . 3.8 pt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.175 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 909' ' ' PHE . . . . . 0.614 ' CE2' HG23 ' A' ' 899' ' ' ILE . 89.1 m-85 . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.835 0.35 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 910' ' ' ASP . . . . . 0.492 ' H ' HD12 ' A' ' 913' ' ' LEU . 25.5 t70 -90.07 169.83 10.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.884 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.09 -42.45 65.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -63.22 -50.29 70.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.113 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 913' ' ' LEU . . . . . 0.515 HD11 ' CD ' ' A' ' 961' ' ' ARG . 20.8 mt -56.89 -50.54 72.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.951 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 914' ' ' ILE . . . . . 0.431 HD13 ' CZ ' ' A' ' 932' ' ' PHE . 66.1 mt -63.51 -59.47 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -50.42 -52.03 41.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 916' ' ' GLU . . . . . 0.775 ' HG3' HD11 ' A' ' 959' ' ' LEU . 31.7 mm-40 -57.04 -43.59 82.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 917' ' ' LEU . . . . . 0.761 HD21 HD13 ' A' ' 963' ' ' ILE . 19.9 mt -54.54 -55.65 27.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.887 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 918' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 917' ' ' LEU . 24.8 mt -34.52 -62.48 0.34 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.951 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -52.68 -52.08 57.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -49.93 -39.07 39.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.908 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 921' ' ' PHE . . . . . 0.536 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 23.8 m-85 -73.36 -41.51 63.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.882 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -52.84 -27.26 17.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.107 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 923' ' ' SER . . . . . 0.549 ' HB3' ' CE1' ' A' ' 924' ' ' PHE . 19.6 t -48.7 -30.27 5.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 924' ' ' PHE . . . . . 0.549 ' CE1' ' HB3' ' A' ' 923' ' ' SER . 0.8 OUTLIER -121.27 -50.58 2.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.913 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -134.54 147.19 19.03 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.475 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -85.46 132.05 34.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.865 0.364 . . . . 0.0 110.889 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 16.8 t -83.2 146.93 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.131 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 928' ' ' ILE . . . . . 0.462 HG13 ' N ' ' A' ' 929' ' ' LEU . 41.8 pt -124.56 -33.36 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.143 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 929' ' ' LEU . . . . . 0.462 ' N ' HG13 ' A' ' 928' ' ' ILE . 8.5 tp -146.59 145.25 30.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.86 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 48.0 mt -135.01 128.9 50.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.122 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 -110.59 123.09 49.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.862 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 932' ' ' PHE . . . . . 0.431 ' CZ ' HD13 ' A' ' 914' ' ' ILE . 71.0 m-85 -89.67 112.74 24.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.902 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 933' ' ' VAL . . . . . 0.711 HG21 ' NE1' ' A' ' 938' ' ' TRP . 2.6 t -83.15 149.05 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.153 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 934' ' ' GLU . . . . . 0.489 ' C ' ' O ' ' A' ' 933' ' ' VAL . 84.5 mt-10 -31.34 -50.03 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -124.65 -23.53 4.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.854 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.46 173.23 6.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 937' ' ' MET . . . . . 0.585 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 16.6 ttt -136.06 106.67 6.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 938' ' ' TRP . . . . . 0.711 ' NE1' HG21 ' A' ' 933' ' ' VAL . 34.3 m0 -88.1 142.24 27.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 939' ' ' VAL . . . . . 0.42 HG12 ' CE1' ' A' ' 941' ' ' PHE . 89.7 t -129.18 120.31 51.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.174 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 940' ' ' THR . . . . . 0.416 ' CG2' ' N ' ' A' ' 941' ' ' PHE . 8.5 m -91.19 153.17 20.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.107 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 941' ' ' PHE . . . . . 0.42 ' CE1' HG12 ' A' ' 939' ' ' VAL . 9.3 m-85 -129.57 154.28 47.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 43.6 tp -52.25 -50.68 61.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.933 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -116.29 171.7 7.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.902 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -84.94 -37.66 9.97 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.467 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 75.4 p -60.73 -29.08 69.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.912 0.387 . . . . 0.0 110.907 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 1.9 p -68.11 -35.06 77.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.818 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -72.55 -12.85 61.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.098 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 27.7 mt -89.48 -26.7 20.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -84.81 -40.88 16.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.9 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 9.1 p -57.24 -17.85 7.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.1 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 951' ' ' LEU . . . . . 0.752 HD21 ' HG ' ' A' ' 967' ' ' LEU . 43.1 mt -52.19 -27.14 13.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.903 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 19.9 m -53.2 -16.27 1.18 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.834 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 953' ' ' LEU . . . . . 0.478 ' HB2' ' CD1' ' A' ' 965' ' ' ILE . 56.8 mt -92.38 19.01 7.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -74.9 105.11 5.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 101.45 -25.24 28.83 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.47 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -43.07 128.88 4.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.763 0.316 . . . . 0.0 110.921 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -95.98 135.09 38.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.855 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 958' ' ' LEU . . . . . 0.41 ' O ' ' N ' ' A' ' 961' ' ' ARG . 14.3 tp -141.37 157.45 45.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.913 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 959' ' ' LEU . . . . . 0.775 HD11 ' HG3' ' A' ' 916' ' ' GLU . 96.2 mt 38.38 45.1 0.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.9 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 3.3 m120 52.88 44.09 30.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.848 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 961' ' ' ARG . . . . . 0.515 ' CD ' HD11 ' A' ' 913' ' ' LEU . 61.2 mtt85 -151.4 105.84 3.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 63.2 m -60.88 115.79 3.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.118 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 963' ' ' ILE . . . . . 0.761 HD13 HD21 ' A' ' 917' ' ' LEU . 75.2 mt -98.56 139.7 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.107 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 13.5 m -122.75 115.75 22.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.125 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 965' ' ' ILE . . . . . 0.478 ' CD1' ' HB2' ' A' ' 953' ' ' LEU . 61.5 mt -102.22 138.2 27.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.142 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -150.6 129.83 12.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.124 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 967' ' ' LEU . . . . . 0.777 HD23 HG12 ' A' ' 895' ' ' VAL . 32.3 mt -65.49 157.87 28.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.893 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 14.7 tptp . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.939 179.831 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 93.3 m . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.789 0.328 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 895' ' ' VAL . . . . . 0.531 HG12 HD23 ' A' ' 967' ' ' LEU . 26.7 m -122.76 140.03 47.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.149 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 896' ' ' LEU . . . . . 0.47 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 6.4 mp -88.8 142.67 27.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.908 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 97.9 t -142.66 124.07 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.135 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 7.8 t -127.57 156.32 42.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.829 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.586 HG22 HG12 ' A' ' 963' ' ' ILE . 2.5 pt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.116 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 909' ' ' PHE . . . . . 0.567 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 58.3 m-85 . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.881 0.372 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 910' ' ' ASP . . . . . 0.461 ' H ' HD12 ' A' ' 913' ' ' LEU . 12.4 t70 -89.74 -179.07 5.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.884 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -58.46 -41.92 86.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.878 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -64.38 -51.64 62.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.082 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 913' ' ' LEU . . . . . 0.876 HD21 ' HD2' ' A' ' 961' ' ' ARG . 72.2 mt -55.2 -53.31 57.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.917 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 44.9 mt -62.69 -61.92 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.133 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -44.55 -58.27 3.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -52.03 -45.68 64.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 917' ' ' LEU . . . . . 0.805 HD21 HD13 ' A' ' 963' ' ' ILE . 23.0 mt -56.58 -53.79 53.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.923 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 918' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 917' ' ' LEU . 80.4 mt -34.45 -54.1 0.52 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.949 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -58.71 -49.83 76.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.902 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 920' ' ' GLN . . . . . 0.735 ' OE1' HD22 ' A' ' 958' ' ' LEU . 19.7 mt-30 -51.89 -36.98 50.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 921' ' ' PHE . . . . . 0.432 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 21.9 m-85 -73.11 -39.89 65.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.845 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -55.9 -33.0 64.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.119 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 53.4 p -54.22 -17.79 3.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.874 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 924' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -121.54 -52.4 2.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.872 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -147.12 154.95 26.29 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.458 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -86.18 126.34 34.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.896 0.379 . . . . 0.0 110.896 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 927' ' ' VAL . . . . . 0.485 HG13 ' O ' ' A' ' 940' ' ' THR . 6.4 t -78.09 150.76 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.175 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 928' ' ' ILE . . . . . 0.469 HG13 ' N ' ' A' ' 929' ' ' LEU . 40.3 pt -120.67 -38.71 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.153 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 929' ' ' LEU . . . . . 0.469 ' N ' HG13 ' A' ' 928' ' ' ILE . 13.3 tp -142.73 151.8 41.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.95 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 930' ' ' ILE . . . . . 0.559 HG12 HG13 ' A' ' 939' ' ' VAL . 76.0 mt -134.87 125.87 46.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.126 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -115.46 125.02 52.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.861 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -94.09 123.55 37.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.862 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 933' ' ' VAL . . . . . 0.728 HG21 ' NE1' ' A' ' 938' ' ' TRP . 5.1 t -91.21 157.31 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.111 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 934' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 933' ' ' VAL . 10.2 mm-40 -33.54 -52.61 0.4 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.911 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -124.72 -24.81 4.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -96.58 171.68 8.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.891 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 937' ' ' MET . . . . . 0.578 ' SD ' HG23 ' A' ' 939' ' ' VAL . 0.3 OUTLIER -132.7 115.08 14.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.892 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 938' ' ' TRP . . . . . 0.728 ' NE1' HG21 ' A' ' 933' ' ' VAL . 31.0 m0 -100.34 146.37 27.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.942 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 939' ' ' VAL . . . . . 0.578 HG23 ' SD ' ' A' ' 937' ' ' MET . 60.4 t -137.07 129.12 43.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.121 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 940' ' ' THR . . . . . 0.485 ' O ' HG13 ' A' ' 927' ' ' VAL . 18.8 m -93.12 153.24 18.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.13 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 941' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -128.05 150.74 49.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 25.0 tp -51.75 -46.37 64.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -118.4 171.06 8.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.855 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -84.44 -42.27 7.48 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.481 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 39.3 p -56.85 -40.57 76.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.881 0.372 . . . . 0.0 110.897 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 1.2 p -54.16 -35.99 62.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.848 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -72.42 -14.44 61.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.15 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 21.9 mt -86.66 -26.4 24.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.928 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -82.76 -50.83 8.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 6.0 p -49.84 -19.45 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.125 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 951' ' ' LEU . . . . . 0.892 HD11 HD11 ' A' ' 967' ' ' LEU . 39.5 mt -55.14 -24.79 28.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.917 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 44.8 t -58.28 -11.75 3.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.867 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 36.6 mt -92.09 13.18 19.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.914 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 954' ' ' ASN . . . . . 0.412 ' O ' ' CG ' ' A' ' 954' ' ' ASN . 3.7 p30 -66.03 117.96 9.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 89.47 -26.09 9.79 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.525 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -40.65 129.28 2.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.751 0.31 . . . . 0.0 110.907 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -97.87 135.22 39.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.854 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 958' ' ' LEU . . . . . 0.735 HD22 ' OE1' ' A' ' 920' ' ' GLN . 18.0 tp -139.16 160.44 39.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.951 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 959' ' ' LEU . . . . . 0.449 ' C ' ' O ' ' A' ' 958' ' ' LEU . 97.1 mt 34.29 37.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 960' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 958' ' ' LEU . 5.4 m120 60.91 48.4 6.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 961' ' ' ARG . . . . . 0.876 ' HD2' HD21 ' A' ' 913' ' ' LEU . 68.8 mtt85 -153.05 106.08 2.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.869 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 5.3 m -61.34 115.41 3.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.132 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 963' ' ' ILE . . . . . 0.805 HD13 HD21 ' A' ' 917' ' ' LEU . 57.8 mt -100.69 144.81 12.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.148 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 3.6 m -127.79 113.03 15.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.109 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 965' ' ' ILE . . . . . . . . . . . . . 61.9 mt -95.17 147.14 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.127 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -154.03 126.95 8.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.061 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 967' ' ' LEU . . . . . 0.892 HD11 HD11 ' A' ' 951' ' ' LEU . 32.9 mt -65.25 157.98 27.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 968' ' ' LYS . . . . . 0.424 ' HE2' ' CH2' ' A' ' 938' ' ' TRP . 16.0 tttp . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 97.7 m . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.789 0.328 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 895' ' ' VAL . . . . . 0.501 HG12 HD23 ' A' ' 967' ' ' LEU . 22.4 m -121.34 138.51 51.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.148 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 896' ' ' LEU . . . . . 0.465 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 5.5 mp -88.99 145.74 25.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.616 HG22 HG12 ' A' ' 965' ' ' ILE . 79.1 t -147.01 126.34 4.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 11.1 t -127.1 152.28 47.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.824 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.552 HG22 HG12 ' A' ' 963' ' ' ILE . 3.5 pt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.122 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 909' ' ' PHE . . . . . 0.583 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 69.0 m-85 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.865 0.364 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 910' ' ' ASP . . . . . 0.532 ' H ' HD12 ' A' ' 913' ' ' LEU . 76.9 m-20 -97.95 169.11 9.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.876 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -48.16 -49.06 33.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.888 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -57.17 -56.04 26.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.089 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 913' ' ' LEU . . . . . 0.532 HD12 ' H ' ' A' ' 910' ' ' ASP . 31.3 mt -49.23 -54.18 17.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 56.0 mt -60.68 -64.48 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.137 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -42.94 -56.78 3.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.83 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -52.57 -50.98 61.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.849 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 917' ' ' LEU . . . . . 0.77 HD21 HD13 ' A' ' 963' ' ' ILE . 25.9 mt -48.15 -57.45 5.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 918' ' ' LEU . . . . . 0.445 ' C ' ' O ' ' A' ' 917' ' ' LEU . 40.5 mt -34.37 -55.37 0.52 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.887 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -56.77 -45.54 82.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.9 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 920' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 917' ' ' LEU . 88.5 mm-40 -58.76 -36.54 74.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 921' ' ' PHE . . . . . 0.525 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 22.1 m-85 -72.64 -47.46 47.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.852 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -48.77 -34.65 12.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.078 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -46.38 -32.87 3.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 924' ' ' PHE . . . . . 0.553 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 0.5 OUTLIER -121.63 -58.5 1.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.915 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -121.02 148.47 17.49 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.525 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 926' ' ' GLU . . . . . 0.5 ' OE2' HG22 ' A' ' 928' ' ' ILE . 2.0 tm-20 -90.1 128.7 36.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.868 0.366 . . . . 0.0 110.874 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 41.1 t -84.14 139.95 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 928' ' ' ILE . . . . . 0.5 HG22 ' OE2' ' A' ' 926' ' ' GLU . 35.4 pt -122.43 -40.54 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.12 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 929' ' ' LEU . . . . . 0.477 ' N ' HG13 ' A' ' 928' ' ' ILE . 15.6 tp -136.83 136.05 38.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.907 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 81.7 mt -122.76 126.56 74.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.089 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 11.8 tpt85 -112.18 124.68 52.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.868 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -93.57 117.01 29.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 933' ' ' VAL . . . . . 0.664 HG21 ' NE1' ' A' ' 938' ' ' TRP . 2.9 t -85.78 156.99 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.104 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 934' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 933' ' ' VAL . 33.1 mt-10 -34.43 -51.33 0.46 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.857 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -125.49 -26.25 3.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -96.16 173.04 7.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.917 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 937' ' ' MET . . . . . 0.583 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 15.3 ttt -134.11 111.73 10.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.905 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 938' ' ' TRP . . . . . 0.664 ' NE1' HG21 ' A' ' 933' ' ' VAL . 38.8 m0 -92.11 148.13 22.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.957 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 43.0 t -134.14 125.8 48.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.083 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 14.0 m -92.46 151.75 20.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.152 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 941' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -132.24 143.87 50.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.862 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 54.2 tp -41.27 -52.87 3.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.878 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -118.17 177.99 4.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -86.67 -48.08 4.6 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.525 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 46.6 t -50.8 -39.07 51.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.863 0.363 . . . . 0.0 110.841 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 56.8 p -57.51 -32.36 66.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.87 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -76.4 -20.91 56.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.086 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 36.5 mt -77.97 -27.93 49.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.926 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -81.93 -51.56 7.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.883 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 9.5 p -48.21 -21.56 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.12 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 951' ' ' LEU . . . . . 0.449 HD21 ' HG ' ' A' ' 967' ' ' LEU . 34.2 mt -49.37 -29.43 6.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.937 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 35.7 p -50.28 -19.77 0.89 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.839 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 76.7 mt -88.84 20.15 3.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.885 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -74.41 106.34 5.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.928 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 98.85 -26.76 22.84 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.461 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -37.97 128.19 1.25 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.71 0.291 . . . . 0.0 110.887 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -93.38 125.15 37.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 15.2 tp -133.01 154.58 50.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 43.2 mt 41.01 47.78 2.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.913 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 51.64 40.5 27.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 961' ' ' ARG . . . . . . . . . . . . . 65.2 mtt85 -147.63 122.69 10.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.858 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 6.1 m -74.17 115.08 13.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.154 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 963' ' ' ILE . . . . . 0.77 HD13 HD21 ' A' ' 917' ' ' LEU . 84.6 mt -99.81 135.51 35.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.124 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 14.9 m -119.74 112.5 19.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.173 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 965' ' ' ILE . . . . . 0.616 HG12 HG22 ' A' ' 897' ' ' VAL . 67.3 mt -98.99 137.48 26.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.122 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -151.37 135.33 16.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.087 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 967' ' ' LEU . . . . . 0.501 HD23 HG12 ' A' ' 895' ' ' VAL . 28.9 mt -66.26 157.98 30.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.907 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.918 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 39.3 m . . . . . 0 N--CA 1.457 -0.125 0 CA-C-O 120.865 0.364 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 895' ' ' VAL . . . . . 0.527 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 17.8 m -117.49 144.09 26.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.169 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 896' ' ' LEU . . . . . 0.472 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 6.8 mp -92.89 137.92 31.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 60.1 t -140.13 131.24 31.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.161 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 3.1 t -130.62 156.32 45.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.881 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.527 HG23 ' CE2' ' A' ' 909' ' ' PHE . 3.3 pt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.183 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 909' ' ' PHE . . . . . 0.539 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 87.4 m-85 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.857 0.36 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 910' ' ' ASP . . . . . 0.812 ' H ' HD12 ' A' ' 913' ' ' LEU . 24.0 t70 -97.89 165.65 11.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.871 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -48.51 -50.06 33.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -56.84 -48.92 76.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.117 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 913' ' ' LEU . . . . . 0.812 HD12 ' H ' ' A' ' 910' ' ' ASP . 72.4 mt -56.72 -50.45 72.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.895 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 50.6 mt -64.0 -63.79 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.108 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -42.07 -56.47 2.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.819 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -54.34 -46.81 72.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.876 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 917' ' ' LEU . . . . . 0.903 HD21 HD13 ' A' ' 963' ' ' ILE . 24.9 mt -54.15 -56.08 21.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.933 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 918' ' ' LEU . . . . . 0.495 ' CD2' HD11 ' A' ' 930' ' ' ILE . 68.3 mt -34.41 -60.6 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.883 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -52.31 -51.07 60.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -52.48 -40.05 61.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 921' ' ' PHE . . . . . 0.564 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 22.9 m-85 -66.82 -44.59 80.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.865 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -50.57 -33.63 22.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.123 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 923' ' ' SER . . . . . 0.54 ' HB3' ' CE1' ' A' ' 924' ' ' PHE . 10.4 t -41.86 -34.64 0.69 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.87 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 924' ' ' PHE . . . . . 0.54 ' CE1' ' HB3' ' A' ' 923' ' ' SER . 0.9 OUTLIER -120.17 -51.68 2.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.844 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -128.27 141.56 12.71 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.442 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -85.58 99.47 11.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.896 0.379 . . . . 0.0 110.894 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 40.2 t -51.23 143.91 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.122 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 928' ' ' ILE . . . . . 0.475 HG13 ' N ' ' A' ' 929' ' ' LEU . 21.0 pt -120.04 -44.8 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.093 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 929' ' ' LEU . . . . . 0.475 ' N ' HG13 ' A' ' 928' ' ' ILE . 11.1 tp -135.56 146.51 48.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.949 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 930' ' ' ILE . . . . . 0.495 HD11 ' CD2' ' A' ' 918' ' ' LEU . 57.0 mt -130.05 137.57 56.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.13 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -125.88 122.29 35.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -88.48 124.07 33.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.845 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 933' ' ' VAL . . . . . 0.644 HG21 ' CD1' ' A' ' 938' ' ' TRP . 13.5 t -92.63 157.52 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.089 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 934' ' ' GLU . . . . . 0.482 ' C ' ' O ' ' A' ' 933' ' ' VAL . 15.2 mm-40 -31.24 -56.03 0.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -121.88 -26.01 4.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.859 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 4.7 tttm -96.12 173.25 7.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.839 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 937' ' ' MET . . . . . 0.539 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 10.8 ttt -132.39 105.93 7.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 938' ' ' TRP . . . . . 0.644 ' CD1' HG21 ' A' ' 933' ' ' VAL . 44.1 m0 -85.25 142.49 29.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.928 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 939' ' ' VAL . . . . . 0.488 HG13 HG12 ' A' ' 930' ' ' ILE . 43.8 t -132.56 129.62 59.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.133 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 940' ' ' THR . . . . . 0.403 HG22 ' N ' ' A' ' 941' ' ' PHE . 32.9 m -92.53 154.23 18.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.162 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 941' ' ' PHE . . . . . 0.413 ' O ' ' C ' ' A' ' 942' ' ' LEU . 11.2 m-85 -134.17 146.97 50.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.865 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 942' ' ' LEU . . . . . 0.413 ' C ' ' O ' ' A' ' 941' ' ' PHE . 23.6 tp -36.91 -61.49 0.55 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -125.62 153.53 43.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -50.5 -51.01 33.96 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.509 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 945' ' ' SER . . . . . 0.587 ' HA ' HD12 ' A' ' 948' ' ' LEU . 82.6 p -46.7 -42.86 17.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.9 0.381 . . . . 0.0 110.843 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 14.5 m -56.32 -30.86 63.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 947' ' ' ALA . . . . . 0.527 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -82.47 -16.73 47.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.118 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 948' ' ' LEU . . . . . 0.587 HD12 ' HA ' ' A' ' 945' ' ' SER . 23.4 mt -83.23 -23.6 32.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.927 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -88.34 -46.47 9.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.92 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 7.2 p -51.33 -22.25 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.148 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 951' ' ' LEU . . . . . 0.465 HD21 ' HG ' ' A' ' 967' ' ' LEU . 39.5 mt -50.41 -24.84 3.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.918 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 32.5 m -55.26 -15.51 2.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 36.5 mt -91.53 17.01 9.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.905 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -69.06 120.85 15.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.929 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 85.63 -27.31 5.35 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.458 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -38.21 127.36 1.35 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.74 0.305 . . . . 0.0 110.893 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -95.4 125.49 40.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.862 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 14.5 tp -134.46 153.44 51.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.969 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 959' ' ' LEU . . . . . 0.441 ' O ' ' CG ' ' A' ' 960' ' ' ASN . 35.0 mt 41.56 49.17 3.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 960' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' A' ' 960' ' ' ASN . 1.7 p-10 47.75 40.29 11.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 961' ' ' ARG . . . . . 0.757 ' HD2' HD21 ' A' ' 913' ' ' LEU . 47.1 mtt85 -147.56 104.99 3.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 27.1 m -58.94 120.88 9.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.133 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 963' ' ' ILE . . . . . 0.903 HD13 HD21 ' A' ' 917' ' ' LEU . 87.2 mt -103.98 143.4 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 8.7 m -127.22 119.93 27.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.134 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 965' ' ' ILE . . . . . . . . . . . . . 63.4 mt -103.77 140.27 22.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.131 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -149.85 137.12 19.75 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.077 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 967' ' ' LEU . . . . . 0.465 ' HG ' HD21 ' A' ' 951' ' ' LEU . 25.1 mt -73.75 153.48 40.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.95 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 968' ' ' LYS . . . . . 0.432 ' HD3' HD11 ' A' ' 896' ' ' LEU . 19.2 tptp . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.89 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 71.9 m . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.805 0.336 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 895' ' ' VAL . . . . . 0.475 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 13.7 m -117.17 142.86 29.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.157 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 896' ' ' LEU . . . . . 0.469 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 5.0 mp -91.74 143.15 26.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 79.8 t -142.44 127.5 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 9.7 t -129.61 158.05 40.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.841 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.517 HG22 HG12 ' A' ' 963' ' ' ILE . 2.7 pt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.12 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 909' ' ' PHE . . . . . 0.579 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 94.1 m-85 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.888 0.375 . . . . 0.0 110.87 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 910' ' ' ASP . . . . . 0.662 ' H ' HD12 ' A' ' 913' ' ' LEU . 9.6 m-20 -85.04 160.11 20.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.884 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -45.64 -40.43 9.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.852 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -65.33 -49.99 67.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.104 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 913' ' ' LEU . . . . . 0.662 HD12 ' H ' ' A' ' 910' ' ' ASP . 29.4 mt -56.76 -45.85 81.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 36.5 mt -69.52 -59.75 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.155 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -48.89 -50.99 32.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.86 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 916' ' ' GLU . . . . . 0.546 ' HG3' HD11 ' A' ' 959' ' ' LEU . 36.6 mm-40 -56.89 -40.8 76.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.86 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 917' ' ' LEU . . . . . 0.95 HD21 HD13 ' A' ' 963' ' ' ILE . 22.0 mt -59.88 -51.64 68.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 918' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 917' ' ' LEU . 30.8 mt -34.89 -64.19 0.28 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.906 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -50.2 -51.98 39.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.904 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 920' ' ' GLN . . . . . 0.443 ' O ' HD11 ' A' ' 953' ' ' LEU . 13.8 mm100 -49.63 -40.5 39.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.922 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 921' ' ' PHE . . . . . 0.553 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 22.7 m-85 -72.37 -42.78 64.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.899 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -50.99 -38.03 48.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.114 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -46.81 -21.13 0.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 924' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 1.4 m-85 -124.0 -58.88 1.54 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.914 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -130.1 151.0 19.26 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.512 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -88.86 125.35 34.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.887 0.375 . . . . 0.0 110.863 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 6.1 t -78.93 150.29 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.141 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 928' ' ' ILE . . . . . 0.475 HG13 ' N ' ' A' ' 929' ' ' LEU . 35.1 pt -125.63 -40.46 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.101 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 929' ' ' LEU . . . . . 0.475 ' N ' HG13 ' A' ' 928' ' ' ILE . 12.0 tp -141.12 146.34 36.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.941 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 930' ' ' ILE . . . . . 0.729 HG12 HG13 ' A' ' 939' ' ' VAL . 51.3 mt -134.62 143.04 38.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.119 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.62 128.69 31.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.849 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -91.99 123.55 35.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.87 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 933' ' ' VAL . . . . . 0.84 HG21 ' NE1' ' A' ' 938' ' ' TRP . 2.6 t -87.89 157.18 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.13 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 934' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 933' ' ' VAL . 45.8 mt-10 -33.49 -49.7 0.3 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.838 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -127.12 -28.22 2.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.867 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 6.8 ttmm -96.02 173.12 7.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 937' ' ' MET . . . . . 0.579 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 12.5 ttt -135.18 108.06 7.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 938' ' ' TRP . . . . . 0.84 ' NE1' HG21 ' A' ' 933' ' ' VAL . 13.4 m0 -94.88 143.62 26.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.929 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 939' ' ' VAL . . . . . 0.729 HG13 HG12 ' A' ' 930' ' ' ILE . 43.6 t -128.65 139.99 50.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.131 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 940' ' ' THR . . . . . 0.456 HG22 ' N ' ' A' ' 941' ' ' PHE . 53.0 m -98.51 156.26 16.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.099 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 941' ' ' PHE . . . . . 0.456 ' N ' HG22 ' A' ' 940' ' ' THR . 13.2 m-85 -136.23 149.86 48.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.916 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 32.5 tp -51.04 -52.13 46.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.953 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -114.69 173.91 6.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.904 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -86.89 -47.18 4.87 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.472 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 13.0 m -56.06 -27.2 52.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.917 0.389 . . . . 0.0 110.882 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 50.6 p -67.91 -28.14 67.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.862 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 947' ' ' ALA . . . . . 0.475 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -79.32 -13.26 59.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.083 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 32.3 mt -85.4 -31.97 22.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.912 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 41.8 m-20 -75.62 -42.33 52.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 5.7 p -56.77 -15.76 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.149 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 951' ' ' LEU . . . . . 0.511 HD21 ' HG ' ' A' ' 967' ' ' LEU . 31.6 mt -55.62 -29.1 58.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.904 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 70.7 m -55.99 -23.16 30.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.845 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 953' ' ' LEU . . . . . 0.476 ' C ' HD12 ' A' ' 965' ' ' ILE . 39.2 mt -82.03 9.08 9.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.887 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.04 119.09 13.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 91.95 -25.41 16.93 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.487 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -44.07 128.65 5.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.748 0.309 . . . . 0.0 110.941 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -93.08 133.27 36.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.922 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 13.8 tp -147.87 158.32 43.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.949 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 959' ' ' LEU . . . . . 0.546 HD11 ' HG3' ' A' ' 916' ' ' GLU . 33.1 mt 40.06 46.71 1.86 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.948 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 48.1 42.13 16.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 961' ' ' ARG . . . . . 0.627 ' HD2' HD21 ' A' ' 913' ' ' LEU . 64.1 mtt85 -152.14 115.22 4.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 12.5 m -68.31 123.97 22.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.115 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 963' ' ' ILE . . . . . 0.95 HD13 HD21 ' A' ' 917' ' ' LEU . 85.8 mt -107.17 143.86 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.083 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 10.1 m -129.1 117.57 21.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.177 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 965' ' ' ILE . . . . . 0.476 HD12 ' C ' ' A' ' 953' ' ' LEU . 23.2 mt -98.64 145.15 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.152 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -155.93 129.6 8.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 967' ' ' LEU . . . . . 0.511 ' HG ' HD21 ' A' ' 951' ' ' LEU . 38.3 mt -65.22 157.7 28.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 968' ' ' LYS . . . . . 0.415 ' HD3' HD11 ' A' ' 896' ' ' LEU . 34.4 tptt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 59.1 m . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.816 0.341 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 895' ' ' VAL . . . . . 0.749 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 12.8 m -118.56 143.42 29.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.118 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 896' ' ' LEU . . . . . 0.463 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 3.5 mp -93.22 145.75 24.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.927 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.421 HG13 ' CG2' ' A' ' 963' ' ' ILE . 98.0 t -146.2 128.57 8.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.131 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 30.9 t -133.21 159.53 39.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.893 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.132 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 909' ' ' PHE . . . . . 0.589 ' CE2' ' HB2' ' A' ' 937' ' ' MET . 45.9 m-85 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.867 0.365 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 910' ' ' ASP . . . . . 0.763 ' H ' HD12 ' A' ' 913' ' ' LEU . 25.8 m-20 -83.71 157.71 22.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.904 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -43.75 -58.4 2.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.904 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -45.26 -58.0 3.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.12 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 913' ' ' LEU . . . . . 0.763 HD12 ' H ' ' A' ' 910' ' ' ASP . 24.7 mt -44.26 -56.23 4.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.925 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 71.4 mt -58.86 -62.21 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -43.46 -67.52 0.27 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 916' ' ' GLU . . . . . 0.66 ' HG3' HD11 ' A' ' 959' ' ' LEU . 8.5 mm-40 -43.78 -55.22 4.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.854 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 917' ' ' LEU . . . . . 0.954 HD21 HD13 ' A' ' 963' ' ' ILE . 30.3 mt -44.97 -58.89 2.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.903 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 918' ' ' LEU . . . . . 0.439 ' C ' ' O ' ' A' ' 917' ' ' LEU . 90.1 mt -35.25 -58.16 0.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.983 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -56.68 -38.52 72.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.924 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 920' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 917' ' ' LEU . 72.7 mm-40 -63.74 -36.67 84.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 921' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -72.02 -37.38 69.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -57.89 -34.04 69.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.131 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -47.91 -25.21 1.25 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 924' ' ' PHE . . . . . 0.477 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 2.4 m-85 -121.64 -64.35 1.23 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.884 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -123.26 154.38 17.24 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.504 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -88.57 135.11 33.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.919 0.39 . . . . 0.0 110.895 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 19.9 t -86.29 149.06 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.115 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 928' ' ' ILE . . . . . 0.479 HG13 ' N ' ' A' ' 929' ' ' LEU . 27.7 pt -129.12 -42.85 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.14 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 929' ' ' LEU . . . . . 0.479 ' N ' HG13 ' A' ' 928' ' ' ILE . 15.8 tp -136.27 145.71 45.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.919 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 64.9 mt -133.72 128.92 54.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.136 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -120.11 126.73 51.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.862 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -92.17 120.59 32.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.841 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 933' ' ' VAL . . . . . 0.772 HG21 ' NE1' ' A' ' 938' ' ' TRP . 3.0 t -86.96 157.09 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.179 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 934' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 933' ' ' VAL . 34.4 mm-40 -33.98 -52.51 0.44 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -124.95 -24.74 4.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.853 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 936' ' ' LYS . . . . . 0.431 ' NZ ' ' HB3' ' A' ' 896' ' ' LEU . 14.7 tttm -97.57 173.07 7.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 937' ' ' MET . . . . . 0.589 ' HB2' ' CE2' ' A' ' 909' ' ' PHE . 16.5 ttt -132.04 115.09 15.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.915 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 938' ' ' TRP . . . . . 0.772 ' NE1' HG21 ' A' ' 933' ' ' VAL . 39.5 m0 -94.63 150.37 20.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.955 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 70.0 t -142.36 128.24 17.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.104 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 5.6 m -95.54 150.88 19.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.115 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 941' ' ' PHE . . . . . 0.446 ' O ' ' C ' ' A' ' 942' ' ' LEU . 9.6 m-85 -129.37 145.59 51.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 942' ' ' LEU . . . . . 0.446 ' C ' ' O ' ' A' ' 941' ' ' PHE . 16.0 tp -34.4 -64.82 0.23 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -114.81 165.57 12.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -65.92 -54.09 26.86 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.52 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 945' ' ' SER . . . . . 0.615 ' HA ' HD12 ' A' ' 948' ' ' LEU . 84.3 p -48.15 -27.14 2.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.912 0.387 . . . . 0.0 110.869 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 69.1 m -67.23 -34.78 78.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 947' ' ' ALA . . . . . 0.749 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -80.04 -13.79 59.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.111 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 948' ' ' LEU . . . . . 0.615 HD12 ' HA ' ' A' ' 945' ' ' SER . 20.0 mt -87.44 -22.97 24.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.933 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 -85.54 -38.48 18.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.88 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 8.4 p -60.09 -21.96 23.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.163 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 951' ' ' LEU . . . . . 0.439 HD21 ' HG ' ' A' ' 967' ' ' LEU . 43.5 mt -50.14 -23.06 1.93 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.924 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 18.6 m -56.9 -15.0 3.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.826 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 953' ' ' LEU . . . . . 0.454 ' HB2' ' CD1' ' A' ' 965' ' ' ILE . 56.9 mt -92.99 11.48 27.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.938 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -63.4 116.51 5.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.888 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 90.67 -25.67 12.77 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.544 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -42.37 128.21 3.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.785 0.326 . . . . 0.0 110.922 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -95.68 128.39 42.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.92 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 14.9 tp -135.58 153.41 51.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.891 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 959' ' ' LEU . . . . . 0.66 HD11 ' HG3' ' A' ' 916' ' ' GLU . 36.0 mt 42.73 49.6 4.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 47.6 44.07 16.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.89 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 961' ' ' ARG . . . . . 0.471 ' CD ' HD11 ' A' ' 913' ' ' LEU . 57.8 mtt-85 -152.29 109.72 3.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 31.1 m -62.56 122.3 15.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.17 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 963' ' ' ILE . . . . . 0.954 HD13 HD21 ' A' ' 917' ' ' LEU . 93.3 mt -105.11 148.8 9.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.173 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 5.7 m -132.67 113.78 13.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.124 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 965' ' ' ILE . . . . . 0.454 ' CD1' ' HB2' ' A' ' 953' ' ' LEU . 56.5 mt -96.58 140.28 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.157 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -149.29 135.46 19.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.119 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 967' ' ' LEU . . . . . 0.439 ' HG ' HD21 ' A' ' 951' ' ' LEU . 26.8 mt -71.89 154.95 40.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.894 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 13.6 tptm . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 179.886 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 69.4 m . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.816 0.341 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 895' ' ' VAL . . . . . 0.612 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 17.1 m -115.45 143.68 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.15 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 896' ' ' LEU . . . . . 0.469 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 5.0 mp -91.65 141.94 28.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 80.6 t -137.03 129.72 44.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.132 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 12.4 t -133.46 158.48 42.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.83 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.429 HG22 HG12 ' A' ' 963' ' ' ILE . 2.5 pt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.117 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 909' ' ' PHE . . . . . 0.573 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 92.9 m-85 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.829 0.347 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 910' ' ' ASP . . . . . 0.441 ' H ' HD12 ' A' ' 913' ' ' LEU . 26.8 m-20 -96.71 173.05 7.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.845 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -53.75 -36.71 62.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.854 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -69.0 -49.54 56.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.071 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 913' ' ' LEU . . . . . 0.441 HD12 ' H ' ' A' ' 910' ' ' ASP . 22.2 mt -59.06 -44.83 91.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 54.3 mt -69.74 -59.88 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.151 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -41.58 -64.92 0.5 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.843 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -47.27 -56.05 7.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 917' ' ' LEU . . . . . 0.759 HD21 HD13 ' A' ' 963' ' ' ILE . 26.9 mt -42.16 -54.22 3.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 918' ' ' LEU . . . . . . . . . . . . . 62.8 mt -40.46 -57.69 1.74 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.954 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -58.71 -42.93 89.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -58.71 -38.8 79.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 921' ' ' PHE . . . . . 0.563 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 24.5 m-85 -69.92 -37.39 75.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -56.27 -35.45 67.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.071 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.7 m -44.53 -29.16 0.67 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 924' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 1.8 m-85 -121.3 -59.6 1.7 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.849 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -124.26 140.21 12.48 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.514 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -82.52 99.41 9.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.814 0.34 . . . . 0.0 110.88 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 927' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 940' ' ' THR . 34.7 t -50.27 143.71 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.163 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 928' ' ' ILE . . . . . 0.654 HD13 ' HA ' ' A' ' 942' ' ' LEU . 15.3 pt -120.02 -39.97 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.15 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 929' ' ' LEU . . . . . . . . . . . . . 8.6 tp -140.44 149.36 42.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.913 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 930' ' ' ILE . . . . . 0.589 HG12 HG13 ' A' ' 939' ' ' VAL . 41.9 mt -137.05 145.58 29.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.104 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 8.1 ttp180 -135.78 124.19 23.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.917 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -87.75 120.38 29.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.909 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 933' ' ' VAL . . . . . 0.694 HG21 ' CD1' ' A' ' 938' ' ' TRP . 3.6 t -87.15 157.15 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.106 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 934' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 933' ' ' VAL . 22.8 mm-40 -34.04 -53.72 0.47 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -124.17 -21.57 4.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.834 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 16.9 ttmt -99.93 172.94 6.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 937' ' ' MET . . . . . 0.573 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 15.2 ttt -131.85 109.03 9.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.841 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 938' ' ' TRP . . . . . 0.694 ' CD1' HG21 ' A' ' 933' ' ' VAL . 43.4 m0 -89.41 143.13 27.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.913 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 939' ' ' VAL . . . . . 0.589 HG13 HG12 ' A' ' 930' ' ' ILE . 46.6 t -135.8 122.73 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.095 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 940' ' ' THR . . . . . 0.445 ' O ' HG13 ' A' ' 927' ' ' VAL . 18.4 m -91.04 152.94 20.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.154 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 941' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -129.21 155.53 45.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.869 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 942' ' ' LEU . . . . . 0.654 ' HA ' HD13 ' A' ' 928' ' ' ILE . 16.1 tp -38.47 -56.72 1.23 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.959 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -136.11 165.67 25.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.862 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -52.97 -53.44 33.72 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.461 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 945' ' ' SER . . . . . 0.411 ' HA ' HD12 ' A' ' 948' ' ' LEU . 77.3 p -46.38 -44.6 17.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.835 0.35 . . . . 0.0 110.847 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 72.2 m -55.17 -32.85 62.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 947' ' ' ALA . . . . . 0.612 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -82.51 -13.43 56.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.102 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 948' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 945' ' ' SER . 60.2 mt -85.65 -28.35 24.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.909 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -85.37 -34.09 21.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.13 -20.26 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.16 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 951' ' ' LEU . . . . . 0.424 HD21 ' HG ' ' A' ' 967' ' ' LEU . 41.2 mt -52.85 -26.56 15.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.93 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 9.7 m -56.36 -21.49 24.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.841 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 26.6 mt -82.04 4.96 20.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.89 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.16 122.71 17.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 88.7 -26.56 8.12 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.485 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -42.32 127.15 3.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.752 0.31 . . . . 0.0 110.913 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -93.63 130.82 39.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 14.8 tp -141.36 152.46 44.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.913 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 81.4 mt 42.03 48.42 4.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.964 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 4.4 m120 48.57 40.74 16.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.839 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 961' ' ' ARG . . . . . . . . . . . . . 51.5 mtt85 -148.94 105.0 3.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.871 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 56.3 m -62.67 121.35 13.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.12 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 963' ' ' ILE . . . . . 0.759 HD13 HD21 ' A' ' 917' ' ' LEU . 64.7 mt -102.32 152.87 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.14 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 964' ' ' THR . . . . . 0.42 ' N ' HG22 ' A' ' 963' ' ' ILE . 11.6 m -136.45 117.51 14.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.1 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 965' ' ' ILE . . . . . . . . . . . . . 33.7 mt -100.37 143.62 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.104 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -154.28 129.38 9.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.128 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 967' ' ' LEU . . . . . 0.58 HD23 HG12 ' A' ' 895' ' ' VAL . 36.5 mt -63.15 158.0 20.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.926 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 12.7 tptp . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 179.854 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 97.5 m . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.825 0.345 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 895' ' ' VAL . . . . . 0.448 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 17.2 m -115.0 142.48 27.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.113 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 896' ' ' LEU . . . . . 0.471 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 3.9 mp -91.58 142.64 27.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 897' ' ' VAL . . . . . 0.419 HG22 HG12 ' A' ' 965' ' ' ILE . 94.5 t -139.86 131.43 32.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.131 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 11.8 t -132.6 151.73 51.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.827 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 899' ' ' ILE . . . . . 0.476 HG22 HG12 ' A' ' 963' ' ' ILE . 3.8 pt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.159 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 909' ' ' PHE . . . . . 0.592 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 24.6 m-85 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.895 0.378 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 910' ' ' ASP . . . . . 0.66 ' H ' HD12 ' A' ' 913' ' ' LEU . 23.6 t70 -89.89 168.3 12.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.85 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 911' ' ' ASP . . . . . 0.409 ' N ' ' CG ' ' A' ' 910' ' ' ASP . 0.7 OUTLIER -49.04 -45.89 43.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -61.46 -58.27 8.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.095 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 913' ' ' LEU . . . . . 0.855 HD21 ' HD2' ' A' ' 961' ' ' ARG . 84.3 mt -47.84 -47.18 31.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.88 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 57.3 mt -66.47 -64.28 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.118 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -39.34 -61.93 0.73 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 916' ' ' GLU . . . . . 0.4 ' HG3' HD11 ' A' ' 959' ' ' LEU . 30.7 mm-40 -47.83 -57.25 5.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.934 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 917' ' ' LEU . . . . . 0.98 HD21 HD13 ' A' ' 963' ' ' ILE . 33.8 mt -41.73 -56.91 2.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 918' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 917' ' ' LEU . 37.5 mt -36.11 -57.54 0.7 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -54.83 -42.78 72.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 920' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 917' ' ' LEU . 60.5 mm-40 -61.17 -39.14 89.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.913 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 921' ' ' PHE . . . . . 0.54 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 22.0 m-85 -71.34 -34.56 70.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -60.62 -34.52 74.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.086 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -47.24 -23.72 0.59 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.851 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 924' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 0.6 OUTLIER -125.42 -55.97 1.53 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.896 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -127.56 141.23 12.45 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.469 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -83.55 100.26 10.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.88 0.372 . . . . 0.0 110.884 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 60.9 t -53.14 146.32 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.134 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 928' ' ' ILE . . . . . . . . . . . . . 29.1 pt -124.85 -37.38 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.159 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 929' ' ' LEU . . . . . . . . . . . . . 22.2 tp -139.7 146.88 40.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.964 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 64.1 mt -136.23 129.26 46.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.119 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -118.81 124.7 47.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -90.96 119.53 31.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.862 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 933' ' ' VAL . . . . . 0.638 HG21 ' NE1' ' A' ' 938' ' ' TRP . 9.0 t -85.64 157.27 3.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.148 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 934' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 933' ' ' VAL . 65.7 mt-10 -33.77 -50.34 0.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.871 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.76 -26.2 3.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.841 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 936' ' ' LYS . . . . . 0.41 ' O ' ' N ' ' A' ' 933' ' ' VAL . 1.0 OUTLIER -96.48 173.2 7.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 -179.984 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 937' ' ' MET . . . . . 0.592 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 18.8 ttt -134.8 110.39 9.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.848 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 938' ' ' TRP . . . . . 0.638 ' NE1' HG21 ' A' ' 933' ' ' VAL . 43.8 m0 -89.51 152.31 21.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.939 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 939' ' ' VAL . . . . . 0.441 HG12 ' CE1' ' A' ' 941' ' ' PHE . 93.0 t -140.99 123.57 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.127 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 18.8 m -90.4 150.04 22.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.137 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 941' ' ' PHE . . . . . 0.441 ' CE1' HG12 ' A' ' 939' ' ' VAL . 10.8 m-85 -129.41 150.49 50.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.891 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 942' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 941' ' ' PHE . 21.7 tp -37.09 -59.62 0.71 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.909 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -130.41 163.26 27.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 944' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 947' ' ' ALA . . . -55.49 -56.84 21.55 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.5 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 945' ' ' SER . . . . . 0.524 ' HA ' HD12 ' A' ' 948' ' ' LEU . 68.6 p -39.57 -48.71 2.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.889 0.376 . . . . 0.0 110.836 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 18.3 m -54.14 -37.93 64.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 947' ' ' ALA . . . . . 0.448 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -74.57 -13.81 60.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.098 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 948' ' ' LEU . . . . . 0.524 HD12 ' HA ' ' A' ' 945' ' ' SER . 26.7 mt -89.29 -21.85 22.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -88.77 -44.85 10.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.91 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 7.3 p -52.45 -22.76 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.109 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 31.1 mt -48.68 -26.65 2.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.904 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 26.3 m -52.78 -16.14 0.91 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.889 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 36.5 mt -92.13 16.48 11.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.865 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -70.41 119.0 13.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 87.8 -27.92 6.28 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.499 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -38.61 127.52 1.49 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.73 0.3 . . . . 0.0 110.896 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -97.17 122.87 40.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.904 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 14.2 tp -132.91 156.75 46.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 959' ' ' LEU . . . . . 0.453 ' O ' ' CG ' ' A' ' 960' ' ' ASN . 24.9 mt 42.19 49.23 4.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.931 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 960' ' ' ASN . . . . . 0.453 ' CG ' ' O ' ' A' ' 959' ' ' LEU . 0.9 OUTLIER 47.53 38.94 8.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 179.939 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 961' ' ' ARG . . . . . 0.855 ' HD2' HD21 ' A' ' 913' ' ' LEU . 49.7 mtt85 -146.88 112.0 5.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.871 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 55.8 m -64.9 119.52 10.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.127 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 963' ' ' ILE . . . . . 0.98 HD13 HD21 ' A' ' 917' ' ' LEU . 89.1 mt -102.12 145.65 11.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.115 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 7.6 m -130.43 110.26 11.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.126 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 965' ' ' ILE . . . . . 0.419 HG12 HG22 ' A' ' 897' ' ' VAL . 62.5 mt -96.64 136.61 26.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.146 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -147.72 134.47 20.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.136 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 967' ' ' LEU . . . . . . . . . . . . . 26.9 mt -64.54 155.75 32.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.927 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 11.9 tptp . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.883 179.853 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 N-CA-C 112.527 -0.229 . . . . 0.0 112.527 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 4.8 t -147.28 119.85 8.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.858 0.361 . . . . 0.0 110.879 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 30.0 t -112.57 137.31 50.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.784 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . 97.76 113.03 3.12 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.534 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 1.2 t -174.34 113.38 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.893 0.378 . . . . 0.0 110.841 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 20.9 m -82.62 86.98 6.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.835 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 164.48 -126.64 1.53 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.519 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . 159.89 43.08 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.482 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 99.1 m -97.01 120.01 36.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 0.0 111.125 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 895' ' ' VAL . . . . . 0.575 HG12 HD23 ' A' ' 967' ' ' LEU . 17.7 m -116.26 142.24 30.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.076 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 896' ' ' LEU . . . . . 0.465 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 6.5 mp -90.52 139.15 30.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.926 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.403 HG13 ' CG2' ' A' ' 963' ' ' ILE . 70.5 t -139.01 125.29 23.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.139 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 11.1 t -126.6 155.02 43.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.862 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.551 HG12 ' CE2' ' A' ' 909' ' ' PHE . 2.6 pt -120.26 131.71 71.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.123 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.66 119.09 22.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 901' ' ' SER . . . . . . . . . . . . . 1.4 t -133.31 178.87 6.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.832 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 3.2 m -101.28 -48.39 4.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.87 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 14.7 mt -86.2 151.45 54.1 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.615 0.721 . . . . 0.0 110.895 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -76.86 -15.89 16.52 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.686 2.257 . . . . 0.0 112.358 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -97.66 11.16 37.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 906' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -109.45 -22.11 12.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.87 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 38.9 m-20 -48.62 -22.7 0.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.894 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -67.64 137.66 55.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.88 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 909' ' ' PHE . . . . . 0.757 ' HA ' HD12 ' A' ' 913' ' ' LEU . 79.7 m-85 -84.34 132.51 34.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.904 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -97.56 -177.25 3.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.835 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -61.92 -36.07 80.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -67.72 -57.36 6.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.112 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 913' ' ' LEU . . . . . 0.757 HD12 ' HA ' ' A' ' 909' ' ' PHE . 22.6 mt -49.79 -47.0 51.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.923 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 47.5 mt -69.99 -65.93 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.125 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -38.81 -53.47 1.68 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.843 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 916' ' ' GLU . . . . . 0.468 ' HB3' HD21 ' A' ' 958' ' ' LEU . 60.8 mm-40 -58.24 -51.15 70.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.893 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 917' ' ' LEU . . . . . 0.974 HD21 HD13 ' A' ' 963' ' ' ILE . 23.9 mt -48.93 -54.79 14.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.883 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 918' ' ' LEU . . . . . 0.434 ' C ' ' O ' ' A' ' 917' ' ' LEU . 52.4 mt -35.04 -58.81 0.52 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.939 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -54.76 -51.17 66.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.934 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 920' ' ' GLN . . . . . 0.972 ' NE2' HD22 ' A' ' 958' ' ' LEU . 14.4 mt-30 -51.27 -41.43 60.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.926 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 921' ' ' PHE . . . . . 0.505 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 23.6 m-85 -70.93 -32.1 68.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -58.3 -39.22 78.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.097 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -45.03 -25.58 0.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.918 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 924' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 1.0 OUTLIER -120.96 -64.1 1.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.878 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -121.33 145.08 16.96 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.467 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -85.82 97.23 10.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.88 0.372 . . . . 0.0 110.902 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 29.1 t -46.31 145.64 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.107 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 928' ' ' ILE . . . . . 0.468 HG13 ' N ' ' A' ' 929' ' ' LEU . 25.1 pt -126.63 -42.89 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.167 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 929' ' ' LEU . . . . . 0.468 ' N ' HG13 ' A' ' 928' ' ' ILE . 10.2 tp -133.7 145.84 50.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.946 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 930' ' ' ILE . . . . . 0.41 HD11 ' CD2' ' A' ' 918' ' ' LEU . 81.7 mt -133.69 124.58 47.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.099 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 41.1 ttt180 -115.21 124.35 51.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.91 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -90.76 122.42 33.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.912 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 933' ' ' VAL . . . . . 0.723 HG21 ' NE1' ' A' ' 938' ' ' TRP . 2.7 t -90.51 156.94 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.151 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 934' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 933' ' ' VAL . 14.7 mt-10 -34.49 -52.12 0.49 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.9 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.93 -25.52 3.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.896 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -96.63 172.92 7.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.864 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 937' ' ' MET . . . . . 0.565 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 15.9 ttt -133.54 110.73 10.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.903 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 938' ' ' TRP . . . . . 0.723 ' NE1' HG21 ' A' ' 933' ' ' VAL . 37.8 m0 -90.85 148.98 22.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.924 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 939' ' ' VAL . . . . . 0.44 ' O ' HG22 ' A' ' 895' ' ' VAL . 47.6 t -137.88 124.83 28.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.106 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 21.3 m -93.0 150.48 20.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.147 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 941' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -128.49 158.56 38.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.839 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 23.2 tp -40.72 -53.54 2.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.939 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -134.48 167.82 20.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.866 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -64.74 -47.4 83.68 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.523 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 70.5 m -50.06 -43.86 51.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.923 0.392 . . . . 0.0 110.831 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 1.9 t -56.64 -36.72 69.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.91 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 947' ' ' ALA . . . . . 0.468 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -69.82 -13.64 62.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.103 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 948' ' ' LEU . . . . . 0.404 ' O ' HD12 ' A' ' 951' ' ' LEU . 23.8 mt -87.15 -25.23 24.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -82.78 -38.08 23.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 9.0 p -61.28 -18.47 18.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.139 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 951' ' ' LEU . . . . . 0.524 HD21 ' HG ' ' A' ' 967' ' ' LEU . 58.7 mt -53.27 -17.84 2.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.941 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 46.3 m -61.77 -12.98 19.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.888 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 953' ' ' LEU . . . . . 0.486 ' HB2' ' CD1' ' A' ' 965' ' ' ILE . 75.3 mt -96.86 12.84 30.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.956 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -66.03 107.24 1.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.934 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 100.02 -26.85 22.9 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.487 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 8.4 tmtm? -40.17 128.86 2.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.772 0.32 . . . . 0.0 110.909 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -93.01 130.38 38.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.848 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 958' ' ' LEU . . . . . 0.972 HD22 ' NE2' ' A' ' 920' ' ' GLN . 16.2 tp -136.3 145.99 46.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.931 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 959' ' ' LEU . . . . . 0.587 HD13 HD23 ' A' ' 913' ' ' LEU . 26.0 mt 44.94 52.24 8.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.953 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 49.26 31.85 3.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 961' ' ' ARG . . . . . . . . . . . . . 56.0 mtt-85 -138.89 111.76 7.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 18.7 m -66.25 116.57 7.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.164 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 963' ' ' ILE . . . . . 0.974 HD13 HD21 ' A' ' 917' ' ' LEU . 92.9 mt -97.82 137.21 26.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.114 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 9.6 m -122.41 110.42 15.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.134 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 965' ' ' ILE . . . . . 0.486 ' CD1' ' HB2' ' A' ' 953' ' ' LEU . 38.3 mt -94.61 143.23 12.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.139 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -157.3 133.26 9.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.149 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 967' ' ' LEU . . . . . 0.575 HD23 HG12 ' A' ' 895' ' ' VAL . 31.8 mt -67.12 157.73 32.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.905 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 19.3 tptp -87.93 91.14 8.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.897 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 87.6 p -60.31 143.51 89.12 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.647 0.737 . . . . 0.0 110.852 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -78.06 115.07 3.7 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.665 2.243 . . . . 0.0 112.39 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 34.1 p -58.71 -42.91 89.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -101.39 146.72 17.39 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.505 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.75 155.23 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.727 2.285 . . . . 0.0 112.32 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 98.2 p -77.6 -44.57 27.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.88 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 1.8 t -63.81 165.56 8.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.869 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.509 -179.994 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 47.9 t -126.81 83.67 2.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.905 0.383 . . . . 0.0 110.836 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 29.8 t -73.05 105.31 4.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.877 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . -155.93 -131.61 1.43 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.482 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 47.8 m 54.14 38.36 28.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.873 0.368 . . . . 0.0 110.855 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 41.4 t -48.96 -54.96 13.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.819 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -111.13 -135.07 6.71 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.455 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . -158.64 42.89 0.49 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.47 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 53.6 m -90.11 121.75 32.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.822 0.344 . . . . 0.0 111.143 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 895' ' ' VAL . . . . . 0.599 HG12 HD23 ' A' ' 967' ' ' LEU . 16.8 m -112.23 141.6 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.122 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 896' ' ' LEU . . . . . 0.534 ' HG ' ' CD1' ' A' ' 938' ' ' TRP . 3.6 mp -91.84 148.07 22.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.93 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.401 HG13 ' CG2' ' A' ' 963' ' ' ILE . 58.1 t -145.3 127.37 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.165 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 6.4 t -127.82 153.95 46.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.891 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.562 HG22 HG12 ' A' ' 963' ' ' ILE . 2.1 pt -122.84 130.52 74.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.109 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -89.76 120.02 30.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.918 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 901' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 902' ' ' SER . 16.6 t -134.95 139.08 44.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 902' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 901' ' ' SER . 66.2 p -38.01 -54.56 1.31 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 61.8 mt -94.53 147.47 33.29 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.647 0.737 . . . . 0.0 110.907 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -77.17 -32.08 3.32 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.691 2.261 . . . . 0.0 112.352 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -67.58 -9.58 44.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.886 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 906' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -101.56 11.78 38.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -72.95 -2.02 19.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.894 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -80.98 128.68 33.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.899 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 909' ' ' PHE . . . . . 0.59 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 87.5 m-85 -72.64 121.41 19.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.872 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 910' ' ' ASP . . . . . 0.447 ' H ' HD12 ' A' ' 913' ' ' LEU . 32.3 t70 -87.51 166.42 14.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.876 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -49.32 -44.83 44.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.855 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -62.96 -52.29 63.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.105 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 913' ' ' LEU . . . . . 0.754 HD21 ' HD2' ' A' ' 961' ' ' ARG . 50.3 mt -53.69 -49.31 68.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.921 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 47.3 mt -65.85 -61.62 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.14 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -42.77 -60.72 1.47 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.869 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -48.92 -52.62 23.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.909 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 917' ' ' LEU . . . . . 0.979 HD21 HD13 ' A' ' 963' ' ' ILE . 29.6 mt -47.81 -54.71 11.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 918' ' ' LEU . . . . . 0.472 ' CD2' HD11 ' A' ' 930' ' ' ILE . 87.4 mt -35.22 -59.12 0.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.905 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -54.79 -44.66 73.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.89 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 62.5 mm-40 -57.46 -41.08 79.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 921' ' ' PHE . . . . . 0.53 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 23.5 m-85 -70.05 -34.22 72.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -60.67 -34.39 74.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.089 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -47.12 -24.15 0.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 924' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 1.2 m-85 -125.7 -55.23 1.52 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.878 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -129.16 135.07 8.25 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.453 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -79.08 98.37 6.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.918 0.39 . . . . 0.0 110.914 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 42.2 t -51.63 151.46 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.132 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 928' ' ' ILE . . . . . 0.479 HG13 ' N ' ' A' ' 929' ' ' LEU . 20.1 pt -125.81 -45.43 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.1 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 929' ' ' LEU . . . . . 0.479 ' N ' HG13 ' A' ' 928' ' ' ILE . 11.2 tp -132.87 148.08 52.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 930' ' ' ILE . . . . . 0.618 HG12 HG13 ' A' ' 939' ' ' VAL . 74.5 mt -133.12 132.86 58.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.128 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -120.87 123.92 43.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.847 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -90.69 120.18 31.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.877 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 933' ' ' VAL . . . . . 0.624 HG21 ' NE1' ' A' ' 938' ' ' TRP . 2.6 t -90.48 157.13 2.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.086 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 934' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 933' ' ' VAL . 58.3 mt-10 -33.94 -51.6 0.41 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.908 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -125.19 -25.49 3.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.878 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 936' ' ' LYS . . . . . 0.4 ' O ' ' N ' ' A' ' 933' ' ' VAL . 12.0 tttt -98.27 172.98 7.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.881 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 937' ' ' MET . . . . . 0.59 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 13.5 ttt -135.33 110.65 9.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 938' ' ' TRP . . . . . 0.624 ' NE1' HG21 ' A' ' 933' ' ' VAL . 40.2 m0 -88.69 149.11 23.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.944 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 939' ' ' VAL . . . . . 0.618 HG13 HG12 ' A' ' 930' ' ' ILE . 12.1 t -139.12 129.36 32.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.128 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 17.3 m -93.73 151.15 19.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.151 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 941' ' ' PHE . . . . . 0.422 ' O ' ' C ' ' A' ' 942' ' ' LEU . 9.5 m-85 -130.56 139.82 50.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.917 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 942' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 941' ' ' PHE . 24.5 tp -35.14 -62.5 0.38 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.909 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -116.38 154.47 30.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.87 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -58.54 -50.01 71.23 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.442 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 12.6 t -48.21 -43.48 32.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.848 0.356 . . . . 0.0 110.857 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 14.6 m -55.77 -29.02 58.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.853 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 947' ' ' ALA . . . . . 0.492 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -81.44 -23.0 37.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.073 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 38.3 mt -79.68 -25.71 41.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -84.6 -51.44 6.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.873 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 950' ' ' VAL . . . . . 0.425 ' CG2' HD12 ' A' ' 953' ' ' LEU . 9.8 p -47.55 -21.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.163 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 951' ' ' LEU . . . . . 0.64 HD21 ' HG ' ' A' ' 967' ' ' LEU . 35.3 mt -49.52 -27.25 4.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.959 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 74.8 m -53.72 -15.29 1.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.903 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 953' ' ' LEU . . . . . 0.425 HD12 ' CG2' ' A' ' 950' ' ' VAL . 57.7 mt -90.36 16.51 8.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.926 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.95 120.01 14.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 955' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 956' ' ' LYS . . . 86.21 -25.94 6.62 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.493 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 956' ' ' LYS . . . . . 0.423 ' HE3' HD13 ' A' ' 958' ' ' LEU . 8.9 tmtm? -36.21 126.84 0.77 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.747 0.308 . . . . 0.0 110.857 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -94.72 125.59 39.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 958' ' ' LEU . . . . . 0.423 HD13 ' HE3' ' A' ' 956' ' ' LYS . 14.2 tp -138.35 153.69 48.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 959' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 913' ' ' LEU . 45.3 mt 41.79 48.39 3.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 960' ' ' ASN . . . . . 0.415 ' CG ' ' C ' ' A' ' 959' ' ' LEU . 0.7 OUTLIER 46.5 42.94 11.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 961' ' ' ARG . . . . . 0.754 ' HD2' HD21 ' A' ' 913' ' ' LEU . 45.8 mtt85 -149.69 105.27 3.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 7.4 m -59.49 122.16 13.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.111 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 963' ' ' ILE . . . . . 0.979 HD13 HD21 ' A' ' 917' ' ' LEU . 88.3 mt -106.69 142.35 19.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.152 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 6.5 m -126.48 116.41 21.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.135 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 965' ' ' ILE . . . . . . . . . . . . . 67.6 mt -98.03 139.28 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.179 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -148.7 128.09 13.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.07 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 967' ' ' LEU . . . . . 0.64 ' HG ' HD21 ' A' ' 951' ' ' LEU . 30.4 mt -66.51 157.46 32.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 968' ' ' LYS . . . . . 0.421 ' HD3' HD11 ' A' ' 896' ' ' LEU . 30.5 tptt -97.81 102.55 14.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 67.8 p -127.1 93.12 42.39 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.663 0.744 . . . . 0.0 110.842 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -44.12 -50.41 7.66 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.672 2.248 . . . . 0.0 112.344 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 3.3 t -71.29 124.28 24.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -124.9 95.31 0.48 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.478 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.31 137.07 18.52 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.668 2.245 . . . . 0.0 112.332 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 45.4 m -96.57 99.74 11.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 12.6 t -69.53 83.64 0.42 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.862 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.534 -179.992 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 73.7 m -100.31 -55.74 2.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.912 0.387 . . . . 0.0 110.872 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 25.9 p -86.55 124.07 32.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.813 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . 162.24 87.27 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.474 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 20.2 m -46.43 169.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.888 0.375 . . . . 0.0 110.802 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 17.0 t -70.55 121.93 18.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.822 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 137.84 131.19 2.89 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.488 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . -105.26 57.52 0.49 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.481 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 86.8 m -86.67 120.18 27.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.817 0.341 . . . . 0.0 111.174 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 895' ' ' VAL . . . . . 0.451 HG12 HD23 ' A' ' 967' ' ' LEU . 27.5 m -120.19 139.28 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.143 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 896' ' ' LEU . . . . . 0.463 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 6.4 mp -89.18 138.97 30.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.415 HG13 ' CG2' ' A' ' 963' ' ' ILE . 63.8 t -139.71 122.61 17.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.138 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 16.5 t -125.66 155.5 40.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.902 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.565 HG22 HG12 ' A' ' 963' ' ' ILE . 2.3 pt -121.1 129.31 75.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.128 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 48.9 mttp -69.71 110.72 5.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 901' ' ' SER . . . . . . . . . . . . . 11.7 p -131.98 151.53 51.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.838 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 31.3 t -92.94 -43.93 8.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.839 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 9.8 mt -84.4 150.88 58.25 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.588 0.709 . . . . 0.0 110.944 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.78 -16.99 18.24 Favored 'Trans proline' 0 N--CA 1.466 -0.133 0 C-N-CA 122.714 2.276 . . . . 0.0 112.359 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -97.23 25.13 5.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.927 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 906' ' ' ASN . . . . . 0.402 ' C ' ' N ' ' A' ' 908' ' ' PHE . 95.2 m-20 -129.99 -32.63 1.83 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.885 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -42.63 -25.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.862 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 908' ' ' PHE . . . . . 0.402 ' N ' ' C ' ' A' ' 906' ' ' ASN . 24.1 m-85 -76.04 145.62 40.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 909' ' ' PHE . . . . . 0.527 ' CE2' HG12 ' A' ' 899' ' ' ILE . 27.1 m-85 -89.73 121.91 32.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.893 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 910' ' ' ASP . . . . . 0.46 ' H ' HD12 ' A' ' 913' ' ' LEU . 3.0 m-20 -86.18 177.31 7.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.871 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -55.17 -42.96 73.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.859 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -63.96 -47.24 81.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.076 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 913' ' ' LEU . . . . . 0.926 HD21 ' HD2' ' A' ' 961' ' ' ARG . 52.1 mt -61.01 -48.95 79.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.926 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 49.6 mt -65.81 -59.95 3.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.14 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -45.28 -58.01 3.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.902 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -50.84 -52.53 40.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.891 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 917' ' ' LEU . . . . . 0.909 HD21 HD13 ' A' ' 963' ' ' ILE . 29.6 mt -46.4 -54.01 9.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.909 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 918' ' ' LEU . . . . . 0.414 ' C ' ' O ' ' A' ' 917' ' ' LEU . 20.6 mt -36.63 -64.42 0.34 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.939 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -50.14 -51.92 39.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.912 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -50.47 -40.97 52.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 921' ' ' PHE . . . . . 0.579 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 24.1 m-85 -69.74 -48.18 60.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.855 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -48.19 -28.31 2.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.108 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 923' ' ' SER . . . . . 0.554 ' HB3' ' CD1' ' A' ' 924' ' ' PHE . 16.7 t -47.49 -29.66 2.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.897 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 924' ' ' PHE . . . . . 0.554 ' CD1' ' HB3' ' A' ' 923' ' ' SER . 1.0 OUTLIER -123.02 -64.43 1.18 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.856 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -115.74 155.29 16.37 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.51 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -91.96 138.44 31.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.885 0.374 . . . . 0.0 110.909 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 55.9 t -93.07 146.16 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.114 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 928' ' ' ILE . . . . . 0.491 HG13 ' N ' ' A' ' 929' ' ' LEU . 30.2 pt -123.32 -42.86 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.107 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 929' ' ' LEU . . . . . 0.491 ' N ' HG13 ' A' ' 928' ' ' ILE . 15.0 tp -138.76 141.81 38.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 94.3 mt -127.36 125.47 65.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.154 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -113.44 122.82 48.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -90.6 122.14 33.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.928 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 933' ' ' VAL . . . . . 0.569 HG21 ' NE1' ' A' ' 938' ' ' TRP . 2.9 t -89.9 157.09 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.158 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 934' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 933' ' ' VAL . 61.8 mt-10 -34.11 -50.53 0.4 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.891 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -126.05 -26.73 3.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.823 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 936' ' ' LYS . . . . . 0.417 ' NZ ' ' HB2' ' A' ' 936' ' ' LYS . 0.7 OUTLIER -96.53 172.73 7.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.933 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 937' ' ' MET . . . . . 0.507 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 14.5 ttt -135.26 111.78 9.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.863 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 938' ' ' TRP . . . . . 0.569 ' NE1' HG21 ' A' ' 933' ' ' VAL . 37.0 m0 -92.47 146.33 23.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 939' ' ' VAL . . . . . 0.41 HG12 ' CE1' ' A' ' 941' ' ' PHE . 65.0 t -132.62 121.27 44.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.132 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 18.9 m -85.18 152.59 23.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.156 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 941' ' ' PHE . . . . . 0.41 ' CE1' HG12 ' A' ' 939' ' ' VAL . 12.0 m-85 -133.74 141.84 47.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 19.7 tp -42.55 -47.97 5.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.899 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -120.63 176.13 5.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -89.74 -39.2 6.28 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.519 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 36.0 p -59.54 -41.23 89.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.921 0.391 . . . . 0.0 110.861 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 80.0 p -56.38 -34.45 66.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.881 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -70.81 -15.18 62.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.103 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 25.5 mt -84.01 -31.53 25.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -75.67 -49.31 18.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.842 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 8.5 p -53.35 -17.31 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.143 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 951' ' ' LEU . . . . . 0.472 HD21 ' HG ' ' A' ' 967' ' ' LEU . 52.3 mt -52.98 -24.96 10.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 35.9 p -55.88 -22.92 28.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 76.7 mt -83.25 17.9 1.92 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -72.63 110.35 6.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 96.02 -26.42 20.89 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.481 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -38.33 127.46 1.39 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.732 0.301 . . . . 0.0 110.897 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -94.9 128.42 41.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.901 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 958' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 961' ' ' ARG . 13.7 tp -136.97 160.04 40.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.926 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 959' ' ' LEU . . . . . 0.406 ' C ' ' O ' ' A' ' 958' ' ' LEU . 43.5 mt 37.7 43.07 0.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.967 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 8.9 m120 55.44 43.31 28.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.871 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 961' ' ' ARG . . . . . 0.926 ' HD2' HD21 ' A' ' 913' ' ' LEU . 69.2 mtt-85 -149.71 122.89 8.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.844 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 6.0 m -75.05 112.72 11.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.119 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 963' ' ' ILE . . . . . 0.909 HD13 HD21 ' A' ' 917' ' ' LEU . 82.8 mt -98.02 138.17 23.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.088 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 9.3 m -122.13 113.25 19.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.109 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 965' ' ' ILE . . . . . 0.409 HG12 HG22 ' A' ' 897' ' ' VAL . 55.3 mt -98.75 135.07 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.113 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -149.27 136.63 20.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.095 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 967' ' ' LEU . . . . . 0.472 ' HG ' HD21 ' A' ' 951' ' ' LEU . 30.7 mt -65.44 156.58 31.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.895 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 968' ' ' LYS . . . . . 0.418 ' HE3' ' CH2' ' A' ' 938' ' ' TRP . 21.5 tttt -96.2 144.04 26.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 94.1 p -69.61 144.42 93.97 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.666 0.746 . . . . 0.0 110.886 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -78.02 171.27 17.46 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.751 2.301 . . . . 0.0 112.327 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 32.8 p -121.62 -58.57 1.75 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.916 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . 128.81 167.72 12.23 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.481 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.45 161.53 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.739 2.293 . . . . 0.0 112.326 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 36.7 t -134.21 140.67 46.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.873 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 43.2 m -128.59 127.44 42.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.837 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.449 179.973 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.446 -0.262 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 2.2 m -103.78 88.33 3.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.844 0.354 . . . . 0.0 110.872 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 15.0 m -105.52 154.36 20.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.831 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . 70.76 158.86 2.8 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.507 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 4.8 m -74.12 148.94 41.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.926 0.394 . . . . 0.0 110.822 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 77.5 p -137.42 157.16 47.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.832 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -60.88 -167.59 0.39 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.503 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . -141.51 42.95 1.12 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.474 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 84.8 m -127.23 122.47 34.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.823 0.344 . . . . 0.0 111.136 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 895' ' ' VAL . . . . . 0.712 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 11.3 m -114.25 147.19 17.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.117 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 896' ' ' LEU . . . . . 0.46 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 3.5 mp -96.17 144.26 26.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.937 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.418 HG22 HG12 ' A' ' 965' ' ' ILE . 59.2 t -143.72 131.88 18.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.137 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 14.2 t -134.14 160.23 38.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.82 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.42 HG22 HG12 ' A' ' 963' ' ' ILE . 4.1 pt -121.62 162.19 21.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.162 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 900' ' ' LYS . . . . . 0.452 ' CD ' ' HB ' ' A' ' 962' ' ' THR . 31.6 mtpt -99.33 105.45 17.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 901' ' ' SER . . . . . . . . . . . . . 10.7 m -137.88 136.22 36.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.826 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 37.3 m -80.19 -61.05 2.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 17.1 mt -58.49 147.9 67.35 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.638 0.732 . . . . 0.0 110.915 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.59 -13.14 18.31 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.669 2.246 . . . . 0.0 112.346 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -99.97 20.37 14.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.885 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 906' ' ' ASN . . . . . 0.492 ' O ' ' N ' ' A' ' 908' ' ' PHE . 41.4 m-20 -123.6 -37.84 2.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.917 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -38.02 -27.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.857 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 908' ' ' PHE . . . . . 0.492 ' N ' ' O ' ' A' ' 906' ' ' ASN . 38.4 m-85 -65.35 153.35 41.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 909' ' ' PHE . . . . . 0.567 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 90.0 m-85 -95.55 107.67 19.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.841 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 910' ' ' ASP . . . . . 0.663 ' H ' HD12 ' A' ' 913' ' ' LEU . 7.4 t70 -72.44 163.61 27.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.842 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -51.47 -35.95 42.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.831 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -70.49 -50.95 32.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.091 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 913' ' ' LEU . . . . . 0.849 HD21 ' HD2' ' A' ' 961' ' ' ARG . 87.4 mt -54.8 -35.43 63.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 91.2 mt -79.28 -65.0 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.14 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -39.69 -55.97 1.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.919 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 916' ' ' GLU . . . . . 0.535 ' HB3' HD21 ' A' ' 958' ' ' LEU . 69.0 mm-40 -51.95 -48.46 64.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 917' ' ' LEU . . . . . 1.008 HD21 HD13 ' A' ' 963' ' ' ILE . 28.8 mt -55.06 -47.49 74.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 918' ' ' LEU . . . . . . . . . . . . . 44.6 mt -43.29 -55.58 3.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -58.63 -38.65 78.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 39.4 mm-40 -64.31 -35.83 82.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.888 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 921' ' ' PHE . . . . . 0.557 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 19.4 m-85 -76.03 -33.01 59.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -58.24 -31.92 67.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.104 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 923' ' ' SER . . . . . 0.478 ' OG ' ' CE2' ' A' ' 924' ' ' PHE . 31.9 p -56.93 -13.51 2.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.855 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 924' ' ' PHE . . . . . 0.478 ' CE2' ' OG ' ' A' ' 923' ' ' SER . 74.5 m-85 -125.97 -57.33 1.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.86 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -137.17 140.14 11.14 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.462 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -74.96 98.85 3.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.896 0.379 . . . . 0.0 110.871 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 58.0 t -50.29 145.16 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.146 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 928' ' ' ILE . . . . . 0.571 HD13 ' HA ' ' A' ' 942' ' ' LEU . 20.0 pt -120.28 -45.38 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.138 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 929' ' ' LEU . . . . . 0.479 ' N ' HG13 ' A' ' 928' ' ' ILE . 11.2 tp -137.78 151.85 48.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.914 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 40.7 mt -135.97 129.85 48.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.113 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 21.4 ttt-85 -116.56 123.8 48.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -91.58 123.85 35.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.885 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 933' ' ' VAL . . . . . 0.759 HG21 ' NE1' ' A' ' 938' ' ' TRP . 3.6 t -90.78 156.97 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.17 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 934' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 933' ' ' VAL . 61.2 mm-40 -34.37 -51.32 0.45 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.1 -25.46 3.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.803 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.03 173.02 7.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 937' ' ' MET . . . . . 0.567 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 15.1 ttt -134.19 113.51 12.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.877 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 938' ' ' TRP . . . . . 0.759 ' NE1' HG21 ' A' ' 933' ' ' VAL . 37.1 m0 -93.89 151.89 19.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.889 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 939' ' ' VAL . . . . . 0.437 HG12 ' CE1' ' A' ' 941' ' ' PHE . 39.8 t -134.86 139.19 47.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.161 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 940' ' ' THR . . . . . 0.421 HG22 HD11 ' A' ' 928' ' ' ILE . 29.2 m -110.66 146.8 35.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.15 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 941' ' ' PHE . . . . . 0.437 ' CE1' HG12 ' A' ' 939' ' ' VAL . 9.7 m-85 -130.21 149.84 51.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.884 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 942' ' ' LEU . . . . . 0.571 ' HA ' HD13 ' A' ' 928' ' ' ILE . 21.2 tp -40.25 -63.63 0.6 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.902 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -107.43 168.48 9.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.91 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -76.42 -49.8 7.91 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.482 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 6.6 p -49.41 -27.25 3.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.921 0.391 . . . . 0.0 110.883 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 70.5 m -63.22 -47.59 81.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.864 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 947' ' ' ALA . . . . . 0.712 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -60.28 -27.88 67.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.107 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 18.3 mt -73.66 -25.12 60.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.933 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -81.8 -45.05 16.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.919 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 950' ' ' VAL . . . . . 0.508 HG12 ' O ' ' A' ' 947' ' ' ALA . 3.2 p -57.83 -18.8 10.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.13 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 951' ' ' LEU . . . . . 0.483 HD21 ' HG ' ' A' ' 967' ' ' LEU . 23.0 mt -51.77 -31.42 26.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.962 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 6.4 t -51.52 -17.19 0.74 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.837 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 39.8 mt -87.85 13.76 10.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.888 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -66.28 117.22 8.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 90.88 -26.7 10.29 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.5 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -41.43 128.54 3.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.794 0.331 . . . . 0.0 110.881 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -97.78 130.43 44.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.857 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 958' ' ' LEU . . . . . 0.535 HD21 ' HB3' ' A' ' 916' ' ' GLU . 15.3 tp -134.74 156.21 49.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.935 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 959' ' ' LEU . . . . . 0.427 HD11 ' HG3' ' A' ' 916' ' ' GLU . 47.0 mt 38.83 46.02 1.01 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.922 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 51.88 45.32 28.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.847 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 961' ' ' ARG . . . . . 0.849 ' HD2' HD21 ' A' ' 913' ' ' LEU . 52.0 mtt85 -151.65 105.42 3.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.925 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 962' ' ' THR . . . . . 0.452 ' HB ' ' CD ' ' A' ' 900' ' ' LYS . 18.7 m -57.75 117.49 4.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.152 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 963' ' ' ILE . . . . . 1.008 HD13 HD21 ' A' ' 917' ' ' LEU . 97.4 mt -101.14 139.03 23.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 4.2 m -123.66 116.06 22.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.177 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 965' ' ' ILE . . . . . 0.418 HG12 HG22 ' A' ' 897' ' ' VAL . 55.2 mt -101.1 139.94 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.159 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -152.03 131.25 12.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.142 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 967' ' ' LEU . . . . . 0.54 HD23 HG12 ' A' ' 895' ' ' VAL . 33.7 mt -64.55 157.87 25.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.939 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -83.75 -69.95 0.6 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 86.1 p -159.84 145.16 11.44 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.615 0.721 . . . . 0.0 110.879 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -77.64 13.13 1.72 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.682 2.254 . . . . 0.0 112.373 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 7.6 m -151.7 125.47 9.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.825 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . 147.16 73.72 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.459 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -46.38 -41.27 22.87 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.653 2.236 . . . . 0.0 112.358 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 2.0 m 53.68 32.56 14.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 16.3 p -83.59 170.72 14.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.852 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.531 -179.929 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 1.6 t -81.39 137.2 35.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.894 0.378 . . . . 0.0 110.822 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 79.7 p -64.02 -10.23 20.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.838 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . 109.77 102.82 2.75 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.53 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 13.5 t -75.76 131.29 39.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.826 0.346 . . . . 0.0 110.9 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 14.5 t -98.78 108.43 21.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.865 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -163.34 -91.82 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.483 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . 81.7 -38.06 2.49 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.485 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 33.9 m -84.75 119.73 25.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.798 0.332 . . . . 0.0 111.19 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 895' ' ' VAL . . . . . 0.766 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 13.9 m -116.31 139.76 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.152 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 896' ' ' LEU . . . . . 0.47 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 3.2 mp -89.53 150.82 22.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.891 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 64.3 t -144.95 131.66 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.178 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 5.2 t -133.53 154.71 50.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.53 HG23 ' CE2' ' A' ' 909' ' ' PHE . 4.1 pt -119.91 164.17 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.111 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 5.9 tptp -100.06 103.68 15.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 901' ' ' SER . . . . . . . . . . . . . 73.1 m -140.1 134.4 31.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.861 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 63.2 m -74.33 -66.04 0.78 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.87 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 28.0 mt -52.16 144.15 22.56 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.633 0.73 . . . . 0.0 110.921 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.29 -11.16 19.23 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.717 2.278 . . . . 0.0 112.33 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -98.87 0.94 45.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.89 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 906' ' ' ASN . . . . . 0.485 ' O ' ' N ' ' A' ' 908' ' ' PHE . 2.8 m120 -104.49 -32.59 8.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.899 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -38.97 -26.4 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 908' ' ' PHE . . . . . 0.485 ' N ' ' O ' ' A' ' 906' ' ' ASN . 51.2 m-85 -71.98 136.84 46.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 909' ' ' PHE . . . . . 0.563 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 50.6 m-85 -75.3 133.88 41.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.88 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -96.91 169.1 10.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -48.12 -38.55 18.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.878 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -67.59 -54.24 21.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.064 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 913' ' ' LEU . . . . . 0.571 ' O ' HD12 ' A' ' 917' ' ' LEU . 36.7 mt -52.92 -42.01 64.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.908 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 60.7 mt -74.08 -64.91 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.11 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -40.02 -61.55 0.85 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 916' ' ' GLU . . . . . 0.573 ' HG3' HD11 ' A' ' 959' ' ' LEU . 74.9 mm-40 -48.89 -55.52 11.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.904 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 917' ' ' LEU . . . . . 0.803 HD21 HD13 ' A' ' 963' ' ' ILE . 24.9 mt -46.5 -54.15 9.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 918' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 917' ' ' LEU . 89.4 mt -36.81 -59.39 0.69 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -55.35 -48.69 73.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -53.16 -41.3 65.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.938 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 921' ' ' PHE . . . . . 0.557 ' CZ ' ' HB3' ' A' ' 917' ' ' LEU . 19.8 m-85 -64.72 -45.0 88.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.925 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -54.03 -30.99 49.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.102 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 29.7 t -45.54 -30.98 1.62 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 924' ' ' PHE . . . . . 0.532 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 1.0 OUTLIER -120.73 -57.63 1.88 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -127.03 152.22 18.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.512 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -87.62 135.51 33.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.855 0.36 . . . . 0.0 110.889 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 46.7 t -87.7 145.93 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.113 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 928' ' ' ILE . . . . . 0.449 HG13 ' N ' ' A' ' 929' ' ' LEU . 26.6 pt -120.65 -41.56 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.093 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 929' ' ' LEU . . . . . 0.449 ' N ' HG13 ' A' ' 928' ' ' ILE . 21.9 tp -141.06 149.05 41.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.95 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 58.4 mt -133.24 132.54 58.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.144 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -118.39 130.58 56.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -97.59 120.78 38.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.851 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 933' ' ' VAL . . . . . 0.57 HG21 ' NE1' ' A' ' 938' ' ' TRP . 2.8 t -91.58 157.12 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.109 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 934' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 933' ' ' VAL . 44.3 mt-10 -33.56 -54.01 0.43 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.905 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -124.5 -22.42 4.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.817 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 6.3 ttmt -99.59 173.14 6.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.868 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 937' ' ' MET . . . . . 0.563 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 17.3 ttt -136.14 114.31 11.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 938' ' ' TRP . . . . . 0.57 ' NE1' HG21 ' A' ' 933' ' ' VAL . 37.8 m0 -94.72 143.9 26.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.96 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 47.9 t -130.78 137.82 55.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.16 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 19.4 m -106.85 144.36 33.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.18 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 941' ' ' PHE . . . . . 0.444 ' O ' ' C ' ' A' ' 942' ' ' LEU . 6.0 m-85 -125.38 144.22 50.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.909 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 942' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 941' ' ' PHE . 43.1 tp -34.33 -67.84 0.13 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.925 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -104.44 171.81 7.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.903 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -76.02 -49.6 8.48 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.499 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 945' ' ' SER . . . . . 0.428 ' HA ' HD12 ' A' ' 948' ' ' LEU . 95.6 p -50.44 -25.93 4.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.865 0.364 . . . . 0.0 110.869 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 60.7 m -65.63 -42.59 91.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.793 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 947' ' ' ALA . . . . . 0.766 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -68.62 -16.29 63.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.091 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 948' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 945' ' ' SER . 13.6 mt -87.86 -24.18 23.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.948 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -81.71 -51.05 8.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.944 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 950' ' ' VAL . . . . . 0.467 ' CG2' HD12 ' A' ' 953' ' ' LEU . 9.8 p -52.02 -20.11 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.135 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 951' ' ' LEU . . . . . 0.593 HD21 ' HG ' ' A' ' 967' ' ' LEU . 73.0 mt -50.72 -20.73 1.33 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 26.1 m -61.88 -9.43 6.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.822 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 953' ' ' LEU . . . . . 0.467 HD12 ' CG2' ' A' ' 950' ' ' VAL . 58.8 mt -95.76 11.55 33.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.926 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -67.16 117.43 9.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 90.28 -23.06 23.47 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.517 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.05 127.14 8.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.731 0.3 . . . . 0.0 110.915 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -93.06 123.06 36.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 14.9 tp -129.35 154.94 46.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.948 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 959' ' ' LEU . . . . . 0.573 HD11 ' HG3' ' A' ' 916' ' ' GLU . 39.0 mt 39.23 46.29 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.906 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 50.95 46.06 26.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.86 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 961' ' ' ARG . . . . . . . . . . . . . 41.4 mtt85 -152.02 106.47 3.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.929 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 7.7 m -60.16 111.18 1.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.141 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 963' ' ' ILE . . . . . 0.803 HD13 HD21 ' A' ' 917' ' ' LEU . 79.7 mt -95.78 146.32 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.152 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 5.4 m -129.43 118.23 21.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.131 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 965' ' ' ILE . . . . . . . . . . . . . 60.8 mt -105.11 141.28 20.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.086 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -151.59 135.69 16.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.064 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 967' ' ' LEU . . . . . 0.593 ' HG ' HD21 ' A' ' 951' ' ' LEU . 31.5 mt -68.22 158.13 33.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.917 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 968' ' ' LYS . . . . . 0.435 ' HG3' ' N ' ' A' ' 969' ' ' SER . 11.3 tptt -96.56 153.5 17.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 969' ' ' SER . . . . . 0.435 ' N ' ' HG3' ' A' ' 968' ' ' LYS . 44.9 p -129.89 92.78 36.0 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.664 0.745 . . . . 0.0 110.908 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.17 92.36 1.0 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.687 2.258 . . . . 0.0 112.388 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 53.2 p -55.97 155.83 5.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.869 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . 119.91 -95.38 0.59 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.446 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -78.49 131.94 10.81 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.684 2.256 . . . . 0.0 112.358 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 46.0 p -70.79 -49.85 42.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.869 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 1.8 m -85.68 -61.0 1.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.836 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.515 -179.956 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 25.3 p -131.93 105.18 7.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.838 0.352 . . . . 0.0 110.871 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 93.8 p -79.48 102.91 9.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.891 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . -151.93 -162.57 10.9 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.49 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 32.2 p -101.53 -45.2 5.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.88 0.371 . . . . 0.0 110.828 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 3.3 m -74.15 140.84 45.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 80.37 85.16 0.65 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.468 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . -138.26 38.66 1.67 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.441 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 90.3 m -88.05 128.8 35.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.794 0.33 . . . . 0.0 111.131 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 895' ' ' VAL . . . . . 0.539 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 23.7 m -121.0 138.86 50.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.138 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 896' ' ' LEU . . . . . 0.46 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 4.1 mp -89.71 146.4 24.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 70.2 t -144.83 125.32 7.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.098 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 10.6 t -128.07 154.13 46.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.848 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.663 HG22 HG12 ' A' ' 963' ' ' ILE . 3.6 pt -122.34 144.98 29.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -98.77 110.22 22.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 901' ' ' SER . . . . . . . . . . . . . 1.7 t -123.1 136.19 54.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.817 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 5.6 m -42.07 -47.85 4.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.829 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 14.8 mt -98.87 150.0 36.27 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.604 0.716 . . . . 0.0 110.96 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.72 -30.87 4.48 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.722 2.281 . . . . 0.0 112.343 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -70.45 -11.49 60.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 906' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -101.72 13.15 35.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.845 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -75.98 0.49 18.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.908 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -87.77 122.51 31.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.922 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 909' ' ' PHE . . . . . 0.583 ' CE2' HG23 ' A' ' 899' ' ' ILE . 91.6 m-85 -63.08 128.25 34.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.914 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.29 179.41 5.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -57.3 -45.43 84.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -57.66 -57.69 11.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.108 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 913' ' ' LEU . . . . . 0.525 HD21 ' HD2' ' A' ' 961' ' ' ARG . 87.4 mt -49.48 -55.24 13.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.965 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 49.6 mt -60.64 -63.49 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.096 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -41.12 -59.45 1.49 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -53.84 -48.94 69.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.866 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 917' ' ' LEU . . . . . 0.809 HD21 HD13 ' A' ' 963' ' ' ILE . 27.5 mt -50.97 -58.67 5.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.887 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 918' ' ' LEU . . . . . 0.469 ' CD2' HD11 ' A' ' 930' ' ' ILE . 73.0 mt -34.44 -48.16 0.34 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.915 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -63.77 -45.98 87.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.891 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 920' ' ' GLN . . . . . 0.454 ' N ' ' O ' ' A' ' 917' ' ' LEU . 15.2 mm-40 -58.1 -35.04 70.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.914 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 921' ' ' PHE . . . . . 0.553 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 17.6 m-85 -75.2 -37.7 61.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -57.76 -32.62 67.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.114 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -50.82 -23.3 2.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 924' ' ' PHE . . . . . 0.58 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 0.4 OUTLIER -125.13 -58.29 1.46 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.909 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -129.33 150.53 18.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.432 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -88.99 132.37 34.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.885 0.374 . . . . 0.0 110.86 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 22.9 t -84.58 147.33 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.19 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 928' ' ' ILE . . . . . 0.463 HG13 ' N ' ' A' ' 929' ' ' LEU . 41.6 pt -123.38 -38.19 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.158 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 929' ' ' LEU . . . . . 0.463 ' N ' HG13 ' A' ' 928' ' ' ILE . 12.0 tp -141.78 147.86 37.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 930' ' ' ILE . . . . . 0.469 HD11 ' CD2' ' A' ' 918' ' ' LEU . 79.4 mt -133.42 124.55 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.119 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -111.68 125.8 54.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -91.98 123.89 35.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.846 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 933' ' ' VAL . . . . . 0.741 HG21 ' CD1' ' A' ' 938' ' ' TRP . 3.1 t -92.07 157.02 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.078 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 934' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 933' ' ' VAL . 15.8 mt-10 -34.35 -52.37 0.48 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -125.08 -25.47 3.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.825 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.02 173.04 7.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.914 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 937' ' ' MET . . . . . 0.548 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 15.1 ttt -132.51 108.35 9.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 938' ' ' TRP . . . . . 0.741 ' CD1' HG21 ' A' ' 933' ' ' VAL . 38.1 m0 -90.26 144.89 25.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.961 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 61.1 t -131.76 133.56 61.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.131 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 940' ' ' THR . . . . . 0.462 HG22 ' N ' ' A' ' 941' ' ' PHE . 51.6 m -96.81 156.31 16.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.138 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 941' ' ' PHE . . . . . 0.462 ' N ' HG22 ' A' ' 940' ' ' THR . 15.1 m-85 -137.93 144.39 41.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.879 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 29.9 tp -47.04 -44.57 20.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.949 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -123.44 170.39 10.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.921 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -86.34 -41.15 7.08 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.465 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 38.6 p -54.66 -35.21 63.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.839 0.352 . . . . 0.0 110.86 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.76 -40.95 98.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.841 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 947' ' ' ALA . . . . . 0.539 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -64.44 -19.09 65.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.097 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 23.9 mt -83.45 -27.41 29.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -81.82 -51.26 8.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.921 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 7.0 p -48.02 -21.5 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.096 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 951' ' ' LEU . . . . . 0.604 HD21 ' HG ' ' A' ' 967' ' ' LEU . 34.1 mt -49.11 -28.44 4.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.918 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 1.1 t -50.9 -17.54 0.59 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 46.6 mt -90.39 17.32 7.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.895 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -70.87 110.79 5.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.884 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 93.66 -25.14 22.64 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.493 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -39.38 127.23 1.82 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.705 0.288 . . . . 0.0 110.865 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -94.24 125.08 38.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.87 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 958' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 959' ' ' LEU . 14.9 tp -135.41 158.65 43.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.882 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 959' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 958' ' ' LEU . 51.8 mt 38.23 44.24 0.67 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.927 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 2.7 m120 51.56 44.39 29.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 961' ' ' ARG . . . . . 0.525 ' HD2' HD21 ' A' ' 913' ' ' LEU . 34.1 mtt85 -151.45 108.69 3.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 8.6 m -62.14 118.24 7.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.132 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 963' ' ' ILE . . . . . 0.809 HD13 HD21 ' A' ' 917' ' ' LEU . 92.0 mt -103.7 137.63 31.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.136 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 7.0 m -121.47 112.78 18.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.184 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 965' ' ' ILE . . . . . . . . . . . . . 61.8 mt -97.42 139.98 18.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.105 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -149.01 138.36 21.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.098 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 967' ' ' LEU . . . . . 0.604 ' HG ' HD21 ' A' ' 951' ' ' LEU . 39.0 mt -75.84 156.07 34.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.897 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -90.24 155.77 18.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.912 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 18.2 t -116.74 92.86 39.44 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.675 0.75 . . . . 0.0 110.893 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -44.54 149.17 1.09 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.705 2.27 . . . . 0.0 112.316 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 14.6 t -124.99 154.5 41.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . 113.07 95.68 2.2 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.504 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.91 93.19 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.65 2.233 . . . . 0.0 112.379 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 29.1 t -168.88 149.21 4.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.846 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 8.1 t -122.23 -48.91 2.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.89 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.475 -179.985 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 112.418 -0.273 . . . . 0.0 112.418 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 89.0 p -102.0 -5.06 25.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.905 0.383 . . . . 0.0 110.852 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 36.8 p -95.02 174.03 7.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.882 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . -61.2 -171.91 0.91 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.492 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 29.6 t -136.1 154.24 51.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.84 0.352 . . . . 0.0 110.86 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 59.9 p -148.63 152.28 36.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.86 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 41.07 -157.72 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.486 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . -161.67 37.4 0.39 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.474 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 54.1 m -98.27 121.57 40.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.786 0.327 . . . . 0.0 111.149 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 895' ' ' VAL . . . . . 0.562 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 21.4 m -119.09 141.33 39.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.13 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 896' ' ' LEU . . . . . 0.46 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 4.5 mp -90.23 142.25 27.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.419 HG22 HG12 ' A' ' 965' ' ' ILE . 96.6 t -141.83 129.54 21.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.114 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 4.4 t -131.49 160.11 36.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.842 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.434 HG12 ' CE1' ' A' ' 909' ' ' PHE . 2.0 pt -123.21 115.03 44.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.149 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 8.9 tttp -96.63 122.64 39.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 901' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 902' ' ' SER . 1.4 t -126.94 163.54 23.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.857 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 902' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 901' ' ' SER . 47.4 m -36.18 -63.61 0.37 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.863 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 42.6 mt -98.57 157.48 34.21 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.539 0.685 . . . . 0.0 110.928 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -77.13 -25.12 8.97 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.65 2.234 . . . . 0.0 112.332 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -75.49 5.07 6.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 906' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -116.75 14.8 15.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.897 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -83.92 37.5 0.6 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.902 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -99.75 144.76 28.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 909' ' ' PHE . . . . . 0.566 ' CE2' ' HB2' ' A' ' 937' ' ' MET . 47.2 m-85 -91.58 95.66 10.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.889 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 910' ' ' ASP . . . . . 0.716 ' H ' HD12 ' A' ' 913' ' ' LEU . 24.2 m-20 -73.89 161.85 29.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.857 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -49.35 -50.97 37.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.865 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -54.78 -50.58 68.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.13 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 913' ' ' LEU . . . . . 0.716 HD12 ' H ' ' A' ' 910' ' ' ASP . 20.1 mt -51.72 -52.3 49.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 54.2 mt -60.73 -57.99 9.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.147 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -49.49 -64.0 0.94 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.893 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 916' ' ' GLU . . . . . 0.777 ' HG3' HD11 ' A' ' 959' ' ' LEU . 5.2 mm-40 -44.9 -50.45 10.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.892 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 917' ' ' LEU . . . . . 1.022 HD21 HD13 ' A' ' 963' ' ' ILE . 28.4 mt -48.37 -55.1 11.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 918' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 917' ' ' LEU . 58.4 mt -36.47 -62.98 0.43 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.941 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -54.0 -44.8 71.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -56.5 -37.39 70.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.883 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 921' ' ' PHE . . . . . 0.509 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 24.2 m-85 -73.74 -39.22 64.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.857 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -53.79 -28.07 32.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 923' ' ' SER . . . . . 0.502 ' HB3' ' CE1' ' A' ' 924' ' ' PHE . 40.9 t -46.14 -30.84 2.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.834 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 924' ' ' PHE . . . . . 0.56 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 0.3 OUTLIER -122.66 -65.09 1.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.873 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -111.67 144.96 17.7 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.462 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -87.47 96.52 10.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.874 0.369 . . . . 0.0 110.89 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 44.4 t -53.02 144.08 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.131 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 928' ' ' ILE . . . . . 0.47 HG13 ' N ' ' A' ' 929' ' ' LEU . 15.2 pt -121.92 -46.79 2.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.102 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 929' ' ' LEU . . . . . 0.47 ' N ' HG13 ' A' ' 928' ' ' ILE . 17.3 tp -131.08 149.73 52.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 45.2 mt -135.13 136.1 51.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.176 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -119.8 121.43 39.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.882 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -87.43 116.85 25.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 933' ' ' VAL . . . . . 0.775 HG21 ' NE1' ' A' ' 938' ' ' TRP . 2.9 t -85.54 156.01 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.126 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 934' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 933' ' ' VAL . 31.1 mt-10 -34.21 -51.36 0.44 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -124.15 -27.14 3.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.877 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -96.01 173.06 7.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 937' ' ' MET . . . . . 0.566 ' HB2' ' CE2' ' A' ' 909' ' ' PHE . 17.7 ttt -135.01 106.69 6.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 938' ' ' TRP . . . . . 0.775 ' NE1' HG21 ' A' ' 933' ' ' VAL . 33.3 m0 -85.92 153.6 22.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.924 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 939' ' ' VAL . . . . . 0.442 ' O ' HG22 ' A' ' 895' ' ' VAL . 87.4 t -139.74 128.25 26.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.139 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 27.0 m -90.95 151.51 21.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.128 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 941' ' ' PHE . . . . . 0.438 ' O ' ' C ' ' A' ' 942' ' ' LEU . 11.6 m-85 -132.68 141.84 48.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.857 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 942' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 941' ' ' PHE . 19.6 tp -34.41 -64.59 0.24 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.89 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -117.82 150.96 38.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.874 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -53.43 -45.95 65.4 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.458 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 14.6 t -50.77 -41.05 56.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.845 0.355 . . . . 0.0 110.832 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 9.2 m -58.77 -26.29 63.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.836 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 947' ' ' ALA . . . . . 0.562 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -81.58 -13.11 58.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.127 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 33.6 mt -88.06 -28.08 21.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.953 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 33.0 m-20 -82.88 -45.37 14.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 8.7 p -53.47 -22.79 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.174 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 951' ' ' LEU . . . . . 0.481 HD21 ' HG ' ' A' ' 967' ' ' LEU . 63.1 mt -50.95 -25.54 4.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.886 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 15.3 m -54.4 -16.65 2.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.849 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 23.4 mt -89.61 16.02 8.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.912 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -68.44 119.96 13.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.937 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 955' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 956' ' ' LYS . . . 88.11 -30.79 4.98 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.524 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 956' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 955' ' ' GLY . 8.6 tmtm? -35.38 127.87 0.58 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.693 0.282 . . . . 0.0 110.911 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -96.41 131.8 42.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.835 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 13.5 tp -138.1 154.56 49.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 959' ' ' LEU . . . . . 0.777 HD11 ' HG3' ' A' ' 916' ' ' GLU . 87.6 mt 39.53 45.39 1.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.938 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 55.96 46.36 22.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 961' ' ' ARG . . . . . . . . . . . . . 46.3 mtt85 -154.64 121.86 5.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.884 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 8.3 m -74.08 108.39 6.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.124 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 963' ' ' ILE . . . . . 1.022 HD13 HD21 ' A' ' 917' ' ' LEU . 90.1 mt -88.95 130.94 37.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.177 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 9.2 m -116.45 119.38 35.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.1 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 965' ' ' ILE . . . . . 0.419 HG12 HG22 ' A' ' 897' ' ' VAL . 59.3 mt -103.36 140.31 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.124 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -149.47 136.06 19.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.082 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 967' ' ' LEU . . . . . 0.481 ' HG ' HD21 ' A' ' 951' ' ' LEU . 27.0 mt -70.57 154.62 41.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.921 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -87.17 148.59 25.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.871 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 89.7 p -121.36 79.0 36.22 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.676 0.751 . . . . 0.0 110.862 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 970' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 971' ' ' SER . 72.6 Cg_exo -44.76 147.43 1.83 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.669 2.246 . . . . 0.0 112.353 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 971' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 970' ' ' PRO . 3.3 t -37.84 -53.87 1.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.917 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . 157.37 95.3 0.11 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.467 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.84 130.51 12.51 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.67 2.247 . . . . 0.0 112.338 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 37.6 p -166.4 140.31 4.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.873 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 3.3 m -47.12 -59.61 3.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.855 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.466 -179.976 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 N-CA-C 112.531 -0.227 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 65.6 p -75.58 82.35 2.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.869 0.366 . . . . 0.0 110.858 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 19.6 m 44.75 41.99 5.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.827 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . -100.7 156.19 19.34 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.525 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 8.3 t -39.27 -50.49 1.99 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 110.842 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 59.8 p -63.28 144.43 56.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.865 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 94.72 87.79 1.7 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.486 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . -121.04 34.9 3.85 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.499 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 97.3 m -102.35 119.13 38.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.792 0.33 . . . . 0.0 111.157 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 895' ' ' VAL . . . . . 0.658 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 20.3 m -112.72 140.06 34.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.091 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 896' ' ' LEU . . . . . 0.47 ' HG ' ' CD1' ' A' ' 938' ' ' TRP . 3.9 mp -91.46 142.68 27.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.566 HG22 HG12 ' A' ' 965' ' ' ILE . 93.7 t -140.46 124.92 18.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.135 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 18.0 t -127.54 154.88 44.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.456 HD13 HD13 ' A' ' 913' ' ' LEU . 5.2 pt -121.41 155.66 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.107 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -99.65 109.17 21.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 901' ' ' SER . . . . . . . . . . . . . 15.6 m -139.64 129.09 24.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 55.2 m -52.59 -74.39 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 21.4 mt -65.05 150.53 95.23 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.614 0.721 . . . . 0.0 110.862 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.68 -26.8 9.53 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.735 2.29 . . . . 0.0 112.359 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -69.56 -1.9 9.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.885 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 906' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -118.13 -14.33 9.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 -63.73 -8.15 9.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.869 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -93.83 128.97 40.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.855 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 909' ' ' PHE . . . . . 0.673 ' HA ' HD12 ' A' ' 913' ' ' LEU . 91.5 m-85 -62.61 119.98 10.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.873 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -93.1 -178.59 4.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -55.72 -42.53 75.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.854 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -65.5 -57.89 7.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.102 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 913' ' ' LEU . . . . . 0.673 HD12 ' HA ' ' A' ' 909' ' ' PHE . 19.4 mt -49.96 -45.84 51.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.938 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 44.2 mt -71.47 -64.76 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.102 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -38.03 -59.58 0.83 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 916' ' ' GLU . . . . . 0.509 ' HB3' HD21 ' A' ' 958' ' ' LEU . 33.8 mm-40 -52.25 -52.33 53.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.863 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 917' ' ' LEU . . . . . 1.032 HD21 HD13 ' A' ' 963' ' ' ILE . 31.6 mt -49.58 -55.93 11.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.918 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 918' ' ' LEU . . . . . 0.439 ' C ' ' O ' ' A' ' 917' ' ' LEU . 77.8 mt -35.06 -57.86 0.55 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -58.15 -40.79 82.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.92 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 920' ' ' GLN . . . . . 0.433 ' N ' ' O ' ' A' ' 917' ' ' LEU . 35.6 mm-40 -61.56 -38.08 86.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 921' ' ' PHE . . . . . 0.566 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 20.1 m-85 -70.88 -36.06 72.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -58.86 -34.65 71.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.133 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.7 m -47.18 -26.54 1.18 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 924' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 0.7 OUTLIER -121.01 -65.37 1.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.894 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -122.22 150.76 16.95 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.507 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -85.71 140.16 30.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.881 0.372 . . . . 0.0 110.879 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 62.1 t -94.74 142.63 13.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.076 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 928' ' ' ILE . . . . . 0.487 HG13 ' N ' ' A' ' 929' ' ' LEU . 41.4 pt -121.64 -39.92 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.13 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 929' ' ' LEU . . . . . 0.487 ' N ' HG13 ' A' ' 928' ' ' ILE . 17.7 tp -139.97 139.21 36.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.926 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 74.0 mt -127.52 129.47 70.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.123 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 5.0 tpm_? -116.23 125.25 51.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.888 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -94.84 114.9 26.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 933' ' ' VAL . . . . . 0.605 HG21 ' NE1' ' A' ' 938' ' ' TRP . 2.6 t -83.41 157.11 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.167 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 934' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 933' ' ' VAL . 53.2 mt-10 -34.04 -50.85 0.4 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.909 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -125.31 -25.93 3.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.855 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 936' ' ' LYS . . . . . 0.447 ' O ' ' N ' ' A' ' 933' ' ' VAL . 1.0 OUTLIER -97.3 169.83 9.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 937' ' ' MET . . . . . 0.518 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 16.4 ttt -132.03 111.52 11.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.844 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 938' ' ' TRP . . . . . 0.605 ' NE1' HG21 ' A' ' 933' ' ' VAL . 39.2 m0 -91.96 144.13 25.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.932 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 939' ' ' VAL . . . . . 0.436 HG12 ' CE1' ' A' ' 941' ' ' PHE . 47.0 t -131.46 135.82 58.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 23.1 m -108.88 148.17 31.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.133 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 941' ' ' PHE . . . . . 0.436 ' CE1' HG12 ' A' ' 939' ' ' VAL . 6.9 m-85 -128.32 152.14 48.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.826 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 45.1 tp -41.92 -62.73 0.85 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.944 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -105.63 172.3 6.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -77.49 -44.83 12.04 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.517 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 45.6 t -56.67 -30.5 63.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.872 0.368 . . . . 0.0 110.858 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 72.7 m -58.94 -33.94 71.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.819 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 947' ' ' ALA . . . . . 0.658 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -74.19 -20.19 60.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.057 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 30.0 mt -83.48 -26.06 30.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.871 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -80.14 -41.24 25.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.87 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 8.2 p -61.75 -21.98 27.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.159 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 50.7 mt -50.38 -25.41 3.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 952' ' ' SER . . . . . 0.423 ' HB2' ' CE2' ' A' ' 924' ' ' PHE . 67.9 m -56.1 -13.72 2.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.832 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 24.4 mt -93.3 17.24 11.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.908 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -70.77 119.24 14.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 88.09 -25.26 9.12 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.489 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -41.63 127.43 3.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.759 0.314 . . . . 0.0 110.896 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -95.65 124.28 39.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.86 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 958' ' ' LEU . . . . . 0.509 HD21 ' HB3' ' A' ' 916' ' ' GLU . 14.9 tp -131.93 151.64 51.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.931 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 44.0 mt 41.14 49.63 3.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.916 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 50.47 37.27 15.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 961' ' ' ARG . . . . . 0.441 ' HD2' ' CD2' ' A' ' 913' ' ' LEU . 56.9 mtt85 -143.63 106.06 4.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.851 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 60.5 m -65.31 112.78 3.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.14 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 963' ' ' ILE . . . . . 1.032 HD13 HD21 ' A' ' 917' ' ' LEU . 71.2 mt -93.17 149.26 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.128 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 1.7 m -131.94 109.02 9.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.136 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 965' ' ' ILE . . . . . 0.566 HG12 HG22 ' A' ' 897' ' ' VAL . 70.3 mt -92.5 139.24 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.102 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -150.6 135.17 17.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.103 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 967' ' ' LEU . . . . . . . . . . . . . 26.6 mt -67.94 154.39 41.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.895 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 16.7 tptp -86.63 113.2 22.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.925 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 95.0 p -145.48 144.18 22.14 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.617 0.722 . . . . 0.0 110.897 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.62 -48.44 13.83 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.709 2.273 . . . . 0.0 112.343 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 3.8 m -132.42 130.33 40.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.84 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -65.34 -71.18 0.92 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.489 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.68 101.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.688 2.258 . . . . 0.0 112.315 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 69.8 m -56.61 145.57 28.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.88 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 21.0 t -150.01 168.78 22.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.829 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.502 179.998 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 58.3 m -151.9 163.5 39.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.898 0.38 . . . . 0.0 110.865 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 5.9 t -155.09 164.21 39.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.853 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . -106.54 51.64 0.73 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.454 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 37.2 m -78.0 171.24 15.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.93 0.395 . . . . 0.0 110.859 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 32.7 t -167.57 134.11 2.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.825 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 125.94 98.37 1.11 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.482 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . -97.05 53.45 1.38 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.496 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 89.4 m -98.05 120.41 38.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.887 0.375 . . . . 0.0 111.129 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 895' ' ' VAL . . . . . 0.695 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 10.8 m -113.63 138.61 42.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.088 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 896' ' ' LEU . . . . . 0.463 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 4.2 mp -90.47 143.57 26.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.968 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.423 HG13 ' CG2' ' A' ' 963' ' ' ILE . 95.6 t -141.78 130.36 22.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.107 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 10.8 t -129.53 152.37 49.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.551 HG23 ' CE2' ' A' ' 909' ' ' PHE . 2.8 pt -121.05 141.79 40.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.111 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 900' ' ' LYS . . . . . 0.427 ' HD2' ' N ' ' A' ' 900' ' ' LYS . 0.0 OUTLIER -85.89 109.62 18.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.936 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 901' ' ' SER . . . . . . . . . . . . . 95.1 p -124.97 161.55 26.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.826 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 23.5 m -96.48 -39.03 9.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.884 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 38.0 mt -98.63 151.0 37.25 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.572 0.701 . . . . 0.0 110.922 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.49 -13.62 20.36 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.702 2.268 . . . . 0.0 112.31 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -94.16 11.42 30.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.862 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 906' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -122.99 -26.16 4.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 907' ' ' ASN . . . . . 0.431 ' O ' HD11 ' A' ' 899' ' ' ILE . 36.2 p-10 -48.02 -28.02 2.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -74.76 115.96 14.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 909' ' ' PHE . . . . . 0.585 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 97.1 m-85 -51.07 119.92 4.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 910' ' ' ASP . . . . . 0.711 ' H ' HD12 ' A' ' 913' ' ' LEU . 6.3 t70 -84.71 179.02 7.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.87 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -58.61 -45.26 89.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -60.15 -60.85 3.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.068 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 913' ' ' LEU . . . . . 0.862 HD11 ' NH1' ' A' ' 961' ' ' ARG . 35.4 mt -45.31 -49.49 12.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.961 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 52.0 mt -63.6 -53.19 48.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.157 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -46.4 -56.63 5.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.846 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 916' ' ' GLU . . . . . 0.64 ' OE2' HD21 ' A' ' 959' ' ' LEU . 13.6 mt-10 -56.65 -51.49 68.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 917' ' ' LEU . . . . . 0.902 HD21 HD13 ' A' ' 963' ' ' ILE . 51.0 mt -46.13 -57.85 4.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 918' ' ' LEU . . . . . . . . . . . . . 99.3 mt -36.95 -62.99 0.45 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.953 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -54.02 -44.22 70.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.919 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -57.67 -38.91 75.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 921' ' ' PHE . . . . . 0.543 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 23.3 m-85 -72.68 -36.88 68.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.903 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -56.73 -32.69 65.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.102 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -52.04 -17.89 1.21 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.854 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 924' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 1.8 m-85 -126.06 -58.17 1.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.88 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -134.68 151.12 20.28 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.505 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -83.1 134.95 34.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.887 0.375 . . . . 0.0 110.872 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 41.2 t -89.01 143.47 11.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.177 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 928' ' ' ILE . . . . . 0.487 HG13 ' N ' ' A' ' 929' ' ' LEU . 20.4 pt -121.82 -45.83 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 929' ' ' LEU . . . . . 0.487 ' N ' HG13 ' A' ' 928' ' ' ILE . 25.5 tp -131.66 146.16 52.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 93.5 mt -136.71 122.86 28.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.113 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -111.26 123.35 50.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -87.64 118.58 27.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 933' ' ' VAL . . . . . 0.737 HG21 ' NE1' ' A' ' 938' ' ' TRP . 3.5 t -86.17 157.14 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.119 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 934' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 933' ' ' VAL . 32.3 mt-10 -33.82 -53.82 0.45 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -124.18 -20.73 5.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.89 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 19.3 tttt -101.31 173.04 6.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.897 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 937' ' ' MET . . . . . 0.585 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 12.7 ttt -133.58 114.03 13.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.897 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 938' ' ' TRP . . . . . 0.737 ' NE1' HG21 ' A' ' 933' ' ' VAL . 43.3 m0 -91.25 146.2 24.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 939' ' ' VAL . . . . . 0.479 HG12 ' CE1' ' A' ' 941' ' ' PHE . 61.0 t -136.15 122.27 30.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.117 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 6.8 m -91.07 150.49 21.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.151 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 941' ' ' PHE . . . . . 0.479 ' CE1' HG12 ' A' ' 939' ' ' VAL . 9.1 m-85 -130.28 144.26 51.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.912 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 942' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 941' ' ' PHE . 61.1 tp -34.55 -59.76 0.45 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -117.9 169.65 9.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.892 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -71.68 -49.13 25.36 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.514 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 74.1 p -50.56 -28.61 8.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.859 0.362 . . . . 0.0 110.857 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 6.0 m -67.05 -32.32 73.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.881 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 947' ' ' ALA . . . . . 0.695 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -82.36 -13.82 56.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.086 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 42.8 mt -87.36 -29.53 21.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.924 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -82.49 -37.66 24.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.903 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 9.2 p -61.94 -15.61 14.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.098 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 951' ' ' LEU . . . . . 0.644 HD11 HD11 ' A' ' 967' ' ' LEU . 40.0 mt -53.93 -26.32 24.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.94 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 33.3 t -53.46 -15.78 1.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.861 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 36.9 mt -89.89 14.15 12.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.929 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -68.76 116.97 9.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.864 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 90.58 -25.82 12.22 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.473 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 956' ' ' LYS . . . . . 0.58 ' HZ3' HD13 ' A' ' 958' ' ' LEU . 3.5 tmtt? -39.71 127.76 2.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.744 0.307 . . . . 0.0 110.883 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -94.48 131.37 40.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.901 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 958' ' ' LEU . . . . . 0.58 HD13 ' HZ3' ' A' ' 956' ' ' LYS . 15.8 tp -141.35 153.18 44.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.881 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 959' ' ' LEU . . . . . 0.64 HD21 ' OE2' ' A' ' 916' ' ' GLU . 38.2 mt 41.42 48.2 3.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.952 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 960' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 960' ' ' ASN . 1.4 p-10 48.18 42.41 17.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 961' ' ' ARG . . . . . 0.862 ' NH1' HD11 ' A' ' 913' ' ' LEU . 73.9 mtt180 -149.72 108.49 3.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 6.8 m -60.26 119.11 7.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.156 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 963' ' ' ILE . . . . . 0.902 HD13 HD21 ' A' ' 917' ' ' LEU . 91.4 mt -102.6 134.0 44.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.148 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 3.8 m -119.76 119.17 32.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.108 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 965' ' ' ILE . . . . . . . . . . . . . 51.2 mt -101.26 142.12 16.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.128 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -151.21 131.5 13.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.082 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 967' ' ' LEU . . . . . 0.644 HD11 HD11 ' A' ' 951' ' ' LEU . 30.9 mt -69.85 158.34 35.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 968' ' ' LYS . . . . . 0.458 ' O ' ' C ' ' A' ' 969' ' ' SER . 18.5 tptt -98.65 145.14 27.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.935 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 969' ' ' SER . . . . . 0.458 ' C ' ' O ' ' A' ' 968' ' ' LYS . 27.3 m -33.84 97.01 0.11 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.655 0.741 . . . . 0.0 110.851 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 970' ' ' PRO . . . . . 0.432 ' N ' ' O ' ' A' ' 968' ' ' LYS . 61.8 Cg_endo -76.93 41.75 0.98 Allowed 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.678 2.252 . . . . 0.0 112.323 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 68.7 m -51.09 -45.0 61.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.864 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . 86.96 94.07 0.9 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.499 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -76.64 133.53 14.29 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.659 2.239 . . . . 0.0 112.399 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 23.1 t -74.34 167.56 21.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.866 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 6.1 m -62.92 163.87 8.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.85 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.457 -179.981 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.42 -0.272 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 38.7 p -138.52 171.17 14.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.874 0.369 . . . . 0.0 110.843 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 20.2 t -65.44 110.93 2.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.884 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 889' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 890' ' ' SER . . . -134.26 -81.78 0.16 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.494 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 890' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 889' ' ' GLY . 60.5 p 34.57 38.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.914 0.387 . . . . 0.0 110.875 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 3.5 m -138.66 139.44 38.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.839 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 125.95 -170.01 17.85 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.476 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . 119.46 -84.59 0.37 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.495 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 75.8 m -93.53 116.94 29.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.839 0.352 . . . . 0.0 111.122 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 895' ' ' VAL . . . . . 0.566 HG12 HD23 ' A' ' 967' ' ' LEU . 18.8 m -112.29 142.92 23.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.125 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 896' ' ' LEU . . . . . 0.468 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 4.2 mp -91.08 146.84 23.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.651 HG22 HG12 ' A' ' 965' ' ' ILE . 92.9 t -146.9 125.56 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.118 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 6.4 t -125.71 155.59 40.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.549 HG23 ' CE2' ' A' ' 909' ' ' PHE . 2.2 pt -121.82 137.23 56.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.093 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 34.4 mtmt -88.93 113.81 24.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.899 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 901' ' ' SER . . . . . 0.403 ' HB2' ' CB ' ' A' ' 906' ' ' ASN . 78.5 p -125.5 139.56 53.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.861 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 38.9 m -42.05 -64.03 0.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.862 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 7.4 mt -96.34 140.98 22.48 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.571 0.701 . . . . 0.0 110.907 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -49.71 -43.59 39.46 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.657 2.238 . . . . 0.0 112.371 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -56.7 -15.42 4.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.865 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 906' ' ' ASN . . . . . 0.403 ' CB ' ' HB2' ' A' ' 901' ' ' SER . 96.6 m-20 -98.07 14.92 25.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.887 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -83.0 -13.02 56.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.859 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -75.82 127.83 33.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 909' ' ' PHE . . . . . 0.549 ' CE2' HG23 ' A' ' 899' ' ' ILE . 76.2 m-85 -64.43 127.36 31.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 910' ' ' ASP . . . . . 0.585 ' H ' HD12 ' A' ' 913' ' ' LEU . 35.0 m-20 -92.99 159.03 15.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.879 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -45.08 -49.71 11.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -53.92 -51.92 62.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.087 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 913' ' ' LEU . . . . . 0.649 HD11 ' CD ' ' A' ' 961' ' ' ARG . 41.3 mt -53.36 -53.45 50.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.909 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 54.2 mt -60.14 -62.9 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.125 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -42.38 -51.03 5.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -61.49 -44.11 97.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.864 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 917' ' ' LEU . . . . . 0.842 HD21 HD13 ' A' ' 963' ' ' ILE . 26.1 mt -56.84 -57.9 10.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 918' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 917' ' ' LEU . 66.5 mt -34.82 -48.83 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -64.94 -47.56 77.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 60.2 mm-40 -55.75 -37.43 68.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 921' ' ' PHE . . . . . 0.571 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 22.4 m-85 -67.32 -50.8 58.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -46.27 -24.23 0.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.07 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 923' ' ' SER . . . . . 0.449 ' HB3' ' CE1' ' A' ' 924' ' ' PHE . 31.2 t -48.76 -32.06 7.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 924' ' ' PHE . . . . . 0.57 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 0.3 OUTLIER -123.18 -52.94 1.84 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -131.84 147.92 18.85 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.524 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -84.87 135.43 34.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.854 0.359 . . . . 0.0 110.926 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 11.9 t -81.86 145.37 8.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.143 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 928' ' ' ILE . . . . . 0.62 HD13 ' HA ' ' A' ' 942' ' ' LEU . 42.8 pt -122.17 -36.39 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.161 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 929' ' ' LEU . . . . . 0.478 ' N ' HG13 ' A' ' 928' ' ' ILE . 10.2 tp -144.09 146.48 32.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.889 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 50.0 mt -135.9 128.8 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.135 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 16.0 ttt-85 -118.75 123.93 46.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.907 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -91.22 122.06 33.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 933' ' ' VAL . . . . . 0.574 HG21 ' NE1' ' A' ' 938' ' ' TRP . 2.8 t -90.22 157.09 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.114 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 934' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 933' ' ' VAL . 81.2 mm-40 -33.71 -51.77 0.39 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.886 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -124.96 -26.18 3.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 7.9 ttmm -96.45 170.87 8.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 937' ' ' MET . . . . . 0.466 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 16.2 ttt -134.46 112.17 10.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.863 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 938' ' ' TRP . . . . . 0.574 ' NE1' HG21 ' A' ' 933' ' ' VAL . 36.0 m0 -93.35 142.13 27.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 53.9 t -130.48 127.43 62.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.171 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 8.9 m -98.57 152.63 19.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 941' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -127.92 145.89 50.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 942' ' ' LEU . . . . . 0.62 ' HA ' HD13 ' A' ' 928' ' ' ILE . 22.7 tp -41.22 -40.84 1.69 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.949 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -130.39 176.69 7.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.919 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -86.32 -53.76 2.87 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.526 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 59.0 p -46.69 -22.34 0.28 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.882 0.372 . . . . 0.0 110.884 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 2.1 p -75.22 -37.12 61.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.841 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 947' ' ' ALA . . . . . 0.499 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -70.7 -16.35 62.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 29.1 mt -84.05 -28.87 27.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.943 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -80.95 -46.48 15.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.859 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 7.6 p -53.83 -17.38 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.127 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 60.8 mt -53.15 -23.27 7.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.872 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 1.8 t -59.05 -11.15 3.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.838 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 51.1 mt -94.03 16.26 14.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 954' ' ' ASN . . . . . 0.402 ' O ' ' CG ' ' A' ' 954' ' ' ASN . 1.9 p30 -70.64 119.37 14.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 955' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 956' ' ' LYS . . . 86.15 -28.48 5.11 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.531 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 956' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 955' ' ' GLY . 0.1 OUTLIER -36.13 127.23 0.75 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.756 0.313 . . . . 0.0 110.873 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -92.94 128.02 38.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 14.2 tp -138.41 148.41 44.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.95 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 49.4 mt 43.13 52.53 5.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.944 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 44.83 44.7 7.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.904 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 961' ' ' ARG . . . . . 0.649 ' CD ' HD11 ' A' ' 913' ' ' LEU . 41.6 mtt85 -151.33 106.07 3.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.844 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 6.3 m -61.44 119.02 7.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.088 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 963' ' ' ILE . . . . . 0.842 HD13 HD21 ' A' ' 917' ' ' LEU . 92.7 mt -102.47 139.88 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.147 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 6.1 m -124.73 112.25 16.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.119 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 965' ' ' ILE . . . . . 0.651 HG12 HG22 ' A' ' 897' ' ' VAL . 61.4 mt -98.42 139.04 21.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.077 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -153.84 137.88 16.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.129 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 967' ' ' LEU . . . . . 0.566 HD23 HG12 ' A' ' 895' ' ' VAL . 26.2 mt -68.63 156.37 38.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.922 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 11.6 tptm -74.3 -59.07 2.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 3.8 m -158.92 154.36 22.38 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.717 0.77 . . . . 0.0 110.808 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.19 -26.24 7.8 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.649 2.233 . . . . 0.0 112.351 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 13.2 t -101.09 -54.04 2.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.87 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . 178.64 178.77 48.21 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.529 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -76.93 -22.58 11.44 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.669 2.246 . . . . 0.0 112.332 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 26.5 t -157.22 107.82 2.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 41.9 m -147.91 161.85 40.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.874 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.467 179.99 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.461 -0.256 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 31.9 t -88.3 84.62 6.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.858 0.361 . . . . 0.0 110.877 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 3.3 m -107.64 140.73 40.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.849 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . 136.67 146.92 5.26 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.473 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 8.5 t 56.66 40.15 29.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.862 0.363 . . . . 0.0 110.9 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 50.6 p -140.18 136.37 33.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 100.08 168.91 29.42 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.524 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . -151.35 45.22 0.64 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.513 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 87.5 m -108.31 126.74 53.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.786 0.327 . . . . 0.0 111.146 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 895' ' ' VAL . . . . . 0.442 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 6.3 m -120.09 137.0 55.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.115 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 896' ' ' LEU . . . . . 0.471 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 4.7 mp -89.2 142.94 27.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.906 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.408 HG13 ' CG2' ' A' ' 963' ' ' ILE . 99.4 t -140.22 127.69 23.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.166 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 13.5 t -130.18 156.68 44.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.83 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.489 HG22 HG12 ' A' ' 963' ' ' ILE . 4.1 pt -121.17 150.36 24.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.122 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.73 107.72 19.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 901' ' ' SER . . . . . . . . . . . . . 60.4 p -127.97 162.2 27.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.869 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 73.1 m -99.58 -45.39 5.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.89 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 12.3 mt -89.14 156.04 49.1 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.635 0.731 . . . . 0.0 110.893 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.14 -19.69 15.34 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.647 2.231 . . . . 0.0 112.394 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -89.98 17.03 7.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 906' ' ' ASN . . . . . 0.428 ' O ' ' N ' ' A' ' 908' ' ' PHE . 3.3 m-80 -127.66 -34.07 2.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.912 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 36.4 p-10 -40.96 -26.41 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 908' ' ' PHE . . . . . 0.428 ' N ' ' O ' ' A' ' 906' ' ' ASN . 15.4 m-85 -76.17 159.99 30.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.914 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 909' ' ' PHE . . . . . 0.581 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 49.8 m-85 -96.63 134.19 40.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -98.75 178.79 4.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.89 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -58.56 -26.04 63.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.863 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -78.52 -57.39 3.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.11 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 913' ' ' LEU . . . . . 0.608 HD21 ' CD ' ' A' ' 961' ' ' ARG . 82.0 mt -52.87 -39.95 63.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.97 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 914' ' ' ILE . . . . . 0.435 HD13 ' CZ ' ' A' ' 932' ' ' PHE . 28.9 mt -72.57 -64.09 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.164 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -43.21 -54.07 4.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.84 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -55.43 -51.03 68.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 917' ' ' LEU . . . . . 0.93 HD21 HD13 ' A' ' 963' ' ' ILE . 20.6 mt -48.94 -54.14 16.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.905 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 918' ' ' LEU . . . . . 0.426 ' C ' ' O ' ' A' ' 917' ' ' LEU . 41.9 mt -34.75 -65.79 0.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.905 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -51.11 -52.26 45.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 920' ' ' GLN . . . . . 0.4 ' O ' HD11 ' A' ' 953' ' ' LEU . 89.3 mm-40 -48.85 -40.2 28.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.873 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 921' ' ' PHE . . . . . 0.549 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 23.1 m-85 -71.21 -42.79 68.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 922' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 924' ' ' PHE . . . -49.62 -39.48 35.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.095 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.7 m -43.02 -24.25 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.837 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 924' ' ' PHE . . . . . 0.554 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 0.6 OUTLIER -123.67 -63.02 1.26 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -123.13 147.24 16.67 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.469 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -84.39 128.01 34.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.931 0.396 . . . . 0.0 110.88 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 34.4 t -81.71 144.24 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.144 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 928' ' ' ILE . . . . . 0.486 HG13 ' N ' ' A' ' 929' ' ' LEU . 23.9 pt -123.18 -44.72 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.1 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 929' ' ' LEU . . . . . 0.486 ' N ' HG13 ' A' ' 928' ' ' ILE . 21.0 tp -134.48 144.05 47.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.964 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 930' ' ' ILE . . . . . 0.462 ' H ' HD12 ' A' ' 929' ' ' LEU . 43.5 mt -135.71 134.55 51.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.118 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.26 124.52 32.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 932' ' ' PHE . . . . . 0.435 ' CZ ' HD13 ' A' ' 914' ' ' ILE . 30.4 m-85 -86.95 118.66 26.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 933' ' ' VAL . . . . . 0.71 HG21 ' CD1' ' A' ' 938' ' ' TRP . 2.6 t -82.95 157.37 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 934' ' ' GLU . . . . . 0.472 ' C ' ' O ' ' A' ' 933' ' ' VAL . 29.4 mm-40 -32.24 -53.41 0.3 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.905 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -125.31 -25.89 3.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -97.23 173.14 7.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.9 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 937' ' ' MET . . . . . 0.581 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 15.3 ttt -135.71 110.29 8.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.907 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 938' ' ' TRP . . . . . 0.71 ' CD1' HG21 ' A' ' 933' ' ' VAL . 20.3 m0 -95.95 138.58 33.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.874 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 939' ' ' VAL . . . . . 0.426 HG12 ' CE1' ' A' ' 941' ' ' PHE . 94.4 t -122.35 134.97 63.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.117 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 52.3 m -98.62 148.96 23.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.145 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 941' ' ' PHE . . . . . 0.426 ' CE1' HG12 ' A' ' 939' ' ' VAL . 9.3 m-85 -130.69 152.06 50.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.862 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 942' ' ' LEU . . . . . 0.421 ' HA ' HD13 ' A' ' 928' ' ' ILE . 55.5 tp -48.79 -53.53 18.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.891 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -115.91 177.81 4.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -87.34 -46.92 4.82 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.494 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 91.8 p -50.89 -39.47 54.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.924 0.392 . . . . 0.0 110.857 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.11 -27.63 67.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.858 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 947' ' ' ALA . . . . . 0.442 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -80.22 -15.38 57.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.135 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 21.6 mt -87.34 -29.35 21.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.907 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -79.9 -41.35 26.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.903 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 4.3 p -56.06 -16.92 3.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.166 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 951' ' ' LEU . . . . . 0.651 HD21 ' HG ' ' A' ' 967' ' ' LEU . 31.1 mt -52.65 -29.74 27.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 3.1 m -53.03 -25.56 12.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.861 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 953' ' ' LEU . . . . . 0.555 ' C ' HD12 ' A' ' 965' ' ' ILE . 32.1 mt -78.95 9.04 4.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.948 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 954' ' ' ASN . . . . . 0.414 ' N ' HD12 ' A' ' 965' ' ' ILE . 0.4 OUTLIER -70.43 118.49 13.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.841 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 92.33 -26.38 13.85 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.442 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 956' ' ' LYS . . . . . 0.677 ' NZ ' HD13 ' A' ' 958' ' ' LEU . 3.7 tmtt? -42.08 128.35 3.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.751 0.31 . . . . 0.0 110.893 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -93.87 127.17 39.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 958' ' ' LEU . . . . . 0.677 HD13 ' NZ ' ' A' ' 956' ' ' LYS . 13.6 tp -140.45 157.07 46.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.955 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 37.4 mt 39.1 44.84 0.98 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.954 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 6.8 m120 49.79 44.36 24.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.906 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 961' ' ' ARG . . . . . 0.608 ' CD ' HD21 ' A' ' 913' ' ' LEU . 52.0 mtt180 -152.07 108.06 3.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 2.9 m -61.81 118.67 7.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.102 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 963' ' ' ILE . . . . . 0.93 HD13 HD21 ' A' ' 917' ' ' LEU . 86.3 mt -103.24 137.94 29.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.12 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 9.7 m -123.87 117.43 24.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.183 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 965' ' ' ILE . . . . . 0.555 HD12 ' C ' ' A' ' 953' ' ' LEU . 19.1 mt -97.77 146.93 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.186 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -155.18 128.86 8.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.098 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 967' ' ' LEU . . . . . 0.651 ' HG ' HD21 ' A' ' 951' ' ' LEU . 33.5 mt -66.05 157.98 29.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.88 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 968' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 969' ' ' SER . 15.8 tptp -105.12 -63.67 1.21 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.899 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 969' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 968' ' ' LYS . 18.3 p -34.74 143.93 0.21 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.674 0.749 . . . . 0.0 110.872 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -78.1 106.62 2.19 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.701 2.267 . . . . 0.0 112.362 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 24.1 m -76.93 -49.05 16.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.883 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -72.93 -175.7 29.16 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.486 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.6 141.53 7.95 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.701 2.268 . . . . 0.0 112.367 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 30.1 t -45.73 143.37 2.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.858 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 97.0 p -158.15 177.3 11.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.848 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.499 179.993 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 36.8 p -155.36 160.03 40.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.863 0.363 . . . . 0.0 110.864 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 18.3 m -107.42 159.21 16.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.858 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . -123.31 -43.95 0.34 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.504 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 97.3 p -71.74 -44.21 64.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.887 0.375 . . . . 0.0 110.889 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 3.5 t -57.52 163.21 2.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.844 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -87.84 -114.29 1.12 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.47 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . -151.36 45.71 0.62 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.467 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 87.2 m -90.79 126.95 36.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.762 0.315 . . . . 0.0 111.21 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 895' ' ' VAL . . . . . 0.676 HG12 HD23 ' A' ' 967' ' ' LEU . 17.6 m -118.18 138.81 47.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.165 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 896' ' ' LEU . . . . . 0.47 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 6.3 mp -90.34 138.63 31.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.936 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.521 HG22 HG12 ' A' ' 965' ' ' ILE . 86.6 t -139.54 124.3 20.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.1 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 12.3 t -127.96 155.68 43.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.848 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.545 HG22 HG12 ' A' ' 963' ' ' ILE . 2.7 pt -120.37 135.22 61.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.144 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -96.16 115.92 28.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.9 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 901' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 902' ' ' SER . 5.6 t -132.28 145.02 51.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.824 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 902' ' ' SER . . . . . 0.438 ' C ' ' O ' ' A' ' 901' ' ' SER . 3.4 m -35.04 -58.12 0.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.887 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 9.1 mt -98.21 144.34 27.9 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.639 0.733 . . . . 0.0 110.889 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.88 -23.17 14.33 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.65 2.233 . . . . 0.0 112.346 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -64.41 -17.15 63.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.853 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 906' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -98.94 13.56 32.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -58.16 -29.55 65.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -61.26 154.75 22.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.883 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 909' ' ' PHE . . . . . 0.588 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 48.3 m-85 -100.01 140.54 34.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.86 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 910' ' ' ASP . . . . . 0.428 ' H ' HD12 ' A' ' 913' ' ' LEU . 0.3 OUTLIER -99.99 177.56 5.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.898 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.66 -45.31 77.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -59.65 -54.99 40.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.093 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 913' ' ' LEU . . . . . 0.428 HD12 ' H ' ' A' ' 910' ' ' ASP . 22.2 mt -53.47 -54.81 31.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.931 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 46.3 mt -58.86 -57.85 9.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.164 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -50.26 -63.98 0.95 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 916' ' ' GLU . . . . . 0.43 ' HB3' HD21 ' A' ' 958' ' ' LEU . 50.3 mm-40 -45.71 -50.16 13.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.847 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 917' ' ' LEU . . . . . 0.886 HD21 HD13 ' A' ' 963' ' ' ILE . 28.2 mt -50.3 -53.24 30.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.937 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 918' ' ' LEU . . . . . 0.524 HD21 ' CD1' ' A' ' 930' ' ' ILE . 88.4 mt -38.59 -62.44 0.6 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.955 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -53.16 -53.68 46.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.925 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 -47.65 -45.34 27.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.857 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 921' ' ' PHE . . . . . 0.578 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 23.7 m-85 -60.26 -49.04 79.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.839 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -45.29 -33.5 2.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.073 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 923' ' ' SER . . . . . 0.521 ' HB3' ' CD1' ' A' ' 924' ' ' PHE . 8.6 t -41.18 -29.84 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 924' ' ' PHE . . . . . 0.521 ' CD1' ' HB3' ' A' ' 923' ' ' SER . 1.6 m-85 -120.02 -58.92 1.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.893 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -130.76 154.65 20.82 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.536 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -87.05 139.45 30.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 0.0 110.938 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 44.1 t -87.25 146.15 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 928' ' ' ILE . . . . . 0.491 HG13 ' N ' ' A' ' 929' ' ' LEU . 46.1 pt -122.7 -38.46 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.124 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 929' ' ' LEU . . . . . 0.491 ' N ' HG13 ' A' ' 928' ' ' ILE . 11.4 tp -142.41 146.24 34.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 930' ' ' ILE . . . . . 0.524 ' CD1' HD21 ' A' ' 918' ' ' LEU . 79.1 mt -132.09 131.51 61.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.153 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 15.8 ttp180 -121.3 124.3 44.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.879 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -91.38 121.8 33.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 933' ' ' VAL . . . . . 0.634 HG21 ' CD1' ' A' ' 938' ' ' TRP . 4.7 t -89.38 157.27 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.123 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 934' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 933' ' ' VAL . 15.2 mm-40 -33.28 -54.5 0.41 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.942 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.03 -21.61 5.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.859 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -98.98 171.68 7.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.869 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 937' ' ' MET . . . . . 0.588 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 17.2 ttt -131.81 108.66 9.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 938' ' ' TRP . . . . . 0.634 ' CD1' HG21 ' A' ' 933' ' ' VAL . 41.5 m0 -90.82 144.77 25.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.905 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 87.0 t -133.56 131.24 57.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.143 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 17.8 m -97.19 150.45 20.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.129 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 941' ' ' PHE . . . . . 0.425 ' O ' ' C ' ' A' ' 942' ' ' LEU . 9.9 m-85 -129.83 144.99 51.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.893 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 942' ' ' LEU . . . . . 0.425 ' C ' ' O ' ' A' ' 941' ' ' PHE . 30.3 tp -35.94 -56.88 0.7 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.924 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -122.09 164.91 16.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.871 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -66.95 -44.9 87.66 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.478 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 95.2 p -52.22 -37.45 55.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.868 0.366 . . . . 0.0 110.889 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 49.4 m -57.72 -37.51 73.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.857 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 947' ' ' ALA . . . . . 0.532 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -73.05 -25.24 60.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.058 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 28.8 mt -76.63 -23.83 53.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.923 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 37.3 m-20 -88.26 -50.25 6.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.85 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 9.6 p -49.66 -18.65 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.166 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 951' ' ' LEU . . . . . 0.689 HD11 ' CD1' ' A' ' 967' ' ' LEU . 24.4 mt -52.38 -28.51 19.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.907 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 952' ' ' SER . . . . . 0.518 ' HB2' ' CZ ' ' A' ' 924' ' ' PHE . 20.6 m -50.95 -17.54 0.6 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 37.7 mt -88.45 17.48 5.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.946 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -71.43 120.79 17.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 86.51 -24.48 8.45 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.495 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -40.49 128.92 2.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.732 0.301 . . . . 0.0 110.938 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -94.59 134.01 37.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.905 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 958' ' ' LEU . . . . . 0.43 HD21 ' HB3' ' A' ' 916' ' ' GLU . 14.6 tp -144.52 146.77 32.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 56.0 mt 44.82 52.06 8.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.958 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 45.13 44.02 8.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.89 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 961' ' ' ARG . . . . . . . . . . . . . 71.0 mtt-85 -150.54 110.49 4.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.917 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 6.4 m -64.41 120.13 11.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.13 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 963' ' ' ILE . . . . . 0.886 HD13 HD21 ' A' ' 917' ' ' LEU . 82.7 mt -103.93 139.53 24.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.156 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 6.7 m -123.8 116.87 23.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.122 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 965' ' ' ILE . . . . . 0.521 HG12 HG22 ' A' ' 897' ' ' VAL . 61.0 mt -102.07 140.57 20.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.142 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -152.68 128.8 10.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.117 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 967' ' ' LEU . . . . . 0.689 ' CD1' HD11 ' A' ' 951' ' ' LEU . 30.7 mt -67.98 158.37 32.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -82.11 96.91 7.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 48.4 t -109.91 91.34 10.73 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.638 0.732 . . . . 0.0 110.868 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.44 90.51 1.19 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.638 2.225 . . . . 0.0 112.392 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 22.1 m -87.1 135.83 33.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.834 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . 158.22 174.82 28.42 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.465 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.54 147.6 2.71 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.699 2.266 . . . . 0.0 112.336 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 2.7 m -50.61 104.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.844 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 26.0 m -108.87 42.31 1.44 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.883 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.488 -179.967 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 27.3 p -84.62 148.71 26.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.888 0.375 . . . . 0.0 110.816 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 31.1 t -166.03 141.86 4.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.856 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . -123.51 100.57 0.66 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.455 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 94.5 p -124.06 123.3 40.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.888 0.375 . . . . 0.0 110.853 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 14.2 m -92.42 133.21 36.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.91 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 892' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 894' ' ' THR . . . -138.78 89.75 0.2 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.448 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . -38.21 -29.57 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.482 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 894' ' ' THR . . . . . 0.437 ' N ' ' O ' ' A' ' 892' ' ' GLY . 99.5 m -87.89 115.7 25.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.797 0.332 . . . . 0.0 111.144 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 895' ' ' VAL . . . . . 0.777 HG12 HD23 ' A' ' 967' ' ' LEU . 16.9 m -115.06 139.51 40.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.156 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 896' ' ' LEU . . . . . 0.465 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 4.7 mp -88.98 143.22 27.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.468 HG22 HG12 ' A' ' 965' ' ' ILE . 89.1 t -141.08 127.01 19.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.113 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 11.4 t -129.08 155.78 44.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.864 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.614 HG23 ' CE2' ' A' ' 909' ' ' PHE . 3.8 pt -120.03 138.07 51.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.175 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.27 106.58 13.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.888 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 901' ' ' SER . . . . . . . . . . . . . 2.6 m -139.63 126.39 20.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.89 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 18.9 m -58.6 -70.66 0.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.846 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 35.1 mt -65.38 151.71 93.59 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.616 0.722 . . . . 0.0 110.956 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 904' ' ' PRO . . . . . 0.532 ' O ' ' CE2' ' A' ' 908' ' ' PHE . 61.5 Cg_endo -76.43 -26.97 8.19 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.681 2.254 . . . . 0.0 112.332 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 905' ' ' GLU . . . . . 0.4 ' HG3' ' ND2' ' A' ' 906' ' ' ASN . 17.1 pt-20 -70.0 -0.83 8.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.937 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 906' ' ' ASN . . . . . 0.4 ' ND2' ' HG3' ' A' ' 905' ' ' GLU . 25.7 m-80 -118.14 -17.73 9.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.928 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -58.28 -28.93 65.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.908 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 908' ' ' PHE . . . . . 0.532 ' CE2' ' O ' ' A' ' 904' ' ' PRO . 8.0 m-85 -74.47 124.06 25.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 909' ' ' PHE . . . . . 0.614 ' CE2' HG23 ' A' ' 899' ' ' ILE . 89.1 m-85 -58.93 125.03 21.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.896 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 910' ' ' ASP . . . . . 0.492 ' H ' HD12 ' A' ' 913' ' ' LEU . 25.5 t70 -90.07 169.83 10.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.884 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.09 -42.45 65.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -63.22 -50.29 70.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.113 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 913' ' ' LEU . . . . . 0.515 HD11 ' CD ' ' A' ' 961' ' ' ARG . 20.8 mt -56.89 -50.54 72.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.951 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 914' ' ' ILE . . . . . 0.431 HD13 ' CZ ' ' A' ' 932' ' ' PHE . 66.1 mt -63.51 -59.47 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -50.42 -52.03 41.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 916' ' ' GLU . . . . . 0.775 ' HG3' HD11 ' A' ' 959' ' ' LEU . 31.7 mm-40 -57.04 -43.59 82.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 917' ' ' LEU . . . . . 0.761 HD21 HD13 ' A' ' 963' ' ' ILE . 19.9 mt -54.54 -55.65 27.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.887 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 918' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 917' ' ' LEU . 24.8 mt -34.52 -62.48 0.34 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.951 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -52.68 -52.08 57.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -49.93 -39.07 39.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.908 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 921' ' ' PHE . . . . . 0.536 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 23.8 m-85 -73.36 -41.51 63.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.882 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -52.84 -27.26 17.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.107 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 923' ' ' SER . . . . . 0.549 ' HB3' ' CE1' ' A' ' 924' ' ' PHE . 19.6 t -48.7 -30.27 5.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 924' ' ' PHE . . . . . 0.549 ' CE1' ' HB3' ' A' ' 923' ' ' SER . 0.8 OUTLIER -121.27 -50.58 2.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.913 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -134.54 147.19 19.03 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.475 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -85.46 132.05 34.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.865 0.364 . . . . 0.0 110.889 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 16.8 t -83.2 146.93 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.131 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 928' ' ' ILE . . . . . 0.462 HG13 ' N ' ' A' ' 929' ' ' LEU . 41.8 pt -124.56 -33.36 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.143 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 929' ' ' LEU . . . . . 0.462 ' N ' HG13 ' A' ' 928' ' ' ILE . 8.5 tp -146.59 145.25 30.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.86 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 48.0 mt -135.01 128.9 50.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.122 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 -110.59 123.09 49.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.862 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 932' ' ' PHE . . . . . 0.431 ' CZ ' HD13 ' A' ' 914' ' ' ILE . 71.0 m-85 -89.67 112.74 24.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.902 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 933' ' ' VAL . . . . . 0.711 HG21 ' NE1' ' A' ' 938' ' ' TRP . 2.6 t -83.15 149.05 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.153 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 934' ' ' GLU . . . . . 0.489 ' C ' ' O ' ' A' ' 933' ' ' VAL . 84.5 mt-10 -31.34 -50.03 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -124.65 -23.53 4.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.854 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.46 173.23 6.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 937' ' ' MET . . . . . 0.585 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 16.6 ttt -136.06 106.67 6.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 938' ' ' TRP . . . . . 0.711 ' NE1' HG21 ' A' ' 933' ' ' VAL . 34.3 m0 -88.1 142.24 27.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 939' ' ' VAL . . . . . 0.42 HG12 ' CE1' ' A' ' 941' ' ' PHE . 89.7 t -129.18 120.31 51.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.174 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 940' ' ' THR . . . . . 0.416 ' CG2' ' N ' ' A' ' 941' ' ' PHE . 8.5 m -91.19 153.17 20.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.107 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 941' ' ' PHE . . . . . 0.42 ' CE1' HG12 ' A' ' 939' ' ' VAL . 9.3 m-85 -129.57 154.28 47.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 43.6 tp -52.25 -50.68 61.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.933 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -116.29 171.7 7.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.902 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -84.94 -37.66 9.97 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.467 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 75.4 p -60.73 -29.08 69.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.912 0.387 . . . . 0.0 110.907 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 1.9 p -68.11 -35.06 77.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.818 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -72.55 -12.85 61.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.098 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 27.7 mt -89.48 -26.7 20.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -84.81 -40.88 16.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.9 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 9.1 p -57.24 -17.85 7.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.1 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 951' ' ' LEU . . . . . 0.752 HD21 ' HG ' ' A' ' 967' ' ' LEU . 43.1 mt -52.19 -27.14 13.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.903 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 19.9 m -53.2 -16.27 1.18 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.834 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 953' ' ' LEU . . . . . 0.478 ' HB2' ' CD1' ' A' ' 965' ' ' ILE . 56.8 mt -92.38 19.01 7.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -74.9 105.11 5.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 101.45 -25.24 28.83 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.47 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -43.07 128.88 4.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.763 0.316 . . . . 0.0 110.921 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -95.98 135.09 38.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.855 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 958' ' ' LEU . . . . . 0.41 ' O ' ' N ' ' A' ' 961' ' ' ARG . 14.3 tp -141.37 157.45 45.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.913 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 959' ' ' LEU . . . . . 0.775 HD11 ' HG3' ' A' ' 916' ' ' GLU . 96.2 mt 38.38 45.1 0.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.9 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 3.3 m120 52.88 44.09 30.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.848 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 961' ' ' ARG . . . . . 0.515 ' CD ' HD11 ' A' ' 913' ' ' LEU . 61.2 mtt85 -151.4 105.84 3.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 63.2 m -60.88 115.79 3.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.118 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 963' ' ' ILE . . . . . 0.761 HD13 HD21 ' A' ' 917' ' ' LEU . 75.2 mt -98.56 139.7 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.107 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 13.5 m -122.75 115.75 22.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.125 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 965' ' ' ILE . . . . . 0.478 ' CD1' ' HB2' ' A' ' 953' ' ' LEU . 61.5 mt -102.22 138.2 27.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.142 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -150.6 129.83 12.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.124 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 967' ' ' LEU . . . . . 0.777 HD23 HG12 ' A' ' 895' ' ' VAL . 32.3 mt -65.49 157.87 28.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.893 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 14.7 tptp -95.78 153.14 17.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.939 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 87.2 p -116.55 145.1 34.5 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.65 0.738 . . . . 0.0 110.851 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -78.38 90.31 1.28 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.654 2.236 . . . . 0.0 112.361 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 34.8 m -78.09 151.38 33.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.828 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . 92.67 157.21 33.41 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.432 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.61 154.87 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.671 2.247 . . . . 0.0 112.334 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 30.4 t -41.77 154.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.834 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 1.3 t -90.06 53.44 2.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.8 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.477 -179.974 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 83.2 p -97.92 137.04 37.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.892 0.377 . . . . 0.0 110.839 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 15.2 m -90.21 -49.73 6.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.845 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . 158.45 118.32 0.53 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.45 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 1.5 t -114.59 104.85 12.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.898 0.38 . . . . 0.0 110.786 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 49.1 m -93.67 106.08 18.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.857 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 48.67 -160.3 0.68 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.478 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . -140.4 44.14 1.07 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.497 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 93.3 m -95.88 126.95 41.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.789 0.328 . . . . 0.0 111.149 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 895' ' ' VAL . . . . . 0.531 HG12 HD23 ' A' ' 967' ' ' LEU . 26.7 m -122.76 140.03 47.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.149 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 896' ' ' LEU . . . . . 0.47 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 6.4 mp -88.8 142.67 27.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.908 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 97.9 t -142.66 124.07 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.135 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 7.8 t -127.57 156.32 42.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.829 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.586 HG22 HG12 ' A' ' 963' ' ' ILE . 2.5 pt -125.86 130.61 72.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.116 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -77.71 114.05 16.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 901' ' ' SER . . . . . . . . . . . . . 2.6 t -139.99 122.82 16.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.842 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 3.2 m -50.79 -55.59 16.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.832 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 24.9 mt -80.97 148.25 63.9 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.613 0.721 . . . . 0.0 110.947 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -77.58 -21.9 11.06 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.69 2.26 . . . . 0.0 112.38 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -74.55 -0.62 18.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.921 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 906' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -114.54 -13.22 12.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.845 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 -61.44 -10.26 7.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -92.81 121.09 33.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.878 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 909' ' ' PHE . . . . . 0.567 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 58.3 m-85 -63.07 121.93 14.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.832 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 910' ' ' ASP . . . . . 0.461 ' H ' HD12 ' A' ' 913' ' ' LEU . 12.4 t70 -89.74 -179.07 5.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.884 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -58.46 -41.92 86.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.878 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -64.38 -51.64 62.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.082 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 913' ' ' LEU . . . . . 0.876 HD21 ' HD2' ' A' ' 961' ' ' ARG . 72.2 mt -55.2 -53.31 57.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.917 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 44.9 mt -62.69 -61.92 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.133 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -44.55 -58.27 3.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -52.03 -45.68 64.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 917' ' ' LEU . . . . . 0.805 HD21 HD13 ' A' ' 963' ' ' ILE . 23.0 mt -56.58 -53.79 53.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.923 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 918' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 917' ' ' LEU . 80.4 mt -34.45 -54.1 0.52 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.949 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -58.71 -49.83 76.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.902 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 920' ' ' GLN . . . . . 0.735 ' OE1' HD22 ' A' ' 958' ' ' LEU . 19.7 mt-30 -51.89 -36.98 50.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 921' ' ' PHE . . . . . 0.432 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 21.9 m-85 -73.11 -39.89 65.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.845 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -55.9 -33.0 64.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.119 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 53.4 p -54.22 -17.79 3.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.874 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 924' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -121.54 -52.4 2.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.872 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -147.12 154.95 26.29 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.458 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -86.18 126.34 34.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.896 0.379 . . . . 0.0 110.896 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 927' ' ' VAL . . . . . 0.485 HG13 ' O ' ' A' ' 940' ' ' THR . 6.4 t -78.09 150.76 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.175 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 928' ' ' ILE . . . . . 0.469 HG13 ' N ' ' A' ' 929' ' ' LEU . 40.3 pt -120.67 -38.71 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.153 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 929' ' ' LEU . . . . . 0.469 ' N ' HG13 ' A' ' 928' ' ' ILE . 13.3 tp -142.73 151.8 41.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.95 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 930' ' ' ILE . . . . . 0.559 HG12 HG13 ' A' ' 939' ' ' VAL . 76.0 mt -134.87 125.87 46.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.126 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -115.46 125.02 52.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.861 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -94.09 123.55 37.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.862 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 933' ' ' VAL . . . . . 0.728 HG21 ' NE1' ' A' ' 938' ' ' TRP . 5.1 t -91.21 157.31 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.111 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 934' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 933' ' ' VAL . 10.2 mm-40 -33.54 -52.61 0.4 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.911 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -124.72 -24.81 4.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -96.58 171.68 8.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.891 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 937' ' ' MET . . . . . 0.578 ' SD ' HG23 ' A' ' 939' ' ' VAL . 0.3 OUTLIER -132.7 115.08 14.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.892 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 938' ' ' TRP . . . . . 0.728 ' NE1' HG21 ' A' ' 933' ' ' VAL . 31.0 m0 -100.34 146.37 27.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.942 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 939' ' ' VAL . . . . . 0.578 HG23 ' SD ' ' A' ' 937' ' ' MET . 60.4 t -137.07 129.12 43.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.121 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 940' ' ' THR . . . . . 0.485 ' O ' HG13 ' A' ' 927' ' ' VAL . 18.8 m -93.12 153.24 18.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.13 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 941' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -128.05 150.74 49.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 25.0 tp -51.75 -46.37 64.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -118.4 171.06 8.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.855 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -84.44 -42.27 7.48 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.481 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 39.3 p -56.85 -40.57 76.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.881 0.372 . . . . 0.0 110.897 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 1.2 p -54.16 -35.99 62.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.848 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -72.42 -14.44 61.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.15 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 21.9 mt -86.66 -26.4 24.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.928 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -82.76 -50.83 8.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 6.0 p -49.84 -19.45 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.125 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 951' ' ' LEU . . . . . 0.892 HD11 HD11 ' A' ' 967' ' ' LEU . 39.5 mt -55.14 -24.79 28.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.917 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 44.8 t -58.28 -11.75 3.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.867 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 36.6 mt -92.09 13.18 19.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.914 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 954' ' ' ASN . . . . . 0.412 ' O ' ' CG ' ' A' ' 954' ' ' ASN . 3.7 p30 -66.03 117.96 9.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 89.47 -26.09 9.79 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.525 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -40.65 129.28 2.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.751 0.31 . . . . 0.0 110.907 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -97.87 135.22 39.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.854 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 958' ' ' LEU . . . . . 0.735 HD22 ' OE1' ' A' ' 920' ' ' GLN . 18.0 tp -139.16 160.44 39.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.951 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 959' ' ' LEU . . . . . 0.449 ' C ' ' O ' ' A' ' 958' ' ' LEU . 97.1 mt 34.29 37.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 960' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 958' ' ' LEU . 5.4 m120 60.91 48.4 6.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 961' ' ' ARG . . . . . 0.876 ' HD2' HD21 ' A' ' 913' ' ' LEU . 68.8 mtt85 -153.05 106.08 2.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.869 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 5.3 m -61.34 115.41 3.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.132 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 963' ' ' ILE . . . . . 0.805 HD13 HD21 ' A' ' 917' ' ' LEU . 57.8 mt -100.69 144.81 12.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.148 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 3.6 m -127.79 113.03 15.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.109 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 965' ' ' ILE . . . . . . . . . . . . . 61.9 mt -95.17 147.14 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.127 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -154.03 126.95 8.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.061 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 967' ' ' LEU . . . . . 0.892 HD11 HD11 ' A' ' 951' ' ' LEU . 32.9 mt -65.25 157.98 27.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 968' ' ' LYS . . . . . 0.424 ' HE2' ' CH2' ' A' ' 938' ' ' TRP . 16.0 tttp -123.26 97.09 5.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 61.5 p -158.2 143.64 12.23 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.618 0.723 . . . . 0.0 110.861 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -78.57 104.05 1.76 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.708 2.272 . . . . 0.0 112.33 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 2.8 m -50.91 122.08 6.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.849 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . 156.59 95.3 0.11 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.48 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 973' ' ' PRO . . . . . 0.411 ' O ' ' C ' ' A' ' 974' ' ' SER . 72.5 Cg_exo -44.78 147.28 1.91 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.633 2.222 . . . . 0.0 112.38 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 974' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 973' ' ' PRO . 10.5 t -37.22 131.18 0.84 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.817 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 34.6 m -152.18 127.43 9.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.833 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.498 -179.993 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 58.0 m -100.89 139.08 37.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.839 0.352 . . . . 0.0 110.886 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 3.4 m -63.1 130.04 42.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.851 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . 165.8 91.08 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.522 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 12.9 m -104.33 108.77 20.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.826 0.346 . . . . 0.0 110.826 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 3.5 m -68.85 168.59 13.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.893 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 43.53 -112.38 0.54 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.454 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . 172.12 47.3 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.474 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 97.7 m -88.44 119.51 28.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.789 0.328 . . . . 0.0 111.123 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 895' ' ' VAL . . . . . 0.501 HG12 HD23 ' A' ' 967' ' ' LEU . 22.4 m -121.34 138.51 51.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.148 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 896' ' ' LEU . . . . . 0.465 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 5.5 mp -88.99 145.74 25.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.616 HG22 HG12 ' A' ' 965' ' ' ILE . 79.1 t -147.01 126.34 4.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 11.1 t -127.1 152.28 47.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.824 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.552 HG22 HG12 ' A' ' 963' ' ' ILE . 3.5 pt -120.49 133.59 66.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.122 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -90.71 123.85 34.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.896 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 901' ' ' SER . . . . . . . . . . . . . 1.2 t -137.75 177.8 7.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.846 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 31.9 t -97.67 -56.61 2.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.823 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 13.5 mt -74.92 152.01 86.57 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.645 0.736 . . . . 0.0 110.918 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -77.21 -13.18 17.15 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.684 2.256 . . . . 0.0 112.334 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -95.0 10.12 36.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.874 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 906' ' ' ASN . . . . . 0.432 ' O ' ' N ' ' A' ' 908' ' ' PHE . 46.2 m-20 -107.47 -35.85 6.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 907' ' ' ASN . . . . . 0.414 ' C ' ' O ' ' A' ' 906' ' ' ASN . 30.8 m-20 -37.33 -31.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.883 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 908' ' ' PHE . . . . . 0.432 ' N ' ' O ' ' A' ' 906' ' ' ASN . 10.9 m-85 -74.37 119.14 18.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.897 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 909' ' ' PHE . . . . . 0.583 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 69.0 m-85 -56.84 132.62 52.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 910' ' ' ASP . . . . . 0.532 ' H ' HD12 ' A' ' 913' ' ' LEU . 76.9 m-20 -97.95 169.11 9.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.876 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -48.16 -49.06 33.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.888 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -57.17 -56.04 26.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.089 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 913' ' ' LEU . . . . . 0.532 HD12 ' H ' ' A' ' 910' ' ' ASP . 31.3 mt -49.23 -54.18 17.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 56.0 mt -60.68 -64.48 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.137 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -42.94 -56.78 3.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.83 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -52.57 -50.98 61.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.849 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 917' ' ' LEU . . . . . 0.77 HD21 HD13 ' A' ' 963' ' ' ILE . 25.9 mt -48.15 -57.45 5.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 918' ' ' LEU . . . . . 0.445 ' C ' ' O ' ' A' ' 917' ' ' LEU . 40.5 mt -34.37 -55.37 0.52 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.887 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -56.77 -45.54 82.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.9 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 920' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 917' ' ' LEU . 88.5 mm-40 -58.76 -36.54 74.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 921' ' ' PHE . . . . . 0.525 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 22.1 m-85 -72.64 -47.46 47.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.852 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -48.77 -34.65 12.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.078 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -46.38 -32.87 3.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 924' ' ' PHE . . . . . 0.553 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 0.5 OUTLIER -121.63 -58.5 1.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.915 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -121.02 148.47 17.49 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.525 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 926' ' ' GLU . . . . . 0.5 ' OE2' HG22 ' A' ' 928' ' ' ILE . 2.0 tm-20 -90.1 128.7 36.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.868 0.366 . . . . 0.0 110.874 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 41.1 t -84.14 139.95 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 928' ' ' ILE . . . . . 0.5 HG22 ' OE2' ' A' ' 926' ' ' GLU . 35.4 pt -122.43 -40.54 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.12 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 929' ' ' LEU . . . . . 0.477 ' N ' HG13 ' A' ' 928' ' ' ILE . 15.6 tp -136.83 136.05 38.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.907 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 81.7 mt -122.76 126.56 74.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.089 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 11.8 tpt85 -112.18 124.68 52.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.868 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -93.57 117.01 29.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 933' ' ' VAL . . . . . 0.664 HG21 ' NE1' ' A' ' 938' ' ' TRP . 2.9 t -85.78 156.99 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.104 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 934' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 933' ' ' VAL . 33.1 mt-10 -34.43 -51.33 0.46 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.857 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -125.49 -26.25 3.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -96.16 173.04 7.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.917 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 937' ' ' MET . . . . . 0.583 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 15.3 ttt -134.11 111.73 10.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.905 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 938' ' ' TRP . . . . . 0.664 ' NE1' HG21 ' A' ' 933' ' ' VAL . 38.8 m0 -92.11 148.13 22.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.957 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 43.0 t -134.14 125.8 48.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.083 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 14.0 m -92.46 151.75 20.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.152 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 941' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -132.24 143.87 50.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.862 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 54.2 tp -41.27 -52.87 3.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.878 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -118.17 177.99 4.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -86.67 -48.08 4.6 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.525 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 46.6 t -50.8 -39.07 51.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.863 0.363 . . . . 0.0 110.841 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 56.8 p -57.51 -32.36 66.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.87 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -76.4 -20.91 56.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.086 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 36.5 mt -77.97 -27.93 49.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.926 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -81.93 -51.56 7.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.883 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 9.5 p -48.21 -21.56 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.12 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 951' ' ' LEU . . . . . 0.449 HD21 ' HG ' ' A' ' 967' ' ' LEU . 34.2 mt -49.37 -29.43 6.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.937 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 35.7 p -50.28 -19.77 0.89 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.839 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 76.7 mt -88.84 20.15 3.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.885 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -74.41 106.34 5.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.928 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 98.85 -26.76 22.84 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.461 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -37.97 128.19 1.25 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.71 0.291 . . . . 0.0 110.887 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -93.38 125.15 37.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 15.2 tp -133.01 154.58 50.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 43.2 mt 41.01 47.78 2.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.913 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 51.64 40.5 27.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 961' ' ' ARG . . . . . . . . . . . . . 65.2 mtt85 -147.63 122.69 10.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.858 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 6.1 m -74.17 115.08 13.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.154 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 963' ' ' ILE . . . . . 0.77 HD13 HD21 ' A' ' 917' ' ' LEU . 84.6 mt -99.81 135.51 35.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.124 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 14.9 m -119.74 112.5 19.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.173 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 965' ' ' ILE . . . . . 0.616 HG12 HG22 ' A' ' 897' ' ' VAL . 67.3 mt -98.99 137.48 26.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.122 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -151.37 135.33 16.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.087 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 967' ' ' LEU . . . . . 0.501 HD23 HG12 ' A' ' 895' ' ' VAL . 28.9 mt -66.26 157.98 30.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.907 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.57 121.55 25.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.918 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 88.0 p -66.11 144.2 98.68 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.619 0.723 . . . . 0.0 110.876 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.61 101.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.663 2.242 . . . . 0.0 112.315 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 6.1 t -142.24 114.74 8.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.85 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . 170.25 -99.45 0.15 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.455 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -78.56 17.46 1.1 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.7 2.267 . . . . 0.0 112.368 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 13.4 t -143.31 106.69 4.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.823 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 3.1 t 50.68 42.79 27.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.878 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.476 179.962 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 59.3 p -72.77 -44.31 61.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.845 0.355 . . . . 0.0 110.828 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 2.0 m -103.74 102.77 12.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . -50.37 117.22 4.81 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.519 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 61.9 p -53.63 115.59 2.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.888 0.375 . . . . 0.0 110.874 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 6.6 m -165.48 174.18 10.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.855 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -56.76 -103.89 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.485 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . -170.97 40.07 0.18 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.502 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 39.3 m -82.04 122.84 28.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.865 0.364 . . . . 0.0 111.171 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 895' ' ' VAL . . . . . 0.527 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 17.8 m -117.49 144.09 26.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.169 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 896' ' ' LEU . . . . . 0.472 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 6.8 mp -92.89 137.92 31.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 60.1 t -140.13 131.24 31.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.161 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 3.1 t -130.62 156.32 45.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.881 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.527 HG23 ' CE2' ' A' ' 909' ' ' PHE . 3.3 pt -122.28 135.77 61.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.183 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.73 119.97 23.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 901' ' ' SER . . . . . . . . . . . . . 19.4 p -135.85 174.96 10.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.826 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 1.1 t -110.63 -43.19 3.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.841 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 12.8 mt -87.05 152.75 53.73 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.611 0.72 . . . . 0.0 110.929 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.76 -16.39 16.46 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.689 2.26 . . . . 0.0 112.355 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -99.37 17.67 19.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 906' ' ' ASN . . . . . 0.457 ' O ' ' N ' ' A' ' 908' ' ' PHE . 3.2 m120 -118.23 -35.11 3.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.931 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 907' ' ' ASN . . . . . 0.427 ' O ' HD11 ' A' ' 899' ' ' ILE . 8.6 p30 -40.15 -26.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.926 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 908' ' ' PHE . . . . . 0.457 ' N ' ' O ' ' A' ' 906' ' ' ASN . 56.1 m-85 -70.81 124.61 24.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.878 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 909' ' ' PHE . . . . . 0.539 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 87.4 m-85 -61.28 132.13 52.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.897 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 910' ' ' ASP . . . . . 0.812 ' H ' HD12 ' A' ' 913' ' ' LEU . 24.0 t70 -97.89 165.65 11.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.871 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -48.51 -50.06 33.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -56.84 -48.92 76.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.117 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 913' ' ' LEU . . . . . 0.812 HD12 ' H ' ' A' ' 910' ' ' ASP . 72.4 mt -56.72 -50.45 72.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.895 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 50.6 mt -64.0 -63.79 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.108 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -42.07 -56.47 2.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.819 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -54.34 -46.81 72.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.876 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 917' ' ' LEU . . . . . 0.903 HD21 HD13 ' A' ' 963' ' ' ILE . 24.9 mt -54.15 -56.08 21.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.933 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 918' ' ' LEU . . . . . 0.495 ' CD2' HD11 ' A' ' 930' ' ' ILE . 68.3 mt -34.41 -60.6 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.883 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -52.31 -51.07 60.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -52.48 -40.05 61.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 921' ' ' PHE . . . . . 0.564 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 22.9 m-85 -66.82 -44.59 80.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.865 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -50.57 -33.63 22.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.123 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 923' ' ' SER . . . . . 0.54 ' HB3' ' CE1' ' A' ' 924' ' ' PHE . 10.4 t -41.86 -34.64 0.69 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.87 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 924' ' ' PHE . . . . . 0.54 ' CE1' ' HB3' ' A' ' 923' ' ' SER . 0.9 OUTLIER -120.17 -51.68 2.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.844 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -128.27 141.56 12.71 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.442 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -85.58 99.47 11.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.896 0.379 . . . . 0.0 110.894 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 40.2 t -51.23 143.91 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.122 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 928' ' ' ILE . . . . . 0.475 HG13 ' N ' ' A' ' 929' ' ' LEU . 21.0 pt -120.04 -44.8 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.093 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 929' ' ' LEU . . . . . 0.475 ' N ' HG13 ' A' ' 928' ' ' ILE . 11.1 tp -135.56 146.51 48.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.949 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 930' ' ' ILE . . . . . 0.495 HD11 ' CD2' ' A' ' 918' ' ' LEU . 57.0 mt -130.05 137.57 56.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.13 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -125.88 122.29 35.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -88.48 124.07 33.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.845 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 933' ' ' VAL . . . . . 0.644 HG21 ' CD1' ' A' ' 938' ' ' TRP . 13.5 t -92.63 157.52 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.089 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 934' ' ' GLU . . . . . 0.482 ' C ' ' O ' ' A' ' 933' ' ' VAL . 15.2 mm-40 -31.24 -56.03 0.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -121.88 -26.01 4.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.859 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 4.7 tttm -96.12 173.25 7.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.839 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 937' ' ' MET . . . . . 0.539 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 10.8 ttt -132.39 105.93 7.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 938' ' ' TRP . . . . . 0.644 ' CD1' HG21 ' A' ' 933' ' ' VAL . 44.1 m0 -85.25 142.49 29.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.928 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 939' ' ' VAL . . . . . 0.488 HG13 HG12 ' A' ' 930' ' ' ILE . 43.8 t -132.56 129.62 59.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.133 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 940' ' ' THR . . . . . 0.403 HG22 ' N ' ' A' ' 941' ' ' PHE . 32.9 m -92.53 154.23 18.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.162 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 941' ' ' PHE . . . . . 0.413 ' O ' ' C ' ' A' ' 942' ' ' LEU . 11.2 m-85 -134.17 146.97 50.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.865 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 942' ' ' LEU . . . . . 0.413 ' C ' ' O ' ' A' ' 941' ' ' PHE . 23.6 tp -36.91 -61.49 0.55 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -125.62 153.53 43.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -50.5 -51.01 33.96 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.509 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 945' ' ' SER . . . . . 0.587 ' HA ' HD12 ' A' ' 948' ' ' LEU . 82.6 p -46.7 -42.86 17.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.9 0.381 . . . . 0.0 110.843 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 14.5 m -56.32 -30.86 63.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 947' ' ' ALA . . . . . 0.527 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -82.47 -16.73 47.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.118 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 948' ' ' LEU . . . . . 0.587 HD12 ' HA ' ' A' ' 945' ' ' SER . 23.4 mt -83.23 -23.6 32.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.927 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -88.34 -46.47 9.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.92 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 7.2 p -51.33 -22.25 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.148 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 951' ' ' LEU . . . . . 0.465 HD21 ' HG ' ' A' ' 967' ' ' LEU . 39.5 mt -50.41 -24.84 3.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.918 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 32.5 m -55.26 -15.51 2.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 36.5 mt -91.53 17.01 9.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.905 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -69.06 120.85 15.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.929 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 85.63 -27.31 5.35 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.458 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -38.21 127.36 1.35 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.74 0.305 . . . . 0.0 110.893 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -95.4 125.49 40.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.862 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 14.5 tp -134.46 153.44 51.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.969 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 959' ' ' LEU . . . . . 0.441 ' O ' ' CG ' ' A' ' 960' ' ' ASN . 35.0 mt 41.56 49.17 3.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 960' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' A' ' 960' ' ' ASN . 1.7 p-10 47.75 40.29 11.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 961' ' ' ARG . . . . . 0.757 ' HD2' HD21 ' A' ' 913' ' ' LEU . 47.1 mtt85 -147.56 104.99 3.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 27.1 m -58.94 120.88 9.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.133 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 963' ' ' ILE . . . . . 0.903 HD13 HD21 ' A' ' 917' ' ' LEU . 87.2 mt -103.98 143.4 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 8.7 m -127.22 119.93 27.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.134 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 965' ' ' ILE . . . . . . . . . . . . . 63.4 mt -103.77 140.27 22.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.131 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -149.85 137.12 19.75 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.077 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 967' ' ' LEU . . . . . 0.465 ' HG ' HD21 ' A' ' 951' ' ' LEU . 25.1 mt -73.75 153.48 40.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.95 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 968' ' ' LYS . . . . . 0.432 ' HD3' HD11 ' A' ' 896' ' ' LEU . 19.2 tptp -86.71 149.24 25.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.89 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 66.3 p -58.61 143.48 81.54 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.661 0.743 . . . . 0.0 110.869 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.01 -50.36 11.08 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.681 2.254 . . . . 0.0 112.399 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 14.7 t -55.67 152.73 8.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.854 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -162.44 72.32 0.2 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.474 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.69 163.09 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.698 2.265 . . . . 0.0 112.359 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 38.3 m -81.58 -55.07 4.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.868 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 85.5 p -39.41 116.2 0.58 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.825 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.443 179.955 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 86.3 p -57.08 98.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.847 0.356 . . . . 0.0 110.882 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 87.6 p -92.53 113.84 26.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.825 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . 172.59 165.29 29.42 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.464 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 4.3 t -158.12 145.93 18.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.842 0.353 . . . . 0.0 110.87 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 891' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 892' ' ' GLY . 61.1 p -173.46 178.79 2.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.83 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 892' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 891' ' ' SER . . . -36.89 -81.23 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.445 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . 156.32 46.14 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.48 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 71.9 m -112.03 119.45 38.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.805 0.336 . . . . 0.0 111.159 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 895' ' ' VAL . . . . . 0.475 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 13.7 m -117.17 142.86 29.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.157 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 896' ' ' LEU . . . . . 0.469 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 5.0 mp -91.74 143.15 26.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 79.8 t -142.44 127.5 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 9.7 t -129.61 158.05 40.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.841 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.517 HG22 HG12 ' A' ' 963' ' ' ILE . 2.7 pt -121.54 163.84 19.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.12 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 21.9 mttp -98.85 109.07 21.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 901' ' ' SER . . . . . . . . . . . . . 5.2 m -139.2 128.79 24.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.827 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 2.6 t -76.01 -47.66 24.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.859 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 14.4 mt -73.62 147.63 87.08 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.574 0.702 . . . . 0.0 110.945 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.98 -13.51 19.41 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.675 2.25 . . . . 0.0 112.352 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -99.66 15.18 27.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 906' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 908' ' ' PHE . 2.4 m-80 -118.17 -37.09 3.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.935 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -39.34 -26.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 908' ' ' PHE . . . . . 0.474 ' N ' ' O ' ' A' ' 906' ' ' ASN . 59.0 m-85 -69.1 135.61 51.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.863 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 909' ' ' PHE . . . . . 0.579 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 94.1 m-85 -77.65 119.97 21.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.87 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 910' ' ' ASP . . . . . 0.662 ' H ' HD12 ' A' ' 913' ' ' LEU . 9.6 m-20 -85.04 160.11 20.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.884 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -45.64 -40.43 9.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.852 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -65.33 -49.99 67.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.104 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 913' ' ' LEU . . . . . 0.662 HD12 ' H ' ' A' ' 910' ' ' ASP . 29.4 mt -56.76 -45.85 81.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 36.5 mt -69.52 -59.75 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.155 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -48.89 -50.99 32.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.86 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 916' ' ' GLU . . . . . 0.546 ' HG3' HD11 ' A' ' 959' ' ' LEU . 36.6 mm-40 -56.89 -40.8 76.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.86 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 917' ' ' LEU . . . . . 0.95 HD21 HD13 ' A' ' 963' ' ' ILE . 22.0 mt -59.88 -51.64 68.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 918' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 917' ' ' LEU . 30.8 mt -34.89 -64.19 0.28 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.906 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -50.2 -51.98 39.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.904 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 920' ' ' GLN . . . . . 0.443 ' O ' HD11 ' A' ' 953' ' ' LEU . 13.8 mm100 -49.63 -40.5 39.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.922 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 921' ' ' PHE . . . . . 0.553 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 22.7 m-85 -72.37 -42.78 64.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.899 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -50.99 -38.03 48.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.114 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -46.81 -21.13 0.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 924' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 1.4 m-85 -124.0 -58.88 1.54 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.914 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -130.1 151.0 19.26 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.512 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -88.86 125.35 34.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.887 0.375 . . . . 0.0 110.863 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 6.1 t -78.93 150.29 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.141 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 928' ' ' ILE . . . . . 0.475 HG13 ' N ' ' A' ' 929' ' ' LEU . 35.1 pt -125.63 -40.46 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.101 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 929' ' ' LEU . . . . . 0.475 ' N ' HG13 ' A' ' 928' ' ' ILE . 12.0 tp -141.12 146.34 36.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.941 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 930' ' ' ILE . . . . . 0.729 HG12 HG13 ' A' ' 939' ' ' VAL . 51.3 mt -134.62 143.04 38.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.119 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.62 128.69 31.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.849 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -91.99 123.55 35.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.87 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 933' ' ' VAL . . . . . 0.84 HG21 ' NE1' ' A' ' 938' ' ' TRP . 2.6 t -87.89 157.18 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.13 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 934' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 933' ' ' VAL . 45.8 mt-10 -33.49 -49.7 0.3 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.838 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -127.12 -28.22 2.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.867 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 6.8 ttmm -96.02 173.12 7.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 937' ' ' MET . . . . . 0.579 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 12.5 ttt -135.18 108.06 7.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 938' ' ' TRP . . . . . 0.84 ' NE1' HG21 ' A' ' 933' ' ' VAL . 13.4 m0 -94.88 143.62 26.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.929 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 939' ' ' VAL . . . . . 0.729 HG13 HG12 ' A' ' 930' ' ' ILE . 43.6 t -128.65 139.99 50.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.131 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 940' ' ' THR . . . . . 0.456 HG22 ' N ' ' A' ' 941' ' ' PHE . 53.0 m -98.51 156.26 16.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.099 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 941' ' ' PHE . . . . . 0.456 ' N ' HG22 ' A' ' 940' ' ' THR . 13.2 m-85 -136.23 149.86 48.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.916 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 32.5 tp -51.04 -52.13 46.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.953 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -114.69 173.91 6.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.904 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -86.89 -47.18 4.87 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.472 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 13.0 m -56.06 -27.2 52.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.917 0.389 . . . . 0.0 110.882 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 50.6 p -67.91 -28.14 67.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.862 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 947' ' ' ALA . . . . . 0.475 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -79.32 -13.26 59.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.083 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 32.3 mt -85.4 -31.97 22.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.912 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 41.8 m-20 -75.62 -42.33 52.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 5.7 p -56.77 -15.76 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.149 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 951' ' ' LEU . . . . . 0.511 HD21 ' HG ' ' A' ' 967' ' ' LEU . 31.6 mt -55.62 -29.1 58.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.904 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 70.7 m -55.99 -23.16 30.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.845 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 953' ' ' LEU . . . . . 0.476 ' C ' HD12 ' A' ' 965' ' ' ILE . 39.2 mt -82.03 9.08 9.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.887 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.04 119.09 13.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 91.95 -25.41 16.93 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.487 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -44.07 128.65 5.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.748 0.309 . . . . 0.0 110.941 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -93.08 133.27 36.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.922 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 13.8 tp -147.87 158.32 43.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.949 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 959' ' ' LEU . . . . . 0.546 HD11 ' HG3' ' A' ' 916' ' ' GLU . 33.1 mt 40.06 46.71 1.86 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.948 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 48.1 42.13 16.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 961' ' ' ARG . . . . . 0.627 ' HD2' HD21 ' A' ' 913' ' ' LEU . 64.1 mtt85 -152.14 115.22 4.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 12.5 m -68.31 123.97 22.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.115 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 963' ' ' ILE . . . . . 0.95 HD13 HD21 ' A' ' 917' ' ' LEU . 85.8 mt -107.17 143.86 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.083 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 10.1 m -129.1 117.57 21.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.177 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 965' ' ' ILE . . . . . 0.476 HD12 ' C ' ' A' ' 953' ' ' LEU . 23.2 mt -98.64 145.15 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.152 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -155.93 129.6 8.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 967' ' ' LEU . . . . . 0.511 ' HG ' HD21 ' A' ' 951' ' ' LEU . 38.3 mt -65.22 157.7 28.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 968' ' ' LYS . . . . . 0.415 ' HD3' HD11 ' A' ' 896' ' ' LEU . 34.4 tptt -92.69 150.03 20.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 57.1 p -47.88 142.62 6.95 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.66 0.743 . . . . 0.0 110.856 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.94 165.33 0.09 OUTLIER 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.712 2.274 . . . . 0.0 112.307 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 6.5 t 55.5 43.55 28.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.861 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -78.93 -147.88 3.96 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.485 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.25 117.43 4.85 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.641 2.227 . . . . 0.0 112.376 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 74.8 m -96.7 125.81 41.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 51.5 p 38.99 42.37 0.66 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.852 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.51 179.993 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 12.8 t -110.11 87.96 2.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.865 0.364 . . . . 0.0 110.852 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 47.4 t -111.0 142.5 43.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.875 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . 85.25 84.91 1.0 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.453 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 59.5 p -121.37 123.73 42.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.851 0.358 . . . . 0.0 110.865 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 6.5 t -98.84 140.66 32.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.882 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 64.88 143.13 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.443 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . -107.56 40.65 2.44 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.479 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 59.1 m -92.76 122.18 34.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.816 0.341 . . . . 0.0 111.136 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 895' ' ' VAL . . . . . 0.749 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 12.8 m -118.56 143.42 29.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.118 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 896' ' ' LEU . . . . . 0.463 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 3.5 mp -93.22 145.75 24.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.927 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.421 HG13 ' CG2' ' A' ' 963' ' ' ILE . 98.0 t -146.2 128.57 8.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.131 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 30.9 t -133.21 159.53 39.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.893 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.87 121.42 65.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.132 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 14.1 ttpp -83.62 121.2 26.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 901' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 902' ' ' SER . 1.8 t -132.56 140.07 48.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 902' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 901' ' ' SER . 3.2 m -36.73 -57.12 0.81 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.852 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 61.9 mt -95.08 146.31 31.09 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.589 0.709 . . . . 0.0 110.941 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.27 -27.12 13.89 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.698 2.266 . . . . 0.0 112.355 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -79.75 9.21 5.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.847 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 906' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -119.82 16.59 12.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -87.33 25.56 1.38 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.909 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -84.73 144.38 28.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.856 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 909' ' ' PHE . . . . . 0.589 ' CE2' ' HB2' ' A' ' 937' ' ' MET . 45.9 m-85 -91.59 107.54 19.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.843 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 910' ' ' ASP . . . . . 0.763 ' H ' HD12 ' A' ' 913' ' ' LEU . 25.8 m-20 -83.71 157.71 22.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.904 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -43.75 -58.4 2.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.904 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -45.26 -58.0 3.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.12 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 913' ' ' LEU . . . . . 0.763 HD12 ' H ' ' A' ' 910' ' ' ASP . 24.7 mt -44.26 -56.23 4.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.925 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 71.4 mt -58.86 -62.21 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -43.46 -67.52 0.27 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 916' ' ' GLU . . . . . 0.66 ' HG3' HD11 ' A' ' 959' ' ' LEU . 8.5 mm-40 -43.78 -55.22 4.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.854 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 917' ' ' LEU . . . . . 0.954 HD21 HD13 ' A' ' 963' ' ' ILE . 30.3 mt -44.97 -58.89 2.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.903 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 918' ' ' LEU . . . . . 0.439 ' C ' ' O ' ' A' ' 917' ' ' LEU . 90.1 mt -35.25 -58.16 0.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.983 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -56.68 -38.52 72.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.924 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 920' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 917' ' ' LEU . 72.7 mm-40 -63.74 -36.67 84.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 921' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -72.02 -37.38 69.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -57.89 -34.04 69.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.131 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -47.91 -25.21 1.25 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 924' ' ' PHE . . . . . 0.477 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 2.4 m-85 -121.64 -64.35 1.23 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.884 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -123.26 154.38 17.24 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.504 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -88.57 135.11 33.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.919 0.39 . . . . 0.0 110.895 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 19.9 t -86.29 149.06 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.115 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 928' ' ' ILE . . . . . 0.479 HG13 ' N ' ' A' ' 929' ' ' LEU . 27.7 pt -129.12 -42.85 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.14 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 929' ' ' LEU . . . . . 0.479 ' N ' HG13 ' A' ' 928' ' ' ILE . 15.8 tp -136.27 145.71 45.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.919 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 64.9 mt -133.72 128.92 54.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.136 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -120.11 126.73 51.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.862 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -92.17 120.59 32.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.841 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 933' ' ' VAL . . . . . 0.772 HG21 ' NE1' ' A' ' 938' ' ' TRP . 3.0 t -86.96 157.09 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.179 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 934' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 933' ' ' VAL . 34.4 mm-40 -33.98 -52.51 0.44 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -124.95 -24.74 4.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.853 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 936' ' ' LYS . . . . . 0.431 ' NZ ' ' HB3' ' A' ' 896' ' ' LEU . 14.7 tttm -97.57 173.07 7.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 937' ' ' MET . . . . . 0.589 ' HB2' ' CE2' ' A' ' 909' ' ' PHE . 16.5 ttt -132.04 115.09 15.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.915 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 938' ' ' TRP . . . . . 0.772 ' NE1' HG21 ' A' ' 933' ' ' VAL . 39.5 m0 -94.63 150.37 20.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.955 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 70.0 t -142.36 128.24 17.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.104 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 5.6 m -95.54 150.88 19.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.115 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 941' ' ' PHE . . . . . 0.446 ' O ' ' C ' ' A' ' 942' ' ' LEU . 9.6 m-85 -129.37 145.59 51.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 942' ' ' LEU . . . . . 0.446 ' C ' ' O ' ' A' ' 941' ' ' PHE . 16.0 tp -34.4 -64.82 0.23 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -114.81 165.57 12.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -65.92 -54.09 26.86 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.52 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 945' ' ' SER . . . . . 0.615 ' HA ' HD12 ' A' ' 948' ' ' LEU . 84.3 p -48.15 -27.14 2.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.912 0.387 . . . . 0.0 110.869 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 69.1 m -67.23 -34.78 78.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 947' ' ' ALA . . . . . 0.749 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -80.04 -13.79 59.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.111 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 948' ' ' LEU . . . . . 0.615 HD12 ' HA ' ' A' ' 945' ' ' SER . 20.0 mt -87.44 -22.97 24.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.933 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 -85.54 -38.48 18.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.88 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 8.4 p -60.09 -21.96 23.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.163 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 951' ' ' LEU . . . . . 0.439 HD21 ' HG ' ' A' ' 967' ' ' LEU . 43.5 mt -50.14 -23.06 1.93 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.924 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 18.6 m -56.9 -15.0 3.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.826 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 953' ' ' LEU . . . . . 0.454 ' HB2' ' CD1' ' A' ' 965' ' ' ILE . 56.9 mt -92.99 11.48 27.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.938 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -63.4 116.51 5.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.888 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 90.67 -25.67 12.77 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.544 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -42.37 128.21 3.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.785 0.326 . . . . 0.0 110.922 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -95.68 128.39 42.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.92 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 14.9 tp -135.58 153.41 51.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.891 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 959' ' ' LEU . . . . . 0.66 HD11 ' HG3' ' A' ' 916' ' ' GLU . 36.0 mt 42.73 49.6 4.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 47.6 44.07 16.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.89 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 961' ' ' ARG . . . . . 0.471 ' CD ' HD11 ' A' ' 913' ' ' LEU . 57.8 mtt-85 -152.29 109.72 3.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 31.1 m -62.56 122.3 15.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.17 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 963' ' ' ILE . . . . . 0.954 HD13 HD21 ' A' ' 917' ' ' LEU . 93.3 mt -105.11 148.8 9.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.173 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 5.7 m -132.67 113.78 13.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.124 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 965' ' ' ILE . . . . . 0.454 ' CD1' ' HB2' ' A' ' 953' ' ' LEU . 56.5 mt -96.58 140.28 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.157 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -149.29 135.46 19.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.119 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 967' ' ' LEU . . . . . 0.439 ' HG ' HD21 ' A' ' 951' ' ' LEU . 26.8 mt -71.89 154.95 40.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.894 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -86.74 115.96 24.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 95.7 p -43.42 155.71 0.29 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.659 0.743 . . . . 0.0 110.872 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.56 111.17 0.3 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.672 2.248 . . . . 0.0 112.357 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 43.1 t -90.92 -52.28 4.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.866 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . 175.29 95.26 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.491 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -76.82 41.96 1.0 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.661 2.241 . . . . 0.0 112.307 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 17.6 m -108.39 -60.02 1.79 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.897 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 52.5 p -113.75 126.09 54.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.49 179.982 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 28.1 m -73.06 115.24 12.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.835 0.35 . . . . 0.0 110.913 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 11.9 p -130.57 -44.49 1.1 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.821 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . 157.47 -110.89 0.46 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.507 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 890' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 891' ' ' SER . 60.9 m -127.48 115.69 19.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.885 0.374 . . . . 0.0 110.841 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 891' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 890' ' ' SER . 3.9 t 35.45 39.46 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.89 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 80.44 50.29 5.44 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.44 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . 53.19 37.56 54.88 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.511 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 69.4 m -96.61 120.44 36.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.816 0.341 . . . . 0.0 111.146 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 895' ' ' VAL . . . . . 0.612 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 17.1 m -115.45 143.68 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.15 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 896' ' ' LEU . . . . . 0.469 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 5.0 mp -91.65 141.94 28.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 80.6 t -137.03 129.72 44.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.132 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 12.4 t -133.46 158.48 42.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.83 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.429 HG22 HG12 ' A' ' 963' ' ' ILE . 2.5 pt -119.94 150.56 22.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.117 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -86.47 104.75 16.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 901' ' ' SER . . . . . . . . . . . . . 52.4 p -140.09 136.9 34.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.914 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 17.6 m -72.87 -57.91 3.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.892 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 35.2 mt -76.18 150.3 82.91 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.586 0.708 . . . . 0.0 110.921 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.16 -31.11 8.02 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.698 2.265 . . . . 0.0 112.316 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -65.94 -6.62 13.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.901 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 906' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -107.96 -23.41 12.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 32.1 m-20 -52.8 -19.31 2.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -80.09 136.91 36.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.899 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 909' ' ' PHE . . . . . 0.573 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 92.9 m-85 -79.22 129.93 34.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 910' ' ' ASP . . . . . 0.441 ' H ' HD12 ' A' ' 913' ' ' LEU . 26.8 m-20 -96.71 173.05 7.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.845 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -53.75 -36.71 62.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.854 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -69.0 -49.54 56.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.071 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 913' ' ' LEU . . . . . 0.441 HD12 ' H ' ' A' ' 910' ' ' ASP . 22.2 mt -59.06 -44.83 91.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 54.3 mt -69.74 -59.88 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.151 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -41.58 -64.92 0.5 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.843 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -47.27 -56.05 7.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 917' ' ' LEU . . . . . 0.759 HD21 HD13 ' A' ' 963' ' ' ILE . 26.9 mt -42.16 -54.22 3.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 918' ' ' LEU . . . . . . . . . . . . . 62.8 mt -40.46 -57.69 1.74 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.954 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -58.71 -42.93 89.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -58.71 -38.8 79.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 921' ' ' PHE . . . . . 0.563 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 24.5 m-85 -69.92 -37.39 75.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -56.27 -35.45 67.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.071 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.7 m -44.53 -29.16 0.67 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 924' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 1.8 m-85 -121.3 -59.6 1.7 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.849 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -124.26 140.21 12.48 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.514 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -82.52 99.41 9.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.814 0.34 . . . . 0.0 110.88 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 927' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 940' ' ' THR . 34.7 t -50.27 143.71 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.163 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 928' ' ' ILE . . . . . 0.654 HD13 ' HA ' ' A' ' 942' ' ' LEU . 15.3 pt -120.02 -39.97 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.15 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 929' ' ' LEU . . . . . . . . . . . . . 8.6 tp -140.44 149.36 42.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.913 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 930' ' ' ILE . . . . . 0.589 HG12 HG13 ' A' ' 939' ' ' VAL . 41.9 mt -137.05 145.58 29.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.104 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 8.1 ttp180 -135.78 124.19 23.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.917 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -87.75 120.38 29.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.909 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 933' ' ' VAL . . . . . 0.694 HG21 ' CD1' ' A' ' 938' ' ' TRP . 3.6 t -87.15 157.15 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.106 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 934' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 933' ' ' VAL . 22.8 mm-40 -34.04 -53.72 0.47 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -124.17 -21.57 4.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.834 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 16.9 ttmt -99.93 172.94 6.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 937' ' ' MET . . . . . 0.573 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 15.2 ttt -131.85 109.03 9.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.841 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 938' ' ' TRP . . . . . 0.694 ' CD1' HG21 ' A' ' 933' ' ' VAL . 43.4 m0 -89.41 143.13 27.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.913 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 939' ' ' VAL . . . . . 0.589 HG13 HG12 ' A' ' 930' ' ' ILE . 46.6 t -135.8 122.73 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.095 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 940' ' ' THR . . . . . 0.445 ' O ' HG13 ' A' ' 927' ' ' VAL . 18.4 m -91.04 152.94 20.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.154 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 941' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -129.21 155.53 45.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.869 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 942' ' ' LEU . . . . . 0.654 ' HA ' HD13 ' A' ' 928' ' ' ILE . 16.1 tp -38.47 -56.72 1.23 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.959 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -136.11 165.67 25.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.862 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -52.97 -53.44 33.72 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.461 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 945' ' ' SER . . . . . 0.411 ' HA ' HD12 ' A' ' 948' ' ' LEU . 77.3 p -46.38 -44.6 17.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.835 0.35 . . . . 0.0 110.847 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 72.2 m -55.17 -32.85 62.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 947' ' ' ALA . . . . . 0.612 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -82.51 -13.43 56.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.102 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 948' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 945' ' ' SER . 60.2 mt -85.65 -28.35 24.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.909 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -85.37 -34.09 21.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.13 -20.26 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.16 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 951' ' ' LEU . . . . . 0.424 HD21 ' HG ' ' A' ' 967' ' ' LEU . 41.2 mt -52.85 -26.56 15.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.93 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 9.7 m -56.36 -21.49 24.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.841 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 26.6 mt -82.04 4.96 20.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.89 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.16 122.71 17.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 88.7 -26.56 8.12 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.485 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -42.32 127.15 3.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.752 0.31 . . . . 0.0 110.913 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -93.63 130.82 39.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 14.8 tp -141.36 152.46 44.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.913 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 81.4 mt 42.03 48.42 4.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.964 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 4.4 m120 48.57 40.74 16.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.839 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 961' ' ' ARG . . . . . . . . . . . . . 51.5 mtt85 -148.94 105.0 3.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.871 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 56.3 m -62.67 121.35 13.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.12 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 963' ' ' ILE . . . . . 0.759 HD13 HD21 ' A' ' 917' ' ' LEU . 64.7 mt -102.32 152.87 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.14 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 964' ' ' THR . . . . . 0.42 ' N ' HG22 ' A' ' 963' ' ' ILE . 11.6 m -136.45 117.51 14.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.1 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 965' ' ' ILE . . . . . . . . . . . . . 33.7 mt -100.37 143.62 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.104 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -154.28 129.38 9.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.128 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 967' ' ' LEU . . . . . 0.58 HD23 HG12 ' A' ' 895' ' ' VAL . 36.5 mt -63.15 158.0 20.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.926 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 12.7 tptp -89.14 140.51 29.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 68.3 m -104.84 97.5 12.92 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.673 0.749 . . . . 0.0 110.874 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.93 -5.86 17.36 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.719 2.279 . . . . 0.0 112.376 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 51.8 p -40.17 127.41 2.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.878 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -171.31 -165.83 29.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.481 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -79.38 20.89 0.8 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.656 2.237 . . . . 0.0 112.357 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 34.9 p -57.09 -48.31 78.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 13.1 t -45.86 -46.65 15.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.86 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.529 -179.989 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 46.6 p -94.21 97.42 10.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.88 0.372 . . . . 0.0 110.929 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 19.3 m -102.15 118.1 36.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.871 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . -79.1 112.7 3.51 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.499 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 41.6 m -108.44 159.57 16.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.855 0.36 . . . . 0.0 110.87 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 60.3 m -122.82 146.08 47.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.844 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 135.4 -68.71 0.53 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.477 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . 99.94 47.25 1.78 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.52 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 97.5 m -83.65 121.91 27.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.825 0.345 . . . . 0.0 111.092 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 895' ' ' VAL . . . . . 0.448 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 17.2 m -115.0 142.48 27.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.113 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 896' ' ' LEU . . . . . 0.471 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 3.9 mp -91.58 142.64 27.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 897' ' ' VAL . . . . . 0.419 HG22 HG12 ' A' ' 965' ' ' ILE . 94.5 t -139.86 131.43 32.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.131 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 11.8 t -132.6 151.73 51.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.827 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 899' ' ' ILE . . . . . 0.476 HG22 HG12 ' A' ' 963' ' ' ILE . 3.8 pt -119.95 121.05 64.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.159 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 6.0 tppt? -77.43 117.49 18.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 901' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 902' ' ' SER . 3.8 t -133.45 138.97 46.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.837 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 902' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 901' ' ' SER . 4.0 t -36.85 -55.89 0.88 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.839 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 16.9 mt -98.53 154.11 37.67 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.612 0.72 . . . . 0.0 110.913 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -77.47 -33.86 2.25 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.727 2.285 . . . . 0.0 112.363 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -60.45 -10.31 4.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.9 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 906' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -104.82 15.26 28.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -68.37 -23.43 64.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -66.54 150.82 48.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 909' ' ' PHE . . . . . 0.592 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 24.6 m-85 -96.25 131.05 43.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 910' ' ' ASP . . . . . 0.66 ' H ' HD12 ' A' ' 913' ' ' LEU . 23.6 t70 -89.89 168.3 12.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.85 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 911' ' ' ASP . . . . . 0.409 ' N ' ' CG ' ' A' ' 910' ' ' ASP . 0.7 OUTLIER -49.04 -45.89 43.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -61.46 -58.27 8.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.095 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 913' ' ' LEU . . . . . 0.855 HD21 ' HD2' ' A' ' 961' ' ' ARG . 84.3 mt -47.84 -47.18 31.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.88 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 57.3 mt -66.47 -64.28 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.118 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -39.34 -61.93 0.73 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 916' ' ' GLU . . . . . 0.4 ' HG3' HD11 ' A' ' 959' ' ' LEU . 30.7 mm-40 -47.83 -57.25 5.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.934 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 917' ' ' LEU . . . . . 0.98 HD21 HD13 ' A' ' 963' ' ' ILE . 33.8 mt -41.73 -56.91 2.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 918' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 917' ' ' LEU . 37.5 mt -36.11 -57.54 0.7 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -54.83 -42.78 72.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 920' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 917' ' ' LEU . 60.5 mm-40 -61.17 -39.14 89.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.913 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 921' ' ' PHE . . . . . 0.54 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 22.0 m-85 -71.34 -34.56 70.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -60.62 -34.52 74.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.086 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -47.24 -23.72 0.59 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.851 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 924' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 924' ' ' PHE . 0.6 OUTLIER -125.42 -55.97 1.53 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.896 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -127.56 141.23 12.45 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.469 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -83.55 100.26 10.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.88 0.372 . . . . 0.0 110.884 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 60.9 t -53.14 146.32 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.134 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 928' ' ' ILE . . . . . . . . . . . . . 29.1 pt -124.85 -37.38 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.159 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 929' ' ' LEU . . . . . . . . . . . . . 22.2 tp -139.7 146.88 40.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.964 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 64.1 mt -136.23 129.26 46.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.119 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -118.81 124.7 47.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -90.96 119.53 31.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.862 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 933' ' ' VAL . . . . . 0.638 HG21 ' NE1' ' A' ' 938' ' ' TRP . 9.0 t -85.64 157.27 3.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.148 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 934' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 933' ' ' VAL . 65.7 mt-10 -33.77 -50.34 0.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.871 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.76 -26.2 3.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.841 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 936' ' ' LYS . . . . . 0.41 ' O ' ' N ' ' A' ' 933' ' ' VAL . 1.0 OUTLIER -96.48 173.2 7.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 -179.984 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 937' ' ' MET . . . . . 0.592 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 18.8 ttt -134.8 110.39 9.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.848 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 938' ' ' TRP . . . . . 0.638 ' NE1' HG21 ' A' ' 933' ' ' VAL . 43.8 m0 -89.51 152.31 21.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.939 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 939' ' ' VAL . . . . . 0.441 HG12 ' CE1' ' A' ' 941' ' ' PHE . 93.0 t -140.99 123.57 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.127 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 18.8 m -90.4 150.04 22.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.137 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 941' ' ' PHE . . . . . 0.441 ' CE1' HG12 ' A' ' 939' ' ' VAL . 10.8 m-85 -129.41 150.49 50.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.891 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 942' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 941' ' ' PHE . 21.7 tp -37.09 -59.62 0.71 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.909 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -130.41 163.26 27.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 944' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 947' ' ' ALA . . . -55.49 -56.84 21.55 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.5 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 945' ' ' SER . . . . . 0.524 ' HA ' HD12 ' A' ' 948' ' ' LEU . 68.6 p -39.57 -48.71 2.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.889 0.376 . . . . 0.0 110.836 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 18.3 m -54.14 -37.93 64.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 947' ' ' ALA . . . . . 0.448 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -74.57 -13.81 60.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.098 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 948' ' ' LEU . . . . . 0.524 HD12 ' HA ' ' A' ' 945' ' ' SER . 26.7 mt -89.29 -21.85 22.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -88.77 -44.85 10.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.91 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 7.3 p -52.45 -22.76 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.109 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 31.1 mt -48.68 -26.65 2.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.904 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 26.3 m -52.78 -16.14 0.91 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.889 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 36.5 mt -92.13 16.48 11.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.865 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -70.41 119.0 13.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 87.8 -27.92 6.28 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.499 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -38.61 127.52 1.49 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.73 0.3 . . . . 0.0 110.896 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -97.17 122.87 40.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.904 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 14.2 tp -132.91 156.75 46.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 959' ' ' LEU . . . . . 0.453 ' O ' ' CG ' ' A' ' 960' ' ' ASN . 24.9 mt 42.19 49.23 4.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.931 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 960' ' ' ASN . . . . . 0.453 ' CG ' ' O ' ' A' ' 959' ' ' LEU . 0.9 OUTLIER 47.53 38.94 8.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 179.939 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 961' ' ' ARG . . . . . 0.855 ' HD2' HD21 ' A' ' 913' ' ' LEU . 49.7 mtt85 -146.88 112.0 5.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.871 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 55.8 m -64.9 119.52 10.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.127 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 963' ' ' ILE . . . . . 0.98 HD13 HD21 ' A' ' 917' ' ' LEU . 89.1 mt -102.12 145.65 11.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.115 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 7.6 m -130.43 110.26 11.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.126 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 965' ' ' ILE . . . . . 0.419 HG12 HG22 ' A' ' 897' ' ' VAL . 62.5 mt -96.64 136.61 26.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.146 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -147.72 134.47 20.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.136 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 967' ' ' LEU . . . . . . . . . . . . . 26.9 mt -64.54 155.75 32.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.927 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 11.9 tptp -94.35 -70.52 0.7 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.883 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 99.6 p -42.35 146.5 0.68 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.657 0.741 . . . . 0.0 110.849 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.69 -49.53 10.67 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.711 2.274 . . . . 0.0 112.354 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 28.5 t -161.39 122.37 2.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -46.53 146.25 3.4 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.498 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -77.42 100.48 1.4 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.711 2.274 . . . . 0.0 112.344 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 48.6 m -128.28 144.88 51.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.862 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 48.5 p -85.7 -46.86 10.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.857 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.372 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.487 179.988 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 99.1 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.865 0.364 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 895' ' ' VAL . . . . . 0.575 HG12 HD23 ' A' ' 967' ' ' LEU . 17.7 m -116.26 142.24 30.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.076 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . 0.465 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 6.5 mp -90.52 139.15 30.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.926 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.403 HG13 ' CG2' ' A' ' 963' ' ' ILE . 70.5 t -139.01 125.29 23.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.139 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 11.1 t -126.6 155.02 43.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.862 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.551 HG12 ' CE2' ' A' ' 909' ' ' PHE . 2.6 pt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.123 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 909' ' ' PHE . . . . . 0.757 ' HA ' HD12 ' A' ' 913' ' ' LEU . 79.7 m-85 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.84 0.352 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -97.56 -177.25 3.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.835 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -61.92 -36.07 80.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -67.72 -57.36 6.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.112 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 913' ' ' LEU . . . . . 0.757 HD12 ' HA ' ' A' ' 909' ' ' PHE . 22.6 mt -49.79 -47.0 51.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.923 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 47.5 mt -69.99 -65.93 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.125 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -38.81 -53.47 1.68 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.843 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 916' ' ' GLU . . . . . 0.468 ' HB3' HD21 ' A' ' 958' ' ' LEU . 60.8 mm-40 -58.24 -51.15 70.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.893 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 917' ' ' LEU . . . . . 0.974 HD21 HD13 ' A' ' 963' ' ' ILE . 23.9 mt -48.93 -54.79 14.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.883 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 918' ' ' LEU . . . . . 0.434 ' C ' ' O ' ' A' ' 917' ' ' LEU . 52.4 mt -35.04 -58.81 0.52 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.939 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -54.76 -51.17 66.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.934 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 920' ' ' GLN . . . . . 0.972 ' NE2' HD22 ' A' ' 958' ' ' LEU . 14.4 mt-30 -51.27 -41.43 60.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.926 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 921' ' ' PHE . . . . . 0.505 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 23.6 m-85 -70.93 -32.1 68.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -58.3 -39.22 78.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.097 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -45.03 -25.58 0.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.918 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 924' ' ' PHE . . . . . 0.531 ' N ' ' CD1' ' A' ' 924' ' ' PHE . 1.0 OUTLIER -120.96 -64.1 1.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.878 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -121.33 145.08 16.96 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.467 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -85.82 97.23 10.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.88 0.372 . . . . 0.0 110.902 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 29.1 t -46.31 145.64 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.107 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 928' ' ' ILE . . . . . 0.468 HG13 ' N ' ' A' ' 929' ' ' LEU . 25.1 pt -126.63 -42.89 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.167 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 929' ' ' LEU . . . . . 0.468 ' N ' HG13 ' A' ' 928' ' ' ILE . 10.2 tp -133.7 145.84 50.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.946 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 930' ' ' ILE . . . . . 0.41 HD11 ' CD2' ' A' ' 918' ' ' LEU . 81.7 mt -133.69 124.58 47.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.099 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 41.1 ttt180 -115.21 124.35 51.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.91 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -90.76 122.42 33.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.912 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 933' ' ' VAL . . . . . 0.723 HG21 ' NE1' ' A' ' 938' ' ' TRP . 2.7 t -90.51 156.94 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.151 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 934' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 933' ' ' VAL . 14.7 mt-10 -34.49 -52.12 0.49 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.9 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.93 -25.52 3.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.896 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -96.63 172.92 7.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.864 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 937' ' ' MET . . . . . 0.565 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 15.9 ttt -133.54 110.73 10.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.903 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 938' ' ' TRP . . . . . 0.723 ' NE1' HG21 ' A' ' 933' ' ' VAL . 37.8 m0 -90.85 148.98 22.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.924 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 939' ' ' VAL . . . . . 0.44 ' O ' HG22 ' A' ' 895' ' ' VAL . 47.6 t -137.88 124.83 28.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.106 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 21.3 m -93.0 150.48 20.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.147 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 941' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -128.49 158.56 38.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.839 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 23.2 tp -40.72 -53.54 2.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.939 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -134.48 167.82 20.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.866 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -64.74 -47.4 83.68 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.523 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 70.5 m -50.06 -43.86 51.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.923 0.392 . . . . 0.0 110.831 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 1.9 t -56.64 -36.72 69.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.91 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 947' ' ' ALA . . . . . 0.468 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -69.82 -13.64 62.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.103 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 948' ' ' LEU . . . . . 0.404 ' O ' HD12 ' A' ' 951' ' ' LEU . 23.8 mt -87.15 -25.23 24.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -82.78 -38.08 23.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 9.0 p -61.28 -18.47 18.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.139 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 951' ' ' LEU . . . . . 0.524 HD21 ' HG ' ' A' ' 967' ' ' LEU . 58.7 mt -53.27 -17.84 2.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.941 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 46.3 m -61.77 -12.98 19.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.888 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 953' ' ' LEU . . . . . 0.486 ' HB2' ' CD1' ' A' ' 965' ' ' ILE . 75.3 mt -96.86 12.84 30.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.956 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -66.03 107.24 1.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.934 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 100.02 -26.85 22.9 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.487 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 8.4 tmtm? -40.17 128.86 2.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.772 0.32 . . . . 0.0 110.909 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -93.01 130.38 38.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.848 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 958' ' ' LEU . . . . . 0.972 HD22 ' NE2' ' A' ' 920' ' ' GLN . 16.2 tp -136.3 145.99 46.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.931 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 959' ' ' LEU . . . . . 0.587 HD13 HD23 ' A' ' 913' ' ' LEU . 26.0 mt 44.94 52.24 8.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.953 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 49.26 31.85 3.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 961' ' ' ARG . . . . . . . . . . . . . 56.0 mtt-85 -138.89 111.76 7.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 18.7 m -66.25 116.57 7.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.164 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 963' ' ' ILE . . . . . 0.974 HD13 HD21 ' A' ' 917' ' ' LEU . 92.9 mt -97.82 137.21 26.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.114 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 9.6 m -122.41 110.42 15.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.134 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 965' ' ' ILE . . . . . 0.486 ' CD1' ' HB2' ' A' ' 953' ' ' LEU . 38.3 mt -94.61 143.23 12.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.139 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -157.3 133.26 9.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.149 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 967' ' ' LEU . . . . . 0.575 HD23 HG12 ' A' ' 895' ' ' VAL . 31.8 mt -67.12 157.73 32.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.905 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 19.3 tptp . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.897 179.842 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 53.6 m . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.822 0.344 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 895' ' ' VAL . . . . . 0.599 HG12 HD23 ' A' ' 967' ' ' LEU . 16.8 m -112.23 141.6 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.122 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . 0.534 ' HG ' ' CD1' ' A' ' 938' ' ' TRP . 3.6 mp -91.84 148.07 22.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.93 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.401 HG13 ' CG2' ' A' ' 963' ' ' ILE . 58.1 t -145.3 127.37 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.165 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 6.4 t -127.82 153.95 46.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.891 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.562 HG22 HG12 ' A' ' 963' ' ' ILE . 2.1 pt . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.109 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 909' ' ' PHE . . . . . 0.59 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 87.5 m-85 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.866 0.365 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 910' ' ' ASP . . . . . 0.447 ' H ' HD12 ' A' ' 913' ' ' LEU . 32.3 t70 -87.51 166.42 14.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.876 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -49.32 -44.83 44.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.855 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -62.96 -52.29 63.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.105 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 913' ' ' LEU . . . . . 0.754 HD21 ' HD2' ' A' ' 961' ' ' ARG . 50.3 mt -53.69 -49.31 68.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.921 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 47.3 mt -65.85 -61.62 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.14 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -42.77 -60.72 1.47 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.869 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -48.92 -52.62 23.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.909 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 917' ' ' LEU . . . . . 0.979 HD21 HD13 ' A' ' 963' ' ' ILE . 29.6 mt -47.81 -54.71 11.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 918' ' ' LEU . . . . . 0.472 ' CD2' HD11 ' A' ' 930' ' ' ILE . 87.4 mt -35.22 -59.12 0.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.905 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -54.79 -44.66 73.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.89 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 62.5 mm-40 -57.46 -41.08 79.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 921' ' ' PHE . . . . . 0.53 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 23.5 m-85 -70.05 -34.22 72.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -60.67 -34.39 74.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.089 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -47.12 -24.15 0.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 924' ' ' PHE . . . . . 0.52 ' N ' ' CD1' ' A' ' 924' ' ' PHE . 1.2 m-85 -125.7 -55.23 1.52 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.878 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -129.16 135.07 8.25 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.453 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -79.08 98.37 6.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.918 0.39 . . . . 0.0 110.914 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 42.2 t -51.63 151.46 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.132 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 928' ' ' ILE . . . . . 0.479 HG13 ' N ' ' A' ' 929' ' ' LEU . 20.1 pt -125.81 -45.43 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.1 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 929' ' ' LEU . . . . . 0.479 ' N ' HG13 ' A' ' 928' ' ' ILE . 11.2 tp -132.87 148.08 52.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 930' ' ' ILE . . . . . 0.618 HG12 HG13 ' A' ' 939' ' ' VAL . 74.5 mt -133.12 132.86 58.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.128 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -120.87 123.92 43.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.847 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -90.69 120.18 31.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.877 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 933' ' ' VAL . . . . . 0.624 HG21 ' NE1' ' A' ' 938' ' ' TRP . 2.6 t -90.48 157.13 2.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.086 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 934' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 933' ' ' VAL . 58.3 mt-10 -33.94 -51.6 0.41 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.908 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -125.19 -25.49 3.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.878 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 936' ' ' LYS . . . . . 0.4 ' O ' ' N ' ' A' ' 933' ' ' VAL . 12.0 tttt -98.27 172.98 7.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.881 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 937' ' ' MET . . . . . 0.59 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 13.5 ttt -135.33 110.65 9.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 938' ' ' TRP . . . . . 0.624 ' NE1' HG21 ' A' ' 933' ' ' VAL . 40.2 m0 -88.69 149.11 23.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.944 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 939' ' ' VAL . . . . . 0.618 HG13 HG12 ' A' ' 930' ' ' ILE . 12.1 t -139.12 129.36 32.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.128 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 17.3 m -93.73 151.15 19.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.151 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 941' ' ' PHE . . . . . 0.422 ' O ' ' C ' ' A' ' 942' ' ' LEU . 9.5 m-85 -130.56 139.82 50.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.917 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 942' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 941' ' ' PHE . 24.5 tp -35.14 -62.5 0.38 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.909 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -116.38 154.47 30.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.87 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -58.54 -50.01 71.23 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.442 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 12.6 t -48.21 -43.48 32.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.848 0.356 . . . . 0.0 110.857 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 14.6 m -55.77 -29.02 58.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.853 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 947' ' ' ALA . . . . . 0.492 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -81.44 -23.0 37.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.073 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 38.3 mt -79.68 -25.71 41.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -84.6 -51.44 6.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.873 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 950' ' ' VAL . . . . . 0.425 ' CG2' HD12 ' A' ' 953' ' ' LEU . 9.8 p -47.55 -21.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.163 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 951' ' ' LEU . . . . . 0.64 HD21 ' HG ' ' A' ' 967' ' ' LEU . 35.3 mt -49.52 -27.25 4.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.959 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 74.8 m -53.72 -15.29 1.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.903 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 953' ' ' LEU . . . . . 0.425 HD12 ' CG2' ' A' ' 950' ' ' VAL . 57.7 mt -90.36 16.51 8.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.926 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.95 120.01 14.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 955' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 956' ' ' LYS . . . 86.21 -25.94 6.62 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.493 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 956' ' ' LYS . . . . . 0.423 ' HE3' HD13 ' A' ' 958' ' ' LEU . 8.9 tmtm? -36.21 126.84 0.77 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.747 0.308 . . . . 0.0 110.857 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -94.72 125.59 39.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 958' ' ' LEU . . . . . 0.423 HD13 ' HE3' ' A' ' 956' ' ' LYS . 14.2 tp -138.35 153.69 48.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 959' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 913' ' ' LEU . 45.3 mt 41.79 48.39 3.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 960' ' ' ASN . . . . . 0.415 ' CG ' ' C ' ' A' ' 959' ' ' LEU . 0.7 OUTLIER 46.5 42.94 11.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 961' ' ' ARG . . . . . 0.754 ' HD2' HD21 ' A' ' 913' ' ' LEU . 45.8 mtt85 -149.69 105.27 3.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 7.4 m -59.49 122.16 13.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.111 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 963' ' ' ILE . . . . . 0.979 HD13 HD21 ' A' ' 917' ' ' LEU . 88.3 mt -106.69 142.35 19.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.152 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 6.5 m -126.48 116.41 21.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.135 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 965' ' ' ILE . . . . . . . . . . . . . 67.6 mt -98.03 139.28 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.179 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -148.7 128.09 13.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.07 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 967' ' ' LEU . . . . . 0.64 ' HG ' HD21 ' A' ' 951' ' ' LEU . 30.4 mt -66.51 157.46 32.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 968' ' ' LYS . . . . . 0.421 ' HD3' HD11 ' A' ' 896' ' ' LEU . 30.5 tptt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 86.8 m . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.817 0.341 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 895' ' ' VAL . . . . . 0.451 HG12 HD23 ' A' ' 967' ' ' LEU . 27.5 m -120.19 139.28 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.143 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . 0.463 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 6.4 mp -89.18 138.97 30.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.415 HG13 ' CG2' ' A' ' 963' ' ' ILE . 63.8 t -139.71 122.61 17.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.138 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 16.5 t -125.66 155.5 40.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.902 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.565 HG22 HG12 ' A' ' 963' ' ' ILE . 2.3 pt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.128 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 909' ' ' PHE . . . . . 0.527 ' CE2' HG12 ' A' ' 899' ' ' ILE . 27.1 m-85 . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.841 0.353 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 910' ' ' ASP . . . . . 0.46 ' H ' HD12 ' A' ' 913' ' ' LEU . 3.0 m-20 -86.18 177.31 7.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.871 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -55.17 -42.96 73.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.859 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -63.96 -47.24 81.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.076 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 913' ' ' LEU . . . . . 0.926 HD21 ' HD2' ' A' ' 961' ' ' ARG . 52.1 mt -61.01 -48.95 79.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.926 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 49.6 mt -65.81 -59.95 3.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.14 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -45.28 -58.01 3.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.902 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -50.84 -52.53 40.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.891 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 917' ' ' LEU . . . . . 0.909 HD21 HD13 ' A' ' 963' ' ' ILE . 29.6 mt -46.4 -54.01 9.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.909 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 918' ' ' LEU . . . . . 0.414 ' C ' ' O ' ' A' ' 917' ' ' LEU . 20.6 mt -36.63 -64.42 0.34 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.939 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -50.14 -51.92 39.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.912 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -50.47 -40.97 52.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 921' ' ' PHE . . . . . 0.579 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 24.1 m-85 -69.74 -48.18 60.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.855 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -48.19 -28.31 2.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.108 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 923' ' ' SER . . . . . 0.554 ' HB3' ' CD1' ' A' ' 924' ' ' PHE . 16.7 t -47.49 -29.66 2.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.897 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 924' ' ' PHE . . . . . 0.554 ' CD1' ' HB3' ' A' ' 923' ' ' SER . 1.0 OUTLIER -123.02 -64.43 1.18 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.856 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -115.74 155.29 16.37 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.51 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -91.96 138.44 31.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.885 0.374 . . . . 0.0 110.909 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 55.9 t -93.07 146.16 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.114 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 928' ' ' ILE . . . . . 0.491 HG13 ' N ' ' A' ' 929' ' ' LEU . 30.2 pt -123.32 -42.86 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.107 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 929' ' ' LEU . . . . . 0.491 ' N ' HG13 ' A' ' 928' ' ' ILE . 15.0 tp -138.76 141.81 38.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 94.3 mt -127.36 125.47 65.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.154 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -113.44 122.82 48.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -90.6 122.14 33.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.928 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 933' ' ' VAL . . . . . 0.569 HG21 ' NE1' ' A' ' 938' ' ' TRP . 2.9 t -89.9 157.09 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.158 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 934' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 933' ' ' VAL . 61.8 mt-10 -34.11 -50.53 0.4 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.891 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -126.05 -26.73 3.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.823 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 936' ' ' LYS . . . . . 0.417 ' HB2' ' NZ ' ' A' ' 936' ' ' LYS . 0.7 OUTLIER -96.53 172.73 7.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.933 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 937' ' ' MET . . . . . 0.507 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 14.5 ttt -135.26 111.78 9.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.863 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 938' ' ' TRP . . . . . 0.569 ' NE1' HG21 ' A' ' 933' ' ' VAL . 37.0 m0 -92.47 146.33 23.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 939' ' ' VAL . . . . . 0.41 HG12 ' CE1' ' A' ' 941' ' ' PHE . 65.0 t -132.62 121.27 44.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.132 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 18.9 m -85.18 152.59 23.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.156 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 941' ' ' PHE . . . . . 0.41 ' CE1' HG12 ' A' ' 939' ' ' VAL . 12.0 m-85 -133.74 141.84 47.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 19.7 tp -42.55 -47.97 5.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.899 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -120.63 176.13 5.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -89.74 -39.2 6.28 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.519 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 36.0 p -59.54 -41.23 89.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.921 0.391 . . . . 0.0 110.861 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 80.0 p -56.38 -34.45 66.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.881 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -70.81 -15.18 62.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.103 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 25.5 mt -84.01 -31.53 25.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -75.67 -49.31 18.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.842 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 8.5 p -53.35 -17.31 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.143 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 951' ' ' LEU . . . . . 0.472 HD21 ' HG ' ' A' ' 967' ' ' LEU . 52.3 mt -52.98 -24.96 10.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 35.9 p -55.88 -22.92 28.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 76.7 mt -83.25 17.9 1.92 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -72.63 110.35 6.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 96.02 -26.42 20.89 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.481 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -38.33 127.46 1.39 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.732 0.301 . . . . 0.0 110.897 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -94.9 128.42 41.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.901 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 958' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 961' ' ' ARG . 13.7 tp -136.97 160.04 40.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.926 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 959' ' ' LEU . . . . . 0.406 ' C ' ' O ' ' A' ' 958' ' ' LEU . 43.5 mt 37.7 43.07 0.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.967 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 55.44 43.31 28.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.871 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 961' ' ' ARG . . . . . 0.926 ' HD2' HD21 ' A' ' 913' ' ' LEU . 69.2 mtt-85 -149.71 122.89 8.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.844 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 6.0 m -75.05 112.72 11.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.119 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 963' ' ' ILE . . . . . 0.909 HD13 HD21 ' A' ' 917' ' ' LEU . 82.8 mt -98.02 138.17 23.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.088 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 9.3 m -122.13 113.25 19.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.109 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 965' ' ' ILE . . . . . 0.409 HG12 HG22 ' A' ' 897' ' ' VAL . 55.3 mt -98.75 135.07 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.113 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -149.27 136.63 20.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.095 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 967' ' ' LEU . . . . . 0.472 ' HG ' HD21 ' A' ' 951' ' ' LEU . 30.7 mt -65.44 156.58 31.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.895 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 968' ' ' LYS . . . . . 0.418 ' HE3' ' CH2' ' A' ' 938' ' ' TRP . 21.5 tttt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 84.8 m . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.823 0.344 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 895' ' ' VAL . . . . . 0.712 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 11.3 m -114.25 147.19 17.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.117 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . 0.46 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 3.5 mp -96.17 144.26 26.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.937 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.418 HG22 HG12 ' A' ' 965' ' ' ILE . 59.2 t -143.72 131.88 18.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.137 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 14.2 t -134.14 160.23 38.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.82 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.42 HG22 HG12 ' A' ' 963' ' ' ILE . 4.1 pt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.162 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 909' ' ' PHE . . . . . 0.567 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 90.0 m-85 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.899 0.381 . . . . 0.0 110.841 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 910' ' ' ASP . . . . . 0.663 ' H ' HD12 ' A' ' 913' ' ' LEU . 7.4 t70 -72.44 163.61 27.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.842 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -51.47 -35.95 42.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.831 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -70.49 -50.95 32.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.091 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 913' ' ' LEU . . . . . 0.849 HD21 ' HD2' ' A' ' 961' ' ' ARG . 87.4 mt -54.8 -35.43 63.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 91.2 mt -79.28 -65.0 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.14 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -39.69 -55.97 1.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.919 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 916' ' ' GLU . . . . . 0.535 ' HB3' HD21 ' A' ' 958' ' ' LEU . 69.0 mm-40 -51.95 -48.46 64.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 917' ' ' LEU . . . . . 1.008 HD21 HD13 ' A' ' 963' ' ' ILE . 28.8 mt -55.06 -47.49 74.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 918' ' ' LEU . . . . . . . . . . . . . 44.6 mt -43.29 -55.58 3.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -58.63 -38.65 78.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 39.4 mm-40 -64.31 -35.83 82.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.888 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 921' ' ' PHE . . . . . 0.557 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 19.4 m-85 -76.03 -33.01 59.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -58.24 -31.92 67.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.104 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 923' ' ' SER . . . . . 0.478 ' OG ' ' CE2' ' A' ' 924' ' ' PHE . 31.9 p -56.93 -13.51 2.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.855 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 924' ' ' PHE . . . . . 0.478 ' CE2' ' OG ' ' A' ' 923' ' ' SER . 74.5 m-85 -125.97 -57.33 1.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.86 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -137.17 140.14 11.14 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.462 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -74.96 98.85 3.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.896 0.379 . . . . 0.0 110.871 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 58.0 t -50.29 145.16 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.146 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 928' ' ' ILE . . . . . 0.571 HD13 ' HA ' ' A' ' 942' ' ' LEU . 20.0 pt -120.28 -45.38 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.138 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 929' ' ' LEU . . . . . 0.479 ' N ' HG13 ' A' ' 928' ' ' ILE . 11.2 tp -137.78 151.85 48.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.914 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 40.7 mt -135.97 129.85 48.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.113 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 21.4 ttt-85 -116.56 123.8 48.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -91.58 123.85 35.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.885 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 933' ' ' VAL . . . . . 0.759 HG21 ' NE1' ' A' ' 938' ' ' TRP . 3.6 t -90.78 156.97 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.17 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 934' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 933' ' ' VAL . 61.2 mm-40 -34.37 -51.32 0.45 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.1 -25.46 3.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.803 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.03 173.02 7.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 937' ' ' MET . . . . . 0.567 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 15.1 ttt -134.19 113.51 12.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.877 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 938' ' ' TRP . . . . . 0.759 ' NE1' HG21 ' A' ' 933' ' ' VAL . 37.1 m0 -93.89 151.89 19.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.889 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 939' ' ' VAL . . . . . 0.437 HG12 ' CE1' ' A' ' 941' ' ' PHE . 39.8 t -134.86 139.19 47.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.161 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 940' ' ' THR . . . . . 0.421 HG22 HD11 ' A' ' 928' ' ' ILE . 29.2 m -110.66 146.8 35.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.15 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 941' ' ' PHE . . . . . 0.437 ' CE1' HG12 ' A' ' 939' ' ' VAL . 9.7 m-85 -130.21 149.84 51.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.884 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 942' ' ' LEU . . . . . 0.571 ' HA ' HD13 ' A' ' 928' ' ' ILE . 21.2 tp -40.25 -63.63 0.6 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.902 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -107.43 168.48 9.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.91 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -76.42 -49.8 7.91 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.482 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 6.6 p -49.41 -27.25 3.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.921 0.391 . . . . 0.0 110.883 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 70.5 m -63.22 -47.59 81.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.864 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 947' ' ' ALA . . . . . 0.712 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -60.28 -27.88 67.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.107 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 18.3 mt -73.66 -25.12 60.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.933 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -81.8 -45.05 16.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.919 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 950' ' ' VAL . . . . . 0.508 HG12 ' O ' ' A' ' 947' ' ' ALA . 3.2 p -57.83 -18.8 10.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.13 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 951' ' ' LEU . . . . . 0.483 HD21 ' HG ' ' A' ' 967' ' ' LEU . 23.0 mt -51.77 -31.42 26.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.962 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 6.4 t -51.52 -17.19 0.74 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.837 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 39.8 mt -87.85 13.76 10.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.888 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -66.28 117.22 8.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 90.88 -26.7 10.29 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.5 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -41.43 128.54 3.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.794 0.331 . . . . 0.0 110.881 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -97.78 130.43 44.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.857 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 958' ' ' LEU . . . . . 0.535 HD21 ' HB3' ' A' ' 916' ' ' GLU . 15.3 tp -134.74 156.21 49.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.935 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 959' ' ' LEU . . . . . 0.427 HD11 ' HG3' ' A' ' 916' ' ' GLU . 47.0 mt 38.83 46.02 1.01 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.922 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 51.88 45.32 28.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.847 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 961' ' ' ARG . . . . . 0.849 ' HD2' HD21 ' A' ' 913' ' ' LEU . 52.0 mtt85 -151.65 105.42 3.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.925 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 18.7 m -57.75 117.49 4.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.152 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 963' ' ' ILE . . . . . 1.008 HD13 HD21 ' A' ' 917' ' ' LEU . 97.4 mt -101.14 139.03 23.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 4.2 m -123.66 116.06 22.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.177 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 965' ' ' ILE . . . . . 0.418 HG12 HG22 ' A' ' 897' ' ' VAL . 55.2 mt -101.1 139.94 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.159 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -152.03 131.25 12.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.142 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 967' ' ' LEU . . . . . 0.54 HD23 HG12 ' A' ' 895' ' ' VAL . 33.7 mt -64.55 157.87 25.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.939 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 22.8 tptm . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 179.849 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 33.9 m . . . . . 0 N--CA 1.457 -0.107 0 CA-C-O 120.798 0.332 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 895' ' ' VAL . . . . . 0.766 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 13.9 m -116.31 139.76 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.152 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . 0.47 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 3.2 mp -89.53 150.82 22.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.891 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 64.3 t -144.95 131.66 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.178 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 5.2 t -133.53 154.71 50.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.53 HG23 ' CE2' ' A' ' 909' ' ' PHE . 4.1 pt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.111 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 909' ' ' PHE . . . . . 0.563 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 50.6 m-85 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.854 0.359 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -96.91 169.1 10.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -48.12 -38.55 18.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.878 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -67.59 -54.24 21.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.064 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 913' ' ' LEU . . . . . 0.571 ' O ' HD12 ' A' ' 917' ' ' LEU . 36.7 mt -52.92 -42.01 64.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.908 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 60.7 mt -74.08 -64.91 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.11 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -40.02 -61.55 0.85 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 916' ' ' GLU . . . . . 0.573 ' HG3' HD11 ' A' ' 959' ' ' LEU . 74.9 mm-40 -48.89 -55.52 11.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.904 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 917' ' ' LEU . . . . . 0.803 HD21 HD13 ' A' ' 963' ' ' ILE . 24.9 mt -46.5 -54.15 9.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 918' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 917' ' ' LEU . 89.4 mt -36.81 -59.39 0.69 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -55.35 -48.69 73.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -53.16 -41.3 65.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.938 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 921' ' ' PHE . . . . . 0.557 ' CZ ' ' HB3' ' A' ' 917' ' ' LEU . 19.8 m-85 -64.72 -45.0 88.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.925 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -54.03 -30.99 49.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.102 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 29.7 t -45.54 -30.98 1.62 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 924' ' ' PHE . . . . . 0.532 ' N ' ' CD1' ' A' ' 924' ' ' PHE . 1.0 OUTLIER -120.73 -57.63 1.88 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -127.03 152.22 18.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.512 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -87.62 135.51 33.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.855 0.36 . . . . 0.0 110.889 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 46.7 t -87.7 145.93 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.113 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 928' ' ' ILE . . . . . 0.449 HG13 ' N ' ' A' ' 929' ' ' LEU . 26.6 pt -120.65 -41.56 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.093 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 929' ' ' LEU . . . . . 0.449 ' N ' HG13 ' A' ' 928' ' ' ILE . 21.9 tp -141.06 149.05 41.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.95 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 58.4 mt -133.24 132.54 58.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.144 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -118.39 130.58 56.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -97.59 120.78 38.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.851 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 933' ' ' VAL . . . . . 0.57 HG21 ' NE1' ' A' ' 938' ' ' TRP . 2.8 t -91.58 157.12 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.109 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 934' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 933' ' ' VAL . 44.3 mt-10 -33.56 -54.01 0.43 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.905 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -124.5 -22.42 4.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.817 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 6.3 ttmt -99.59 173.14 6.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.868 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 937' ' ' MET . . . . . 0.563 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 17.3 ttt -136.14 114.31 11.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 938' ' ' TRP . . . . . 0.57 ' NE1' HG21 ' A' ' 933' ' ' VAL . 37.8 m0 -94.72 143.9 26.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.96 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 47.9 t -130.78 137.82 55.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.16 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 19.4 m -106.85 144.36 33.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.18 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 941' ' ' PHE . . . . . 0.444 ' O ' ' C ' ' A' ' 942' ' ' LEU . 6.0 m-85 -125.38 144.22 50.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.909 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 942' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 941' ' ' PHE . 43.1 tp -34.33 -67.84 0.13 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.925 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -104.44 171.81 7.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.903 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -76.02 -49.6 8.48 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.499 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 945' ' ' SER . . . . . 0.428 ' HA ' HD12 ' A' ' 948' ' ' LEU . 95.6 p -50.44 -25.93 4.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.865 0.364 . . . . 0.0 110.869 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 60.7 m -65.63 -42.59 91.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.793 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 947' ' ' ALA . . . . . 0.766 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -68.62 -16.29 63.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.091 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 948' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 945' ' ' SER . 13.6 mt -87.86 -24.18 23.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.948 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -81.71 -51.05 8.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.944 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 950' ' ' VAL . . . . . 0.467 ' CG2' HD12 ' A' ' 953' ' ' LEU . 9.8 p -52.02 -20.11 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.135 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 951' ' ' LEU . . . . . 0.593 HD21 ' HG ' ' A' ' 967' ' ' LEU . 73.0 mt -50.72 -20.73 1.33 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 26.1 m -61.88 -9.43 6.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.822 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 953' ' ' LEU . . . . . 0.467 HD12 ' CG2' ' A' ' 950' ' ' VAL . 58.8 mt -95.76 11.55 33.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.926 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -67.16 117.43 9.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 90.28 -23.06 23.47 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.517 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.05 127.14 8.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.731 0.3 . . . . 0.0 110.915 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -93.06 123.06 36.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 14.9 tp -129.35 154.94 46.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.948 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 959' ' ' LEU . . . . . 0.573 HD11 ' HG3' ' A' ' 916' ' ' GLU . 39.0 mt 39.23 46.29 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.906 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 50.95 46.06 26.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.86 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 961' ' ' ARG . . . . . . . . . . . . . 41.4 mtt85 -152.02 106.47 3.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.929 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 7.7 m -60.16 111.18 1.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.141 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 963' ' ' ILE . . . . . 0.803 HD13 HD21 ' A' ' 917' ' ' LEU . 79.7 mt -95.78 146.32 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.152 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 5.4 m -129.43 118.23 21.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.131 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 965' ' ' ILE . . . . . . . . . . . . . 60.8 mt -105.11 141.28 20.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.086 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -151.59 135.69 16.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.064 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 967' ' ' LEU . . . . . 0.593 ' HG ' HD21 ' A' ' 951' ' ' LEU . 31.5 mt -68.22 158.13 33.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.917 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 11.3 tptt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 179.857 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 90.3 m . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.794 0.33 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 895' ' ' VAL . . . . . 0.539 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 23.7 m -121.0 138.86 50.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.138 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . 0.46 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 4.1 mp -89.71 146.4 24.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 70.2 t -144.83 125.32 7.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.098 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 10.6 t -128.07 154.13 46.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.848 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.663 HG22 HG12 ' A' ' 963' ' ' ILE . 3.6 pt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 909' ' ' PHE . . . . . 0.583 ' CE2' HG23 ' A' ' 899' ' ' ILE . 91.6 m-85 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.839 0.352 . . . . 0.0 110.914 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.29 179.41 5.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -57.3 -45.43 84.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -57.66 -57.69 11.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.108 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 913' ' ' LEU . . . . . 0.525 HD21 ' HD2' ' A' ' 961' ' ' ARG . 87.4 mt -49.48 -55.24 13.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.965 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 49.6 mt -60.64 -63.49 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.096 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -41.12 -59.45 1.49 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -53.84 -48.94 69.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.866 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 917' ' ' LEU . . . . . 0.809 HD21 HD13 ' A' ' 963' ' ' ILE . 27.5 mt -50.97 -58.67 5.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.887 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 918' ' ' LEU . . . . . 0.469 ' CD2' HD11 ' A' ' 930' ' ' ILE . 73.0 mt -34.44 -48.16 0.34 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.915 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -63.77 -45.98 87.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.891 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 920' ' ' GLN . . . . . 0.454 ' N ' ' O ' ' A' ' 917' ' ' LEU . 15.2 mm-40 -58.1 -35.04 70.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.914 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 921' ' ' PHE . . . . . 0.553 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 17.6 m-85 -75.2 -37.7 61.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -57.76 -32.62 67.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.114 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -50.82 -23.3 2.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 924' ' ' PHE . . . . . 0.58 ' N ' ' CD1' ' A' ' 924' ' ' PHE . 0.4 OUTLIER -125.13 -58.29 1.46 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.909 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -129.33 150.53 18.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.432 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -88.99 132.37 34.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.885 0.374 . . . . 0.0 110.86 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 22.9 t -84.58 147.33 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.19 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 928' ' ' ILE . . . . . 0.463 HG13 ' N ' ' A' ' 929' ' ' LEU . 41.6 pt -123.38 -38.19 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.158 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 929' ' ' LEU . . . . . 0.463 ' N ' HG13 ' A' ' 928' ' ' ILE . 12.0 tp -141.78 147.86 37.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 930' ' ' ILE . . . . . 0.469 HD11 ' CD2' ' A' ' 918' ' ' LEU . 79.4 mt -133.42 124.55 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.119 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -111.68 125.8 54.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -91.98 123.89 35.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.846 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 933' ' ' VAL . . . . . 0.741 HG21 ' CD1' ' A' ' 938' ' ' TRP . 3.1 t -92.07 157.02 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.078 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 934' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 933' ' ' VAL . 15.8 mt-10 -34.35 -52.37 0.48 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -125.08 -25.47 3.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.825 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.02 173.04 7.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.914 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 937' ' ' MET . . . . . 0.548 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 15.1 ttt -132.51 108.35 9.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 938' ' ' TRP . . . . . 0.741 ' CD1' HG21 ' A' ' 933' ' ' VAL . 38.1 m0 -90.26 144.89 25.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.961 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 61.1 t -131.76 133.56 61.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.131 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 940' ' ' THR . . . . . 0.462 HG22 ' N ' ' A' ' 941' ' ' PHE . 51.6 m -96.81 156.31 16.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.138 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 941' ' ' PHE . . . . . 0.462 ' N ' HG22 ' A' ' 940' ' ' THR . 15.1 m-85 -137.93 144.39 41.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.879 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 29.9 tp -47.04 -44.57 20.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.949 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -123.44 170.39 10.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.921 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -86.34 -41.15 7.08 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.465 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 38.6 p -54.66 -35.21 63.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.839 0.352 . . . . 0.0 110.86 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.76 -40.95 98.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.841 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 947' ' ' ALA . . . . . 0.539 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -64.44 -19.09 65.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.097 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 23.9 mt -83.45 -27.41 29.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -81.82 -51.26 8.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.921 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 7.0 p -48.02 -21.5 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.096 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 951' ' ' LEU . . . . . 0.604 HD21 ' HG ' ' A' ' 967' ' ' LEU . 34.1 mt -49.11 -28.44 4.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.918 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 1.1 t -50.9 -17.54 0.59 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 46.6 mt -90.39 17.32 7.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.895 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -70.87 110.79 5.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.884 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 93.66 -25.14 22.64 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.493 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -39.38 127.23 1.82 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.705 0.288 . . . . 0.0 110.865 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -94.24 125.08 38.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.87 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 958' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 959' ' ' LEU . 14.9 tp -135.41 158.65 43.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.882 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 959' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 958' ' ' LEU . 51.8 mt 38.23 44.24 0.67 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.927 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 51.56 44.39 29.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 961' ' ' ARG . . . . . 0.525 ' HD2' HD21 ' A' ' 913' ' ' LEU . 34.1 mtt85 -151.45 108.69 3.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 8.6 m -62.14 118.24 7.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.132 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 963' ' ' ILE . . . . . 0.809 HD13 HD21 ' A' ' 917' ' ' LEU . 92.0 mt -103.7 137.63 31.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.136 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 7.0 m -121.47 112.78 18.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.184 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 965' ' ' ILE . . . . . . . . . . . . . 61.8 mt -97.42 139.98 18.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.105 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -149.01 138.36 21.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.098 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 967' ' ' LEU . . . . . 0.604 ' HG ' HD21 ' A' ' 951' ' ' LEU . 39.0 mt -75.84 156.07 34.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.897 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 22.0 tptm . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.912 179.822 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 54.1 m . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.786 0.327 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 895' ' ' VAL . . . . . 0.562 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 21.4 m -119.09 141.33 39.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.13 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . 0.46 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 4.5 mp -90.23 142.25 27.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.419 HG22 HG12 ' A' ' 965' ' ' ILE . 96.6 t -141.83 129.54 21.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.114 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 4.4 t -131.49 160.11 36.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.842 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.434 HG12 ' CE1' ' A' ' 909' ' ' PHE . 2.0 pt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.149 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 909' ' ' PHE . . . . . 0.566 ' CE2' ' HB2' ' A' ' 937' ' ' MET . 47.2 m-85 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.888 0.375 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 910' ' ' ASP . . . . . 0.716 ' H ' HD12 ' A' ' 913' ' ' LEU . 24.2 m-20 -73.89 161.85 29.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.857 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -49.35 -50.97 37.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.865 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -54.78 -50.58 68.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.13 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 913' ' ' LEU . . . . . 0.716 HD12 ' H ' ' A' ' 910' ' ' ASP . 20.1 mt -51.72 -52.3 49.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 54.2 mt -60.73 -57.99 9.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.147 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -49.49 -64.0 0.94 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.893 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 916' ' ' GLU . . . . . 0.777 ' HG3' HD11 ' A' ' 959' ' ' LEU . 5.2 mm-40 -44.9 -50.45 10.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.892 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 917' ' ' LEU . . . . . 1.022 HD21 HD13 ' A' ' 963' ' ' ILE . 28.4 mt -48.37 -55.1 11.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 918' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 917' ' ' LEU . 58.4 mt -36.47 -62.98 0.43 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.941 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -54.0 -44.8 71.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -56.5 -37.39 70.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.883 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 921' ' ' PHE . . . . . 0.509 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 24.2 m-85 -73.74 -39.22 64.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.857 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -53.79 -28.07 32.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 923' ' ' SER . . . . . 0.502 ' HB3' ' CE1' ' A' ' 924' ' ' PHE . 40.9 t -46.14 -30.84 2.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.834 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 924' ' ' PHE . . . . . 0.56 ' N ' ' CD1' ' A' ' 924' ' ' PHE . 0.3 OUTLIER -122.66 -65.09 1.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.873 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -111.67 144.96 17.7 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.462 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -87.47 96.52 10.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.874 0.369 . . . . 0.0 110.89 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 44.4 t -53.02 144.08 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.131 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 928' ' ' ILE . . . . . 0.47 HG13 ' N ' ' A' ' 929' ' ' LEU . 15.2 pt -121.92 -46.79 2.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.102 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 929' ' ' LEU . . . . . 0.47 ' N ' HG13 ' A' ' 928' ' ' ILE . 17.3 tp -131.08 149.73 52.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 45.2 mt -135.13 136.1 51.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.176 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -119.8 121.43 39.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.882 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -87.43 116.85 25.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 933' ' ' VAL . . . . . 0.775 HG21 ' NE1' ' A' ' 938' ' ' TRP . 2.9 t -85.54 156.01 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.126 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 934' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 933' ' ' VAL . 31.1 mt-10 -34.21 -51.36 0.44 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -124.15 -27.14 3.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.877 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -96.01 173.06 7.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 937' ' ' MET . . . . . 0.566 ' HB2' ' CE2' ' A' ' 909' ' ' PHE . 17.7 ttt -135.01 106.69 6.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 938' ' ' TRP . . . . . 0.775 ' NE1' HG21 ' A' ' 933' ' ' VAL . 33.3 m0 -85.92 153.6 22.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.924 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 939' ' ' VAL . . . . . 0.442 ' O ' HG22 ' A' ' 895' ' ' VAL . 87.4 t -139.74 128.25 26.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.139 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 27.0 m -90.95 151.51 21.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.128 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 941' ' ' PHE . . . . . 0.438 ' O ' ' C ' ' A' ' 942' ' ' LEU . 11.6 m-85 -132.68 141.84 48.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.857 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 942' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 941' ' ' PHE . 19.6 tp -34.41 -64.59 0.24 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.89 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -117.82 150.96 38.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.874 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -53.43 -45.95 65.4 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.458 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 14.6 t -50.77 -41.05 56.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.845 0.355 . . . . 0.0 110.832 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 9.2 m -58.77 -26.29 63.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.836 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 947' ' ' ALA . . . . . 0.562 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -81.58 -13.11 58.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.127 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 33.6 mt -88.06 -28.08 21.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.953 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 33.0 m-20 -82.88 -45.37 14.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 8.7 p -53.47 -22.79 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.174 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 951' ' ' LEU . . . . . 0.481 HD21 ' HG ' ' A' ' 967' ' ' LEU . 63.1 mt -50.95 -25.54 4.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.886 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 15.3 m -54.4 -16.65 2.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.849 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 23.4 mt -89.61 16.02 8.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.912 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -68.44 119.96 13.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.937 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 955' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 956' ' ' LYS . . . 88.11 -30.79 4.98 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.524 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 956' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 955' ' ' GLY . 8.6 tmtm? -35.38 127.87 0.58 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.693 0.282 . . . . 0.0 110.911 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -96.41 131.8 42.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.835 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 13.5 tp -138.1 154.56 49.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 959' ' ' LEU . . . . . 0.777 HD11 ' HG3' ' A' ' 916' ' ' GLU . 87.6 mt 39.53 45.39 1.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.938 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 55.96 46.36 22.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 961' ' ' ARG . . . . . . . . . . . . . 46.3 mtt85 -154.64 121.86 5.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.884 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 8.3 m -74.08 108.39 6.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.124 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 963' ' ' ILE . . . . . 1.022 HD13 HD21 ' A' ' 917' ' ' LEU . 90.1 mt -88.95 130.94 37.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.177 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 9.2 m -116.45 119.38 35.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.1 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 965' ' ' ILE . . . . . 0.419 HG12 HG22 ' A' ' 897' ' ' VAL . 59.3 mt -103.36 140.31 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.124 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -149.47 136.06 19.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.082 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 967' ' ' LEU . . . . . 0.481 ' HG ' HD21 ' A' ' 951' ' ' LEU . 27.0 mt -70.57 154.62 41.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.921 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 16.2 tptm . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.871 179.856 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 97.3 m . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.792 0.33 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 895' ' ' VAL . . . . . 0.658 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 20.3 m -112.72 140.06 34.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.091 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . 0.47 ' HG ' ' CD1' ' A' ' 938' ' ' TRP . 3.9 mp -91.46 142.68 27.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.566 HG22 HG12 ' A' ' 965' ' ' ILE . 93.7 t -140.46 124.92 18.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.135 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 18.0 t -127.54 154.88 44.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.456 HD13 HD13 ' A' ' 913' ' ' LEU . 5.2 pt . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.107 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 909' ' ' PHE . . . . . 0.673 ' HA ' HD12 ' A' ' 913' ' ' LEU . 91.5 m-85 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.861 0.363 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -93.1 -178.59 4.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -55.72 -42.53 75.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.854 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -65.5 -57.89 7.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.102 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 913' ' ' LEU . . . . . 0.673 HD12 ' HA ' ' A' ' 909' ' ' PHE . 19.4 mt -49.96 -45.84 51.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.938 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 44.2 mt -71.47 -64.76 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.102 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -38.03 -59.58 0.83 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 916' ' ' GLU . . . . . 0.509 ' HB3' HD21 ' A' ' 958' ' ' LEU . 33.8 mm-40 -52.25 -52.33 53.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.863 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 917' ' ' LEU . . . . . 1.032 HD21 HD13 ' A' ' 963' ' ' ILE . 31.6 mt -49.58 -55.93 11.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.918 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 918' ' ' LEU . . . . . 0.439 ' C ' ' O ' ' A' ' 917' ' ' LEU . 77.8 mt -35.06 -57.86 0.55 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -58.15 -40.79 82.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.92 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 920' ' ' GLN . . . . . 0.433 ' N ' ' O ' ' A' ' 917' ' ' LEU . 35.6 mm-40 -61.56 -38.08 86.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 921' ' ' PHE . . . . . 0.566 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 20.1 m-85 -70.88 -36.06 72.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -58.86 -34.65 71.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.133 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.7 m -47.18 -26.54 1.18 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 924' ' ' PHE . . . . . 0.523 ' N ' ' CD1' ' A' ' 924' ' ' PHE . 0.7 OUTLIER -121.01 -65.37 1.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.894 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -122.22 150.76 16.95 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.507 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -85.71 140.16 30.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.881 0.372 . . . . 0.0 110.879 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 62.1 t -94.74 142.63 13.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.076 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 928' ' ' ILE . . . . . 0.487 HG13 ' N ' ' A' ' 929' ' ' LEU . 41.4 pt -121.64 -39.92 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.13 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 929' ' ' LEU . . . . . 0.487 ' N ' HG13 ' A' ' 928' ' ' ILE . 17.7 tp -139.97 139.21 36.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.926 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 74.0 mt -127.52 129.47 70.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.123 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 5.0 tpm_? -116.23 125.25 51.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.888 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -94.84 114.9 26.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 933' ' ' VAL . . . . . 0.605 HG21 ' NE1' ' A' ' 938' ' ' TRP . 2.6 t -83.41 157.11 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.167 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 934' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 933' ' ' VAL . 53.2 mt-10 -34.04 -50.85 0.4 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.909 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -125.31 -25.93 3.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.855 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 936' ' ' LYS . . . . . 0.447 ' O ' ' N ' ' A' ' 933' ' ' VAL . 1.0 OUTLIER -97.3 169.83 9.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 937' ' ' MET . . . . . 0.518 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 16.4 ttt -132.03 111.52 11.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.844 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 938' ' ' TRP . . . . . 0.605 ' NE1' HG21 ' A' ' 933' ' ' VAL . 39.2 m0 -91.96 144.13 25.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.932 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 939' ' ' VAL . . . . . 0.436 HG12 ' CE1' ' A' ' 941' ' ' PHE . 47.0 t -131.46 135.82 58.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 23.1 m -108.88 148.17 31.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.133 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 941' ' ' PHE . . . . . 0.436 ' CE1' HG12 ' A' ' 939' ' ' VAL . 6.9 m-85 -128.32 152.14 48.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.826 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 45.1 tp -41.92 -62.73 0.85 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.944 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -105.63 172.3 6.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -77.49 -44.83 12.04 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.517 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 45.6 t -56.67 -30.5 63.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.872 0.368 . . . . 0.0 110.858 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 72.7 m -58.94 -33.94 71.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.819 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 947' ' ' ALA . . . . . 0.658 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -74.19 -20.19 60.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.057 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 30.0 mt -83.48 -26.06 30.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.871 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -80.14 -41.24 25.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.87 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 8.2 p -61.75 -21.98 27.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.159 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 50.7 mt -50.38 -25.41 3.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 952' ' ' SER . . . . . 0.423 ' HB2' ' CE2' ' A' ' 924' ' ' PHE . 67.9 m -56.1 -13.72 2.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.832 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 24.4 mt -93.3 17.24 11.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.908 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -70.77 119.24 14.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 88.09 -25.26 9.12 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.489 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -41.63 127.43 3.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.759 0.314 . . . . 0.0 110.896 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -95.65 124.28 39.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.86 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 958' ' ' LEU . . . . . 0.509 HD21 ' HB3' ' A' ' 916' ' ' GLU . 14.9 tp -131.93 151.64 51.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.931 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 44.0 mt 41.14 49.63 3.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.916 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 50.47 37.27 15.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 961' ' ' ARG . . . . . 0.441 ' HD2' ' CD2' ' A' ' 913' ' ' LEU . 56.9 mtt85 -143.63 106.06 4.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.851 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 60.5 m -65.31 112.78 3.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.14 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 963' ' ' ILE . . . . . 1.032 HD13 HD21 ' A' ' 917' ' ' LEU . 71.2 mt -93.17 149.26 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.128 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 1.7 m -131.94 109.02 9.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.136 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 965' ' ' ILE . . . . . 0.566 HG12 HG22 ' A' ' 897' ' ' VAL . 70.3 mt -92.5 139.24 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.102 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -150.6 135.17 17.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.103 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 967' ' ' LEU . . . . . . . . . . . . . 26.6 mt -67.94 154.39 41.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.895 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 16.7 tptp . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.925 179.806 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 89.4 m . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.887 0.375 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 895' ' ' VAL . . . . . 0.695 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 10.8 m -113.63 138.61 42.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.088 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . 0.463 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 4.2 mp -90.47 143.57 26.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.968 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.423 HG13 ' CG2' ' A' ' 963' ' ' ILE . 95.6 t -141.78 130.36 22.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.107 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 10.8 t -129.53 152.37 49.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.551 HG23 ' CE2' ' A' ' 909' ' ' PHE . 2.8 pt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.111 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 909' ' ' PHE . . . . . 0.585 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 97.1 m-85 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.855 0.36 . . . . 0.0 110.878 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 910' ' ' ASP . . . . . 0.711 ' H ' HD12 ' A' ' 913' ' ' LEU . 6.3 t70 -84.71 179.02 7.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.87 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -58.61 -45.26 89.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -60.15 -60.85 3.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.068 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 913' ' ' LEU . . . . . 0.862 HD11 ' NH1' ' A' ' 961' ' ' ARG . 35.4 mt -45.31 -49.49 12.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.961 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 52.0 mt -63.6 -53.19 48.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.157 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -46.4 -56.63 5.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.846 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 916' ' ' GLU . . . . . 0.64 ' OE2' HD21 ' A' ' 959' ' ' LEU . 13.6 mt-10 -56.65 -51.49 68.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 917' ' ' LEU . . . . . 0.902 HD21 HD13 ' A' ' 963' ' ' ILE . 51.0 mt -46.13 -57.85 4.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 918' ' ' LEU . . . . . . . . . . . . . 99.3 mt -36.95 -62.99 0.45 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.953 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -54.02 -44.22 70.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.919 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 44.5 mm-40 -57.67 -38.91 75.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 921' ' ' PHE . . . . . 0.543 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 23.3 m-85 -72.68 -36.88 68.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.903 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -56.73 -32.69 65.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.102 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -52.04 -17.89 1.21 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.854 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 924' ' ' PHE . . . . . 0.499 ' N ' ' CD1' ' A' ' 924' ' ' PHE . 1.8 m-85 -126.06 -58.17 1.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.88 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -134.68 151.12 20.28 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.505 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -83.1 134.95 34.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.887 0.375 . . . . 0.0 110.872 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 41.2 t -89.01 143.47 11.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.177 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 928' ' ' ILE . . . . . 0.487 HG13 ' N ' ' A' ' 929' ' ' LEU . 20.4 pt -121.82 -45.83 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 929' ' ' LEU . . . . . 0.487 ' N ' HG13 ' A' ' 928' ' ' ILE . 25.5 tp -131.66 146.16 52.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 93.5 mt -136.71 122.86 28.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.113 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -111.26 123.35 50.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -87.64 118.58 27.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 933' ' ' VAL . . . . . 0.737 HG21 ' NE1' ' A' ' 938' ' ' TRP . 3.5 t -86.17 157.14 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.119 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 934' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 933' ' ' VAL . 32.3 mt-10 -33.82 -53.82 0.45 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -124.18 -20.73 5.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.89 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 19.3 tttt -101.31 173.04 6.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.897 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 937' ' ' MET . . . . . 0.585 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 12.7 ttt -133.58 114.03 13.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.897 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 938' ' ' TRP . . . . . 0.737 ' NE1' HG21 ' A' ' 933' ' ' VAL . 43.3 m0 -91.25 146.2 24.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 939' ' ' VAL . . . . . 0.479 HG12 ' CE1' ' A' ' 941' ' ' PHE . 61.0 t -136.15 122.27 30.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.117 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 6.8 m -91.07 150.49 21.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.151 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 941' ' ' PHE . . . . . 0.479 ' CE1' HG12 ' A' ' 939' ' ' VAL . 9.1 m-85 -130.28 144.26 51.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.912 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 942' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 941' ' ' PHE . 61.1 tp -34.55 -59.76 0.45 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -117.9 169.65 9.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.892 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -71.68 -49.13 25.36 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.514 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 74.1 p -50.56 -28.61 8.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.859 0.362 . . . . 0.0 110.857 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 6.0 m -67.05 -32.32 73.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.881 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 947' ' ' ALA . . . . . 0.695 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -82.36 -13.82 56.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.086 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 42.8 mt -87.36 -29.53 21.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.924 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -82.49 -37.66 24.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.903 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 9.2 p -61.94 -15.61 14.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.098 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 951' ' ' LEU . . . . . 0.644 HD11 HD11 ' A' ' 967' ' ' LEU . 40.0 mt -53.93 -26.32 24.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.94 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 33.3 t -53.46 -15.78 1.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.861 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 36.9 mt -89.89 14.15 12.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.929 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -68.76 116.97 9.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.864 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 90.58 -25.82 12.22 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.473 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 956' ' ' LYS . . . . . 0.59 ' HZ3' HD13 ' A' ' 958' ' ' LEU . 3.5 tmtt? -39.71 127.76 2.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.744 0.307 . . . . 0.0 110.883 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -94.48 131.37 40.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.901 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 958' ' ' LEU . . . . . 0.59 HD13 ' HZ3' ' A' ' 956' ' ' LYS . 15.8 tp -141.35 153.18 44.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.881 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 959' ' ' LEU . . . . . 0.64 HD21 ' OE2' ' A' ' 916' ' ' GLU . 38.2 mt 41.42 48.2 3.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.952 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 960' ' ' ASN . . . . . 0.444 ' CG ' ' O ' ' A' ' 959' ' ' LEU . 14.1 p30 48.18 42.41 17.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 961' ' ' ARG . . . . . 0.862 ' NH1' HD11 ' A' ' 913' ' ' LEU . 73.9 mtt180 -149.72 108.49 3.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 6.8 m -60.26 119.11 7.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.156 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 963' ' ' ILE . . . . . 0.902 HD13 HD21 ' A' ' 917' ' ' LEU . 91.4 mt -102.6 134.0 44.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.148 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 3.8 m -119.76 119.17 32.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.108 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 965' ' ' ILE . . . . . . . . . . . . . 51.2 mt -101.26 142.12 16.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.128 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -151.21 131.5 13.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.082 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 967' ' ' LEU . . . . . 0.644 HD11 HD11 ' A' ' 951' ' ' LEU . 30.9 mt -69.85 158.34 35.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 18.5 tptt . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.935 179.85 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 75.8 m . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.839 0.352 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 895' ' ' VAL . . . . . 0.566 HG12 HD23 ' A' ' 967' ' ' LEU . 18.8 m -112.29 142.92 23.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.125 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . 0.468 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 4.2 mp -91.08 146.84 23.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.651 HG22 HG12 ' A' ' 965' ' ' ILE . 92.9 t -146.9 125.56 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.118 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 6.4 t -125.71 155.59 40.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.549 HG23 ' CE2' ' A' ' 909' ' ' PHE . 2.2 pt . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.093 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 909' ' ' PHE . . . . . 0.549 ' CE2' HG23 ' A' ' 899' ' ' ILE . 76.2 m-85 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.849 0.356 . . . . 0.0 110.883 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 910' ' ' ASP . . . . . 0.585 ' H ' HD12 ' A' ' 913' ' ' LEU . 35.0 m-20 -92.99 159.03 15.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.879 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -45.08 -49.71 11.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -53.92 -51.92 62.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.087 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 913' ' ' LEU . . . . . 0.649 HD11 ' CD ' ' A' ' 961' ' ' ARG . 41.3 mt -53.36 -53.45 50.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.909 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 54.2 mt -60.14 -62.9 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.125 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -42.38 -51.03 5.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -61.49 -44.11 97.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.864 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 917' ' ' LEU . . . . . 0.842 HD21 HD13 ' A' ' 963' ' ' ILE . 26.1 mt -56.84 -57.9 10.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 918' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 917' ' ' LEU . 66.5 mt -34.82 -48.83 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -64.94 -47.56 77.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 60.2 mm-40 -55.75 -37.43 68.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 921' ' ' PHE . . . . . 0.571 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 22.4 m-85 -67.32 -50.8 58.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -46.27 -24.23 0.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.07 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 923' ' ' SER . . . . . 0.449 ' HB3' ' CE1' ' A' ' 924' ' ' PHE . 31.2 t -48.76 -32.06 7.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 924' ' ' PHE . . . . . 0.57 ' N ' ' CD1' ' A' ' 924' ' ' PHE . 0.3 OUTLIER -123.18 -52.94 1.84 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -131.84 147.92 18.85 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.524 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -84.87 135.43 34.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.854 0.359 . . . . 0.0 110.926 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 11.9 t -81.86 145.37 8.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.143 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 928' ' ' ILE . . . . . 0.62 HD13 ' HA ' ' A' ' 942' ' ' LEU . 42.8 pt -122.17 -36.39 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.161 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 929' ' ' LEU . . . . . 0.478 ' N ' HG13 ' A' ' 928' ' ' ILE . 10.2 tp -144.09 146.48 32.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.889 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 50.0 mt -135.9 128.8 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.135 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 16.0 ttt-85 -118.75 123.93 46.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.907 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -91.22 122.06 33.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 933' ' ' VAL . . . . . 0.574 HG21 ' NE1' ' A' ' 938' ' ' TRP . 2.8 t -90.22 157.09 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.114 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 934' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 933' ' ' VAL . 81.2 mm-40 -33.71 -51.77 0.39 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.886 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -124.96 -26.18 3.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 7.9 ttmm -96.45 170.87 8.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 937' ' ' MET . . . . . 0.466 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 16.2 ttt -134.46 112.17 10.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.863 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 938' ' ' TRP . . . . . 0.574 ' NE1' HG21 ' A' ' 933' ' ' VAL . 36.0 m0 -93.35 142.13 27.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 53.9 t -130.48 127.43 62.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.171 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 8.9 m -98.57 152.63 19.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 941' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -127.92 145.89 50.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 942' ' ' LEU . . . . . 0.62 ' HA ' HD13 ' A' ' 928' ' ' ILE . 22.7 tp -41.22 -40.84 1.69 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.949 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -130.39 176.69 7.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.919 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -86.32 -53.76 2.87 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.526 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 59.0 p -46.69 -22.34 0.28 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.882 0.372 . . . . 0.0 110.884 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 2.1 p -75.22 -37.12 61.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.841 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 947' ' ' ALA . . . . . 0.499 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -70.7 -16.35 62.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 29.1 mt -84.05 -28.87 27.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.943 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -80.95 -46.48 15.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.859 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 7.6 p -53.83 -17.38 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.127 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 60.8 mt -53.15 -23.27 7.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.872 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 1.8 t -59.05 -11.15 3.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.838 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 51.1 mt -94.03 16.26 14.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 954' ' ' ASN . . . . . 0.402 ' O ' ' CG ' ' A' ' 954' ' ' ASN . 1.9 p30 -70.64 119.37 14.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 955' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 956' ' ' LYS . . . 86.15 -28.48 5.11 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.531 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 956' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 955' ' ' GLY . 0.1 OUTLIER -36.13 127.23 0.75 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.756 0.313 . . . . 0.0 110.873 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -92.94 128.02 38.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 14.2 tp -138.41 148.41 44.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.95 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 49.4 mt 43.13 52.53 5.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.944 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 44.83 44.7 7.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.904 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 961' ' ' ARG . . . . . 0.649 ' CD ' HD11 ' A' ' 913' ' ' LEU . 41.6 mtt85 -151.33 106.07 3.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.844 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 6.3 m -61.44 119.02 7.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.088 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 963' ' ' ILE . . . . . 0.842 HD13 HD21 ' A' ' 917' ' ' LEU . 92.7 mt -102.47 139.88 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.147 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 6.1 m -124.73 112.25 16.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.119 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 965' ' ' ILE . . . . . 0.651 HG12 HG22 ' A' ' 897' ' ' VAL . 61.4 mt -98.42 139.04 21.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.077 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -153.84 137.88 16.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.129 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 967' ' ' LEU . . . . . 0.566 HD23 HG12 ' A' ' 895' ' ' VAL . 26.2 mt -68.63 156.37 38.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.922 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 11.6 tptm . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 179.837 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 87.5 m . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.786 0.327 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 895' ' ' VAL . . . . . 0.442 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 6.3 m -120.09 137.0 55.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.115 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . 0.471 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 4.7 mp -89.2 142.94 27.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.906 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.408 HG13 ' CG2' ' A' ' 963' ' ' ILE . 99.4 t -140.22 127.69 23.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.166 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 13.5 t -130.18 156.68 44.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.83 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.489 HG22 HG12 ' A' ' 963' ' ' ILE . 4.1 pt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.122 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 909' ' ' PHE . . . . . 0.581 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 49.8 m-85 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.826 0.346 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -98.75 178.79 4.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.89 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -58.56 -26.04 63.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.863 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -78.52 -57.39 3.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.11 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 913' ' ' LEU . . . . . 0.608 HD21 ' CD ' ' A' ' 961' ' ' ARG . 82.0 mt -52.87 -39.95 63.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.97 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 914' ' ' ILE . . . . . 0.435 HD13 ' CZ ' ' A' ' 932' ' ' PHE . 28.9 mt -72.57 -64.09 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.164 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -43.21 -54.07 4.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.84 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -55.43 -51.03 68.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 917' ' ' LEU . . . . . 0.93 HD21 HD13 ' A' ' 963' ' ' ILE . 20.6 mt -48.94 -54.14 16.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.905 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 918' ' ' LEU . . . . . 0.426 ' C ' ' O ' ' A' ' 917' ' ' LEU . 41.9 mt -34.75 -65.79 0.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.905 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -51.11 -52.26 45.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 920' ' ' GLN . . . . . 0.4 ' O ' HD11 ' A' ' 953' ' ' LEU . 89.3 mm-40 -48.85 -40.2 28.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.873 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 921' ' ' PHE . . . . . 0.549 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 23.1 m-85 -71.21 -42.79 68.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 922' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 924' ' ' PHE . . . -49.62 -39.48 35.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.095 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.7 m -43.02 -24.25 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.837 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 924' ' ' PHE . . . . . 0.554 ' N ' ' CD1' ' A' ' 924' ' ' PHE . 0.6 OUTLIER -123.67 -63.02 1.26 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -123.13 147.24 16.67 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.469 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -84.39 128.01 34.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.931 0.396 . . . . 0.0 110.88 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 34.4 t -81.71 144.24 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.144 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 928' ' ' ILE . . . . . 0.486 HG13 ' N ' ' A' ' 929' ' ' LEU . 23.9 pt -123.18 -44.72 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.1 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 929' ' ' LEU . . . . . 0.486 ' N ' HG13 ' A' ' 928' ' ' ILE . 21.0 tp -134.48 144.05 47.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.964 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 930' ' ' ILE . . . . . 0.462 ' H ' HD12 ' A' ' 929' ' ' LEU . 43.5 mt -135.71 134.55 51.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.118 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.26 124.52 32.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 932' ' ' PHE . . . . . 0.435 ' CZ ' HD13 ' A' ' 914' ' ' ILE . 30.4 m-85 -86.95 118.66 26.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 933' ' ' VAL . . . . . 0.71 HG21 ' CD1' ' A' ' 938' ' ' TRP . 2.6 t -82.95 157.37 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 934' ' ' GLU . . . . . 0.472 ' C ' ' O ' ' A' ' 933' ' ' VAL . 29.4 mm-40 -32.24 -53.41 0.3 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.905 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -125.31 -25.89 3.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -97.23 173.14 7.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.9 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 937' ' ' MET . . . . . 0.581 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 15.3 ttt -135.71 110.29 8.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.907 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 938' ' ' TRP . . . . . 0.71 ' CD1' HG21 ' A' ' 933' ' ' VAL . 20.3 m0 -95.95 138.58 33.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.874 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 939' ' ' VAL . . . . . 0.426 HG12 ' CE1' ' A' ' 941' ' ' PHE . 94.4 t -122.35 134.97 63.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.117 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 52.3 m -98.62 148.96 23.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.145 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 941' ' ' PHE . . . . . 0.426 ' CE1' HG12 ' A' ' 939' ' ' VAL . 9.3 m-85 -130.69 152.06 50.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.862 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 942' ' ' LEU . . . . . 0.421 ' HA ' HD13 ' A' ' 928' ' ' ILE . 55.5 tp -48.79 -53.53 18.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.891 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -115.91 177.81 4.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -87.34 -46.92 4.82 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.494 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 91.8 p -50.89 -39.47 54.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.924 0.392 . . . . 0.0 110.857 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.11 -27.63 67.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.858 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 947' ' ' ALA . . . . . 0.442 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -80.22 -15.38 57.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.135 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 21.6 mt -87.34 -29.35 21.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.907 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -79.9 -41.35 26.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.903 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 4.3 p -56.06 -16.92 3.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.166 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 951' ' ' LEU . . . . . 0.651 HD21 ' HG ' ' A' ' 967' ' ' LEU . 31.1 mt -52.65 -29.74 27.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 3.1 m -53.03 -25.56 12.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.861 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 953' ' ' LEU . . . . . 0.555 ' C ' HD12 ' A' ' 965' ' ' ILE . 32.1 mt -78.95 9.04 4.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.948 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 954' ' ' ASN . . . . . 0.414 ' N ' HD12 ' A' ' 965' ' ' ILE . 0.4 OUTLIER -70.43 118.49 13.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.841 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 92.33 -26.38 13.85 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.442 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 956' ' ' LYS . . . . . 0.677 ' NZ ' HD13 ' A' ' 958' ' ' LEU . 3.7 tmtt? -42.08 128.35 3.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.751 0.31 . . . . 0.0 110.893 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -93.87 127.17 39.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 958' ' ' LEU . . . . . 0.677 HD13 ' NZ ' ' A' ' 956' ' ' LYS . 13.6 tp -140.45 157.07 46.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.955 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 37.4 mt 39.1 44.84 0.98 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.954 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 49.79 44.36 24.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.906 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 961' ' ' ARG . . . . . 0.608 ' CD ' HD21 ' A' ' 913' ' ' LEU . 52.0 mtt180 -152.07 108.06 3.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 2.9 m -61.81 118.67 7.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.102 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 963' ' ' ILE . . . . . 0.93 HD13 HD21 ' A' ' 917' ' ' LEU . 86.3 mt -103.24 137.94 29.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.12 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 9.7 m -123.87 117.43 24.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.183 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 965' ' ' ILE . . . . . 0.555 HD12 ' C ' ' A' ' 953' ' ' LEU . 19.1 mt -97.77 146.93 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.186 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -155.18 128.86 8.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.098 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 967' ' ' LEU . . . . . 0.651 ' HG ' HD21 ' A' ' 951' ' ' LEU . 33.5 mt -66.05 157.98 29.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.88 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 15.8 tptp . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.899 179.85 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 87.2 m . . . . . 0 N--CA 1.457 -0.11 0 CA-C-O 120.762 0.315 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 895' ' ' VAL . . . . . 0.676 HG12 HD23 ' A' ' 967' ' ' LEU . 17.6 m -118.18 138.81 47.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.165 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . 0.47 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 6.3 mp -90.34 138.63 31.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.936 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.521 HG22 HG12 ' A' ' 965' ' ' ILE . 86.6 t -139.54 124.3 20.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.1 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 12.3 t -127.96 155.68 43.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.848 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.545 HG22 HG12 ' A' ' 963' ' ' ILE . 2.7 pt . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.144 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 909' ' ' PHE . . . . . 0.588 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 48.3 m-85 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.885 0.374 . . . . 0.0 110.86 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 910' ' ' ASP . . . . . 0.428 ' H ' HD12 ' A' ' 913' ' ' LEU . 0.3 OUTLIER -99.99 177.56 5.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.898 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.66 -45.31 77.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -59.65 -54.99 40.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.093 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 913' ' ' LEU . . . . . 0.428 HD12 ' H ' ' A' ' 910' ' ' ASP . 22.2 mt -53.47 -54.81 31.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.931 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 46.3 mt -58.86 -57.85 9.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.164 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -50.26 -63.98 0.95 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 916' ' ' GLU . . . . . 0.43 ' HB3' HD21 ' A' ' 958' ' ' LEU . 50.3 mm-40 -45.71 -50.16 13.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.847 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 917' ' ' LEU . . . . . 0.886 HD21 HD13 ' A' ' 963' ' ' ILE . 28.2 mt -50.3 -53.24 30.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.937 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 918' ' ' LEU . . . . . 0.524 HD21 ' CD1' ' A' ' 930' ' ' ILE . 88.4 mt -38.59 -62.44 0.6 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.955 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -53.16 -53.68 46.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.925 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 -47.65 -45.34 27.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.857 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 921' ' ' PHE . . . . . 0.578 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 23.7 m-85 -60.26 -49.04 79.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.839 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -45.29 -33.5 2.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.073 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 923' ' ' SER . . . . . 0.521 ' HB3' ' CD1' ' A' ' 924' ' ' PHE . 8.6 t -41.18 -29.84 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 924' ' ' PHE . . . . . 0.521 ' CD1' ' HB3' ' A' ' 923' ' ' SER . 1.6 m-85 -120.02 -58.92 1.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.893 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -130.76 154.65 20.82 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.536 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -87.05 139.45 30.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 0.0 110.938 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 44.1 t -87.25 146.15 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 928' ' ' ILE . . . . . 0.491 HG13 ' N ' ' A' ' 929' ' ' LEU . 46.1 pt -122.7 -38.46 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.124 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 929' ' ' LEU . . . . . 0.491 ' N ' HG13 ' A' ' 928' ' ' ILE . 11.4 tp -142.41 146.24 34.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 930' ' ' ILE . . . . . 0.524 ' CD1' HD21 ' A' ' 918' ' ' LEU . 79.1 mt -132.09 131.51 61.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.153 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 15.8 ttp180 -121.3 124.3 44.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.879 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -91.38 121.8 33.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 933' ' ' VAL . . . . . 0.634 HG21 ' CD1' ' A' ' 938' ' ' TRP . 4.7 t -89.38 157.27 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.123 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 934' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 933' ' ' VAL . 15.2 mm-40 -33.28 -54.5 0.41 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.942 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.03 -21.61 5.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.859 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -98.98 171.68 7.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.869 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 937' ' ' MET . . . . . 0.588 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 17.2 ttt -131.81 108.66 9.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 938' ' ' TRP . . . . . 0.634 ' CD1' HG21 ' A' ' 933' ' ' VAL . 41.5 m0 -90.82 144.77 25.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.905 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 87.0 t -133.56 131.24 57.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.143 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 17.8 m -97.19 150.45 20.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.129 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 941' ' ' PHE . . . . . 0.425 ' O ' ' C ' ' A' ' 942' ' ' LEU . 9.9 m-85 -129.83 144.99 51.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.893 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 942' ' ' LEU . . . . . 0.425 ' C ' ' O ' ' A' ' 941' ' ' PHE . 30.3 tp -35.94 -56.88 0.7 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.924 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -122.09 164.91 16.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.871 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -66.95 -44.9 87.66 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.478 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 95.2 p -52.22 -37.45 55.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.868 0.366 . . . . 0.0 110.889 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 49.4 m -57.72 -37.51 73.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.857 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 947' ' ' ALA . . . . . 0.532 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -73.05 -25.24 60.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.058 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 28.8 mt -76.63 -23.83 53.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.923 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 37.3 m-20 -88.26 -50.25 6.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.85 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 9.6 p -49.66 -18.65 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.166 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 951' ' ' LEU . . . . . 0.689 HD11 ' CD1' ' A' ' 967' ' ' LEU . 24.4 mt -52.38 -28.51 19.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.907 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 952' ' ' SER . . . . . 0.518 ' HB2' ' CZ ' ' A' ' 924' ' ' PHE . 20.6 m -50.95 -17.54 0.6 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 37.7 mt -88.45 17.48 5.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.946 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -71.43 120.79 17.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 86.51 -24.48 8.45 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.495 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -40.49 128.92 2.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.732 0.301 . . . . 0.0 110.938 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -94.59 134.01 37.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.905 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 958' ' ' LEU . . . . . 0.43 HD21 ' HB3' ' A' ' 916' ' ' GLU . 14.6 tp -144.52 146.77 32.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 56.0 mt 44.82 52.06 8.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.958 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 45.13 44.02 8.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.89 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 961' ' ' ARG . . . . . . . . . . . . . 71.0 mtt-85 -150.54 110.49 4.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.917 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 6.4 m -64.41 120.13 11.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.13 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 963' ' ' ILE . . . . . 0.886 HD13 HD21 ' A' ' 917' ' ' LEU . 82.7 mt -103.93 139.53 24.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.156 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 6.7 m -123.8 116.87 23.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.122 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 965' ' ' ILE . . . . . 0.521 HG12 HG22 ' A' ' 897' ' ' VAL . 61.0 mt -102.07 140.57 20.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.142 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -152.68 128.8 10.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.117 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 967' ' ' LEU . . . . . 0.689 ' CD1' HD11 ' A' ' 951' ' ' LEU . 30.7 mt -67.98 158.37 32.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 179.82 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 99.5 m . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.797 0.332 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 895' ' ' VAL . . . . . 0.777 HG12 HD23 ' A' ' 967' ' ' LEU . 16.9 m -115.06 139.51 40.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.156 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . 0.465 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 4.7 mp -88.98 143.22 27.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.468 HG22 HG12 ' A' ' 965' ' ' ILE . 89.1 t -141.08 127.01 19.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.113 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 11.4 t -129.08 155.78 44.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.864 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.614 HG23 ' CE2' ' A' ' 909' ' ' PHE . 3.8 pt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.175 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 909' ' ' PHE . . . . . 0.614 ' CE2' HG23 ' A' ' 899' ' ' ILE . 89.1 m-85 . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.835 0.35 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 910' ' ' ASP . . . . . 0.492 ' H ' HD12 ' A' ' 913' ' ' LEU . 25.5 t70 -90.07 169.83 10.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.884 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.09 -42.45 65.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -63.22 -50.29 70.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.113 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 913' ' ' LEU . . . . . 0.515 HD11 ' CD ' ' A' ' 961' ' ' ARG . 20.8 mt -56.89 -50.54 72.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.951 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 914' ' ' ILE . . . . . 0.431 HD13 ' CZ ' ' A' ' 932' ' ' PHE . 66.1 mt -63.51 -59.47 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -50.42 -52.03 41.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 916' ' ' GLU . . . . . 0.775 ' HG3' HD11 ' A' ' 959' ' ' LEU . 31.7 mm-40 -57.04 -43.59 82.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 917' ' ' LEU . . . . . 0.761 HD21 HD13 ' A' ' 963' ' ' ILE . 19.9 mt -54.54 -55.65 27.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.887 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 918' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 917' ' ' LEU . 24.8 mt -34.52 -62.48 0.34 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.951 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -52.68 -52.08 57.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -49.93 -39.07 39.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.908 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 921' ' ' PHE . . . . . 0.536 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 23.8 m-85 -73.36 -41.51 63.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.882 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -52.84 -27.26 17.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.107 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 923' ' ' SER . . . . . 0.549 ' HB3' ' CE1' ' A' ' 924' ' ' PHE . 19.6 t -48.7 -30.27 5.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 924' ' ' PHE . . . . . 0.549 ' CE1' ' HB3' ' A' ' 923' ' ' SER . 0.8 OUTLIER -121.27 -50.58 2.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.913 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -134.54 147.19 19.03 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.475 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -85.46 132.05 34.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.865 0.364 . . . . 0.0 110.889 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 16.8 t -83.2 146.93 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.131 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 928' ' ' ILE . . . . . 0.462 HG13 ' N ' ' A' ' 929' ' ' LEU . 41.8 pt -124.56 -33.36 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.143 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 929' ' ' LEU . . . . . 0.462 ' N ' HG13 ' A' ' 928' ' ' ILE . 8.5 tp -146.59 145.25 30.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.86 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 48.0 mt -135.01 128.9 50.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.122 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 -110.59 123.09 49.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.862 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 932' ' ' PHE . . . . . 0.431 ' CZ ' HD13 ' A' ' 914' ' ' ILE . 71.0 m-85 -89.67 112.74 24.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.902 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 933' ' ' VAL . . . . . 0.711 HG21 ' NE1' ' A' ' 938' ' ' TRP . 2.6 t -83.15 149.05 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.153 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 934' ' ' GLU . . . . . 0.489 ' C ' ' O ' ' A' ' 933' ' ' VAL . 84.5 mt-10 -31.34 -50.03 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -124.65 -23.53 4.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.854 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.46 173.23 6.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 937' ' ' MET . . . . . 0.585 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 16.6 ttt -136.06 106.67 6.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 938' ' ' TRP . . . . . 0.711 ' NE1' HG21 ' A' ' 933' ' ' VAL . 34.3 m0 -88.1 142.24 27.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 939' ' ' VAL . . . . . 0.42 HG12 ' CE1' ' A' ' 941' ' ' PHE . 89.7 t -129.18 120.31 51.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.174 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 940' ' ' THR . . . . . 0.416 ' CG2' ' N ' ' A' ' 941' ' ' PHE . 8.5 m -91.19 153.17 20.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.107 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 941' ' ' PHE . . . . . 0.42 ' CE1' HG12 ' A' ' 939' ' ' VAL . 9.3 m-85 -129.57 154.28 47.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 43.6 tp -52.25 -50.68 61.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.933 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -116.29 171.7 7.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.902 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -84.94 -37.66 9.97 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.467 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 75.4 p -60.73 -29.08 69.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.912 0.387 . . . . 0.0 110.907 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 1.9 p -68.11 -35.06 77.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.818 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -72.55 -12.85 61.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.098 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 27.7 mt -89.48 -26.7 20.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -84.81 -40.88 16.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.9 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 9.1 p -57.24 -17.85 7.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.1 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 951' ' ' LEU . . . . . 0.752 HD21 ' HG ' ' A' ' 967' ' ' LEU . 43.1 mt -52.19 -27.14 13.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.903 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 19.9 m -53.2 -16.27 1.18 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.834 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 953' ' ' LEU . . . . . 0.478 ' HB2' ' CD1' ' A' ' 965' ' ' ILE . 56.8 mt -92.38 19.01 7.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -74.9 105.11 5.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 101.45 -25.24 28.83 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.47 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -43.07 128.88 4.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.763 0.316 . . . . 0.0 110.921 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -95.98 135.09 38.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.855 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 958' ' ' LEU . . . . . 0.41 ' O ' ' N ' ' A' ' 961' ' ' ARG . 14.3 tp -141.37 157.45 45.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.913 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 959' ' ' LEU . . . . . 0.775 HD11 ' HG3' ' A' ' 916' ' ' GLU . 96.2 mt 38.38 45.1 0.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.9 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 52.88 44.09 30.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.848 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 961' ' ' ARG . . . . . 0.515 ' CD ' HD11 ' A' ' 913' ' ' LEU . 61.2 mtt85 -151.4 105.84 3.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 63.2 m -60.88 115.79 3.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.118 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 963' ' ' ILE . . . . . 0.761 HD13 HD21 ' A' ' 917' ' ' LEU . 75.2 mt -98.56 139.7 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.107 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 13.5 m -122.75 115.75 22.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.125 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 965' ' ' ILE . . . . . 0.478 ' CD1' ' HB2' ' A' ' 953' ' ' LEU . 61.5 mt -102.22 138.2 27.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.142 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -150.6 129.83 12.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.124 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 967' ' ' LEU . . . . . 0.777 HD23 HG12 ' A' ' 895' ' ' VAL . 32.3 mt -65.49 157.87 28.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.893 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 14.7 tptp . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.939 179.831 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 93.3 m . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.789 0.328 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 895' ' ' VAL . . . . . 0.531 HG12 HD23 ' A' ' 967' ' ' LEU . 26.7 m -122.76 140.03 47.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.149 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . 0.47 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 6.4 mp -88.8 142.67 27.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.908 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 97.9 t -142.66 124.07 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.135 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 7.8 t -127.57 156.32 42.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.829 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.586 HG22 HG12 ' A' ' 963' ' ' ILE . 2.5 pt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.116 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 909' ' ' PHE . . . . . 0.567 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 58.3 m-85 . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.881 0.372 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 910' ' ' ASP . . . . . 0.461 ' H ' HD12 ' A' ' 913' ' ' LEU . 12.4 t70 -89.74 -179.07 5.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.884 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -58.46 -41.92 86.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.878 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -64.38 -51.64 62.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.082 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 913' ' ' LEU . . . . . 0.876 HD21 ' HD2' ' A' ' 961' ' ' ARG . 72.2 mt -55.2 -53.31 57.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.917 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 44.9 mt -62.69 -61.92 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.133 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -44.55 -58.27 3.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -52.03 -45.68 64.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 917' ' ' LEU . . . . . 0.805 HD21 HD13 ' A' ' 963' ' ' ILE . 23.0 mt -56.58 -53.79 53.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.923 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 918' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 917' ' ' LEU . 80.4 mt -34.45 -54.1 0.52 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.949 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -58.71 -49.83 76.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.902 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 920' ' ' GLN . . . . . 0.735 ' OE1' HD22 ' A' ' 958' ' ' LEU . 19.7 mt-30 -51.89 -36.98 50.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 921' ' ' PHE . . . . . 0.432 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 21.9 m-85 -73.11 -39.89 65.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.845 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -55.9 -33.0 64.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.119 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 53.4 p -54.22 -17.79 3.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.874 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 924' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -121.54 -52.4 2.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.872 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -147.12 154.95 26.29 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.458 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -86.18 126.34 34.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.896 0.379 . . . . 0.0 110.896 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 927' ' ' VAL . . . . . 0.485 HG13 ' O ' ' A' ' 940' ' ' THR . 6.4 t -78.09 150.76 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.175 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 928' ' ' ILE . . . . . 0.469 HG13 ' N ' ' A' ' 929' ' ' LEU . 40.3 pt -120.67 -38.71 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.153 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 929' ' ' LEU . . . . . 0.469 ' N ' HG13 ' A' ' 928' ' ' ILE . 13.3 tp -142.73 151.8 41.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.95 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 930' ' ' ILE . . . . . 0.559 HG12 HG13 ' A' ' 939' ' ' VAL . 76.0 mt -134.87 125.87 46.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.126 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -115.46 125.02 52.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.861 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -94.09 123.55 37.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.862 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 933' ' ' VAL . . . . . 0.728 HG21 ' NE1' ' A' ' 938' ' ' TRP . 5.1 t -91.21 157.31 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.111 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 934' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 933' ' ' VAL . 10.2 mm-40 -33.54 -52.61 0.4 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.911 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -124.72 -24.81 4.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -96.58 171.68 8.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.891 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 937' ' ' MET . . . . . 0.578 ' SD ' HG23 ' A' ' 939' ' ' VAL . 0.3 OUTLIER -132.7 115.08 14.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.892 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 938' ' ' TRP . . . . . 0.728 ' NE1' HG21 ' A' ' 933' ' ' VAL . 31.0 m0 -100.34 146.37 27.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.942 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 939' ' ' VAL . . . . . 0.578 HG23 ' SD ' ' A' ' 937' ' ' MET . 60.4 t -137.07 129.12 43.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.121 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 940' ' ' THR . . . . . 0.485 ' O ' HG13 ' A' ' 927' ' ' VAL . 18.8 m -93.12 153.24 18.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.13 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 941' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -128.05 150.74 49.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 25.0 tp -51.75 -46.37 64.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -118.4 171.06 8.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.855 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -84.44 -42.27 7.48 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.481 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 39.3 p -56.85 -40.57 76.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.881 0.372 . . . . 0.0 110.897 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 1.2 p -54.16 -35.99 62.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.848 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -72.42 -14.44 61.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.15 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 21.9 mt -86.66 -26.4 24.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.928 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -82.76 -50.83 8.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 6.0 p -49.84 -19.45 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.125 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 951' ' ' LEU . . . . . 0.892 HD11 HD11 ' A' ' 967' ' ' LEU . 39.5 mt -55.14 -24.79 28.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.917 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 44.8 t -58.28 -11.75 3.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.867 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 36.6 mt -92.09 13.18 19.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.914 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 954' ' ' ASN . . . . . 0.412 ' O ' ' CG ' ' A' ' 954' ' ' ASN . 3.7 p30 -66.03 117.96 9.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 89.47 -26.09 9.79 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.525 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -40.65 129.28 2.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.751 0.31 . . . . 0.0 110.907 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -97.87 135.22 39.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.854 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 958' ' ' LEU . . . . . 0.735 HD22 ' OE1' ' A' ' 920' ' ' GLN . 18.0 tp -139.16 160.44 39.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.951 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 959' ' ' LEU . . . . . 0.449 ' C ' ' O ' ' A' ' 958' ' ' LEU . 97.1 mt 34.29 37.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 960' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 958' ' ' LEU . 6.7 m-80 60.91 48.4 6.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 961' ' ' ARG . . . . . 0.876 ' HD2' HD21 ' A' ' 913' ' ' LEU . 68.8 mtt85 -153.05 106.08 2.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.869 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 5.3 m -61.34 115.41 3.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.132 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 963' ' ' ILE . . . . . 0.805 HD13 HD21 ' A' ' 917' ' ' LEU . 57.8 mt -100.69 144.81 12.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.148 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 3.6 m -127.79 113.03 15.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.109 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 965' ' ' ILE . . . . . . . . . . . . . 61.9 mt -95.17 147.14 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.127 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -154.03 126.95 8.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.061 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 967' ' ' LEU . . . . . 0.892 HD11 HD11 ' A' ' 951' ' ' LEU . 32.9 mt -65.25 157.98 27.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 968' ' ' LYS . . . . . 0.424 ' HE2' ' CH2' ' A' ' 938' ' ' TRP . 16.0 tttp . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 97.7 m . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.789 0.328 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 895' ' ' VAL . . . . . 0.501 HG12 HD23 ' A' ' 967' ' ' LEU . 22.4 m -121.34 138.51 51.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.148 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . 0.465 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 5.5 mp -88.99 145.74 25.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.616 HG22 HG12 ' A' ' 965' ' ' ILE . 79.1 t -147.01 126.34 4.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 11.1 t -127.1 152.28 47.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.824 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.552 HG22 HG12 ' A' ' 963' ' ' ILE . 3.5 pt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.122 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 909' ' ' PHE . . . . . 0.583 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 69.0 m-85 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.865 0.364 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 910' ' ' ASP . . . . . 0.532 ' H ' HD12 ' A' ' 913' ' ' LEU . 76.9 m-20 -97.95 169.11 9.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.876 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -48.16 -49.06 33.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.888 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -57.17 -56.04 26.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.089 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 913' ' ' LEU . . . . . 0.532 HD12 ' H ' ' A' ' 910' ' ' ASP . 31.3 mt -49.23 -54.18 17.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 56.0 mt -60.68 -64.48 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.137 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -42.94 -56.78 3.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.83 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -52.57 -50.98 61.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.849 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 917' ' ' LEU . . . . . 0.77 HD21 HD13 ' A' ' 963' ' ' ILE . 25.9 mt -48.15 -57.45 5.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 918' ' ' LEU . . . . . 0.445 ' C ' ' O ' ' A' ' 917' ' ' LEU . 40.5 mt -34.37 -55.37 0.52 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.887 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -56.77 -45.54 82.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.9 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 920' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 917' ' ' LEU . 88.5 mm-40 -58.76 -36.54 74.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 921' ' ' PHE . . . . . 0.525 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 22.1 m-85 -72.64 -47.46 47.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.852 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -48.77 -34.65 12.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.078 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -46.38 -32.87 3.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 924' ' ' PHE . . . . . 0.553 ' N ' ' CD1' ' A' ' 924' ' ' PHE . 0.5 OUTLIER -121.63 -58.5 1.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.915 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -121.02 148.47 17.49 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.525 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 926' ' ' GLU . . . . . 0.5 ' OE2' HG22 ' A' ' 928' ' ' ILE . 2.0 tm-20 -90.1 128.7 36.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.868 0.366 . . . . 0.0 110.874 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 41.1 t -84.14 139.95 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 928' ' ' ILE . . . . . 0.5 HG22 ' OE2' ' A' ' 926' ' ' GLU . 35.4 pt -122.43 -40.54 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.12 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 929' ' ' LEU . . . . . 0.477 ' N ' HG13 ' A' ' 928' ' ' ILE . 15.6 tp -136.83 136.05 38.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.907 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 81.7 mt -122.76 126.56 74.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.089 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 11.8 tpt85 -112.18 124.68 52.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.868 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -93.57 117.01 29.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 933' ' ' VAL . . . . . 0.664 HG21 ' NE1' ' A' ' 938' ' ' TRP . 2.9 t -85.78 156.99 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.104 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 934' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 933' ' ' VAL . 33.1 mt-10 -34.43 -51.33 0.46 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.857 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -125.49 -26.25 3.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -96.16 173.04 7.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.917 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 937' ' ' MET . . . . . 0.583 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 15.3 ttt -134.11 111.73 10.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.905 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 938' ' ' TRP . . . . . 0.664 ' NE1' HG21 ' A' ' 933' ' ' VAL . 38.8 m0 -92.11 148.13 22.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.957 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 43.0 t -134.14 125.8 48.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.083 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 14.0 m -92.46 151.75 20.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.152 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 941' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -132.24 143.87 50.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.862 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 54.2 tp -41.27 -52.87 3.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.878 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -118.17 177.99 4.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -86.67 -48.08 4.6 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.525 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 46.6 t -50.8 -39.07 51.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.863 0.363 . . . . 0.0 110.841 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 56.8 p -57.51 -32.36 66.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.87 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -76.4 -20.91 56.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.086 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 36.5 mt -77.97 -27.93 49.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.926 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -81.93 -51.56 7.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.883 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 9.5 p -48.21 -21.56 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.12 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 951' ' ' LEU . . . . . 0.449 HD21 ' HG ' ' A' ' 967' ' ' LEU . 34.2 mt -49.37 -29.43 6.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.937 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 35.7 p -50.28 -19.77 0.89 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.839 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 76.7 mt -88.84 20.15 3.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.885 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -74.41 106.34 5.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.928 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 98.85 -26.76 22.84 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.461 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -37.97 128.19 1.25 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.71 0.291 . . . . 0.0 110.887 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -93.38 125.15 37.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 15.2 tp -133.01 154.58 50.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 43.2 mt 41.01 47.78 2.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.913 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 51.64 40.5 27.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 961' ' ' ARG . . . . . . . . . . . . . 65.2 mtt85 -147.63 122.69 10.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.858 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 6.1 m -74.17 115.08 13.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.154 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 963' ' ' ILE . . . . . 0.77 HD13 HD21 ' A' ' 917' ' ' LEU . 84.6 mt -99.81 135.51 35.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.124 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 14.9 m -119.74 112.5 19.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.173 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 965' ' ' ILE . . . . . 0.616 HG12 HG22 ' A' ' 897' ' ' VAL . 67.3 mt -98.99 137.48 26.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.122 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -151.37 135.33 16.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.087 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 967' ' ' LEU . . . . . 0.501 HD23 HG12 ' A' ' 895' ' ' VAL . 28.9 mt -66.26 157.98 30.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.907 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.918 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 39.3 m . . . . . 0 N--CA 1.457 -0.125 0 CA-C-O 120.865 0.364 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 895' ' ' VAL . . . . . 0.527 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 17.8 m -117.49 144.09 26.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.169 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . 0.472 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 6.8 mp -92.89 137.92 31.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 60.1 t -140.13 131.24 31.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.161 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 3.1 t -130.62 156.32 45.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.881 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.527 HG23 ' CE2' ' A' ' 909' ' ' PHE . 3.3 pt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.183 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 909' ' ' PHE . . . . . 0.539 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 87.4 m-85 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.857 0.36 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 910' ' ' ASP . . . . . 0.812 ' H ' HD12 ' A' ' 913' ' ' LEU . 24.0 t70 -97.89 165.65 11.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.871 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -48.51 -50.06 33.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -56.84 -48.92 76.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.117 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 913' ' ' LEU . . . . . 0.812 HD12 ' H ' ' A' ' 910' ' ' ASP . 72.4 mt -56.72 -50.45 72.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.895 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 50.6 mt -64.0 -63.79 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.108 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -42.07 -56.47 2.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.819 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -54.34 -46.81 72.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.876 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 917' ' ' LEU . . . . . 0.903 HD21 HD13 ' A' ' 963' ' ' ILE . 24.9 mt -54.15 -56.08 21.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.933 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 918' ' ' LEU . . . . . 0.495 ' CD2' HD11 ' A' ' 930' ' ' ILE . 68.3 mt -34.41 -60.6 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.883 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -52.31 -51.07 60.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -52.48 -40.05 61.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 921' ' ' PHE . . . . . 0.564 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 22.9 m-85 -66.82 -44.59 80.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.865 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -50.57 -33.63 22.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.123 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 923' ' ' SER . . . . . 0.54 ' HB3' ' CE1' ' A' ' 924' ' ' PHE . 10.4 t -41.86 -34.64 0.69 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.87 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 924' ' ' PHE . . . . . 0.54 ' CE1' ' HB3' ' A' ' 923' ' ' SER . 0.9 OUTLIER -120.17 -51.68 2.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.844 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -128.27 141.56 12.71 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.442 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -85.58 99.47 11.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.896 0.379 . . . . 0.0 110.894 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 40.2 t -51.23 143.91 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.122 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 928' ' ' ILE . . . . . 0.475 HG13 ' N ' ' A' ' 929' ' ' LEU . 21.0 pt -120.04 -44.8 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.093 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 929' ' ' LEU . . . . . 0.475 ' N ' HG13 ' A' ' 928' ' ' ILE . 11.1 tp -135.56 146.51 48.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.949 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 930' ' ' ILE . . . . . 0.495 HD11 ' CD2' ' A' ' 918' ' ' LEU . 57.0 mt -130.05 137.57 56.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.13 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -125.88 122.29 35.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -88.48 124.07 33.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.845 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 933' ' ' VAL . . . . . 0.644 HG21 ' CD1' ' A' ' 938' ' ' TRP . 13.5 t -92.63 157.52 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.089 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 934' ' ' GLU . . . . . 0.482 ' C ' ' O ' ' A' ' 933' ' ' VAL . 15.2 mm-40 -31.24 -56.03 0.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -121.88 -26.01 4.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.859 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 4.7 tttm -96.12 173.25 7.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.839 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 937' ' ' MET . . . . . 0.539 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 10.8 ttt -132.39 105.93 7.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 938' ' ' TRP . . . . . 0.644 ' CD1' HG21 ' A' ' 933' ' ' VAL . 44.1 m0 -85.25 142.49 29.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.928 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 939' ' ' VAL . . . . . 0.488 HG13 HG12 ' A' ' 930' ' ' ILE . 43.8 t -132.56 129.62 59.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.133 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 940' ' ' THR . . . . . 0.403 HG22 ' N ' ' A' ' 941' ' ' PHE . 32.9 m -92.53 154.23 18.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.162 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 941' ' ' PHE . . . . . 0.413 ' O ' ' C ' ' A' ' 942' ' ' LEU . 11.2 m-85 -134.17 146.97 50.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.865 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 942' ' ' LEU . . . . . 0.413 ' C ' ' O ' ' A' ' 941' ' ' PHE . 23.6 tp -36.91 -61.49 0.55 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -125.62 153.53 43.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -50.5 -51.01 33.96 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.509 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 945' ' ' SER . . . . . 0.587 ' HA ' HD12 ' A' ' 948' ' ' LEU . 82.6 p -46.7 -42.86 17.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.9 0.381 . . . . 0.0 110.843 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 14.5 m -56.32 -30.86 63.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 947' ' ' ALA . . . . . 0.527 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -82.47 -16.73 47.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.118 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 948' ' ' LEU . . . . . 0.587 HD12 ' HA ' ' A' ' 945' ' ' SER . 23.4 mt -83.23 -23.6 32.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.927 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -88.34 -46.47 9.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.92 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 7.2 p -51.33 -22.25 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.148 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 951' ' ' LEU . . . . . 0.465 HD21 ' HG ' ' A' ' 967' ' ' LEU . 39.5 mt -50.41 -24.84 3.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.918 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 32.5 m -55.26 -15.51 2.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 36.5 mt -91.53 17.01 9.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.905 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -69.06 120.85 15.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.929 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 85.63 -27.31 5.35 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.458 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -38.21 127.36 1.35 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.74 0.305 . . . . 0.0 110.893 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -95.4 125.49 40.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.862 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 14.5 tp -134.46 153.44 51.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.969 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 959' ' ' LEU . . . . . 0.441 ' O ' ' CG ' ' A' ' 960' ' ' ASN . 35.0 mt 41.56 49.17 3.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 960' ' ' ASN . . . . . 0.441 ' CG ' ' O ' ' A' ' 959' ' ' LEU . 13.0 p30 47.75 40.29 11.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 961' ' ' ARG . . . . . 0.757 ' HD2' HD21 ' A' ' 913' ' ' LEU . 47.1 mtt85 -147.56 104.99 3.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 27.1 m -58.94 120.88 9.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.133 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 963' ' ' ILE . . . . . 0.903 HD13 HD21 ' A' ' 917' ' ' LEU . 87.2 mt -103.98 143.4 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 8.7 m -127.22 119.93 27.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.134 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 965' ' ' ILE . . . . . . . . . . . . . 63.4 mt -103.77 140.27 22.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.131 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -149.85 137.12 19.75 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.077 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 967' ' ' LEU . . . . . 0.465 ' HG ' HD21 ' A' ' 951' ' ' LEU . 25.1 mt -73.75 153.48 40.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.95 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 968' ' ' LYS . . . . . 0.432 ' HD3' HD11 ' A' ' 896' ' ' LEU . 19.2 tptp . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.89 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 71.9 m . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.805 0.336 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 895' ' ' VAL . . . . . 0.475 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 13.7 m -117.17 142.86 29.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.157 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . 0.469 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 5.0 mp -91.74 143.15 26.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 79.8 t -142.44 127.5 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 9.7 t -129.61 158.05 40.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.841 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.517 HG22 HG12 ' A' ' 963' ' ' ILE . 2.7 pt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.12 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 909' ' ' PHE . . . . . 0.579 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 94.1 m-85 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.888 0.375 . . . . 0.0 110.87 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 910' ' ' ASP . . . . . 0.662 ' H ' HD12 ' A' ' 913' ' ' LEU . 9.6 m-20 -85.04 160.11 20.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.884 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -45.64 -40.43 9.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.852 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -65.33 -49.99 67.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.104 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 913' ' ' LEU . . . . . 0.662 HD12 ' H ' ' A' ' 910' ' ' ASP . 29.4 mt -56.76 -45.85 81.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 36.5 mt -69.52 -59.75 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.155 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -48.89 -50.99 32.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.86 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 916' ' ' GLU . . . . . 0.546 ' HG3' HD11 ' A' ' 959' ' ' LEU . 36.6 mm-40 -56.89 -40.8 76.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.86 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 917' ' ' LEU . . . . . 0.95 HD21 HD13 ' A' ' 963' ' ' ILE . 22.0 mt -59.88 -51.64 68.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 918' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 917' ' ' LEU . 30.8 mt -34.89 -64.19 0.28 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.906 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -50.2 -51.98 39.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.904 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 920' ' ' GLN . . . . . 0.443 ' O ' HD11 ' A' ' 953' ' ' LEU . 13.8 mm100 -49.63 -40.5 39.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.922 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 921' ' ' PHE . . . . . 0.553 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 22.7 m-85 -72.37 -42.78 64.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.899 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -50.99 -38.03 48.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.114 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -46.81 -21.13 0.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 924' ' ' PHE . . . . . 0.475 ' N ' ' CD1' ' A' ' 924' ' ' PHE . 1.4 m-85 -124.0 -58.88 1.54 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.914 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -130.1 151.0 19.26 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.512 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -88.86 125.35 34.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.887 0.375 . . . . 0.0 110.863 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 6.1 t -78.93 150.29 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.141 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 928' ' ' ILE . . . . . 0.475 HG13 ' N ' ' A' ' 929' ' ' LEU . 35.1 pt -125.63 -40.46 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.101 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 929' ' ' LEU . . . . . 0.475 ' N ' HG13 ' A' ' 928' ' ' ILE . 12.0 tp -141.12 146.34 36.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.941 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 930' ' ' ILE . . . . . 0.729 HG12 HG13 ' A' ' 939' ' ' VAL . 51.3 mt -134.62 143.04 38.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.119 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.62 128.69 31.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.849 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -91.99 123.55 35.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.87 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 933' ' ' VAL . . . . . 0.84 HG21 ' NE1' ' A' ' 938' ' ' TRP . 2.6 t -87.89 157.18 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.13 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 934' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 933' ' ' VAL . 45.8 mt-10 -33.49 -49.7 0.3 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.838 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -127.12 -28.22 2.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.867 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 6.8 ttmm -96.02 173.12 7.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 937' ' ' MET . . . . . 0.579 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 12.5 ttt -135.18 108.06 7.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 938' ' ' TRP . . . . . 0.84 ' NE1' HG21 ' A' ' 933' ' ' VAL . 13.4 m0 -94.88 143.62 26.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.929 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 939' ' ' VAL . . . . . 0.729 HG13 HG12 ' A' ' 930' ' ' ILE . 43.6 t -128.65 139.99 50.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.131 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 940' ' ' THR . . . . . 0.456 HG22 ' N ' ' A' ' 941' ' ' PHE . 53.0 m -98.51 156.26 16.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.099 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 941' ' ' PHE . . . . . 0.456 ' N ' HG22 ' A' ' 940' ' ' THR . 13.2 m-85 -136.23 149.86 48.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.916 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 32.5 tp -51.04 -52.13 46.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.953 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -114.69 173.91 6.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.904 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -86.89 -47.18 4.87 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.472 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 13.0 m -56.06 -27.2 52.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.917 0.389 . . . . 0.0 110.882 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 50.6 p -67.91 -28.14 67.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.862 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 947' ' ' ALA . . . . . 0.475 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -79.32 -13.26 59.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.083 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 32.3 mt -85.4 -31.97 22.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.912 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 41.8 m-20 -75.62 -42.33 52.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 5.7 p -56.77 -15.76 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.149 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 951' ' ' LEU . . . . . 0.511 HD21 ' HG ' ' A' ' 967' ' ' LEU . 31.6 mt -55.62 -29.1 58.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.904 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 70.7 m -55.99 -23.16 30.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.845 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 953' ' ' LEU . . . . . 0.476 ' C ' HD12 ' A' ' 965' ' ' ILE . 39.2 mt -82.03 9.08 9.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.887 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.04 119.09 13.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 91.95 -25.41 16.93 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.487 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -44.07 128.65 5.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.748 0.309 . . . . 0.0 110.941 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -93.08 133.27 36.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.922 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 13.8 tp -147.87 158.32 43.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.949 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 959' ' ' LEU . . . . . 0.546 HD11 ' HG3' ' A' ' 916' ' ' GLU . 33.1 mt 40.06 46.71 1.86 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.948 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 48.1 42.13 16.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 961' ' ' ARG . . . . . 0.627 ' HD2' HD21 ' A' ' 913' ' ' LEU . 64.1 mtt85 -152.14 115.22 4.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 12.5 m -68.31 123.97 22.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.115 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 963' ' ' ILE . . . . . 0.95 HD13 HD21 ' A' ' 917' ' ' LEU . 85.8 mt -107.17 143.86 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.083 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 10.1 m -129.1 117.57 21.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.177 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 965' ' ' ILE . . . . . 0.476 HD12 ' C ' ' A' ' 953' ' ' LEU . 23.2 mt -98.64 145.15 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.152 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -155.93 129.6 8.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 967' ' ' LEU . . . . . 0.511 ' HG ' HD21 ' A' ' 951' ' ' LEU . 38.3 mt -65.22 157.7 28.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 968' ' ' LYS . . . . . 0.415 ' HD3' HD11 ' A' ' 896' ' ' LEU . 34.4 tptt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 59.1 m . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.816 0.341 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 895' ' ' VAL . . . . . 0.749 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 12.8 m -118.56 143.42 29.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.118 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . 0.463 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 3.5 mp -93.22 145.75 24.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.927 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.421 HG13 ' CG2' ' A' ' 963' ' ' ILE . 98.0 t -146.2 128.57 8.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.131 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 30.9 t -133.21 159.53 39.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.893 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.132 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 909' ' ' PHE . . . . . 0.589 ' CE2' ' HB2' ' A' ' 937' ' ' MET . 45.9 m-85 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.867 0.365 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 910' ' ' ASP . . . . . 0.763 ' H ' HD12 ' A' ' 913' ' ' LEU . 25.8 m-20 -83.71 157.71 22.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.904 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -43.75 -58.4 2.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.904 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -45.26 -58.0 3.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.12 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 913' ' ' LEU . . . . . 0.763 HD12 ' H ' ' A' ' 910' ' ' ASP . 24.7 mt -44.26 -56.23 4.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.925 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 71.4 mt -58.86 -62.21 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -43.46 -67.52 0.27 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 916' ' ' GLU . . . . . 0.66 ' HG3' HD11 ' A' ' 959' ' ' LEU . 8.5 mm-40 -43.78 -55.22 4.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.854 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 917' ' ' LEU . . . . . 0.954 HD21 HD13 ' A' ' 963' ' ' ILE . 30.3 mt -44.97 -58.89 2.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.903 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 918' ' ' LEU . . . . . 0.439 ' C ' ' O ' ' A' ' 917' ' ' LEU . 90.1 mt -35.25 -58.16 0.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.983 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -56.68 -38.52 72.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.924 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 920' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 917' ' ' LEU . 72.7 mm-40 -63.74 -36.67 84.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 921' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -72.02 -37.38 69.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -57.89 -34.04 69.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.131 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -47.91 -25.21 1.25 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 924' ' ' PHE . . . . . 0.477 ' N ' ' CD1' ' A' ' 924' ' ' PHE . 2.4 m-85 -121.64 -64.35 1.23 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.884 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -123.26 154.38 17.24 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.504 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -88.57 135.11 33.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.919 0.39 . . . . 0.0 110.895 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 19.9 t -86.29 149.06 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.115 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 928' ' ' ILE . . . . . 0.479 HG13 ' N ' ' A' ' 929' ' ' LEU . 27.7 pt -129.12 -42.85 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.14 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 929' ' ' LEU . . . . . 0.479 ' N ' HG13 ' A' ' 928' ' ' ILE . 15.8 tp -136.27 145.71 45.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.919 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 64.9 mt -133.72 128.92 54.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.136 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -120.11 126.73 51.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.862 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -92.17 120.59 32.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.841 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 933' ' ' VAL . . . . . 0.772 HG21 ' NE1' ' A' ' 938' ' ' TRP . 3.0 t -86.96 157.09 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.179 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 934' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 933' ' ' VAL . 34.4 mm-40 -33.98 -52.51 0.44 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -124.95 -24.74 4.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.853 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 936' ' ' LYS . . . . . 0.431 ' NZ ' ' HB3' ' A' ' 896' ' ' LEU . 14.7 tttm -97.57 173.07 7.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 937' ' ' MET . . . . . 0.589 ' HB2' ' CE2' ' A' ' 909' ' ' PHE . 16.5 ttt -132.04 115.09 15.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.915 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 938' ' ' TRP . . . . . 0.772 ' NE1' HG21 ' A' ' 933' ' ' VAL . 39.5 m0 -94.63 150.37 20.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.955 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 70.0 t -142.36 128.24 17.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.104 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 5.6 m -95.54 150.88 19.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.115 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 941' ' ' PHE . . . . . 0.446 ' O ' ' C ' ' A' ' 942' ' ' LEU . 9.6 m-85 -129.37 145.59 51.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 942' ' ' LEU . . . . . 0.446 ' C ' ' O ' ' A' ' 941' ' ' PHE . 16.0 tp -34.4 -64.82 0.23 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -114.81 165.57 12.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -65.92 -54.09 26.86 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.52 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 945' ' ' SER . . . . . 0.615 ' HA ' HD12 ' A' ' 948' ' ' LEU . 84.3 p -48.15 -27.14 2.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.912 0.387 . . . . 0.0 110.869 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 69.1 m -67.23 -34.78 78.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 947' ' ' ALA . . . . . 0.749 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -80.04 -13.79 59.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.111 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 948' ' ' LEU . . . . . 0.615 HD12 ' HA ' ' A' ' 945' ' ' SER . 20.0 mt -87.44 -22.97 24.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.933 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 -85.54 -38.48 18.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.88 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 8.4 p -60.09 -21.96 23.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.163 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 951' ' ' LEU . . . . . 0.439 HD21 ' HG ' ' A' ' 967' ' ' LEU . 43.5 mt -50.14 -23.06 1.93 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.924 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 18.6 m -56.9 -15.0 3.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.826 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 953' ' ' LEU . . . . . 0.454 ' HB2' ' CD1' ' A' ' 965' ' ' ILE . 56.9 mt -92.99 11.48 27.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.938 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -63.4 116.51 5.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.888 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 90.67 -25.67 12.77 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.544 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -42.37 128.21 3.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.785 0.326 . . . . 0.0 110.922 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -95.68 128.39 42.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.92 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 14.9 tp -135.58 153.41 51.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.891 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 959' ' ' LEU . . . . . 0.66 HD11 ' HG3' ' A' ' 916' ' ' GLU . 36.0 mt 42.73 49.6 4.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 47.6 44.07 16.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.89 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 961' ' ' ARG . . . . . 0.471 ' CD ' HD11 ' A' ' 913' ' ' LEU . 57.8 mtt-85 -152.29 109.72 3.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 31.1 m -62.56 122.3 15.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.17 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 963' ' ' ILE . . . . . 0.954 HD13 HD21 ' A' ' 917' ' ' LEU . 93.3 mt -105.11 148.8 9.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.173 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 5.7 m -132.67 113.78 13.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.124 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 965' ' ' ILE . . . . . 0.454 ' CD1' ' HB2' ' A' ' 953' ' ' LEU . 56.5 mt -96.58 140.28 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.157 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -149.29 135.46 19.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.119 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 967' ' ' LEU . . . . . 0.439 ' HG ' HD21 ' A' ' 951' ' ' LEU . 26.8 mt -71.89 154.95 40.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.894 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 13.6 tptm . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 179.886 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 69.4 m . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.816 0.341 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 895' ' ' VAL . . . . . 0.612 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 17.1 m -115.45 143.68 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.15 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . 0.469 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 5.0 mp -91.65 141.94 28.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 80.6 t -137.03 129.72 44.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.132 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 12.4 t -133.46 158.48 42.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.83 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.429 HG22 HG12 ' A' ' 963' ' ' ILE . 2.5 pt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.117 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 909' ' ' PHE . . . . . 0.573 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 92.9 m-85 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.829 0.347 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 910' ' ' ASP . . . . . 0.441 ' H ' HD12 ' A' ' 913' ' ' LEU . 26.8 m-20 -96.71 173.05 7.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.845 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -53.75 -36.71 62.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.854 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -69.0 -49.54 56.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.071 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 913' ' ' LEU . . . . . 0.441 HD12 ' H ' ' A' ' 910' ' ' ASP . 22.2 mt -59.06 -44.83 91.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 54.3 mt -69.74 -59.88 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.151 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -41.58 -64.92 0.5 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.843 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -47.27 -56.05 7.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 917' ' ' LEU . . . . . 0.759 HD21 HD13 ' A' ' 963' ' ' ILE . 26.9 mt -42.16 -54.22 3.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 918' ' ' LEU . . . . . . . . . . . . . 62.8 mt -40.46 -57.69 1.74 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.954 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -58.71 -42.93 89.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -58.71 -38.8 79.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 921' ' ' PHE . . . . . 0.563 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 24.5 m-85 -69.92 -37.39 75.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -56.27 -35.45 67.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.071 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.7 m -44.53 -29.16 0.67 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 924' ' ' PHE . . . . . 0.496 ' N ' ' CD1' ' A' ' 924' ' ' PHE . 1.8 m-85 -121.3 -59.6 1.7 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.849 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -124.26 140.21 12.48 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.514 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -82.52 99.41 9.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.814 0.34 . . . . 0.0 110.88 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 927' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 940' ' ' THR . 34.7 t -50.27 143.71 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.163 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 928' ' ' ILE . . . . . 0.654 HD13 ' HA ' ' A' ' 942' ' ' LEU . 15.3 pt -120.02 -39.97 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.15 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 929' ' ' LEU . . . . . . . . . . . . . 8.6 tp -140.44 149.36 42.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.913 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 930' ' ' ILE . . . . . 0.589 HG12 HG13 ' A' ' 939' ' ' VAL . 41.9 mt -137.05 145.58 29.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.104 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 8.1 ttp180 -135.78 124.19 23.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.917 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -87.75 120.38 29.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.909 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 933' ' ' VAL . . . . . 0.694 HG21 ' CD1' ' A' ' 938' ' ' TRP . 3.6 t -87.15 157.15 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.106 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 934' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 933' ' ' VAL . 22.8 mm-40 -34.04 -53.72 0.47 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -124.17 -21.57 4.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.834 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 16.9 ttmt -99.93 172.94 6.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 937' ' ' MET . . . . . 0.573 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 15.2 ttt -131.85 109.03 9.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.841 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 938' ' ' TRP . . . . . 0.694 ' CD1' HG21 ' A' ' 933' ' ' VAL . 43.4 m0 -89.41 143.13 27.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.913 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 939' ' ' VAL . . . . . 0.589 HG13 HG12 ' A' ' 930' ' ' ILE . 46.6 t -135.8 122.73 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.095 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 940' ' ' THR . . . . . 0.445 ' O ' HG13 ' A' ' 927' ' ' VAL . 18.4 m -91.04 152.94 20.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.154 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 941' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -129.21 155.53 45.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.869 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 942' ' ' LEU . . . . . 0.654 ' HA ' HD13 ' A' ' 928' ' ' ILE . 16.1 tp -38.47 -56.72 1.23 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.959 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -136.11 165.67 25.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.862 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -52.97 -53.44 33.72 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.461 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 945' ' ' SER . . . . . 0.411 ' HA ' HD12 ' A' ' 948' ' ' LEU . 77.3 p -46.38 -44.6 17.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.835 0.35 . . . . 0.0 110.847 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 72.2 m -55.17 -32.85 62.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 947' ' ' ALA . . . . . 0.612 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -82.51 -13.43 56.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.102 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 948' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 945' ' ' SER . 60.2 mt -85.65 -28.35 24.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.909 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -85.37 -34.09 21.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.13 -20.26 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.16 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 951' ' ' LEU . . . . . 0.424 HD21 ' HG ' ' A' ' 967' ' ' LEU . 41.2 mt -52.85 -26.56 15.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.93 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 9.7 m -56.36 -21.49 24.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.841 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 26.6 mt -82.04 4.96 20.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.89 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.16 122.71 17.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 88.7 -26.56 8.12 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.485 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -42.32 127.15 3.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.752 0.31 . . . . 0.0 110.913 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -93.63 130.82 39.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 14.8 tp -141.36 152.46 44.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.913 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 81.4 mt 42.03 48.42 4.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.964 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 48.57 40.74 16.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.839 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 961' ' ' ARG . . . . . . . . . . . . . 51.5 mtt85 -148.94 105.0 3.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.871 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 56.3 m -62.67 121.35 13.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.12 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 963' ' ' ILE . . . . . 0.759 HD13 HD21 ' A' ' 917' ' ' LEU . 64.7 mt -102.32 152.87 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.14 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 964' ' ' THR . . . . . 0.42 ' N ' HG22 ' A' ' 963' ' ' ILE . 11.6 m -136.45 117.51 14.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.1 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 965' ' ' ILE . . . . . . . . . . . . . 33.7 mt -100.37 143.62 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.104 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -154.28 129.38 9.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.128 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 967' ' ' LEU . . . . . 0.58 HD23 HG12 ' A' ' 895' ' ' VAL . 36.5 mt -63.15 158.0 20.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.926 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 12.7 tptp . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 179.854 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 97.5 m . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.825 0.345 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 895' ' ' VAL . . . . . 0.448 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 17.2 m -115.0 142.48 27.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.113 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . 0.471 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 3.9 mp -91.58 142.64 27.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 897' ' ' VAL . . . . . 0.419 HG22 HG12 ' A' ' 965' ' ' ILE . 94.5 t -139.86 131.43 32.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.131 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 11.8 t -132.6 151.73 51.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.827 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 899' ' ' ILE . . . . . 0.476 HG22 HG12 ' A' ' 963' ' ' ILE . 3.8 pt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.159 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 909' ' ' PHE . . . . . 0.592 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 24.6 m-85 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.895 0.378 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 910' ' ' ASP . . . . . 0.66 ' H ' HD12 ' A' ' 913' ' ' LEU . 23.6 t70 -89.89 168.3 12.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.85 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 911' ' ' ASP . . . . . 0.409 ' N ' ' CG ' ' A' ' 910' ' ' ASP . 0.7 OUTLIER -49.04 -45.89 43.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -61.46 -58.27 8.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.095 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 913' ' ' LEU . . . . . 0.855 HD21 ' HD2' ' A' ' 961' ' ' ARG . 84.3 mt -47.84 -47.18 31.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.88 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 57.3 mt -66.47 -64.28 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.118 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -39.34 -61.93 0.73 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 916' ' ' GLU . . . . . 0.4 ' HG3' HD11 ' A' ' 959' ' ' LEU . 30.7 mm-40 -47.83 -57.25 5.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.934 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 917' ' ' LEU . . . . . 0.98 HD21 HD13 ' A' ' 963' ' ' ILE . 33.8 mt -41.73 -56.91 2.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 918' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 917' ' ' LEU . 37.5 mt -36.11 -57.54 0.7 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -54.83 -42.78 72.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 920' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 917' ' ' LEU . 60.5 mm-40 -61.17 -39.14 89.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.913 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 921' ' ' PHE . . . . . 0.54 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 22.0 m-85 -71.34 -34.56 70.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -60.62 -34.52 74.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.086 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -47.24 -23.72 0.59 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.851 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 924' ' ' PHE . . . . . 0.558 ' N ' ' CD1' ' A' ' 924' ' ' PHE . 0.6 OUTLIER -125.42 -55.97 1.53 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.896 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -127.56 141.23 12.45 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.469 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -83.55 100.26 10.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.88 0.372 . . . . 0.0 110.884 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 60.9 t -53.14 146.32 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.134 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 928' ' ' ILE . . . . . . . . . . . . . 29.1 pt -124.85 -37.38 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.159 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 929' ' ' LEU . . . . . . . . . . . . . 22.2 tp -139.7 146.88 40.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.964 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 64.1 mt -136.23 129.26 46.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.119 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -118.81 124.7 47.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -90.96 119.53 31.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.862 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 933' ' ' VAL . . . . . 0.638 HG21 ' NE1' ' A' ' 938' ' ' TRP . 9.0 t -85.64 157.27 3.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.148 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 934' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 933' ' ' VAL . 65.7 mt-10 -33.77 -50.34 0.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.871 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.76 -26.2 3.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.841 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 936' ' ' LYS . . . . . 0.41 ' O ' ' N ' ' A' ' 933' ' ' VAL . 1.0 OUTLIER -96.48 173.2 7.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 -179.984 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 937' ' ' MET . . . . . 0.592 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 18.8 ttt -134.8 110.39 9.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.848 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 938' ' ' TRP . . . . . 0.638 ' NE1' HG21 ' A' ' 933' ' ' VAL . 43.8 m0 -89.51 152.31 21.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.939 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 939' ' ' VAL . . . . . 0.441 HG12 ' CE1' ' A' ' 941' ' ' PHE . 93.0 t -140.99 123.57 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.127 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 18.8 m -90.4 150.04 22.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.137 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 941' ' ' PHE . . . . . 0.441 ' CE1' HG12 ' A' ' 939' ' ' VAL . 10.8 m-85 -129.41 150.49 50.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.891 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 942' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 941' ' ' PHE . 21.7 tp -37.09 -59.62 0.71 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.909 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -130.41 163.26 27.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 944' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 947' ' ' ALA . . . -55.49 -56.84 21.55 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.5 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 945' ' ' SER . . . . . 0.524 ' HA ' HD12 ' A' ' 948' ' ' LEU . 68.6 p -39.57 -48.71 2.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.889 0.376 . . . . 0.0 110.836 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 18.3 m -54.14 -37.93 64.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 947' ' ' ALA . . . . . 0.448 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -74.57 -13.81 60.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.098 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 948' ' ' LEU . . . . . 0.524 HD12 ' HA ' ' A' ' 945' ' ' SER . 26.7 mt -89.29 -21.85 22.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -88.77 -44.85 10.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.91 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 7.3 p -52.45 -22.76 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.109 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 31.1 mt -48.68 -26.65 2.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.904 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 26.3 m -52.78 -16.14 0.91 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.889 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 36.5 mt -92.13 16.48 11.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.865 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.41 119.0 13.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 87.8 -27.92 6.28 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.499 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -38.61 127.52 1.49 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.73 0.3 . . . . 0.0 110.896 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -97.17 122.87 40.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.904 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 14.2 tp -132.91 156.75 46.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 959' ' ' LEU . . . . . 0.453 ' O ' ' CG ' ' A' ' 960' ' ' ASN . 24.9 mt 42.19 49.23 4.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.931 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 960' ' ' ASN . . . . . 0.453 ' CG ' ' O ' ' A' ' 959' ' ' LEU . 17.0 p30 47.53 38.94 8.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 961' ' ' ARG . . . . . 0.855 ' HD2' HD21 ' A' ' 913' ' ' LEU . 49.7 mtt85 -146.88 112.0 5.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.871 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 55.8 m -64.9 119.52 10.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.127 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 963' ' ' ILE . . . . . 0.98 HD13 HD21 ' A' ' 917' ' ' LEU . 89.1 mt -102.12 145.65 11.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.115 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 7.6 m -130.43 110.26 11.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.126 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 965' ' ' ILE . . . . . 0.419 HG12 HG22 ' A' ' 897' ' ' VAL . 62.5 mt -96.64 136.61 26.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.146 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -147.72 134.47 20.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.136 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 967' ' ' LEU . . . . . . . . . . . . . 26.9 mt -64.54 155.75 32.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.927 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 11.9 tptp . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.883 179.853 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 N-CA-C 112.527 -0.229 . . . . 0.0 112.527 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 4.8 t -147.28 119.85 8.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.858 0.361 . . . . 0.0 110.879 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 30.0 t -112.57 137.31 50.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.784 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . 97.76 113.03 3.12 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.534 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 1.2 t -174.34 113.38 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.893 0.378 . . . . 0.0 110.841 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 20.9 m -82.62 86.98 6.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.835 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 164.48 -126.64 1.53 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.519 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . 159.89 43.08 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.482 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 99.1 m -97.01 120.01 36.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 0.0 111.125 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 895' ' ' VAL . . . . . 0.575 HG12 HD23 ' A' ' 967' ' ' LEU . 17.7 m -116.26 142.24 30.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.076 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . 0.465 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 6.5 mp -90.52 139.15 30.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.926 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.403 HG13 ' CG2' ' A' ' 963' ' ' ILE . 70.5 t -139.01 125.29 23.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.139 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 11.1 t -126.6 155.02 43.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.862 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.551 HG12 ' CE2' ' A' ' 909' ' ' PHE . 2.6 pt -120.26 131.71 71.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.123 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.66 119.09 22.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 901' ' ' SER . . . . . . . . . . . . . 1.4 t -133.31 178.87 6.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.832 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 3.2 m -101.28 -48.39 4.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.87 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 14.7 mt -86.2 151.45 54.1 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.615 0.721 . . . . 0.0 110.895 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -76.86 -15.89 16.52 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.686 2.257 . . . . 0.0 112.358 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -97.66 11.16 37.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 906' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -109.45 -22.11 12.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.87 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 38.9 m-20 -48.62 -22.7 0.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.894 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -67.64 137.66 55.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.88 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 909' ' ' PHE . . . . . 0.757 ' HA ' HD12 ' A' ' 913' ' ' LEU . 79.7 m-85 -84.34 132.51 34.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.904 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -97.56 -177.25 3.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.835 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -61.92 -36.07 80.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -67.72 -57.36 6.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.112 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 913' ' ' LEU . . . . . 0.757 HD12 ' HA ' ' A' ' 909' ' ' PHE . 22.6 mt -49.79 -47.0 51.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.923 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 47.5 mt -69.99 -65.93 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.125 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -38.81 -53.47 1.68 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.843 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 916' ' ' GLU . . . . . 0.468 ' HB3' HD21 ' A' ' 958' ' ' LEU . 60.8 mm-40 -58.24 -51.15 70.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.893 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 917' ' ' LEU . . . . . 0.974 HD21 HD13 ' A' ' 963' ' ' ILE . 23.9 mt -48.93 -54.79 14.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.883 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 918' ' ' LEU . . . . . 0.434 ' C ' ' O ' ' A' ' 917' ' ' LEU . 52.4 mt -35.04 -58.81 0.52 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.939 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -54.76 -51.17 66.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.934 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 920' ' ' GLN . . . . . 0.972 ' NE2' HD22 ' A' ' 958' ' ' LEU . 14.4 mt-30 -51.27 -41.43 60.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.926 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 921' ' ' PHE . . . . . 0.505 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 23.6 m-85 -70.93 -32.1 68.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -58.3 -39.22 78.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.097 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -45.03 -25.58 0.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.918 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 924' ' ' PHE . . . . . 0.531 ' N ' ' CD1' ' A' ' 924' ' ' PHE . 1.0 OUTLIER -120.96 -64.1 1.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.878 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -121.33 145.08 16.96 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.467 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -85.82 97.23 10.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.88 0.372 . . . . 0.0 110.902 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 29.1 t -46.31 145.64 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.107 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 928' ' ' ILE . . . . . 0.468 HG13 ' N ' ' A' ' 929' ' ' LEU . 25.1 pt -126.63 -42.89 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.167 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 929' ' ' LEU . . . . . 0.468 ' N ' HG13 ' A' ' 928' ' ' ILE . 10.2 tp -133.7 145.84 50.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.946 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 930' ' ' ILE . . . . . 0.41 HD11 ' CD2' ' A' ' 918' ' ' LEU . 81.7 mt -133.69 124.58 47.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.099 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 41.1 ttt180 -115.21 124.35 51.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.91 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -90.76 122.42 33.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.912 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 933' ' ' VAL . . . . . 0.723 HG21 ' NE1' ' A' ' 938' ' ' TRP . 2.7 t -90.51 156.94 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.151 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 934' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 933' ' ' VAL . 14.7 mt-10 -34.49 -52.12 0.49 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.9 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.93 -25.52 3.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.896 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -96.63 172.92 7.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.864 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 937' ' ' MET . . . . . 0.565 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 15.9 ttt -133.54 110.73 10.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.903 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 938' ' ' TRP . . . . . 0.723 ' NE1' HG21 ' A' ' 933' ' ' VAL . 37.8 m0 -90.85 148.98 22.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.924 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 939' ' ' VAL . . . . . 0.44 ' O ' HG22 ' A' ' 895' ' ' VAL . 47.6 t -137.88 124.83 28.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.106 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 21.3 m -93.0 150.48 20.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.147 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 941' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -128.49 158.56 38.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.839 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 23.2 tp -40.72 -53.54 2.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.939 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -134.48 167.82 20.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.866 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -64.74 -47.4 83.68 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.523 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 70.5 m -50.06 -43.86 51.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.923 0.392 . . . . 0.0 110.831 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 1.9 t -56.64 -36.72 69.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.91 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 947' ' ' ALA . . . . . 0.468 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -69.82 -13.64 62.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.103 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 948' ' ' LEU . . . . . 0.404 ' O ' HD12 ' A' ' 951' ' ' LEU . 23.8 mt -87.15 -25.23 24.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -82.78 -38.08 23.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 9.0 p -61.28 -18.47 18.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.139 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 951' ' ' LEU . . . . . 0.524 HD21 ' HG ' ' A' ' 967' ' ' LEU . 58.7 mt -53.27 -17.84 2.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.941 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 46.3 m -61.77 -12.98 19.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.888 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 953' ' ' LEU . . . . . 0.486 ' HB2' ' CD1' ' A' ' 965' ' ' ILE . 75.3 mt -96.86 12.84 30.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.956 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -66.03 107.24 1.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.934 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 100.02 -26.85 22.9 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.487 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 8.4 tmtm? -40.17 128.86 2.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.772 0.32 . . . . 0.0 110.909 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -93.01 130.38 38.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.848 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 958' ' ' LEU . . . . . 0.972 HD22 ' NE2' ' A' ' 920' ' ' GLN . 16.2 tp -136.3 145.99 46.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.931 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . 0.587 HD13 HD23 ' A' ' 913' ' ' LEU . 26.0 mt 44.94 52.24 8.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.953 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 49.26 31.85 3.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 961' ' ' ARG . . . . . . . . . . . . . 56.0 mtt-85 -138.89 111.76 7.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 18.7 m -66.25 116.57 7.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.164 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 963' ' ' ILE . . . . . 0.974 HD13 HD21 ' A' ' 917' ' ' LEU . 92.9 mt -97.82 137.21 26.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.114 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 9.6 m -122.41 110.42 15.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.134 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 965' ' ' ILE . . . . . 0.486 ' CD1' ' HB2' ' A' ' 953' ' ' LEU . 38.3 mt -94.61 143.23 12.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.139 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -157.3 133.26 9.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.149 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 967' ' ' LEU . . . . . 0.575 HD23 HG12 ' A' ' 895' ' ' VAL . 31.8 mt -67.12 157.73 32.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.905 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 19.3 tptp -87.93 91.14 8.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.897 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 87.6 p -60.31 143.51 89.12 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.647 0.737 . . . . 0.0 110.852 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -78.06 115.07 3.7 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.665 2.243 . . . . 0.0 112.39 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 34.1 p -58.71 -42.91 89.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -101.39 146.72 17.39 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.505 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.75 155.23 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.727 2.285 . . . . 0.0 112.32 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 98.2 p -77.6 -44.57 27.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.88 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 1.8 t -63.81 165.56 8.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.869 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.509 -179.994 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 47.9 t -126.81 83.67 2.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.905 0.383 . . . . 0.0 110.836 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 29.8 t -73.05 105.31 4.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.877 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . -155.93 -131.61 1.43 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.482 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 47.8 m 54.14 38.36 28.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.873 0.368 . . . . 0.0 110.855 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 41.4 t -48.96 -54.96 13.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.819 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -111.13 -135.07 6.71 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.455 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . -158.64 42.89 0.49 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.47 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 53.6 m -90.11 121.75 32.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.822 0.344 . . . . 0.0 111.143 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 895' ' ' VAL . . . . . 0.599 HG12 HD23 ' A' ' 967' ' ' LEU . 16.8 m -112.23 141.6 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.122 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . 0.534 ' HG ' ' CD1' ' A' ' 938' ' ' TRP . 3.6 mp -91.84 148.07 22.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.93 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.401 HG13 ' CG2' ' A' ' 963' ' ' ILE . 58.1 t -145.3 127.37 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.165 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 6.4 t -127.82 153.95 46.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.891 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.562 HG22 HG12 ' A' ' 963' ' ' ILE . 2.1 pt -122.84 130.52 74.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.109 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -89.76 120.02 30.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.918 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 901' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 902' ' ' SER . 16.6 t -134.95 139.08 44.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 902' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 901' ' ' SER . 66.2 p -38.01 -54.56 1.31 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 61.8 mt -94.53 147.47 33.29 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.647 0.737 . . . . 0.0 110.907 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -77.17 -32.08 3.32 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.691 2.261 . . . . 0.0 112.352 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -67.58 -9.58 44.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.886 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 906' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -101.56 11.78 38.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -72.95 -2.02 19.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.894 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -80.98 128.68 33.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.899 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 909' ' ' PHE . . . . . 0.59 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 87.5 m-85 -72.64 121.41 19.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.872 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 910' ' ' ASP . . . . . 0.447 ' H ' HD12 ' A' ' 913' ' ' LEU . 32.3 t70 -87.51 166.42 14.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.876 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -49.32 -44.83 44.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.855 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -62.96 -52.29 63.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.105 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 913' ' ' LEU . . . . . 0.754 HD21 ' HD2' ' A' ' 961' ' ' ARG . 50.3 mt -53.69 -49.31 68.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.921 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 47.3 mt -65.85 -61.62 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.14 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -42.77 -60.72 1.47 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.869 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -48.92 -52.62 23.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.909 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 917' ' ' LEU . . . . . 0.979 HD21 HD13 ' A' ' 963' ' ' ILE . 29.6 mt -47.81 -54.71 11.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 918' ' ' LEU . . . . . 0.472 ' CD2' HD11 ' A' ' 930' ' ' ILE . 87.4 mt -35.22 -59.12 0.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.905 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -54.79 -44.66 73.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.89 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 62.5 mm-40 -57.46 -41.08 79.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 921' ' ' PHE . . . . . 0.53 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 23.5 m-85 -70.05 -34.22 72.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -60.67 -34.39 74.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.089 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -47.12 -24.15 0.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 924' ' ' PHE . . . . . 0.52 ' N ' ' CD1' ' A' ' 924' ' ' PHE . 1.2 m-85 -125.7 -55.23 1.52 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.878 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -129.16 135.07 8.25 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.453 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -79.08 98.37 6.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.918 0.39 . . . . 0.0 110.914 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 42.2 t -51.63 151.46 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.132 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 928' ' ' ILE . . . . . 0.479 HG13 ' N ' ' A' ' 929' ' ' LEU . 20.1 pt -125.81 -45.43 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.1 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 929' ' ' LEU . . . . . 0.479 ' N ' HG13 ' A' ' 928' ' ' ILE . 11.2 tp -132.87 148.08 52.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 930' ' ' ILE . . . . . 0.618 HG12 HG13 ' A' ' 939' ' ' VAL . 74.5 mt -133.12 132.86 58.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.128 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -120.87 123.92 43.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.847 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -90.69 120.18 31.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.877 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 933' ' ' VAL . . . . . 0.624 HG21 ' NE1' ' A' ' 938' ' ' TRP . 2.6 t -90.48 157.13 2.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.086 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 934' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 933' ' ' VAL . 58.3 mt-10 -33.94 -51.6 0.41 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.908 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -125.19 -25.49 3.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.878 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 936' ' ' LYS . . . . . 0.4 ' O ' ' N ' ' A' ' 933' ' ' VAL . 12.0 tttt -98.27 172.98 7.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.881 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 937' ' ' MET . . . . . 0.59 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 13.5 ttt -135.33 110.65 9.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 938' ' ' TRP . . . . . 0.624 ' NE1' HG21 ' A' ' 933' ' ' VAL . 40.2 m0 -88.69 149.11 23.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.944 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 939' ' ' VAL . . . . . 0.618 HG13 HG12 ' A' ' 930' ' ' ILE . 12.1 t -139.12 129.36 32.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.128 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 17.3 m -93.73 151.15 19.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.151 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 941' ' ' PHE . . . . . 0.422 ' O ' ' C ' ' A' ' 942' ' ' LEU . 9.5 m-85 -130.56 139.82 50.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.917 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 942' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 941' ' ' PHE . 24.5 tp -35.14 -62.5 0.38 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.909 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -116.38 154.47 30.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.87 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -58.54 -50.01 71.23 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.442 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 12.6 t -48.21 -43.48 32.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.848 0.356 . . . . 0.0 110.857 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 14.6 m -55.77 -29.02 58.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.853 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 947' ' ' ALA . . . . . 0.492 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -81.44 -23.0 37.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.073 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 38.3 mt -79.68 -25.71 41.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -84.6 -51.44 6.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.873 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 950' ' ' VAL . . . . . 0.425 ' CG2' HD12 ' A' ' 953' ' ' LEU . 9.8 p -47.55 -21.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.163 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 951' ' ' LEU . . . . . 0.64 HD21 ' HG ' ' A' ' 967' ' ' LEU . 35.3 mt -49.52 -27.25 4.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.959 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 74.8 m -53.72 -15.29 1.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.903 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 953' ' ' LEU . . . . . 0.425 HD12 ' CG2' ' A' ' 950' ' ' VAL . 57.7 mt -90.36 16.51 8.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.926 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.95 120.01 14.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 955' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 956' ' ' LYS . . . 86.21 -25.94 6.62 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.493 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 956' ' ' LYS . . . . . 0.423 ' HE3' HD13 ' A' ' 958' ' ' LEU . 8.9 tmtm? -36.21 126.84 0.77 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.747 0.308 . . . . 0.0 110.857 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -94.72 125.59 39.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 958' ' ' LEU . . . . . 0.423 HD13 ' HE3' ' A' ' 956' ' ' LYS . 14.2 tp -138.35 153.69 48.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 913' ' ' LEU . 45.3 mt 41.79 48.39 3.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 960' ' ' ASN . . . . . 0.415 ' CG ' ' C ' ' A' ' 959' ' ' LEU . 0.7 OUTLIER 46.5 42.94 11.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 961' ' ' ARG . . . . . 0.754 ' HD2' HD21 ' A' ' 913' ' ' LEU . 45.8 mtt85 -149.69 105.27 3.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 7.4 m -59.49 122.16 13.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.111 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 963' ' ' ILE . . . . . 0.979 HD13 HD21 ' A' ' 917' ' ' LEU . 88.3 mt -106.69 142.35 19.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.152 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 6.5 m -126.48 116.41 21.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.135 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 965' ' ' ILE . . . . . . . . . . . . . 67.6 mt -98.03 139.28 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.179 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -148.7 128.09 13.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.07 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 967' ' ' LEU . . . . . 0.64 ' HG ' HD21 ' A' ' 951' ' ' LEU . 30.4 mt -66.51 157.46 32.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 968' ' ' LYS . . . . . 0.421 ' HD3' HD11 ' A' ' 896' ' ' LEU . 30.5 tptt -97.81 102.55 14.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 67.8 p -127.1 93.12 42.39 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.663 0.744 . . . . 0.0 110.842 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -44.12 -50.41 7.66 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.672 2.248 . . . . 0.0 112.344 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 3.3 t -71.29 124.28 24.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -124.9 95.31 0.48 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.478 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.31 137.07 18.52 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.668 2.245 . . . . 0.0 112.332 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 45.4 m -96.57 99.74 11.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 12.6 t -69.53 83.64 0.42 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.862 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.534 -179.992 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 73.7 m -100.31 -55.74 2.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.912 0.387 . . . . 0.0 110.872 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 25.9 p -86.55 124.07 32.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.813 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . 162.24 87.27 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.474 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 20.2 m -46.43 169.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.888 0.375 . . . . 0.0 110.802 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 17.0 t -70.55 121.93 18.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.822 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 137.84 131.19 2.89 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.488 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . -105.26 57.52 0.49 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.481 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 86.8 m -86.67 120.18 27.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.817 0.341 . . . . 0.0 111.174 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 895' ' ' VAL . . . . . 0.451 HG12 HD23 ' A' ' 967' ' ' LEU . 27.5 m -120.19 139.28 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.143 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . 0.463 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 6.4 mp -89.18 138.97 30.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.415 HG13 ' CG2' ' A' ' 963' ' ' ILE . 63.8 t -139.71 122.61 17.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.138 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 16.5 t -125.66 155.5 40.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.902 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.565 HG22 HG12 ' A' ' 963' ' ' ILE . 2.3 pt -121.1 129.31 75.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.128 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 48.9 mttp -69.71 110.72 5.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 901' ' ' SER . . . . . . . . . . . . . 11.7 p -131.98 151.53 51.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.838 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 31.3 t -92.94 -43.93 8.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.839 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 9.8 mt -84.4 150.88 58.25 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.588 0.709 . . . . 0.0 110.944 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.78 -16.99 18.24 Favored 'Trans proline' 0 N--CA 1.466 -0.133 0 C-N-CA 122.714 2.276 . . . . 0.0 112.359 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -97.23 25.13 5.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.927 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 906' ' ' ASN . . . . . 0.402 ' C ' ' N ' ' A' ' 908' ' ' PHE . 95.2 m-20 -129.99 -32.63 1.83 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.885 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -42.63 -25.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.862 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 908' ' ' PHE . . . . . 0.402 ' N ' ' C ' ' A' ' 906' ' ' ASN . 24.1 m-85 -76.04 145.62 40.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 909' ' ' PHE . . . . . 0.527 ' CE2' HG12 ' A' ' 899' ' ' ILE . 27.1 m-85 -89.73 121.91 32.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.893 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 910' ' ' ASP . . . . . 0.46 ' H ' HD12 ' A' ' 913' ' ' LEU . 3.0 m-20 -86.18 177.31 7.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.871 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -55.17 -42.96 73.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.859 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -63.96 -47.24 81.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.076 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 913' ' ' LEU . . . . . 0.926 HD21 ' HD2' ' A' ' 961' ' ' ARG . 52.1 mt -61.01 -48.95 79.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.926 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 49.6 mt -65.81 -59.95 3.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.14 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -45.28 -58.01 3.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.902 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -50.84 -52.53 40.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.891 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 917' ' ' LEU . . . . . 0.909 HD21 HD13 ' A' ' 963' ' ' ILE . 29.6 mt -46.4 -54.01 9.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.909 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 918' ' ' LEU . . . . . 0.414 ' C ' ' O ' ' A' ' 917' ' ' LEU . 20.6 mt -36.63 -64.42 0.34 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.939 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -50.14 -51.92 39.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.912 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -50.47 -40.97 52.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 921' ' ' PHE . . . . . 0.579 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 24.1 m-85 -69.74 -48.18 60.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.855 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -48.19 -28.31 2.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.108 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 923' ' ' SER . . . . . 0.554 ' HB3' ' CD1' ' A' ' 924' ' ' PHE . 16.7 t -47.49 -29.66 2.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.897 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 924' ' ' PHE . . . . . 0.554 ' CD1' ' HB3' ' A' ' 923' ' ' SER . 1.0 OUTLIER -123.02 -64.43 1.18 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.856 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -115.74 155.29 16.37 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.51 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -91.96 138.44 31.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.885 0.374 . . . . 0.0 110.909 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 55.9 t -93.07 146.16 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.114 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 928' ' ' ILE . . . . . 0.491 HG13 ' N ' ' A' ' 929' ' ' LEU . 30.2 pt -123.32 -42.86 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.107 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 929' ' ' LEU . . . . . 0.491 ' N ' HG13 ' A' ' 928' ' ' ILE . 15.0 tp -138.76 141.81 38.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 94.3 mt -127.36 125.47 65.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.154 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -113.44 122.82 48.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -90.6 122.14 33.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.928 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 933' ' ' VAL . . . . . 0.569 HG21 ' NE1' ' A' ' 938' ' ' TRP . 2.9 t -89.9 157.09 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.158 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 934' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 933' ' ' VAL . 61.8 mt-10 -34.11 -50.53 0.4 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.891 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -126.05 -26.73 3.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.823 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 936' ' ' LYS . . . . . 0.417 ' HB2' ' NZ ' ' A' ' 936' ' ' LYS . 0.7 OUTLIER -96.53 172.73 7.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.933 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 937' ' ' MET . . . . . 0.507 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 14.5 ttt -135.26 111.78 9.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.863 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 938' ' ' TRP . . . . . 0.569 ' NE1' HG21 ' A' ' 933' ' ' VAL . 37.0 m0 -92.47 146.33 23.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 939' ' ' VAL . . . . . 0.41 HG12 ' CE1' ' A' ' 941' ' ' PHE . 65.0 t -132.62 121.27 44.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.132 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 18.9 m -85.18 152.59 23.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.156 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 941' ' ' PHE . . . . . 0.41 ' CE1' HG12 ' A' ' 939' ' ' VAL . 12.0 m-85 -133.74 141.84 47.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 19.7 tp -42.55 -47.97 5.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.899 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -120.63 176.13 5.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -89.74 -39.2 6.28 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.519 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 36.0 p -59.54 -41.23 89.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.921 0.391 . . . . 0.0 110.861 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 80.0 p -56.38 -34.45 66.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.881 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -70.81 -15.18 62.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.103 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 25.5 mt -84.01 -31.53 25.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -75.67 -49.31 18.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.842 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 8.5 p -53.35 -17.31 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.143 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 951' ' ' LEU . . . . . 0.472 HD21 ' HG ' ' A' ' 967' ' ' LEU . 52.3 mt -52.98 -24.96 10.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 35.9 p -55.88 -22.92 28.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 76.7 mt -83.25 17.9 1.92 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -72.63 110.35 6.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 96.02 -26.42 20.89 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.481 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -38.33 127.46 1.39 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.732 0.301 . . . . 0.0 110.897 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -94.9 128.42 41.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.901 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 958' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 961' ' ' ARG . 13.7 tp -136.97 160.04 40.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.926 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . 0.406 ' C ' ' O ' ' A' ' 958' ' ' LEU . 43.5 mt 37.7 43.07 0.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.967 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 55.44 43.31 28.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.871 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 961' ' ' ARG . . . . . 0.926 ' HD2' HD21 ' A' ' 913' ' ' LEU . 69.2 mtt-85 -149.71 122.89 8.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.844 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 6.0 m -75.05 112.72 11.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.119 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 963' ' ' ILE . . . . . 0.909 HD13 HD21 ' A' ' 917' ' ' LEU . 82.8 mt -98.02 138.17 23.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.088 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 9.3 m -122.13 113.25 19.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.109 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 965' ' ' ILE . . . . . 0.409 HG12 HG22 ' A' ' 897' ' ' VAL . 55.3 mt -98.75 135.07 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.113 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -149.27 136.63 20.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.095 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 967' ' ' LEU . . . . . 0.472 ' HG ' HD21 ' A' ' 951' ' ' LEU . 30.7 mt -65.44 156.58 31.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.895 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 968' ' ' LYS . . . . . 0.418 ' HE3' ' CH2' ' A' ' 938' ' ' TRP . 21.5 tttt -96.2 144.04 26.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 94.1 p -69.61 144.42 93.97 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.666 0.746 . . . . 0.0 110.886 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -78.02 171.27 17.46 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.751 2.301 . . . . 0.0 112.327 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 32.8 p -121.62 -58.57 1.75 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.916 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . 128.81 167.72 12.23 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.481 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.45 161.53 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.739 2.293 . . . . 0.0 112.326 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 36.7 t -134.21 140.67 46.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.873 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 43.2 m -128.59 127.44 42.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.837 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.449 179.973 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.446 -0.262 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 2.2 m -103.78 88.33 3.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.844 0.354 . . . . 0.0 110.872 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 15.0 m -105.52 154.36 20.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.831 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . 70.76 158.86 2.8 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.507 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 4.8 m -74.12 148.94 41.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.926 0.394 . . . . 0.0 110.822 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 77.5 p -137.42 157.16 47.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.832 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -60.88 -167.59 0.39 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.503 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . -141.51 42.95 1.12 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.474 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 84.8 m -127.23 122.47 34.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.823 0.344 . . . . 0.0 111.136 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 895' ' ' VAL . . . . . 0.712 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 11.3 m -114.25 147.19 17.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.117 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . 0.46 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 3.5 mp -96.17 144.26 26.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.937 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.418 HG22 HG12 ' A' ' 965' ' ' ILE . 59.2 t -143.72 131.88 18.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.137 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 14.2 t -134.14 160.23 38.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.82 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.42 HG22 HG12 ' A' ' 963' ' ' ILE . 4.1 pt -121.62 162.19 21.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.162 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 900' ' ' LYS . . . . . 0.452 ' CD ' ' HB ' ' A' ' 962' ' ' THR . 31.6 mtpt -99.33 105.45 17.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 901' ' ' SER . . . . . . . . . . . . . 10.7 m -137.88 136.22 36.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.826 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 37.3 m -80.19 -61.05 2.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 17.1 mt -58.49 147.9 67.35 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.638 0.732 . . . . 0.0 110.915 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.59 -13.14 18.31 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.669 2.246 . . . . 0.0 112.346 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -99.97 20.37 14.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.885 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 906' ' ' ASN . . . . . 0.492 ' O ' ' N ' ' A' ' 908' ' ' PHE . 41.4 m-20 -123.6 -37.84 2.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.917 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -38.02 -27.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.857 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 908' ' ' PHE . . . . . 0.492 ' N ' ' O ' ' A' ' 906' ' ' ASN . 38.4 m-85 -65.35 153.35 41.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 909' ' ' PHE . . . . . 0.567 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 90.0 m-85 -95.55 107.67 19.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.841 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 910' ' ' ASP . . . . . 0.663 ' H ' HD12 ' A' ' 913' ' ' LEU . 7.4 t70 -72.44 163.61 27.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.842 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -51.47 -35.95 42.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.831 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -70.49 -50.95 32.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.091 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 913' ' ' LEU . . . . . 0.849 HD21 ' HD2' ' A' ' 961' ' ' ARG . 87.4 mt -54.8 -35.43 63.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 91.2 mt -79.28 -65.0 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.14 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -39.69 -55.97 1.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.919 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 916' ' ' GLU . . . . . 0.535 ' HB3' HD21 ' A' ' 958' ' ' LEU . 69.0 mm-40 -51.95 -48.46 64.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 917' ' ' LEU . . . . . 1.008 HD21 HD13 ' A' ' 963' ' ' ILE . 28.8 mt -55.06 -47.49 74.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 918' ' ' LEU . . . . . . . . . . . . . 44.6 mt -43.29 -55.58 3.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -58.63 -38.65 78.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 39.4 mm-40 -64.31 -35.83 82.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.888 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 921' ' ' PHE . . . . . 0.557 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 19.4 m-85 -76.03 -33.01 59.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -58.24 -31.92 67.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.104 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 923' ' ' SER . . . . . 0.478 ' OG ' ' CE2' ' A' ' 924' ' ' PHE . 31.9 p -56.93 -13.51 2.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.855 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 924' ' ' PHE . . . . . 0.478 ' CE2' ' OG ' ' A' ' 923' ' ' SER . 74.5 m-85 -125.97 -57.33 1.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.86 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -137.17 140.14 11.14 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.462 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -74.96 98.85 3.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.896 0.379 . . . . 0.0 110.871 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 58.0 t -50.29 145.16 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.146 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 928' ' ' ILE . . . . . 0.571 HD13 ' HA ' ' A' ' 942' ' ' LEU . 20.0 pt -120.28 -45.38 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.138 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 929' ' ' LEU . . . . . 0.479 ' N ' HG13 ' A' ' 928' ' ' ILE . 11.2 tp -137.78 151.85 48.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.914 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 40.7 mt -135.97 129.85 48.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.113 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 21.4 ttt-85 -116.56 123.8 48.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -91.58 123.85 35.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.885 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 933' ' ' VAL . . . . . 0.759 HG21 ' NE1' ' A' ' 938' ' ' TRP . 3.6 t -90.78 156.97 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.17 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 934' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 933' ' ' VAL . 61.2 mm-40 -34.37 -51.32 0.45 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.1 -25.46 3.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.803 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.03 173.02 7.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 937' ' ' MET . . . . . 0.567 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 15.1 ttt -134.19 113.51 12.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.877 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 938' ' ' TRP . . . . . 0.759 ' NE1' HG21 ' A' ' 933' ' ' VAL . 37.1 m0 -93.89 151.89 19.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.889 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 939' ' ' VAL . . . . . 0.437 HG12 ' CE1' ' A' ' 941' ' ' PHE . 39.8 t -134.86 139.19 47.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.161 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 940' ' ' THR . . . . . 0.421 HG22 HD11 ' A' ' 928' ' ' ILE . 29.2 m -110.66 146.8 35.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.15 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 941' ' ' PHE . . . . . 0.437 ' CE1' HG12 ' A' ' 939' ' ' VAL . 9.7 m-85 -130.21 149.84 51.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.884 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 942' ' ' LEU . . . . . 0.571 ' HA ' HD13 ' A' ' 928' ' ' ILE . 21.2 tp -40.25 -63.63 0.6 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.902 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -107.43 168.48 9.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.91 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -76.42 -49.8 7.91 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.482 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 6.6 p -49.41 -27.25 3.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.921 0.391 . . . . 0.0 110.883 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 70.5 m -63.22 -47.59 81.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.864 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 947' ' ' ALA . . . . . 0.712 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -60.28 -27.88 67.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.107 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 18.3 mt -73.66 -25.12 60.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.933 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -81.8 -45.05 16.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.919 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 950' ' ' VAL . . . . . 0.508 HG12 ' O ' ' A' ' 947' ' ' ALA . 3.2 p -57.83 -18.8 10.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.13 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 951' ' ' LEU . . . . . 0.483 HD21 ' HG ' ' A' ' 967' ' ' LEU . 23.0 mt -51.77 -31.42 26.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.962 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 6.4 t -51.52 -17.19 0.74 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.837 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 39.8 mt -87.85 13.76 10.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.888 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -66.28 117.22 8.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 90.88 -26.7 10.29 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.5 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -41.43 128.54 3.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.794 0.331 . . . . 0.0 110.881 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -97.78 130.43 44.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.857 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 958' ' ' LEU . . . . . 0.535 HD21 ' HB3' ' A' ' 916' ' ' GLU . 15.3 tp -134.74 156.21 49.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.935 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . 0.427 HD11 ' HG3' ' A' ' 916' ' ' GLU . 47.0 mt 38.83 46.02 1.01 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.922 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 51.88 45.32 28.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.847 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 961' ' ' ARG . . . . . 0.849 ' HD2' HD21 ' A' ' 913' ' ' LEU . 52.0 mtt85 -151.65 105.42 3.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.925 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 962' ' ' THR . . . . . 0.452 ' HB ' ' CD ' ' A' ' 900' ' ' LYS . 18.7 m -57.75 117.49 4.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.152 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 963' ' ' ILE . . . . . 1.008 HD13 HD21 ' A' ' 917' ' ' LEU . 97.4 mt -101.14 139.03 23.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 4.2 m -123.66 116.06 22.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.177 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 965' ' ' ILE . . . . . 0.418 HG12 HG22 ' A' ' 897' ' ' VAL . 55.2 mt -101.1 139.94 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.159 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -152.03 131.25 12.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.142 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 967' ' ' LEU . . . . . 0.54 HD23 HG12 ' A' ' 895' ' ' VAL . 33.7 mt -64.55 157.87 25.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.939 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -83.75 -69.95 0.6 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 86.1 p -159.84 145.16 11.44 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.615 0.721 . . . . 0.0 110.879 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -77.64 13.13 1.72 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.682 2.254 . . . . 0.0 112.373 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 7.6 m -151.7 125.47 9.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.825 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . 147.16 73.72 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.459 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -46.38 -41.27 22.87 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.653 2.236 . . . . 0.0 112.358 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 2.0 m 53.68 32.56 14.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 16.3 p -83.59 170.72 14.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.852 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.531 -179.929 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 1.6 t -81.39 137.2 35.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.894 0.378 . . . . 0.0 110.822 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 79.7 p -64.02 -10.23 20.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.838 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . 109.77 102.82 2.75 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.53 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 13.5 t -75.76 131.29 39.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.826 0.346 . . . . 0.0 110.9 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 14.5 t -98.78 108.43 21.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.865 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -163.34 -91.82 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.483 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . 81.7 -38.06 2.49 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.485 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 33.9 m -84.75 119.73 25.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.798 0.332 . . . . 0.0 111.19 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 895' ' ' VAL . . . . . 0.766 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 13.9 m -116.31 139.76 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.152 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . 0.47 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 3.2 mp -89.53 150.82 22.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.891 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 64.3 t -144.95 131.66 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.178 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 5.2 t -133.53 154.71 50.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.53 HG23 ' CE2' ' A' ' 909' ' ' PHE . 4.1 pt -119.91 164.17 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.111 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 5.9 tptp -100.06 103.68 15.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 901' ' ' SER . . . . . . . . . . . . . 73.1 m -140.1 134.4 31.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.861 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 63.2 m -74.33 -66.04 0.78 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.87 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 28.0 mt -52.16 144.15 22.56 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.633 0.73 . . . . 0.0 110.921 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.29 -11.16 19.23 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.717 2.278 . . . . 0.0 112.33 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -98.87 0.94 45.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.89 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 906' ' ' ASN . . . . . 0.531 ' N ' HD22 ' A' ' 906' ' ' ASN . 1.2 m-80 -104.49 -32.59 8.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.899 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -38.97 -26.4 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 908' ' ' PHE . . . . . 0.485 ' N ' ' O ' ' A' ' 906' ' ' ASN . 51.2 m-85 -71.98 136.84 46.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 909' ' ' PHE . . . . . 0.563 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 50.6 m-85 -75.3 133.88 41.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.88 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -96.91 169.1 10.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -48.12 -38.55 18.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.878 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -67.59 -54.24 21.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.064 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 913' ' ' LEU . . . . . 0.571 ' O ' HD12 ' A' ' 917' ' ' LEU . 36.7 mt -52.92 -42.01 64.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.908 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 60.7 mt -74.08 -64.91 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.11 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -40.02 -61.55 0.85 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 916' ' ' GLU . . . . . 0.573 ' HG3' HD11 ' A' ' 959' ' ' LEU . 74.9 mm-40 -48.89 -55.52 11.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.904 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 917' ' ' LEU . . . . . 0.803 HD21 HD13 ' A' ' 963' ' ' ILE . 24.9 mt -46.5 -54.15 9.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 918' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 917' ' ' LEU . 89.4 mt -36.81 -59.39 0.69 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -55.35 -48.69 73.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -53.16 -41.3 65.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.938 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 921' ' ' PHE . . . . . 0.557 ' CZ ' ' HB3' ' A' ' 917' ' ' LEU . 19.8 m-85 -64.72 -45.0 88.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.925 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -54.03 -30.99 49.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.102 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 29.7 t -45.54 -30.98 1.62 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 924' ' ' PHE . . . . . 0.532 ' N ' ' CD1' ' A' ' 924' ' ' PHE . 1.0 OUTLIER -120.73 -57.63 1.88 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -127.03 152.22 18.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.512 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -87.62 135.51 33.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.855 0.36 . . . . 0.0 110.889 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 46.7 t -87.7 145.93 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.113 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 928' ' ' ILE . . . . . 0.449 HG13 ' N ' ' A' ' 929' ' ' LEU . 26.6 pt -120.65 -41.56 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.093 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 929' ' ' LEU . . . . . 0.449 ' N ' HG13 ' A' ' 928' ' ' ILE . 21.9 tp -141.06 149.05 41.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.95 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 58.4 mt -133.24 132.54 58.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.144 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -118.39 130.58 56.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -97.59 120.78 38.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.851 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 933' ' ' VAL . . . . . 0.57 HG21 ' NE1' ' A' ' 938' ' ' TRP . 2.8 t -91.58 157.12 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.109 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 934' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 933' ' ' VAL . 44.3 mt-10 -33.56 -54.01 0.43 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.905 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -124.5 -22.42 4.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.817 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 6.3 ttmt -99.59 173.14 6.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.868 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 937' ' ' MET . . . . . 0.563 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 17.3 ttt -136.14 114.31 11.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 938' ' ' TRP . . . . . 0.57 ' NE1' HG21 ' A' ' 933' ' ' VAL . 37.8 m0 -94.72 143.9 26.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.96 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 47.9 t -130.78 137.82 55.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.16 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 19.4 m -106.85 144.36 33.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.18 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 941' ' ' PHE . . . . . 0.444 ' O ' ' C ' ' A' ' 942' ' ' LEU . 6.0 m-85 -125.38 144.22 50.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.909 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 942' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 941' ' ' PHE . 43.1 tp -34.33 -67.84 0.13 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.925 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -104.44 171.81 7.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.903 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -76.02 -49.6 8.48 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.499 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 945' ' ' SER . . . . . 0.428 ' HA ' HD12 ' A' ' 948' ' ' LEU . 95.6 p -50.44 -25.93 4.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.865 0.364 . . . . 0.0 110.869 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 60.7 m -65.63 -42.59 91.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.793 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 947' ' ' ALA . . . . . 0.766 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -68.62 -16.29 63.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.091 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 948' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 945' ' ' SER . 13.6 mt -87.86 -24.18 23.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.948 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -81.71 -51.05 8.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.944 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 950' ' ' VAL . . . . . 0.467 ' CG2' HD12 ' A' ' 953' ' ' LEU . 9.8 p -52.02 -20.11 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.135 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 951' ' ' LEU . . . . . 0.593 HD21 ' HG ' ' A' ' 967' ' ' LEU . 73.0 mt -50.72 -20.73 1.33 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.91 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 26.1 m -61.88 -9.43 6.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.822 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 953' ' ' LEU . . . . . 0.467 HD12 ' CG2' ' A' ' 950' ' ' VAL . 58.8 mt -95.76 11.55 33.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.926 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -67.16 117.43 9.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 90.28 -23.06 23.47 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.517 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.05 127.14 8.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.731 0.3 . . . . 0.0 110.915 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -93.06 123.06 36.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 14.9 tp -129.35 154.94 46.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.948 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . 0.573 HD11 ' HG3' ' A' ' 916' ' ' GLU . 39.0 mt 39.23 46.29 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.906 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 50.95 46.06 26.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.86 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 961' ' ' ARG . . . . . . . . . . . . . 41.4 mtt85 -152.02 106.47 3.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.929 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 7.7 m -60.16 111.18 1.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.141 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 963' ' ' ILE . . . . . 0.803 HD13 HD21 ' A' ' 917' ' ' LEU . 79.7 mt -95.78 146.32 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.152 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 5.4 m -129.43 118.23 21.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.131 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 965' ' ' ILE . . . . . . . . . . . . . 60.8 mt -105.11 141.28 20.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.086 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -151.59 135.69 16.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.064 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 967' ' ' LEU . . . . . 0.593 ' HG ' HD21 ' A' ' 951' ' ' LEU . 31.5 mt -68.22 158.13 33.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.917 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 968' ' ' LYS . . . . . 0.435 ' HG3' ' N ' ' A' ' 969' ' ' SER . 11.3 tptt -96.56 153.5 17.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 969' ' ' SER . . . . . 0.435 ' N ' ' HG3' ' A' ' 968' ' ' LYS . 44.9 p -129.89 92.78 36.0 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.664 0.745 . . . . 0.0 110.908 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.17 92.36 1.0 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.687 2.258 . . . . 0.0 112.388 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 53.2 p -55.97 155.83 5.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.869 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . 119.91 -95.38 0.59 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.446 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -78.49 131.94 10.81 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.684 2.256 . . . . 0.0 112.358 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 46.0 p -70.79 -49.85 42.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.869 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 1.8 m -85.68 -61.0 1.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.836 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.515 -179.956 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 25.3 p -131.93 105.18 7.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.838 0.352 . . . . 0.0 110.871 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 93.8 p -79.48 102.91 9.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.891 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . -151.93 -162.57 10.9 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.49 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 32.2 p -101.53 -45.2 5.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.88 0.371 . . . . 0.0 110.828 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 3.3 m -74.15 140.84 45.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 80.37 85.16 0.65 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.468 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . -138.26 38.66 1.67 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.441 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 90.3 m -88.05 128.8 35.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.794 0.33 . . . . 0.0 111.131 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 895' ' ' VAL . . . . . 0.539 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 23.7 m -121.0 138.86 50.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.138 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . 0.46 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 4.1 mp -89.71 146.4 24.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 70.2 t -144.83 125.32 7.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.098 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 10.6 t -128.07 154.13 46.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.848 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.663 HG22 HG12 ' A' ' 963' ' ' ILE . 3.6 pt -122.34 144.98 29.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -98.77 110.22 22.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 901' ' ' SER . . . . . . . . . . . . . 1.7 t -123.1 136.19 54.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.817 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 5.6 m -42.07 -47.85 4.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.829 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 14.8 mt -98.87 150.0 36.27 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.604 0.716 . . . . 0.0 110.96 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.72 -30.87 4.48 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.722 2.281 . . . . 0.0 112.343 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -70.45 -11.49 60.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 906' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -101.72 13.15 35.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.845 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -75.98 0.49 18.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.908 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -87.77 122.51 31.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.922 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 909' ' ' PHE . . . . . 0.583 ' CE2' HG23 ' A' ' 899' ' ' ILE . 91.6 m-85 -63.08 128.25 34.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.914 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.29 179.41 5.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -57.3 -45.43 84.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -57.66 -57.69 11.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.108 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 913' ' ' LEU . . . . . 0.525 HD21 ' HD2' ' A' ' 961' ' ' ARG . 87.4 mt -49.48 -55.24 13.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.965 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 49.6 mt -60.64 -63.49 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.096 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -41.12 -59.45 1.49 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -53.84 -48.94 69.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.866 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 917' ' ' LEU . . . . . 0.809 HD21 HD13 ' A' ' 963' ' ' ILE . 27.5 mt -50.97 -58.67 5.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.887 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 918' ' ' LEU . . . . . 0.469 ' CD2' HD11 ' A' ' 930' ' ' ILE . 73.0 mt -34.44 -48.16 0.34 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.915 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -63.77 -45.98 87.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.891 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 920' ' ' GLN . . . . . 0.454 ' N ' ' O ' ' A' ' 917' ' ' LEU . 15.2 mm-40 -58.1 -35.04 70.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.914 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 921' ' ' PHE . . . . . 0.553 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 17.6 m-85 -75.2 -37.7 61.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -57.76 -32.62 67.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.114 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -50.82 -23.3 2.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 924' ' ' PHE . . . . . 0.58 ' N ' ' CD1' ' A' ' 924' ' ' PHE . 0.4 OUTLIER -125.13 -58.29 1.46 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.909 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -129.33 150.53 18.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.432 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -88.99 132.37 34.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.885 0.374 . . . . 0.0 110.86 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 22.9 t -84.58 147.33 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.19 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 928' ' ' ILE . . . . . 0.463 HG13 ' N ' ' A' ' 929' ' ' LEU . 41.6 pt -123.38 -38.19 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.158 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 929' ' ' LEU . . . . . 0.463 ' N ' HG13 ' A' ' 928' ' ' ILE . 12.0 tp -141.78 147.86 37.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 930' ' ' ILE . . . . . 0.469 HD11 ' CD2' ' A' ' 918' ' ' LEU . 79.4 mt -133.42 124.55 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.119 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -111.68 125.8 54.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -91.98 123.89 35.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.846 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 933' ' ' VAL . . . . . 0.741 HG21 ' CD1' ' A' ' 938' ' ' TRP . 3.1 t -92.07 157.02 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.078 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 934' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 933' ' ' VAL . 15.8 mt-10 -34.35 -52.37 0.48 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -125.08 -25.47 3.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.825 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.02 173.04 7.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.914 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 937' ' ' MET . . . . . 0.548 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 15.1 ttt -132.51 108.35 9.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 938' ' ' TRP . . . . . 0.741 ' CD1' HG21 ' A' ' 933' ' ' VAL . 38.1 m0 -90.26 144.89 25.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.961 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 61.1 t -131.76 133.56 61.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.131 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 940' ' ' THR . . . . . 0.462 HG22 ' N ' ' A' ' 941' ' ' PHE . 51.6 m -96.81 156.31 16.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.138 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 941' ' ' PHE . . . . . 0.462 ' N ' HG22 ' A' ' 940' ' ' THR . 15.1 m-85 -137.93 144.39 41.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.879 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 29.9 tp -47.04 -44.57 20.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.949 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -123.44 170.39 10.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.921 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -86.34 -41.15 7.08 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.465 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 38.6 p -54.66 -35.21 63.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.839 0.352 . . . . 0.0 110.86 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.76 -40.95 98.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.841 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 947' ' ' ALA . . . . . 0.539 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -64.44 -19.09 65.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.097 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 23.9 mt -83.45 -27.41 29.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -81.82 -51.26 8.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.921 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 7.0 p -48.02 -21.5 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.096 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 951' ' ' LEU . . . . . 0.604 HD21 ' HG ' ' A' ' 967' ' ' LEU . 34.1 mt -49.11 -28.44 4.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.918 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 1.1 t -50.9 -17.54 0.59 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 46.6 mt -90.39 17.32 7.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.895 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -70.87 110.79 5.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.884 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 93.66 -25.14 22.64 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.493 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -39.38 127.23 1.82 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.705 0.288 . . . . 0.0 110.865 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -94.24 125.08 38.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.87 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 958' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 959' ' ' LEU . 14.9 tp -135.41 158.65 43.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.882 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 958' ' ' LEU . 51.8 mt 38.23 44.24 0.67 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.927 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 51.56 44.39 29.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 961' ' ' ARG . . . . . 0.525 ' HD2' HD21 ' A' ' 913' ' ' LEU . 34.1 mtt85 -151.45 108.69 3.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 8.6 m -62.14 118.24 7.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.132 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 963' ' ' ILE . . . . . 0.809 HD13 HD21 ' A' ' 917' ' ' LEU . 92.0 mt -103.7 137.63 31.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.136 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 7.0 m -121.47 112.78 18.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.184 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 965' ' ' ILE . . . . . . . . . . . . . 61.8 mt -97.42 139.98 18.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.105 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -149.01 138.36 21.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.098 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 967' ' ' LEU . . . . . 0.604 ' HG ' HD21 ' A' ' 951' ' ' LEU . 39.0 mt -75.84 156.07 34.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.897 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -90.24 155.77 18.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.912 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 18.2 t -116.74 92.86 39.44 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.675 0.75 . . . . 0.0 110.893 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -44.54 149.17 1.09 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.705 2.27 . . . . 0.0 112.316 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 14.6 t -124.99 154.5 41.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . 113.07 95.68 2.2 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.504 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.91 93.19 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.65 2.233 . . . . 0.0 112.379 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 29.1 t -168.88 149.21 4.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.846 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 8.1 t -122.23 -48.91 2.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.89 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.475 -179.985 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 112.418 -0.273 . . . . 0.0 112.418 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 89.0 p -102.0 -5.06 25.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.905 0.383 . . . . 0.0 110.852 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 36.8 p -95.02 174.03 7.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.882 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . -61.2 -171.91 0.91 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.492 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 29.6 t -136.1 154.24 51.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.84 0.352 . . . . 0.0 110.86 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 59.9 p -148.63 152.28 36.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.86 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 41.07 -157.72 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.486 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . -161.67 37.4 0.39 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.474 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 54.1 m -98.27 121.57 40.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.786 0.327 . . . . 0.0 111.149 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 895' ' ' VAL . . . . . 0.562 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 21.4 m -119.09 141.33 39.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.13 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . 0.46 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 4.5 mp -90.23 142.25 27.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.419 HG22 HG12 ' A' ' 965' ' ' ILE . 96.6 t -141.83 129.54 21.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.114 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 4.4 t -131.49 160.11 36.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.842 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.434 HG12 ' CE1' ' A' ' 909' ' ' PHE . 2.0 pt -123.21 115.03 44.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.149 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 8.9 tttp -96.63 122.64 39.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 901' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 902' ' ' SER . 1.4 t -126.94 163.54 23.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.857 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 902' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 901' ' ' SER . 47.4 m -36.18 -63.61 0.37 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.863 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 42.6 mt -98.57 157.48 34.21 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.539 0.685 . . . . 0.0 110.928 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -77.13 -25.12 8.97 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.65 2.234 . . . . 0.0 112.332 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -75.49 5.07 6.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 906' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -116.75 14.8 15.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.897 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -83.92 37.5 0.6 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.902 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -99.75 144.76 28.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 909' ' ' PHE . . . . . 0.566 ' CE2' ' HB2' ' A' ' 937' ' ' MET . 47.2 m-85 -91.58 95.66 10.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.889 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 910' ' ' ASP . . . . . 0.716 ' H ' HD12 ' A' ' 913' ' ' LEU . 24.2 m-20 -73.89 161.85 29.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.857 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -49.35 -50.97 37.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.865 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -54.78 -50.58 68.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.13 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 913' ' ' LEU . . . . . 0.716 HD12 ' H ' ' A' ' 910' ' ' ASP . 20.1 mt -51.72 -52.3 49.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 54.2 mt -60.73 -57.99 9.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.147 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -49.49 -64.0 0.94 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.893 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 916' ' ' GLU . . . . . 0.777 ' HG3' HD11 ' A' ' 959' ' ' LEU . 5.2 mm-40 -44.9 -50.45 10.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.892 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 917' ' ' LEU . . . . . 1.022 HD21 HD13 ' A' ' 963' ' ' ILE . 28.4 mt -48.37 -55.1 11.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 918' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 917' ' ' LEU . 58.4 mt -36.47 -62.98 0.43 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.941 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -54.0 -44.8 71.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -56.5 -37.39 70.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.883 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 921' ' ' PHE . . . . . 0.509 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 24.2 m-85 -73.74 -39.22 64.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.857 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -53.79 -28.07 32.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 923' ' ' SER . . . . . 0.502 ' HB3' ' CE1' ' A' ' 924' ' ' PHE . 40.9 t -46.14 -30.84 2.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.834 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 924' ' ' PHE . . . . . 0.56 ' N ' ' CD1' ' A' ' 924' ' ' PHE . 0.3 OUTLIER -122.66 -65.09 1.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.873 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -111.67 144.96 17.7 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.462 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -87.47 96.52 10.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.874 0.369 . . . . 0.0 110.89 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 44.4 t -53.02 144.08 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.131 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 928' ' ' ILE . . . . . 0.47 HG13 ' N ' ' A' ' 929' ' ' LEU . 15.2 pt -121.92 -46.79 2.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.102 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 929' ' ' LEU . . . . . 0.47 ' N ' HG13 ' A' ' 928' ' ' ILE . 17.3 tp -131.08 149.73 52.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 45.2 mt -135.13 136.1 51.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.176 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -119.8 121.43 39.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.882 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -87.43 116.85 25.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 933' ' ' VAL . . . . . 0.775 HG21 ' NE1' ' A' ' 938' ' ' TRP . 2.9 t -85.54 156.01 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.126 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 934' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 933' ' ' VAL . 31.1 mt-10 -34.21 -51.36 0.44 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -124.15 -27.14 3.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.877 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -96.01 173.06 7.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 937' ' ' MET . . . . . 0.566 ' HB2' ' CE2' ' A' ' 909' ' ' PHE . 17.7 ttt -135.01 106.69 6.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 938' ' ' TRP . . . . . 0.775 ' NE1' HG21 ' A' ' 933' ' ' VAL . 33.3 m0 -85.92 153.6 22.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.924 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 939' ' ' VAL . . . . . 0.442 ' O ' HG22 ' A' ' 895' ' ' VAL . 87.4 t -139.74 128.25 26.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.139 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 27.0 m -90.95 151.51 21.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.128 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 941' ' ' PHE . . . . . 0.438 ' O ' ' C ' ' A' ' 942' ' ' LEU . 11.6 m-85 -132.68 141.84 48.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.857 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 942' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 941' ' ' PHE . 19.6 tp -34.41 -64.59 0.24 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.89 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -117.82 150.96 38.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.874 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -53.43 -45.95 65.4 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.458 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 14.6 t -50.77 -41.05 56.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.845 0.355 . . . . 0.0 110.832 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 9.2 m -58.77 -26.29 63.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.836 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 947' ' ' ALA . . . . . 0.562 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -81.58 -13.11 58.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.127 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 33.6 mt -88.06 -28.08 21.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.953 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 33.0 m-20 -82.88 -45.37 14.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 8.7 p -53.47 -22.79 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.174 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 951' ' ' LEU . . . . . 0.481 HD21 ' HG ' ' A' ' 967' ' ' LEU . 63.1 mt -50.95 -25.54 4.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.886 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 15.3 m -54.4 -16.65 2.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.849 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 23.4 mt -89.61 16.02 8.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.912 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -68.44 119.96 13.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.937 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 955' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 956' ' ' LYS . . . 88.11 -30.79 4.98 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.524 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 956' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 955' ' ' GLY . 8.6 tmtm? -35.38 127.87 0.58 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.693 0.282 . . . . 0.0 110.911 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -96.41 131.8 42.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.835 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 13.5 tp -138.1 154.56 49.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . 0.777 HD11 ' HG3' ' A' ' 916' ' ' GLU . 87.6 mt 39.53 45.39 1.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.938 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 55.96 46.36 22.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 961' ' ' ARG . . . . . . . . . . . . . 46.3 mtt85 -154.64 121.86 5.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.884 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 8.3 m -74.08 108.39 6.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.124 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 963' ' ' ILE . . . . . 1.022 HD13 HD21 ' A' ' 917' ' ' LEU . 90.1 mt -88.95 130.94 37.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.177 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 9.2 m -116.45 119.38 35.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.1 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 965' ' ' ILE . . . . . 0.419 HG12 HG22 ' A' ' 897' ' ' VAL . 59.3 mt -103.36 140.31 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.124 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -149.47 136.06 19.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.082 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 967' ' ' LEU . . . . . 0.481 ' HG ' HD21 ' A' ' 951' ' ' LEU . 27.0 mt -70.57 154.62 41.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.921 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -87.17 148.59 25.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.871 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 89.7 p -121.36 79.0 36.22 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.676 0.751 . . . . 0.0 110.862 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 970' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 971' ' ' SER . 72.6 Cg_exo -44.76 147.43 1.83 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.669 2.246 . . . . 0.0 112.353 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 971' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 970' ' ' PRO . 3.3 t -37.84 -53.87 1.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.917 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . 157.37 95.3 0.11 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.467 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.84 130.51 12.51 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.67 2.247 . . . . 0.0 112.338 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 37.6 p -166.4 140.31 4.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.873 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 3.3 m -47.12 -59.61 3.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.855 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.466 -179.976 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 N-CA-C 112.531 -0.227 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 65.6 p -75.58 82.35 2.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.869 0.366 . . . . 0.0 110.858 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 19.6 m 44.75 41.99 5.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.827 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . -100.7 156.19 19.34 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.525 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 8.3 t -39.27 -50.49 1.99 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 110.842 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 59.8 p -63.28 144.43 56.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.865 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 94.72 87.79 1.7 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.486 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . -121.04 34.9 3.85 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.499 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 97.3 m -102.35 119.13 38.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.792 0.33 . . . . 0.0 111.157 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 895' ' ' VAL . . . . . 0.658 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 20.3 m -112.72 140.06 34.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.091 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . 0.47 ' HG ' ' CD1' ' A' ' 938' ' ' TRP . 3.9 mp -91.46 142.68 27.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.566 HG22 HG12 ' A' ' 965' ' ' ILE . 93.7 t -140.46 124.92 18.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.135 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 18.0 t -127.54 154.88 44.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.456 HD13 HD13 ' A' ' 913' ' ' LEU . 5.2 pt -121.41 155.66 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.107 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -99.65 109.17 21.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 901' ' ' SER . . . . . . . . . . . . . 15.6 m -139.64 129.09 24.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 55.2 m -52.59 -74.39 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 21.4 mt -65.05 150.53 95.23 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.614 0.721 . . . . 0.0 110.862 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.68 -26.8 9.53 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.735 2.29 . . . . 0.0 112.359 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -69.56 -1.9 9.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.885 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 906' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -118.13 -14.33 9.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 -63.73 -8.15 9.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.869 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -93.83 128.97 40.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.855 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 909' ' ' PHE . . . . . 0.673 ' HA ' HD12 ' A' ' 913' ' ' LEU . 91.5 m-85 -62.61 119.98 10.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.873 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -93.1 -178.59 4.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -55.72 -42.53 75.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.854 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -65.5 -57.89 7.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.102 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 913' ' ' LEU . . . . . 0.673 HD12 ' HA ' ' A' ' 909' ' ' PHE . 19.4 mt -49.96 -45.84 51.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.938 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 44.2 mt -71.47 -64.76 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.102 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -38.03 -59.58 0.83 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 916' ' ' GLU . . . . . 0.509 ' HB3' HD21 ' A' ' 958' ' ' LEU . 33.8 mm-40 -52.25 -52.33 53.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.863 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 917' ' ' LEU . . . . . 1.032 HD21 HD13 ' A' ' 963' ' ' ILE . 31.6 mt -49.58 -55.93 11.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.918 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 918' ' ' LEU . . . . . 0.439 ' C ' ' O ' ' A' ' 917' ' ' LEU . 77.8 mt -35.06 -57.86 0.55 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -58.15 -40.79 82.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.92 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 920' ' ' GLN . . . . . 0.433 ' N ' ' O ' ' A' ' 917' ' ' LEU . 35.6 mm-40 -61.56 -38.08 86.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 921' ' ' PHE . . . . . 0.566 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 20.1 m-85 -70.88 -36.06 72.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -58.86 -34.65 71.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.133 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.7 m -47.18 -26.54 1.18 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 924' ' ' PHE . . . . . 0.523 ' N ' ' CD1' ' A' ' 924' ' ' PHE . 0.7 OUTLIER -121.01 -65.37 1.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.894 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -122.22 150.76 16.95 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.507 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -85.71 140.16 30.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.881 0.372 . . . . 0.0 110.879 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 62.1 t -94.74 142.63 13.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.076 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 928' ' ' ILE . . . . . 0.487 HG13 ' N ' ' A' ' 929' ' ' LEU . 41.4 pt -121.64 -39.92 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.13 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 929' ' ' LEU . . . . . 0.487 ' N ' HG13 ' A' ' 928' ' ' ILE . 17.7 tp -139.97 139.21 36.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.926 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 74.0 mt -127.52 129.47 70.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.123 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 5.0 tpm_? -116.23 125.25 51.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.888 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -94.84 114.9 26.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 933' ' ' VAL . . . . . 0.605 HG21 ' NE1' ' A' ' 938' ' ' TRP . 2.6 t -83.41 157.11 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.167 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 934' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 933' ' ' VAL . 53.2 mt-10 -34.04 -50.85 0.4 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.909 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -125.31 -25.93 3.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.855 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 936' ' ' LYS . . . . . 0.447 ' O ' ' N ' ' A' ' 933' ' ' VAL . 1.0 OUTLIER -97.3 169.83 9.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 937' ' ' MET . . . . . 0.518 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 16.4 ttt -132.03 111.52 11.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.844 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 938' ' ' TRP . . . . . 0.605 ' NE1' HG21 ' A' ' 933' ' ' VAL . 39.2 m0 -91.96 144.13 25.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.932 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 939' ' ' VAL . . . . . 0.436 HG12 ' CE1' ' A' ' 941' ' ' PHE . 47.0 t -131.46 135.82 58.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 23.1 m -108.88 148.17 31.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.133 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 941' ' ' PHE . . . . . 0.436 ' CE1' HG12 ' A' ' 939' ' ' VAL . 6.9 m-85 -128.32 152.14 48.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.826 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 45.1 tp -41.92 -62.73 0.85 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.944 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -105.63 172.3 6.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -77.49 -44.83 12.04 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.517 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 45.6 t -56.67 -30.5 63.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.872 0.368 . . . . 0.0 110.858 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 72.7 m -58.94 -33.94 71.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.819 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 947' ' ' ALA . . . . . 0.658 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -74.19 -20.19 60.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.057 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 30.0 mt -83.48 -26.06 30.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.871 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -80.14 -41.24 25.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.87 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 8.2 p -61.75 -21.98 27.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.159 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 50.7 mt -50.38 -25.41 3.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 952' ' ' SER . . . . . 0.423 ' HB2' ' CE2' ' A' ' 924' ' ' PHE . 67.9 m -56.1 -13.72 2.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.832 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 24.4 mt -93.3 17.24 11.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.908 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -70.77 119.24 14.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 88.09 -25.26 9.12 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.489 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -41.63 127.43 3.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.759 0.314 . . . . 0.0 110.896 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -95.65 124.28 39.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.86 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 958' ' ' LEU . . . . . 0.509 HD21 ' HB3' ' A' ' 916' ' ' GLU . 14.9 tp -131.93 151.64 51.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.931 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 44.0 mt 41.14 49.63 3.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.916 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 50.47 37.27 15.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 961' ' ' ARG . . . . . 0.441 ' HD2' ' CD2' ' A' ' 913' ' ' LEU . 56.9 mtt85 -143.63 106.06 4.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.851 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 60.5 m -65.31 112.78 3.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.14 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 963' ' ' ILE . . . . . 1.032 HD13 HD21 ' A' ' 917' ' ' LEU . 71.2 mt -93.17 149.26 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.128 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 1.7 m -131.94 109.02 9.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.136 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 965' ' ' ILE . . . . . 0.566 HG12 HG22 ' A' ' 897' ' ' VAL . 70.3 mt -92.5 139.24 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.102 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -150.6 135.17 17.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.103 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 967' ' ' LEU . . . . . . . . . . . . . 26.6 mt -67.94 154.39 41.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.895 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 16.7 tptp -86.63 113.2 22.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.925 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 95.0 p -145.48 144.18 22.14 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.617 0.722 . . . . 0.0 110.897 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.62 -48.44 13.83 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.709 2.273 . . . . 0.0 112.343 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 3.8 m -132.42 130.33 40.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.84 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -65.34 -71.18 0.92 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.489 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.68 101.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.688 2.258 . . . . 0.0 112.315 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 69.8 m -56.61 145.57 28.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.88 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 21.0 t -150.01 168.78 22.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.829 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.502 179.998 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 58.3 m -151.9 163.5 39.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.898 0.38 . . . . 0.0 110.865 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 5.9 t -155.09 164.21 39.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.853 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . -106.54 51.64 0.73 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.454 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 37.2 m -78.0 171.24 15.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.93 0.395 . . . . 0.0 110.859 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 32.7 t -167.57 134.11 2.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.825 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 125.94 98.37 1.11 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.482 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . -97.05 53.45 1.38 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.496 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 89.4 m -98.05 120.41 38.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.887 0.375 . . . . 0.0 111.129 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 895' ' ' VAL . . . . . 0.695 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 10.8 m -113.63 138.61 42.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.088 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . 0.463 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 4.2 mp -90.47 143.57 26.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.968 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.423 HG13 ' CG2' ' A' ' 963' ' ' ILE . 95.6 t -141.78 130.36 22.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.107 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 10.8 t -129.53 152.37 49.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.551 HG23 ' CE2' ' A' ' 909' ' ' PHE . 2.8 pt -121.05 141.79 40.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.111 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 900' ' ' LYS . . . . . 0.427 ' HD2' ' N ' ' A' ' 900' ' ' LYS . 0.0 OUTLIER -85.89 109.62 18.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.936 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 901' ' ' SER . . . . . . . . . . . . . 95.1 p -124.97 161.55 26.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.826 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 23.5 m -96.48 -39.03 9.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.884 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 38.0 mt -98.63 151.0 37.25 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.572 0.701 . . . . 0.0 110.922 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.49 -13.62 20.36 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.702 2.268 . . . . 0.0 112.31 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -94.16 11.42 30.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.862 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 906' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -122.99 -26.16 4.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 907' ' ' ASN . . . . . 0.431 ' O ' HD11 ' A' ' 899' ' ' ILE . 36.2 p-10 -48.02 -28.02 2.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -74.76 115.96 14.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 909' ' ' PHE . . . . . 0.585 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 97.1 m-85 -51.07 119.92 4.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 910' ' ' ASP . . . . . 0.711 ' H ' HD12 ' A' ' 913' ' ' LEU . 6.3 t70 -84.71 179.02 7.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.87 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -58.61 -45.26 89.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -60.15 -60.85 3.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.068 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 913' ' ' LEU . . . . . 0.862 HD11 ' NH1' ' A' ' 961' ' ' ARG . 35.4 mt -45.31 -49.49 12.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.961 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 52.0 mt -63.6 -53.19 48.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.157 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -46.4 -56.63 5.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.846 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 916' ' ' GLU . . . . . 0.64 ' OE2' HD21 ' A' ' 959' ' ' LEU . 13.6 mt-10 -56.65 -51.49 68.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 917' ' ' LEU . . . . . 0.902 HD21 HD13 ' A' ' 963' ' ' ILE . 51.0 mt -46.13 -57.85 4.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 918' ' ' LEU . . . . . . . . . . . . . 99.3 mt -36.95 -62.99 0.45 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.953 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -54.02 -44.22 70.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.919 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 44.5 mm-40 -57.67 -38.91 75.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 921' ' ' PHE . . . . . 0.543 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 23.3 m-85 -72.68 -36.88 68.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.903 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -56.73 -32.69 65.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.102 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -52.04 -17.89 1.21 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.854 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 924' ' ' PHE . . . . . 0.499 ' N ' ' CD1' ' A' ' 924' ' ' PHE . 1.8 m-85 -126.06 -58.17 1.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.88 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -134.68 151.12 20.28 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.505 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -83.1 134.95 34.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.887 0.375 . . . . 0.0 110.872 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 41.2 t -89.01 143.47 11.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.177 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 928' ' ' ILE . . . . . 0.487 HG13 ' N ' ' A' ' 929' ' ' LEU . 20.4 pt -121.82 -45.83 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 929' ' ' LEU . . . . . 0.487 ' N ' HG13 ' A' ' 928' ' ' ILE . 25.5 tp -131.66 146.16 52.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 93.5 mt -136.71 122.86 28.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.113 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -111.26 123.35 50.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -87.64 118.58 27.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 933' ' ' VAL . . . . . 0.737 HG21 ' NE1' ' A' ' 938' ' ' TRP . 3.5 t -86.17 157.14 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.119 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 934' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 933' ' ' VAL . 32.3 mt-10 -33.82 -53.82 0.45 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -124.18 -20.73 5.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.89 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 19.3 tttt -101.31 173.04 6.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.897 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 937' ' ' MET . . . . . 0.585 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 12.7 ttt -133.58 114.03 13.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.897 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 938' ' ' TRP . . . . . 0.737 ' NE1' HG21 ' A' ' 933' ' ' VAL . 43.3 m0 -91.25 146.2 24.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 939' ' ' VAL . . . . . 0.479 HG12 ' CE1' ' A' ' 941' ' ' PHE . 61.0 t -136.15 122.27 30.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.117 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 6.8 m -91.07 150.49 21.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.151 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 941' ' ' PHE . . . . . 0.479 ' CE1' HG12 ' A' ' 939' ' ' VAL . 9.1 m-85 -130.28 144.26 51.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.912 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 942' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 941' ' ' PHE . 61.1 tp -34.55 -59.76 0.45 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -117.9 169.65 9.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.892 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -71.68 -49.13 25.36 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.514 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 74.1 p -50.56 -28.61 8.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.859 0.362 . . . . 0.0 110.857 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 6.0 m -67.05 -32.32 73.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.881 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 947' ' ' ALA . . . . . 0.695 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -82.36 -13.82 56.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.086 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 42.8 mt -87.36 -29.53 21.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.924 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -82.49 -37.66 24.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.903 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 9.2 p -61.94 -15.61 14.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.098 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 951' ' ' LEU . . . . . 0.644 HD11 HD11 ' A' ' 967' ' ' LEU . 40.0 mt -53.93 -26.32 24.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.94 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 33.3 t -53.46 -15.78 1.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.861 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 36.9 mt -89.89 14.15 12.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.929 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -68.76 116.97 9.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.864 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 90.58 -25.82 12.22 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.473 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 956' ' ' LYS . . . . . 0.59 ' HZ3' HD13 ' A' ' 958' ' ' LEU . 3.5 tmtt? -39.71 127.76 2.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.744 0.307 . . . . 0.0 110.883 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -94.48 131.37 40.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.901 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 958' ' ' LEU . . . . . 0.59 HD13 ' HZ3' ' A' ' 956' ' ' LYS . 15.8 tp -141.35 153.18 44.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.881 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . 0.64 HD21 ' OE2' ' A' ' 916' ' ' GLU . 38.2 mt 41.42 48.2 3.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.952 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 960' ' ' ASN . . . . . 0.444 ' CG ' ' O ' ' A' ' 959' ' ' LEU . 14.1 p30 48.18 42.41 17.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 961' ' ' ARG . . . . . 0.862 ' NH1' HD11 ' A' ' 913' ' ' LEU . 73.9 mtt180 -149.72 108.49 3.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 6.8 m -60.26 119.11 7.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.156 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 963' ' ' ILE . . . . . 0.902 HD13 HD21 ' A' ' 917' ' ' LEU . 91.4 mt -102.6 134.0 44.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.148 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 3.8 m -119.76 119.17 32.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.108 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 965' ' ' ILE . . . . . . . . . . . . . 51.2 mt -101.26 142.12 16.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.128 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -151.21 131.5 13.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.082 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 967' ' ' LEU . . . . . 0.644 HD11 HD11 ' A' ' 951' ' ' LEU . 30.9 mt -69.85 158.34 35.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 968' ' ' LYS . . . . . 0.458 ' O ' ' C ' ' A' ' 969' ' ' SER . 18.5 tptt -98.65 145.14 27.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.935 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 969' ' ' SER . . . . . 0.458 ' C ' ' O ' ' A' ' 968' ' ' LYS . 27.3 m -33.84 97.01 0.11 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.655 0.741 . . . . 0.0 110.851 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 970' ' ' PRO . . . . . 0.432 ' N ' ' O ' ' A' ' 968' ' ' LYS . 61.8 Cg_endo -76.93 41.75 0.98 Allowed 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.678 2.252 . . . . 0.0 112.323 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 68.7 m -51.09 -45.0 61.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.864 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . 86.96 94.07 0.9 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.499 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -76.64 133.53 14.29 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.659 2.239 . . . . 0.0 112.399 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 23.1 t -74.34 167.56 21.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.866 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 6.1 m -62.92 163.87 8.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.85 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.457 -179.981 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.42 -0.272 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 38.7 p -138.52 171.17 14.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.874 0.369 . . . . 0.0 110.843 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 20.2 t -65.44 110.93 2.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.884 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 889' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 890' ' ' SER . . . -134.26 -81.78 0.16 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.494 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 890' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 889' ' ' GLY . 60.5 p 34.57 38.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.914 0.387 . . . . 0.0 110.875 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 3.5 m -138.66 139.44 38.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.839 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 125.95 -170.01 17.85 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.476 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . 119.46 -84.59 0.37 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.495 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 75.8 m -93.53 116.94 29.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.839 0.352 . . . . 0.0 111.122 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 895' ' ' VAL . . . . . 0.566 HG12 HD23 ' A' ' 967' ' ' LEU . 18.8 m -112.29 142.92 23.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.125 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . 0.468 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 4.2 mp -91.08 146.84 23.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.651 HG22 HG12 ' A' ' 965' ' ' ILE . 92.9 t -146.9 125.56 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.118 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 6.4 t -125.71 155.59 40.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.549 HG23 ' CE2' ' A' ' 909' ' ' PHE . 2.2 pt -121.82 137.23 56.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.093 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 34.4 mtmt -88.93 113.81 24.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.899 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 901' ' ' SER . . . . . 0.403 ' HB2' ' CB ' ' A' ' 906' ' ' ASN . 78.5 p -125.5 139.56 53.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.861 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 38.9 m -42.05 -64.03 0.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.862 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 7.4 mt -96.34 140.98 22.48 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.571 0.701 . . . . 0.0 110.907 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -49.71 -43.59 39.46 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.657 2.238 . . . . 0.0 112.371 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -56.7 -15.42 4.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.865 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 906' ' ' ASN . . . . . 0.403 ' CB ' ' HB2' ' A' ' 901' ' ' SER . 96.6 m-20 -98.07 14.92 25.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.887 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -83.0 -13.02 56.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.859 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -75.82 127.83 33.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 909' ' ' PHE . . . . . 0.549 ' CE2' HG23 ' A' ' 899' ' ' ILE . 76.2 m-85 -64.43 127.36 31.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 910' ' ' ASP . . . . . 0.585 ' H ' HD12 ' A' ' 913' ' ' LEU . 35.0 m-20 -92.99 159.03 15.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.879 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -45.08 -49.71 11.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -53.92 -51.92 62.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.087 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 913' ' ' LEU . . . . . 0.649 HD11 ' CD ' ' A' ' 961' ' ' ARG . 41.3 mt -53.36 -53.45 50.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.909 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 54.2 mt -60.14 -62.9 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.125 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -42.38 -51.03 5.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -61.49 -44.11 97.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.864 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 917' ' ' LEU . . . . . 0.842 HD21 HD13 ' A' ' 963' ' ' ILE . 26.1 mt -56.84 -57.9 10.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 918' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 917' ' ' LEU . 66.5 mt -34.82 -48.83 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -64.94 -47.56 77.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 60.2 mm-40 -55.75 -37.43 68.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 921' ' ' PHE . . . . . 0.571 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 22.4 m-85 -67.32 -50.8 58.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -46.27 -24.23 0.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.07 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 923' ' ' SER . . . . . 0.449 ' HB3' ' CE1' ' A' ' 924' ' ' PHE . 31.2 t -48.76 -32.06 7.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 924' ' ' PHE . . . . . 0.57 ' N ' ' CD1' ' A' ' 924' ' ' PHE . 0.3 OUTLIER -123.18 -52.94 1.84 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -131.84 147.92 18.85 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.524 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -84.87 135.43 34.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.854 0.359 . . . . 0.0 110.926 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 11.9 t -81.86 145.37 8.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.143 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 928' ' ' ILE . . . . . 0.62 HD13 ' HA ' ' A' ' 942' ' ' LEU . 42.8 pt -122.17 -36.39 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.161 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 929' ' ' LEU . . . . . 0.478 ' N ' HG13 ' A' ' 928' ' ' ILE . 10.2 tp -144.09 146.48 32.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.889 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 50.0 mt -135.9 128.8 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.135 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 16.0 ttt-85 -118.75 123.93 46.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.907 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -91.22 122.06 33.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 933' ' ' VAL . . . . . 0.574 HG21 ' NE1' ' A' ' 938' ' ' TRP . 2.8 t -90.22 157.09 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.114 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 934' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 933' ' ' VAL . 81.2 mm-40 -33.71 -51.77 0.39 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.886 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -124.96 -26.18 3.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 7.9 ttmm -96.45 170.87 8.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 937' ' ' MET . . . . . 0.466 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 16.2 ttt -134.46 112.17 10.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.863 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 938' ' ' TRP . . . . . 0.574 ' NE1' HG21 ' A' ' 933' ' ' VAL . 36.0 m0 -93.35 142.13 27.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 53.9 t -130.48 127.43 62.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.171 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 8.9 m -98.57 152.63 19.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 941' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -127.92 145.89 50.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 942' ' ' LEU . . . . . 0.62 ' HA ' HD13 ' A' ' 928' ' ' ILE . 22.7 tp -41.22 -40.84 1.69 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.949 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -130.39 176.69 7.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.919 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -86.32 -53.76 2.87 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.526 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 59.0 p -46.69 -22.34 0.28 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.882 0.372 . . . . 0.0 110.884 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 2.1 p -75.22 -37.12 61.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.841 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 947' ' ' ALA . . . . . 0.499 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -70.7 -16.35 62.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.096 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 29.1 mt -84.05 -28.87 27.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.943 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -80.95 -46.48 15.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.859 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 7.6 p -53.83 -17.38 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.127 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 60.8 mt -53.15 -23.27 7.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.872 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 1.8 t -59.05 -11.15 3.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.838 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 51.1 mt -94.03 16.26 14.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 954' ' ' ASN . . . . . 0.402 ' O ' ' CG ' ' A' ' 954' ' ' ASN . 1.9 p30 -70.64 119.37 14.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 955' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 956' ' ' LYS . . . 86.15 -28.48 5.11 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.531 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 956' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 955' ' ' GLY . 0.1 OUTLIER -36.13 127.23 0.75 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.756 0.313 . . . . 0.0 110.873 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -92.94 128.02 38.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 14.2 tp -138.41 148.41 44.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.95 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 49.4 mt 43.13 52.53 5.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.944 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 44.83 44.7 7.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.904 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 961' ' ' ARG . . . . . 0.649 ' CD ' HD11 ' A' ' 913' ' ' LEU . 41.6 mtt85 -151.33 106.07 3.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.844 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 6.3 m -61.44 119.02 7.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.088 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 963' ' ' ILE . . . . . 0.842 HD13 HD21 ' A' ' 917' ' ' LEU . 92.7 mt -102.47 139.88 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.147 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 6.1 m -124.73 112.25 16.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.119 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 965' ' ' ILE . . . . . 0.651 HG12 HG22 ' A' ' 897' ' ' VAL . 61.4 mt -98.42 139.04 21.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.077 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -153.84 137.88 16.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.129 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 967' ' ' LEU . . . . . 0.566 HD23 HG12 ' A' ' 895' ' ' VAL . 26.2 mt -68.63 156.37 38.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.922 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 11.6 tptm -74.3 -59.07 2.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 3.8 m -158.92 154.36 22.38 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.717 0.77 . . . . 0.0 110.808 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.19 -26.24 7.8 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.649 2.233 . . . . 0.0 112.351 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 13.2 t -101.09 -54.04 2.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.87 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . 178.64 178.77 48.21 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.529 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -76.93 -22.58 11.44 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.669 2.246 . . . . 0.0 112.332 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 26.5 t -157.22 107.82 2.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 41.9 m -147.91 161.85 40.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.874 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.467 179.99 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.461 -0.256 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 31.9 t -88.3 84.62 6.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.858 0.361 . . . . 0.0 110.877 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 3.3 m -107.64 140.73 40.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.849 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . 136.67 146.92 5.26 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.473 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 8.5 t 56.66 40.15 29.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.862 0.363 . . . . 0.0 110.9 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 50.6 p -140.18 136.37 33.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 100.08 168.91 29.42 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.524 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . -151.35 45.22 0.64 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.513 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 87.5 m -108.31 126.74 53.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.786 0.327 . . . . 0.0 111.146 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 895' ' ' VAL . . . . . 0.442 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 6.3 m -120.09 137.0 55.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.115 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . 0.471 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 4.7 mp -89.2 142.94 27.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.906 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.408 HG13 ' CG2' ' A' ' 963' ' ' ILE . 99.4 t -140.22 127.69 23.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.166 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 13.5 t -130.18 156.68 44.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.83 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.489 HG22 HG12 ' A' ' 963' ' ' ILE . 4.1 pt -121.17 150.36 24.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.122 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.73 107.72 19.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 901' ' ' SER . . . . . . . . . . . . . 60.4 p -127.97 162.2 27.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.869 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 73.1 m -99.58 -45.39 5.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.89 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 12.3 mt -89.14 156.04 49.1 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.635 0.731 . . . . 0.0 110.893 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.14 -19.69 15.34 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.647 2.231 . . . . 0.0 112.394 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -89.98 17.03 7.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 906' ' ' ASN . . . . . 0.428 ' O ' ' N ' ' A' ' 908' ' ' PHE . 3.3 m-80 -127.66 -34.07 2.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.912 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 36.4 p-10 -40.96 -26.41 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 908' ' ' PHE . . . . . 0.428 ' N ' ' O ' ' A' ' 906' ' ' ASN . 15.4 m-85 -76.17 159.99 30.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.914 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 909' ' ' PHE . . . . . 0.581 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 49.8 m-85 -96.63 134.19 40.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 910' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -98.75 178.79 4.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.89 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -58.56 -26.04 63.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.863 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -78.52 -57.39 3.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.11 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 913' ' ' LEU . . . . . 0.608 HD21 ' CD ' ' A' ' 961' ' ' ARG . 82.0 mt -52.87 -39.95 63.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.97 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 914' ' ' ILE . . . . . 0.435 HD13 ' CZ ' ' A' ' 932' ' ' PHE . 28.9 mt -72.57 -64.09 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.164 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -43.21 -54.07 4.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.84 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -55.43 -51.03 68.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 917' ' ' LEU . . . . . 0.93 HD21 HD13 ' A' ' 963' ' ' ILE . 20.6 mt -48.94 -54.14 16.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.905 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 918' ' ' LEU . . . . . 0.426 ' C ' ' O ' ' A' ' 917' ' ' LEU . 41.9 mt -34.75 -65.79 0.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.905 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -51.11 -52.26 45.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 920' ' ' GLN . . . . . 0.4 ' O ' HD11 ' A' ' 953' ' ' LEU . 89.3 mm-40 -48.85 -40.2 28.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.873 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 921' ' ' PHE . . . . . 0.549 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 23.1 m-85 -71.21 -42.79 68.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 922' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 924' ' ' PHE . . . -49.62 -39.48 35.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.095 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.7 m -43.02 -24.25 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.837 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 924' ' ' PHE . . . . . 0.554 ' N ' ' CD1' ' A' ' 924' ' ' PHE . 0.6 OUTLIER -123.67 -63.02 1.26 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -123.13 147.24 16.67 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.469 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -84.39 128.01 34.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.931 0.396 . . . . 0.0 110.88 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 34.4 t -81.71 144.24 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.144 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 928' ' ' ILE . . . . . 0.486 HG13 ' N ' ' A' ' 929' ' ' LEU . 23.9 pt -123.18 -44.72 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.1 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 929' ' ' LEU . . . . . 0.486 ' N ' HG13 ' A' ' 928' ' ' ILE . 21.0 tp -134.48 144.05 47.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.964 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 930' ' ' ILE . . . . . 0.462 ' H ' HD12 ' A' ' 929' ' ' LEU . 43.5 mt -135.71 134.55 51.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.118 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.26 124.52 32.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 932' ' ' PHE . . . . . 0.435 ' CZ ' HD13 ' A' ' 914' ' ' ILE . 30.4 m-85 -86.95 118.66 26.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 933' ' ' VAL . . . . . 0.71 HG21 ' CD1' ' A' ' 938' ' ' TRP . 2.6 t -82.95 157.37 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 934' ' ' GLU . . . . . 0.472 ' C ' ' O ' ' A' ' 933' ' ' VAL . 29.4 mm-40 -32.24 -53.41 0.3 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.905 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -125.31 -25.89 3.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -97.23 173.14 7.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.9 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 937' ' ' MET . . . . . 0.581 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 15.3 ttt -135.71 110.29 8.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.907 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 938' ' ' TRP . . . . . 0.71 ' CD1' HG21 ' A' ' 933' ' ' VAL . 20.3 m0 -95.95 138.58 33.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.874 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 939' ' ' VAL . . . . . 0.426 HG12 ' CE1' ' A' ' 941' ' ' PHE . 94.4 t -122.35 134.97 63.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.117 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 52.3 m -98.62 148.96 23.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.145 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 941' ' ' PHE . . . . . 0.426 ' CE1' HG12 ' A' ' 939' ' ' VAL . 9.3 m-85 -130.69 152.06 50.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.862 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 942' ' ' LEU . . . . . 0.421 ' HA ' HD13 ' A' ' 928' ' ' ILE . 55.5 tp -48.79 -53.53 18.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.891 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -115.91 177.81 4.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -87.34 -46.92 4.82 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.494 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 91.8 p -50.89 -39.47 54.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.924 0.392 . . . . 0.0 110.857 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.11 -27.63 67.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.858 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 947' ' ' ALA . . . . . 0.442 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -80.22 -15.38 57.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.135 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 21.6 mt -87.34 -29.35 21.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.907 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -79.9 -41.35 26.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.903 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 4.3 p -56.06 -16.92 3.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.166 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 951' ' ' LEU . . . . . 0.651 HD21 ' HG ' ' A' ' 967' ' ' LEU . 31.1 mt -52.65 -29.74 27.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 3.1 m -53.03 -25.56 12.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.861 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 953' ' ' LEU . . . . . 0.555 ' C ' HD12 ' A' ' 965' ' ' ILE . 32.1 mt -78.95 9.04 4.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.948 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 954' ' ' ASN . . . . . 0.414 ' N ' HD12 ' A' ' 965' ' ' ILE . 0.4 OUTLIER -70.43 118.49 13.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.841 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 92.33 -26.38 13.85 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.442 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 956' ' ' LYS . . . . . 0.677 ' NZ ' HD13 ' A' ' 958' ' ' LEU . 3.7 tmtt? -42.08 128.35 3.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.751 0.31 . . . . 0.0 110.893 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -93.87 127.17 39.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 958' ' ' LEU . . . . . 0.677 HD13 ' NZ ' ' A' ' 956' ' ' LYS . 13.6 tp -140.45 157.07 46.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.955 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 37.4 mt 39.1 44.84 0.98 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.954 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 49.79 44.36 24.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.906 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 961' ' ' ARG . . . . . 0.608 ' CD ' HD21 ' A' ' 913' ' ' LEU . 52.0 mtt180 -152.07 108.06 3.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 2.9 m -61.81 118.67 7.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.102 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 963' ' ' ILE . . . . . 0.93 HD13 HD21 ' A' ' 917' ' ' LEU . 86.3 mt -103.24 137.94 29.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.12 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 9.7 m -123.87 117.43 24.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.183 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 965' ' ' ILE . . . . . 0.555 HD12 ' C ' ' A' ' 953' ' ' LEU . 19.1 mt -97.77 146.93 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.186 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -155.18 128.86 8.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.098 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 967' ' ' LEU . . . . . 0.651 ' HG ' HD21 ' A' ' 951' ' ' LEU . 33.5 mt -66.05 157.98 29.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.88 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 968' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 969' ' ' SER . 15.8 tptp -105.12 -63.67 1.21 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.899 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 969' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 968' ' ' LYS . 18.3 p -34.74 143.93 0.21 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.674 0.749 . . . . 0.0 110.872 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -78.1 106.62 2.19 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.701 2.267 . . . . 0.0 112.362 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 24.1 m -76.93 -49.05 16.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.883 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -72.93 -175.7 29.16 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.486 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.6 141.53 7.95 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.701 2.268 . . . . 0.0 112.367 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 30.1 t -45.73 143.37 2.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.858 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 97.0 p -158.15 177.3 11.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.848 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.499 179.993 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 36.8 p -155.36 160.03 40.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.863 0.363 . . . . 0.0 110.864 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 18.3 m -107.42 159.21 16.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.858 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . -123.31 -43.95 0.34 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.504 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 97.3 p -71.74 -44.21 64.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.887 0.375 . . . . 0.0 110.889 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 3.5 t -57.52 163.21 2.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.844 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -87.84 -114.29 1.12 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.47 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . -151.36 45.71 0.62 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.467 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 87.2 m -90.79 126.95 36.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.762 0.315 . . . . 0.0 111.21 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 895' ' ' VAL . . . . . 0.676 HG12 HD23 ' A' ' 967' ' ' LEU . 17.6 m -118.18 138.81 47.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.165 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . 0.47 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 6.3 mp -90.34 138.63 31.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.936 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.521 HG22 HG12 ' A' ' 965' ' ' ILE . 86.6 t -139.54 124.3 20.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.1 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 12.3 t -127.96 155.68 43.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.848 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.545 HG22 HG12 ' A' ' 963' ' ' ILE . 2.7 pt -120.37 135.22 61.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.144 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -96.16 115.92 28.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.9 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 901' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 902' ' ' SER . 5.6 t -132.28 145.02 51.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.824 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 902' ' ' SER . . . . . 0.438 ' C ' ' O ' ' A' ' 901' ' ' SER . 3.4 m -35.04 -58.12 0.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.887 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 9.1 mt -98.21 144.34 27.9 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.639 0.733 . . . . 0.0 110.889 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.88 -23.17 14.33 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.65 2.233 . . . . 0.0 112.346 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -64.41 -17.15 63.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.853 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 906' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -98.94 13.56 32.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -58.16 -29.55 65.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -61.26 154.75 22.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.883 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 909' ' ' PHE . . . . . 0.588 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 48.3 m-85 -100.01 140.54 34.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.86 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 910' ' ' ASP . . . . . 0.428 ' H ' HD12 ' A' ' 913' ' ' LEU . 0.3 OUTLIER -99.99 177.56 5.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.898 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.66 -45.31 77.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -59.65 -54.99 40.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.093 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 913' ' ' LEU . . . . . 0.428 HD12 ' H ' ' A' ' 910' ' ' ASP . 22.2 mt -53.47 -54.81 31.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.931 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 46.3 mt -58.86 -57.85 9.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.164 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -50.26 -63.98 0.95 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 916' ' ' GLU . . . . . 0.43 ' HB3' HD21 ' A' ' 958' ' ' LEU . 50.3 mm-40 -45.71 -50.16 13.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.847 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 917' ' ' LEU . . . . . 0.886 HD21 HD13 ' A' ' 963' ' ' ILE . 28.2 mt -50.3 -53.24 30.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.937 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 918' ' ' LEU . . . . . 0.524 HD21 ' CD1' ' A' ' 930' ' ' ILE . 88.4 mt -38.59 -62.44 0.6 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.955 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -53.16 -53.68 46.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.925 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 -47.65 -45.34 27.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.857 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 921' ' ' PHE . . . . . 0.578 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 23.7 m-85 -60.26 -49.04 79.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.839 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -45.29 -33.5 2.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.073 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 923' ' ' SER . . . . . 0.521 ' HB3' ' CD1' ' A' ' 924' ' ' PHE . 8.6 t -41.18 -29.84 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 924' ' ' PHE . . . . . 0.521 ' CD1' ' HB3' ' A' ' 923' ' ' SER . 1.6 m-85 -120.02 -58.92 1.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.893 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -130.76 154.65 20.82 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.536 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -87.05 139.45 30.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 0.0 110.938 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 44.1 t -87.25 146.15 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 928' ' ' ILE . . . . . 0.491 HG13 ' N ' ' A' ' 929' ' ' LEU . 46.1 pt -122.7 -38.46 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.124 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 929' ' ' LEU . . . . . 0.491 ' N ' HG13 ' A' ' 928' ' ' ILE . 11.4 tp -142.41 146.24 34.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 930' ' ' ILE . . . . . 0.524 ' CD1' HD21 ' A' ' 918' ' ' LEU . 79.1 mt -132.09 131.51 61.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.153 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 15.8 ttp180 -121.3 124.3 44.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.879 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -91.38 121.8 33.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 933' ' ' VAL . . . . . 0.634 HG21 ' CD1' ' A' ' 938' ' ' TRP . 4.7 t -89.38 157.27 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.123 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 934' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 933' ' ' VAL . 15.2 mm-40 -33.28 -54.5 0.41 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.942 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.03 -21.61 5.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.859 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -98.98 171.68 7.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.869 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 937' ' ' MET . . . . . 0.588 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 17.2 ttt -131.81 108.66 9.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 938' ' ' TRP . . . . . 0.634 ' CD1' HG21 ' A' ' 933' ' ' VAL . 41.5 m0 -90.82 144.77 25.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.905 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 87.0 t -133.56 131.24 57.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.143 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 17.8 m -97.19 150.45 20.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.129 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 941' ' ' PHE . . . . . 0.425 ' O ' ' C ' ' A' ' 942' ' ' LEU . 9.9 m-85 -129.83 144.99 51.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.893 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 942' ' ' LEU . . . . . 0.425 ' C ' ' O ' ' A' ' 941' ' ' PHE . 30.3 tp -35.94 -56.88 0.7 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.924 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -122.09 164.91 16.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.871 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -66.95 -44.9 87.66 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.478 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 95.2 p -52.22 -37.45 55.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.868 0.366 . . . . 0.0 110.889 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 49.4 m -57.72 -37.51 73.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.857 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 947' ' ' ALA . . . . . 0.532 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -73.05 -25.24 60.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.058 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 28.8 mt -76.63 -23.83 53.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.923 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 37.3 m-20 -88.26 -50.25 6.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.85 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 9.6 p -49.66 -18.65 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.166 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 951' ' ' LEU . . . . . 0.689 HD11 ' CD1' ' A' ' 967' ' ' LEU . 24.4 mt -52.38 -28.51 19.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.907 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 952' ' ' SER . . . . . 0.518 ' HB2' ' CZ ' ' A' ' 924' ' ' PHE . 20.6 m -50.95 -17.54 0.6 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 37.7 mt -88.45 17.48 5.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.946 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -71.43 120.79 17.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 86.51 -24.48 8.45 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.495 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -40.49 128.92 2.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.732 0.301 . . . . 0.0 110.938 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -94.59 134.01 37.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.905 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 958' ' ' LEU . . . . . 0.43 HD21 ' HB3' ' A' ' 916' ' ' GLU . 14.6 tp -144.52 146.77 32.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 56.0 mt 44.82 52.06 8.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.958 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 45.13 44.02 8.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.89 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 961' ' ' ARG . . . . . . . . . . . . . 71.0 mtt-85 -150.54 110.49 4.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.917 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 6.4 m -64.41 120.13 11.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.13 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 963' ' ' ILE . . . . . 0.886 HD13 HD21 ' A' ' 917' ' ' LEU . 82.7 mt -103.93 139.53 24.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.156 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 6.7 m -123.8 116.87 23.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.122 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 965' ' ' ILE . . . . . 0.521 HG12 HG22 ' A' ' 897' ' ' VAL . 61.0 mt -102.07 140.57 20.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.142 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -152.68 128.8 10.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.117 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 967' ' ' LEU . . . . . 0.689 ' CD1' HD11 ' A' ' 951' ' ' LEU . 30.7 mt -67.98 158.37 32.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -82.11 96.91 7.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 48.4 t -109.91 91.34 10.73 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.638 0.732 . . . . 0.0 110.868 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.44 90.51 1.19 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.638 2.225 . . . . 0.0 112.392 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 22.1 m -87.1 135.83 33.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.834 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . 158.22 174.82 28.42 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.465 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.54 147.6 2.71 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.699 2.266 . . . . 0.0 112.336 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 2.7 m -50.61 104.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.844 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 26.0 m -108.87 42.31 1.44 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.883 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.488 -179.967 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 27.3 p -84.62 148.71 26.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.888 0.375 . . . . 0.0 110.816 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 31.1 t -166.03 141.86 4.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.856 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . -123.51 100.57 0.66 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.455 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 94.5 p -124.06 123.3 40.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.888 0.375 . . . . 0.0 110.853 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 14.2 m -92.42 133.21 36.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.91 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 892' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 894' ' ' THR . . . -138.78 89.75 0.2 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.448 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . -38.21 -29.57 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.482 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 894' ' ' THR . . . . . 0.437 ' N ' ' O ' ' A' ' 892' ' ' GLY . 99.5 m -87.89 115.7 25.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.797 0.332 . . . . 0.0 111.144 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 895' ' ' VAL . . . . . 0.777 HG12 HD23 ' A' ' 967' ' ' LEU . 16.9 m -115.06 139.51 40.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.156 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . 0.465 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 4.7 mp -88.98 143.22 27.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.468 HG22 HG12 ' A' ' 965' ' ' ILE . 89.1 t -141.08 127.01 19.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.113 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 11.4 t -129.08 155.78 44.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.864 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.614 HG23 ' CE2' ' A' ' 909' ' ' PHE . 3.8 pt -120.03 138.07 51.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.175 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.27 106.58 13.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.888 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 901' ' ' SER . . . . . . . . . . . . . 2.6 m -139.63 126.39 20.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.89 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 18.9 m -58.6 -70.66 0.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.846 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 35.1 mt -65.38 151.71 93.59 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.616 0.722 . . . . 0.0 110.956 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . 0.532 ' O ' ' CE2' ' A' ' 908' ' ' PHE . 61.5 Cg_endo -76.43 -26.97 8.19 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.681 2.254 . . . . 0.0 112.332 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . 0.4 ' HG3' ' ND2' ' A' ' 906' ' ' ASN . 17.1 pt-20 -70.0 -0.83 8.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.937 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 906' ' ' ASN . . . . . 0.4 ' ND2' ' HG3' ' A' ' 905' ' ' GLU . 25.7 m-80 -118.14 -17.73 9.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.928 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -58.28 -28.93 65.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.908 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 908' ' ' PHE . . . . . 0.532 ' CE2' ' O ' ' A' ' 904' ' ' PRO . 8.0 m-85 -74.47 124.06 25.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 909' ' ' PHE . . . . . 0.614 ' CE2' HG23 ' A' ' 899' ' ' ILE . 89.1 m-85 -58.93 125.03 21.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.896 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 910' ' ' ASP . . . . . 0.492 ' H ' HD12 ' A' ' 913' ' ' LEU . 25.5 t70 -90.07 169.83 10.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.884 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.09 -42.45 65.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -63.22 -50.29 70.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.113 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 913' ' ' LEU . . . . . 0.515 HD11 ' CD ' ' A' ' 961' ' ' ARG . 20.8 mt -56.89 -50.54 72.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.951 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 914' ' ' ILE . . . . . 0.431 HD13 ' CZ ' ' A' ' 932' ' ' PHE . 66.1 mt -63.51 -59.47 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -50.42 -52.03 41.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 916' ' ' GLU . . . . . 0.775 ' HG3' HD11 ' A' ' 959' ' ' LEU . 31.7 mm-40 -57.04 -43.59 82.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 917' ' ' LEU . . . . . 0.761 HD21 HD13 ' A' ' 963' ' ' ILE . 19.9 mt -54.54 -55.65 27.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.887 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 918' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 917' ' ' LEU . 24.8 mt -34.52 -62.48 0.34 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.951 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -52.68 -52.08 57.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -49.93 -39.07 39.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.908 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 921' ' ' PHE . . . . . 0.536 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 23.8 m-85 -73.36 -41.51 63.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.882 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -52.84 -27.26 17.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.107 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 923' ' ' SER . . . . . 0.549 ' HB3' ' CE1' ' A' ' 924' ' ' PHE . 19.6 t -48.7 -30.27 5.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 924' ' ' PHE . . . . . 0.549 ' CE1' ' HB3' ' A' ' 923' ' ' SER . 0.8 OUTLIER -121.27 -50.58 2.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.913 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -134.54 147.19 19.03 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.475 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -85.46 132.05 34.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.865 0.364 . . . . 0.0 110.889 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 16.8 t -83.2 146.93 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.131 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 928' ' ' ILE . . . . . 0.462 HG13 ' N ' ' A' ' 929' ' ' LEU . 41.8 pt -124.56 -33.36 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.143 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 929' ' ' LEU . . . . . 0.462 ' N ' HG13 ' A' ' 928' ' ' ILE . 8.5 tp -146.59 145.25 30.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.86 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 48.0 mt -135.01 128.9 50.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.122 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 -110.59 123.09 49.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.862 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 932' ' ' PHE . . . . . 0.431 ' CZ ' HD13 ' A' ' 914' ' ' ILE . 71.0 m-85 -89.67 112.74 24.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.902 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 933' ' ' VAL . . . . . 0.711 HG21 ' NE1' ' A' ' 938' ' ' TRP . 2.6 t -83.15 149.05 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.153 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 934' ' ' GLU . . . . . 0.489 ' C ' ' O ' ' A' ' 933' ' ' VAL . 84.5 mt-10 -31.34 -50.03 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -124.65 -23.53 4.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.854 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.46 173.23 6.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 937' ' ' MET . . . . . 0.585 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 16.6 ttt -136.06 106.67 6.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 938' ' ' TRP . . . . . 0.711 ' NE1' HG21 ' A' ' 933' ' ' VAL . 34.3 m0 -88.1 142.24 27.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 939' ' ' VAL . . . . . 0.42 HG12 ' CE1' ' A' ' 941' ' ' PHE . 89.7 t -129.18 120.31 51.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.174 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 940' ' ' THR . . . . . 0.416 ' CG2' ' N ' ' A' ' 941' ' ' PHE . 8.5 m -91.19 153.17 20.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.107 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 941' ' ' PHE . . . . . 0.42 ' CE1' HG12 ' A' ' 939' ' ' VAL . 9.3 m-85 -129.57 154.28 47.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 43.6 tp -52.25 -50.68 61.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.933 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -116.29 171.7 7.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.902 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -84.94 -37.66 9.97 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.467 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 75.4 p -60.73 -29.08 69.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.912 0.387 . . . . 0.0 110.907 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 1.9 p -68.11 -35.06 77.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.818 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -72.55 -12.85 61.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.098 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 27.7 mt -89.48 -26.7 20.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -84.81 -40.88 16.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.9 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 9.1 p -57.24 -17.85 7.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.1 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 951' ' ' LEU . . . . . 0.752 HD21 ' HG ' ' A' ' 967' ' ' LEU . 43.1 mt -52.19 -27.14 13.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.903 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 19.9 m -53.2 -16.27 1.18 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.834 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 953' ' ' LEU . . . . . 0.478 ' HB2' ' CD1' ' A' ' 965' ' ' ILE . 56.8 mt -92.38 19.01 7.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -74.9 105.11 5.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 101.45 -25.24 28.83 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.47 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -43.07 128.88 4.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.763 0.316 . . . . 0.0 110.921 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -95.98 135.09 38.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.855 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 958' ' ' LEU . . . . . 0.41 ' O ' ' N ' ' A' ' 961' ' ' ARG . 14.3 tp -141.37 157.45 45.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.913 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . 0.775 HD11 ' HG3' ' A' ' 916' ' ' GLU . 96.2 mt 38.38 45.1 0.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.9 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 52.88 44.09 30.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.848 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 961' ' ' ARG . . . . . 0.515 ' CD ' HD11 ' A' ' 913' ' ' LEU . 61.2 mtt85 -151.4 105.84 3.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 63.2 m -60.88 115.79 3.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.118 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 963' ' ' ILE . . . . . 0.761 HD13 HD21 ' A' ' 917' ' ' LEU . 75.2 mt -98.56 139.7 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.107 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 13.5 m -122.75 115.75 22.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.125 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 965' ' ' ILE . . . . . 0.478 ' CD1' ' HB2' ' A' ' 953' ' ' LEU . 61.5 mt -102.22 138.2 27.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.142 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -150.6 129.83 12.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.124 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 967' ' ' LEU . . . . . 0.777 HD23 HG12 ' A' ' 895' ' ' VAL . 32.3 mt -65.49 157.87 28.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.893 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 14.7 tptp -95.78 153.14 17.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.939 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 87.2 p -116.55 145.1 34.5 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.65 0.738 . . . . 0.0 110.851 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -78.38 90.31 1.28 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.654 2.236 . . . . 0.0 112.361 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 34.8 m -78.09 151.38 33.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.828 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . 92.67 157.21 33.41 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.432 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.61 154.87 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.671 2.247 . . . . 0.0 112.334 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 30.4 t -41.77 154.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.834 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 1.3 t -90.06 53.44 2.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.8 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.477 -179.974 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 83.2 p -97.92 137.04 37.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.892 0.377 . . . . 0.0 110.839 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 15.2 m -90.21 -49.73 6.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.845 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . 158.45 118.32 0.53 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.45 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 1.5 t -114.59 104.85 12.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.898 0.38 . . . . 0.0 110.786 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 49.1 m -93.67 106.08 18.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.857 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 48.67 -160.3 0.68 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.478 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . -140.4 44.14 1.07 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.497 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 93.3 m -95.88 126.95 41.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.789 0.328 . . . . 0.0 111.149 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 895' ' ' VAL . . . . . 0.531 HG12 HD23 ' A' ' 967' ' ' LEU . 26.7 m -122.76 140.03 47.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.149 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . 0.47 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 6.4 mp -88.8 142.67 27.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.908 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 97.9 t -142.66 124.07 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.135 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 7.8 t -127.57 156.32 42.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.829 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.586 HG22 HG12 ' A' ' 963' ' ' ILE . 2.5 pt -125.86 130.61 72.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.116 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -77.71 114.05 16.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 901' ' ' SER . . . . . . . . . . . . . 2.6 t -139.99 122.82 16.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.842 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 3.2 m -50.79 -55.59 16.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.832 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 24.9 mt -80.97 148.25 63.9 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.613 0.721 . . . . 0.0 110.947 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -77.58 -21.9 11.06 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.69 2.26 . . . . 0.0 112.38 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -74.55 -0.62 18.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.921 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 906' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 -114.54 -13.22 12.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.845 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 -61.44 -10.26 7.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -92.81 121.09 33.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.878 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 909' ' ' PHE . . . . . 0.567 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 58.3 m-85 -63.07 121.93 14.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.832 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 910' ' ' ASP . . . . . 0.461 ' H ' HD12 ' A' ' 913' ' ' LEU . 12.4 t70 -89.74 -179.07 5.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.884 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -58.46 -41.92 86.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.878 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -64.38 -51.64 62.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.082 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 913' ' ' LEU . . . . . 0.876 HD21 ' HD2' ' A' ' 961' ' ' ARG . 72.2 mt -55.2 -53.31 57.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.917 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 44.9 mt -62.69 -61.92 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.133 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -44.55 -58.27 3.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -52.03 -45.68 64.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 917' ' ' LEU . . . . . 0.805 HD21 HD13 ' A' ' 963' ' ' ILE . 23.0 mt -56.58 -53.79 53.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.923 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 918' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 917' ' ' LEU . 80.4 mt -34.45 -54.1 0.52 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.949 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -58.71 -49.83 76.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.902 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 920' ' ' GLN . . . . . 0.735 ' OE1' HD22 ' A' ' 958' ' ' LEU . 19.7 mt-30 -51.89 -36.98 50.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 921' ' ' PHE . . . . . 0.432 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 21.9 m-85 -73.11 -39.89 65.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.845 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -55.9 -33.0 64.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.119 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 53.4 p -54.22 -17.79 3.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.874 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 924' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -121.54 -52.4 2.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.872 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -147.12 154.95 26.29 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.458 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -86.18 126.34 34.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.896 0.379 . . . . 0.0 110.896 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 927' ' ' VAL . . . . . 0.485 HG13 ' O ' ' A' ' 940' ' ' THR . 6.4 t -78.09 150.76 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.175 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 928' ' ' ILE . . . . . 0.469 HG13 ' N ' ' A' ' 929' ' ' LEU . 40.3 pt -120.67 -38.71 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.153 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 929' ' ' LEU . . . . . 0.469 ' N ' HG13 ' A' ' 928' ' ' ILE . 13.3 tp -142.73 151.8 41.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.95 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 930' ' ' ILE . . . . . 0.559 HG12 HG13 ' A' ' 939' ' ' VAL . 76.0 mt -134.87 125.87 46.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.126 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -115.46 125.02 52.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.861 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -94.09 123.55 37.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.862 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 933' ' ' VAL . . . . . 0.728 HG21 ' NE1' ' A' ' 938' ' ' TRP . 5.1 t -91.21 157.31 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.111 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 934' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 933' ' ' VAL . 10.2 mm-40 -33.54 -52.61 0.4 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.911 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -124.72 -24.81 4.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -96.58 171.68 8.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.891 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 937' ' ' MET . . . . . 0.578 ' SD ' HG23 ' A' ' 939' ' ' VAL . 0.3 OUTLIER -132.7 115.08 14.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.892 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 938' ' ' TRP . . . . . 0.728 ' NE1' HG21 ' A' ' 933' ' ' VAL . 31.0 m0 -100.34 146.37 27.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.942 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 939' ' ' VAL . . . . . 0.578 HG23 ' SD ' ' A' ' 937' ' ' MET . 60.4 t -137.07 129.12 43.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.121 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 940' ' ' THR . . . . . 0.485 ' O ' HG13 ' A' ' 927' ' ' VAL . 18.8 m -93.12 153.24 18.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.13 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 941' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -128.05 150.74 49.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 25.0 tp -51.75 -46.37 64.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -118.4 171.06 8.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.855 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -84.44 -42.27 7.48 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.481 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 39.3 p -56.85 -40.57 76.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.881 0.372 . . . . 0.0 110.897 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 1.2 p -54.16 -35.99 62.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.848 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -72.42 -14.44 61.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.15 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 21.9 mt -86.66 -26.4 24.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.928 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -82.76 -50.83 8.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 6.0 p -49.84 -19.45 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.125 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 951' ' ' LEU . . . . . 0.892 HD11 HD11 ' A' ' 967' ' ' LEU . 39.5 mt -55.14 -24.79 28.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.917 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 44.8 t -58.28 -11.75 3.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.867 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 36.6 mt -92.09 13.18 19.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.914 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 954' ' ' ASN . . . . . 0.412 ' O ' ' CG ' ' A' ' 954' ' ' ASN . 3.7 p30 -66.03 117.96 9.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 89.47 -26.09 9.79 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.525 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -40.65 129.28 2.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.751 0.31 . . . . 0.0 110.907 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -97.87 135.22 39.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.854 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 958' ' ' LEU . . . . . 0.735 HD22 ' OE1' ' A' ' 920' ' ' GLN . 18.0 tp -139.16 160.44 39.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.951 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . 0.449 ' C ' ' O ' ' A' ' 958' ' ' LEU . 97.1 mt 34.29 37.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 960' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 958' ' ' LEU . 6.7 m-80 60.91 48.4 6.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 961' ' ' ARG . . . . . 0.876 ' HD2' HD21 ' A' ' 913' ' ' LEU . 68.8 mtt85 -153.05 106.08 2.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.869 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 5.3 m -61.34 115.41 3.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.132 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 963' ' ' ILE . . . . . 0.805 HD13 HD21 ' A' ' 917' ' ' LEU . 57.8 mt -100.69 144.81 12.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.148 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 3.6 m -127.79 113.03 15.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.109 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 965' ' ' ILE . . . . . . . . . . . . . 61.9 mt -95.17 147.14 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.127 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -154.03 126.95 8.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.061 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 967' ' ' LEU . . . . . 0.892 HD11 HD11 ' A' ' 951' ' ' LEU . 32.9 mt -65.25 157.98 27.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 968' ' ' LYS . . . . . 0.424 ' HE2' ' CH2' ' A' ' 938' ' ' TRP . 16.0 tttp -123.26 97.09 5.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 61.5 p -158.2 143.64 12.23 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.618 0.723 . . . . 0.0 110.861 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -78.57 104.05 1.76 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.708 2.272 . . . . 0.0 112.33 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 2.8 m -50.91 122.08 6.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.849 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . 156.59 95.3 0.11 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.48 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 973' ' ' PRO . . . . . 0.411 ' O ' ' C ' ' A' ' 974' ' ' SER . 72.5 Cg_exo -44.78 147.28 1.91 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.633 2.222 . . . . 0.0 112.38 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 974' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 973' ' ' PRO . 10.5 t -37.22 131.18 0.84 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.817 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 34.6 m -152.18 127.43 9.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.833 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.498 -179.993 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 58.0 m -100.89 139.08 37.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.839 0.352 . . . . 0.0 110.886 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 3.4 m -63.1 130.04 42.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.851 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . 165.8 91.08 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.522 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 12.9 m -104.33 108.77 20.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.826 0.346 . . . . 0.0 110.826 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 3.5 m -68.85 168.59 13.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.893 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 43.53 -112.38 0.54 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.454 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . 172.12 47.3 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.474 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 97.7 m -88.44 119.51 28.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.789 0.328 . . . . 0.0 111.123 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 895' ' ' VAL . . . . . 0.501 HG12 HD23 ' A' ' 967' ' ' LEU . 22.4 m -121.34 138.51 51.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.148 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . 0.465 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 5.5 mp -88.99 145.74 25.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.616 HG22 HG12 ' A' ' 965' ' ' ILE . 79.1 t -147.01 126.34 4.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 11.1 t -127.1 152.28 47.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.824 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.552 HG22 HG12 ' A' ' 963' ' ' ILE . 3.5 pt -120.49 133.59 66.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.122 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -90.71 123.85 34.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.896 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 901' ' ' SER . . . . . . . . . . . . . 1.2 t -137.75 177.8 7.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.846 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 31.9 t -97.67 -56.61 2.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.823 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 13.5 mt -74.92 152.01 86.57 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.645 0.736 . . . . 0.0 110.918 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -77.21 -13.18 17.15 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.684 2.256 . . . . 0.0 112.334 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -95.0 10.12 36.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.874 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 906' ' ' ASN . . . . . 0.432 ' O ' ' N ' ' A' ' 908' ' ' PHE . 46.2 m-20 -107.47 -35.85 6.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 907' ' ' ASN . . . . . 0.414 ' C ' ' O ' ' A' ' 906' ' ' ASN . 30.8 m-20 -37.33 -31.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.883 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 908' ' ' PHE . . . . . 0.432 ' N ' ' O ' ' A' ' 906' ' ' ASN . 10.9 m-85 -74.37 119.14 18.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.897 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 909' ' ' PHE . . . . . 0.583 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 69.0 m-85 -56.84 132.62 52.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 910' ' ' ASP . . . . . 0.532 ' H ' HD12 ' A' ' 913' ' ' LEU . 76.9 m-20 -97.95 169.11 9.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.876 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -48.16 -49.06 33.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.888 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -57.17 -56.04 26.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.089 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 913' ' ' LEU . . . . . 0.532 HD12 ' H ' ' A' ' 910' ' ' ASP . 31.3 mt -49.23 -54.18 17.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 56.0 mt -60.68 -64.48 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.137 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -42.94 -56.78 3.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.83 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -52.57 -50.98 61.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.849 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 917' ' ' LEU . . . . . 0.77 HD21 HD13 ' A' ' 963' ' ' ILE . 25.9 mt -48.15 -57.45 5.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 918' ' ' LEU . . . . . 0.445 ' C ' ' O ' ' A' ' 917' ' ' LEU . 40.5 mt -34.37 -55.37 0.52 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.887 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -56.77 -45.54 82.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.9 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 920' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 917' ' ' LEU . 88.5 mm-40 -58.76 -36.54 74.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 921' ' ' PHE . . . . . 0.525 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 22.1 m-85 -72.64 -47.46 47.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.852 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -48.77 -34.65 12.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.078 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -46.38 -32.87 3.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 924' ' ' PHE . . . . . 0.553 ' N ' ' CD1' ' A' ' 924' ' ' PHE . 0.5 OUTLIER -121.63 -58.5 1.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.915 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -121.02 148.47 17.49 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.525 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 926' ' ' GLU . . . . . 0.5 ' OE2' HG22 ' A' ' 928' ' ' ILE . 2.0 tm-20 -90.1 128.7 36.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.868 0.366 . . . . 0.0 110.874 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 41.1 t -84.14 139.95 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 928' ' ' ILE . . . . . 0.5 HG22 ' OE2' ' A' ' 926' ' ' GLU . 35.4 pt -122.43 -40.54 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.12 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 929' ' ' LEU . . . . . 0.477 ' N ' HG13 ' A' ' 928' ' ' ILE . 15.6 tp -136.83 136.05 38.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.907 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 81.7 mt -122.76 126.56 74.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.089 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 11.8 tpt85 -112.18 124.68 52.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.868 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -93.57 117.01 29.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 933' ' ' VAL . . . . . 0.664 HG21 ' NE1' ' A' ' 938' ' ' TRP . 2.9 t -85.78 156.99 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.104 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 934' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 933' ' ' VAL . 33.1 mt-10 -34.43 -51.33 0.46 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.857 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -125.49 -26.25 3.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -96.16 173.04 7.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.917 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 937' ' ' MET . . . . . 0.583 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 15.3 ttt -134.11 111.73 10.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.905 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 938' ' ' TRP . . . . . 0.664 ' NE1' HG21 ' A' ' 933' ' ' VAL . 38.8 m0 -92.11 148.13 22.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.957 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 43.0 t -134.14 125.8 48.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.083 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 14.0 m -92.46 151.75 20.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.152 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 941' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -132.24 143.87 50.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.862 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 54.2 tp -41.27 -52.87 3.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.878 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -118.17 177.99 4.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -86.67 -48.08 4.6 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.525 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 46.6 t -50.8 -39.07 51.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.863 0.363 . . . . 0.0 110.841 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 56.8 p -57.51 -32.36 66.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.87 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 947' ' ' ALA . . . . . . . . . . . . . . . -76.4 -20.91 56.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.086 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 36.5 mt -77.97 -27.93 49.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.926 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -81.93 -51.56 7.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.883 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 9.5 p -48.21 -21.56 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.12 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 951' ' ' LEU . . . . . 0.449 HD21 ' HG ' ' A' ' 967' ' ' LEU . 34.2 mt -49.37 -29.43 6.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.937 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 35.7 p -50.28 -19.77 0.89 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.839 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 76.7 mt -88.84 20.15 3.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.885 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -74.41 106.34 5.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.928 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 98.85 -26.76 22.84 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.461 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -37.97 128.19 1.25 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.71 0.291 . . . . 0.0 110.887 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -93.38 125.15 37.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 15.2 tp -133.01 154.58 50.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 43.2 mt 41.01 47.78 2.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.913 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 51.64 40.5 27.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 961' ' ' ARG . . . . . . . . . . . . . 65.2 mtt85 -147.63 122.69 10.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.858 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 6.1 m -74.17 115.08 13.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.154 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 963' ' ' ILE . . . . . 0.77 HD13 HD21 ' A' ' 917' ' ' LEU . 84.6 mt -99.81 135.51 35.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.124 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 14.9 m -119.74 112.5 19.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.173 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 965' ' ' ILE . . . . . 0.616 HG12 HG22 ' A' ' 897' ' ' VAL . 67.3 mt -98.99 137.48 26.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.122 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -151.37 135.33 16.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.087 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 967' ' ' LEU . . . . . 0.501 HD23 HG12 ' A' ' 895' ' ' VAL . 28.9 mt -66.26 157.98 30.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.907 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.57 121.55 25.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.918 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 88.0 p -66.11 144.2 98.68 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.619 0.723 . . . . 0.0 110.876 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.61 101.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.663 2.242 . . . . 0.0 112.315 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 6.1 t -142.24 114.74 8.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.85 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . 170.25 -99.45 0.15 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.455 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -78.56 17.46 1.1 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.7 2.267 . . . . 0.0 112.368 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 13.4 t -143.31 106.69 4.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.823 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 3.1 t 50.68 42.79 27.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.878 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.476 179.962 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 59.3 p -72.77 -44.31 61.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.845 0.355 . . . . 0.0 110.828 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 2.0 m -103.74 102.77 12.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . -50.37 117.22 4.81 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.519 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 61.9 p -53.63 115.59 2.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.888 0.375 . . . . 0.0 110.874 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 6.6 m -165.48 174.18 10.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.855 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -56.76 -103.89 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.485 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . -170.97 40.07 0.18 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.502 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 39.3 m -82.04 122.84 28.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.865 0.364 . . . . 0.0 111.171 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 895' ' ' VAL . . . . . 0.527 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 17.8 m -117.49 144.09 26.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.169 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . 0.472 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 6.8 mp -92.89 137.92 31.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 60.1 t -140.13 131.24 31.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.161 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 3.1 t -130.62 156.32 45.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.881 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.527 HG23 ' CE2' ' A' ' 909' ' ' PHE . 3.3 pt -122.28 135.77 61.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.183 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.73 119.97 23.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 901' ' ' SER . . . . . . . . . . . . . 19.4 p -135.85 174.96 10.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.826 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 1.1 t -110.63 -43.19 3.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.841 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 12.8 mt -87.05 152.75 53.73 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.611 0.72 . . . . 0.0 110.929 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.76 -16.39 16.46 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.689 2.26 . . . . 0.0 112.355 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -99.37 17.67 19.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 906' ' ' ASN . . . . . 0.457 ' O ' ' N ' ' A' ' 908' ' ' PHE . 1.8 m-80 -118.23 -35.11 3.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.931 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 907' ' ' ASN . . . . . 0.427 ' O ' HD11 ' A' ' 899' ' ' ILE . 8.6 p30 -40.15 -26.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.926 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 908' ' ' PHE . . . . . 0.457 ' N ' ' O ' ' A' ' 906' ' ' ASN . 56.1 m-85 -70.81 124.61 24.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.878 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 909' ' ' PHE . . . . . 0.539 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 87.4 m-85 -61.28 132.13 52.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.897 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 910' ' ' ASP . . . . . 0.812 ' H ' HD12 ' A' ' 913' ' ' LEU . 24.0 t70 -97.89 165.65 11.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.871 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -48.51 -50.06 33.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -56.84 -48.92 76.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.117 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 913' ' ' LEU . . . . . 0.812 HD12 ' H ' ' A' ' 910' ' ' ASP . 72.4 mt -56.72 -50.45 72.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.895 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 50.6 mt -64.0 -63.79 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.108 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -42.07 -56.47 2.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.819 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -54.34 -46.81 72.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.876 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 917' ' ' LEU . . . . . 0.903 HD21 HD13 ' A' ' 963' ' ' ILE . 24.9 mt -54.15 -56.08 21.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.933 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 918' ' ' LEU . . . . . 0.495 ' CD2' HD11 ' A' ' 930' ' ' ILE . 68.3 mt -34.41 -60.6 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.883 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -52.31 -51.07 60.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -52.48 -40.05 61.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 921' ' ' PHE . . . . . 0.564 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 22.9 m-85 -66.82 -44.59 80.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.865 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -50.57 -33.63 22.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.123 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 923' ' ' SER . . . . . 0.54 ' HB3' ' CE1' ' A' ' 924' ' ' PHE . 10.4 t -41.86 -34.64 0.69 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.87 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 924' ' ' PHE . . . . . 0.54 ' CE1' ' HB3' ' A' ' 923' ' ' SER . 0.9 OUTLIER -120.17 -51.68 2.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.844 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -128.27 141.56 12.71 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.442 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -85.58 99.47 11.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.896 0.379 . . . . 0.0 110.894 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 40.2 t -51.23 143.91 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.122 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 928' ' ' ILE . . . . . 0.475 HG13 ' N ' ' A' ' 929' ' ' LEU . 21.0 pt -120.04 -44.8 2.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.093 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 929' ' ' LEU . . . . . 0.475 ' N ' HG13 ' A' ' 928' ' ' ILE . 11.1 tp -135.56 146.51 48.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.949 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 930' ' ' ILE . . . . . 0.495 HD11 ' CD2' ' A' ' 918' ' ' LEU . 57.0 mt -130.05 137.57 56.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.13 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -125.88 122.29 35.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -88.48 124.07 33.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.845 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 933' ' ' VAL . . . . . 0.644 HG21 ' CD1' ' A' ' 938' ' ' TRP . 13.5 t -92.63 157.52 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.089 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 934' ' ' GLU . . . . . 0.482 ' C ' ' O ' ' A' ' 933' ' ' VAL . 15.2 mm-40 -31.24 -56.03 0.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -121.88 -26.01 4.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.859 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 4.7 tttm -96.12 173.25 7.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.839 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 937' ' ' MET . . . . . 0.539 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 10.8 ttt -132.39 105.93 7.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 938' ' ' TRP . . . . . 0.644 ' CD1' HG21 ' A' ' 933' ' ' VAL . 44.1 m0 -85.25 142.49 29.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.928 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 939' ' ' VAL . . . . . 0.488 HG13 HG12 ' A' ' 930' ' ' ILE . 43.8 t -132.56 129.62 59.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.133 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 940' ' ' THR . . . . . 0.403 HG22 ' N ' ' A' ' 941' ' ' PHE . 32.9 m -92.53 154.23 18.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.162 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 941' ' ' PHE . . . . . 0.413 ' O ' ' C ' ' A' ' 942' ' ' LEU . 11.2 m-85 -134.17 146.97 50.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.865 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 942' ' ' LEU . . . . . 0.413 ' C ' ' O ' ' A' ' 941' ' ' PHE . 23.6 tp -36.91 -61.49 0.55 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.909 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -125.62 153.53 43.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -50.5 -51.01 33.96 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.509 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 945' ' ' SER . . . . . 0.587 ' HA ' HD12 ' A' ' 948' ' ' LEU . 82.6 p -46.7 -42.86 17.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.9 0.381 . . . . 0.0 110.843 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 14.5 m -56.32 -30.86 63.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 947' ' ' ALA . . . . . 0.527 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -82.47 -16.73 47.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.118 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 948' ' ' LEU . . . . . 0.587 HD12 ' HA ' ' A' ' 945' ' ' SER . 23.4 mt -83.23 -23.6 32.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.927 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -88.34 -46.47 9.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.92 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 7.2 p -51.33 -22.25 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.148 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 951' ' ' LEU . . . . . 0.465 HD21 ' HG ' ' A' ' 967' ' ' LEU . 39.5 mt -50.41 -24.84 3.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.918 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 32.5 m -55.26 -15.51 2.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 36.5 mt -91.53 17.01 9.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.905 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -69.06 120.85 15.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.929 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 85.63 -27.31 5.35 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.458 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -38.21 127.36 1.35 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.74 0.305 . . . . 0.0 110.893 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -95.4 125.49 40.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.862 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 14.5 tp -134.46 153.44 51.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.969 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . 0.441 ' O ' ' CG ' ' A' ' 960' ' ' ASN . 35.0 mt 41.56 49.17 3.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 960' ' ' ASN . . . . . 0.441 ' CG ' ' O ' ' A' ' 959' ' ' LEU . 13.0 p30 47.75 40.29 11.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 961' ' ' ARG . . . . . 0.757 ' HD2' HD21 ' A' ' 913' ' ' LEU . 47.1 mtt85 -147.56 104.99 3.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 27.1 m -58.94 120.88 9.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.133 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 963' ' ' ILE . . . . . 0.903 HD13 HD21 ' A' ' 917' ' ' LEU . 87.2 mt -103.98 143.4 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 8.7 m -127.22 119.93 27.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.134 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 965' ' ' ILE . . . . . . . . . . . . . 63.4 mt -103.77 140.27 22.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.131 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -149.85 137.12 19.75 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.077 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 967' ' ' LEU . . . . . 0.465 ' HG ' HD21 ' A' ' 951' ' ' LEU . 25.1 mt -73.75 153.48 40.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.95 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 968' ' ' LYS . . . . . 0.432 ' HD3' HD11 ' A' ' 896' ' ' LEU . 19.2 tptp -86.71 149.24 25.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.89 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 66.3 p -58.61 143.48 81.54 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.661 0.743 . . . . 0.0 110.869 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.01 -50.36 11.08 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.681 2.254 . . . . 0.0 112.399 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 14.7 t -55.67 152.73 8.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.854 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -162.44 72.32 0.2 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.474 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.69 163.09 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.698 2.265 . . . . 0.0 112.359 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 38.3 m -81.58 -55.07 4.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.868 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 85.5 p -39.41 116.2 0.58 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.825 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.443 179.955 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 86.3 p -57.08 98.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.847 0.356 . . . . 0.0 110.882 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 87.6 p -92.53 113.84 26.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.825 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . 172.59 165.29 29.42 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.464 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 4.3 t -158.12 145.93 18.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.842 0.353 . . . . 0.0 110.87 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 891' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 892' ' ' GLY . 61.1 p -173.46 178.79 2.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.83 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 892' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 891' ' ' SER . . . -36.89 -81.23 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.445 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . 156.32 46.14 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.48 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 71.9 m -112.03 119.45 38.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.805 0.336 . . . . 0.0 111.159 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 895' ' ' VAL . . . . . 0.475 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 13.7 m -117.17 142.86 29.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.157 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . 0.469 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 5.0 mp -91.74 143.15 26.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 79.8 t -142.44 127.5 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 9.7 t -129.61 158.05 40.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.841 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.517 HG22 HG12 ' A' ' 963' ' ' ILE . 2.7 pt -121.54 163.84 19.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.12 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 21.9 mttp -98.85 109.07 21.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 901' ' ' SER . . . . . . . . . . . . . 5.2 m -139.2 128.79 24.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.827 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 2.6 t -76.01 -47.66 24.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.859 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 14.4 mt -73.62 147.63 87.08 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.574 0.702 . . . . 0.0 110.945 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.98 -13.51 19.41 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.675 2.25 . . . . 0.0 112.352 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -99.66 15.18 27.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 906' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 908' ' ' PHE . 2.4 m-80 -118.17 -37.09 3.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.935 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -39.34 -26.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 908' ' ' PHE . . . . . 0.474 ' N ' ' O ' ' A' ' 906' ' ' ASN . 59.0 m-85 -69.1 135.61 51.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.863 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 909' ' ' PHE . . . . . 0.579 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 94.1 m-85 -77.65 119.97 21.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.87 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 910' ' ' ASP . . . . . 0.662 ' H ' HD12 ' A' ' 913' ' ' LEU . 9.6 m-20 -85.04 160.11 20.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.884 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -45.64 -40.43 9.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.852 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -65.33 -49.99 67.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.104 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 913' ' ' LEU . . . . . 0.662 HD12 ' H ' ' A' ' 910' ' ' ASP . 29.4 mt -56.76 -45.85 81.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 36.5 mt -69.52 -59.75 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.155 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -48.89 -50.99 32.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.86 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 916' ' ' GLU . . . . . 0.546 ' HG3' HD11 ' A' ' 959' ' ' LEU . 36.6 mm-40 -56.89 -40.8 76.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.86 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 917' ' ' LEU . . . . . 0.95 HD21 HD13 ' A' ' 963' ' ' ILE . 22.0 mt -59.88 -51.64 68.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 918' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 917' ' ' LEU . 30.8 mt -34.89 -64.19 0.28 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.906 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -50.2 -51.98 39.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.904 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 920' ' ' GLN . . . . . 0.443 ' O ' HD11 ' A' ' 953' ' ' LEU . 13.8 mm100 -49.63 -40.5 39.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.922 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 921' ' ' PHE . . . . . 0.553 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 22.7 m-85 -72.37 -42.78 64.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.899 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -50.99 -38.03 48.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.114 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -46.81 -21.13 0.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 924' ' ' PHE . . . . . 0.475 ' N ' ' CD1' ' A' ' 924' ' ' PHE . 1.4 m-85 -124.0 -58.88 1.54 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.914 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -130.1 151.0 19.26 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.512 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -88.86 125.35 34.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.887 0.375 . . . . 0.0 110.863 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 6.1 t -78.93 150.29 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.141 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 928' ' ' ILE . . . . . 0.475 HG13 ' N ' ' A' ' 929' ' ' LEU . 35.1 pt -125.63 -40.46 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.101 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 929' ' ' LEU . . . . . 0.475 ' N ' HG13 ' A' ' 928' ' ' ILE . 12.0 tp -141.12 146.34 36.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.941 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 930' ' ' ILE . . . . . 0.729 HG12 HG13 ' A' ' 939' ' ' VAL . 51.3 mt -134.62 143.04 38.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.119 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.62 128.69 31.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.849 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -91.99 123.55 35.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.87 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 933' ' ' VAL . . . . . 0.84 HG21 ' NE1' ' A' ' 938' ' ' TRP . 2.6 t -87.89 157.18 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.13 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 934' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 933' ' ' VAL . 45.8 mt-10 -33.49 -49.7 0.3 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.838 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -127.12 -28.22 2.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.867 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 6.8 ttmm -96.02 173.12 7.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 937' ' ' MET . . . . . 0.579 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 12.5 ttt -135.18 108.06 7.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 938' ' ' TRP . . . . . 0.84 ' NE1' HG21 ' A' ' 933' ' ' VAL . 13.4 m0 -94.88 143.62 26.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.929 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 939' ' ' VAL . . . . . 0.729 HG13 HG12 ' A' ' 930' ' ' ILE . 43.6 t -128.65 139.99 50.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.131 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 940' ' ' THR . . . . . 0.456 HG22 ' N ' ' A' ' 941' ' ' PHE . 53.0 m -98.51 156.26 16.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.099 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 941' ' ' PHE . . . . . 0.456 ' N ' HG22 ' A' ' 940' ' ' THR . 13.2 m-85 -136.23 149.86 48.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.916 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 942' ' ' LEU . . . . . . . . . . . . . 32.5 tp -51.04 -52.13 46.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.953 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -114.69 173.91 6.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.904 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -86.89 -47.18 4.87 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.472 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 945' ' ' SER . . . . . . . . . . . . . 13.0 m -56.06 -27.2 52.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.917 0.389 . . . . 0.0 110.882 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 50.6 p -67.91 -28.14 67.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.862 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 947' ' ' ALA . . . . . 0.475 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -79.32 -13.26 59.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.083 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 948' ' ' LEU . . . . . . . . . . . . . 32.3 mt -85.4 -31.97 22.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.912 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 41.8 m-20 -75.62 -42.33 52.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 5.7 p -56.77 -15.76 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.149 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 951' ' ' LEU . . . . . 0.511 HD21 ' HG ' ' A' ' 967' ' ' LEU . 31.6 mt -55.62 -29.1 58.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.904 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 70.7 m -55.99 -23.16 30.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.845 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 953' ' ' LEU . . . . . 0.476 ' C ' HD12 ' A' ' 965' ' ' ILE . 39.2 mt -82.03 9.08 9.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.887 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.04 119.09 13.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 91.95 -25.41 16.93 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.487 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -44.07 128.65 5.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.748 0.309 . . . . 0.0 110.941 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -93.08 133.27 36.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.922 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 13.8 tp -147.87 158.32 43.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.949 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . 0.546 HD11 ' HG3' ' A' ' 916' ' ' GLU . 33.1 mt 40.06 46.71 1.86 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.948 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 48.1 42.13 16.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 961' ' ' ARG . . . . . 0.627 ' HD2' HD21 ' A' ' 913' ' ' LEU . 64.1 mtt85 -152.14 115.22 4.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 12.5 m -68.31 123.97 22.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.115 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 963' ' ' ILE . . . . . 0.95 HD13 HD21 ' A' ' 917' ' ' LEU . 85.8 mt -107.17 143.86 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.083 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 10.1 m -129.1 117.57 21.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.177 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 965' ' ' ILE . . . . . 0.476 HD12 ' C ' ' A' ' 953' ' ' LEU . 23.2 mt -98.64 145.15 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.152 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -155.93 129.6 8.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 967' ' ' LEU . . . . . 0.511 ' HG ' HD21 ' A' ' 951' ' ' LEU . 38.3 mt -65.22 157.7 28.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 968' ' ' LYS . . . . . 0.415 ' HD3' HD11 ' A' ' 896' ' ' LEU . 34.4 tptt -92.69 150.03 20.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 57.1 p -47.88 142.62 6.95 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.66 0.743 . . . . 0.0 110.856 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.94 165.33 0.09 OUTLIER 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.712 2.274 . . . . 0.0 112.307 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 6.5 t 55.5 43.55 28.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.861 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -78.93 -147.88 3.96 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.485 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.25 117.43 4.85 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.641 2.227 . . . . 0.0 112.376 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 74.8 m -96.7 125.81 41.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 51.5 p 38.99 42.37 0.66 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.852 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.51 179.993 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 12.8 t -110.11 87.96 2.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.865 0.364 . . . . 0.0 110.852 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 47.4 t -111.0 142.5 43.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.875 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . 85.25 84.91 1.0 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.453 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 59.5 p -121.37 123.73 42.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.851 0.358 . . . . 0.0 110.865 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 6.5 t -98.84 140.66 32.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.882 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 64.88 143.13 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.443 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . -107.56 40.65 2.44 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.479 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 59.1 m -92.76 122.18 34.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.816 0.341 . . . . 0.0 111.136 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 895' ' ' VAL . . . . . 0.749 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 12.8 m -118.56 143.42 29.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.118 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . 0.463 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 3.5 mp -93.22 145.75 24.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.927 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.421 HG13 ' CG2' ' A' ' 963' ' ' ILE . 98.0 t -146.2 128.57 8.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.131 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 30.9 t -133.21 159.53 39.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.893 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.87 121.42 65.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.132 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 14.1 ttpp -83.62 121.2 26.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 901' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 902' ' ' SER . 1.8 t -132.56 140.07 48.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 902' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 901' ' ' SER . 3.2 m -36.73 -57.12 0.81 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.852 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 61.9 mt -95.08 146.31 31.09 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.589 0.709 . . . . 0.0 110.941 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.27 -27.12 13.89 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.698 2.266 . . . . 0.0 112.355 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -79.75 9.21 5.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.847 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 906' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -119.82 16.59 12.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -87.33 25.56 1.38 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.909 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -84.73 144.38 28.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.856 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 909' ' ' PHE . . . . . 0.589 ' CE2' ' HB2' ' A' ' 937' ' ' MET . 45.9 m-85 -91.59 107.54 19.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.843 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 910' ' ' ASP . . . . . 0.763 ' H ' HD12 ' A' ' 913' ' ' LEU . 25.8 m-20 -83.71 157.71 22.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.904 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -43.75 -58.4 2.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.904 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -45.26 -58.0 3.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.12 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 913' ' ' LEU . . . . . 0.763 HD12 ' H ' ' A' ' 910' ' ' ASP . 24.7 mt -44.26 -56.23 4.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.925 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 71.4 mt -58.86 -62.21 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -43.46 -67.52 0.27 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 916' ' ' GLU . . . . . 0.66 ' HG3' HD11 ' A' ' 959' ' ' LEU . 8.5 mm-40 -43.78 -55.22 4.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.854 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 917' ' ' LEU . . . . . 0.954 HD21 HD13 ' A' ' 963' ' ' ILE . 30.3 mt -44.97 -58.89 2.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.903 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 918' ' ' LEU . . . . . 0.439 ' C ' ' O ' ' A' ' 917' ' ' LEU . 90.1 mt -35.25 -58.16 0.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.983 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -56.68 -38.52 72.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.924 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 920' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 917' ' ' LEU . 72.7 mm-40 -63.74 -36.67 84.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 921' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -72.02 -37.38 69.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -57.89 -34.04 69.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.131 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -47.91 -25.21 1.25 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 924' ' ' PHE . . . . . 0.477 ' N ' ' CD1' ' A' ' 924' ' ' PHE . 2.4 m-85 -121.64 -64.35 1.23 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.884 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -123.26 154.38 17.24 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.504 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -88.57 135.11 33.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.919 0.39 . . . . 0.0 110.895 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 19.9 t -86.29 149.06 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.115 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 928' ' ' ILE . . . . . 0.479 HG13 ' N ' ' A' ' 929' ' ' LEU . 27.7 pt -129.12 -42.85 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.14 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 929' ' ' LEU . . . . . 0.479 ' N ' HG13 ' A' ' 928' ' ' ILE . 15.8 tp -136.27 145.71 45.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.919 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 64.9 mt -133.72 128.92 54.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.136 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -120.11 126.73 51.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.862 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -92.17 120.59 32.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.841 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 933' ' ' VAL . . . . . 0.772 HG21 ' NE1' ' A' ' 938' ' ' TRP . 3.0 t -86.96 157.09 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.179 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 934' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 933' ' ' VAL . 34.4 mm-40 -33.98 -52.51 0.44 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -124.95 -24.74 4.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.853 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 936' ' ' LYS . . . . . 0.431 ' NZ ' ' HB3' ' A' ' 896' ' ' LEU . 14.7 tttm -97.57 173.07 7.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 937' ' ' MET . . . . . 0.589 ' HB2' ' CE2' ' A' ' 909' ' ' PHE . 16.5 ttt -132.04 115.09 15.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.915 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 938' ' ' TRP . . . . . 0.772 ' NE1' HG21 ' A' ' 933' ' ' VAL . 39.5 m0 -94.63 150.37 20.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.955 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 939' ' ' VAL . . . . . . . . . . . . . 70.0 t -142.36 128.24 17.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.104 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 5.6 m -95.54 150.88 19.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.115 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 941' ' ' PHE . . . . . 0.446 ' O ' ' C ' ' A' ' 942' ' ' LEU . 9.6 m-85 -129.37 145.59 51.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 942' ' ' LEU . . . . . 0.446 ' C ' ' O ' ' A' ' 941' ' ' PHE . 16.0 tp -34.4 -64.82 0.23 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -114.81 165.57 12.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -65.92 -54.09 26.86 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.52 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 945' ' ' SER . . . . . 0.615 ' HA ' HD12 ' A' ' 948' ' ' LEU . 84.3 p -48.15 -27.14 2.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.912 0.387 . . . . 0.0 110.869 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 69.1 m -67.23 -34.78 78.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 947' ' ' ALA . . . . . 0.749 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -80.04 -13.79 59.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.111 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 948' ' ' LEU . . . . . 0.615 HD12 ' HA ' ' A' ' 945' ' ' SER . 20.0 mt -87.44 -22.97 24.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.933 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 -85.54 -38.48 18.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.88 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 8.4 p -60.09 -21.96 23.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.163 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 951' ' ' LEU . . . . . 0.439 HD21 ' HG ' ' A' ' 967' ' ' LEU . 43.5 mt -50.14 -23.06 1.93 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.924 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 18.6 m -56.9 -15.0 3.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.826 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 953' ' ' LEU . . . . . 0.454 ' HB2' ' CD1' ' A' ' 965' ' ' ILE . 56.9 mt -92.99 11.48 27.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.938 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -63.4 116.51 5.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.888 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 90.67 -25.67 12.77 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.544 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -42.37 128.21 3.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.785 0.326 . . . . 0.0 110.922 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -95.68 128.39 42.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.92 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 14.9 tp -135.58 153.41 51.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.891 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . 0.66 HD11 ' HG3' ' A' ' 916' ' ' GLU . 36.0 mt 42.73 49.6 4.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 47.6 44.07 16.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.89 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 961' ' ' ARG . . . . . 0.471 ' CD ' HD11 ' A' ' 913' ' ' LEU . 57.8 mtt-85 -152.29 109.72 3.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 31.1 m -62.56 122.3 15.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.17 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 963' ' ' ILE . . . . . 0.954 HD13 HD21 ' A' ' 917' ' ' LEU . 93.3 mt -105.11 148.8 9.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.173 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 5.7 m -132.67 113.78 13.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.124 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 965' ' ' ILE . . . . . 0.454 ' CD1' ' HB2' ' A' ' 953' ' ' LEU . 56.5 mt -96.58 140.28 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.157 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -149.29 135.46 19.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.119 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 967' ' ' LEU . . . . . 0.439 ' HG ' HD21 ' A' ' 951' ' ' LEU . 26.8 mt -71.89 154.95 40.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.894 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -86.74 115.96 24.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 95.7 p -43.42 155.71 0.29 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.659 0.743 . . . . 0.0 110.872 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.56 111.17 0.3 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.672 2.248 . . . . 0.0 112.357 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 43.1 t -90.92 -52.28 4.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.866 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . 175.29 95.26 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.491 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -76.82 41.96 1.0 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.661 2.241 . . . . 0.0 112.307 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 17.6 m -108.39 -60.02 1.79 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.897 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 52.5 p -113.75 126.09 54.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.49 179.982 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 28.1 m -73.06 115.24 12.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.835 0.35 . . . . 0.0 110.913 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 11.9 p -130.57 -44.49 1.1 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.821 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . 157.47 -110.89 0.46 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.507 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 890' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 891' ' ' SER . 60.9 m -127.48 115.69 19.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.885 0.374 . . . . 0.0 110.841 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 891' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 890' ' ' SER . 3.9 t 35.45 39.46 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.89 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 80.44 50.29 5.44 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.44 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . 53.19 37.56 54.88 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.511 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 69.4 m -96.61 120.44 36.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.816 0.341 . . . . 0.0 111.146 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 895' ' ' VAL . . . . . 0.612 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 17.1 m -115.45 143.68 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.15 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . 0.469 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 5.0 mp -91.65 141.94 28.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . . . . . . . . . 80.6 t -137.03 129.72 44.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.132 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 12.4 t -133.46 158.48 42.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.83 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.429 HG22 HG12 ' A' ' 963' ' ' ILE . 2.5 pt -119.94 150.56 22.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.117 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -86.47 104.75 16.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 901' ' ' SER . . . . . . . . . . . . . 52.4 p -140.09 136.9 34.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.914 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 902' ' ' SER . . . . . . . . . . . . . 17.6 m -72.87 -57.91 3.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.892 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 35.2 mt -76.18 150.3 82.91 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.586 0.708 . . . . 0.0 110.921 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.16 -31.11 8.02 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.698 2.265 . . . . 0.0 112.316 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -65.94 -6.62 13.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.901 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 906' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -107.96 -23.41 12.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 32.1 m-20 -52.8 -19.31 2.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -80.09 136.91 36.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.899 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 909' ' ' PHE . . . . . 0.573 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 92.9 m-85 -79.22 129.93 34.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 910' ' ' ASP . . . . . 0.441 ' H ' HD12 ' A' ' 913' ' ' LEU . 26.8 m-20 -96.71 173.05 7.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.845 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 911' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -53.75 -36.71 62.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.854 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -69.0 -49.54 56.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.071 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 913' ' ' LEU . . . . . 0.441 HD12 ' H ' ' A' ' 910' ' ' ASP . 22.2 mt -59.06 -44.83 91.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 54.3 mt -69.74 -59.88 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.151 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -41.58 -64.92 0.5 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.843 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 916' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -47.27 -56.05 7.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 917' ' ' LEU . . . . . 0.759 HD21 HD13 ' A' ' 963' ' ' ILE . 26.9 mt -42.16 -54.22 3.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 918' ' ' LEU . . . . . . . . . . . . . 62.8 mt -40.46 -57.69 1.74 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.954 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -58.71 -42.93 89.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 920' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -58.71 -38.8 79.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 921' ' ' PHE . . . . . 0.563 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 24.5 m-85 -69.92 -37.39 75.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -56.27 -35.45 67.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.071 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.7 m -44.53 -29.16 0.67 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 924' ' ' PHE . . . . . 0.496 ' N ' ' CD1' ' A' ' 924' ' ' PHE . 1.8 m-85 -121.3 -59.6 1.7 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.849 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -124.26 140.21 12.48 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.514 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -82.52 99.41 9.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.814 0.34 . . . . 0.0 110.88 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 927' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 940' ' ' THR . 34.7 t -50.27 143.71 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.163 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 928' ' ' ILE . . . . . 0.654 HD13 ' HA ' ' A' ' 942' ' ' LEU . 15.3 pt -120.02 -39.97 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.15 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 929' ' ' LEU . . . . . . . . . . . . . 8.6 tp -140.44 149.36 42.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.913 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 930' ' ' ILE . . . . . 0.589 HG12 HG13 ' A' ' 939' ' ' VAL . 41.9 mt -137.05 145.58 29.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.104 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 8.1 ttp180 -135.78 124.19 23.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.917 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -87.75 120.38 29.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.909 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 933' ' ' VAL . . . . . 0.694 HG21 ' CD1' ' A' ' 938' ' ' TRP . 3.6 t -87.15 157.15 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.106 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 934' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 933' ' ' VAL . 22.8 mm-40 -34.04 -53.72 0.47 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -124.17 -21.57 4.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.834 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 936' ' ' LYS . . . . . . . . . . . . . 16.9 ttmt -99.93 172.94 6.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 937' ' ' MET . . . . . 0.573 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 15.2 ttt -131.85 109.03 9.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.841 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 938' ' ' TRP . . . . . 0.694 ' CD1' HG21 ' A' ' 933' ' ' VAL . 43.4 m0 -89.41 143.13 27.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.913 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 939' ' ' VAL . . . . . 0.589 HG13 HG12 ' A' ' 930' ' ' ILE . 46.6 t -135.8 122.73 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.095 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 940' ' ' THR . . . . . 0.445 ' O ' HG13 ' A' ' 927' ' ' VAL . 18.4 m -91.04 152.94 20.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.154 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 941' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -129.21 155.53 45.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.869 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 942' ' ' LEU . . . . . 0.654 ' HA ' HD13 ' A' ' 928' ' ' ILE . 16.1 tp -38.47 -56.72 1.23 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.959 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -136.11 165.67 25.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.862 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 944' ' ' GLY . . . . . . . . . . . . . . . -52.97 -53.44 33.72 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.461 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 945' ' ' SER . . . . . 0.411 ' HA ' HD12 ' A' ' 948' ' ' LEU . 77.3 p -46.38 -44.6 17.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.835 0.35 . . . . 0.0 110.847 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 72.2 m -55.17 -32.85 62.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 947' ' ' ALA . . . . . 0.612 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -82.51 -13.43 56.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.102 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 948' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 945' ' ' SER . 60.2 mt -85.65 -28.35 24.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.909 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -85.37 -34.09 21.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.13 -20.26 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.16 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 951' ' ' LEU . . . . . 0.424 HD21 ' HG ' ' A' ' 967' ' ' LEU . 41.2 mt -52.85 -26.56 15.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.93 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 9.7 m -56.36 -21.49 24.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.841 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 26.6 mt -82.04 4.96 20.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.89 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.16 122.71 17.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 88.7 -26.56 8.12 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.485 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -42.32 127.15 3.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.752 0.31 . . . . 0.0 110.913 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -93.63 130.82 39.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 14.8 tp -141.36 152.46 44.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.913 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . . . . . . . . . 81.4 mt 42.03 48.42 4.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.964 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 960' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 48.57 40.74 16.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.839 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 961' ' ' ARG . . . . . . . . . . . . . 51.5 mtt85 -148.94 105.0 3.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.871 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 56.3 m -62.67 121.35 13.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.12 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 963' ' ' ILE . . . . . 0.759 HD13 HD21 ' A' ' 917' ' ' LEU . 64.7 mt -102.32 152.87 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.14 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 964' ' ' THR . . . . . 0.42 ' N ' HG22 ' A' ' 963' ' ' ILE . 11.6 m -136.45 117.51 14.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.1 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 965' ' ' ILE . . . . . . . . . . . . . 33.7 mt -100.37 143.62 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.104 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -154.28 129.38 9.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.128 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 967' ' ' LEU . . . . . 0.58 HD23 HG12 ' A' ' 895' ' ' VAL . 36.5 mt -63.15 158.0 20.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.926 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 12.7 tptp -89.14 140.51 29.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 68.3 m -104.84 97.5 12.92 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.673 0.749 . . . . 0.0 110.874 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.93 -5.86 17.36 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.719 2.279 . . . . 0.0 112.376 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 51.8 p -40.17 127.41 2.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.878 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -171.31 -165.83 29.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.481 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -79.38 20.89 0.8 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.656 2.237 . . . . 0.0 112.357 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 34.9 p -57.09 -48.31 78.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 13.1 t -45.86 -46.65 15.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.86 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.529 -179.989 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 886' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 887' ' ' SER . . . . . . . . . . . . . 46.6 p -94.21 97.42 10.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.88 0.372 . . . . 0.0 110.929 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 888' ' ' SER . . . . . . . . . . . . . 19.3 m -102.15 118.1 36.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.871 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 889' ' ' GLY . . . . . . . . . . . . . . . -79.1 112.7 3.51 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.499 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 890' ' ' SER . . . . . . . . . . . . . 41.6 m -108.44 159.57 16.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.855 0.36 . . . . 0.0 110.87 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 891' ' ' SER . . . . . . . . . . . . . 60.3 m -122.82 146.08 47.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.844 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 135.4 -68.71 0.53 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.477 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 893' ' ' GLY . . . . . . . . . . . . . . . 99.94 47.25 1.78 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.52 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 894' ' ' THR . . . . . . . . . . . . . 97.5 m -83.65 121.91 27.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.825 0.345 . . . . 0.0 111.092 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 895' ' ' VAL . . . . . 0.448 ' CG1' ' HB1' ' A' ' 947' ' ' ALA . 17.2 m -115.0 142.48 27.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.113 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . 0.471 ' HG ' ' NE1' ' A' ' 938' ' ' TRP . 3.9 mp -91.58 142.64 27.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 897' ' ' VAL . . . . . 0.419 HG22 HG12 ' A' ' 965' ' ' ILE . 94.5 t -139.86 131.43 32.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.131 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 898' ' ' SER . . . . . . . . . . . . . 11.8 t -132.6 151.73 51.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.827 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 899' ' ' ILE . . . . . 0.476 HG22 HG12 ' A' ' 963' ' ' ILE . 3.8 pt -119.95 121.05 64.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.159 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 900' ' ' LYS . . . . . . . . . . . . . 6.0 tppt? -77.43 117.49 18.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 901' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 902' ' ' SER . 3.8 t -133.45 138.97 46.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.837 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 902' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 901' ' ' SER . 4.0 t -36.85 -55.89 0.88 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.839 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 903' ' ' LEU . . . . . . . . . . . . . 16.9 mt -98.53 154.11 37.67 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.612 0.72 . . . . 0.0 110.913 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 904' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -77.47 -33.86 2.25 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.727 2.285 . . . . 0.0 112.363 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 905' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -60.45 -10.31 4.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.9 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 906' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -104.82 15.26 28.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 907' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -68.37 -23.43 64.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 908' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -66.54 150.82 48.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 909' ' ' PHE . . . . . 0.592 ' CE1' ' HB2' ' A' ' 937' ' ' MET . 24.6 m-85 -96.25 131.05 43.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 910' ' ' ASP . . . . . 0.66 ' H ' HD12 ' A' ' 913' ' ' LEU . 23.6 t70 -89.89 168.3 12.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.85 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 911' ' ' ASP . . . . . 0.409 ' N ' ' CG ' ' A' ' 910' ' ' ASP . 0.7 OUTLIER -49.04 -45.89 43.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 912' ' ' ALA . . . . . . . . . . . . . . . -61.46 -58.27 8.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.095 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 913' ' ' LEU . . . . . 0.855 HD21 ' HD2' ' A' ' 961' ' ' ARG . 84.3 mt -47.84 -47.18 31.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.88 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 914' ' ' ILE . . . . . . . . . . . . . 57.3 mt -66.47 -64.28 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.118 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 915' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -39.34 -61.93 0.73 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 916' ' ' GLU . . . . . 0.4 ' HG3' HD11 ' A' ' 959' ' ' LEU . 30.7 mm-40 -47.83 -57.25 5.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.934 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 917' ' ' LEU . . . . . 0.98 HD21 HD13 ' A' ' 963' ' ' ILE . 33.8 mt -41.73 -56.91 2.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 918' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 917' ' ' LEU . 37.5 mt -36.11 -57.54 0.7 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 919' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -54.83 -42.78 72.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 920' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 917' ' ' LEU . 60.5 mm-40 -61.17 -39.14 89.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.913 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 921' ' ' PHE . . . . . 0.54 ' CE2' ' HB3' ' A' ' 917' ' ' LEU . 22.0 m-85 -71.34 -34.56 70.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 922' ' ' ALA . . . . . . . . . . . . . . . -60.62 -34.52 74.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.086 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 923' ' ' SER . . . . . . . . . . . . . 1.8 m -47.24 -23.72 0.59 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.851 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 924' ' ' PHE . . . . . 0.558 ' N ' ' CD1' ' A' ' 924' ' ' PHE . 0.6 OUTLIER -125.42 -55.97 1.53 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.896 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -127.56 141.23 12.45 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.469 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 926' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -83.55 100.26 10.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.88 0.372 . . . . 0.0 110.884 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 927' ' ' VAL . . . . . . . . . . . . . 60.9 t -53.14 146.32 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.134 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 928' ' ' ILE . . . . . . . . . . . . . 29.1 pt -124.85 -37.38 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.159 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 929' ' ' LEU . . . . . . . . . . . . . 22.2 tp -139.7 146.88 40.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.964 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 930' ' ' ILE . . . . . . . . . . . . . 64.1 mt -136.23 129.26 46.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.119 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 931' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -118.81 124.7 47.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 932' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -90.96 119.53 31.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.862 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 933' ' ' VAL . . . . . 0.638 HG21 ' NE1' ' A' ' 938' ' ' TRP . 9.0 t -85.64 157.27 3.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.148 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 934' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 933' ' ' VAL . 65.7 mt-10 -33.77 -50.34 0.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.871 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 935' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.76 -26.2 3.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.841 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 936' ' ' LYS . . . . . 0.41 ' O ' ' N ' ' A' ' 933' ' ' VAL . 1.0 OUTLIER -96.48 173.2 7.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 -179.984 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 937' ' ' MET . . . . . 0.592 ' HB2' ' CE1' ' A' ' 909' ' ' PHE . 18.8 ttt -134.8 110.39 9.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.848 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 938' ' ' TRP . . . . . 0.638 ' NE1' HG21 ' A' ' 933' ' ' VAL . 43.8 m0 -89.51 152.31 21.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.939 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 939' ' ' VAL . . . . . 0.441 HG12 ' CE1' ' A' ' 941' ' ' PHE . 93.0 t -140.99 123.57 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.127 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 940' ' ' THR . . . . . . . . . . . . . 18.8 m -90.4 150.04 22.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.137 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 941' ' ' PHE . . . . . 0.441 ' CE1' HG12 ' A' ' 939' ' ' VAL . 10.8 m-85 -129.41 150.49 50.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.891 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 942' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 941' ' ' PHE . 21.7 tp -37.09 -59.62 0.71 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.909 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 943' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -130.41 163.26 27.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 944' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 947' ' ' ALA . . . -55.49 -56.84 21.55 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.5 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 945' ' ' SER . . . . . 0.524 ' HA ' HD12 ' A' ' 948' ' ' LEU . 68.6 p -39.57 -48.71 2.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.889 0.376 . . . . 0.0 110.836 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 946' ' ' SER . . . . . . . . . . . . . 18.3 m -54.14 -37.93 64.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 947' ' ' ALA . . . . . 0.448 ' HB1' ' CG1' ' A' ' 895' ' ' VAL . . . -74.57 -13.81 60.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.098 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 948' ' ' LEU . . . . . 0.524 HD12 ' HA ' ' A' ' 945' ' ' SER . 26.7 mt -89.29 -21.85 22.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 949' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -88.77 -44.85 10.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.91 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 950' ' ' VAL . . . . . . . . . . . . . 7.3 p -52.45 -22.76 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.109 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 951' ' ' LEU . . . . . . . . . . . . . 31.1 mt -48.68 -26.65 2.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.904 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 952' ' ' SER . . . . . . . . . . . . . 26.3 m -52.78 -16.14 0.91 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.889 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 953' ' ' LEU . . . . . . . . . . . . . 36.5 mt -92.13 16.48 11.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.865 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 954' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.41 119.0 13.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 955' ' ' GLY . . . . . . . . . . . . . . . 87.8 -27.92 6.28 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.499 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 956' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -38.61 127.52 1.49 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.73 0.3 . . . . 0.0 110.896 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 957' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -97.17 122.87 40.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.904 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 958' ' ' LEU . . . . . . . . . . . . . 14.2 tp -132.91 156.75 46.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 959' ' ' LEU . . . . . 0.453 ' O ' ' CG ' ' A' ' 960' ' ' ASN . 24.9 mt 42.19 49.23 4.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.931 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 960' ' ' ASN . . . . . 0.453 ' CG ' ' O ' ' A' ' 959' ' ' LEU . 17.0 p30 47.53 38.94 8.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 961' ' ' ARG . . . . . 0.855 ' HD2' HD21 ' A' ' 913' ' ' LEU . 49.7 mtt85 -146.88 112.0 5.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.871 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 962' ' ' THR . . . . . . . . . . . . . 55.8 m -64.9 119.52 10.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.127 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 963' ' ' ILE . . . . . 0.98 HD13 HD21 ' A' ' 917' ' ' LEU . 89.1 mt -102.12 145.65 11.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.115 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 964' ' ' THR . . . . . . . . . . . . . 7.6 m -130.43 110.26 11.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.126 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 965' ' ' ILE . . . . . 0.419 HG12 HG22 ' A' ' 897' ' ' VAL . 62.5 mt -96.64 136.61 26.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.146 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 966' ' ' ALA . . . . . . . . . . . . . . . -147.72 134.47 20.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.136 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 967' ' ' LEU . . . . . . . . . . . . . 26.9 mt -64.54 155.75 32.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.927 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 968' ' ' LYS . . . . . . . . . . . . . 11.9 tptp -94.35 -70.52 0.7 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.883 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 969' ' ' SER . . . . . . . . . . . . . 99.6 p -42.35 146.5 0.68 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.657 0.741 . . . . 0.0 110.849 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 970' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.69 -49.53 10.67 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.711 2.274 . . . . 0.0 112.354 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 971' ' ' SER . . . . . . . . . . . . . 28.5 t -161.39 122.37 2.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 972' ' ' GLY . . . . . . . . . . . . . . . -46.53 146.25 3.4 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.498 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 973' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -77.42 100.48 1.4 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.711 2.274 . . . . 0.0 112.344 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 48.6 m -128.28 144.88 51.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.862 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 975' ' ' SER . . . . . . . . . . . . . 48.5 p -85.7 -46.86 10.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.857 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 976' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.372 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.487 179.988 . . . . . . . . 0 0 . 1 stop_ save_